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Subfertility in grazing dairy cows: insights from a multi-omic 




Dairy cow subfertility is a worldwide issue arising from multiple factors. One of its main manifestations 
is around 30% early pregnancy loss by day 7 of gestation in seasonal, pasture-grazed dairy herds. 
Pregnancy loss has a substantial impact on the seasonal grazing dairy cow as the mating period is short 
(six to nine weeks in length), and cows need to conceive while under strong metabolic stress to support 
their peak milk production. Factors in the uterine luminal fluid (ULF), on which the early embryo 
depends for sustenance and growth, appear to determine a portion of early pregnancy losses, and it 
is hypothesised that those factors improve with increasing days postpartum. 
The present study examined the molecular composition of uterine luminal fluid (ULF) in day-7 pregnant 
dairy cows. Eighty cows were inseminated, and their uteri flushed 7 days later at two different oestrus 
cycles within three months of calving. Embryos recovered in those flushing samples were graded to 
estimate their potential viability and relate it to uterine suitability for pregnancy. The molecular milieu 
of ULF was investigated using three techniques: label-free quantitative proteomic analysis by LC-
MS/MS, targeted metabolomic analysis by GC-MS/MS, and metabolic fingerprinting by REIMS (direct 
infusion mass spectrometry). For a more comprehensive perspective of the animals’ conditions, 
potentially relevant variables at the cow-level were also measured and analysed. Moreover, links 
between embryo quality and differentially abundant molecules were investigated at the biochemical 
pathway level and by uni- and multivariate analyses, to screen for potential biomarkers of uterine 




Clear indications of differences across time postpartum were observed in the cow-level variables, 
signifying contrasting metabolic conditions between early- and mid-postpartum, with interaction 
between the actual time (days postpartum) and the number of oestrus events (oestrus after calving). 
Concomitantly, 33% more good- and excellent-quality embryos were found with increased days and 
oestrus cycles postpartum, reflecting a general positive effect of postpartum recovery on reproductive 
function.  
A total of 1504 proteins were detected and measured in ULF, of which 472 had not been previously 
reported in this fluid. The abundance of 20 proteins varied relating to embryo quality, with various 
suggested roles in uterine function and embryogenesis-related pathways. Some of those proteins were 
macrophage migration inhibitory factor, phospholipase A2, myostatin, alpha-1-antiproteinase and 
prostaglandin reductase 1, involved in immune and development processes. Two proteins, cystatin C 
and pyruvate kinase M2, were more abundant in ULF with degenerate embryos (4-16 cells) and thus 
were considered promising protein biomarker candidates.  
For biological validation, the effect of those proteins was tested on in vitro embryo culture system, 
together with cathepsin B, a protease potentially relevant to embryo quality. Different concentrations 
of each test protein were added to culture media; their effect was assessed based on development to 
tight morula and blastocyst stages, as well as embryo grade. Some evidence of a positive (of cystatin 
C) or negative (of pyruvate kinase M) effect on embryo development was observed. 
Targeted metabolomic analysis of ULF showed 31 compounds’ abundance varying along days and/or 
oestrus cycles after calving, with most (n = 25) decreasing with increasing days postpartum. These were 
chiefly carbohydrates (e.g. xylulose, ribose, fructose), and organic acids (e.g. malic, ethylmalonic and 
glyceric acids). Based on metabolomics data, pathways dysregulated at early postpartum included 
glycine, serine, and threonine metabolism, glycerolipid metabolism, beta alanine metabolism, pentose 
and glucuronate interconversions, cysteine, and methionine metabolism. Joint pathway analysis of 
proteomics and metabolomics data uncovered differentially regulated metabolic, signalling, and 
immune processes across oestrus cycles. Furthermore, dysregulation of protein metabolism and 
EGFR1 signalling in ULF appear to influence embryo development past the 16-cell stage. 
A method for rapid metabolic fingerprinting based on a novel mass spectrometry technology (rapid 
evaporative ionisation mass spectrometry, REIMS) was tested for potential diagnostic applications. The 
method was successful at obtaining a distinct spectral profile of ULF, however its implementation for 




Multivariate analyses (PCA and PLS-DA) of proteomic and metabolomic data suggested that the 
molecular microenvironment of the uterus is determined by the interaction of multiple factors at the 
animal level, and modelling of these intricate mechanisms is more challenging than previously thought.  
In conclusion, this project’s results advanced the characterisation of the molecular environment of 
bovine ULF. This study also provided evidence of links between molecular abundance of proteins and 
metabolites in the uterine environment to cow postpartum recovery and putatively to embryo quality, 
pinpointing metabolic and signalling pathways as potential mechanisms of action. The relevance of 
these molecular changes for diagnosing pregnancy suitability requires further research, of which 
concurrent analysis of follicular and uterine fluids at early postpartum is particularly promising. 
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AA: amino acid 
ANOVA: analysis of variance 
AU: arbitrary units 
BCS: body condition score 
BHB: beta hydroxybutyrate 
CatB: cathepsin B 
CysC: cystatin C 
CL: corpus luteum 
CV: coefficient of variation 
Dpp: days postpartum 
DTT: dithiothreitol 
E2: oestradiol 
EGFR1: epithelial growth factor receptor 1 
ESPL: exclusion scheduled precursor list 
ET: embryo transfer 
EV: extracellular vesicle 
FDR: false discovery rate, as defined by Benjamini and Hochberg (1995) 
FF: follicular fluid 
GC-MS/MS: gas chromatography coupled with tandem mass-spectrometry 
GO: gene ontology 





IFNT: interferon tau 
IMPaLA: integrated molecular pathway level analysis online tool 
KEGG: Kyoto Encyclopaedia of Genes and Genomes 
LC-MS/MS: liquid chromatography coupled with tandem mass-spectrometry 
LFQ: label-free quantitation 
LC-MS: liquid chromatography coupled with (single) mass-spectrometry 
LOESS: locally weighted scatter-plot smoother 
miRNA: micro ribonucleic acid 
m/z: mass over charge  
NCBI: National Centre for Biotechnology Information 
NEFA: non-esterified fatty acids 
OC: oestrus after calving (1 or 3) 
OLF: oviduct luminal fluid 
O-PLSDA: orthogonal partial least squares discriminant analysis 
P4: progesterone 
PCA: principal component analysis 
PKM(2): pyruvate kinase subtype M(2) 
PTM: posttranslational modifications 
Q2: goodness of prediction (predicted variation) 
QC: quality control 
QC-RFSC: quality control random forests signal correction 
R2: goodness of fit (explained variation) 




Rt: retention time 
SDC: sodium deoxycholate 
sPLSDA: sparse partial least squares discriminant analysis 
SPS: (uterine) size and position score 
TCEP: Tris (2-carboxyethyl) phosphine 
TIC: total ion chromatogram 
ULF: uterine luminal fluid 
 
Trials, experiments, and other work-specific terms 
 
I: grade 1 embryos (tight morulae and blastocysts) 
II: grade 2 embryos (tight morulae and blastocysts) 
III: grade 3 embryos (tight morulae and blastocysts) 
IV: 4- to 16-cell embryos (no 2-cell embryo was found in the present study) 
V: 1- cell embryos or oocytes 
VI: equivalent to NR, a class in the EQ1b system 
Exp M1: Metabolomics experiment 1, protocol optimisation 
Exp M2: Metabolomics experiment 2, testing heavy proline as a dilution tracer 
Exp M3: Metabolomics experiment 3, preliminary REIMS metabolomic fingerprinting 
Exp M4: Metabolomics experiment 4, main GC-MS/MS metabolomics experiment  
Exp M5: Metabolomics experiment 5, main REIMS metabolomic fingerprinting experiment 
Exp P1: Proteomics experiment 1, protocol optimisation 




Exp P3: Proteomics experiment 3, main proteomics trial 
Exp E1: Embryo in vitro culture experiment 1, supplementing cystatin C (CysC) 
Exp E2: Embryo in vitro culture experiment 2, supplementing cathepsin B (CatB) 
Exp E3: Embryo in vitro culture experiment 3, supplementing pyruvate kinase M (PKM) 
EQ1: embryo quality classification 1 (five groups, I-V) 
EQ1b: embryo quality classification 1 (like EQ1, plus including ULF with no embryo recovered as “VI”) 
EQ2: embryo quality classification 2, with two groups, I (optimal) vs III-V (suboptimal) 
EQ3 embryo quality classification 3, with two groups, I-III (pregnant) vs IV-V (non-pregnant)  
Farm Trial 1: small preliminary trial to test the use of tracer. 
Farm Trial 2: main trial (2017) 
Farm Trial 3: main trial (2018) 
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1.1 Background – dairy cow subfertility 
Dairy cows’ reproductive performance has been on the decline in the last decades in New Zealand 
and all over the world, and the causes are still being debated (Lucy 2001, Thatcher et al. 2011). This 
generalised impaired fertility is related to changes in cow physiology and management associated 
with increased milk production (LeBlanc 2010). More specifically, there seems to be a combination of 
various physiological and management factors at play, including: 1) genetic (breed, strain within 
breed), 2) diet and management, 3) endocrine and 4) reproductive tract factors (Evans and Walsh 
2011). The latter are the focus of the present investigation, specifically the uterine luminal fluid 
(ULF). 
The dairy industry is one of the leading economic sectors in New Zealand, accounting for a 
contribution of 8.2 billion dollars to the country’s total GDP (Anonymous 2018). It is subject to 
political and commercial pressure to improve environmental performance, while required to stay 
competitive in the international market (von Keyserlingk et al. 2013). Therefore, efforts into 
optimising all aspects of the industry need to be addressed, including management and genetic 
factors (Jay and Morad 2007).  
There has been a worldwide increase of milk production starting in the early 20th century (Royal et 
al. 2000). This increase is reflected in some of the most common parameters to measure milk 
production, namely total milk volume and milk solids (protein and fat) weight. These parameters 
differ in their significance: New Zealand’s pricing system is based upon milk solids weight, with a 
deduction made for volume produced (Harris and Kolver 2001). In New Zealand, milk solids weight 
per cow per lactation increased 43% (259 kg/y to 372 kg/y) from 1992/1993 to 2008 (NZ Dairy Report 
Anonymous 2018). Concomitant to this, the rate of cows in-calf within six weeks of the seasonal 
planned start of mating decreased by about 20% (Burke et al. 2008).  
Substantial economic losses, management difficulties and animal welfare concerns (Lucy 2001) have 
motivated a great deal of research to unravel the mechanisms of reduced fertility. Considerable 
progress to halt the decline in dairy cow fertility has been made in recent years using genetic 
approaches (Berglund 2008, García-Ruiz et al. 2016), but genetic variation in female fertility has a 




1.1.1 Key events of early pregnancy in cow 
Lonergan and Forde (2014) provide a succinct description of the main events taking place before 
embryo implantation in cattle (Figure 1-1). In brief, embryonic development starts after ovulation 
and fertilisation of the oocyte, which takes place in the oviduct. The resulting embryo migrates 
towards the uterus while increasing in cell number without increasing in volume through a series of 
cleavage stages. The bovine embryo enters the uterus 4 to 5 days after fertilisation at approximately 
the 16-cell to morula stage. The morula stage embryo undergoes compaction before completing its 
first lineage decision at the blastocyst stage. At this stage, approximately 7 days after fertilization, it 
consists of a trophectoderm which develops further to form the placenta, and an inner cell mass that 
eventually becomes the foetus. Around day 9, the spherical blastocyst hatches from the zona 
pellucida and commences to grow and change its shape from spherical to ovoid with the inner cell 
mass changing to a flattened embryonic disc. From day 12 to 14, the elongating embryo starts a 
transition period preceding a rapid increase in length: the 2 mm ovoid conceptus at day 13 reaches a 
length of around 60 mm by day 16, although considerable variation is observed between individuals 
(Berg et al. 2010, Ribeiro et al. 2016b). It is at this stage that the embryo begins gastrulation and the 
third cell lineage (the mesoderm) appears. Up to day 19, conceptuses (which comprise the embryo 
and extra-embryonic membranes) can be recovered by simple uterine flushing, but after that point 
the elongated conceptus starts to implant, its trophectoderm attaching to the luminal epithelium of 
the endometrium (Lonergan and Forde 2014). Throughout this period, the endometrial tissue also 
goes through increasingly conspicuous changes that allow for embryonic development and posterior 
implantation (Forde et al. 2011, Forde et al. 2012a), and constitutes an interdependent system with 
the endometrium and the extracellular fluid (uterine luminal fluid, ULF) that permeates them, 
reviewed in the next section. These changes of endometrial tissue modify the ULF biomolecular 
background (Rodriguez-Alonso, 2020a) and are important for the context of this research. 
 
 
Figure 1-1 Stages of development of pre-fertilisation and early pregnancy. Adapted from Graf et al. 




1.1.2 Determinants of reproductive success 
The development and birth of a healthy calf is a long process that depends on three main elements. 
These are paternal (comprehensively reviewed by Ceciliani et al. 2017), maternal, and the embryo 
itself (Artus et al. 2020). The relevance of this distinction between maternal and embryo factors is 
illustrated by studies assessing their relative effects: a previous meta-analysis of 46 sets of data 
comprising 4560 recipient cows using either embryo transfer or animals inseminated and 
concurrently receiving embryo transfer, demonstrated clear independent effects of embryos and 
recipient cows on embryo survival to parturition (McMillan 1998). More recently, Maillo et al. (2012) 
and Rizos et al. (2010) transferred good quality embryos synchronised with the recipient’s day of 
oestrus -at either day 2 or day 7-; five or seven days after, they found embryos of markedly better 
quality in heifers and dry cows than in lactating cows, demonstrating the strong effect of the 
oviductal and uterine environments on embryo growth. Complementary molecular evidence of the 
same phenomenon was supplied by Moraes et al. (2018a), who transferred in vivo produced day-7 
high-quality embryos to high and lower fertility beef heifers, describing substantial differences in the 
uterine transcriptomics of these animal groups at day 17 (ten days after embryo transfer, i.e. ET). 
These studies provide decisive evidence of the role of the uterine environment in pregnancy success, 
to a large extent independent of embryo quality (Lonergan et al. 2016).  
1.1.3 Challenges for the postpartum dairy cow 
Fertility problems can and should be considered from long before mating and conception. Coming 
into oestrus is arguably the first stage on the way to delivering a healthy calf; indeed, a prolonged 
post-partum anovulatory interval is considered a major form of infertility in New Zealand dairy cattle 
(McNaughton et al. 2003). This is especially critical in New Zealand and other countries with seasonal 
grazing dairying systems in which a circannual cycle needs to be maintained in order to synchronise 
feed requirements with pasture availability over the course of the year (Figure 1-2) (Roche et al. 
2011). The peripartum and early postpartum period (one month before to two-three months after 
calving) are indeed the most critical period for the cows’ health, in which their immune response 
needs to be strong enough to clear uterine pathogens while avoiding a hyperinflammatory state that 
is detrimental for physiological recovery and subsequent pregnancy (LeBlanc 2014). Along with the 
immune challenges, cows undergo high levels of metabolic stress due to much of their energy being 
diverted from physiological sustenance and recovery postpartum to milk production (Chagas et al. 
2007). This substantial metabolic challenge results in a negative energy balance, whereby more 





Figure 1-2 Schematic relationship between dairy cow feed requirements and herbal production, 
assuming a stocking rate of 3.3 cows/ha. To maintain a circannual (yearly) cycle to 
synchronise peaks in feed requirement and grass availability, cows need to get 
pregnant as soon as possible after calving. AI: artificial insemination. Modified from 
Roche et al. (2011). 
The consequences of negative energy balance often include mobilisation of fat reserves and ketosis, 
indicated by loss of body condition score (BCS; Roche et al. 2009) and by higher blood concentrations 
of non-esterified fatty acids and beta-hydroxybutyrate, respectively (LeBlanc et al. 2011). Another 
aspect related to energetic disequilibrium is realised by lower concentrations of circulating glucose, 
diverted to milk production (Lucy et al. 2014), in what is called “uncoupling of the somatotropic axis” 
(Lucy et al. 2001). This entails ensuing low concentrations of insulin and high concentrations of 
growth hormone (“GH”, also called somatotropin), while decreasing expression of GH receptors (Lucy 
et al. 2001). A reduced number of GH receptors results in diminished secretion of insulin-like growth 
factor 1 (IGF1) (Lucy et al. 2014), a key hormonal link between metabolism and reproductive function 
(Kim 2014). IGF1 is instrumental in growth regulation in most mammal tissues (Jones and Clemmons 
1995) and fundamental in postpartum recovery of reproductive functions (Garcia-Garcia 2012), 
hence the magnitude of this somatotropic axis destabilisation on resumption of ovulation (Chagas et 
al. 2007). 
In addition to physiologically recovering from the adverse metabolic situation detailed, cows need to 
undergo uterine involution before their reproductive tract can successfully support embryo 
development (Breuel et al. 1993). This process is delayed by the metabolic and endocrine issues just 




seasonal grazing systems like New Zealand cows must get pregnant by 85-90 days postpartum (dpp) 
to keep the annual calving-to-calving interval (Scully et al. 2013, Roche et al. 2017). While these 
morphological aspects have been well characterised, molecular changes in the reproductive tract 
along early postpartum and their relationship with resumption of cyclicity are still poorly understood 
(Wathes et al. 2009, Ribeiro et al. 2016a, Bauersachs et al. 2017, Forde et al. 2017, Edelhoff et al. 
2020). 
Suitability for pregnancy across the postpartum period 
Due to the strong and often long-lasting effect of peripartum stress on the cow’s health discussed, a 
trend for reproductive performance to improve later in the postpartum period is generally seen 
(Roche et al. 2009, Ferraz et al. 2016).  
A classic study examining the effect of BCS on high producing dairy cows was conducted by Carvalho 
et al. (2014). In their first experiment, higher (≥2.75) versus lower (≤2.50) body condition score (BCS) 
at time of artificial insemination (AI) resulted in higher pregnancy rates (Carvalho et al. 2014). In their 
second experiment, 70-day pregnancy rates of cows that lost, maintained, or gained BCS from calving 
to 21 dpp were 23%, 36%, and 78%, respectively, but no effect of BCS changes was observed in one 
of the farms (Carvalho et al. 2014). In their third experiment, super-ovulated cows that lost the most 
weight from calving to 63 dpp had a significantly lower proportion of transferable embryos and 
higher proportion of degenerate embryos, all at day 7. This implies that in their animal model, body 
weight loss (as a result of negative energy balance) had a more pivotal effect on pregnancy than 
absolute body weight or BCS when these are within the intermediate range (2.25-3:25 in a 5-point 
scale). Santos et al. (2009) found a significant effect of BCS change between calving and AI (at around 
65 dpp), but also of absolute values at each timepoint. Finally, Vasconcelos et al. (2006) compared 
pregnancy rates of lactating high producing dairy cows that underwent AI or ET (from non-lactating 
Holstein donors) from 50 to >500 dpp. They found 40% higher rates of pregnancy at day 25 in the ET 
vs AI group (59% vs 36%) in what may indicate lactation effects on oocytes; however, higher milk 
production was also associated to higher embryo death after ET (Vasconcelos et al. 2006) and thus 
presumably on uterine effects. Leroy et al. (2005a) described reduced pregnancy rates following ET 
of high producing lactating cows around a year after calving, showing that milk production can affect 
fertility independently from postpartum stress. In some cases, no effect of dpp on embryo survival 
was observed, though only after an average of 65 (Ferraz et al. 2016), 80 (Chebel et al. 2008) and 165 
(Demetrio et al. 2007) dpp. Importantly, ET is normally conducted with day-7 embryos to 
synchronised recipients  (Chebel et al. 2008) and for research purposes (Demetrio et al. 2007, Block 




growth, oviductal and early uterine phases are all bypassed, and determining the crucial steps is not 
possible (Vasconcelos et al. 2006, Demetrio et al. 2007). 
Bates and Saldias (2019) showed a positive effect of higher dpp on pregnancy rates independent of 
BCS. This may be related to presence of clinical or subclinical conditions as suggested by (Ribeiro et 
al. 2016a). Finally, it may be that either undergoing pregnancy, lactation, or both, has long-lasting 
detrimental effects on fertility compared to nulliparous heifers, regardless of lack of metabolic stress 
at the time of AI (Berg et al. 2010). 
Hormonal interventions 
As a way of simplifying reproductive management and often remediating subfertility and infertility in 
cows, hormonal treatments are commonly implemented (Santos et al. 2004, Lima et al. 2010). 
Macmillan (2010) provides an excellent description of the characteristics and evolution of 
reproductive synchronisation technologies. Briefly, treatments mimic the natural patterns of 
hormonal fluctuations across oestrus and typically consist of luteolytic compounds (prostaglandin F2-
alpha or its synthetic analogues, cloprostenol) i.e. to induce luteolysis, sometimes combined with 
gonadotropin-releasing hormone (GnRH) analogues before and after to synchronise oestrus 
(Macmillan 2010). In the case of anoestrus lactating cows (i.e. that do not resume cycling), an 
additional therapeutic intervention is implemented by intravaginally placing a controlled internal 
drug release (CIDR) device four to nine days after insemination, for six to 12 days; the mechanisms by 
which this locally-supplied progesterone increases pregnancy rates are unclear (Macmillan and 
Peterson 1993). Evidence for effects of progesterone supplementation ranging from positive to null 
(Van Cleeff et al. 1992, Van Cleeff et al. 1996, Larson et al. 2007, Lamb et al. 2010, Herlihy et al. 2012) 
and negative (Santos et al. 2004, Saint-Dizier et al. 2019) has emerged. In normal physiological 
conditions, numerous molecular processes appear to be regulated by progesterone that are likely to 
determine fertility (Forde et al. 2010, Forde et al. 2012b, França et al. 2017, Simintiras et al. 2019a, b, 
Simintiras et al. 2019c). One important process dependent on progesterone is ULF secretion, which in 
turns influences embryo growth and its production of interferon tau (Lucy et al. 2014), examined 
later. 
Periods of reproductive wastage  
Wiltbank et al. (2016) describes five pivotal stages of pregnancy loss. Firstly, fertilisation failure often 
occurs because of heat stress or high progesterone concentrations near the time of insemination due 
to incomplete lysis of the corpus luteum (CL) (Pugliesi et al. 2014) and can represent up to 20% of the 
losses (Ryan et al. 1993). In the next pivotal stage (day 0-7 after insemination), which accounts for 30 




(Sartori et al. 2002) and postpartum metabolic issues (McDougall et al. 2011). During the following 
stages the embryo failures tend to be lower, and are associated with ill-timed elongation and 
imbalances in ULF (Stage 3, day 8-day 28 after AI, 20-30% losses), inadequate placentome formation 
and vascular development problems (Stage 4, second month, 5-20% losses) and unilateral twins 
(Stage 5, third month, 2% losses), as reviewed by Wiltbank et al. (2016).  
Uterine, oviductal and follicular fluids 
Uterine and oviductal luminal fluids 
Systemic determinants of bovine fertility have been extensively discussed by Garnsworthy et al. 
(2008) with a focus on the interaction between feeding, lactation status, metabolic balance and 
hormones. Those aspects certainly influence fertility, but an understanding of the local conditions of 
the reproductive tract is crucial. A review by Evans and Walsh (2011) highlighted the importance of 
the uterine microenvironment, emphasising the role of factors such as presence of pathogenic 
bacteria and concentration of hormones and other important molecules.  
There is vast evidence that the local conditions in the oviduct and uterus, including chemical 
composition and viscosity of fluids, temperature gradients and ciliary motility (Hunter 2012) affect 
reproductive outcomes in several ways (Rodríguez-Alonso et al. 2020a). For instance, reproductive 
biofluids exert a considerable effect on sperm transport and thus can substantially influence 
fertilisation (reviewed by Salilew-Wondim et al. 2012). The oviductal isthmus cells also capacitate 
spermatozoa, thus augmenting the efficiency of the fertilisation process and reducing the likelihood 
of polyspermy (Wiltbank et al. 2016). Recent studies continue to reveal other important roles of the 
oviduct on early pregnancy, showing physiologically relevant changes in its molecular composition 
across the oestrus cycle (Lamy et al. 2016a, Lamy et al. 2016b, Banliat et al. 2019b), a positive effect 
of oviductal hormone supplementation on embryos cultured in vitro (Banliat et al. 2019a), and 
interactions between OLF proteins and the early bovine embryo (Banliat et al. 2020). However, 
sampling the bovine oviduct in vivo is notoriously more challenging than sampling ULF, with only one 
technique reported recently by Papp et al. (2019). Another important consideration is that the 
oviductal environment has been replicated much more successfully than that of the uterus: transfer 
of embryos cultured in vitro up to day 7 (i.e. during the period when embryos develop in the oviduct 
and early uterine phase) generally results in successful pregnancies (Lonergan and Forde 2014), 
whereas no in vitro culture system has been able to physiologically emulate the elongation phase 
that can only occur in a later uterine phase (Ramos-Ibeas et al. 2020b, Isaac and Pfeffer 2021). These 




Reproductive biofluids such as OLF and especially ULF surround and provide nourishment to the early 
conceptus (embryo and accompanying placental structures) up to implantation around day 19 
(Spencer et al. 2016). Both biofluids contain many kinds of molecules, such as proteins (including 
enzymes, growth factors and cytokines), amino acids, sugars, lipids and inorganic ions (reviewed by 
Roberts and Bazer 1988). The precise origin of molecules found in these fluids is often uncertain, but 
is likely a result of several processes: active secretion from endometrial tissues (Roberts and Bazer 
1988) and the conceptus  (Forde and Lonergan 2017), as well as molecules derived from epithelial 
cell renewal and apoptosis (Mondéjar et al. 2012) and maternal blood (Faulkner et al. 2012). When 
considering that experimental procedures are required to characterise these fluids, another 
component is added to the mixture: molecules released into the ULF because of damage due to 
sampling (Papp et al. 2019). These processes are further described next. 
Concerning molecules actively released to ULF by endometrium cells, two processes intervene: one 
regulated by both endocrine mechanisms independent of the presence of an embryo, i.e. hormonal 
fluctuations that are determined by the oestrus cycle (Forde et al. 2014a, Tribulo et al. 2019) and by 
metabolic status (Harlow et al. 2018), and the paracrine influence of an embryo (Sponchiado et al. 
2017). In that regard, a first stage of embryo-maternal communication in uterus has been shown to 
commence at least at day 7 after conception (Sponchiado et al. 2017), with limited evidence of 
oviductal transcriptome differences induced by embryo presence in bovine at day 3 (Maillo et al. 
2015, Rodríguez-Alonso et al. 2020a) and by porcine sperm at insemination (Almiñana et al. 2014). A 
second stage of embryo-maternal communication is the period classically known as “maternal 
recognition of pregnancy” (Spencer et al. 2016), when significant molecular and physiological 
changes start to occur in the uterus as a consequence of the presence of an embryo (Mamo et al. 
2012). This stage is triggered by interferon tau (IFNT) -the most widely known pregnancy recognition 
molecule in cows and sheep- signalling at around day 14 of pregnancy (Robinson et al. 2006). Blood 
components are known to be exuded to ULF through the uterine epithelium (Hunter 2012), but 
secretions from the endometrial tissues are still indispensable for pregnancy success, as evidenced 
by the fact that uterine gland knock-out ewes failed to sustain pregnancies after day 5 (Gray et al. 
2002). A remarkable contribution to elucidating this was the work of Faulkner et al. (2012), which 
showed that many proteins are differentially abundant in bovine ULF compared to plasma. 
Hugentobler et al. (2007a,b; 2008) also found different concentrations of amino acids, energy 
substrates and ions respectively, providing evidence that ULF is not simply a by-product of blood, but 
that active regulation is involved to regulate its composition. 
The uterine environment also differs between nulliparous (heifers) and multiparous (second or third 




nulliparous (i.e. virgin heifers) and lactating moderately productive dairy cows at day 2 after 
ovulation. Upon flushing at day 7, they found that more embryos were recovered from nulliparous 
than lactating cows and those tended to be of better quality, showing that a percentage of the losses 
depends on oviductal and uterine environment and that the uterus of a lactating dairy cow may be 
less capable of supporting early embryo development (Rizos et al. 2010). 
Follicular fluid and oocyte quality 
Another crucial determinant of reproductive success is oocyte quality (Camargo et al. 2006). Oocyte 
growth inside the follicle is a slow process that lasts about six months in cattle (Lussier et al. 1987). 
During this period, the oocyte acquires the competence to undergo meiotic maturation by an 
interaction between the oocyte and the theca and granulosa cells (Senbon et al. 2003) and 
accumulates transcripts and proteins that will guide the maturation, fertilisation, and initiate embryo 
development (Kruip et al. 2000). Oocyte quality is related to its follicular environment and reflects 
events and conditions occurring presently as well as months earlier, and this is particularly relevant 
considering the impact of diseases: both those systemic and local can affect reproduction well after 
disease resolution (Gilbert 2019). This influence does not only occur in the uterine environment, but 
also at the level of ovary and oocyte production (Gilbert 2019). In fact, bacterial lipopolysaccharide or 
endotoxin (a harmful compound produced by many microorganisms) due to infection can be found in 
follicular fluid in higher concentrations than in systemic circulation or even in the infected uterus 
(Groebner et al. 2011b, Gilbert 2019). 
Due to the abovementioned relevance of the local conditions of the ovaries and uterus, different 
experimental approaches can be taken. For instance, some studies have studied endometrial tissue 
samples in vivo (Katagiri and Moriyoshi 2013) or post-mortem (Berendt et al. 2005, Belaz et al. 2016), 
or in a simpler and less invasive strategy, through analysis of uterine flushings (ULF) (Muñoz et al. 
2012, Forde et al. 2014a). Additionally, analysing ULF is a convenient approach because it lacks high 
abundance cellular proteins and has a much less complex proteome, compared to endometrial tissue 
(Spencer et al. 2008).  
Interplay of fluids within the reproductive tract 
To date, little research has been reported on the specific molecular interdependence of oviduct and 
uterine fluids. The exchange of fluids within the reproductive tract is complex; fluid transfer has been 
shown between OLF and ULF at the utero-tubal junction (Hunter et al. 2011), by a counter-current 
mechanism between ovary, oviduct, uterus and blood (Einer-Jensen and Hunter 2005) and likely also 
through peritoneal fluid (Hunter et al. 2007). Research by Hugentobler et al. (2007a,b; 2008; 2010) 




across animals, time of oestrus, and with progesterone concentration in blood. Therefore, although 
changes at the animal level are likely to affect sections of the reproductive tract following similar 
trends (Leroy et al. 2018, Jordaens et al. 2020), inferences between phenomena occurring in OLF and 
ULF must be done with caution.  
1.1.4 Omics technologies and biomarker discovery 
To understand the factors underlying this and other physiological conundrums, the trend in clinical 
and veterinary biochemistry has shifted in the last 30 years from investigating a few molecules in 
classical studies towards high-throughput methods (commonly referred to as ‘omics’) analysing 
hundreds or thousands of compounds.  
Genomics and transcriptomics are the earliest examples of omics technologies and have been 
instrumental in determining processes underlying the physiology of reproduction. Genomics has 
been used to refine selection for fertility traits in addition to the standard production traits (Ortega 
et al. 2017). Transcriptomic data, on the other hand, furthered our knowledge of changes in gene 
expression, as well as how genes function as part of networks and pathways (Borrageiro et al. 2018). 
Improvements in both equipment and data processing have increased the popularity and volume of 
the more recently developed proteomic and metabolomic fields. Proteins and metabolites are closer 
to phenotype than genomic traits and tend to be highly informative of the organism’s functional 
state, while also reflecting genetic factors (Nagana Gowda and Raftery 2016). Moreover, post-
translational regulation processes hinder quantitative predictions of protein levels based on 
transcript abundance, and therefore proteomics offers unique advantages over transcriptomics 
(Arnold and Frohlich 2011). Insight from transcriptomics studies in this area has been reviewed by 
Forde and Lonergan (2012) and Ulbrich et al. (2013). Metabolomic analysis, in turn, has proven useful 
for exploratory experiments and biomarker discovery and validation (Nagana Gowda and Raftery 
2016). 
Proteomics 
Proteomics is the large-scale investigation of the total protein complement of a given biological 
system (Aebersold and Mann 2003). For its study, two main experimental platforms exist, one 
consisting of gel separation of proteins dependent on their size (and often also isoelectric point), and  
“gel-free” whereby proteins are dissolved in liquid and undergo separations through 
chromatography and are detected and measured by mass spectrometry. Gel-free approaches are the 
most widely used nowadays due to its higher coverage in number of protein species detected 




liquid chromatography – tandem mass spectrometry (LC-MS/MS) because of its robustness, speed, 
sensitivity and throughput (Rappsilber et al. 2003). The analysis’s output consists of a list of masses 
corresponding to precursor and product ions (chiefly peptide sequence resulting from peptide 
precursor ion fragmentation) together with their retention time. Informatic tools are used to 
determine the peptide sequence of the ions detected using information from databases, and 
quantify them (Aebersold and Mann 2003).  
Metabolomics 
Metabolites are a heterogeneous group of molecules sharing the common trait of a low molecular 
weight (i.e. under 1500 Da). Because metabolites are closest to an individual’s phenotype, they are 
especially relevant when looking for biomarkers for the biological conditions studied (Smolinska et al. 
2012). 
Different techniques are currently in use for metabolomic analysis. Some of the most widely used 
include the abovementioned LC-MS/MS, gas chromatography-tandem mass spectrometry (GC-
MS/MS) and nuclear-magnetic resonance (NMR). The latest is the least labour-demanding, but at the 
expense of reduced sensitivity (More et al. 2015). Gas chromatography coupled to tandem mass 
spectrometry (GC-MS/MS) was chosen as the main platform for metabolomic analysis in this project 
due to suitability for analysis of low molecular weight compounds related to known biochemical 
pathways, as well as its high resolution, separation efficiency and reproducibility compared to liquid 
chromatography or NMR (Bedair and Sumner 2008). The existence of proven systems for broad 
targeted methods can improve the number of compounds identified compared to untargeted 
analysis (Rochat 2016). 
Metabolic fingerprinting using direct infusion mass spectrometry 
Another type of metabolomic analysis is characterised by direct mass spectrometry techniques, 
based on ambient ionisation (Cooks et al. 2006). The main advantage of this type of technology is its 
ease of implementation and speed, often requiring minimal or no sample preparation (Black et al. 
2016). A new technique in this realm is rapid evaporative ionisation mass spectrometry (REIMS), 
originally developed for real-time recognition of tumorous tissue in cancer surgery (Balog et al. 
2010). Mass spectra patterns obtained produce a “fingerprint” (a distinctive pattern) of the sample 
analysed, but are generally unable to reliably identify specific molecular species in the samples (van 
Ruth et al. 2003). In recent years this technique has been applied to study many types of sample 
aiming for high-throughput or industrial applications, particularly in meat (reviewed by Ross et al. 




knowledge of the author, no reports of this technique being used on liquid samples have been 
published. 
Application of direct MS analysis can help bridge the gap between laboratory and on-site applications 
(Ren et al. 2014). However, it is unlikely to substitute MS platforms with a chromatographic 
separation step such (e.g. LC- or GC-MS/MS) for scientific research purposes, due to its generally 
lower resolutive power and reproducibility, as well as its limited ability for compound identification 
(van Ruth et al. 2003, Ross et al. 2020). 
Data analysis approaches 
The instrumental analysis stage examined is fundamental in an omics workflow. However, further 
data handling, processing and integration are equally important. A brief description of the 
procedures employed in this project are presented next, while details of their application are 
presented in the respective methodology section of each chapter. 
Multivariate analysis and modelling 
It is common practice in an omics experiment to obtain a visual overview of the data generated as a 
first assessment of the results. Typically, this is done by principal component analysis (PCA), a 
multivariate method that - among other applications - can provide a readily interpretable means of 
identifying trends in the data, especially clustering and outliers (Jolliffe 1986). Indeed, PCA can 
extract a small number of feature patterns that represent most of the variation present in the 
original data, as well as the general relationships between measurements (Worley and Powers 2013). 
PCA is an unsupervised method, that is, no information regarding the factor(s) of interest is used in 
identifying trends in the data; colour- or shape-coding are usually implemented after the analysis for 
visualisation purposes only (Worley and Powers 2013). Conversely, partial least squares discriminant 
analysis (PLS-DA) is a supervised method: it aims to appraise how useful are the omics measurements 
at predicting one or more response variables, e.g. a disease or an altered physiological condition 
compared to healthy or normal individuals (Worley and Powers 2016). Two variants of PLS-DA were 
chosen for this analysis: orthogonal (OPLS-DA) and sparse (sPLS-DA). Compared to standard PLS-DA, 
its orthogonal variety provides a more analyst-friendly output: the variation that is predictive of 
group/condition from the condition-unrelated variation is segregated in different axes of a two-
dimensional plot (Bylesjö et al. 2006). One caveat is that only binary classification is possible with 
OPLS-DA (Bylesjö et al. 2006). Conversely, sPLS-DA performs feature selection and parameter tuning 
with the aim of generating models with better predicting ability than standard PLS-DA at reduced 




Two parameters are useful when evaluating a model’s performance, R2 and Q2. R2 represents the 
goodness of fit, i.e. how well is the data in the training set reproduced mathematically by the model; 
Q2 quantifies the predictive performance of the model (how well it predicts data in a new/test set) 
(Eriksson et al. 1994). There is a compromise between goodness of fit (to the training data) and 
predictive ability (to new, test data) and applying cross-validation procedures can be useful for 
estimating these parameters and tuning the model consequently according to the goals of the 
analysis (Eriksson et al. 1994). Furthermore, PLS-DA approaches have measures to prevent 
overfitting, i.e. the production of models that adjust to and accurately explain a relationship between 
factors and dependent variables in the training set, but perform poorly when predicting new data 
(Hawkins 2004).  
Univariate analysis 
Statistical analysis of individual variables is highly relevant in omics research, particularly for 
biomarker discovery (discussed later). To test for differences in a variable across groups, Student’s t-
test is usually employed when there are two groups, and ANOVA when there are three groups or 
more. Those tests are known as parametric, i.e. they require that certain conditions be met (normal 
distribution of residues, independent sampling, and uniform variance across all the range of values). 
When one or more of those assumptions is not met, two options are possible: transforming the data 
(applying a function such as logarithm, power, etc.) to meet the assumptions for parametric tests, or 
using a non-parametric alternative, i.e. Mann Whitney U test instead of Student’s T test, or Kruskal-
Wallis instead of ANOVA (Thompson 1986). 
From a theoretical point of view, ANOVA is a special case of regression analysis in which the predictor 
variables are strictly categorical (Thompson 1986). Binomial regression analysis was performed in 
Chapter 7 to estimate the quantitative relationship between a factor (the supplementation of a test 
protein) and the response variable (embryo development). 
An important concept when conducting univariate analysis on omics experiments is false discovery 
rate (FDR). Because many features (hundreds or thousands) are analysed in each experiment, the 
likelihood of false positives increases substantially; for example, testing differences in 1000 variables 
at a 5% significance will result in an average of 50 variables found different when they are not. 
Multiple testing correction is therefore necessary to control the number of false positives. False 




whose formula is    (Benjamini and Hochberg 
1995), where E=chosen threshold, FP= false positives, TP= true positives, and R is the number of H0 
(null hypotheses) rejected. FDR is then the proportion of the rejected null hypotheses which are 
erroneously rejected (Benjamini and Hochberg 1995). 
Multiomics and pathway analyses 
In addition to the approaches presented above, to make sense of the substantial amount of 
information generated by omics analyses and identify trends within, multi-omics integrated 
investigation is highly beneficial. Integrated approaches can serve to uncover new biological 
phenomena, which would not be readily apparent from any single analysis (Weston and Hood 2004, 
Li et al. 2013). One of the most widely used integrated analysis methods is pathway analysis, 
whereby pathways are defined as “models describing the interactions of genes, proteins, or 
metabolites within cells, tissues or organisms, not simple lists of genes” (Mitrea et al. 2013). Related 
methodologies that are sometimes erroneously referred to as pathway analysis include functional 
classification based on specific aspects of the molecules studied. A typical approach for gene and 
protein data is Gene Ontology (GO) term enrichment analysis, which delivers insight on important 
molecular functions, cellular components and biological processes most closely linked to the 
phenomenon of interest (Ashburner et al. 2000). It is necessary to examine the purpose of this 
classification system to avoid misguided conclusions. According to Schulz et al. (2009), ontologies in 
the biomedical realm aim to offer “a system of domain-independent distinctions to structure 
domain-specific theories with the goal of integrating and retrieving data and fostering 
interoperability”. The authors also emphasise that simplifications necessary to encode biological 
facts to ontology terms inevitably result in some errors and underrepresentation (Schulz et al. 2009). 
As new information is added to the knowledgebase, it becomes more reliable, however it is a broad 
exploratory tool that can provide leads but hardly strong empirical results. In the present work, two 
types of pathway analysis approaches are used. Pathway overrepresentation analysis tests the 
biological interrelationships of features with significance values under a defined threshold are 
analysed (Mitrea et al. 2013). In the other type, pathway enrichment analysis, all features are 
considered regardless of their statistical significance, to discover subtle yet consistent changes in 
biological processes (Mitrea et al. 2013); many enrichment analysis methods also consider the 
relative position of the molecules within the pathway (Bayerlová et al. 2015). Lastly, when referring 




equivalent phenomena, merely pointing at an atypical behaviour of a certain biological process. Since 
mechanistic knowledge of reaction dynamics is usually not available in these tools, the specific 
changes within the pathway still require manual curation and analysis (Nguyen et al. 2019). 
The ultimate goal of omics studies and their integration is embodied in the concept of “systems 
biology”, that is, the fine-grained understanding of interactions and functional relationships between 
physical entities in the cell and at higher levels of organisation (Kitano 2002). Systems-level 
understanding of biology requires substantial amount of ‘‘omics’’ data, requiring improved 
throughput, agility, comprehensiveness, and precision (Feng et al. 2008, Zhang et al. 2010). One key 
goal of systems biology is to allow for reliable predictions of the system-wide effect of a given 
perturbation at the molecular level, but this has not been realised yet. 
Biomarker discovery 
A biomarker is defined as ‘‘a characteristic that is objectively measured and evaluated as an indicator 
of normal biologic or pathogenic processes or pharmacological responses to a therapeutic 
intervention’’ (Chakravarty 2003). An ideal biomarker is easy to measure with minimally invasive 
procedures and therefore it is natural that urine and blood have been investigated extensively for 
biomarker discovery (Nagana Gowda and Raftery 2016). Results for fertility traits, however, have 
been mixed. Molecular analyses of bovine plasma (Hailemariam et al. 2014) and urine (Dervishi et al. 
2018) have shown potential for diagnosing metritis (inflammation of the uterus caused by bacterial 
infection) but to the author’s knowledge measurement of canonical biochemical biomarkers, i.e. 
progesterone (P4), non-esterified fatty acids (NEFA), and beta hydroxybutyrate (BHB), in blood, milk 
or urine has consistently failed to reliably predict or diagnose fertility parameters without additional 
information (Pieterse et al. 1990, Breukelman et al. 2012).  
In contrast, omics studies of local conditions within the maternal reproductive tract might shed light 
onto this, as exemplified by the work of (Mikolajczyk et al. 2006): the authors assessed the potential 
of leukaemia inhibitory factor (LIF) as an indicator of fertility in both blood and uterine fluid in 
humans. The concentration of LIF in blood did not correlate with fertility, but its concentration 
in uterine fluid did, highlighting the importance of obtaining samples in the affected organ (in this 
case, the reproductive tract) to aid in the identification of molecules or pathways relevant to the 
condition of interest.  
Taken together, proteomics and metabolomics of extracellular fluids can be referred to as 




secreted by cells or tissues at any given time under particular physiologic, pathologic or experimental 
conditions” (Dominguez et al. 2010). This topic is presented next. 
1.1.5 Secretomics of bovine ULF 
A systematic review was published as part of the present work that compiles and discusses 
proteomic and metabolomic research of the cow reproductive biofluids (OLF, ULF and follicular fluid) 
with a focus on the interaction between inflammation, disease and fertility (Aranciaga et al. 2020). 
Surveyed studies that conducted proteomic and metabolomic investigations of ULF are presented in 
Table S1-1. Some important points discussed in the review are technical (reproducibility across 
studies and effect of breed, management, sampling and reporting), key molecules underlying 
reproductive issues, biomarker candidates of endometritis and fertility, as well as differences in 
reproductive biofluid molecular composition due to hormones and pregnancy status. Three main 
conclusions ensued from the systematic review. Firstly, that higher technical standards are required 
to establish a “healthy cow” benchmark to compare to. Secondly, that supplementation of specific 
compounds to improve fertility is promising but more research is needed to elucidate its effect on 
the molecular milieu of the reproductive tract. Thirdly, that further development of in vivo and highly 
localised sampling procedures of reproductive organs is paramount.  
Immediate antecedents of the present work 
In previous work by this group a similar trial was conducted on commercial farms in 2014-2015 (Berg 
et al. 2017). Seasonal pasture-grazed New Zealand crossbred dairy cows were artificially inseminated 
(AI) and their uteri were either flushed on day 7 or day 15 or scanned for conception at day 28/35 or 
day 70, including examination and grading of embryos when present. In accordance with the results 
of Butler (2000), and Diskin and Morris (2008), most embryo loss (30%) occurred within the first 7 
days following fertilisation (Berg et al. 2017). In this biological model (representative of the average 
NZ herd), parameters such as cow age, milk production, calving body condition score (BCS), or 
change in BCS from calving to insemination were not found to significantly affect embryo survival. On 
the other hand, cow and sire used for insemination, progesterone concentration at day 7, dpp and 
the number of oestrous cycles after calving (OC) were all associated with increased conception rates 
(Berg et al. 2017). In the same study, cows inseminated on their first OC carried a viable embryo at 
day 7 only in 30% of the cases, whereas 60% of cows inseminated in their third OC had a viable 
embryo by day 7. This is likely related to the intense metabolic stress that dairy cows suffer in the 
early postpartum period, in which physiological recovery and uterine involution compete for energy 
supply with the udders in their peak milk production. Berg et al. (2017) also assessed causes of 




and those penetrated by sperm (eggs) that failed to progress further; results showed that 85% of the 
oocytes and embryos recovered at day 7 had been penetrated by sperm (Berg et al. 2017). This 
indicates that failure of sperm to reach the site of fertilisation or to penetrate the oocyte were not 
major factors in conception loss.  
The importance of uterine conditions for the preimplantation period accounting for most pregnancy 
failures in New Zealand dairy cows motivated the present research, examining the uterine 
environment at seven days after insemination. Importantly, research using different breeds and 
production systems, such as highly producing US Holstein cows and beef heifers, has been markedly 
different, and this is discussed in Chapter 8. 
1.2 Rationale and aims of this work 
The starting hypothesis of this work was that there are differences in one or more biochemical 
pathways regarding two factors: between cows that get pregnant versus those that do not; and 
between those pregnant on their first oestrus cycle after calving (OC1) from those that only get 
pregnant on their third oestrus after calving (OC3), and that these differences can be determined by 
proteomic and metabolomic analysis of their uterine fluid. Thus, the aim of this study was to 
investigate molecular differences in the ULF microenvironment between different physiological 
states (OC1 and OC3) through proteomic and metabolomic analysis of uterine flushings at day 7 after 
insemination. More specifically, the analysis involved extracting both proteins and metabolites 
present in ULF, processing the samples and analysing them by liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) for proteomics and gas chromatography-tandem mass spectrometry (GC-
MS/MS) and REIMS (rapid evaporative ionisation-mass spectrometry) for metabolomics.  
Blood samples were also analysed for concentration of progesterone and metabolites indicative of 
energy balance: circulating concentrations of NEFA and BHB are useful to assess the relative 
adaptation to negative energy balance conditions (Herdt 2000). The concentration of serum NEFA 
indicates the degree of depletion of fat reserves, whereas BHB concentration manifests fat oxidation 
in liver (LeBlanc 2010). Progesterone concentration was determined both to confirm oestrous status 
and to determine potential correlations with molecular changes in ULF (Costello et al. 2010). 
The same pattern of insemination followed by collection of uterine flushes and blood samples was 
repeated in two consecutive breeding seasons and is presented in detail in Chapter 2. Data from 
omics experiments were analysed separately as well as integrated under a multi-omics holistic 
approach, and biological validation of the effect of potential biomarker candidates was tested by in 





To gain insight in biochemical processes underlying uncharacterised pregnancy losses and to obtain 
proteomic and metabolomic markers from the ULF of New Zealand dairy cows correlated to already 
determined differences in pregnancy rate that can be used to estimate the probability of a successful 
pregnancy. 
Perspectives 
Results from metabolomics and proteomics analyses may be instrumental to selecting individuals 
with a desirable genotype, devising a supplementation treatment to improve embryo development 
in uterus and during in vitro culture of embryos. Bovine in vitro embryo production is used 
worldwide and in 2018 over one million in vitro bovine embryos were produced, accounting for 69% 





Animal and sample collection 
2.1 Introduction 
As stated in Chapter 1, the aim of this work was to unravel the proximal factors (i.e. in the uterus) 
causing differential embryo development, as well as their interplay with distal factors (at the animal 
level). For this, a suitable animal model was devised taking into account the characteristics of the 
seasonal pasture grazed  dairy cow (with a focus on the New Zealand herd) and minimising the number 
of covariates, particularly bull effect (Berg et al. 2010) by using semen from a single sire with high 
breeding value for conception rate, and uniform management conditions. The methodology of choice 
was inseminating early post-partum cows at two timepoints and flushing their uterine luminal fluid 
(ULF) seven days post-insemination with saline solution. This allowed sampling the molecules in the 
ULF as well as recovering an embryo when present, to assess its reproductive outcome.  
This chapter describes the animals used in different trials in the present work, the trial design and 
outcomes regarding both cows’ and embryos’ phenotypes. Farm Trial 1 was a preliminary trial to test 
the application of an internal standard of sample concentration, whereas Farm Trials 2 and 3 used 
cows from the main herd located at the research dairy farm and followed the same protocols in 
consecutive years, using different animals each year (i.e. subgroups within the main herd). In each of 
Farm Trials 2 and 3, the same cows were sampled in both their first and third spontaneous OC (oestrus 
after calving), to determine the effect of increased recovery time (both in number of oestrus cycles 
and days postpartum) after calving on reproductive performance.  
2.2 Materials and methods 
2.2.1 Reagents and consumables 
Cloprostenol 250 ug/ml (estroPlan, synthetic analogue to prostaglandin F2a) was purchased from 
Parnell Laboratories (Auckland, New Zealand). Eazi-breed CIDR (controlled internal drug release inserts 
containing 1.38 g progesterone) were sourced from Zoetis Ltd. (Auckland, New Zealand). Isotonic 
sterile saline (0.9% sodium chloride intravenous infusion) and Hartmans solution (Ringer’s lactate 
solution) containing 3.17 g/l sodium lactate, 6 g/l sodium chloride, 400 mg/l potassium chloride, and 
270 mg/l calcium chloride dihydrate were bought from Baxter (Toongabbie, NSW, Australia). 
Bomacaine (Lignocaine hydrochloride monohydrate 20 mg/ml) used as an epidural analgesia was 




was purchased from ICP Bio Ltd. (Auckland, New Zealand) and leupeptin from Sigma-Aldrich (St. Louis, 
MO, USA). Synthetic releasing analogue of GnRH (Gonadotrophin Releasing Hormone, Receptal, 4 
µg/ml buserelin) was supplied by (MSD animal health, Wellington, NZ). 
Metricheck devices were bought from Simcro (Hamilton, New Zealand). E-Z Way filters with pore size 
of 64 microns were bought from SPI-MFG (Canton, TX, USA). “Red-top” plastic tubes (regular tubes 
without any anticoagulant or preservative added) for blood sample collection were purchased from 
Vacutainer (Becton Dickinson, Auckland, New Zealand). Fifteen-ml plastic tubes were acquired from 
Eppendorf (Hamburg, Germany), and Foley three-way embryo collection catheters (size 20) from 
Minitube (Tiefenbach, Germany). 
2.2.2 Farm and animal management 
All animal handling was done in accordance with the 1999 Animal Protection Regulations of New 
Zealand and with prior approval of the Ruakura Animal Ethics Committee (register number: AE 
Applications 14255 and 14432).  
Cows were maintained at the AgResearch’s Tokanui Farm (38°03'51.4"S 175°19'50.8"E). The farm 
operates under a seasonal pastoral system, predominately grazed on annual and perennial ryegrass 
and white clover, supplemented with silage and minerals (Table S2-1). The research farm’s yearly 
average production was 1.33 kg milk solids/day/cow in 2017 and 1.59 in 2018 with peak occurring on 
the 29th and 25th October, respectively. Calving occurred during July through to September in 2017 and 
2018 and breeding (artificial insemination) commenced the first week in October in both years. 
2.2.3 Phenotypical parameters 
Production and physiological parameters of each individual cow were collected daily through a cow 
monitoring and milking management digital system, DataFlowTM (SCR Ltd., Netanya, Israel). Additional 
information was gathered by MINDA (LIC, Hamilton, New Zealand), a tool for herd management and 
visual assessment on-farm. Information from these resources was made available for this project.  
The information extracted from the sources cited above included breed composition, age, calving date, 
average daily milk production, live weight, and semen batch.  
The herd was predominately Friesian (F) and crossbred animals, crossbred defined as less than 12/16 
Friesian. These included Jersey and Ayrshire. One variable tested was the proportion of Friesian 
genetics. For this, the proportion values were logit-transformed; to avoid infinite values, 0.01 was 




2.2.4 Experimental design 
Farm Trial 1: use of tracer 
Farm Trial 1 determined the feasibility of adding an internal standard to the flushing media, with the 
purpose of accounting for dilution and recovery efficiency of the flushing procedure (analysed in 
Experiment M2, section 4.3). Non-lactating Friesian cows (n=12) were synchronised using a fixed-time 
AI programme employing a CIDR as per Macmillan and Peterson (1993) to ensure all animals were at 
day 7 at the time of flushing. The animal synchronisation method and experimental design is presented 
in Figure 2-1. 
 
Figure 2-1 Synchronisation method for Farm Trial 1, testing the effect of isotope-labelled proline as 
tracer for dilution estimation. Doses: Day 0, Receptal 2.5 ml (10 µg buserelin, i.e. 
“GnRH1”) + Progesterone 1.38 g. Day 7, estroPLAN (500 mg cloprostenol, i.e. “PGF2α”), 
2 ml each AM and PM. Day 10, Receptal 2.5 ml (10 µg buserelin) 
Details of the processing and analysis of these samples are described in section 4.3. 
Farm Trials 2 and 3: uterine fluid collection with embryo recovery 
Cows for Farm Trials 2 and 3 were selected using the same enrolment scheme in both years (Figure 
2-2):  
1 Daily monitoring of oestrous behaviour during morning milking. 
2 Cows were enrolled and inseminated on their first spontaneous oestrus after calving (OC1), 
followed by uterine flushing at day 7.  
3 A second dose of 500 mg cloprostenol (a progesterone analogue) on day 15 of first oestrus 
was administered to cows that failed to exhibit a return to oestrus (i.e. day 15 after AI and day 
8 after flushing) to cause luteolysis, ensuring a return to heat, especially important in the cases 
where an embryo was not recovered.  
4 Track and report OC2 and OC3, without experimental interventions. 











In Farm Trials 2 and 3, the approach taken was to minimise hormonal interventions as this is known 
to affect fertility parameters (Van Cleeff et al. 1996), so cows were inseminated when they came to 
oestrus naturally. This had the purpose of reflecting the natural postpartum evolution of the cow: in 
ewes, distinct dissimilarities were found in the OLF proteome of animals experiencing synchronised 
vs spontaneous oestrus (Soleilhavoup et al. 2016). Practical and ethical implications (Chenault et al. 
2003) were also taken into consideration. 
Other studies have chosen a different strategy: by exerting a higher degree of manipulation 
(synchronising and transferring embryos from the same donor or donors) it is easier to distinguish 
the effects of the uterine environment from the oocyte quality. Key elements of the two approaches 
are summarised in Table 2-1. The implications of this trade-off are further discussed in Chapter 8. 
Table 2-1 Different approaches to in vivo theriogenology experiments. 
Present work 
Gegenfurtner et al. (2020), Shorten et al. 
(2018), and others 
Naturally cycling Synchronised 
No CIDR 
CIDR (progesterone supplementation) 
represents an extra disturbance 
Long sampling period that does not overlook 
differences in recovery and resuming oestrus 
in cows 
Easier to sample and account for season effect, 
and to distinguish embryonic from maternal 
factors 
Artificial insemination Embryo transfer 
Figure 2-2 Experimental design of Farm Trials 2 and 3. The flushing process includes embryo 








Cloprostenol injection (if no 
oestrus was observed within 8 
days of flushing) 
AI (day 0) + 
flushing (day 7) 
Blood samples, day 
0,4,7 
AI (day 0) + 
flushing (day 7) 









All cows in the milking herd were monitored daily for oestrous behaviour during the morning milking. 
Tail paint was used as the oestrus detection aid. In this method, a strip of enamel paint is applied on 
the animals’ first coccygeal vertebra (i.e. the area near the base of the tail). When an animal comes 
into heat, her rubbing behaviour increases substantially and is highly prone to being mounted by other 
cows, causing the paint on her back to wear off. A day after the paint is applied, an operator assesses 
the amount of paint left in a scale from 5 (intact) to 0 (completely rubbed off; Macmillan and Curnow 
1977). Cows were tail painted when they joined the milking herd four days after calving and reapplied 
as required. Only animals with tail paint scores 0 or 1 (bare or rubbed, indicative of being receptive to 
mounting by other cows) were selected for enrolment. Tail paint colour was changed after enrolment 
on first oestrus (insemination) and subsequent second and third oestrus.  
Cows exhibiting their first oestrus after calving were drafted from the herd and further assessed before 
enrolment (i.e. inseminated) only if fulfilling the following criteria: 
1 No history of calving difficulties; no mastitis, metritis, and metabolic disease within the first 21 
days. 
2 At least ≥24 days post-partum (i.e. a commonly accepted regular period of post-partum uterine 
recovery; Roberts 1986, Humblot 2001). Furthermore, no embryos are recovered from NZ 
dairy cows less than 24 days post-partum (Deb Berg, personal communication). Enrolment 
preference was given to cows 2 to 7 years of age, but cows greater than 7 years of age (n=6) 
were enrolled to achieve the minimum number of 80 cows to achieve statistical power at the 
10% level. 
3 Body Condition Score (BCS) greater than 3.0 (in a 5 point scale where 1=emaciated and 
5=obese; Roche et al. 2004). 
4 OC1 observed before the 15th of September. This ensured OC3 would occur during the six 
weeks of the routine artificial insemination on the farm. 
Animal Evaluation and Insemination 
Cows drafted from the main herd were inseminated after the morning milking. Verification of oestrus 
was determined by good uterine tone and the presence of a large follicle at insemination. The same 
inseminators (n=2) were used for both years. Cows enrolled were inseminated using frozen-thawed 




Before insemination, uterine involution was assessed by rectal palpation of uterine horns for uterine 
tone and the uterine position in the pelvic cavity. The cow was assigned a uterine size and position 
score (SPS) based on the criteria of Young et al. (2017). An SPS1 score indicated that the uterus was 
positioned entirely within the pelvic cavity; SPS2 score indicated the cervix is within the pelvic cavity 
and the uterine horns were outside the pelvic cavity and a SPS3 was the cervix and uterine horns lie 
outside of the pelvic cavity. Uterine horns were examined by sonography using a SonoSite M-Turbo 
Ultrasound system. The presence of fluid in the uterine lumen was recorded and both uterine horn 
diameters were measured at the greater curvature of the horns and recorded. Uterine health was 
determined by the presence of purulent vaginal discharge score using the Metricheck device 
consisting of a 50-cm-long stainless-steel rod with a 4-cm hemisphere of silicon used to retrieve 
vaginal contents. Using this method, vaginal secretion scores > 2 indicate purulent vaginal discharge 
endometritis (McDougall et al. 2007). Thus, only cows with scores <2 were enrolled. 
Blood sampling 
Blood serum samples were taken at AI (day 0) of all enrolled cows via coccygeal venepuncture into a 
10 ml red top (i.e. regular plastic) tube. Subsequent blood samples were taken at the same time in the 
morning at day 4 and day 7. Blood samples were incubated upright at room temperature for no longer 
than 60 minutes to allow clotting, then centrifuged at 3,000 g for 10 min. Resulting serum was sub-
aliquoted and stored at -20oC for analysis of oestradiol, progesterone, non-esterified fatty acids (NEFA) 
and beta-hydroxybutyrate (BHB) at day 0, and the latter three at days 4 and 7 of both first and third 
oestrus cycles.  
Progesterone and oestradiol concentrations analysis in blood serum were performed by Liggins 
Institute, University of Auckland, using an electrochemiluminescence immunoassay kit through an 
Elecsys e41 (2018) or COBAS e601 (2019) analyser. Two quality controls were performed, at the middle 
and top of the range of detection. The average CV (coefficient of variation) for the controls were 6.14% 
and 4.31% (mid concentration range) and 2.8% and 3.57% (high concentration range) for oestradiol 
and progesterone respectively (Table S2-2). NEFA & BHB analysis were performed by New Zealand 
Veterinary Pathology (NZVP); the CV of the controls were 5.87% (BHB) and 1.47% (NEFA) (Table S2-2). 
Sonography 
Sonography was performed as described by Jaureguiberry et al. (2017). A portable ultrasound 
machine, SonoSite M-Turbo Ultrasound system (Fujifilm, Bothell WA, USA) fitted with a 5-8 MHz sector 
array transducer was used to scan both ovaries. All images were saved after measurements with the 




diameters were measured. The uterine diameters were defined as the distance between the inner 
echogenic boundaries of the uterine lining in each of the dimensions of the image. On day 2 
ultrasonography was used to verify ovulation and to measure and record the dimensions (length and 
width) of the developing CL (corpus luteum). 
On embryo recovery day (day 7) the ovary was scanned after flushing. The image of the CL was 
captured on the screen at its maximum area. The horizontal and vertical diameters were measured 
using the electronic callipers to determine the mean maximum cross-sectional diameter of the CL and 
its inner vacuole (if present). The luteal area (mm2) was calculated as A=  x r2. The radius (r) was 
calculated as 0.5 x mean maximum cross-sectional area. 
Uterine flushing and embryo grading 
Seven days after insemination (i.e.  day 7) non-surgical uterine flushing was performed in the uterine 
horn ipsilateral to the CL (corpus luteum). Prior to flushing, 5 ml epidural analgesic (Bomacaine) was 
administered. A silicon ET Foley three-way embryo collection catheter was placed into the ipsilateral 
uterine horn, to ensure approximately one third of the anterior uterine horn was flushed with 
isotonic sterile saline solution (ISS- Ledgard et al. (2012). The uterine horn was massaged gently to 
ensure the ISS solution reached the anterior tip of the horn and to recover the majority of ISS 
solution. The ISS containing the uterine contents was passed through an E-Z Way Filter (stainless 
steel pore size of 64 microns) chosen to prevent protein binding, to capture both flushing debris and 
the embryo while the fluid passed through the filter and was collected in a 50 ml polypropylene 
collection tube (Eppendorf AG, Hamburg, Germany). To prevent proteolytic degradation by 
endogenous and exogenous proteases, leupeptin (a protease inhibitor) to a final concentration of 10 
µM was added immediately after collection and ULF samples were placed on ice. Next, samples were 
centrifuged at 2,500 g for 10 mins at 4°C to remove cellular debris. The supernatant was aliquoted 
into 15 ml plastic tubes and snap-frozen on dry ice. Samples were held at -80°C until analysis. 
The filter was immediately searched for an embryo using a Nikon SMZ1500 stereo microscope.  
When no embryo was found upon inspection of the filter, a second flush (methodologically identical 
to the first) was performed using embryo-flushing medium (300 to 500 ml per horn) and an embryo 
was searched in this second flush. Flushing medium consisted of Hartmann solution, containing 
potassium chloride (0. 04%), sodium chloride (0.6%), sodium lactate (0.322%) and calcium chloride 
(0.027%) supplemented with 1 ml of M-3-morpholinopropane-1-sulfonic acid (MOPS), pH 7.4, and 1 
ml of BSA (20% w/v). The final concentration of the flushing medium was 1mM MOPS and 0.02% w/v 




Embryo grading and classification 
The fluid recovered from the flush using embryo-flushing medium was searched using a 
stereomicroscope as detailed above and repeated up to three times. In all cases an embryo was found, 
it was evaluated for stage and grade according to the International Embryo Transfer Society (IETS) 



















Figure 2-3 Photographs of day 7 embryos taken at 50x in a Nikon SMZ1500 stereo microscope. A) 
One cell zygote (class V), B) Degenerate 8-cell (class IV), C) Grade 2 morula (class II), D) 
Grade 3 morula (class III), E) Grade 1 tight morula (class I), F) Grade 3 tight morula 
(class III), G) Grade 1 early blastocyst (class I), H) Grade 3 early blastocyst (class III), I) 
Grade 1 blastocyst (class I), J) Grade 3 blastocyst (class III).  
Briefly, two embryo phenotypical factors were considered. Firstly, embryo size (i.e. developmental 
stage) was measured by counting the number of cells in the embryo up to the 16-cell stage using 
microscopy (60x). Embryos at higher developmental stages were named according to standard 
convention (morula, compact morula, early blastocysts, and blastocysts). 
Embryo grade was defined following the four-values scale developed by (Bo and Mapletoft 2018), one 
of the most widely used measures of bovine embryo quality. Based on the morphological integrity of 
the embryos (symmetry, size, colour, density), they are graded from grade 1 (best) to grade 4 (dead or 
degenerate). For reference, Figure 2-3 shows pictures of embryos of different developmental stages 
and grades at day 7. 
Three different embryo classification systems were devised. The first system, EQ1, used all 
classifiable embryos, excluding ULF discarded due to the animal being diagnosed as sick. It was 
devised a priori on the basis of being the most biologically accurate, having five classes 
corresponding to distinct embryo phenotypes and designated with roman numerals throughout this 
G 100 µm 
H 
100 µm 







work: 1 cell oocytes/embryos (i.e. potentially due to fertilisation failure, “V”), 4- to 16-cell 
(development potentially blocked; in this study, no 2-cell embryos were recovered, “IV”), grade 3 
(low quality embryo at the right development stage, i.e. tight morula or blastocyst, “III”), grade 2 
(good quality at an adequate development stage, “II”), and grade 1 (excellent quality, “I”). A variant 
of this system (“EQ1b”) was also used in this chapter, in which ULF flushings where no embryo was 
recovered were encoded as class “VI”. 
Two simpler, binary classification systems (EQ2 and EQ3) were also established. Under EQ2, I 
embryos were classed as “optimal” and V, IV and III as “suboptimal” (Table 2-2 and Figure 2-4), 
responding to both biological and technical issues. Class II embryos were excluded from this binary 
classification because of the likely overlap with classes I and III embryos. Indeed, reducing the 
overlap between juxtaposed classes is important for modelling purposes: predictive models tend to 
be significantly more accurate when the number of groups or classes is smallest and most divergent 
(Smith et al. 2000). System EQ3 was devised to test the hypothesis that two broad embryo stage 
groups (16 cells or under -i.e. classes V and IV- vs tight morula stage or more advanced development 
-i.e. classes III, II and I) were determined by a general physiological conditions of the cow, affecting all 
stages of embryo development, and termed “pregnant” and “non-pregnant”, respectively.  
Table 2-2 Embryo classification schemes used, based on size and grade.  
Phenotype EQ1 EQ1b EQ2 EQ3 
Grade 1 I I Optimal 
Pregnant Grade 2 II II  
Grade 3 III III 
Suboptimal 4 to 16 cells IV IV Non-
pregnant 1 cell V V 
Infected N/A N/A N/A N/A 






Figure 2-4 Schematic summary of the embryo quality classification systems employed. 
In vitro culture after flushing 
To gain additional understanding of the phenomena driving the observed embryo phenotypes, a 
subset (50%) of tight morulae and early blastocysts retrieved from ULF flushings were cultured for an 
additional 24 h. A detailed description of these techniques and tools is presented in Chapter 7. In 
brief, recovered tight morulae and early blastocysts were immediately placed in EMCARE Holding 
solution (ICP bio, Auckland, New Zealand), washed twice, placed in 0.25 ml embryo transfer straws, 
transported to laboratory within 3 h, washed twice in LSOF medium, and individually placed in a 10 µl 
drop of LSOF overlaid with mineral oil (Sigma). Embryos were cultured overnight at 7% O2, 5% CO2 
and 88% N2 in a modular incubator at 38.5°C. The following morning, embryos were evaluated for 
stage and grade as described above (Bo and Mapletoft 2018).  
2.2.5 Statistical analysis 
R statistical software v4.0.2 (R Core Team 2019) was used for all statistical analysis. Effect of oestrus 
number after calving (OC) and year on the phenotypic parameters were analysed by t-test (paired for 
OC and unpaired for year). Missing values were imputed using the predictive mean matching method 
of the mice (“Multivariate Imputation by Chained Equations“) package v3.11.0 (Buuren and 
Groothuis-Oudshoorn 2010). Effect of days post-partum (dpp) at insemination on the phenotypic 
parameters was tested by a general linear model (regression). In all cases, non-normally distributed 
variables were log-transformed to satisfy the conditions for t-test. Statistical analysis of embryo 
proportions was carried out by Fisher’s Exact test using R’s fisher.test base function. 
EQ1(b)
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Embryo phenotype analyses 
A research question posed was whether the ULF samples where no embryo was recovered were 
reflecting a biological phenomenon or a result of technical issues. This was evaluated in two ways: by 
observing the results of a PCA procedure using proteomics data as variables (following the methods 
described in Chapter 5) to check for clustering or outliers, and secondly by determining differences 
between embryo phenotypes by univariate analysis. 
2.3 Results and discussion 
In this section, an overview of the animals’ data is presented first, along with differences in 
phenotypical parameters at the cow level (BCS, hormonal concentrations in blood, etc.) by calving 
year (i.e. Farm Trials 2 vs 3). Then, the effects of OC and dpp in both years were tested on the same 
parameters at the individual and group (trial) level respectively. Lastly, the effect of calving season, 
dpp and OC, along with cow phenotypical parameters on embryo recovery and quality were tested. 
Additionally, when many univariate tests are conducted simultaneously, it is likely that some of those 
are false positives (i.e. p-values<0.05 by chance). Therefore, besides p-value, a q-value (the 
proportion of tests showing significant differences that are expected to be false, also known as False 
Discovery Rate) is reported, for multiple test correction (Benjamini and Hochberg 1995). The same 
FDR criterion (0.05, i.e. 5%) was used throughout this project. 
2.3.1  Overall descriptive statistics and year effect 
Descriptive statistics for cows used in Farm Trials 2 and 3 are displayed in Table 2-3, in total and by 
year. Differences between years were assessed by t-test. Significant differences in five parameters 
were found between cows in the two milking seasons (i.e. years): average daily milk production in 
the week of calving and the weeks before and after (all q<0.001), serum progesterone (P4) at day 7 
(q<0.027), and SPS score (q<0.028). Animals from the 2018 milking season showed higher milk 
production and serum concentration of P4, and lower SPS score. Importantly, as a commercial 
decision by the farm managers, a decrease in dry matter intake in 2017 of 3 kg (19%), may have also 
contributed to some of the differences observed.  
Table 2-3 Descriptive statistics in variables measured across all animals used in Farm Trials 2 and 3 
together, by year, and statistical differences by t-test. Values are expressed as means ± 
standard deviation. Abbreviations: Avg, average; BHB, beta-hydroxybutyrate; CL, 
corpus luteum; dpp, days postpartum; E2, oestradiol; NEFA, non-esterified fatty acids; 





Farm Trial 2 
(2017) 
Farm Trial 3 
(2018) 
p-value q-value 
% Friesian ancestry 70±28 74±26 67±30 0.156 0.305 
Age (y) 5.19±1.89 5.36 ± 2.51 5.1 ± 1.21 0.36 0.532 
Avg. BHB (mM) 0.55±0.12 0.58 ± 0.12 0.55 ± 0.09 0.152 0.305 
Avg. daily milk yield (L). O+ 1 
week 
18.42±3.31 16.71 ± 3.2 19.69 ± 2.88 >0.001 >0.001 
Avg. daily milk yield (L). O 
week 
18.55±3.58 16.92 ± 3.77 19.69 ± 2.95 >0.001 >0.001 
Avg. daily milk yield (L). O-1 
week 
18.56±3.42 17.12 ± 3.77 19.57 ± 2.82 >0.001 >0.001 
Avg. horn section area (cm2) 6.91 ± 2.31 Not measured 6.91 ± 2.31 NA NA 
Avg. NEFA (mM) 0.45±0.34 0.44 ± 0.22 0.42 ± 0.27 0.577 0.701 
Avg. P4 (ng/ml) 2.18±0.87 2.11 ± 0.87 2.41 ± 0.85 0.002 0.061 
Body condition score (BCS) 3.95±0.44 3.91 ± 0.3 3.97 ± 0.49 0.511 0.643 
BHB day 0 (mM) 0.53±0.18 0.54 ± 0.18 0.55 ± 0.16 0.676 0.766 
BHB day 4 (mM) 0.54±0.18 0.56 ± 0.18 0.55 ± 0.14 0.605 0.709 
BHB day 7 (mM) 0.59±0.18 0.63 ± 0.21 0.56 ± 0.13 0.04 0.167 
CL area day 2 (cm2) 1.36±0.99 1.17 ± 0.58 1.46 ± 1.16 0.084 0.19 
CL area day 7 (cm2) 5.06±2.09 4.84 ± 2.15 5.24 ± 1.63 0.174 0.305 
CL area of luteal tissue day 7 (-
vac)1 
1.09±0.62 0.9±0.52 1.4±0.65 0.021 0.059 
Dpp 58±6.84 56.15 ± 21.29 61.16 ± 22.63 0.977 1 
E2 day 0 (ng/ml) 20.04±11.5 21.35 ± 11.78 19.02 ± 11.29 0.179 0.305 
Flush vol. recovered (ml) 17.21±4.51 17.04 ± 3.45 17.53 ± 4.94 0.46 0.619 
Metriscore 1.08±0.35 1.1 ± 0.36 1.05 ± 0.33 0.474 0.619 
NEFA day 0 (mM) 0.6±0.46 0.54 ± 0.29 0.63 ± 0.49 0.191 0.31 
NEFA day 4 (mM) 0.42±0.57 0.4 ± 0.28 0.35 ± 0.29 0.251 0.388 
NEFA day 7 (mM) 0.34±0.29 0.37 ± 0.31 0.28 ± 0.23 0.08 0.055 




P4 day 4 (ng/ml) 1.62±0.82 1.62 ± 0.96 1.62 ± 0.7 1 1 
P4 day 7 (ng/ml) 4.73±1.98 4.45 ± 1.72 5.19 ± 1.91 0.007 0.028 
EQ1 3.48±2.05 3.82 ± 2.05 3.22 ± 2.04 0.051 0.123 
Size and position score (SPS) 1.55±0.57 1.81 ± 0.57 1.47 ± 0.55 0.006 0.027 
Tail paint score 0.35±0.56 0.45 ± 0.59 0.28 ± 0.52 0.048 0.123 
1 CL area of the luteal tissue Is the CL area minus the area of the vacuole.  
Metabolic clearance rate was not measured in this study, but a 20% increase in dry matter intake for 
moderate milk yield cattle would be expected to increase liver blood flow and thus metabolic 
clearance rate for progesterone (Sangsritavong et al. 2002). A lower SPS score, indicating 
reproductive tracts better suited for pregnancy, was possibly related to differences in dry matter 
intake, although uterine location and size result from the interaction of many different factors (de 
Rezende et al. 2020). Furthermore, no significant differences were found in most of the physiological 
and biochemical parameters analysed, suggesting a high degree of inter-year consistency. In further 
analyses, groups were balanced regarding the proportion of individuals per year so that these 
differences would not affect embryo development analyses.  
2.3.2 Effect of oestrus after calving (OC) and days post-partum (dpp) on animal 
phenotype 
The effect of OC on the animal level parameters was examined by paired t-test, and effect of dpp at 
insemination by general linear models (regression). There was a general agreement between 
variables significantly different between OC and according to dpp (Table 2-4); two points of 
discrepancy between OC and dpp were blood beta hydroxybutyrate (BHB) concentrations and effect 
on embryo phenotype, discussed below.  
Milk yield in the week of oestrus, and the weeks before and after, all decreased with both OC and 
dpp, signifying the cows’ transitioning out of their peak milk production. Because of lower milk yield, 
along with more time for recovery from the previous pregnancy, body condition score (BCS) was 
higher at third OC (p<0.001), implying a positive energy balance. This is reflected by the metabolic 
indicators measured: blood concentrations of non-esterified fatty acids (NEFA) and BHB decreased 
with dpp at day 0 (p<0.001) or tended to decrease at days 4 and 7 (p=0.056 and p=0.087 
respectively) of oestrus, indicative of the improvement in metabolic status over time (Bernabucci et 
al. 2005). Similarly, average uterine horn size decreased with dpp (p=0.017) and OC (p=0.03). An 
interesting finding was that tail paint score was significantly lower at OC3 (p<0.001), suggesting that 




contributes to their overall reproductive performance. The increased concentration of oestradiol in 
cows on OC3 and along dpp is likely an important determinant of this heightened in-heat behaviour 
(Lyimo et al. 2000).  
Perhaps related to the overall metabolic conditions of the animals, oestradiol, and progesterone 
concentrations in blood at insemination (day 0) were higher at OC3 (all at q<0.001). One contributing 
factor of this difference is that the lower milk production by OC3 is accompanied by a decrease in 
feed intake, and consequently, lower metabolic clearance (Sangsritavong et al. 2002).  
In more detail, the process linking feed intake and hormonal concentration is as follows. Higher feed 
consumption causes increased liver function, to convert blood glucose into glycogen. This increase in 
liver function brings about a rise in blood flow through liver, and hormones present in blood (e.g. 
progesterone and oestradiol) are metabolised at a higher speed because of this augmented blood 
flow rate (Parr et al. 1993).  
In this case, it is possible that reduced dry matter intake later postpartum caused the amount of 
blood filtered by the liver to decrease, hence the amount of sexual hormones metabolised and 
excreted was also reduced. So, even though the secretion rate might remain stable, it stays in the 
circulation for longer and exerts a stronger effect (Diskin et al. 2006). These are hypothetical 
considerations, as feed intake was not measured in this study.  
No differences in area were found for CL at day 2 but CL tissue area (CL total area minus vacuole 
area) at day 7 increased with OC and dpp. Progesterone concentrations at the three timepoints 
measured however, were not different by OC (p>0.4) or dpp (p>0.31). This suggests that in this study, 
although progesterone is produced by the CL, CL size is not correlated to the amount of progesterone 
found in systemic circulation, being affected by the interaction of the processes discussed. This is in 
line with the results of Scully et al. (2015), who examined CL tissue area, CL blood flow, uterine 
homogeneity and progesterone concentrations. They found differences between pregnant and non-
pregnant beef heifers at day 16, but not at days 7 and 14 of pregnancy: specifically, non-pregnant 
cows showed a clear reduction of CL size from day 16 after insemination, whereas the CL of pregnant 
cows maintained its size (Scully et al. 2015).  
Effect of days postpartum on embryo quality  
An effect on embryo quality according to EQ1b (embryos classed from I to V in decreasing order of 
quality, plus non-recovery encoded as VI; q<0.001) and trend on EQ1 (embryos classed I to V; 
q=0.073) was observed for dpp but not OC. Specifically, embryos of higher quality were recovered as 
time postpartum increased. This agrees with the results of Berg et al. (2017), who showed that both 




Trends along OC and dpp in the variables examined tend to agree, though some discrepancies were 
also observed. These small discrepancies are unsurprising when observing a typical occurrence in 
breeding patterns in cattle herds: there is an overlap in OC across the season, i.e. at a given 
timepoint some cows will be expressing their OC1 while others are experiencing OC2 or even OC3. 
For example, in the present study, early cycling cows in this herd resumed ovulation (OC) at 11 dpp, 
while the last OC1 registered was at 70 dpp, by which point 20% of the herd had experienced their 
OC3. Based on the factors examined above, the physiological state of a cow can be distinctly 
different between early and late cyclers. This finding is important to establish the relevance of this 
study with similar studies from the literature. Furthermore, the effect of those parameters on 
embryo quality phenotype was examined next. A final consideration is that early pregnancies of day-
7 transferred embryos occurring in winter were associated with smaller embryo size at day 14 of 
pregnancy compared to those in spring or autumn, though it is unclear whether seasonal effects 
were acting at the recipient level, on the oocytes, or both (Berg et al. 2010). 
Table 2-4 Descriptive statistics of animals used and effect of the number of oestrus cycles after 
calving (OC) or days post-partum (dpp) on phenotypic variables, tested by paired t-test 
(OC) or linear regression (dpp). Values are mean±standard deviation. q-values: 
corrected for false discovery rate (FDR). Bold: significantly different variables by OC. 
Underlined: significantly different variables by dpp. Abbreviations: Avg, average; BHB, 
beta hydroxybutyrate; CL, corpus luteum; dpp, days postpartum; E2, oestradiol; NEFA, 
non-esterified fatty acids; O, oestrus; P4, progesterone; EQ1(b), embryo classification 
system 1 (see text). 
 Oestrus after calving (OC) days postpartum (dpp) 










Avg. BHB (mM) 0.59 ± 0.11 0.54 ± 0.09 0.002 0.002 0.072 0.119 0.013 




17.63 ± 3.18 0.002 0.003 0.001 0.003 0.054 
Avg. daily milk yield (l). O 
week 
19.5 ± 3.55 17.51 ± 3.35 >0.001 >0.001 >0.001 0.001 0.07 
Avg. daily milk yield (l). O-1 
week 
19.28 ± 3.4 17.78 ± 3.38 0.003 0.008 >0.001 0.001 0.063 
Avg. horn section area (cm2) 7.44 ± 2.01 6.38 ± 2.47 0.003 0.037 0.017 0.032 0.046 
Avg. NEFA (mM) 0.59 ± 0.23 0.27 ± 0.13 >0.001 >0.001 >0.001 >0.001 0.376 




BHB day 0 (mM) 0.61 ± 0.18 0.48 ± 0.12 >0.001 >0.001 >0.001 >0.001 0.078 
BHB day 4 (mM) 0.59 ± 0.16 0.51 ± 0.15 0.001 0.001 0.05 0.087 0.016 
BHB day 7 (mM) 0.56 ± 0.18 0.62 ± 0.16 0.004 0.041 0.031 0.056 0.02 
CL area day 2 (cm2) 1.28 ± 1.03 1.43 ± 0.97 0.344 0.523 0.367 0.465 -0.001 
CL area luteal tissue day 7 (-
vac; cm2) 
3.94 ± 1.92 4.38 ± 1.65 0.355 0.169 >0.001 0.001 0.063 
Days postpartum (dpp) 
38.89 ± 
11.27 
70.31 ± 18.62 >0.001 >0.001 NA NA NA 
E2 day 0 (ng/ml) 
14.39 ± 
9.19 
25.62 ± 10.9 >0.001 >0.001 >0.001 >0.001 0.137 
Metriscore 1.07 ± 0.3 1.06 ± 0.39 0.8 0.981 0.885 0.909 -0.006 
NEFA day 0 (mM) 0.78 ± 0.47 0.4 ± 0.23 >0.001 >0.001 >0.001 >0.001 0.171 
NEFA day 4 (mM) 0.53 ± 0.28 0.21 ± 0.18 >0.001 >0.001 >0.001 >0.001 0.259 
NEFA day 7 (mM) 0.46 ± 0.29 0.18 ± 0.14 >0.001 >0.001 >0.001 >0.001 0.262 
P4 day 0 (ng/ml) 0.29 ± 0.8 0.39 ± 0.47 0.306 0.485 0.71 0.771 -0.005 
P4 day 4 (ng/ml) 1.62 ± 0.84 1.62 ± 0.8 0.969 1 0.483 0.553 -0.003 
P4 day 7 (ng/ml) 4.95 ± 2.03 4.79 ± 1.68 0.564 0.798 0.207 0.303 0.003 
EQ1 2.46±1.41 2.17±1.33 0.249 0.426 0.056 0.073 0.021 
EQ1b 3.68 ± 2.04 3.28 ± 2.07 0.193 0.319 >0.001 >0.001 0.126 
Size and position score (SPS) 1.55 ± 0.54 1.53 ± 0.6 0.839 0.997 0.922 0.922 -0.008 
Tail paint score 0.49 ± 0.61 0.15 ± 0.4 >0.001 >0.001 >0.001 0.001 0.07 
2.3.3 Embryo phenotype 
The question of what is considered a viable embryo is not trivial. Studies in this area report viability 
estimates based on embryo grades that span a large range and with limited agreement (Table S2-3), 
though morphological grade is generally a better indicator of viability than developmental stage 
(tight morula, early blastocyst, etc.) at the time of transfer (Chebel et al. 2008). Other parameters 
have been associated with viability, including amino acid turnover (Sturmey et al. 2010, Hemmings et 
al. 2012) and release of other metabolites into the culture medium (Muñoz et al. 2014, Gomez et al. 




Incorporating differences in viability according to embryo stage in addition to embryo grade was 
intended in the present study but was not feasible due to a particularity of the experimental design 
chosen. Enrolled cows in Farm trials 2 and 3 cycled naturally at the oestrus events used in the 
experiments, without the use of synchronising protocols. Because heat detection was carried out by 
a technician observing the cows twice a day, the exact time of heat and insemination were within a 
12 h range. In this timeframe an embryo can develop from a tight morula to an early blastocyst, or 
from early blastocyst to hatched blastocyst (Alvarez et al. 2008); this implies that differences in 
embryo size observed at flushing could be related to ULF factors just as they could simply be a 
consequence of a few hours’ difference in ovulation time. Conversely, embryo grade is a time-
agnostic parameter (Hasler 2001), and thus was chosen as the main embryo classification phenotypic 
factor. One working hypothesis of this work is that there is a trend of increased viability with 
development from class V to class I. An exception/addition to this system were embryos of 16 cells or 
under (before compaction), including one cell embryos/oocytes, that were considered non-viable 
based on their delayed or arrested development. Finally, in 33% of ULF flushing samples no embryo 
was recovered (“NR”, non-recovery, discussed in a subsequent section).  
Trends by year and oestrus number 
Similar proportions of embryo phenotypes were observed in Farm Trials 2 and 3 (conducted in 2017 
and 2018 respectively) and between OC1 and OC3 in both years (Table 2-5). Recovery rates (i.e. 
proportion of ULF flushing samples where an embryo was found) was consistent across cycles (65% 
in OC1 and 67% in OC3). One important difference was a much higher proportion of excellent and 
good embryos (I and II) relative to total embryos recovered in OC3 compared to OC1 (78.9% vs 
55.9%), and lower number of III embryos (7% vs 22%) (Fisher’s chi-square p=0.0151). Similar 
proportions were found in the experiment of Berg et al. (2017) in NZ dairy cows conducted in several 
farms which reported that an increasing number of OC improved conception outcome to day 70. This 
is intimately related to the time after calving needed for uterine involution and to restore general 
metabolic function, as discussed in Chapter 1 and above. Of note, in two cases, ULF flushings 
recovered were turbid and not clear; ULF samples were examined under 200x phase contrast 
microscope (Nikon), finding that the turbidity of the fluid was due to eukaryotic cells, i.e. not caused 
by bacterial infection. Those samples were excluded from the data set.  
Potential determinants of embryo development 
No significant difference was found in the proportion of embryos under the 16-cell stage (i.e. classes 
IV and V) in both oestrus cycles (chi square p=0.2). A possibility is that those were predominantly 




(affecting oocyte quality) may constitute primary determinants of embryo development. The 8- to 
16-cell stage is a critical development milestone as activation of the embryonic genome must occur 
for further embryo development, and this milestone occurs while the embryo resides in the oviduct 
(Moussa et al. 2015). The ULF molecular milieu thus may affect embryo quality and determine 
embryo fate only beyond the 16-cell developmental threshold (Zhang and Smith 2015), i.e. after it 
started increasing its signal transduction apparatus (Misirlioglu et al. 2006). A higher proportion of 
embryo failure during OC1 may be related to cows having higher serum NEFA concentrations during 
the week of insemination. This hypothesis is supported by plentiful evidence (Van Hoeck et al. 2014, 
Leroy et al. 2018, Jordaens et al. 2020) that oocytes and early developmental embryos are more 
susceptible to high NEFA concentrations than later stage embryos. Alternatively, it is possible that 
oocyte quality was similar for both cycles or better at OC1, having started developing before the 
animal experience the peripartum metabolic shock (Britt 1991, Galvão et al. 2010), but that the 
oviduct was under severe metabolic compromise. Conflicting evidence exists, however: Matoba et al. 
(2012) observed no detrimental effect of metabolic stress -and associated higher concentrations of 
NEFA in blood- in postpartum (7-85 dpp) dairy cows on oocyte ability to develop to blastocyst stage. 
The implications of NEFA-induced embryo loss are further discussed in Chapter 8.  
Significance of time-dependent embryo losses 
The concurrent decrease of single cell embryos and increase in 4-16 cells from OC1 to OC3 might be 
evidencing the interaction of oocyte and uterine factors affecting embryo development in different 
ways at several timepoints (McMillan 1998). That is, oocyte quality is possibly the main determinant 
of embryo development, but that OLF and ULF also affect embryo viability substantially (Lonergan et 
al. 2016), as shown in vitro (Lopera-Vasquez et al. 2017, Hamdi et al. 2018) and in vivo (Katagiri and 
Moriyoshi 2013, Tríbulo et al. 2018). From this standpoint, good quality oocytes may develop to 
grade 3, 2 or 1 depending on ULF factors. Bad quality oocytes, conversely, may either not be 
fertilised and remain at the 1-cell stage in suboptimal OLF, or progress up to the 16-cell stage in 
optimal OLF environments; both cases constitute early embryonic death (Ahmad et al. 1997). This 
and other scenarios are explored in subsequent chapters, including comparisons of molecular 
composition of ULF harbouring embryos of different grades and sizes, except for those where no 
embryo was recovered. Non-recovery is discussed next. 
Table 2-5 Proportions of embryo phenotypes found in ULF according to number of observed 
oestrus events postpartum. *significantly different (p<0.05) by Fisher’s chi square test. 




Embryo stage and grade 
Number and % of 
embryos recovered 
Number and % of 
embryos recovered 
Number and % of 
embryos recovered 
Compact morula and 
blastocysts -Total (I-III) 
46 (78.0%) 49 (86.0%) 95 (81.9%) 
Excellent and good 
(Grades 1-2, I-II) 
33 (55.9%) 45 (78.9%)* 78 (67.2%) 
Poor (Grade 3, III) 13 (22.0%) 4 (7.0%)* 17 (14.7%) 
Morula (IV) 1 (1.7%) 0 1 (0.9%) 
2-16 cell (IV) 3 (5.1%) 6 (10.5%) 9 (7.8%) 
Single cell (V) 9 (15.3%) 2 (3.5%) 11 (9.5%) 
Total embryos 59 57 116 
 
Cow phenotype effect on embryo quality 
The effect of the parameters measured on the enrolled animals on the embryos found upon flushing 
their uteri was determined by regression analysis, using the systems designed as EQ1 and EQ1b as 
explained above (Table 2-6). Metriscore (p=0.03), tail paint score (p=0.04, q=0.17) and NEFA blood 
concentration at day 4 (p-0.07, q=0.28) were found to differ (or tend to differ) between classes 
according to EQ1 (embryo quality system excluding NR, Figure 2-4). The first two parameters are 
intrinsically subjective, i.e. highly dependent on the personnel in charge of the measurements and 
thus affected by a higher degree of variability. It is however interesting that a relationship was 
observed between these parameters and embryo quality. These results may be interpreted as 
follows: cows with low tail paint score (tail paint rubbed off), displaying stronger heat behaviour at 
oestrus tend to be in a better hormonal and metabolic condition and better prepared for pregnancy 
(Cummins et al. 2012, Diskin et al. 2015). Additionally, cows with low metriscore have lower 
intrauterine bacterial load, resulting in less inflammatory perturbations to the embryo environment 
(Jaureguiberry et al. 2017). 
This supports the theory behind the EQ3 system presented above, where distinct effects of oocyte 
quality (long and short term) and uterine milieu (chiefly short term) determine embryo quality 
sequentially. The trend of a significant effect of NEFA at day 4 is noteworthy, though unlikely to 
become a useful factor for prediction of uterine suitability because of two reasons: high variability 
within groups, and absence of effect at other timepoints, coinciding with the analysis of Santos and 




observed could be related to factors not tested here and that have been shown essential for 
pregnancy, such as the number of hormonal receptors in endometrium (Diedrich et al. 2007).  
Table 2-6 Phenotype descriptive statistics according to embryo class (EQ1b). P- and q-values 
correspond to regression of EQ1 and EQ1b to the cow level variables. Underlined are 
variables with a significant effect on embryo quality or tending to significance. 
Abbreviations: Avg, average; BHB, beta-hydroxybutyrate; CL, corpus luteum; dpp, days 
postpartum; E2, oestradiol; NEFA, non-esterified fatty acids; O, oestrus; P4, 
progesterone; Q1(b), embryo classification system 1 (see text). 
 EQ1 EQ1b 









Age (y) 5.21±1 5.43±2 4.8±2 5.67±1 6.47±3 4.84±2 0.17 0.53 0.72 0.89 
Avg. daily 
milk yield 
(l) O week 


















0.39±0.3 0.43±0.3 0.5±0.3 0.31±0.2 0.51±0.2 0.43±0.2 0.4 0.79 0.39 0.89 
BHB day 0 
(mM) 
0.55±0.2 0.51±0.2 0.6±0.2 0.53±0.2 0.56±0.2 0.54±0.2 0.56 0.79 0.28 0.89 
BHB day 4 
(mM) 
0.58±0.2 0.5±0.2 0.6±0.2 0.53±0.1 0.57±0.2 0.55±0.1 0.79 0.93 0.65 0.89 
BHB day 7 
(mM) 




CL area day 
7 (- vac; 
cm2) 
4.65±1.8 4.38±1.4 4.7±1.5 4.87±1.5 4.25±1.3 3.3±2 0.52 0.79 0.04 0.89 
CL area day 
2 (cm2) 




66±21 57±20 48±19 74±24 53±21 44±19 0.08 0.29 0.94 0.94 
E2 day 0 
(ng/ml) 















6.75±2 6.33±1.6 7.53±1.7 0.29 0.71 0.79 0.89 
Metriscore 1±0.01 1±0.03 
1.03±0.
1 







0.57±0.1 0.56±0.1 0.57±0.1 0.82 0.93 0.78 0.89 
NEFA day 0 
(mM) 
0.59±0.5 0.62±0.4 0.6±0.5 0.48±0.4 0.61±0.4 0.59±0.4 0.47 0.79 0.83 0.89 
NEFA day 4 
(mM) 
0.32±0.3 0.32±0.3 0.5±0.4 0.24±0.2 0.51±0.3 0.37±0.3 0.07 0.28 0.36 0.89 
NEFA day 7 
(mM) 
0.25±0.2 0.33±0.3 0.4±0.3 0.22±0.2 0.41±0.3 0.34±0.3 0.13 0.45 0.58 0.89 
P4 average 
(ng/ml) 
2.34±0.6 2.28±0.6 2.2±0.8 2.21±0.8 2.22±0.9 2.28±1.1 0.33 0.71 0.62 0.89 
P4 day 0 
(ng/ml) 
0.26±0.2 0.24±0.2 0.3±0.6 0.24±0.1 0.3±0.4 0.52±1.1 0.54 0.79 0.41 0.89 
P4 day 4 
(ng/ml) 
1.75±0.7 1.49±0.6 1.7±0.9 1.82±0.7 1.45±0.8 1.56±1 0.43 0.79 0.74 0.89 
P4 day 7 
(ng/ml) 




SPS 1.53±0.6 1.46±0.5 1.6±0.5 1.29±0.5 2±1.3 1.54±0.5 0.97 0.97 0.49 0.89 
Tail paint 
score 
0.18±0.4 0.28±0.5 0.6±0.8 0.11±0.3 0.5±0.5 0.44±0.6 0.04 0.17 0.09 0.89 
 
Non-recovery (NR) of embryos 
Due to the considerable proportion of ULF without embryos recovered (NR, “non-recovery”) and 
some differences observed between statistical analyses of EQ1 and EQ1b -different only by inclusion 
or not of NR ULF flushings as “class VI”-, this was examined further. Cow phenotype parameters 
measured were not different from animals for which an embryo was found in ULF flushing samples 
(Table 2-6). This agreed with PCA and univariate methods using proteomic features of ULF samples, 
in which no clustering of NR samples and no significantly different protein abundance (of NR 
compared to other groups) were observed (described in Chapter 5).  
In other studies, pregnancy determination was conducted by measuring interferon-tau (IFNT). This 
protein, secreted exclusively by the early embryo (Robinson et al. 2006) is responsible for the 
maternal recognition of pregnancy in ruminants (Ealy and Yang 2009). Detection of IFNT in ULF 
during embryo elongation (day 12 to 16) has been used to diagnose pregnancy status in ULF samples 
in which no embryo was recovered (Ribeiro et al. 2016b, Shorten et al. 2018). Research employing 
untargeted proteomics has reported detection of interferon tau at days 16 (Forde et al. 2014a), 17 
(Moraes et al. 2020a) and 19 (Gegenfurtner et al. 2019a). Conversely, IFNT was not detected in this 
study or other experiments examining ULF containing a single day-7 (Muñoz et al. 2012, Beltman et 
al. 2014) or day-10 (Forde et al. 2014a) embryo. However, evidence of IFNT secretion of day-7 
embryos from in vitro research is abundant (reviewed by Forde and Lonergan 2017). Taken together, 
these results suggest that embryos likely produce IFNT from at least day 7 of pregnancy, and that its 
concentration could not be used here to ascertain embryo presence because IFNT would be present 
in concentrations below the sensitivity limit of detection of most untargeted proteomic techniques.  
Lastly, cows with NR at OC1 had, in OC3, the highest proportion of good embryos (60%) and the 
lowest of NR (17%).  
The lack of correlation between the parameters measured and the non-recovery of an embryo in ULF 
flushing samples suggest that no negative phenotypical trait in certain animals caused the absence of 
a recovered embryo. Instead, non-recovery of an embryo is likely the product of technical difficulties 
(i.e. embryo not captured by the flushing medium or not found during screening of the flushing 
sample) as opposed to being caused by an abnormal, detrimental physiological process. A 




had an overall embryo recovery rate of 64.9% (648/998) (Wiebold 1988, Ryan et al. 1993, Sartori et 
al. 2002, Cerri et al. 2009a, Cerri et al. 2009b), with conditions nearly identical to this work. Roche et 
al. (1981) reported embryo recovery rates of 84% and 75% at days 8 and 14 respectively, higher than 
the average likely due to two reasons: flushing heifers, known for better fertility performance 
(Sartori et al. 2002) and post-mortem, reducing the odds of missing the embryo (Velazquez et al. 
2010). 
In vitro culture post-flushing 
Table 2-7 shows the proportion of embryos of each grade with an outcome reflecting improvement, 
no change, or worsened after 24 h cultured in vitro. A chi-square test of independence was carried 
out to ascertain the relationship between embryo culture outcome and grade of embryo at flushing. 
No significant differences were found (chi-square p=0.28), indicating that in vitro culture of day-7 
embryos for 24 h did not produce different outcomes depending on the original grade of the embryo. 
These results may be interpreted as indicating that the culture medium is neutral, slightly better than 
a detrimental ULF but worse than a healthy (beneficial) ULF. More than half of the embryos (56%) did 
not change quality, suggesting that the embryo fate is determined by day 7 in most cases. It is also 
possible that the stress from flushing and changing environment brought about most of the decrease 
in grade observed (Maillo et al. 2016, Ramos-Ibeas et al. 2020a). The small number of embryos (n=5) 
that improved after 24 h of in vitro culture was insufficient to constitute a group for statistical 
analysis. However, future studies are likely to benefit from following this relatively simple yet 






Table 2-7 Post-flushing embryo culture outcomes per grade. An increase or decrease in embryo 




Improved Same Worsened 




Grade 2 17 2 11 4 
Grade 3 12 3 7 2 
2.4 Conclusions 
In the experiments described in this chapter, distinct phenotypical changes were determined related 
to the time between calving and first expressed oestrus, both in number of oestrus events after 
calving (OC) and days post-partum (dpp). Longer post-partum interval measured by dpp significantly 
improved reproductive outcome because of generally ameliorated metabolic (energy) and morpho-
physiologic (uterine involution) status. Many phenotypical variables were tested at cow level, 
including blood concentration of progesterone and metabolites, CL dimensions and BCS, and others. 
Of those, three (metriscore, tail paint score, and NEFA at day 4) were found to have (or tend to have) 
an effect on embryo quality phenotype. However, none of those was deemed a significant 
contributing factor, i.e. with a high potential of application in predicting pregnancy suitability of a 
cow, in agreement with the findings of a recent multi-herd study in New Zealand (Bates and Saldias 
2019). 
As mentioned earlier, a key feature of this investigation is the use of the same animal at two 
distinctly different physiological stages from the early postpartum period through to the planned 
start of mating, the first of its kind to the knowledge of the author. This was deemed important to 
reduce sources of variability (particularly genetic) and to increase statistical power by performing 
paired analyses. The phenotypical variability observed is within normal parameters in a typical herd 
and thus reflects real conditions. 
To better understand the relationship between embryo phenotype, number of OC and dpp, and 






Proteomics method development 
3.1 Introduction 
In omics, a methodological approach that is sound, reliable, and efficient is key to maximise the 
quantity and quality of information extracted from samples. Prior to analysis of the experimental 
sample set, there were two fundamental premises directing method optimisation. One was to 
separate the metabolite-rich from the protein-rich fractions (reducing the total volume of sample 
needed, important in case samples had to be reanalysed). Another reason was to remove both the 
protease inhibitor and salts from the samples before proteomic analysis as those can be detrimental 
by affecting protein folding, which can effect trypsin’s ability to digest the protein and thus result in 
a decreased proteome coverage (Ananthi et al. 2011). 
Both the proteomics and metabolomics workflows include multiple customisable steps. Indeed, 
adjusting parts of the protocols is important for analysis of samples of different characteristics 
(Álvarez-Sánchez et al. 2010). This chapter describes the process of optimising several points in the 
workflow to maximise coverage and reproducibility. 
For proteomics method development, the process was divided into four parts: 1) extraction, 2) 
digestion (including reduction and alkylation), 3) instrument analysis, and 4) informatic analysis. 
Combinations were tested in triplicate unless otherwise stated. 
Optimised methods were selected according to the number of proteins identified. After protocol 
optimisation, to assess whether the setup was effective, Proteomics Experiment 2 (Exp. P2) 
describes a pilot trial carried out to estimate the magnitude of technical variation compared to 
biological variation in proteomics and determine the feasibility of this approach. 
3.2 Materials 
3.2.1 Reagents 
Water, acetonitrile, formic acid and methanol, all LC-MS grade, were sourced from Thermo fisher 
(Waltham, MA, USA). SDC (sodium deoxycholate) was bought from Acros Organics (Geel, Belgium); 
acrylamide, from BioRad (Hercules, CA, USA), and sodium bicarbonate from Fluka (Munich, 




phosphine), IAM (iodoacetamide), urea and thiourea were purchased from Sigma-Aldrich (St. Louis, 
MO, USA). Chloroform was bought from Mallinckrodt (St. Louis, MO, USA). 
Five-ml spin filter columns with 10 kDa molecular weight cut-off (Microsep® advance) were bought 
from Pall (Hamilton, New Zealand), and Slide-a-lyzer 3.5 kDa (12 ml) dialysis casettes from Thermo 
Fisher (Waltham, MA, USA). 
3.2.2 Samples 
ULF (uterine flushing) samples were obtained from a similar trial conducted by this research group in 
2015 and were used here for the specific purpose of protocol optimisation. Both the animals and the 
sampling method used in that trial were identical to those in trials carried out in this project (Farm 
Trials 2 and 3, described in Chapter 2). In detail, 20 cycling cows from several farms in central 
Waikato (New Zealand) were inseminated and flushed as described in section 2.1. A 5 ml aliquot of 
each uterine flushing was pooled for 100 ml final volume. All further method development was 
conducted using this pool as the sample except where otherwise noted. 
3.3 Methods: sample preparation 
3.3.1 ULF sample pre-processing 
Two protocols to isolate the protein fraction from the ULF were trialled, in both cases employing 5 ml 
of uterine flushing. 
a Dialysis using Slide-a-lyzer (Thermo Fisher) dialysis cassettes (3.5 kDa molecular cut-off 
weight). 
b Filtering using a 5 ml Microsep® advance spin filter device (Pall, Hamilton, New Zealand) with 
a 10 kDa molecular weight cut-off.  
Protein concentration of the retentates (high molecular weight fraction) resulting from the spin-
filtering (P0) and the dialysis (PD) were determined using DirectDetect® (Merck Millipore, Mairangi 
Bay, New Zealand) as described by Strug et al. (2014). Next, a volume containing 250 µg of protein 
from each sample was dried by a Centrivap benchtop vacuum concentrator (Labconco, Kansas City, 
KA, USA) at 45 °C for 3 h, and resuspended in 60 µl of 0.1 M ammonium bicarbonate (P0). Likewise, 
the filtrate resulting from the centrifugation was dried down by Centrivap (M0). Both fractions were 





3.3.2 Extraction and processing 
A common approach in proteomics experiments is to process sample material, with the aim of 
reducing the amount of potential contamination.  
In this work, five sample processing methods were trialled, using sample P0 (Fig. 3-1) as a starting 
point: a) none, b) protein denaturation with urea solution, c) chloroform-methanol extraction, d) 
addition of sodium deoxycholate before digestion and e) use of an albumin depletion kit. 
Protein denaturation with urea solution 
As described by Deb-Choudhury et al. (2014), 400 µl of denaturing solution (7 M urea, 2 M thiourea, 
50 mM DTT and SDS 1%) were added to P0 and centrifuged at 14,000 g for 30 min at 4°C resulting in 
sample PU. 
The denaturing solution used is incompatible with LC-MS analysis. Therefore, this protocol (PU) was 
followed by chloroform-methanol extraction as detailed next. 
Chloroform-methanol extraction 
A standard chloroform-methanol protein precipitation (Wessel and Flügge 1984) was tried, both 
preceded by extraction in urea buffer (PU to produce PUCM - Figure 3-) and as a first step (P0 to produce 
PCM). In brief, 400 µl of methanol were added to 100 µl protein solution (250 µg total protein 
resuspended in 100 µl of sample). After vortexing for 20 s, 100 µl chloroform were added and vortexed 
again. Subsequently 300 µl water were added, vortexed and then spun 1 min at 14,000 g (Eppendorf 
benchtop centrifuge 5424, Eppendorf AG, Hamburg, Germany). Next, after the removal of the top 
aqueous layer, 400 µl methanol were added, vortexed and spun again 2 min at 14,000 g. Upon 
methanol removal, samples were dried by Centrivap (PUCM, PCM) or resuspended in 50 µl of 0.1 M 
ammonium bicarbonate before addition of sodium deoxycholate (PCMS). 
Addition of sodium deoxycholate 
Sodium deoxycholate is a detergent shown to improve protein solubility and digestion (Koehn et al. 
2011). The effect of using this reagent on protein identification was tested as follows: addition of 
sodium deoxycholate (final concentration 1% v/v) to the 0.1 M ammonium bicarbonate solution prior 
to the first step in the digestion protocol (i.e. reduction) using filtered samples (P0 to produce PS) or 
extracted by methanol-chloroform (PCM to produce PCMS, Figure 3-1). Sodium deoxycholate was 
precipitated after digestion by the addition of 10% formic acid, upon which the mixture was 





A small number of proteins (chiefly albumin) make up a disproportionally high percentage of the total 
protein complement in uterine fluid (Beltman et al. 2014), and this may obscure detection of less 
abundant proteins (Faulkner et al. 2011). To address this, a kit for physical removal of albumin 
(AlbuminOUT™ Spin Columns, G-Biosciences, St. Louis, MO, USA) was trialled according to the 
manufacturer’s instructions. In short, 50 µl of albumin-binding buffer and 100 µl of resuspended 
uterine flushing were transferred into a 1.5 ml Eppendorf tube. After mixing by pipette, it was 
centrifuged at 10,000 g for 5 min at 4 °C. The supernatant was added to a previously conditioned 
AlbuminOUT™ Spin Column and incubated 2 min at room temperature. The flow-through was 
collected and re-applied to the column. It was spun at 1,000 g for 5 s, whereupon the albumin-free 
flow-through fraction (PAO) was dried by Centrivap and stored at -80 °C for digestion. 
 
Figure 3-1 Method combinations tested for sample preparation in this project's proteomics 
workflow. 
3.3.3 Protein reduction, alkylation, and digestion 
Reduction and alkylation 
Digestion of proteins was performed following the standard protocol by Shevchenko et al. (1996) for 
bottom-up proteomics with modifications in the reagents used for the reduction and alkylation 
steps. Through those processes, disulphide bonds are first reduced and then alkylated. This process 
allows tryptic cleavage of proteins into medium-sized peptides that can be analysed by standard 




Firstly, samples PD, P0, PUCM, PCM, PCMS, PS, PA0, resulting from all combinations trialled in section 3.3.2 
were re-suspended in 50 µL of 0.1 M ammonium bicarbonate. For protein reduction, two reagents 
were tested. Twenty µL of either 100 mM TCEP or DTT were added to the samples and incubated 45 
min at 56 °C on a thermomixer (Eppendorf Thermomixer R Mixer 5355, Eppendorf AG, Hamburg, 
Germany) at 600 rpm.  
For alkylation two reagents were also tested, iodoacetamide (IAM) and acrylamide. Either 20 µL 150 
mM IAM (0.028g of IAM in 1000 µL of 50 mM NH4HCO3, prepared fresh) or acrylamide (1.5 g/ml 
acrylamide in 50 mM NH4HCO3, prepared fresh) (Mineki et al. 2002) were added after reduction and 
incubated in the dark at room temperature for 30 min on a thermomixer at 600 rpm.  
The addition of acetonitrile as an adjuvant to digestion was also tried out as follows: after alkylation, 
tryptic digestion was performed by addition of 5 µg of sequencing grade porcine trypsin (Promega, 
Madison, WI, USA) overnight (16 h) at 37°C on a thermomixer (1:50 w/w trypsin to protein) with or 
without adding acetonitrile to a final concentration of 10% v/v.  
The digests were dried and re-suspended in 50 µL of 0.1% formic acid and were either used for mass 
spectrometry analysis or extracted as detailed next. 
Solid phase extraction 
Extraction matrices are commonly used for cleaning up and fractionating samples before proteomic 
analysis (Żwir-Ferenc and Biziuk 2006). For this, after digestion, tryptic peptides resulting from the 
previous step were extracted using Empore® disks (Meng et al. 2008) in either a three-step or four-
step fashion. 
In brief, Empore® (C18 47-mm) solid extraction disks (Supelco, Bellefonte, PA, USA) were cut in 
squares of 4 mm2 of area and conditioned by sequential 1-min incubations in acetonitrile, methanol, 
and water. Two 4 mm2 squares conditioned Empore® were immersed directly into the peptide 
extract and centrifuged briefly. Peptide extraction was carried out for 2.5 h at room temperature (21 
°C) on a thermomixer at 600 rpm. Subsequently, Empore disks from each sample were then placed 
in separate vials containing 100 µL of 0.1% (m/w) formic acid. Samples were washed by pipetting up 
and down 5 times and then formic acid was discarded.  
Further to this step, two different peptide elution methods were tested, a three-step and a four-step 
elution. For the three-step elution, the Empore disks were placed in 100 µL of 10 mM ammonium 




a tube containing 100 µl of 10 mM ammonium formate: acetonitrile 40:60 v/v and vortexed for 60 
min. Lastly, the procedure was repeated by transferring the disks to ammonium formate: 
acetonitrile 75:25 and vortexed for 60 min.  
The four-step elution was performed in a similar fashion, with elution mixtures of ammonium 
formate: acetonitrile 90:10, 75:25, 50:50, and 25:75. 
In both cases, all fractions were spun in Centrivap to dryness and stored at -20 °C until analysis. 
3.3.4 Chromatography and mass spectrometry 
Liquid chromatography programme 
Two liquid chromatography methods were tested (Table 3-1). In both cases, the mobile phase 
consisted in mixtures of solvent A (0.1% formic acid in MS-grade water), and B (98% acetonitrile, 
0.1% formic acid). The long gradient involved increasing from 2% to 20% B in 45 min, and 20% to 
45% B in 15 min, and up to 95% B, for a total run time of 85 min at a flow rate of 1 µl/min. The short 
gradient run was 2 to 10% B in 2 min, then 10 to 25% B in 8 min, 25 to 95% in 4 min and maintained 
for a further 5 min, for 28 min total running time. After the run, in both programmes a re-
equilibration of 2% B was programmed before the following run.All samples were diluted 10x using 
0.1% v/v formic acid (FA). 
Table 3-1 Liquid Chromatography programme settings for long and short runs.  







0 2 0 2 
0 2 0 2 
2 2 1 2 
47 20 3 10 
62 45 11 25 
66 95 15 95 




73 2 22 2 
85 2 28 2 
Mass spectrometry instrumental setup 
MS/MS analysis was carried out on a nanoAdvance UPLC, coupled to a maXis impact HD (Qq-TOF) 
mass spectrometer equipped with a CaptiveSpray source operated at 1500 V (Bruker). Two μl of 
sample was loaded on a C18AQ Nanotrap column (Bruker, C18AQ, 75 μm × 2 cm, 3 μm, 200 Å). The 
trap column was then switched in line with the analytical column (ProntoSil C18AQ, 100 μm × 15 cm, 
3 μm particles, 200 Å pore size, NanoLCMS Solutions Oroville, CA, USA). The column oven 
temperature was 50 °C. A mix of air and gas-phase acetonitrile was injected around the emitter 
spray tip through a nanoBooster™ (Bruker, Bremen, Germany) to support liquid desolvation and 
increase ionisation efficiency; settings were 3 l/min, dry temperature 150 °C. Samples were 
measured in auto MS/MS mode, in the mass range of m/z 350-1200.  
Mass spectrometry acquisition settings 
Mass spectrometry setups allow adjusting several settings. Trying all possible combinations was 
deemed impractical, therefore 25 runs with different parameters were performed using the same 
pooled sample. Some of them were trialled in short gradient LC runs for time-saving purposes, and if 
presenting an improvement over the by-default conditions, tried again using the long gradient LC 
run. Combinations of the following were tested (default values in bold, settings that are enabled 
only upon activation of a previous parameter in italics). 
Scan and fragmentation 
1 a) Number of precursors (10 or 5) OR  
b) Cycle time (3 or 5 seconds) 
2 a) Acquire MS/MS spectra for empty intervals (tick/not) 
b) [Empty interval] Time slice (1 seconds)  
3 Absolute threshold (1000 counts) 
4 a) Active exclusion (tick/not) 
b) (Active exclusion) Exclude after 1 spectrum 
c) (Active exclusion) Release after 0.2, 1, 1.5 minutes 
5 a) Smart exclusion (tick/not) 
b) [Smart exclusion) 5x or 10x 




6 MS/MS low threshold (1000 cts)    
7 Low - frequency (1, 5, 10 Hz) 
8 MS/MS high threshold (100,000 cts)   
9 High - frequency (10, 15, 20 Hz) 
 
Exclusion Scheduled Precursors List (ESPL) 
A technical limitation of data dependent acquisition methods for tandem MS is that only a limited 
number of molecules detected in the first MS scan are fragmented and scanned on the second step. 
This biases the detection towards peptides derived from the most abundant proteins in the sample 
(Aebersold and Mann, 2003). One workaround is to exclude those abundant, likely unimportant (for 
the biological question at hand) peptides from being fragmented and analysed. Aside from physical 
removal methods as AlbuminOUT™ Spin Columns described earlier, it is possible to create a list of 
peptides from those most abundant proteins along with their m/z and retention time and set the MS 
programme to not select them for fragmentation. This feature is known as Exclusion Scheduled 
Precursors List (ESPL) (Zerck et al. 2013). 
The same pooled sample was injected three times and the list of all peptide species identified was 
surveyed. From this list, m/z and retention time of the peptides corresponding to one of the five 
most abundant proteins by sum of peak areas of the top-3 peptides (Table S3.1a) were used to 
create a list of peptides to exclude; a fragment example is in Table S3.1b.  
3.3.5 Software analysis 
Two proteomics packages were trialled: ProteinScape Version: 4.0.3 315, Build id: 20161220-0956 
(Bruker Daltonics Inc) and PEAKS Studio v.10.0, build 20190129 (BSI, Waterloo, Canada). 
Proteinscape searching against Swissprot was used during the method optimisation stages of sample 
processing and digestion, while PEAKS studio was used after. Peptide-spectrum match searches 
against three databases were performed, namely Swissprot, Uniprot (which includes Swissprot and 
TrEMBL) and NCBI.  
Different search engines were used for protein identification. Proteinscape employs Mascot v. 2.5.1 
(Matrix Science, UK). PEAKS Studio has its proprietary search engine (PEAKS DB) with variants (PTM 
for extra post-translational modifications and Spider for amino acid substitutions); it also allows 
searches using Mascot v 2.5.1 (Matrix Science, UK) and Xtandem! v. Alanine (2017.02.01). Searches 
using external search engines need to be combined with a tool called “InChorus search” with a 




A further step was setting parameters at different levels of stringency. These included choice of 
post-translational modifications (both fixed and variable), mutations, peptide and protein score 
thresholds, and minimum unique peptides per protein identified. 
Parameters kept stable were enzyme trypsin semi-specific, de novo score (ALC%) threshold 50%, 
peptide-spectrum match (PSM) false discovery rate of 1%, maximum 3 missed cleavages per peptide.  
3.3.6 Variation sources – pilot trial 
A pilot trial (Exp. P2) was set up according to Maes et al. (2015). Briefly, 5 ml ULF samples from 5 
cows enrolled in a previous similar trial were used. Twenty ml were processed from samples of an 
additional cow in that trial, and from it resulted 6 technical (preparation) replicates (4A-F) (Figure 
3-2). One of the biological replicates was injected 4 times to appraise the extent of variation due to 
analysis in the instrument. Samples were run both in single MS (for quantification) and tandem 
MS/MS, to identify the proteins detected. 
Two different approaches were employed to evaluate relative contributions to variation: an 
analytical method dependent on identifications; as well as a multivariate, unsupervised method 
independent of identifications, and therefore able to capture a higher proportion of variation. 
The multivariate, unsupervised method was conducted by importing raw MS data to ProfileAnalysis, 
v2.1.265 (Bruker, Bremen, Germany). Signals for each compound (including adducts with other ions, 
as well as charge states +2 to +5) were combined. Peak areas for each feature were log-transformed 
to reduce heteroscedasticity. Next, Principal Component Analysis (PCA) was performed to examine 
similarity between samples and replicates of different types.  
The analytical method was based on identified proteins. Specifically, it consisted on tabulating the 
areas obtained by label free quantitation (LFQ) using PEAKS following the optimised method detailed 
in section 3.4.6. The MS/MS runs provided identifications, whereas peak areas were calculated from 





Figure 3-2 Experimental design of a preliminary experiment (Exp. P2) to assess the degree of 
technical variation to total variation. Uterine flushing (ULF) samples of 6 cows were 
processed as per protocol 4.1 (1-6). Six technical replicates from one ULF were 
prepared and run as independent samples (4A-4F). Another ULF sample was run four 
times by LC-MS/MS (5F1-5F4). 
Label free quantitation (LFQ) 
As established earlier, differences in amounts of proteins identified were assessed by LFQ, by MS 
(single MS) signal intensity; this is explained in detail in section 5.2.3. Briefly, mass error tolerance 
was 20 ppm, whereas Rt (retention time) shift tolerance was 2 min. Most parameters were left as 
default, including auto-detection of reference sample (taken as the centre for retention time 
alignment) and training samples (used to calculate the feature vector quality). Significance method 
was PEAKSQ, and data was normalised by total ion current. 
To link identifications to quantification data, all six biological replicates were run in MS/MS mode 
and incorporated as a separate group in the LFQ analysis. Both the sum of peak areas from all 
peptides as well as the top-3 peptides of each protein were exported.  
3.4 Results and discussion 
The objective of these experiments was to define the most efficient workflow. This included 
optimising the number of experimental steps to the minimum without sacrificing effectiveness, as 
technical variation is introduced in each stage. Thus, when the addition of a reagent resulted in only 
marginal improvements it was discarded, to reduce time and cost of processes or assays. 
3.4.1 Sample pre-processing 
Number of proteins identified are displayed in Table 3-2. The dialysis method resulted in 55±6 
proteins identified compared to 160±5 identified in the retentate product of the filtering method. 
Considering the additional disadvantage of losing the low MW fraction by dialysing, all further 
sample preparation was conducted using the retentate product of the spin filter process. Further 




Table 3-2 Comparison of number of proteins identified between processing methods. Values 
presented as means ± standard error of the mean. 
Method (fraction) Proteins 
PD (dialysis) 55±6 
P0 (retentate after filtering) 160±5 
PCM (chloroform-methanol extraction) 110±3 
PUCM (urea, chloroform-methanol) 70±2 
PS (addition of sodium deoxycholate (SDC)) 161±4 
PCMS (chloroform-methanol, SDC) 133±3 
PAO (retentate after Albumin depletion) 68±5 
 
3.4.2 Sample processing, extraction, albumin removal 
Both urea extraction and addition of sodium deoxycholate (SDC) have been reported to enhance 
detection by MS and reduce the amount of non-proteinaceous contaminants (Masuda et al. 2008). 
Regarding ULF samples, urea extraction resulted in 70±2 proteins identified (PUCM) compared to 160±5 
using the retentate (P0). Chloroform-methanol extraction also reduced the number of proteins 
identified (110±3 vs 160±5 proteins). As of the effect of SDC, it brought about an improvement over 
the use of chloroform-methanol extraction alone, but an average of only one extra protein was 
identified when this was used compared to without addition of SDC (133±3 for PCMS,  161±5 PS, 160±5 
P0 ). This minimal gain did not justify including this step.  
Albumin removal using resin columns (PAO) also resulted in a lower number of proteins identified, 
compared to the unprocessed retentate (P0) (68±5 vs 160±5). In summary, no denaturation or 
extraction step improved protein identification over the use of unprocessed retentate of spin-column 
filtering (P0). Therefore, unprocessed retentate of ULF was used thereafter. Steps are depicted in 





Figure 3-3 Processing protocol parameters trialled. Filtering without additional processing was 
chosen as the preferred method. 
3.4.3 Digestion 
Iodised alkylation reagents such as IAM may generate artefacts, specifically non-biological post-
translational modifications (Nielsen et al. 2008). Thus, acrylamide, an alternative alkylation reagent, 
was also trialled. In order of decreased performance, the combinations trialled produced the 
following number of proteins identified: DTT + IAM = 160 proteins; DTT + acrylamide, 133 proteins; 
TCEP + IAM, 129 proteins; TCEP + acrylamide, 118 proteins). DTT was clearly the optimal reduction 
reagent in this setup, whereas for alkylation, the higher number of protein identifications motivated 
in the selection of IAM as the preferred option, also considering the extremely toxic nature of 
acrylamide. As mentioned earlier, the use of IAM results in well-characterised modifications of 
proteins, especially carbamidomethylation of cysteine (Nielsen et al. 2008). Thus, this was included 
in subsequent protein searches as a variable post-translational modification (PTM). 
Incorporation of a digestion adjuvant -acetonitrile (ACN)- to a final concentration of 10% v/v resulted 
in decreased number of identified proteins in this setup (120±11 vs 160±5 under the same 
parameters without addition of acetonitrile) and was therefore not further performed. 
Solid phase extraction 
Neither 3- and 4-step solid phase extraction protocols, used for clean-up prior to LC-MS, increased 




fraction) and running time (extra 85 minutes per fraction). Specifically, 141±10 (4 fractions) and 
153±8 (3 fractions) proteins were identified, as opposed to 160±5 proteins without any solid phase 
extraction. 
Summarising, the optimal digestion protocol included reduction of ULF proteins with DTT, alkylation 




Figure 3-4 Protocol parameters trialled (digestion preparation). Chosen protocol was reduction 
with DTT, alkylation with IAM, no acetonitrile added as an adjuvant, no solid phase 
extraction with Empore disks. 
3.4.4 LC and MS parameters, use of Exclusion Lists 
Liquid chromatography 
The average number of proteins in the short gradient programme was 84±13, whereas the long 
programme resulted in 160±5 identified proteins. Because there were no substantial differences in 
reproducibility, the long gradient programme was used hereafter. Table 3-3 shows the effect of 
selected permutations on number of proteins identified, using Proteinscape. Alternative settings 
provided substantially less protein identifications than the standard method (160±5), therefore the 





Figure 3-5 Liquid chromatography and mass spectrometry parameters trialled. Optimal settings 




Table 3-3 Number of proteins identified with each combination of liquid chromatography and mass spectrometry settings trialled. First row for each LC 






































Long 10 NA No No 1000 No NA NA No 1000 1 100000 20 160
Long 10 NA Yes 2 1000 No NA NA 5 1000 1 100000 20 134
Long 10 3 No No 1000 No NA NA No 1000 1 100000 10 99
Long 10 NA No No 1000 No NA NA No 1000 1 100000 15 99
Long 10 NA No No 1000 No NA NA No 1000 5 100000 20 95
Long 10 NA No No 1000 No NA NA No 1000 10 100000 20 101
Long 10 NA No No 1000 Yes NA 0.2 5 1000 1 100000 20 100
Long 10 NA No No 1000 Yes NA 0.2 5 1000 1 100000 20 83
Long 10 NA No No 10000 Yes NA 0.2 5 1000 1 100000 20 77
Long 10 NA No No 10000 No NA NA No 1500 0.1 100000 20 97
Long 2 NA No No 1000 No NA NA 5 1500 0.1 10000 0.5 28
Long 10 NA No No 5000 Yes NA NA 5 1000 1 100000 20 86
Long 10 3 No No 1000 No NA NA No 1500 0.1 100000 20 91
Long 10 NA No No 1000 No NA NA No 1500 0.1 10000 0.5 62
short 10 NA No No 1000 No NA NA No 1000 1 100000 20 84
Short 10 NA No No 1000 No NA NA No 1000 1 100000 15 38
Short 2 NA No No 1000 No NA NA No 1500 0.1 10000 0.5 9
Short 10 NA No No 1000 Yes NA 0.2 No 1500 0.1 10000 0.5 34
Short 10 NA No No 1000 No NA NA No 1500 0.1 10000 0.5 23
Short 10 NA No No 5000 No NA NA No 1000 1 100000 20 28
Short 5 NA No No 1000 No 2 NA 5 1000 1 100000 20 32
Short 10 NA Yes 2 1000 No NA NA 5 1000 1 100000 20 49
Short 20 NA Yes 1 1000 No NA NA No 1000 1 100000 20 50
Short 10 NA No No 1000 No NA NA No 1000 1 100000 10 67
Short 5 NA No No 1000 No NA NA No 1000 1 100000 15 70
Short 10 NA No No 1000 No 2 1 No 1000 10 100000 20 77





Exclusion Scheduled Precursors List (ESPL) 
The creation, importing and application of the exclusion list in the MS control software, otofControl 
v. 4.4.4.4 (Bruker, Bremen, Germany) required strict parameters. These included file format, specific 
rules for naming files and entering data, step order to import into the software, etc. Moreover, 
anecdotal evidence from colleagues using the same instrument suggested that this software was 
optimised for inclusion scheduled precursor lists and that exclusion lists might not work simply 
because of software limitations (Evelyne Maes, personal communication). 
A peptide list corresponding to albumin (most abundant protein in ULF samples) or the top-5 
proteins was generated from the results of the optimised run (top row, Table 3-). Different ESPL were 
added to the MS method used in 14 separate runs. Although some peptide fragments in the list were 
effectively excluded, this did not result in greater number of identifications. In fact, some fragments 
outside of the set m/z and Rt ranges were also excluded by the instrument during analysis. The 
application of ESPL thus resulted in 75±17 proteins identified, compared to the original 160 of the 
run from which the exclusion list was derived. Therefore, this approach was discarded. 
To sum up, the settings chosen were a long programme for LC runs, default settings in MS/MS 
analysis, and no application of ESPL (Figure 3-6). 
3.4.5 Software analysis 
Software package and databases 
Instrumental steps described so far were assessed by number of proteins identified as well as inter-
replicate consistency using Proteinscape. Subsequently, to select the best protein identification 
software, the performance of Proteinscape and PEAKS studio (specifically, using PEAKS DB as the 
search tool) were compared using Uniprot. Protein identifications were higher using PEAKS studio 
compared to Proteinscape (235±14 vs 160±5), likely due to its improved algorithm that uses both 
database searches as well as de novo peptide identification, thus augmenting the number of peptides 
identified (Zhang et al. 2012). From this point on, all further optimisation was performed using PEAKS 
studio. 
Next, the implementation of different protein databases (NCBI, Uniprot and Swissprot) using PEAKS 
DB as the search tool was trialled. Number of proteins identified were 321±7 for NCBI, 235±11 for 
Uniprot and 208±14 for Swissprot. The non-curated nature of the NCBI database resulted in the 




identified were in fact the same protein under different accession numbers. With regards to the 
other two databases, Uniprot -which comprises the curated database of Swissprot and its 
automatically annotated supplement TrEMBL (O'Donovan et al. 2002)- was chosen due to its balance 
between number of proteins identified and the reliability of the matches. 
Search engine 
InChorus search is a functionality of PEAKS studio that incorporates results from up to four search 
engines, increasing number of hits and confidence, as positive identifications resulting from different 
algorithms are more reliable (Shteynberg et al. 2013). Quantification using PEAKS studio requires 
both simple (MS) and tandem (MS/MS) data; the method optimisation for identification belong in 
the second category.  
MS/MS chromatography data from a run using the optimised parameters as per above were 
analysed using the four main search tools in PEAKS studio: PEAKS DB, PEAKS PTM, Spider and 
InChorus. In that order, the number of proteins identified using the standard run and searching 
against Uniprot was 235, 276, 279 and 327. An important caveat is that quantification using InChorus 
identification is not supported in PEAKS studio. Therefore, the other three search tools were 
considered further for use in label-free quantification experiments. 
Protein search parameters 
PEAKS Studio includes an algorithm that detects the most common post-translational modifications 
(PTM) and incorporates them into the following steps of the search (PEAKS PTM search). Based on 
the number of PTM across all proteins identified, carbamylation (M) was set as fixed modification, 
whereas carbamidomethylation (C) ubiquitin (CKST), deamidation (NQ) and methylation (KR) were 
set as variable modifications. 
Mass error tolerance parameters were examined using Spider, a search tool in PEAKS Studio that 
repeats the peptide search of unassigned spectra against proteins already identified in a PEAKS DB 
search, potentially increasing coverage and identifying new mutations. Combinations tested were 
precursor mass error (5 or 10 ppm), and fragment ion tolerance (0.05 or 0.02 Da). The combination 
that resulted in the highest number of identifications was 10 ppm and 0.02 Da (279 proteins), 
whereas 5 ppm and 0.05 Da was the least effective (198 proteins), in both cases at 1% false discovery 
rate (Benjamini and Hochberg 1995). 
A key distinction between Spider and PEAKS PTM is that the first search tool considers the existence 
of amino acids (AA) mutations in its search. A lengthy list of mutations was suggested by results from 




not been reported in the NCBI library. The substantial number of suggested mutations that are 
unreported in the NCBI library points at an overconfident algorithm (Table 3-4). PEAKS PTM results 
were deemed more reliable and constituted the preferred search tool to use in LFQ experiments. 
To summarise, the optimal software setup was PEAKS Studio, using Uniprot as the database. The 
most suitable search engine was PEAKS PTM for quantification and InChorus for identification 
purposes only, with one unique peptide required to accept an identified protein (Figure 3-7). 
Table 3-4 Most frequent post-translational modifications and putative mutations as identified by 
PEAKS Studio’s Spider search tool. Position indicates what amino acids this 
modification is searched on; “#PSM” is the number of peptide-spectrum match 




Carbamidomethyl C 1828 
Ubiquitin CKST 1743 
Deamidation NQ 496 
Ala -> Gln Q 346 
Gly -> Asn NQ 184 
Methylation KR 84 
Val -> Arg R 79 






Figure 3-7 Software tools and parameters trialled. Optimal options were PEAKS Studio, using 
Uniprot as protein database, with PEAKS PTM for quantitation, and InChorus for 
identification purposes only. Other settings are detailed in text, section 3.4.3. 
3.4.6 Optimal protocol summary 
Sample preparation 
Firstly, 5 ml spin filter columns 10 kDa molecular weight cut-off Microsep® advance (Pall, Hamilton, 
New Zealand) were rinsed with saline solution (Baxter, Toongabbie, Australia) twice to remove glycerol 
(which interfered with metabolomics analysis) and left to dry under a fume hood. Then, 5 ml aliquots 
were taken from each ULF sample and centrifuged in said spin filter columns to fractionate them. 
The protein content of the retentates was measured using DirectDetect® (Merck Millipore, Mairangi 
Bay, New Zealand) plates. A volume containing 250 µg was taken and dried using a Centrivap benchtop 
vacuum concentrator (Labconco, Kansas City, KA, USA) at 45 °C for 3 h, following which were 
resuspended in 60 µl of 0.1 M ammonium bicarbonate (Fluka Munich, Germany). Then, samples were 
reduced with 20 µl of 100 mM DTT (Sigma-Aldrich, St. Louis, MO, USA). for 45 min at 56 °C on a 
thermomixer (Eppendorf Thermomixer R Mixer 5355, Eppendorf AG, Hamburg, Germany) at 600 rpm, 
followed by alkylation with 20 µL 150mM IAM (Sigma-Aldrich, St. Louis, MO, USA) (solution in 
ammonium bicarbonate) in the dark at room temperature for 30 min on a thermomixer at 600 rpm.  
Tryptic digestion was performed by addition of 5 µg of sequencing grade porcine trypsin (Promega, 




the digests were dried and re-suspended in 50 µl of 0.1% formic acid (Thermo-fisher, Waltham, MA, 
USA) in LC-grade water (Thermo-fisher, Waltham, MA, USA) and used for LC-MS/MS analysis. 
LC-MS/MS analysis 
Five μl of the peptide digest were added to 45 μl 0.1% FA and this 1:10 dilution was used for LC 
analysis. The mobile phase consisted in mixtures of solvent A (0.1% formic acid in MS-grade water, 
v/v), and B (98% acetonitrile, 0.1% formic acid, v/v). Elution was with a gradient from 2% to 20% B in 
45 min, and 20% to 45% B in 15 min, and up to 95% B, for a total run time of 85 min at a flow rate of 
1 μl/min. LC-MS and LC-MS/MS analysis was carried out on an UltiMate 3000 RSLC nano UHPLC 
(Thermo Fisher), coupled to an Impact HD (Q-TOF) mass spectrometer equipped with a CaptiveSpray 
source (Bruker, Bremen, Germany). Two μl of sample were loaded on a Dionex Nanotrap column (5 
mm × 300μm inner diameter, with 5 μm C18 beads, Thermo Fisher). The trap column was then 
switched in line with the analytical column (ProntoSil C18AQ, 100 μm × 15 cm, 3 μm particles, 200 Å 
pore size, NanoLCMS Solutions Oroville, CA, USA). The column oven temperature was 50 °C. A mix of 
air and gas-phase acetonitrile was injected around the emitter spray tip through a nanoBooster™ 
(Bruker, Bremen, Germany) to support liquid desolvation and increase ionisation efficiency; settings 
were 3 l/min, dry temperature 150 °C.  
Samples were measured in auto MS/MS mode, in the mass range of m/z 350-1200. One MS scan 
from m/z 350-1200 at 1 Hz was followed by tandem MS scans of the top 10 precursor ions at 1-20 Hz 
by CID (collisional induced dissociation), and with dynamic exclusion of 90 s, with ions reconsidered if 
intensity increased more than 4-fold within the exclusion period). Up to 10 precursors were selected 
for fragmentation. The LFQ (Label-Free Quantitation) method employed was based on two types of 
information: protein identification (obtained through tandem MS, i.e. MS/MS runs) and protein 
quantification (single MS runs). For identification-purposed (MS/MS) analysis, 64 ULF samples (picked 
at random and run throughout) were run undiluted to maximise the number of peptide ions 
detected. Thus, when analysed with single MS (i.e. without fragmentation) samples were diluted 1:10 
to prevent signal saturation. PEAKS Studio’s functionality was used to link precursor ions of these 
runs to those identified in MS/MS runs. 
3.4.7 Proteomic analysis 
PEAKS Studio v.10.0, build 20190129 (BSI Inc., Waterloo, Canada) was used for proteomic analysis, 
specifically by PEAKS PTM, with protein identification augmented by InChorus search, a multi-engine 
search tool that incorporates results from Mascot, X!Tandem, and the PEAKS de novo search engine. 
Protein identification was performed searching against an in-house database comprising all bovine 




Consortium 2018), with the following parameters: semi-specific trypsin as enzyme, maximum 3 
missed cleavages per peptide, precursor mass error 10 ppm, and fragment ion tolerance 0.02 Da. 
Carbamylation (M) was set as fixed modification, whereas ubiquitin (CKST), carbamidomethylation 
(C), deamidation (NQ) and methylation (KR) were set as variable modifications. Protein quantification 
by PEAKSQ significance method followed a label-free approach, with mass error tolerance of 20 ppm 
and retention shift tolerance of 2 min. Settings for export were: minimum one unique peptide per 
protein group, de novo score (ALC%) threshold 50% and peptide-spectrum match (PSM) false 
discovery rate 1%. For quantification, the top hit of each protein group was used, and protein 
abundance was calculated as the peak area sum of the top-3 unique peptides, normalised by total 
ion current (TIC) of each sample divided by the reference sample chosen automatically by PEAKS 
studio.  
Informatic analysis 
PEAKS Studio v.10.0, build 20190129 (BSI, Waterloo, Canada) was used for software analysis.  
Protein identification was performed searching against Uniprot (Uniprot Consortium 2018) with the 
following parameters: semi-specific trypsin as enzyme, de novo score (ALC%) threshold 50%, peptide-
spectrum match (PSM) false discovery rate 1%, maximum 3 missed cleavages per peptide, precursor 
mass error 10 ppm, and fragment ion tolerance 0.02 Da. Carbamylation (M) was set as fixed 
modification, whereas ubiquitin (CKST), carbamidomethylation (C), deamidation (NQ) and 
methylation (KR) were set as variable modifications. 
Protein quantification followed a label-free approach, with mass error tolerance of 0.01 Da, and Rt 
shift tolerance of 2 min. Most parameters were left as default, including auto-detection of reference 
sample (taken as the centre for retention time alignment) and training samples (used to calculate the 
feature vector quality). Significance method was PEAKSQ, and data normalised by total ion 
chromatogram (TIC). 
3.4.8 Variation sources 
The aim of this trial was to assess the proportion of variation corresponding to true biological 
differences as opposed to error stemming from technical factors. This was necessary to confirm 






One approach employed to assess relative importance of variation sources was a PCA using features 
directly, bypassing the identification step so that all features could be included in the analysis. In the 
main trials presented in further chapters, identifying the proteins detected was important and thus a 
different method was employed. 
The clustering of samples according to the first two principal components confirmed that injection 
replicates are the most reproducible, followed by technical (e.g. sample preparation) replicates, 
whereas those two groups and the other four biological replicates did not cluster (Figure 3-8). Note 
one slight outlier among the technical replicates (pointed by a green arrow). 
 
Figure 3-8 Principal component analysis (PCA) plot using the peptide features detected by LC-
MS/MS analysis of uterine luminal fluid in the preliminary proteomics experiment to 
assess the degree of technical to total variation. 
Univariate analysis 
To obtain a numeric estimate of the differences observed in the principal component analysis, 
protein abundance (sum of top-3 peptide peak areas) identified by PEAKS as detailed in section 3.4.6 
were tabulated and grouped to estimate the proportion of variation of three origins: LC injection, 
technical (i.e. sample preparation, which also includes LC injection), and total (biological, technical 
and injection). The coefficient of variation (CV) for each type of replicate was calculated to obtain the 
proportion of technical variation to total variation. 
A total of 332 proteins were identified, out of which 300 were consistently detected, i.e. in at least 
70% of the samples in each group. Injection CV was under 20% for more than 200 proteins. Total 
technical variation was less than 30% of the total variation for 108 proteins (40% of the protein set) 
Purple: Injection replicates 
Green: Technical replicates 












i.e. 70% of the variation detected was biological. A similar number of proteins presented technical 
variation between 30 and 60% of the total, while a further 44 proteins evidenced between 60 to 90%. 
Some 20% of the proteins had technical variations in the range of the total, which indicates that 
potentially the biological differences between samples could be obscured by variability in the setup 
(Figure 3-9).  
Taking the results of both assessment methods together the conclusion was that the biological 
component in the variation of most of the proteins was likely to be detectable and quantifiable.  
In conclusion, the procedures presented in this chapter resulted in a satisfactory level of performance 
to carry out the main proteomics experiment using this instrumental setup (Exp. P3, Chapter 5).  
 
Figure 3-9 Pareto plot showing number of proteins in each range of percentage of coefficient of 
variation (CV) due to technical aspects vs total CV, which includes technical and 






Metabolomics method development 
4.1 Introduction 
As described in Chapter 1, metabolites are the endpoint of many endogenous processes and highly 
informative about their functional state, while also reflecting genetic factors. Because metabolites 
are closest to an individual’s phenotype, they are especially relevant when looking for biomarkers for 
the biological conditions being studied (Smolinska et al. 2012). In addition to individual biomarker 
discovery, a deeper understanding of metabolic pathways evolving throughout the postpartum 
period relevant to embryo development may result in improved herd fertility parameters. 
In addition to characterising changes in the ULF molecular landscape that putatively influence early 
embryo development, a potential application of a metabolomic fingerprinting method was tested 
using rapid evaporative ionisation mass spectrometry (REIMS), an instrumental platform based on 
direct infusion mass spectrometry. One of the goals of this project was to test if a molecular 
fingerprint of ULF is feasible, with the aim of assessing its potential to identify a receptive uterus 
before embryo transfer.  
4.1.1 Variability of sample volume 
Uterine flushing in vivo presents a key challenge: the volume of ULF originally sampled is unknown 
and complete recovery of the liquid is never obtained, complicating comparisons of abundance of 
molecules across samples (Velazquez et al. 2010). Thus, to account for differences in recovery 
efficiency of the flushing process, and potentially of the fluid dilution, a small trial was designed to 
test the use of an isotopic tracer.   
The molecule tested in this work as a tracer was stable-isotope-labelled proline. It is not present 
naturally in the animal yet mimics a biological compound (native proline). This was added to the 
flushing medium as an internal standard to account for dilution and recovery efficiency of the 
flushing procedure. Stable isotopes have been successfully employed to study nitrogen flux and 
energy expenditure (Klein and Klein 1987) as well as other nutritional parameters (Iyengar 2002), and 
proven to be safe for human application, including in infants (Klein and Klein 1987). 
4.1.2 Aims 
The main aim was to develop an experimental method to characterise the ULF metabolome 
effectively and reliably (Metabolomics Experiment 1, “Exp. M1”). A secondary aim was to test the 
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application of a tracer molecule as an internal standard to account for variation caused by dilution of 
ULF during flushing, as well as testing the safety of its application (Exp. M2). Finally, Exp. M3 
evaluated the use of a direct infusion mass spectrometry technique (REIMS) to generate a 
metabolomic fingerprint of ULF, in a first step to appraise the potential of this approach as a 
diagnostic tool for uterine receptivity in a further experiment. 
ULF flushing samples have not been extensively measured using metabolomics, so it was important 
to ensure that protocols developed for blood plasma were appropriate. Therefore, different 
approaches were trialled in two steps of the GC-MS/MS workflow, and their suitability determined by 
coverage (number of metabolites detected) as well as technical reproducibility. 
4.2 Materials and methods 
4.2.1 Reagents and samples 
Chloroform was bought from Mallinckrodt (St. Louis, MO, USA). LC-quality water and methanol were 
sourced from Thermo fisher (Waltham, MA, USA); trimethylsilyltrifluoroacetamide (MSTFA) with 1% 
trimethylchlorosilane (TMCS) and methoxamine-hydrochloride solution in pyridine (30 mg/ml) were 
obtained from Sigma-Aldrich (St. Louis, MO, USA). Medical-grade saline solution 0.9% NaCl was 
acquired from Baxter (Toongabbie, NSW, Australia).  
Alkane retention index standards (C7-C33) were bought from Restek Corporation (Bellefonte, PA, 
USA). Internal standard mix (Alanine d4, Benzoic acid d5, Leucine d10, Citric acid d4, Glucose 1,2 
13C2, Tyrosine d2, Stearic acid d35 and Tryptophan d5, Methyl nonadecanoate, all 4 µg/ml) was 
prepared in-house from chemicals sourced from Cambridge Isotope Laboratories (Tewksbury, MA, 
US). Isotope-labelled L-Proline (13C5, 99%; 15N, 99%) was also sourced from Cambridge Isotope 
Laboratories. 
4.2.2 Experimental design 
Experiment M1: pre-fractionation and extraction for GC-MS/MS 
The method was optimised for uterine fluid by testing two pre-fractionation alternatives and two 
extraction methods in a 2x2 design (Table 4-8) using 5 ULF pooled technical replicates per treatment. 
The effect of pre-fractionation was assessed by comparing ULF samples as described in section 3.3.1, 
specifically a) unprocessed ULF flushing fluid, or b) filtrate from ULF spin column filtration (fraction of 




Table 4-8 Latin square - methodological combinations for GC-MS/MS metabolomics optimisation 
experiments. 
 Monophasic extraction (M) Biphasic extraction (B) 
Whole ULF (W) 5 technical replicates (WM) 5 technical replicates (WB) 
ULF Filtrate (F) 5 technical replicates (FM) 5 technical replicates (FB) 
 
A second aspect was the extraction protocol, either monophasic (Jiye et al. 2005) or biphasic 
(Armirotti et al. 2014). Two outcome variables were examined to decide the most suitable approach 
for Experiment M4 (main GC-MS/MS metabolomics experiment, Chapter 6): number of transitions or 
features (metabolites) identified for each combination of methods and reproducibility. This was 
assessed by two independent methods. Analytically, the number of features detected whose peak 
areas presented a coefficient of variation equal to or lower than 10% was determined, across 
technical replicates. A second parameter considered was the degree of clustering in non-supervised 
statistical analysis (PCA). This parameter indicates similarity between replicates, both qualitatively 
and quantitatively, and thus it is a useful tool to compare treatments (Lenz et al. 2016).  
 
Figure 4-3 Experimental workflows trialled for GC-MS/MS protocol optimisation to analyse ULF. 
*Filtered with centrifugal spin columns as detailed in Chapter 3. Abbreviations: CHCl3, 
chloroform; GC, gas chromatography; MeOH, methanol; MSTFA, methyl-silyl 
trifluoroacetamide; Rcf, relative centrifugal force; TMCS: trimethyl-silyl chloride.  
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In all cases, targeted analysis was used for optimisation, with centring and auto-scaling as the default 
data pre-treatment. This process results in each variable (i.e. metabolite peak area) having a mean of 
zero and variance equal to one (Jackson 2005). Its main feature is that all variables are given equal 
weight, reflecting the premise that in living beings, relative abundance cannot be taken as a proxy of 
biological importance (van den Berg et al. 2006). An alternative analysis strategy investigated was 
full-scan (untargeted) GC-MS/MS analysis, using the parameters presented in the following section. 
Sample processing methods 
Samples used were described in 2.2.4 (Farm Trials 2 and 3). Workflows are depicted in Figure 4-3, 
The first step tested in this experiment was pre-processing, as described in 3.3.1. In brief, 5 ml 
aliquots from a pool of ULF from 20 different cows were filtered using Microsep® spin filter columns 
with 10 kDa molecular weight cut-off (Pall, Hamilton, New Zealand), which resulted in a retentate 
and a filtrate fraction (“F”). Both the filtrate fraction and whole (“W”) ULF 5 ml aliquots were dried 
down by vacuum centrifuge concentrator (Labconco, Kansas City, KA, USA) and kept at -80 °C until 
analysis. 
The two extraction methods were similar except for the initial steps. Briefly, the dried fraction was 
re-suspended in 50 µl LC-grade water, and 10 µl of internal standard (IS) mix was subsequently 
added. Then, 450 µl of a mixture of chloroform: methanol (1:1 v/v) (biphasic) or 450 µl of methanol: 
water (4:1 v/v) (monophasic) was added and shaken for 3 min at 30 Hz in a bead shaker (Qiagen, 
Stockach, Germany). For the biphasic extraction, tubes were placed at -20 °C for 30 min and then 200 
µl of water were added.  
From this point on, the workflows were the same. The samples were shaken for a further 3 min at 30 
Hz and centrifuged at 10,000 rcf for 15 min at 4 °C. A 200 µl aliquot of the upper phase (biphasic) or 
supernatant (monophasic) were transferred to a GC glass vial insert and dried completely in vacuum 
centrifuge concentrator at 35 °C for 2 h. Samples were then derivatised using a two-step  procedure. 
Methoxymation was accomplished by addition of 30 µl of methoxamine-hydrochloride solution in 
pyridine (30 mg/ml) and incubating for 1 h at 40 °C. Sylilation was conducted by adding 30 µL of N-
Methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) with 1% (w/v) trimethylchlorosilane (TMCS) and 
incubating for 1 h at 40 °C. 
Targeted analysis 
Samples were analysed using a broad-based targeted GC-MS/MS metabolomics method. For this, GC 
was performed on a BPX5 capillary column with 0.25 mm internal diameter, 0.25 µm film thickness, 
and 30 m length (SGE Ltd, Australia). One µL of derivatised sample was injected at a starting 
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temperature of 60 °C for 2 min then ramped to 320 °C at 15 °C/min and held for 3 min, using He as 
the carrier gas at a constant linear velocity of 39 cm/s.  
A Shimadzu 8040 GC-MS/MS instrument (Shimadzu, Kyoto, Japan) was employed for mass 
spectrometry analysis, with the following settings: interface temperature 280 °C, the ion source 200 
°C, ionisation voltage 70 eV. Mass measured range was 45 to 600 m/z, at a 0.2 s interval. 
Mass spectrometry parameters were predetermined and optimised for the same system and column 
based on injection of standards as part of the Smart Metabolites Database package (Shimadzu, 
Kyoto, Japan). This commercially developed method package for targeted metabolomics contains 
452 multiple reaction monitoring (MRM) transitions, totalling 311 unique metabolites. These 
metabolites cover a broad range of compound classes including organic acids, energy metabolism 
intermediates, amino acids, some fatty acids, and mono- and di-saccharides.  
In this technical approach, metabolite identification is based on two factors. One is retention index 
(Gonzalez and Nardillo 1999), that is, retention time relative to a series of alkane standards (C7–C33) 
injected during the same batch. This allows reliable comparisons independent of actual retention 
time between batches and even across different GC-MS platforms. The second is MRM transition, 
where a compound must have not only the right initial fragment from the initial electron impact 
ionisation fragmentation (precursor ion), but also the correct fragment after further fragmentation 
(product ion), and a roughly similar intensity (peak area) ratio between precursor and product ion 
(Hansen et al. 2011). Peaks were automatically integrated and each of the 452 transitions further 
checked manually for correct qualifier/quantifier ion ratio and retention time. 
All peak areas were normalised using internal standards (Jonsson et al. 2005). This approach aims to 
standardise samples’ peak areas by adding the same amount of internal standard (IS) mix to all 
samples; differences in the peak areas of these compounds are a measure of the magnitude of 
technical error. Specifically, values of peak areas of IS for all samples were tabulated, centred, and 
autoscaled (transformed so that each variable had a mean of 0 and a standard deviation of 1, to 
correct for magnitude differences across variables). Next, principal component analysis (PCA) was 
performed using R statistical software v4.0.2 (R Team 2019). The first component of the PCA 
represents the dimension with the highest amount of variability across samples due to all IS peak 
areas; the (loading) value of each sample in this component is considered to summarise variation 
arising from differences in peak areas of all IS. Lastly, all metabolite peak areas in the samples were 
divided by the loading value of the first component of the PCA in that sample, and the resulting 
values were used thereafter for all further analyses. 
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Afterwards, two parameters were evaluated. Firstly, the number of features detected in each group 
(coverage) and the number of those with coefficients of variation (CV) lower than 10% within each 
group were assessed. Secondly, sample clustering in non-supervised statistical analysis (PCA) was 
examined. The tightness of clustering indicates both qualitative and quantitative similarity between 
replicates (Worley and Powers 2013). Plots were produced using the R package ggplot2 (Wickham 
2016).  
Untargeted analysis 
Settings were identical to those for targeted analysis except that instead of measuring set transitions, 
a full scan of ions in the region of 30 to 650 m/z was performed. 
Experiment M2: heavy proline as tracer to estimate sample dilution 
The animals used in this experiment were sampled in Farm Trial 1 and were similar in breed to those 
in the main herd. Differences were that the animals were synchronised to be at the same cycling 
stage (oestrus), were not lactating, and that due to the novel use of a xenobiotic they were kept 
separated in a containment unit. Further details of the animals and the schedule of synchronisation 
and sampling have been presented in section 2.2.4. 
The molecule chosen as tracer was isotope-labelled L-Proline (13C5, 99%; 15N, 99%), a compound 
commonly used as an internal standard for technical variation introduced during sample preparation 
in metabolomics experiments (Koek et al. 2006). This proline is identical to the naturally most 
abundant proline isotopical form except for its molecular weight (6 Da heavier). This property 
enables its detection as a separate peak in mass spectrometry analysis even though its 
chromatographic retention time is the same as native proline.  
Procedure 
Firstly, three tracer concentrations (0.1, 1 or 10 µg/ml) in a range based on the report of Koek et al. 
(2006) were tested to determine the optimal concentration for detection; this was 1 µg/ml. Flushing 
medium was prepared by adding 1 ml of tracer stock solution (500 µg/ml) to 500 ml of saline solution 
for a final volume of 1 µg/ml. Uterine flushing was performed as detailed in 2.2.4, using 30 ml of 
flushing medium. The flushed liquid was collected, snap-frozen and kept at -80 °C. ULF samples of six 
animals were further analysed, following filtration and extraction as per 4.2.2. 
A 5 ml blood sample was taken from all animals at four times: t0 (immediately before flushing), and 
at 1, 6 and 24 h (t1, t6, t24) post-flushing, and stored as plasma according to the protocol in section 
2.2.4. Plasma samples from two animals at all timepoints were further analysed by GC-MS/MS. 
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Along with ULF and plasma samples, the following were analysed: a saline blank, three aliquots of 
tracer-spiked flushing medium, standards of heavy proline dissolved in LC-MS grade water (i.e. stock 
solution of 4.2 mg/ml and a dilution at 1 µg/ml, both as positive controls), and a QC pool made of 
aliquots of all other sample types to assess instrument performance. Except for the standards of 
heavy proline, all other sample types were filtered and extracted as per 4.2.2. Gas chromatography 
and tandem mass spectrometry equipment and settings used were described in section 4.2.2. 
Chromatogram peaks for tracer were manually checked, tracer peak areas quantified and tabulated. 
Transfer to bloodstream was assessed based on the abundance differences between tracer peak 
areas of ULF and blood samples. 
Experiment M3: Metabolomic fingerprinting by direct infusion mass spectrometry 
Fourteen ULF samples as described in 3.2.2 from a previous similar trial were used to refine the 
direct infusion mass spectrometry technique (REIMS). In brief, 2 ml of ULF sample were pipetted into 
a foil cup (Wilton Inc., Wellington, New Zealand) and vaporised using a handheld monopolar device 
(“iKnife”) fitted with a diathermy electrosurgical generator (Erbe VIO 50C, Erbe Medical UK Ltd, UK) 
at 50 V cutting mode in triplicate measurement, with cone voltage set to 100 V and heater bias to 20 
V. The MS data was acquired in both positive and negative ionisation mode using a Waters Xevo® G2 
qToF mass spectrometer with REIMS interface (Waters Corp. Wilmslow, UK), run in resolution mode 
at 100 μl/min isopropanol flow rate, with a scan time of 0.5 s and a mass range of m/z 50-1500. The 
instrument was calibrated using 5 mM sodium formate in isopropanol (infused via REIMS’s matrix 
inlet) prior to analysis. Sample measurement consisted in sliding the tip of the knife along the surface 
of the ULF sample for 2 s (positive ionisation mode) or 4 s (negative ionisation mode), three to four 
times per sample, with a 15 s window between burns to allow time for clearing the signal. Data 
processing was conducted as described by Ross et al. (2020). In brief, the sample files were split into 
separate files for each replicate using ProGenesis Bridge (Waters). Mass alignment and baseline 
subtraction were carried out with the same software, with 0.1 Da mass tolerance for feature 
selection. ProGenesis QI (Waters) was employed for noise correction. Mass adjustment for all 
features were adjusted to an internal lock-mass peak area of ion 121.25 m/z (an adduct of 
protonated isopropanol) in positive mode, and peak area of ion 325.3 m/z (consistently the largest 
peak, putatively identified as arginylasparagine) in negative mode. In both ionisation modes, peak 
intensity was normalised to total ion current. 
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4.3 Results and discussion 
4.3.1 Experiment M1: development of optimal GC-MS/MS protocol 
Coverage and univariate analysis of reproducibility 
All method combinations were equally effective in terms of coverage, i.e. 209-211 features 
identified, out of a total 452 features scanned for in the mass spectrometry package used (Figure 
4-2). This was considered satisfactory, especially in light of other studies using the same method 
reporting 159 compounds detected in human plasma (Uji et al. 2017) and 91 detected in soybean 
(Makino et al. 2020). When examining the number of reproducible features (i.e. with CV <10%), the 
most robust combination was filtering and biphasic extraction (96 highly reproducible features), 
followed by non-filtered and monophasic extraction (81), filtered and monophasic (70) and lastly, 
non-filtered and biphasic (20). On closer inspection, compounds higher in filtrate fractions compared 
to whole samples were mostly amino acids and other organic acids, whereas the main differences 
between monophasic and biphasic extractions were in monosaccharide concentrations.  
 
Figure 4-2 Number of metabolites detected per replicate following each workflow combining either 






There are some reports of trends for sample processing methods to favour extraction of specific 
metabolite classes, such as lipids by monophasic extraction (Calderón et al. 2019), and sugar 
phosphates by biphasic extraction (Prasannan et al. 2018). However, this last study also suggested 
that despite differences in specific metabolites, both types of extraction can be used to adequately 
extract all the predominant metabolite classes (Prasannan et al. 2018), which was also evident in this 
study.  Differences in the metabolites detected according to the platform employed are further 
examined in Chapter 6.  
Multivariate analysis of reproducibility 
Reproducibility was further assessed by visual inspection of a PCA plot displaying the first two 
principal components. Samples in the FB group (filtrate fraction, processed by biphasic method) 
presented by far the tightest clustering in the two dimensions encompassing the most variance in a 
PCA (Figure 4-3). 
Considering results from both univariate and multivariate analyses, FB (filtrate and biphasic 
extraction) was the methodology of choice for the main experiment (Exp. M4). 
  
Figure 4-3 Principal Component Analysis (first two components) showing the degree of similarity 
between technical replicates. Abbreviations: FB, filtrate biphasic; FM, filtrate 




Samples were analysed by an alternative approach. Instead of pre-selecting specific ions for 
fragmentation, all ions in the 30-650 m/z window were analysed and fragmented. This resulted in a 
high number of features detected (532). However, only 86 were identified by the m/z of the 
precursor and product ions in mass spectrometry analysis, due to not all metabolites being well 
characterised and included in metabolite libraries. The overlaps and differences between the 
metabolites identified by each approach are examined in Chapter 6. For the present work, compound 
identification was crucial and therefore the targeted method was selected. 
Glycerol contamination 
Following preliminary runs, an unexpectedly high glycerol peak was detected in the spectra of 
filtered samples which saturated the detector and interfered with closely eluting compounds. By 
comparing spectra with those obtained from non-filtered samples, the source of the glycerol 
contamination was found to be the plastic filters in the spin columns. A simple washing with saline 
solution followed by centrifuging 10 min at 10,000 g was able to remove most of the glycerol from 
the columns and improved accurate detection of three compounds that were otherwise saturated by 
the glycerol signal (data not shown). 
4.3.2 Experiment M2: Tracer 
Tracer peak annotation and identification 
The goals of this experiment were to determine the validity of quantifying tracer peak area as a proxy 
of dilution during sampling, and to confirm no transfer occurred from uterine lumen to bloodstream.  
The first step was sample preparation and measurement by GC-MS/MS. ULF samples from 6 cows 
(both whole and their filtered fraction <10 kDa, Table 4.1) and plasma samples from two cows at four 
timepoints (before flushing, and 1, 6 and 24 h after) were processed and analysed, along with QC 
pooled samples, saline solution blanks (negative control), aliquots of tracer-spiked flushing medium, 
and standards of tracer dissolved in MS grade water, i.e. stock solution of 4.2 mg/ml and a dilution at 
5 µg/ml (both as positive controls).  
Next, manual inspection of peaks was carried out to verify that the area values reported by the 
automatic software analysis corresponded to the tracer. Representative chromatograms of tracer 
transitions in the six types of samples (ULF, QC pools, saline blanks, saline spiked with tracer, tracer 
stock solution, and plasma) are displayed in Figure 4-4. For identification of the tracer peak, the Rt 
and qualifier to quantifier ion ratios were taken as standard to which the other runs were compared. 
The most prevalent peak in ULF, QC and plasma samples was classed as an unidentified compound. 











Figure 4-4 GC-MS/MS analysis (Exp. M2 - tracer): representative chromatograms for each type of 
sample. A: plasma sample from cow #14 at t1, i.e. taken 1 h after flushing B: detail 
from A. C: ULF flushing sample. D: detail of C (8x zoom). E: saline blank. F: spiked saline 
(flushing medium), batch 7. G: Tracer standard. H: Quality control pool A (QCA).  
examination evidenced a small peak of tracer in ULF and QC samples, preceding and partially co-
eluting with the dominant peak (Figure A-8-2). Even though both the automatic and manual peak 
annotation were performed as consistently as possible, some error is unavoidable as the overlap 
between peaks hinders unequivocal delimitation.  
After peak verification, quantification was carried out using the quantifier ion peak areas (transition 
189>73.1) as per the software developer’s specifications. Worthy of note, the qualifier transition was 
a suitable candidate for quantification as none appeared in plasma samples or blank. In fact, similar 
trends were observed as when using quantifier transition; however, because of its lower intensity, 
this resulted in an increased error. In consequence, quantifier ion peak area was used hereafter.  
Tracer peak quantification 
The stock solution presented a peak of considerable intensity (over 400,000 arbitrary units). An 
aliquot of the stock solution was diluted to the same concentration as the samples (1 µg/ml); its peak 
area of 6457 units was taken as a reference of this concentration. In the case of spiked flushing 
medium, the three aliquots taken from different batches were technical replicates and expected to 
present peaks at least at the same level of the ULF samples, if not more, as no dilution would have 
occurred by the volume of fluid originally present in the uterine lumen. The discrepancies observed 
between what could be considered technical replicates, might be related to the high amount of salt 
that did not dissolve fully in the small volumes of solvents added during the extraction and 
derivatisation stages. The replicate with the biggest peak area (3560 units) is likely representative of 
the spiked flushing medium. This indicates a potential decrease of 45% of tracer amount during the 
filtering and chemical extraction steps. 
QC runs represent injection replicates, whose purpose was to determine differences in the 
instrument performance across this experiment; their areas varied up to 30%, which is not surprising 
at low intensities (i.e. under 10,000, and especially under 1,000; Table A-1). However, the peak areas 
of other compounds with higher intensities were similar and therefore the reproducibility of this 
experiment was considered satisfactory. 
Regarding ULF samples, the volume recovered in each case was within an 8 ml range (19 to 27 ml), 




Transfer to blood 
As mentioned, no tracer peak was observed for plasma samples (Figure 4-5, Table A-11). Inspection 
of the tracer peak area values in blood samples at different timepoints showed that the biggest areas 
corresponded to T0 samples, i.e. before flushing and therefore before any tracer could have entered 
the bloodstream. The absence of a detectable amount of tracer in blood samples in this experiment 
was potentially caused by the substantial dilution that would have occurred if any amount of tracer 
had indeed entered the bloodstream. The concentration of tracer added to the flushing medium was 
optimal to measure it in uterine fluid -of an estimated volume of under 10 ml (Schultz et al. 1971)-. 
On the other hand, the total amount of blood in a cow is usually in the range of 20 to 25 l (Reynolds 
1953). Had any material transfer occurred, it would have resulted in a change below the limit of 
detection sensitivity of the instrument. 
 
Figure 4-5 Tracer peak areas of the different types of samples. QC, quality control (pooled ULF) 
samples. Area is expressed in arbitrary units (AU). 
Applicability of the tracer approach for dilution estimates 
Aside from the use of heavy proline as a tracer, other strategies to calculate dilution and volume 
were considered. One is the use of a readily diffusible molecule that can spread freely between blood 
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and ULF. In a successful example of a similar technique, urea has been effective for dilution 
calculations when performing lung epithelial fluid flushing in humans (Rennard et al. 1986), based on 
the assumption that urea can diffuse almost unrestrained throughout body fluids and compartments 
(Taylor et al. 1965). However, the application of this strategy for ULF requires extensive method 
development and validation, and this was deemed outside the scope of the present work. 
The biological rationale motivating this experiment was that differences in the degree of uterine 
involution might be an important factor in the differences in reproductive performance observed in 
this animal model (Berg et al. 2017). Uterine involution has been highly relevant and indicative of 
recovery post-partum and readiness for a pregnancy (Kiracofe 1980), directly as well as indirectly by 
determining post-partum disease (Sheldon et al. 2006). While this preliminary data showed 
consistency in the recovered volumes, these cows were synchronised to day 7 of oestrus and the 
uterus was well involved as these cows were not lactating. Greater variation in the recovered 
flushing medium volume was likely to occur in dairy cows 23 to 80 days postpartum in Farm Trials 2 
and 3. This is because when the uterine horns are not contained within the pelvis, some fluid can be 
trapped in the uterine horns as these cannot be lifted sufficiently to allow all flushing liquid to flow 
down. Thus, along with implementing the tracer approach described, SPS score (indicative of the 
position of the reproductive tract in the pelvic cavity as explained in Chapter 2) was included as a 
variable in the analysis. Moreover, another factor that can affect fluid recovery are technical issues, 
especially the catheter balloon not making a tight seal of the uterine walls; this results in some fluid 
escaping the catheter and not being recovered. 
In summary, the results of this preliminary trial pointed at the uterine flushing method producing a 
measurable degree of mixing and dilution between the ULF and the flushing medium. The differences 
observed justified its use in the main trials (Farm Trials 2 and 3, analysed in chapters 5 and 6), 
considering that the safety of tracer application to lactating animals was confirmed due to negligible 
or undetectable transfer from uterus to general circulation. SPS score was also considered important 
as a covariate to account for recovery differences. 
4.3.3 Targeted metabolomics: optimal protocol 
Based on the methods trialled in Exp. M1, the protocol to be used for sample analysis in the main 
experiment was decided. It was decided that the tracer (i.e. isotope-labelled proline) be added to the 
saline solution to make up the flushing medium, at the tested concentration of 1 µg/ml.  Following is 




Firstly, 5 ml spin filter columns 10 kDa molecular weight cut-off Microsep® advance (Pall, Hamilton, 
New Zealand) were rinsed with saline solution twice to remove glycerol and left to dry under a fume 
hood. Then, 5 ml aliquots were taken from each (tracer-spiked) ULF sample and centrifuged in said 
spin filter columns to fractionate them. The filtrate (4.8 ± 0.2ml) was collected and dried down in a 
Centrivap benchtop vacuum concentrator (Labconco, Kansas City, KA, USA) at 45 °C for 3 h and kept 
at -80 °C until analysis. 
Next, the dried fraction was resuspended in 50 µl water, and 10 µl of internal standard mix (Alanine 
d4, Benzoic acid d5, Leucine d10, Citric acid d4, Glucose 1,2 13C2, Tyrosine d2, Stearic acid d35 and 
Tryptophan d5, Methyl nonadecanoate, all 4 µg/ml, prepared in-house from chemicals sourced from 
Cambridge Isotope Laboratories, Tewksbury, MA, US) was added. Biphasic extraction was carried out 
by adding 450 µl of a mixture of chloroform (Mallinckrodt, St. Louis, MO, USA): methanol (Thermo-
fisher, Waltham, MA, USA) (1:1 v/v) and shaken for 3 min at 30 Hz in a bead shaker (Qiagen, 
Stockach, Germany). Tubes were placed at -20 °C for 30 min and then 200 µl of MS-grade water 
(Thermo-fisher, Waltham, MA, USA) were added. The samples were shaken for a further 3 min at 30 
Hz and centrifuged at 10,000 g for 15 min at 4 °C. Two hundred µl of the upper phase (biphasic) were 
transferred to a GC glass vial insert and dried completely in vacuum centrifuge concentrator 
(Labconco, Kansas City, KA, USA) at 35 °C for 2 h. Samples were then derivatised using a two-step 
derivatisation procedure. Methoxymation was accomplished by addition of 30 µl of methoxamine-
hydrochloride solution in pyridine (30 mg/ml) (Sigma-Aldrich, St. Louis, MO, USA) and incubating for 
1 h at 40 °C. Sylilation was conducted by adding 30 µL of N-Methyl-N-trimethylsilyltrifluoroacetamide 
(MSTFA) with 1% trimethylchlorosilane (TMCS) (Sigma-Aldrich, St. Louis, MO, USA). and incubating 
for 1 h at 40 °C. 
4.3.4 Experiment M3: Optimisation of direct infusion mass spectrometry for 
metabolomic fingerprinting 
Direct infusion mass spectrometry analysis with REIMS was carried out as per usual practice in this 
laboratory (Ross et al. 2020), which typically employs solid sample matrices like meat or, 
occasionally, vegetables. Despite REIMS being a technology optimised for analysis of solid samples, it 
was possible to analyse (i.e. obtain spectra) ULF samples. However, this was not the case with plain 
water. It is likely that the presence of sodium chloride in the flushing solution (main constituent of 





In negative mode, a total of 4933 features (ions) were detected, of which 2862 were kept after 
removing those in blanks, for a final number of 2294 after removing features not quantified (i.e. 
zeroes). Similar values were observed for analysis in positive mode (4971 features detected; 2238 
only in ULF samples, of which 1533 were quantified). Sampling in positive mode produced cleaner 
burns (i.e. more clearly defined peaks in total ion chromatogram) and therefore sample 
reproducibility based on features obtained in this ionisation mode was expected to be higher (Figure 
A-8-). However, this did not result in visible improvements in technical reproducibility, i.e. outlier 
burns (technical replicates) were observed by multivariate analysis (PCA) in both modes (Figure 
A-8-4). 
In this regard, a matrix effect has been reported, whereby certain materials produce cleaner spectra 
in either positive (fruit; Arena et al. 2020) or negative (bacterial cultures; Bodai et al. 2018) polarity, 
however this phenomenon has not been studied in depth. 
Averaging technical replicates considered reliable for each cow, PCA plotting showed a trend towards 
clustering based on embryo quality, though the low number of samples precluded conclusive 
interpretations (Figure 4-6). 
In summary, a measurable metabolomic fingerprint was achieved by REIMS in both positive and 
negative ionisation mode; thus, this approach was suitable for the main metabolomic fingerprinting 
experiment (Exp. M5).  






Figure 4-6 REIMS (rapid evaporative ionisation mass spectrometry) reproducibility assessed by 
PCA. A, positive ionisation mode; B, negative ionisation mode; C: combined. Colours 
indicate embryo quality: Red, non-viable (1-16 cells); blue, potentially viable (Grade3); 
green, viable (Grade 1-2). 
 
4.4 Conclusions 
Several alternatives were trialled at different steps of the method for broad targeted metabolomic 
analysis. This process concluded with the choice of filtrate ULF extracted by a biphasic method as the 
optimal protocol to use in the main experiment in this project. Moreover, the targeted approach 
assayed was deemed more suitable for this experiment than the untargeted due to the difference in 





tracer, assayed in Exp. M2, enabled measuring the degree of flushing-induced dilution of ULF across 
samples. This, as well as the confirmation of the safety of its use, motivated the decision of adding 
tracer to flushing medium in the main metabolomics experiment (Chapter 6). 
Lastly, the untargeted, ambient mass spectrometry approach tested in Exp. M3 was effective at 
obtaining a metabolic fingerprint of ULF and therefore suitable for measuring the main experimental 







This part of the project aimed to explore relationships between abundance of protein species in 
bovine uterine luminal fluid (ULF) with embryo phenotypes sampled and with days post-partum or 
number of oestrus after calving (OC). This investigation was accomplished by liquid chromatography 
– tandem mass spectrometry (LC-MS/MS)-based molecular analysis of ULF samples collected in Farm 
Trials 2 and 3 over two years at OC1 and OC3, as explained in Chapter 2.  
This chapter is organised as follows. Firstly, presence and degree of blood contamination and 
technical reproducibility throughout the experiment were assessed. Afterwards, the ULF proteome -
as detected in this experiment- was analysed qualitatively by itself and compared with previous 
studies. This comprised number of proteins identified, functional analysis (Gene Ontology terms and 
pathways represented), and proteins predicted to be secreted. Next, univariate analysis was carried 
out to determine differences in the molecular composition of ULF containing embryos of dissimilar 
quality. Lastly, the dataset was explored by multivariate analyses, firstly unsupervised (PCA) followed 
by supervised (sPLS-DA and OPLS-DA). The predictive potential of the models created was evaluated 
by cross-validation. 
5.2 Materials and methods 
All ULF samples corresponding to the main experiment were prepared according to the optimised 
protocol as described in section 3.4.6, with the following modifications. 
5.2.1 Assessment of blood contamination 
A low to moderate degree of tissue damage is a regular occurrence during uterine flushing 
(Velazquez et al. 2010). This can constitute an issue because, as described in Chapter 1, ULF and 
blood share a sizable portion of their proteome (Faulkner et al. 2012). Differentiating which biofluid 
those common proteins originated from is not feasible, and this can severely affect quantitative 
protein abundance determinations (Helfrich et al. 2020). Blood contamination creates a red tinge 
caused by the high concentration of haemoglobin and this can be indicative of the degree of blood 
present in the sample (Guise and Gwazdauskas 1987). In this study, sample colour was assessed 
visually before spin column filtration according to Martins et al. (2018), a step not undertaken in the 
preliminary trial as pooled samples were used. Colour was recorded on a scale from 0 (completely 
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transparent) to 4 (deeply red tinted samples). This classification had the primary purpose of 
estimating the degree of blood contamination; a second purpose was to appraise the protein 
concentration of the samples to ensure they were within the detection range of the method, as 
explained below. 
Protein concentration of the retentate (high molecular weight fraction) was determined using 
DirectDetect® (Merck Millipore, Mairangi Bay, New Zealand) as described by Strug et al. (2014). 
Samples with a colour score ≥ 2 were diluted 1:10 with distilled water before the measurement to 
keep readings within the concentration range 0.5-5 mg/ml protein. In this range, there is a linear 
relationship between infrared absorbance and protein concentration and therefore allows for the 
most accurate estimates.  
5.2.2 Protocol for ULF sample analysis 
The full protocol is detailed in section 3.4.6. In short, sample preparation consisted of filtering ULF 
using 10 kDa cut-off spin-columns, without any denaturing or extraction steps, noting their colour in 
a scale from 0 to 4. Next, protein concentration was measured using DirectDetect; and then a volume 
of retentate containing 250 µg of protein was reduced with DTT, alkylated with IAM, and digested 
with trypsin. The LC programme involved a gradient separation (described fully in chapter 3) 
between 2% B to 95 % B with a total length of 85 minutes followed by re-equilibration at 2% B. 
5.2.3 Experimental design 
All samples were prepared and run in a randomised order using the “random” function in MS Excel 
v.2002 (Microsoft Inc., Build 12527.21330). The LFQ (Label-Free Quantitation) method employed to 
quantify proteins in the samples followed the specifications of Dong et al. (2020). Briefly, this 
approach requires two types of information: protein identification (obtained through tandem MS, i.e. 
MS/MS runs) and protein quantification (single MS runs). Both types of runs were included in each 
batch. For identification-purposed (MS/MS) analysis, ULF samples were run undiluted to maximise 
the number of peptide ions detected. This resulted in many peaks reaching the detector’s maximum 
intensity threshold, detrimental for reliable quantification. Thus, when analysed with single MS (i.e. 
without fragmentation) samples were diluted 1:10 to enable quantification, using PEAKS Studio’s 
functionality to link precursor ions of these runs to those identified in MS/MS runs. The sum of the 
top-3 peptides for each protein was used to calculate abundance. 
Quality control system 
Based on the system proposed by Bittremieux et al. (2018), two types of quality control (QC) were 
carried out as one of the methods to assess the system’s performance throughout the experiment. 
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First, a bovine serum albumin (BSA) standard at a concentration of 5 µM was run twice in each batch 
as routine so comparisons to historical QC runs in our lab could be made. It was run in a shorter LC 
programme (28 minutes total time, as described in 3.3.4) to save instrument time. The peak areas of 
six of the most consistent ions were plotted across time to evaluate the performance of the mass 
spectrometry system. Table 5-9 shows an example of the sample run list of a batch. Additionally, a 
pooled QC sample was run in a standard 85 min LC programme (the same as the ULF samples). For 
this, 20 ULF samples were pooled for a QC pool to be injected in every batch. These pool QC samples 
were also used for batch correction, as explained later.  
Table 5-9 Run order in a batch (example). Green: ULF test samples - quantitation. Pink: ULF 
samples – protein identification. Purple: ULF pooled sample (control). Blue: BSA 
standard (control). Grey: blank. 
Sample Type 
1160 1.18 ULF sample (MS) 
1026 3.17 ULF sample (MS) 
1118 3.18 ULF sample (MS) 
1118 3.18 ULF sample (MS) 
1167 3.18 ULF sample (MS) 
BSA QC_A (MS/MS)  
2020 3.18 ULF sample (MS) 
1105 3.18 ULF sample (MS) 
1114 3.18 ULF sample (MS) 
1165 1.18 ULF sample (MS) 
Pool QC_B (MS/MS) 
1116 1.18 ULF sample (MS/MS) 
BSA QC_A (MS/MS)  
Column clean Blank (MS/MS) 
5.2.4 Informatic and statistical analysis 
PEAKS studio using Uniprot was used for protein identification and LFQ, specifically by using the 
PEAKS PTM algorithm. Batch correction was applied using the QC-RFSC (Quality Control Random 
  
 88 
Forests Signal Correction) algorithm choosing the LOESS (Locally Estimated Scatterplot Smoothing) 
method in the W4M Galaxy web-based tool (Dunn et al. 2011).  
Univariate analysis  
Embryo classification was performed as detailed in Chapter 2. Then, to determine differentially 
abundant proteins between groups, protein abundance measured in arbitrary units was firstly 
square-root transformed, to correct for pronounced right-skewness, i.e. distributions where the 
mean is to the right of the median, with many zero values.  
Then, differences in molecules’ abundance in ULF between embryo classes (EQ1-3) or oestrus after 
calving (OC) were assessed either by ANOVA or Kruskal-Wallis non-parametric test (for variables that 
did not satisfy the criteria of distribution normality and/or homogeneity of variance), and linear 
regression to test for the effect of dpp. All statistical tests were performed using the R base package 
v4.0.2 (R Team 2019), using a 5% false discovery rate (FDR) to correct for multiple testing (Benjamini 
and Hochberg 1995), and this was expressed as “q-value”. To determine which groups were 
different, Tukey test (parametric) was performed using R base package, or Dunn test (non-
parametric) was done using the package pgirmess 1.6.9 (Giraudoux et al. 2018).  
Proteins detected - comparisons with other studies 
Results from ten articles on untargeted proteomic investigation were collected. As different protein 
nomenclature systems were used across the relevant studies, the identifiers were converted to 
Uniprot accession numbers using DAVID v. 6.8, updated May 2016 (Huang et al. 2009). Uniprot 
identifiers were considered unique proteins for the purpose of this comparison. Protein name 
conversion resulted in 2.3% of the proteins not being mapped (165/7168).  
Secreted protein analysis 
This analysis was performed according to Pillai et al. (2017). Firstly, SignalP v5.0 
(http://www.cbs.dtu.dk/services/SignalP) (Almagro Armenteros et al. 2019b) was used to predict 
which proteins identified were potentially secreted via the classical secretory pathway, by identifying 
N-terminal motifs that direct proteins for secretion. In parallel, Outcyte v1.0 (Zhao et al. 2019) was 
employed to predict proteins secreted by non-classical pathways. Next, TargetP v2.0 
(www.cbs.dtu.dk/services/TargetP) was used to exclude mitochondria-bound proteins (Almagro 
Armenteros et al. 2019a), with further refinement through Phobius (http://phobius.sbc.su.se/) (Käll 
et al. 2004, 2007) to remove membrane proteins (i.e. those with transmembrane regions) and 
potentially expand the list of secreted proteins. 
  
 89 
Functional and pathway analysis 
Functional and gene ontology (GO) analyses were performed using GO::TermFinder (Boyle et al. 
2004) concomitantly with the REVIGO visualisation tool (Supek et al. 2011). Metascape (updated 
16/09/2020; Zhou et al. 2019) was used for overrepresentation analysis. These tools are diverse in 
their scope, update frequency, and algorithm used.  
Multivariate analysis 
Multivariate analyses and modelling (PCA, sPLS-DA, and OPLS-DA) were conducted using 
MetaboAnalyst v4.0 and R, packages mixOmics v4.0 (Rohart et al. 2017) and ropls v3.8 (Thévenot et 
al. 2015). Predictive performance was assessed by 10-fold cross-validation. In this process the 
original dataset is divided in 10 subsets at random and models are subsequently fit to 9 of those and 
tested on the subset left out, in turn. The performances of all the models thus produced are 
averaged and indicated by a EQ2 value that goes from 1 (perfect predictive performance) to 0 and 
negative, i.e. no predictive use or overfit (Worley and Powers 2013). 
5.3 Results and discussion 
5.3.1 Blood contamination 
There was a statistically significant positive relationship between colour and protein concentration 
(R2 = 0.28, p<0.001). Additionally, after visual assessment, 11 samples (out of 189) were considered 
contaminated with blood (colour code ≥2.5). These samples, on average, were of a slightly smaller 
volume compared to clear ULF samples at 14.56 ml, whereas the average of transparent samples was 
17.69 ml. However, no statistically significant relationship was observed between ULF volume of 
samples and colour by linear regression analysis (p>0.3). In this regard, it was hypothesised that 
rough flushing might have both hindered sampling medium recovery and caused haemorrhages.  
However, only five samples had especially low volumes recovered (under 8 ml); all other red samples 
were recovered at volumes near average. This complicates appraising the degree to which an 
abnormally shaped uterus hampers flushing and causes injuries and haemorrhages. Nonetheless, 
since it is not possible to determine whether the proteins and metabolites detected in these samples 
originated in ULF or blood, those 11 samples were removed from further analysis. 
5.3.2 Quality control assessment 
The batch correction method employed considers intensity differences in each of the peptides to 
adjust for systematic error. For this, a LOESS (Locally Estimated Scatterplot Smoothing) regression 
model was fitted to the intensity values of the peptides in the pool QC samples. This method fits 
simple models to segments of the data, building a function that describes trends in the variation 
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across samples and generates a smooth curve through the sample set (Cleveland and Devlin 1988). In 
this case, the median intensity of peptides in the pool samples was taken as the scaling factor. 
Pooled QC samples – chromatography and MS quality control  
Figure 5-4 shows an example of the QC chromatograms overlaid. Most of the relevant features 
stayed within the set 2 min Rt tolerance set. No clear trend in overall intensity changes was observed 
(Figure 5-4). Overall, good reproducibility was observed throughout the instrumental analysis, that 
lasted for 25 days of continuous LC-MS/MS runs.  
 
Figure 5-4 Total ion chromatograms corresponding to QC pooled samples diluted 1:10 in 
Experiment P3. N=20 runs. 
Bovine serum albumin (BSA): MS quality control  
As an additional method of quality control, BSA standards were run using a short LC programme (28 
min, details in 3.4.4) at the end of every batch. The shape of the chromatogram and the sequence 
coverage of the peptides detected were evaluated on the spot to determine whether the instrument 
was performing adequately or whether it required tuning.  
Sequence coverage average were similar throughout the experiment, with an even spread on either 
side of the mean (Figure 5-5). This was one indication that instrument performance remained within 
acceptable boundaries throughout the experiment. There was a slight tendency to decrease, likely 
indicative of the normal wearing of the pre-column. According to standard practice in this research 
group, coverage values under 70%, or two under 75% in succession, indicate that a long step of 





Figure 5-5 Peptide sequence coverage of bovine serum albumin (BSA) standard, as obtained from a 
Mascot peptide web search, throughout the experiment. Time in days. Solid line:  linear 
regression; dashed line: LOESS (locally estimated scatterplot smoothing) non-linear 
polynomic regression; dash-dotted line: smoothed conditional spread (LOESS line fitted 
to values below and above the mean regression line). 
5.3.3 Protein identification and ULF proteome meta-analysis 
Informatic analysis of all samples resulted in a total of 1504 proteins detected in this experiment, of 
which 1173 could be quantified. To put these findings in context, a list was compiled of proteins 
reported in studies surveyed characterising the bovine ULF proteome as described in the 
Introduction (Table 5-). This list comprised eleven articles in addition to the present study. The 
number of proteins reported per study ranged from 37 to over 3300; this was related to differences 
in confidence parameters employed as well as technical capabilities. For example, while most studies 
provided the total list of proteins identified, some reported only proteins statistically different 
between groups (Muñoz et al. 2012, Beltman et al. 2014). Moreover, in addition to the significance 
score assigned by the proteomics software, Beltman et al. (2014) further filtered peptides manually, 
considering only those containing ion series of at least 4 amino acid residues. Regarding technical 
capabilities, the performance of tools used in virtually all stages of proteomic analysis is in constant 
improvement, and this is a notable determinant of the amount and quality of the information 
collected, including reported protein quantity and reliability (Lössl et al. 2016). 
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This study included a larger number of animals than previous studies of a similar type. The number of 
animals and total samples analysed per study in the literature averaged 18, ranging from 6 (Beltman 
et al. 2014) to 25 (Moraes et al. 2020a, Moraes et al. 2020b), compared to 92 in the present study. 
The median number of samples analysed -i.e. because animals were analysed at more than one time 
point in some studies, e.g. (Mullen et al. 2012, Muñoz et al. 2012, Forde et al. 2014a)- was 33, 
ranging from n=6 for Muñoz et al. (2012), Beltman et al. (2014), to n=64 in the previous studies, 
whereas n=184 was used in the present study. Notably, some studies sampling a reduced number of 
animals used longer LC separation programmes (Helfrich et al. 2020, Moraes et al. 2020a), and this is 
conducive to a higher number of distinct peptides being detected (Moraes et al. 2020a). The large 
number of samples analysed in this research implied finding a compromise between peptide 
detection (depth) and number of samples run (width). However, the analysis resulted in a 
considerable number of proteins reported at 1504 even with shorter run times because of the higher 
number of samples. 
Next, shared and unique proteins were assessed. A total of 6914 proteins (Uniprot knowledgebase 
entries) were surveyed. Only 66 proteins were present in more than 50% of the studies, i.e. at least in 
six out of the 11 studies (Table S5-1). In addition, 4426 entries were detected in only one study, and 
no protein was identified in more than eight studies out of the eleven surveyed. For illustrative 
purposes, Figure 5-6 shows the overlap in identified proteins across the four studies that reported 
the highest number of proteins identified, including the current work. In this case it is perhaps clearer 
that these recent studies have all identified a similar number of unique proteins, and that the 
proteins detected in more than one study are evenly spread throughout, i.e. there are no outlier 
studies. Proteins reported by the four most comprehensive represent a “core” proteomic signature 
of bovine ULF, constituted by the most consistently abundant proteins (Table S5-1). 
As discussed in Chapter 1, several factors likely underlie these findings. Some are differences in 
animals sampled (including breed), sampling method (and associated contamination with cellular 
debris and/or blood), and sample processing. It is appropriate to compare these 11 studies as in all 
studies, mass spectrometry was performed in DDA (data-dependent acquisition) mode. The 
stochastic nature of the precursor selection favours fragmentation and analysis of the most 
abundant peptides and entails under-sampling of peptides with low and medium abundance (Liu et 
al. 2004). Wider application of the most advanced DIA (data-independent acquisition) setups will 
most certainly contribute to increasing inter-experimental reproducibility (Doerr 2015). The author is 
not aware of any reported experiments employing DIA to investigate the ULF proteome, and such a 
platform was not available for this project. 
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From the 1504 proteins (Uniprot entries) identified in this study, 472 had not been reported in 
bovine ULF by the surveyed articles; moreover, 43 were Swissprot manually curated entries (Table 
S5-2). The full list of proteins detected in this and other studies can be found in Table S5.3. This 
contributes to advancing the characterisation of the total protein complement of the bovine ULF. 
Next, a qualitative exploration of the ULF proteome was undertaken. 
5.3.4 Protein functional analysis of ULF 
The full set of proteins detected in the present study were analysed using Go::TermFinder, assessing 
their relative representation across ontology categories. As expected from any given tissue or 
biofluid, a wide variety of molecular functions and biological processes was observed (Figure 
A-8-898a,b,c). 
Table 5-2 Number of proteins reported in studies surveying the bovine ULF proteome. Number of 
Animals (samples): number between brackets indicates the number of samples 









Munoz et al. 2012 39 5 8 (16) 
Beltman et al. 2014 40 4 6 
Faulkner et al. 2013 89 - 20 
Faulkner et al. 2012 197 16 6 
Forde et al. 2015 242 26 8 
Mullen et al. 2012 702 492 18 (36) 
Moraes et al. 2020 776 73 25 
Forde et al. 2014 887 414 16 (64) 
Gegenfurtner et al. 2020 1737 391 12 
Helfrich et al. 2020 2648 916 5 
Harlow et al. 2018 3316 1690 16 
Present study 1504 472 92 (184) 




Figure 5-6 Venn diagram showing proteins reported in the four studies with the highest number of 
proteins reported. A protein was considered a unique Uniprot accession identifier. 
GO molecular function showed that 41% of the proteins are classified as “binding proteins” and 35% 
as having “catalytic activity”; less represented functions included “molecular function regulator” 
(6%), “structural molecule molecular transducer activity” (4%), “transcription regulator activity” (2%), 
“transporter activity” (1.5%) and “molecular transducer activity” (0.5%). By the very nature of this 
type of analysis, these terms are very general; for instance, “binding proteins” are defined as 
“proteins that interact selectively with any protein or protein complex”, whereas “catalytic activity” 
refers to all enzymes. These will be discussed considering the specific classes and pathways defined 
next. Regarding GO cellular processes, no dominant class was found. The most prevalent classes 
were metabolic proteins (21%) and regulators (18%). “Response to stress” and “immune system 
processes” accounted for 7% and 1% of the proteins, respectively. Based on the findings of the 
review article conducted as part of this project (Aranciaga et al. 2020) a larger proportion of proteins 
involved in these processes was expected, due to their fundamental roles in the physiology of the 
reproductive tract. However, it is important to bear in mind that the number of proteins of a given 
class does not correlate to its class’s biological importance (Pascovici et al. 2012). This classification 
provides an overview of two aspects of the molecular activity within ULF. To examine the roles of 
these processes in the physiology of postpartum recovery and embryo development, the specific 
functions of relevant molecules and classes are discussed later. 
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Finally, GO cellular component classification showed that 62% of the proteins are annotated as 
“cytosolic”, whereas 9% were classed as “membrane proteins” and 14% as “extracellular proteins”. 
The implications of a high proportion of proteins in an extracellular fluid being classified as 
(intra)cellular are examined next.  
Protein origin and cellular location 
Proteins detected in a biofluid would typically be expected to be secreted; the results of the gene 
ontology classification however do not support this. Nonetheless, this is not at odds with similar 
studies that identified a similarly low proportion of typically extracellular proteins, in ULF (Forde et al. 
2014a; 20%, Gegenfurtner et al. 2019a; 14%) and oviduct fluid (Lamy et al. 2016a; 28%). Some 
important considerations are examined next. 
The question of the origin of a protein is intimately related to its function. Distinguishing 
physiologically relevant compounds from those that are present as a by-product of an unrelated 
process is key for this research. As reviewed in Chapter 1, the contents of fluids in the reproductive 
tract (including proteins) originate from several sources. These consist of cellular debris due to 
physiological processes (Mondéjar et al. 2012), sampling-introduced artefacts (Papp et al. 2019), as 
well as molecules secreted by uterine cells, both expressed by those cells (Roberts and Bazer 1988) 
or originating from blood transfer (McRae 1988). Many of those proteins considered secreted go 
through the classical secretory pathway, i.e. containing a signal peptide to the endoplasmic reticulum  
for further processing and extracellular secretion, known as the Sec signal peptide (von Heijne 1990). 
Others are believed to be transported by alternative and potentially undescribed mechanisms 
(Gegenfurtner et al. 2019a). One such alternative mechanism might be exosomes (small membrane-
bound vesicles of endocytic origin): Almiñana et al. (2017) posit that exosomes play a key role in 
oviduct-embryo communication. Supporting this are the reports of Passaro et al. (2016) and Harlow 
et al. (2018) that over half of the proteins detected in ULF were categorised as exosomal according to 
Gene Ontology. Analysis of secreted proteins by a set of specialised informatic tools was carried out 
to formulate hypotheses regarding their relative importance and function. 
Secreted protein analysis 
A total of 1115 proteins were used in four informatic tools, namely SignalP, TargetP, Phobius, and 
Outcyte. The algorithms they use are optimised for different uses, however they all have a function 
to predict secretion via the classical secretion pathway, via Golgi apparatus and granular endoplasmic 
reticule; these contain signal peptides known as Sec, typically characterised by a 5-16 sequence of 
hydrophobic amino acids (von Heijne 1990). Altogether, 408 proteins were predicted to be secreted 
by at least one of the tools, out of which 224 contained a Sec signal peptide (SP) and 184 were 
identified by other, alternative means (“Outcyte unconventional secretion”). There was a significant 
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overlap between proteins classified as secreted with Sec signal peptide by the different tools (Table 
5-310 and Figure 5-7). SignalP is considered the most reliable tool for this determination because it is 
optimised for identification of signal peptide and its location within the protein sequence (list in 
Table S5-4); therefore, those identified by SignalP plus those identified by at least two other tools 
were considered secreted for functional analyses next.  
Proteins predicted to belong in other cellular locations (transmembrane, translocating to 
mitochondria, intracellular) were all considered equal for the purpose of the present work; i.e., they 
were not expected in the extracellular space but were detected in ULF. Additionally, tools whose 
main purpose is not related to identifying putatively secreted proteins (particularly Phobius) indeed 
identified the least putatively secreted proteins (but none was unique to it). 
The results of this analysis are useful in themselves for their contribution to a deeper 
characterisation of the ULF proteome, and were also considered to select molecules to test on in 
vitro embryo culture as examined after. 
Table 5-310 Proteins classified as secreted by different bioinformatic tools. Secreted-SP: secreted 
by the classical secretion pathway, i.e. containing a Sec signalling peptide. 
List names number of distinct elements Unique to one tool 
OutCyte (unconventional) 223 184 
Outcyte (secreted-SP) 56 8 
Phobius (secreted-SP) 179 0 
SignalP (secreted-SP) 209 26 
TargetP (secreted-SP) 184 2 





Figure 5-7 Venn diagram showing number of proteins classified as secreted by different informatic 
tools. 
5.3.5 Molecular factors determining embryo quality 
Further to assessing molecular differences in ULF related to embryo quality, differences between 
oestrus cycles were considered. As seen in Chapter 2, the proportion of cows with embryos of excellent 
and good quality was higher for pregnancies in the third oestrus event after calving, in agreement with 
(Berg et al. 2017) who showed improved fertility outcome with more oestrus cycles after calving. It is 
therefore relevant to factor in oestrus number when examining the relationship between embryo 
quality and molecule abundance, and as an independent metric of animal health. 
Embryo quality, dpp and OAC - Univariate analysis 
Protein abundance (measured as the sum of the areas of the top-3 peptides of each protein, batch-
corrected and square-root transformed) of proteins detected in more than 50% of the samples was 
evaluated by either ANOVA and Tukey tests, or Kruskal-Wallis and Dunn test for proteins that did not 
satisfy the assumptions for parametric tests. Applying a data transformation to the molecule 
abundance data improves the likelihood of it fitting the assumptions for parametric tests (Osborne 
2010). Even in the case of some of the transformed features which do not conform to the normality 
of residues and homoscedasticity assumptions for parametric tests, this type of data transformation 
tends to increase the statistical power of non-parametric tests (Osborne 2010). In this case, the 
skewness of the raw data (median 1.29, mean 1.64) was reduced substantially after square-root 
transformation (median 0.098, mean 0.22, where 0 represents no skewness or a Gaussian 
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distribution). In addition, even after data transformation, the standard deviations were relatively 
large (relative standard deviation of 35%, on average), illustrating the high amount of within-class 
variation. 
From the quantifiable proteins, a total of 388 proteins were protein group replicates, i.e. in which the 
peptides quantified to estimate the protein’s abundance were the same as in one or more other 
proteins. Protein replicates included both strictly replicate entries, considered essentially the same 
protein but found as additional entries in the Trembl database, as well as homologues sharing most 
of their primary sequence (>50%; Pearson 2013). For the purpose of statistical analysis, these are 
replicates and testing those individually has no practical advantage and results in decreased 
statistical power. Therefore, only the top hit in each protein group was analysed by ANOVA; this 
resulted in a dataset of 653 proteins.  
Number of oestrus cycles after calving (OAC) and days postpartum (dpp) 
Firstly, the effect of dpp on protein abundance was examined by linear regression, using OC as a 
covariate. No protein was found to be significantly affected by dpp (Table S5-5). A trend for interaction 
effects of dpp and OC (q=0.065) was found for one uncharacterised protein, however upon 
examination of the scatterplot this was caused by an outlier. Thus, it did not present high potential for 
practical applications and was not pursued further. 
Table 5-411 Proteins in significantly higher abundance in third vs first oestrus postpartum. 
Abbreviations: FC, fold change; OAC, oestrus after calving; q-value, false discovery rate 
according to Benjamini and Hochberg (1995). 
Protein Gene p-value q-value Trend FC 
Peroxyredoxyn 5 PRDX5 0.011 0.035 OAC3>OAC1 1.56 
Haemopexin HPX 0.007 0.048 OAC3>OAC1 1.38 
 
Two proteins were found to be in significantly higher abundance in ULF at OC3 compared to OC1: 
peroxiredoxin 5 and haemopexin (Table 5-411). Peroxiredoxins are proteins typically found in 
mitochondria and peroxisomes, and fulfil signalling and protective functions related to reactive oxygen 
species, particularly hydrogen peroxide (Chae et al. 1994). They are proposed to play important roles 
in embryo development by regulating the redox balance of the embryo cells, together with other 
enzymes such as dehydrogenases, catalases (Guerin et al. 2001). Peroxiredoxin 5 expression has been 
reported from the immature bovine oocyte to after the 16 cell stage embryo (Leyens et al. 2004). Here 
it was found in higher abundance in OC3 (p=0.011). Despite being classified as intracellular, this protein 
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was also found in ULF of both cycling (Harlow et al. 2018, Helfrich et al. 2020) and pregnant (Forde et 
al. 2015) cows.  
Haemopexin is a protein known for binding haem molecules and transporting them to the liver for its 
clearance (Tolosano and Altruda 2002). It is also known as an acute-response protein, i.e. whose 
synthesis is induced following an inflammatory event (Baumann and Gauldie 1994). This protein was 
found in ULF of cycling animals of Holstein and Montebeliarde breeds (Gegenfurtner et al. 2019b) and 
was reported to be downregulated from day 0 to day 35 of pregnancy (Rawat et al. 2016). Faulkner et 
al. (2012) found haemopexin to be in half the abundance in ULF compared to blood plasma. It is not 
clear however why this protein was higher at OC3 in this experiment, when postpartum inflammation 
is assumed to have diminished. The putative role of these proteins is further discussed later in the 
context of molecular changes relative to embryo quality. 
To expand on the molecular changes in the postpartum ULF, a comprehensive analysis of differences 
across oestrus cycles after calving is presented in Chapter 6 using joint pathway analysis. 
Protein abundance effect on embryo quality phenotype 
The proteins found differentially expressed by ANOVA (parametric) or Kruskal-Wallis (non-
parametric) were classified in positive or negative according to which groups were different as 
determined by Tukey (parametric) or Dunn (non-parametric) tests. Results of univariate statistical 
analyses, along with what differences between groups are displayed in Table 5-5 (EQ1 system) and 
Table 5- (EQ2, EQ3). The groups were detailed earlier (Figure 2-4). Briefly, the EQ1 system considered 
5 embryo classes (Roman numerals I to V) in decreasing order of quality: I-III correspond to grade 1-3 
tight morulae and blastocysts, respectively. IV and V designate embryos in arrested development (4-
16 cell), and one-cell (possible fertilisation failure), respectively. The EQ2 system contrasts “Optimal” 
(class I) with “Suboptimal” (grouping classes III-V), whereas the EQ3 classification contrasts 
“Pregnant” (grouping classes I-III) with “Non-pregnant” (grouping classes IV and V). A total of 18 
proteins were found in differential abundance between ULF holding embryos of contrasting quality, 
as discussed next. 
Proteins negatively associated with embryo quality 
This section discusses the 11 proteins found to be upregulated in ULF with poorer quality embryos 
(chiefly class IV) according to the EQ1 classification system explained earlier, and how these proteins 
relate to fertility in the context of literature. 
Dihydropteridine reductase (DHPR) was found in the highest abundance in class IV embryos of 4-16 
cells. This is an enzyme that produces tetrahydrobiopterin (BH-4), an essential cofactor for 
phenylalanine, tyrosine, and tryptophan hydroxylases; it is also involved in folate biosynthesis 
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(Varughese et al. 1992). In human, deficiency of DHPR due to recessive mutations manifests in many 
diseases, the most conspicuous of which is phenylketonuria (Blau 2016). Pregnancies of human 
mothers with phenylketonuria present several problems including spontaneous abortion and 
intrauterine growth retardation (Rouse et al. 1997). In a human kidney cell line, wild-type DHPR 
played an important role in protecting the cells against oxidative stress, but mutant DHPR failed to 
have these beneficial effects (Gu et al. 2017). Rodríguez-Alonso et al. (2020a) found DHPR to be more 
abundant in oviduct fluid of pregnant vs cycling cows, i.e. opposite to what was found here, though 
the spatial (oviduct vs uterus) and temporal (day 3 vs day 7) conditions tested were different.  
Two proteins from one protein family, cystatin B and C, were found in highest abundance in class IV 
(4-16 cell) embryos. Upon examination of the peptide sequences identified, all of them were 
common to both proteins, i.e. no peptide fragment unique to either was detected (Figure A-8-6). This 
is a common occurrence in the proteomics field, in which a protein family is reported instead of a 
protein, due to the lack of means to establish which variant or variants were detected (Miller et al. 
2019). Cystatins are a family of cysteine protease inhibitors found in most eukaryotes and many 
prokaryotes (Kordiš and Turk 2009). Both cystatins B and C are involved in multiple processes 
through interaction with and regulation of cathepsins (Kos et al. 2014), some of the most prominent 
being bone remodelling, inflammation, and cancer aetiology (Abrahamson et al. 2003). It is precisely 
the cathepsin-cystatin interplay that is often investigated. Cystatin B mRNA was found 
downregulated in oestrogen-receptor-knockout mice (Winuthayanon et al. 2015), showing a positive 
association with a healthy reproductive function. It was also found in day 16 and 19 of pregnant 
bovine ULF and in the secretome of day 16 embryos in vitro, but not found at days 10 or 13 of 
pregnancy, or in cyclic animals (Forde et al. 2015). The different timepoints analysed preclude a 
direct comparison to the results in this study, but further research into the role of cystatin B is 
promising. 
Cystatin C is produced by nearly all organs and is found in biological fluids, including blood; it is also 
the most abundant and potent endogenous inhibitor of cathepsins (Lafarge et al. 2010). Cystatin C is 
the main cathepsin inhibitor regulated in tissue remodelling events (Lerner and Grubb 1992) and 
chronic inflammatory diseases (Henskens et al. 1994). The interplay between cathepsin B and 
cystatin C, its main inhibitor in vivo, determines several processes related to pregnancy (Afonso et al. 
1997). One of those processes is immune status regulation (Høglund et al. 2019), a major factor in 
pregnancy establishment that can result in maternal rejection of the partially allogenic embryo (Ott 
2019). Another important process governed by the interaction of cathepsin B and cystatin C is tissue 
remodelling (Kos et al. 2014). This is relevant in this context due to the significant and rapid 
morphological changes within the reproductive tract in the female to allow for pregnancy. Indeed, 
anomalous patterns of cathepsin B and cystatin C abundance were responsible for failed 
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implantation in mice (Afonso et al. 1997). Another study in murine (Baston-Buest et al. 2010) showed 
that the embryonic expression of cystatin C is involved in apoptotic protection against cathepsins 
released during implantation, and that higher expression of cystatin C during metestrus might also 
indicate a signal from the cow that its proliferative endometrium is not ready to bear an embryo.  
Whether the difference in abundance observed was for cystatin B, cystatin C, or both is up for 
discussion. Gegenfurtner et al. (2019b) found cystatin B in all OLF samples but cystatin C only in some 
of them. Moraes et al. (2020a) found cystatin B but not C-); Malo Estepa (2020) found both B and C in 
culture medium of day-16 embryos (i.e. secreted by embryo). Helfrich 2020 found both cystatins in at 
least 5 out of 6 animals. An important source of insight was the secreted protein analysis described 
earlier in this chapter: cystatin C but no other proteins in the cystatin group were classified as 
putatively secreted -through non-conventional mechanisms- by OutCyte, concurring with the report 
of Huh et al. (1995) in mice.  
Acyl-CoA-binding protein (ACBP or DBI) was found in higher abundance in class IV embryos (4-16 
cells) vs class II and III embryos and has been reported as a crucial factor in early pregnancy in mice, 
as DBI-knockout embryos do not develop past the 32-cell stage (Landrock et al. 2010). It was also 
reported by Berendt et al. (2005) to be 7.3-fold more abundant in pregnant uterine tissue compared 
to cyclic, at day 18 of pregnancy or oestrus. No evidence of a negative effect of this protein was 
found, but its potential role in energy supply to the embryo is examined in its pathway context later.  
S100A2 functions as a calcium sensor and modulator, contributing to cellular calcium signalling and 
interacting with other proteins, thus indirectly play a role in many physiological processes (Rust et al. 
2000). S100 proteins tend to be overexpressed in disease, mediating inflammation and with 
antimicrobial activity (Lukanidin and Sleeman 2012) and are known to be induced by 
progesterone(Moraes et al. 2018b). S100A8 and S100A9 were found to be higher in cyclic day 7 UF 
compared to day 13 and may modulate maternal immune function. S100A4 exhibited the opposite 
trend (Mullen et al. 2012) and was suggested to be detrimental to embryo development at day 7 of 
pregnancy by an altered balance between pro-and anti-inflammatory processes (Beltman et al. 
2014). S100A2 transcription was upregulated in pregnant animals, deemed to be important in 
inflammatory regulation (Moraes et al. 2018a). Again, the reason for this protein to be higher 
abundance in ULF holding embryos of suboptimal quality is likely to be the result of a compensation 
mechanism against an undetermined detrimental factor. 
Unc-80-homolog, NALCN channel complex subunit (UNC80) is a membrane protein found in higher 
abundance in class IV embryos compared to all the rest. No reports of this protein were found in 
studies examining the proteome of ULF in any mammal. Its transcript RNA, however, has been 
reported in 9 different tissues in cows according to the Bgee database of mammal transcriptomics 
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(Bastian et al. 2020), including sperm, nervous system and muscle. Mutations in its human homolog 
cause infantile hypotonia, a condition characterised by intrauterine growth retardation and 
frequently foetal death (Perez et al. 2016). Being a membrane protein, it is unlikely to be present in 
ULF due to active secretion. Nonetheless, whether UNC80 was detected in ULF in this study due to 
biological phenomena (i.e. apoptosis) or because of disturbances during sampling necessitates 
targeted research. 
ATP synthase subunit beta is part of a mitochondrial enzymatic complex that produces ATP 
(adenosine triphosphate, the main energy token in cells across all domains of life) by leveraging 
potential energy from a transmembrane gradient (Mulkidjanian et al. 2009). It was found in higher 
abundance in retained placenta compared to normal placenta in cows (Ner-Kluza et al. 2019), but its 
function in this context is largely unknown except for its involvement in anabolism, as detailed in the 
pathway analysis section later.  
Macrophage migration inhibitory factor (MIF) is a well-characterised protein with regulatory capacity 
in immune response and inflammation (Baugh and Bucala 2002), and regulated by interferons in 
sheep (Satterfield et al. 2009). It was reported to be upregulated in bovine pregnancy with a 
suggested regulatory role in vascular development of extraembryonic tissues from at least day 18 of 
pregnancy (Paulesu et al. 2012). Forde et al. (2015) found MIF in similar abundance in ULF of cyclic 
and pregnant cows at days 10-19 of the cycle or pregnancy, whereas Gegenfurtner et al. (2019b) 
found it in higher abundance in OLF of dairy cows with low breeding value for fertility, i.e. of low 
genetic potential for reproductive performance (Pryce et al. 2004); further studies are needed to 
verify the potential of MIF as a genetic fertility biomarker. This is a central molecule in the myeloid 
activation pathway, as explained in the next section. 
Pyruvate kinase M2 (PKM2) was first characterised with regards to its function in glycolysis, i.e. as a 
rate-limiting enzyme synthesising pyruvate from G3P (Tanaka et al. 1967). There are four pyruvate 
kinase isoenzymes in mammals, which are L, R, M1 and M2. The L and R isozymes are generated from 
the PKLR by differential splicing of RNA; the M1 and M2 forms are produced from the PKM gene by 
differential splicing (Takenaka et al. 1996). L isoenzyme (PKL) is mainly found in the liver, R isoenzyme 
(PKR) is mainly found in red blood cells, M1 isoenzyme (PKM1) is mainly found in heart, muscle and 
brain. The M2 isoenzyme (PKM2) is present in most adult human tissues, but is detectable only in 
early foetal tissues as well as in most cancer cells, upregulated as part of a mechanism of protection 
against cancer proliferation (Steták et al. 2007). Originally believed to be nuclear, it has also been 
annotated as cytosolic, secreted and exosomal (Luo and Semenza 2012), rendering it an interesting 
candidate for biomarker discovery. It is also possible that its higher abundance in ULF, as found in 
this study, might indicate an abnormally increased metabolism and that this is detrimental at the 
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pathway level. Most importantly, PKM2 is suggested to be a gatekeeper of cellular growth, apoptosis 
and survival (Harris et al. 2012) and might be an important modulator of uterine remodelling. 
Alpha-1-antiproteinase (SERPINA1) is an extracellular inhibitor of serine proteases whose primary 
target is elastase, but it also has a moderate affinity for plasmin, thrombin and other proteases 
(Silverman et al. 2001). In ULF, SERPINA1 along with SERPINF2 and SERPIND1 were more abundant 
on day 17 of pregnancy in sub-fertile compared to highly fertile beef heifers, all associated to 
haemostasis (blood coagulation) pathways, but no differences were found between cyclic and 
pregnant animals (Moraes et al. 2020a). Conversely, it was reported in higher abundance in pregnant 
vs cycling oviduct fluid in cows (Rodríguez-Alonso et al. 2020a). Many SERPINs (A3-1, A3-7, A3-8, D1 
and H1) were detected in oviduct fluid (Pillai et al. 2017, Gegenfurtner et al. 2019b), potentially 
involved in zona pellucida-sperm interactions (Cesari et al. 2010). SERPINA1 mRNA was found 
downregulated in oestrogen-receptor-knockout mice (Winuthayanon et al. 2015). The apparent 
discrepancies between studies suggest that SERPINA1 plays an important role in pregnancy, but 
whose spatiotemporal pattern is more complex than can be assessed by untargeted studies. An 
interpretation of this protein being more abundant in class IV embryos is that it may indicate an 
underlying detrimental process, instead of directly hindering normal embryo development.  
Prostaglandin reductase 1 (PTGR-1) is an enzyme involved in the degradation of prostaglandins, i.e. 
to halt the pro-inflammatory effects of prostaglandin signalling (Mesa et al. 2015). It was detected in 
bovine ULF in several studies (Mullen et al. 2012, Harlow et al. 2018, Helfrich et al. 2020), but not 
found to be differentially abundant in response to the factors studied (pregnancy status or feeding 
regime). In equine ULF it was significantly upregulated by pregnancy at day 13 (Smits et al. 2017) and 
has been reported to be present in cytoplasm (Mesa et al. 2015) and exosomes (Gonzales et al. 2009) 
in humans. Its higher abundance in poor quality embryos, together with some of the aforementioned 
proteins (S100A2, SERPINA1) suggests that an abnormal regulation of inflammation is hindering 
embryo development in those animals. Additionally, a similar enzyme, prostaglandin reductase 2, 
was found to physically interact with bovine embryos at 4-16 cells and morulae in vitro and suggests 
signalling or regulatory roles of classical metabolic enzymes (Banliat et al. 2020). 
Proteins positively related to embryo quality phenotype 
This section discusses the seven proteins found to be upregulated in ULF with good quality embryos 
according to the EQ1, EQ2 and EQ3 classification systems explained above, and how these proteins 
relate to fertility in the context of the literature. 
Eukaryotic translation initiation factor 5A-1 is a nuclear protein known as a marker for cellular 
proliferation (Nilsson et al. 2004), and has been associated with vulvar cancer in humans (Cracchiolo 
et al. 2004). It is also significantly more abundant in the blastocyst stage compared to previous stages 
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of development in bovine embryos (Demant et al. 2015). In this study, its lower abundance in in 
grade III embryos is suggestive of a poorer development of these. However, no clear tendency was 
apparent across classes. 
Plasminogen is a secreted protease that participates in thrombolysis and extracellular proteolysis 
(Ponting et al. 1992). Its gene expression was significantly upregulated in endometrium of cows with 
severe negative energy balance at two weeks postpartum potentially indicating abnormal tissue 
remodelling (Wathes et al. 2009). In ULF, it was also found to fluctuate throughout the bovine 
oestrus cycle, increasing ten-fold from day 7 to day 13 (Mullen et al. 2012). It was higher in oviduct 
fluid of cyclic vs pregnant cows in the isthmus but not the ampulla region at day 3.5 after oestrus 
(Rodríguez-Alonso et al. 2020a). Both reports showcase the precise regulation of proteomic changes 
in relation to embryo development. In this experiment it was lower in ULF containing class IV 
embryos, but no differences were observed among the other classes. 
Membrane-associated guanylate kinase inverted 3 is a protein known to be downregulated in 
gliomas (a type of brain cancer) and that functions as a tumour suppressor (Ma et al. 2015). In this 
study, it was in lower abundance in ULF containing class V and III embryos, with no other reports of 
its being detected in ULF. Being a membrane protein its involvement in embryo development needs 
further research. 
Phospholipase A2 activating protein (PLAA), as its name indicates, regulates PLA2 and thus the 
production of lyso-phospholipids and prostaglandin precursors from arachidonic acid (Murakami and 
Kudo 2002). Its induction by tumour necrosis factor (TNF)-alpha has been shown to perpetuate an 
inflammatory status in HeLa tumoral cells (Zhang et al. 2008). In this study, PLAA exhibited a linear 
trend from worse to best quality embryos (class V to class I), which may be related to the increased 
amounts of prostaglandin precursors induced by pregnancy (Sponchiado et al. 2017). PLAA was 
however detected at very low intensity and therefore its quantitation is not as reliable as most other 
proteins analysed here. The role of PLA2 is discussed later.  
Triosephosphate isomerase (TIM) is a metabolic enzyme that converts dihydroxyacetone phosphate 
to D-glyceraldehyde-3-phosphate in both gluconeogenesis and glycolysis (Rodríguez-Almazán et al. 
2008) and it is found in cytosol, extracellular space and exosomes (Gonzales et al. 2009). It was found 
in higher abundance in ULF of pregnant vs cyclic ULF at day 8 (Muñoz et al. 2012) and in day 16 of 
pregnancy compared to day 10 (Forde et al. 2014a). In another study also conducted in beef heifers, 
no significant differences were found in the abundance of TIM in ULF holding viable or nonviable 
embryos at day 7 of pregnancy (Beltman et al. 2014). Joint pathway analysis results presented in 
Chapter 6 suggest that this enzyme -linking the galactose metabolism to the pentose phosphate 
pathways- might be increasing the interconversion of monosaccharides (galactose to fructose and 
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ribose). Fructose, but not galactose, was reported to be an energy substrate of cultured sheep 
granulosa cells (Campbell et al. 2010). In this case, higher abundance of TIM might improve embryo 
quality by increasing fructose concentration for use as an energy source. This is further discussed in 
Chapter 6. 
Delta-aminolevulinic acid dehydratase -ALAD(H)-, also known as porphobilinogen synthase, was 
lowest in ULF containing class III embryos. It catalyses the conversion of aminolevulinic acid to 
porphobilinogen and is thus involved in production of heme chemical group and other pyrrolic 
compounds (Tanaka et al. 2011). Polymorphisms in this gene in human mothers are associated with 
differential levels of heavy metals in placenta (Kayaaltı et al. 2016). In cows, transcription of this gene 
was downregulated in endometrium at day 16 after oestrus in pregnant vs cyclic cows (Forde et al. 
2012a). This protein was also found in 4 fold higher abundance at the preovulatory vs postovulatory 
bovine oviduct fluid, and this could indicate a role of ALAD in sperm capacitation (Lamy et al. 2016a). 
Costars family protein (ABRACL) was also found in lower abundance in ULF with class III embryos. It 
intervenes in the regulation of actin filament-based processes (Gaudet et al. 2011) and is thus an 
important modulator of cell motility (Pang et al. 2010). It is also upregulated in human oesophageal 
carcinoma cells (Fan et al. 2020). Little information on any potential role on reproduction is available 
on this protein, but the results obtained herein warrant further investigation. 
Phospholipase A2 (PLA2) was highest in ULF with class I embryos compared to classes III-V, i.e. 
“optimal” vs “suboptimal” embryos, under the EQ2 system (Table 5-6). This secreted protein is 
considered pro-inflammatory; it hydrolyses phospholipids and releases arachidonic acid, a key 
precursor of eicosanoids, i.e. prostaglandins and leukotrienes (Dennis 1994). It is activated by PLAA, 
as explained earlier. In rats, PLA2 is under regulation of oestrogen, indirectly modulated by 
progesterone (Dey et al. 1982). Knock-out mice lacking PLA2 present defective metabolism of 
eicosanoids, and this manifests in impaired reproduction in two ways: parturition complications in 
the maternal side, and non-functional macrophages and ultimately in major neurological and cardiac 
disfunctions in embryos (Bonventre et al. 1997). In cows, uterine infection often causes a switch in 
production of prostaglandins from F-type to E-type by inhibiting phospholipase A2. This prevents 
luteolysis and results in abnormal extension of luteal phases, greatly hindering reproductive 
performance (Sheldon et al. 2009).   
Table 5-5 Proteins in different abundance in ULF containing embryos of different quality (EQ1) at 
flushing on day 7. Values are relative to protein amount in ULF containing class I 
(grade 1) embryos. Highlighted in red/green: potential biomarkers of 
suboptimal/optimal ULF. V: one-cell embryos; IV: 4-16 cell embryos; III, II, I: embryos 
of grade 1,2,3. Letter superscripts indicate statistical differences. 
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Protein name p-value q-value V IV III II I 
Dihydropteridine reductase <0.001 0.001 0.79ab 1.34a 0.71 b 0.84b 1b 
Cystatin-B/C <0.001 0.001 0.78b 1.49a 0.83b 0.77b 1b 
Eukaryotic translation initiation factor 5A-1 <0.001 0.002 0.84ab 1.2a 0.65b 0.89ab 1a 
Acyl-CoA-binding protein (ACBP) 0.001 0.006 0.99ab 1.26a 0.76b 0.79ab 1a 
Protein S100-A2 (Protein S-100L) 0.001 0.007 0.77a 2.73b 0.86b 0.95b 1b 
Glutamic acid-rich-like protein (obsolete) 0.001 0.008 0.75b 1.44a 0.75b 0.9b 1ab 
Unc-80 homolog, NALCN channel complex 
subunit 
0.001 0.011 0.97ab 1.72a 0.72b 0.88b 1b 
ATP synthase subunit beta 0.001 0.012 1abc 1.13a 0.82b 0.82abc 1bc 
Plasminogen 0.009 0.012 0.96ab 0.55a 1b 1.15b 1b 
Membrane-associated guanylate kinase 
inverted 3 
0.009 0.013 0.71b 
0.91a
b 
0.81b 1.14a 1ab 
Macrophage migration inhibitory factor 
(MIF) 
0.002 0.021 0.85ab 1.17a 0.82b 0.86b 1ab 
Pyruvate kinase (Fragment) (PKM2) 0.002 0.023 0.94ab 1.34a 0.78b 0.92b 1ab 
Phospholipase A2 activating protein (PLAA) 0.003 0.026 0.3b 0.3b 0.5ab 0.7ab 1a 
Triosephosphate isomerase (TIM) 0.004 0.032 0.84ab 1.08a 0.78b 0.9ab 1a 
Alpha-1-antiproteinase (Serpin A1) 0.004 0.038 0.97ab 1.4a 0.95b 0.97b 1b 
Delta-aminolevulinic acid dehydratase 
(ALADH) 
0.004 0.038 0.73ab 1.1a 0.63b 0.8ab 1a 
Costars family protein ABRACL 0.006 0.048 1.02ab 
1.05a
b 
0.63b 0.79ab 1a 
Prostaglandin reductase 1 (PTGR-1) 0.006 0.049 0.56ab 1.61a 0.56b 0.67b 1ab 
 
MSTN (myostatin, or growth/differentiation factor 8) is a secreted negative regulator of skeletal 
muscle growth (Carnac et al. 2006), found in lower abundance in class I embryos in this work. Defects 
in MSTN are the cause of the double-muscle phenotype or muscular hypertrophy, a recessive disease 
frequently found in the Asturiana de los Valles and Belgian blue cattle breeds, but not in other breeds 
such as Holstein (Bellinge et al. 2005). This disease is characterized by an increased number of muscle 
fibres, with an increase in muscle mass of 20-25% (Kambadur et al. 1997). Low levels of MSTN are 
found up to day-29 bovine embryos and increase from day 31 up until late gestation (Cassar-Malek et 
al. 2007). Furthermore, MSTN-knock-out bovine foetuses showed downregulated genes in essential 
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developmental processes -ribosomal and extracellular matrix proteins like collagens-, and 
upregulation of others -translation, cell cycle and apoptosis- (Cassar-Malek et al. 2007). Animals in 
this work were not found to present this mutation according to the SPIDER tool of PEAKS Studio, 
though full genotyping would be required to confirm these preliminary findings. Although high 
variability in the abundance of this protein was found in ULF in this work, the evidence presented 
justifies further research. 
Nicotinate phosphoribosyltransferase (NAPRTase) is a cytosolic enzyme that catalyses anabolism of 
NAD+ (nicotinamide adenine dinucleotide), an important redox cofactor in all living cells (Schomburg 
and Stephan 1996). In this work, it was found in higher abundance in ULF containing class I and IV 
embryos vs classes III and V, a classification based on the theory presented earlier (EQ3). Allelic 
variants in genes in the  “nicotinate and nicotinamide metabolism” pathway were significantly 
associated with the likelihood of suffering cystic ovary syndrome in Canadian Holstein cows (Guarini 
et al. 2019), indicating its potential importance in reproductive performance. Moreover, decrease of 
this enzyme in human oocytes is posited as one of the main factors linking age with reduced fertility 
(Massudi et al. 2012, Bertoldo et al. 2020). In this latter work, supplementation of a NAD agonist 
restored fertility to aged reproductively impaired mice, underlining the potential of this enzyme and 
the processes it regulates for non-invasive fertility treatment (Bertoldo et al. 2020). 
Table 5-6 Differentially abundant proteins in ULF grouped according to EQ2 (III to V, i.e. 1-16 cell 
and grade 3 embryos, vs I -grade 1-) EQ3 (V and IV vs III-I) classification systems. q-
value: false discovery rate (see text for details). FC: fold change.  
Protein Gene p-value q-value Trend FC 
Phospholipase A2 PLA2 0.0037 0.052 Optimal>Suboptimal (EQ2) 2.27 
Myostatin GF8 0.01 0.087 Optimal<Suboptimal (EQ2) 0.52 
NAPRTase NAPRT 0.0053 0.0538 Pregnant>Non-pregnant (EQ3) 1.59 
 
Biomarker candidates’ potential for validation 
The proteins presented were assessed for their potential to be assayed on in vitro embryo culture. 
Aspects considered were putative effect on embryo development, cellular location, magnitude of 
difference between good and poor-quality embryos, antecedents in literature, and availability. 
Upon extensive consideration, proteins found to be positively related to embryo quality were 
excluded because it is more technically challenging to test a positive effect compared to a negative 
effect on in vitro embryo culture (Zullo et al. 2016a). Then, out of the negative proteins, some had 
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contradictory evidence in literature to what was observed here: dihydropteridine reductase, Acyl-
CoA-binding protein, S100A2, SERPINA1, prostaglandin reductase. Membrane proteins (both cell and 
mitochondria) were also excluded, i.e. UNC80, ATP synthase subunit beta. 
Cystatin C was the only cystatin determined to be secreted and thus chosen as a potential biomarker 
to try through in vitro embryo culture. Pyruvate kinase M2, in turn, was classified as intracellular by 
Outcyte, Phobius and SignalP. However, there is evidence of its extracellular location by several 
studies (reviewed by Hsu and Hung 2018). Its multiplicity of functions rendered it of special interest. 
The effect of some of those proteins was tested in in vitro embryo culture experiment (Chapter 7). 
Pathway and functional analysis 
As previously mentioned, one way to gain understanding of complex biological data is by ontology 
and pathway investigation. Overrepresentation analysis and enrichment analyses are two of the 
most widely used approaches; here these were carried out using Metascape.  
Overrepresentation assesses the proportion of proteins of a certain class (being cellular component, 
molecular function, biological process, or pathway) over a user-decided threshold (usually statistical 
significance and/or fold change) to the whole set of proteins detected in the study, i.e. background. 
In this type of analysis, all proteins are considered equally important and depends heavily on the 
user’s choice. Pathway enrichment analysis, on the other hand, takes an input of all proteins 
identified together with a measure reflecting its difference between two or more conditions tested 
(usually fold change). Unlike overrepresentation, it tests for coordinate trends in the proteins within 
each pathway, assessing the likelihood of a pathway being up- or down-regulated.  
Table 5 shows the functional categories impacted according to genes in differential abundance 
between favourable and unfavourable conditions, i.e. inputting fold change values of all proteins in 
differential abundance between EQ1-3. 
According to overrepresentation analysis, differentially regulated GO biological processes in ULF 
containing embryos of different classes, in order of increasing FDR (q-value), were “myeloid 
leukocyte activation”, “cofactor metabolic process”, “generation of precursor metabolites and 
energy”, “response to wounding”, “proteolysis in cellular catabolic processes” and “monocarboxylic 
acid metabolic process”. The definitions provided below were obtained from the GO website 
(Ashburner et al. 2000, Gaudet et al. 2011). 
At first sight, these processes are not particularly relevant to the extracellular liquid matrix that 
constitutes ULF. The q-value assigned to each is useful to assess how reliable each term is but is not a 
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rigid parameter meant to preclude consideration and discussion. Therefore, terms above the 
specified significance threshold of 0.05 will still be examined, albeit more briefly.  
Firstly, “cofactor metabolic process” has been rendered obsolete because “it is not meaningful to 
group metabolic processes that are not all chemically related by the fact that they may be used as a 
cofactor” (https://www.ebi.ac.uk/QuickGO, 02/12/2020). 
“Myeloid leukocyte activation” is defined as “a change in the morphology or behaviour of a myeloid 
leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand” and is 
part of the bigger class of “immune system processes”. Most of the proteins in this pathway were 
negatively associated with embryo quality phenotype (CST3, MIF, SERPINA1, PKM, NAPRT, PLG), 
whereas ALAD was the only positively associated with embryo quality (p<0.001, q=0.003). An 
activation of this pathway is typical at the onset of pregnancy in cows (Ott 2019), but the result 
obtained here strongly suggests an abnormal hyperactivation of myeloid leukocytes -macrophages 
and dendritic cells- (Kamat et al. 2016). This disruption of the delicate balance required for allowing 
the semi-allogenic embryo to develop while fending off detrimental bacteria often results in 
pregnancy loss (Ott 2019). 
Generation of precursor metabolites and energy, i.e. “the chemical reactions and pathways resulting 
in the formation of precursor metabolites, substances from which energy is derived, and any process 
involved in the liberation of energy from these substances”. The weak tendency for dysregulation of 
this pathway (p<0.001, q=0.151) was associated with poorer embryo quality in this work, signified by 
higher levels of ATP5F1B, PKM, QDPR, SH3BGRL3, CST3 and MSTN. The discussion presented earlier 
around each of these proteins showcases their diversity and complicates simple interpretations of 
this category’s dysregulation. However, Simintiras et al. (2019a) have shown that progesterone 
reduced total metabolite abundance at day 12 of oestrus, exemplifying the “goldilocks principle of 
embryo development” coined by Leese et al. (2016): although satisfying the metabolic requirements 
of the embryo is crucial, when an upper threshold is crossed the results are as negative as 
insufficiency. It is possible thus that in the present work an increased metabolic status at the cow 







Table 5-7 Functional categories and pathways impacted in ULF containing contrasting embryo 
quality, by Metascape overrepresentation analysis of proteomics data.  
Impact GO Description Proteins p-value q-value 
















































Proteins in the “response to wounding”, i.e. “any process that results in a change in state or activity 
of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) 
as a result of a stimulus indicating damage to the organism”, and a subgroup of the “response to 
stress” mechanisms showed a weak tendency to enrichment in this work (p<0.001, q=0.166). This is 
seemingly at odds with the report of Gegenfurtner et al. (2019b) in oviduct fluid of Montebeliarde (of 
high genetic potential for fertility traits) vs Holstein (of low genetic potential for fertility traits) cattle. 
There, they reported that response to wounding was higher in Montebeliarde compared to Holstein, 
however the location (oviduct) and timeframe (day 3 after oestrus) were dissimilar and thus may not 
be directly comparable. They also showed that metabolic stress due to calving and milking increased 
proteins involved in defence response (Gegenfurtner et al. 2019b), pointing at an increase in 
“response to wounding” proteins being responsible for at least part of the well-characterised 
differences in fertility between breeds. 
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“Proteolysis in cellular catabolic processes” and “monocarboxylic acid metabolic process” had q-
values of 0.93, indicating a high likelihood of their significance being spurious. 
Multivariate analysis and modelling 
Unsupervised multivariate analysis determined trends in the proteomics composition of ULF samples. 
Protein abundance values were auto-scaled, as referred to in Chapters 3 and 4. No trends or 
clustering was observed related to embryo quality (by either of the classification systems employed, 
EQ1-3); Figure A-8- shows principal components 1 and 2 of an example PCA plot according to protein 
abundance features. 
Supervised analysis (OPLS-DA) was also performed to ascertain whether a model was both able to fit 
(explain) data and to predict the response variable (embryo viability or oestrus number) based on 
tendencies in explanatory variables (protein abundances). In all cases, the parameter representing 
degree of fit (R2) was relatively high (consistently over 0.5) but lacked predictive power (Q2<0 for 
OPLS-DA); these results are discussed in Chapter 6 where they are integrated with the analysis of 
metabolomics data. 
5.4 Conclusions 
The present chapter investigated the proteomic composition of ULF and its relationship with embryo 
quality under different frameworks. Many proteins were identified in this work for the first time in 
ULF proteome. Moreover, comparisons between studies showed moderate overlap in the protein 
complement identified in each. Further research is needed to identify the most consistent 
components of ULF and other biofluids, particularly using newer technological approaches. 
Univariate analysis showed differences in ULF protein abundance related to embryo phenotype. 
Some potential biomarker candidates were identified, of which SERPINA1, PKM2 and Cystatin C 
showed high potential for application and were considered for experimental validation purposes. 
Results from metabolomic and joint analyses (presented in the next chapter) were also considered to 







As detailed in Chapter 1, the metabolome is an important component of the uterine environment of 
the dairy cow and highly influential on embryo development. Following the method optimisation 
process described in chapter 4, two metabolomics experiments were carried out to analyse the 
molecular composition of ULF samples collected from Farm trials 2 and 3. These trials encompassed 
the spring reproductive seasons of two years (2017 and 2018) in a herd at Tokanui farm in the 
Waikato area of New Zealand, as specified in Chapter 2.  
The two main metabolomic experiments of this project are described herein. Experiment M4 was 
based on GC-MS/MS targeted metabolomics and was performed to identify metabolites and 
biological processes underlying uterine physiology differences related to the contrasting embryo 
development observed. Integration at functional and pathway levels with proteomics data (Chapter 
5) was also performed. Experiment M5 used REIMS direct infusion mass spectrometry analysis as a 
proof of concept to establish whether the metabolic fingerprint obtained could model or predict 
embryo fate or, alternatively, other relevant physiological parameters. In this case, relevant spectral 
features were putatively identified. 
This chapter had two main goals. Firstly, to characterise the ULF metabolome qualitatively (including 
comparisons with previous related studies) and quantitatively, including integrating these data with 
proteomics data for a systems-level analysis. Secondly, to determine molecules relevant to embryo 
development directly or through the influence of other factors, especially oestrus after calving (OC). 
6.2 Methods 
6.2.1 Experimental design 
Reagents along with their origin are specified in 4.2.1. Samples used were obtained in Farm Trials 2 
and 3, section 2.2.3. In both experiments, all steps of sample preparation and analysis in instrument 
were randomised using the random function in MS Excel, blocking by year and OC. Further 
specifications were followed to ensure inter-sample and inter-batch consistency in these lengthier 
experiments, and these are detailed next. 
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Targeted metabolomic analysis of ULF flushings: Experiment M4 
Experiment M4 (targeted metabolomics) followed the protocol detailed in 4.4.7 with the following 
differences: tracer (heavy proline) peak areas were calculated as detailed in 4.3.2. Quality control 
(QC) procedures were like those detailed for proteomics in Chapter 5. Specifically, in both Exp. M4 
and M5, a pool of at least 20 samples was produced, and aliquots of this pool were run at regular 
intervals (every 10 ULF samples). Batches consisted of ten ULF samples preceded and followed by a 
QC injection. At the end of the batch, a hexane blank and a water blank were also run to confirm the 
absence of carryover.  
Metabolites detected - comparisons with other studies 
Results from five previous studies on untargeted or broadly targeted metabolomic analysis of ULF 
were collected. As different metabolite nomenclature systems were used across the relevant studies, 
the identifiers were batch-converted to HMDB, KEGG and/or PubChem ID using MetaboAnalyst web 
tool v4.0. 
Metabolomic fingerprinting of ULF using direct infusion-MS: Experiment M5 
Experiment M5 was carried out in a similar manner as described for Exp. M3 (Chapter 4). In brief, 
each batch was made up of 10 samples, which were analysed in positive and negative modes, with a 
QC sample analysed at the beginning and end of each batch. The iKnife handheld device was slid on 
the surface of each ULF sample placed in a foil cup to vaporise it and this was siphoned into the 
REIMS machine to generate a mass spectrum. The iKnife was wiped clean in between samples with a 
paper towel and ethanol. At the end of each batch, a saline blank was analysed, and the handheld 
device was thoroughly scrubbed. The instrument was also cleaned by isopropanol infusion for 15 
minutes before proceeding to the next batch. 
Informatic and statistical analysis 
Informatic analysis was performed in a similar manner as detailed in Chapter 5 for Exp. P3. 
Specifically, a spreadsheet containing peak areas for each identified metabolite (Exp. M4) or feature 
(Exp. M5) in each sample (ULF, QC, blanks) was produced and analysed using the statistic and 
bioinformatic approaches explained in Chapter 5. Batch correction was applied using the QC-RFSC 
(Quality Control Random Forests Signal Correction) algorithm choosing the LOESS (Locally Estimated 
Scatterplot Smoothing) method in the W4M Galaxy web-based tool (Dunn et al. 2011). This method 
was chosen over those presented in Chapter 4 -i.e. normalisation by internal standards (Jonsson et al. 
2005) in Exp. M4 and by total ion chromatogram area for Exp. M5 (Ross et al. 2020)- due to its 





Generalised linear model analysis (multiparametric regression) was performed to determine changes 
in the molecular composition of ULF through time (in dpp and OC). Then, the potential effect of 
metabolites and dpp or OC on embryo quality (according to the systems developed, i.e. EQ1, EQ2 and 
EQ3 as described in Chapter 2) was assessed in a similar manner using the GLM function of the base 
package in R 4.0.2 - R Team (2019). 
Multivariate analysis and modelling 
In brief, PCA, sPLS-DA and OPLS-DA were performed using the R packages mixOmics v4.0 (Rohart et 
al. 2017) and ropls v3.8 (Thévenot et al. 2015).  
Functional and pathway analysis 
Enrichment (using KEGG, the Kyoto Encyclopaedia of Genes and Genomes) and overrepresentation 
pathway analyses were performed using IMPaLA version 12 (build January 2019)  
(http://impala.molgen.mpg.de/) (Kamburov et al. 2011) and metaboAnalystR v5.0 
(https://www.metaboanalyst.ca/) (Pang et al. 2020), on all KEGG pathways (metabolic and gene-only, 
regulatory pathways). Impact score, i.e. “the sum of the importance measures of the matched 
metabolites normalised by the sum of the importance measures of all metabolites in each pathway” 
(Xia and Wishart 2010) higher than 0.3 was also used as a threshold of relevance. 
For over-representation analysis the formula Impala uses is: 
pathways p where Ni is the effective size of pathway i, M is the overall number of genes or 
metabolites available to be picked, K is the number of genes or metabolites picked and ki is the 
number of genes or metabolites picked from the pathway. 
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6.3 Results and discussion 
6.3.1 Experiment M4: targeted metabolomics 
Quality control assessment 
Acceptable reproducibility was achieved in experiments, with intra- and inter-batch effects relatively 
small; these were adjusted by the LOESS method as described (Figure A-8-910). However, the 
replacement of a component (the detector) in the GC instrument resulted in noticeably lower 
sharpness and intensity of peaks in Exp. M4 compared to those from preliminary experiments (Exp. 
M1 and M2). This was not apparent in the periodic checks during the running of the samples. It 
however resulted in a lower number of metabolite transitions detected (122 in this experiment 
compared to the >200 detected in Exp. M2 and M3, Chapter 4). Nonetheless, this number is within 
the range of many recent articles in this area, most of which identified less than 200 compounds, 
with the exception of (Moraes et al. 2020a, Moraes et al. 2020b) who reported over 600 compounds, 
most of which were lipids with multiple isomer variants; this is examined next.  
On a different note, the use of heavy proline as a tracer to estimate uterine volume and degree of 
ULF dilution by sampling medium was not employed in Exp. M4 due to inconsistent patterns 
observed in the peak areas for these transitions. The tracer approach was considered a useful 
strategy that did not fulfil its purpose as intended, potentially due to instrument issues. 
The data obtained was further analysed in perspective to previous work, and in terms of individual 
molecules, classes, and pathways. 
Metabolite identification and comparisons to previous studies 
The bovine metabolome is estimated to be constituted by about 50,000 by genomic-scale inference, 
although only around 2,100 have been experimentally detected (Foroutan et al. 2020). Their research 
group created a database – the “Bovine Metabolome Database” (https://bovinedb.ca)- including 
both detected and predicted metabolites in 10 biofluids and tissues, though coverage in the 
reproductive tract is limited (Foroutan et al. 2020). 
To characterise the ULF metabolome in this study, results from a combination of broad targeted and 
untargeted GC-MS/MS analysis were examined. To examine metabolome coverage, all compounds 
identified in Exp. M1 were considered: 278 transitions totalling 209 compounds after removing 
duplicates and internal standards. In addition, compounds identified by full scan, untargeted GC-
MS/MS analysis were included: the 94 features matches were mapped to PubChem id’s resulting in 
81 unique compounds (i.e. some features were fragments of the same compound). This resulted in a 
combined total of 242 unique metabolites mapped to metabolic networks. A Venn diagram shows 
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the overlap between the two approaches (Figure 6-181); the full compound list is displayed in Table 
S6-1. 
 
Figure 6-18 Venn diagram showing metabolites identified by targeted analysis, untargeted analysis, 
or both. 
Comparisons to other studies: meta-analysis 
A list of metabolites detected in the studies analysed from the literature was assembled to 
contextualise the findings of this study in a manner analogue as that described in the previous 
chapter for proteomics data. For this, metabolite identifiers reported in studies conducting 
untargeted or broadly targeted metabolomic analysis of bovine ULF were converted to standard 
names using the batch conversion tool in Metaboanalyst 5.0 (Pang et al. 2020). Compounds 
successfully identified were pooled to create a “background dataset” to be used for pathway 
overrepresentation analysis (described next). Results obtained in one experiment and published in 
more than one article were grouped (Moraes et al. 2020a, Moraes et al. 2020b) and (Simintiras et al. 
2019a, b, Simintiras et al. 2019c). 
Next, overlap between the compounds reported across studies was analysed, along with other 
relevant parameters (total number of compounds and number of animals sampled; Table 6-1). It’s 
important to consider here that comparisons suffer of a certain degree of inexactness because of 
missing data (i.e. incomplete lists available), as well as nomenclature issues. These include notation 
discrepancies (i.e. “2-3-Bisphosphoglyceric acid” vs “2,3-Diphosphoglyceric acid” or “Prolyl 
hydroxyproline” vs “Prolyl-Hydroxyproline”), mismatches, and ambiguous entries (particularly 
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isomers that cannot be resolved by traditional mass spectrometry, such as fatty acids and 
enantiomers of AA); consequently, lists were manually checked and corrected. 
A total of 1382 unique compounds were surveyed from the studies; the present study reports 242, 
above the mean of 219 compounds reported per study. Of those compounds, 1194 (86%) were 
reported in one study only; the average number of unique compounds was 125 (132 in the present 
study). As was the case with the proteomics meta-analysis, the number of animals sampled in this 
study (92) and samples analysed (184) were substantially higher than the average (18 and 23, 
respectively), and more than twice as high as the second largest study (35 animals; Simintiras et al. 
2019a). 
The studies surveyed were less diverse in the instrumental platforms employed and scope than was 
observed with the meta-analysis of proteomics in the previous chapter. This seems sensible, 
considering that metabolomics (i.e. the large-scale analysis of small molecules) is a newer field and in 
fact almost all studies surveyed were performed in the period 2016-2020 using a small number of 
instruments and informatic analysis tools. While most studies detected metabolites classified as 
lipids, these were mainly polar (phospholipids, eicosanoids, carnitines). Only two studies (Simintiras 
et al. 2019b, Moraes et al. 2020b) analysed specifically the hydrophobic fraction of ULF by lipid-
centred methods (“lipidomics”), both reaching the conclusion that pregnancy induces an increase in 
phospholipid content in ULF with the likely purpose of conceptus membrane biogenesis. 
Table 6-112 Metabolites identified in ULF by untargeted or broadly targeted experiments. 
Animals(samples): number between brackets indicates the number of samples 








Tribulo et al. 2018 95 35 4 (16) 
Simintiras et al. 2019 141 49 35 
Sponchiado et al. 2019 201 137 18 
Ribeiro et al. 2016 301 217 30 
Moraes et al.  2020 627 613 25 
Present study 242 132 92 (184) 




No compound was detected in all studies; the most reported (in five studies out of six) were taurine, 
succinic acid, L-malic acid, L-threonine, L-glutamine and L-tyrosine. One hundred and seventy 
compounds were detected in more than one study, predominantly amino acids and derivatives, 
organic acids and carbohydrates, similarly to the compounds detected in experiments in the present 
study. 
Two points summarise the results of this meta-analysis. Firstly, there was limited overlap in the 
metabolite sets reported between studies, underlining the importance of more descriptive analysis 
of this biofluid; this will be greatly aided by newly developed tools for identification in untargeted 
studies and by multi-tissue analyses (Foroutan et al. 2020). Secondly, the present study contributed 
to expand the known universe of metabolites present in ULF by an additional  
Functional analysis of compounds detected in this study 
Next, to assess pathway coverage of the approaches trialled, all compounds detected in the present 
study by both targeted and untargeted analysis were entered in Metaboanalyst’s Pathway 
enrichment tool. Out of the 242 compounds, 231 were mapped to 33 pathways (Table S6-2). 
Pathways enriched (i.e. with more components in the list than expected by taking a sample at 
random from the total metabolome) with false discovery rate (FDR) under 5% (q< 0.05) are shown in 
Table 6-13. Most of those pathways were related to amino acid metabolism or central carbon 
metabolism, which partly reflects the fact that most compounds included in the targeted method 
package were indeed amino acids and organic acids. This is further discussed next. 
Table 6-13 KEGG pathways significantly overrepresented in the full list of metabolites identified 
with respect to the whole bovine metabolome (~2100 compounds) using the 
MetaboAnalyst Pathway Overrepresentation tool. Hits: number of compounds 
detected vs total n of compounds in pathway. q-value= false discovery rate-adjusted 
significance value. 
Metabolite set Hits P-value q-value 
Aminoacyl-tRNA biosynthesis 20/48 <0.001 2.29E-04 
Arginine biosynthesis 9/14 <0.001 0.00103 
Valine, leucine and isoleucine 
biosynthesis 
6/8 <0.001 0.00391 
Citrate cycle (TCA cycle) 8/20 <0.001 0.0412 




As mentioned before, the choice of analysing the hydrophilic fraction is a determining factor of the 
type of metabolites detected in the present study; a choice certainly influenced by the fact that ULF 
is water-based (Roberts and Bazer 1988). Similar results were obtained when classifying all 
compounds in this study by chemical class: the most relevant metabolite class were “organic acids 
and derivatives” (45%), followed by “organic oxygen compounds” (15%), “lipids and lipid-like 
molecules” (11%), and “organo-heterocyclic compounds” and “benzenoids” (7% each).  
The same analysis was repeated including all compounds surveyed from previous studies in the 
meta-analysis, provided they could be mapped to HMDB identifiers (i.e. excluding most lipids), a total 
of 823 metabolites. No pathway was significantly enriched, suggesting that the proportions of 
metabolite classes detected across studies match the class proportions in the KEGG database. 
Integration between general metabolomic tools (e.g. MetaboAnalyst) and specialised lipidomics 
informatic tools such as Lipid Ontology (Molenaar et al. 2019) will greatly aid to attain a more 
comprehensive and objective view of the metabolome of this and other biofluids and tissues. 
In conclusion, the metabolites within significantly enriched pathways detected in the present study 
are likely relevant to biological functions in ULF, but not necessarily in the manner described by the 
canonical pathways listed above. All those processes are in fact known to occur in the cytoplasm 
and/or the mitochondria (TCA cycle), though abundance differences in ULF could be related to 
endometrial cell metabolism (Belaz et al. 2016). To gain an accurate picture of the functionally 
important molecules in ULF in relation to embryo quality, uni- and multivariate analyses were 
conducted, discussed next. 
Comparisons between targeted and untargeted approaches in this study 
The metabolites detected by either GC-MS/MS approach in the present study were contrasted to 
define their scope and usefulness.  
Untargeted analysis GC-MS/MS analysis 
Enrichment analysis showed that the aminoacyl-tRNA biosynthesis pathway was significantly 
enriched (q<0.001) in compounds identified only by untargeted analysis when compared to the total 
set of metabolites detected in this study, consistently identifying 15 amino acids. When adding the 
28 compounds identified by both methods, other pathways enriched at the q<0.05 level were 
“galactose metabolism and starch and sucrose metabolism” (both constituted by carbohydrates and 
other molecules like myo-inositol), “valine, leucine and isoleucine biosynthesis” and “alanine, 
aspartate and glutamate metabolism” (including amino acids and organic acids), and “glyoxylate and 
dicarboxylate metabolism” (AA, glyceric and glycolic acids - Figure A-8-10a).  
Targeted analysis GC-MS/MS analysis 
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The metabolite set detected by the targeted method tended to be enriched (i.e. identified more 
compounds in these than expected if all compounds were equally likely to be detected) in the 
following KEGG pathways (p <0.005; q <0.1): “Glycine, serine and threonine metabolism” (3-
phosphoglyceric acid, glycine, sarcosine, glyceric acid, 2-phosphoglyceric acid and L-cysteine), 
“taurine and hypotaurine metabolism” (L-cysteine, 3-sulfinoalanine and hypotaurine), “glycerolipid 
metabolism” (glycerol, glyceric acid, dihydroxyacetone phosphate and 2-phosphoglyceric acid) and 
“glutathione metabolism” (glycine, L-cysteine, pyroglutamic acid, ornithine, putrescine - Figure 
A-8-10B). An important consideration is that pathway analysis is biased against methods with 
reduced identification potential -i.e. the untargeted approach- (Karnovsky and Li 2020). Furthermore, 
in all the above analyses, the overlap between pathways exemplifies their interconnectedness and is 
a timely reminder that this powerful analysis tool still requires human curation for interpretation and 
to avoid false inferences, as demonstrated by Nguyen et al. (2019). In their work they tested the 
performance of several pathway analysis tools on well-characterised datasets as well as on fabricated 
data; their conclusions show that methods that consider pathway structure are better at finding 
biologically meaningful differences but that all methods are biased (Nguyen et al. 2019). The authors 
also warned about pathways related to amino acid metabolism appearing to be overrepresented; 
these pathways are very well characterised, and this often results in a pronounced bias that requires 
careful manual checking (Nguyen et al. 2019). In the present work, pathway analyses were conducted 
on three of the most widely used platforms, all of which consider pathway internal structure: 
Metaboanalyst for metabolomics data only, Metascape for proteomics data only, and ImPALA for 
joint omics analyses. 
Summarising, the pathway enrichment results of targeted vs untargeted metabolomics indicate that 
specific molecule classes (amino acids, organic acids, and carbohydrates) are preferentially detected 
and measured using GC-MS/MS under both approaches. In this analysis, a key difference between 
targeted and untargeted approaches was the number of identified compounds. Based on these 
observations, further work in this area may be carried out using targeted analysis when the identity 
of the metabolites is crucial for the research question, and untargeted when maximising the number 
of features is more important regardless of the identity of the individual features, such as for 
predictive modelling purposes.  
6.3.2 Integrated analysis: embryo quality and molecular changes postpartum 
Data from both omics’ workflows (Exp. P3 and M4) was also explored by multivariate approaches to 
assess the potential of models to predict embryo quality and OC. In all cases, individual and 
interactive effects of embryo quality, OC and dpp on molecule abundance in ULF were also explored. 
Then, metabolomic data were analysed in a univariate approach to determine differences in the 
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abundance of individual chemical species in ULF. Lastly, metabolite abundance both by itself and 
conjunctly with proteomics data (presented in Chapter 5) was analysed to identify biochemical 
pathways impacted by time postpartum (OC and dpp) and related to embryo quality (EQ1-EQ3). 
Multivariate analysis 
In the case of targeted analysis, from the total 451 metabolites within the Smart Metabolites 
database, 122 were present in at least 70% of the sample runs and QC (107 unique compounds) and 
these were used for statistical and biomarker analysis. 
PCA was carried out using both metabolomic data only, as well as together with the abovementioned 
protein dataset to conform a joint dataset. In turn, PCA were plotted and coloured based on the 
following parameters: the three embryo quality systems (EQ1-3), OC (1 or 3), and year (2017 or 
2018). No clear clustering by any of those variables was observed, or clear outliers (example plot in 
Figure A-8-). This points at the absence of a single dominant physiological parameter determining the 
molecular composition of bovine ULF. Instead, the interplay between post-partum recovery, ULF 
molecular composition and embryo quality requires different analytical approaches, some of which 
are presented next. 
Binary classification using orthogonal partial least-squares discriminant analysis (OPLSDA) 
Modelling and classification using the metabolomic and joint data through sPLSDA (sparse Partial 
Least Square-Discriminant Analysis) was attempted for systems EQ1-3 and OC. In addition, OPLSDA 
was performed for systems EQ2, EQ3 and OC, as it only allows binary classification. EQ2 compared 
ULF containing III, IV and V embryos (“undesirable” group) vs I embryos (“desirable”), while EQ3 
contrasted ULF containing embryos hypothesised to have originated from bad quality oocytes (IV and 
V) vs good quality oocytes (I to III). All models created were tested by 10-fold cross-validation to 
estimate their fit and predictive power. Negative Q2 were obtained in all cases (Table 6-3), i.e. the 
models generated had no predictive power or were overfitted (Lê Cao et al. 2011). In summary, 
predictive models based on multivariate analysis (sPLSDA) of joint omics data were not able to 
predict number of oestrus cycles postpartum (OC) (Q2 = -0.12) or embryo quality, in the EQ1 (Q2=-
0.032), EQ2 (Q2=-0.33) or EQ3 (Q2=-0.14) classification systems. Figure A-8-1313a,b shows 
representative plots of OPLS-DA (EQ2 and EQ3).  
Univariate analysis – days postpartum and oestrus after calving 
Metabolomics data was analysed to determine effects of dpp, OC and their interaction by general 
linear models (Table 6-4144). Nine metabolites were significantly affected by both dpp and OC 
(phosphoric acid, ethylmalonic acid, malic acid, ribulose, 2-aminoethanol, glycerol, D-xylulose, 
glyceric acid and arabinose; q<0.05), in all cases decreasing with time postpartum. Other metabolites 
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that decreased with dpp were cysteine, uridine, inositol, N-acetylmannosamine, 3-hydroxypropionic 
acid, ribonolactone, threonic acid, rhamnose, xylitol, succinic acid, inosine, ribose and lyxose. 
Metabolites with an upward trend in concentration along dpp were 3-aminopropanoic acid, 
putrescine, beta alanine, 2-hydroxyisovaleric acid, and lactic acid. Two metabolites were significantly 
different (both at q=0.047) between OC but not by dpp, ribose 5-phosphate (2.2-fold higher in OC3) 
and fructose (1.95-fold higher in OC1). Additionally, metoprolol (an antihypertensive drug) was 
detected here, though it is likely a misidentification as these animals were not exposed to this 
substance. Finally, no interactive effect of OC and dpp was found for any metabolite, that is, no joint 
effect significantly different than their sum was found. It also signifies that in all cases the trends 
were in the same direction (either decreasing or increasing with dpp and OC). 
Table 6-3 Summary of results of statistical tests and modelling. sPLS-DA/OPLS-DA: 
sparse/orthogonal Partial Least Squares Discriminant Analysis.  








R2 Q2 R2 Q2 
M4 EQ1 0 0 0.1 -0.15 N/A (>2 classes) 
M4 EQ2 0 0 0.11 -0.46 0.309 -0.625 
M4 EQ3 0 0 0.005 -0.17 0.267 -0.426 
M4 OC 11 8 0.049 0.047 0.28 0.1 
M4 dpp 28 2 N/A (regression) 
P3 EQ1 18 0 0.029 -0.25 N/A (>2 classes) 
P3 EQ2 0 2 0.0007 -0.208 0.138 -0.011 
P3 EQ3 0 1 0.174 -0.079 0.219 -0.124 
P3 OC 2 0 0.05 0.037 0.257 -0.073 
P3 dpp 0 0 N/A (regression) 
Joint EQ1 N/A N/A 0.58 -0.032 N/A (>2 classes) 
Joint EQ2 N/A N/A 0.035 -0.33 0.1 -0.13 
Joint EQ3 N/A N/A 0.11 -0.14 0.194 -0.167 




An interesting difference in metabolite abundance that was not accounted for in pathway analysis 
was a higher abundance of lactic acid (lactate) at OC3. The early embryo (up to the morula state) has 
been shown to depend chiefly on pyruvate for growth (Khurana and Niemann 2000), with lactate 
showing similar energetic support for embryo development in vitro (Takahashi and First 1992) and in 
vivo (reviewed by Li and Winuthayanon 2017). Lactate is also one of the most abundant metabolites 
in oviduct fluid exosomes (Gatien et al. 2019). Its concentration in oviduct fluid across oestrus has 
been reported to be up to eightfold higher than in plasma and ULF (Hugentobler et al. 2007b), 
though appears not to be determined by sexual hormones (progesterone or oestradiol) in blood, ULF 
or oviduct fluid (Hugentobler et al. 2010). Additionally, higher lactate concentrations in uterine and 
oviduct fluids can support higher amounts of lactic acid bacteria, of known positive effect on 
postpartum recovery (faster uterine involution, higher prostaglandin-F2alpha in blood - Deng et al. 
(2015)) and uterine health, regulating E. coli-produced-inflammation (Genís et al. 2017) and 
decreasing incidence of metritis (Genís et al. 2018). The increased lactate abundance in ULF at OC3 
could also be partly responsible of increased fertilisation rate by a higher energy supply for sperm 
(Sengupta et al. 2020), In the conditions of the present work, it is not possible to determine whether 
contrasting abundance of lactate or other molecules respond to differential secretion, consumption 
or interconversion, but considering the work cited, lactate warrants further research. 
Table 6-414 Differentially abundant metabolites across dpp and OC, at a q-value <0.05. *not 
naturally occurring. #metabolites higher in OC3 and increasing with dpp. Bold: 
significant effect of both dpp and OC. 
 Days postpartum Oestrus after calving Interaction 






Phosphoric acid <0.001 <0.001 0.149 0.002 0.016 1.77 0.72 1 
Ethylmalonic acid <0.001 <0.001 0.067 0.001 0.011 1.6 0.44 0.7 
Cysteine <0.001 <0.001 0.101 0.017 0.078 1.68 0.17 0.27 
Uridine <0.001 0.0014 0.09 0.047 0.174 1.6 0.38 0.61 
Malic acid <0.001 0.002 0.078 0.001 0.008 2.45 0.21 0.34 
Ribulose <0.001 0.002 0.093 0.001 0.009 2.18 0.55 0.88 
2-Aminoethanol <0.001 0.002 0.101 0.001 0.014 1.5 0.79 1 
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 Days postpartum Oestrus after calving Interaction 






Glycerol <0.001 0.003 0.077 0.003 0.027 1.39 0.64 1 
Inositol <0.001 0.004 0.057 0.173 0.341 1.27 0.57 0.91 
N-Acetylmannosamine <0.001 0.004 0.055 0.19 0.357 1.26 0.62 0.99 
Metoprolol* <0.001 0.004 0.044 0.232 0.389 1.32 0.39 0.62 
3-Hydroxypropionic acid <0.001 0.005 0.098 0.013 0.066 1.82 0.31 0.5 
D-Xylulose <0.001 0.005 0.072 0.008 0.047 1.82 0.31 0.5 
Ribonolactone 0.001 0.007 0.069 0.013 0.066 1.47 0.21 0.34 
Glyceric acid 0.003 0.016 0.068 0.002 0.016 1.64 1 1 
Threonic acid 0.003 0.017 0.088 0.037 0.142 1.58 0.14 0.22 
3-Aminopropanoic acid# 0.004 0019 0.034 0.066 0.222 0.74 0.14 0.22 
Putrescine# 0.004 0.019 0.031 0.079 0.25 0.65 0.21 0.34 
Arabinose 0.005 0.021 0.049 0.008 0.047 1.7 0.57 0.91 
Rhamnose 0.006 0.024 0.016 0.132 0.329 1.86 0.15 0.24 
Beta alanine# 0.007 0.027 0.026 0.12 0.319 0.78 0.9 1 
Xylitol 0.008 0.032 0.046 0.018 0.081 1.56 0.14 0.22 
Succinic acid 0.009 0.033 0.074 0.284 0.431 1.22 0.89 1 
2-Hydroxyisovaleric acid# 0.011 0.039 0.037 0.804 0.89 0.5 0.14 0.22 
Inosine 0.013 0.045 0.027 0.561 0.695 1.24 0.09 0.19 
Lactic acid# 0.014 0.045 0.038 0.428 0.608 0.73 0.95 1 
Ribose 0.014 0.045 0.04 0.013 0.066 1.6 0.83 1 
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 Days postpartum Oestrus after calving Interaction 






Lyxose 0.015 0.047 0.04 0.011 0.061 1.62 0.87 1 
Ribose 5-phosphate# 0.061 0.161 0.007 0.008 0.047 0.45 0.34 0.54 
Fructose 0.117 0.256 0.008 0.007 0.047 1.95 0.12 0.23 
Univariate analysis – embryo quality 
No significant difference was observed in metabolite abundance between embryo quality classes 
under the systems examined (EQ1, EQ2, EQ3: Tables S6-3a, b and c, respectively). This suggested that 
embryo quality differences respond to distinct (though likely interrelated) factors, but this was 
further tested by joint pathway analysis. 
Pathway analysis 
For pathway enrichment analysis, metabolite abundance values were entered in the MetaboAnalyst 
web tool and analysed for differential regulation across dpp and OC. /Forty-five pathways 
represented by more than 2 related compounds were found (Table S6-4). Pathways within the 
criteria established for further analysis (q<0.05 and impact>0.3) are displayed in Table 6-5 and Figure 
A-8-11.  
Table 6-5 Enriched pathways in ULF according to metabolite abundance changes by OC and dpp, 
with q<0.05 and impact>0.3. Matches: differentially abundant metabolites vs metabolites in 
pathway detected in the experiment. Abbreviations: dpp, days postpartum; OC, oestrus after calving. 











Pentose and glucuronate 
interconversions 
3/5 0.009 0.033 0.42 0.004 0.018 0.42 
beta-Alanine metabolism 4/8 <0.001 0.007 0.4 0.004 0.017 0.4 
Cysteine and methionine 
metabolism 
5/10 0.023 0.073 0.34 0.004 0.024 0.34 
Glycerolipid metabolism 2/4 <0.001 <0.001 0.34 0.007 0.003 0.34 
Glycine, serine, and 
threonine metabolism 




In a study of plasma metabolomics at three timepoints of pregnancy some of the same pathways 
were found altered; from day 0 (artificial insemination) to both days 17 and 45 of pregnancy these 
were glycerophospholipid metabolism, pentose and glucuronate interconversions and glycerolipid 
metabolism (Guo and Tao 2018). On day 45, pathways differentially regulated vs day 0 were thiamine 
metabolism, pantothenate and CoA biosynthesis, inositol phosphate metabolism and pentose 
phosphate (Guo and Tao 2018).  
Here, pathways with an impact factor higher than 0.3 were selected for discussion. A superscript was 
added to each differentially abundant molecule in each pathway to indicate the trend across time 
(higher in OC1 or OC3) and their significance (plain: p<0.05 and q<0.1; underlined: q<0.05).  
Glycerolipid metabolism (glycerolOC1, D-glycerateOC1) was posited by Sun et al. (2015) to be one of the 
most ubiquitous and impactful pathways across rumen, milk, serum and urine. Moreover, higher 
abundance of glycerol and D-glycerate in ULF at OC1 could be related to higher triacyl glyceride 
lipids, rendering glycerol and NEFA as products (Nayeri and Stothard 2016). In support of this, 
substantially higher concentrations of NEFA in serum were found at OC1 vs OC3 (Chapter 2). Higher 
concentrations of saturated fatty acids (particularly palmitic and stearic acids) in blood are known to 
be also mirrored by their abundance in follicular fluid (Leroy et al. 2004) and to markedly reduce 
oocyte quality (Leroy et al. 2005b). Also, as detailed in Chapter 1, oocyte development occurs in a 
period of up to six months before ovulating (Lussier et al. 1987). Upregulation of this pathway, 
therefore, suggests low quality oocytes developing during early postpartum as an (or potentially the 
most) important cause of poorer quality embryos on OC3.  
Another factor that could be involved in this pathway being upregulated at OC1 is that this occurs at 
the beginning of spring (end of August and beginning of September), with temperatures typically in 
the range of 5-15°C, whereas OC3 occurred on average 42 days later (Chapter 2, Table   2 -4) , on 
early-mid October with temperatures 3 to 4 degrees warmer on average (www.weather-atlas.com). 
Glycerolipid metabolism, and particularly extracellular lipolysis, is known to increase with lower 
temperatures for thermogenesis, i.e. to maintain an adequately warm body temperature (Prentki 
and Madiraju 2008). It is suggested that farm management decisions on provision of shelter and/or 
housing consider this factor in their reproductive remediation strategies.   
Beta alanine metabolism (3-hydroxypropanoateOC1, beta alanineOC3, L-aspartateOC1, uracilOC3): higher 
concentrations of beta alanine at OC3 might indicate increased catabolism of carnosine, a known 
antioxidant molecule (Boldyrev et al. 2013), which is less required in an improved redox environment 
compared to earlier postpartum (Ledgard et al. 2009). Carnosine was not detected in this study; the 
only reference of its detection in bovine ULF was by Groebner et al. (2011c), who found it in fourfold 
higher abundance in ULF containing in vitro produced  vs cloned (somatic cell nuclear transfer) 
  
 127 
embryos. However, a similar study by the same research group failed to detect both carnosine and 
beta alanine in bovine ULF (Groebner et al. 2011a). Beta alanine in cyclic cow ULF was found to 
increase from day 3 to reach a maximum at day 5 and then decrease at day 7 (Tribulo et al. 2019). It 
is also possible that increased abundance of L-aspartate in ULF at OC3 results in an increased 
abundance of beta alanine without a relevant physiological purpose related to fertility. The 
implications of this pathway being impacted at OC1 require further investigation. 
Pentose and glucuronate interconversions (D-xyluloseOC1, xylitolOC1, L-arabinoseOC1, ribuloseOC1, D-
glucuronateOC1): this pathway was downregulated by OC3 in this study. Guo and Tao (2018) reported 
decrease of metabolites in this pathway at day 17 and 45 of pregnancy in cows’ serum. In the present 
study, the relatively high abundance of ribulose, xylulose and xylitol feed D-ribulose 5-phosphate into 
the pentose phosphate pathway, with the potential aim of producing NADPH to regulate the redox 
balance of the endometrial cells (Agarwal et al. 2012). Endometrial cells can be exposed to high 
oxidising activity product of the antibacterial defensive action of eosinophils and their secreted 
enzymes (Klebanoff and Smith 1970). Additionally, a metabolite matching xylulose and ribulose was 
found in 6-fold higher abundance in day 12 of oestrus in cow ULF vs cows at 14 and 16 days, and at 
the three timepoints in cows receiving progesterone supplementation (Simintiras et al. 2019c). D-
glucuronate, also in this pathway, was also suggested to be regulated by both timepoint within the 
oestrus cycle and blood progesterone concentration, in the same study (Simintiras et al. 2019c). 
Cysteine and methionine metabolism (L-cystathionineOC1, L-serineOC3, L-cysteineOC3, (S)-2-
aminobutanoateOC1, pyruvateOC1) in the present work was activated at OC3, with both L-cysteine and 
L-serine in higher abundance, and L-cystathionine (their precursor) in lower abundance. In apparent 
contraposition, cows under a hormonal manipulation to have reduced corpus luteum (CL) and 
smaller dominant follicle had lower concentration of cystathionine at day 7 of oestrus (França et al. 
2017). Although L-methionine was not detected in the present work, it is conceivable that this amino 
acid would also be produced in higher amounts at OC3, but its temporal regulation is unclear (Tribulo 
et al. 2019). Methionine metabolism modulation was suggested to considerably affect bovine 
embryo growth in vitro, where concentrations of methionine under or over 5 mM decreased embryo 
development (Ikeda et al. 2011). Rumen-protected methionine supplementation has shown 
improvement in certain parameters positively correlated to fertility (Stella 2017) but its effectiveness 
to improve reproductive function per se has not been proven (reviewed by Aranciaga et al. 2020).  
Glycine, serine and threonine metabolism (glycineOC1, L-threonineOC3, L-cystathionineOC1, sarcosine 
OC3, D-glycerateOC1, L-cysteineOC3, pyruvateOC1) was reported by Sun et al. (2015) as one of the most 
impacted in cows fed alfalfa (high protein diet) vs corn stove (low protein diet), with alfalfa-fed cows 
having higher concentration of D-glycerate in urine and creatine in milk. Glycine and serine are non-
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essential amino acids and can be interconverted or converted to other amino acids (L-serine, L-
threonine, L-aspartate) through several different biochemical reactions. This pathway was activated 
at OC3: glycine, L-cystathionine and D-glycerate (precursors) were in higher abundance in ULF at OC1 
and at OC3 it shifted towards the products (particularly L-threonine and L-cysteine). Cysteine 
supplementation was reported to have a positive effect on embryo development in vitro (Caamano 
et al. 1998), whereas threonine was less abundant in ULF of pregnant compared to cyclic heifers at 
day 7 and 10 of pregnancy (Forde et al. 2014b), suggesting sizable consumption by the early embryo.  
Other pathways approaching the threshold were  “Inositol phosphate metabolism” (myo-inositolOC1, 
D-glucuronateOC1, activated in heifers with successful vs unsuccessful pregnancies (Salilew-Wondim 
et al. 2010), “Pyrimidine metabolism” (uridineOC1, uracilOC3, beta alanineOC3) and “Galactose 
metabolism” (sucroseOC3, lactoseOC1, alpha-D-galactoseOC1, D-glucose sameOC1, glycerolOC1, D-
mannoseOC3, myo-inositolOC1). 
Joint pathway analysis 
One of the standard tools for multiomic functional and pathway analyses (IMPaLA) was used for joint 
pathway enrichment analysis of protein and metabolite abundances. This tool searches against 12 
databases and employs an algorithm that requires more extensive manual curation than the other 
tools used in the present work. This is an important consideration when examining this kind of 
biological probing: pathway and functional analysis is meant to be the starting point for generating 
hypotheses and should not be taken as a definite explanation of the phenomena of interest but 
instead should form the basis of future experimental planning. 
Because this method of analysis requires inputting a fold-change value for each compound, this tool 
was not suitable for pathway analysis of the EQ1 system for embryo classification or changes along 
days postpartum. Thus, differentially regulated pathways according to binary factors were used, i.e. 
oestrus cycle after calving and embryo systems EQ2 and EQ3. 
The analysis of differentially regulated pathways between OC1 and OC3 resulted in 18 pathways or 
processes significantly impacted (Table 6-6 and Table S6-5), whereas no differential pathway was 
observed according to EQ2 (q=1, Table S6-6) and three pathways or functions were or tended to be 
differentially regulated according to EQ3 (q<0.1, Table S6-7). Potential implications are described 
next. 
 
Table 6-6 Significantly impacted pathways and functions across oestrus cycles postpartum by joint 
Wilcoxon enrichment analysis of proteins and metabolites using ImPALA web tool v12. 
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 Proteins Metabolites Joint  
Pathway 
detected 














Metabolism 126/1972 <0.001 <0.001 43/1384 0.004 1 <0.001 <0.001 
Metabolism of 
lipids 
19/664 <0.001 0.003 12/620 0.012 1 <0.001 <0.001 
TCR (T cell 
antigen 
receptor) 
24/245 <0.001 0.001 0/0 1 1 <0.001 <0.001 
Immune System 113/1840 <0.001 <0.001 1/136 1 1 <0.001 <0.001 
Neutrophil 
degranulation 
68/490 <0.001 0.001 0/4 1 1 <0.001 0.001 
Biological 
oxidations 
16/231 <0.001 0.028 8/321 0.016 1 <0.001 0.003 
Innate Immune 
System 
98/1077 <0.001 0.001 1/99 1 1 <0.001 0.003 
Metabolism of 
amino acids and 
derivatives 
26/342 <0.001 0.006 22/285 0.406 1 <0.001 0.008 
Gene expression 
(Transcription) 





16/36 <0.001 0.017 0/0 1 1 <0.001 0.018 
Signal 
Transduction 
67/2647 <0.001 0.204 16/271 0.025 1 <0.001 0.033 
Glycolysis / 
Gluconeogenesis  
17/68 <0.001 0.037 3/31 0.25 1 <0.001 0.034 
Phase II - 
Conjugation 
12/115 <0.001 0.204 7/148 0.031 1 <0.001 0.035 
EGFR1 44/457 <0.001 0.035 0/4 1 1 <0.001 0.035 
RNA Polymerase 
II Transcription 





in colon cancer 
17/42 <0.001 0.237 8/35 0.039 1 <0.001 0.046 
Metabolism of 
proteins 
114/2008 <0.001 0.047 12/269 0.38 1 <0.001 0.046 
Metabolism of 
carbohydrates 








29/345 <0.001 0.069 3/48 0.5 1 0.001 0.076 
 
Differentially regulated pathways between OC1 vs OC3 
An unexpected finding was that, in the pathways and functions significantly impacted between OC1 
and OC3, proteins within each pathway were consistently more abundant and metabolites less 
abundant at OC3. In pathway analysis, contrasting changes within a pathway are ubiquitous and 
reflect the static nature of these experiments, as we are still unable to model elusive dynamic 
changes in cells and biofluids (Kitano 2002). Metabolite abundance is also known to vary faster and 
to a higher degree than other biomolecules in response to system perturbations (Woelders et al. 
2011). In addition, metabolites tend to participate in more different pathways and processes than 
proteins (Altmae et al. 2014), and thus protein trends might be more dependable in this case. 
Most pathways identified as impacted were not biochemical routes but, rather, tissue- or organ-level 
processes and general GO functions (Gene Ontology Consortium 2019). Some terms were 
exceedingly general and may thus offer limited insight beyond what was described for the pathway 
analysis with metabolites alone (Table S6-4), particularly in metabolism (general metabolism, 
metabolism of lipids, of carbohydrates, and proteins, metabolic reprogramming in colon cancer). 
Metabolism of amino acids and derivatives as well as glycolysis/gluconeogenesis appear to be more 
active in the ULF environment earlier postpartum in relationship with an increased energetic need 
for tissue remodelling and fighting off pathogens (Esposito et al. 2014). The opposite trends between 
protein and metabolite abundances may signify a time-dependent process whereby higher amounts 
of metabolites upregulate protein expression, and this increase is only detected days or weeks after 
(Breier 1999). Some of these functions are examined next in the context of their potential influence 
on the embryo. Other general terms were RNA polymerase II transcription, gene expression 
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(transcription), and signal transduction. In line with the pathway analyses presented in Chapter 5, 
some interesting similarities point at differential regulation of immune signalling factors, with terms 
including “T-cell antigen receptor”, “innate immune system”, ”Jak-STAT signalling after IL-12 
stimulation”, “EGFR1 (epithelial growth factor receptor 1)”. Other impacted processes include 
“phase-II conjugation” involved in detoxifying xenobiotics, “cellular responses to stress” and 
“biological oxidations”; the significance of most proteins in these processes to be more abundant in 
OC3 may reflect a physiological status better able to cope with oxidative stress (De Maio 1999), 
compared to earlier at OC1. For each of the impacted pathways, Tables S6-8a,b display the relative 
abundance between proteins and metabolites, respectively. 
Differentially regulated pathways between pregnant and non-pregnant ULF (EQ3) 
Results presented in Table 6-7 are somewhat less conclusive than previous pathway analysis findings 
due to their significance values (0.05<q<0.1) being above the previously established threshold 
(q<0.05). However, the exploratory nature of the present study justifies a short discussion. Three 
functions were found (“general metabolism”, q<0.001) or tended to be (“metabolism of proteins” 
and “EGFR1”, q<0.1) generally upregulated in ULF containing class IV-V embryos, i.e. non-pregnant 
according to the EQ3 classification system.  
Table 6-7 Significantly dysregulated pathways and functions in non-pregnant uterine luminal fluid 
(ULF), i.e. EQ3 embryo quality IV and V (arrested at 1-16 cell state) by joint pathway 
enrichment analysis of proteins and metabolites.  
 Proteins Metabolites Joint 
Pathway 
detected 
























EGFR1 44/457 8.66E-05 0.185 0/4 1 1 8.66E-05 0.078 
 
Upregulation of “metabolism” and “metabolism of proteins” points to a heightened molecular 
activity in ULF, potentially caused by systemic metabolic stress and/or inflammation, of autoimmune 
or infectious origin (Gilbert 2019). This molecular hyperactivity results in excessive production of 
reactive oxygen species as a by-product of many chemical reactions and is generally associated with 
decreased viability in both somatic cells and embryos (Leese et al. 2007).  
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The trend for a general dysregulation of the EGFR1 pathway is particularly interesting as EGF 
regulates several processes essential for embryo development (cell cycle, transcription and 
apoptosis) and substantially increases bovine embryo blastocyst rate in vitro (Lonergan et al. 1996). 
This pathway consists of 322 compounds and 219 reactions, originating in the extracellular space and 
with signalling routes in cytoplasm, mitochondria and nucleus (Oda et al. 2005). Importantly, Katagiri 
and Takahashi (2004) reported dysregulation in this pathway (by marked differences in EGF 
concentrations in endometrial tissue) as a potential mechanism of subfertility in repeat breeder 
cows. Furthermore, Katagiri and Moriyoshi (2013) found evidence for progesterone and oestradiol 
regulation of EGF, signifying the importance of this signalling pathway for reproductive function.  
Whereas the specific mechanisms affecting fertility within this pathway are not identifiable in a 
multiomics exploratory analysis like this, six proteins with the most contrasting patterns in the OC vs 
EQ3 pathway analyses were chosen for deeper scrutiny. That is, proteins higher in non-pregnant ULF 
and at OC1, or higher in pregnant ULF and at OC3, representing most likely indicators of poor and 
good uterine suitability, respectively. These were keratin 18, albumin, plectin, KIAA1217, E3 
ubiquitin-protein ligase CBL, and actin-related protein 2 (Table S6-8c). 
Keratin 18 (KRT18) is a cytoskeleton protein expressed in bovine embryos from the morula stage and 
considered a marker of trophectoderm specification (Madeja et al. 2013). Its expression was 
associated with improved quality and higher cell number of cloned bovine embryos (Bang et al. 
2015). In addition, KRT18 gene knockdown reduced blastocyst formation but its function appears to 
overlap with other factors (Goossens et al. 2010). In the present work, the higher abundance of 
KRT18 protein in non-pregnant ULF (containing IV and V embryos) appears to be opposite to previous 
findings. Here, KRT18 might be fulfilling a different function in ULF, such as endometrial epithelium 
growth (Brewer et al. 2020), as suggested by its higher abundance at OC1, when uterine remodelling 
is more active (Scully et al. 2013).  
Albumin is one of the most abundant proteins in both blood and ULF (Guise and Gwazdauskas 1987, 
Alavi-Shoushtari et al. 2006) and has well-known beneficial effects on embryo development, 
including as a carrier of embryokines, an amino acid source, and a regulator of pH, redox state and 
osmotic pressure (Otsuki et al. 2013). The involvement of albumin in the EGFR1 may be by eliciting 
pro-inflammatory responses, though this was reported in human kidney (Reich et al. 2005) and may 
not be relevant in this context. 
Plectin is a cytoskeleton protein whose distribution in the rat uterine epithelium is regulated during 
the embryo implantation period and appears to modulate it (Png and Murphy 2002). In human, it 
appears to be important in endometrial epithelial integrity (Singh and Aplin 2015) and its expression 
is downregulated in women with endometriosis (Kao et al. 2003). Its function in bovine has not been 
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tested, though Papp et al. (2019) reported plectin to be the tenth most abundant protein in bovine 
OLF. Its higher abundance at OC3 and in good embryos suggests its potential as a biomarker for a 
receptive reproductive tract. 
KIAA1217 is related to spinal embryonic development in mice (Kandasamy et al. 2010) and a 
mutation in its gene has been reported to be correlated to lower fertility in cow (Mesbah-Uddin et al. 
2018). KIAA1217 expression was upregulated by ethanol exposure of porcine blastocysts in vitro 
(Pagé-Larivière et al. 2017). In their study, ethanol-induced oxidative damage resulted in lower 
proportions of blastocysts due to developmental arrest and activated oxidative stress control 
pathways (Pagé-Larivière et al. 2017). In the present work, the trend for a higher abundance of 
KIAA1217 in ULF of non-pregnant and OC1 indicates that a similar oxidative effect may have been 
present, due to other oxidisers. 
E3 ubiquitin-protein ligase CBL is a regulator of numerous signalling pathways within immune and 
growth processes, and particularly relevant in apoptosis (Smirnova et al. 2009). A mutation in its 
gene causes development impairment in Ayrshire cattle (Venhoranta 2015). Here, the higher 
abundance of this protein in pregnant and OC3 ULF could be related to endometrial function. 
Actin-related protein 2 abundance fulfils roles as transcription factor and DNA repair in addition to its 
function in the cytoskeleton (Nolen and Pollard 2007). Its inhibition by miRNA in bovine ovarian 
granulosa cells appeared to induce apoptosis necessary for normal follicular development (Ahmad 
2014). The reasons for its higher abundance in non-pregnant and OC1 ULF remain unclear. 
All in all, several processes were found that may underlie the distinct molecular environments of ULF 
at OC1 vs OC3, at the general metabolism, immune, and signalling-endocrine levels. Some of those 
processes appear to affect embryo fate, namely dysregulation of EGFR1.  
Furthermore, differences observed when contrasting pathway analysis results from the different 
approaches (proteomics and metabolomics data alone, or jointly) may arise from the diverse types of 
data input, algorithms and the databases supported. Conducting pathway analysis by these tools 
resulted in a more comprehensive perspective of the range of processes potentially involved in 
uterine physiology and embryo development, though at the expense of low agreement between the 
results from each approach.  
6.3.3 Experiment M5: metabolic fingerprinting 
Quality control 
In Exp. M5 using REIMS, both intra- and inter-batch variation was substantially higher than in 
experiments with GC-MS/MS (Exp. M4), likely caused by subtle differences in pressure applied when 
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operating the iKnife handheld device; these were adjusted by the LOESS method as described (Figure 
A-8-). Next, features present in blanks or with highest abundance in saline spiked with tracer were 
subtracted from all samples as a first processing step. A total of 3429 (2501) features were detected 
originally in positive (negative) ionisation mode, of which 1153 (550) features remained after 
excluding features in blanks (i.e. non-biologically relevant features) as explained above.  
As previously observed in the preliminary test (Exp. M3), analysis in positive ionisation mode 
performed better than in negative mode, with cleaner burns and consistently high peak intensities. 
This is exemplified by peak areas per feature: average raw abundances and standard deviation were 
62.1±28.2 arbitrary units for positive and 44.7±26.9 for negative ionisation mode.   
Univariate analysis  
Univariate analysis was performed as explained above for features acquired in both positive and 
negative ionisation modes and using the three embryo classification systems detailed above (Table 
S6-9). Feature abundance was only different between groups for seven features in negative 
ionisation mode (Table 6-8158). Potential identifications were assigned to three of those. It is 
important to bear in mind that the reliability of these putative identifications is lower compared to 
those obtained by tandem mass spectrometry instruments; for definite identification, a targeted 
(multiple reaction monitoring) method should be used (Ross et al. 2020). No statistically significant 
difference in abundance of features was detected in either positive or negative mode between OC1 
and 3, EQ2 or EQ3 (data not shown). 
Putatively identified compounds 
Based on m/z of the ion features significantly different between class III embryos vs other embryo 
classes (under the EQ1 classification system), three compounds were tentatively identified. As 
explained earlier, definite identification requires either a tandem mass spectrometry method (i.e. 
with a fragmentation) or implementing some method of orthogonal separation (e.g. ion mobility 
chromatography (Kyle et al. 2016), therefore caution needs to be exercised when extracting 
conclusions from these putative identifications. 
Arachidyl-behenate is a wax monoester found in higher abundance in ULF harbouring class III 
embryos compared to classes IV or V. There is evidence of this metabolite class to be important in 
defence (Rawlings 1995) and they make up a substantial proportion of the vernix caseosa, the waxy, 
white substance covering new-born human babies, and also cows, though in smaller amounts 
(Parrish and Fountaine 1952).  
Another compound, putatively identified as 2-methyl-1,3-thiazolidine-2-carboxamide, was 
significantly lower in ULF containing grade 3 embryos compared to 1-16 cell embryos. This 
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metabolite has been putatively identified in human samples but not empirically confirmed. Its 
biological function has not been defined; however, a close structural analogue, AS604872 ((2S)-3-
([1,1'-biphenyl]-4-ylsulfonyl)-N-[(R)-phenyl(2-pyridinyl)methyl]-1,3-thiazolidine-2-carboxamide) is a 
drug used as an PGF2-alpha (prostaglandin) antagonist and has been shown to inhibit uterine 
contractions (Chollet et al. 2007). Whether 2-methyl-1,3-thiazolidine-2-carboxamide is acting as a 
prostaglandin antagonist in the ULF in the present study demands further investigation.  
Finally, a compound putatively identified as a prostaglandin or phospholipid was found in higher 
abundance in ULF harbouring class III embryos. As discussed in the attached review paper (Aranciaga 
et al. 2020), these lipids fulfil crucial functions relevant to fertility and many have been found 
specifically associated to uterine suitability, including 1-stearoyl-GPC (18:0) and 1-palmitoyl-GPC 
(16:0), both increased by exogenous progesterone supplementation at days 12-13 post ovulation 
(Simintiras et al. 2019b). 
Table 6-815 Features detected in REIMS (negative ionisation mode) at a significantly different  
abundance between ULF harbouring embryos of different grade (EQ1) by Kruskal-
Wallis test. Abbreviations: MW, molecular weight; III, grade 3 embryos; IV, 4- to 16-
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Many; arachidyl behenate 

















Fingerprinting related to embryo quality – multivariate analysis and modelling 
PCA was performed to gain an overview of the samples. No clustering was observed when colouring 
the samples by oestrus cycle or embryo quality by any of the described classification systems (EQ1, 
EQ2, EQ3) in positive (Figure A-8-) or negative (Figure A-8-) ionisation mode.  
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Models based on OPLS-DA did not present potential to predict embryo quality (i.e. negative values 
for the Q2 parameter) using features from either ionisation mode or both together (Table 6-).  
To sum up, Exp. M5 was conducted analysing ULF samples of all cows in Farm Trials 2 and 3 with the 
goal of obtaining a rapid metabolic fingerprint that could help assess parameters of interest. While 
good quality molecular spectra were generated, very limited correlations were observed between 
spectral features and the variables analysed. This suggests that the technical variation and low 
sensitivity associated with this instrumental setup may not be optimal for metabolomic 
measurements of ULF. In a study investigating meat metabolite fingerprinting using the REIMS 
detector, replacing the standard handheld sampling device (as was used here) for a robot-operated 
laser system improved the signal-to-noise ratios 17-fold and the model classification accuracy two-
fold (Genangeli et al. 2019), offering an appealing possibility for further studies like the present. 
Other slightly more laborious but comparably versatile tools, such as direct analysis in real time-mass 
spectrometry (DART-MS), can achieve excellent detection sensitivity at the expense of minimum 
sample preparation required (Gross 2014) and may be more suitable for ULF metabolic 
fingerprinting. 
6.4 Summary, further remarks and conclusions 
Two experiments were carried out to survey the ULF metabolome from different angles: Experiment 
M4 based on GC-MS/MS to quantify known metabolites, and Experiment M5 to obtain a rapid 
metabolic fingerprint. One of the goals of these experiments was to obtain insight on important 
metabolic processes affecting embryo quality (with further integration with proteomics data in the 
targeted analysis), and to shortlist potential biomarkers of uterine suitability for pregnancy, 
encompassing embryo phenotype observed and number of oestrus events after calving (OC). 
Whereas no direct significant association was observed between metabolite abundance and embryo 
quality, the abundance of several metabolites was found to differ across time postpartum and this 
may be useful for assessing the metabolic status of the animals and, by extension, allowing 
estimating their readiness for pregnancy. Further studies are needed for empirical validation of these 
findings. Alternatively, it is possible that the metabolic mechanisms most directly regulating embryo 
development implied chemical classes with relatively low coverage in the metabolite package used. 
Two of those groups evidenced to play important endocrine and metabolic roles in the oviductal and 
uterine environments are fatty acids (Ribeiro et al. 2016c) and phospholipids (Belaz et al. 2016, 
Banliat et al. 2019a, Simintiras et al. 2019b). Improving coverage by the use of two or more 
orthogonal (complementary) technologies is generally recommended (Goldansaz et al. 2017). This 
could be attained by concomitant analysis using instrumental techniques such as LC-MS/MS (both 
the typical reverse-phase setup and the rapidly rising hydrophilic interaction liquid chromatography ; 
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Tang et al. 2016). As mentioned in Chapter 1, a key aspect of metabolomics is that no single 
technique can detect more than a few classes in this heterogenic realm, compared to other omics 
(Bedair and Sumner 2008, Álvarez-Sánchez et al. 2010, Beale et al. 2018).  
Analyses from Chapters 5 and 6 showed some indications of the ULF molecular influences on embryo 
viability, and an indirect influence of time postpartum. Yet, the limited agreement in impacted 
pathways and processes between proteins and metabolites suggest that embryo quality is at least 
partly determined through processes not measured herein. Based on the copious literature on early 
pregnancy loss (Artus et al. 2020, Rodríguez-Alonso et al. 2020b), it is hypothesised that the 
interaction of oocyte, oviductal and uterine factors at different degrees determine embryo quality 
phenotype at day 7.  
Another goal was to examine the feasibility of using analysis by one or both instrumental platforms 
for predictive modelling of embryo quality based on metabolite features in ULF. PCA and OPLS-DA of 
the metabolomic, proteomic or joint data delivered models with good fit but limited prognostic 





In vitro embryo culture 
7.1 Introduction 
For empirical validation of the two proteins (cystatin C and pyruvate kinase M) shortlisted as most 
relevant to embryo development in Chapter 5, a set of in vitro embryo culture experiments was 
conducted to directly test the protein effect on the embryo. Additionally, to test the potentially 
embryo-protective effect of cystatin C (CysC), one of its most typical antagonists in vivo (cathepsin B, 
CatB) was also assayed. 
7.1.1 Background 
Embryo culture in vitro is a widely used biotechnology for applications such as increased genetic gain 
and improvement in cattle and other livestock, as well as for fertilisation and developmental 
research (Camargo et al. 2006). Extensive research on in vitro reproductive technologies has resulted 
in significant progress in the efficacy of their application; standard procedures for in vitro maturation 
(IVM), in vitro fertilisation (IVF) and in vitro culture (IVC) have become less complex and result in high 
proportions of transferable quality embryos (Block et al. 2009).  
An in vitro model was deemed suitable for testing the effect of those proteins. Although there are 
clear discrepancies in embryonic outcome between in vivo and in vitro grown embryos (Rizos et al. 
2002), embryo culture is an extensively validated process that allows a high degree of control over 
the conditions in which an oocyte progresses to become a blastocyst around day 7 after fertilisation 
(Tríbulo et al. 2019), matching the time course for this in vivo trial. 
As stated in Chapter 5, two potential biomarkers were selected for biological validation in vitro: 
pyruvate kinase M2 (PKM2) and cystatin C (CysC). As explained earlier, PKM2 is a protein involved in 
regulatory processes aside from its classical role in the glycolysis pathway (Mazurek et al. 2005), 
including immunity regulation and tumour differentiation (Luo and Semenza 2012). CysC is a 
protease inhibitor, prominently expressed in mammal reproductive tissues and with sperm-
capacitation function in humans (Lee et al. 2018), and regulated by interferon tau (IFNT) in cows, 
thus likely important in embryo development (Spencer et al. 2007). Importantly, it is widely reported 
to protect the embryo from damage by proteases, one of which is cathepsin B (CatB; Baston-Buest et 
al. 2010). CatB was included as a test protein in the present set of experiments to help determine a 
protective function of CysC that would otherwise not be apparent in the absence of the detrimental 




CatB is a cystatin-peptidase involved in numerous physiological processes, including apoptosis, 
inflammation, protein metabolism, hormone processing and immunity (Turk et al. 2012). As 
discussed in Chapter 5, alterations in the balance between cathepsins (peptidases/proteases) and 
cystatins (protease inhibitors) result in a variety of disorders (reviewed by Kos et al. 2014) including 
disruption of embryo implantation in mice (Afonso et al. 1997). 
In cows, increased CatB concentration is associated with autophagy in in vitro matured oocytes (Li et 
al. 2019). High expression and activity of CatB were found in poor quality bovine embryos growing in 
vivo, and this effect was reversed in vitro by supplementing E-64, a synthetic inhibitor of multiple 
proteases, among which is CatB (Balboula et al. 2010). Similar observations were reported by 
Yamanaka et al. (2018) examining developmental competence of bovine embryos affected by heat 
shock. 
CatB was not detected by untargeted proteomic analysis in the present study, possibly because of a 
combination of low relative amount and co-elution with more abundant proteins. This is a feature of 
data-dependent acquisition mass-spectrometry discussed earlier when examining the relatively 
meagre overlap between proteins identified in different studies (Section 5.3.3). However, CatB is a 
well characterised component of uterine secretions, having been reported in several studies of 
bovine reproductive tract (Mullen et al. 2012, Harlow et al. 2018, Helfrich et al. 2020) and in other 
mammals such as rat (Balan et al. 2001), pig (Song et al. 2010) and human (Dasari et al. 2007). 
Technical considerations 
The concentration ranges of the proteins to be tested were estimated from literature. For CatB this 
was 15-90 ng/ml based on the results of Tsai et al. (2009) whereas for PKM and CysC the 
concentrations chosen span the typical range tested in similar experiments (Saugandhika et al. 2015, 
Gomez et al. 2017, Algarra et al. 2018), i.e. 0.1-10 µg/ml. Regarding the time of application, no 
protein was added before day 2, i.e. in which the first embryo cleavages are expected. This was 
decided so that fertilisation failure, chiefly dependent on oocyte quality (Rizos et al. 2002) would not 
obscure effects of the proteins added in the culture medium. CysC and CatB were added at both day 
2 and day 5 (at early and late embryo culture, i.e. the oviductal and uterine phases), whereas PKM 
was added at day 4 to coincide with the time when embryos enter the uterus in vivo (Hackett et al. 
1993). 
Another important consideration was the source of the proteins tested. Proteins expressed in 
mammalian cell lines or of mammalian origin to in vitro embryo culture are more biologically 
relevant compared to more economical alternatives (e.g. Escherichia coli and Saccharomyces 
cerevisiae), primarily due to abnormal patterns of folding and post-translational modifications in 
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unicellular organisms (Berlec and Štrukelj 2013). Thus, proteins that were expressed from 
mammalian cell lines were chosen. Due to the lack of suitable bovine alternatives, human CatB 
(homology to bovine 83.6%), human CysC (66.4% overall homology to bovine, >90% homology in N-
terminal and C-terminal active sites), and mouse PKM (96.4% homology to bovine) were used.  
This set of experiments was designed in two stages, the first experiment added each of the test 
proteins individually to IVC medium (three replicates). Depending on the outcomes of those 
experiments, a second stage would be conducted using an appropriate concentration of the test 
proteins.  
7.1.2 Aims 
The experiments in this part of the project were conducted to test the effect of selected proteins at 
several concentrations on key parameters of embryo development in vitro, early embryo 
development, kinetics of development to day 5, and embryo development to day 7, and to create an 
activity curve based on the concentration of any protein(s) shown to affect embryo development. 
7.2 Materials and methods 
Briefly, three experiments, each testing the effect of one of the selected proteins, were carried out in 
triplicate. Embryo experiment 1 (“Exp. E1”) tested the effect of CysC on proportion of a) cleaved 
embryos , b) degenerate embryos less than eight cells, c) degenerate embryos greater than eight 
cells , d) tight morulae and blastocysts (TM-B), e) total blastocysts (B), and f) blastocysts of grade 1 or 
2 (B1-2). Proportions of B and B1-2 were evaluated at day 7. Embryo experiments 2 and 3 (Exp. E2 
and E3) evaluated the same criteria to assess the effect of CatB and PKM, respectively. 
7.2.1 Reagents and consumables 
In this section, consumables and media used are listed. Then, subsections for each experimental 
stage present the equipment, consumables, and media reagents employed.  
Costar® plastic Stripettes were acquired from Sigma (St. Louis, MO, USA). Pasteur (glass) pipettes 
were acquired from Interlab (Wellington, NZ); Falcon® polystyrene petri dishes 30 and 60 mm were 
acquired from Corning Inc. (Corning, NY, USA) and 90 mm-sized petri dishes from Citotest (Haimen, 
China). Mineral oil used was Light oil (Sigma, St. Louis, MO, USA). Base culture medium: TCM-199 
with Earl’s salts and L-glutamine, without sodium bicarbonate, was bought from Gibco 31100035, 
Life Technologies, Auckland. This is a standard base medium containing a mixture of vital nutrients, 
including energy substrates, amino acids, vitamins, and minerals (details in Table S7-1). In vitro 
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fertilisation and embryo culture media was prepared in house and based on Synthetic Oviduct Fluid 
("SOF"; Tervit et al. 1972) modified by Thompson et al. (2000). 
Oocyte recovery (aspiration medium):  
Sterile 15 ml Falcon® polypropylene conical centrifuge tubes were bought from Corning Inc. (Corning, 
NY, USA). Oocytes were recovered under vacuum using a sterile bung and blunt needle (18” gauge) 
developed and crafted in-house. Aspiration pump was a Cook Veterinary Products model VMAR 5100 
(Cook, SA, Australia) and active vacuum was 40 to 45 mm Hg of negative pressure. Sterile 0.9% saline 
solution was bought from Baxter (Toongabbie, NSW, Australia). Aspiration medium H199: HEPES-
buffered version of TCM 199 comprising 20 mM HEPES, 5 mM NaHCO3, 50 µg/ml kanamycin sulphate 
(Sigma K1377) supplemented with 2% fetal calf serum (v/v; Moregate, Australia NZ Batch 48827103) 
and 1.85 µl/ml of liquid heparin (Multiparin, 5000 international units/ml). 
Oocyte maturation (IVM medium):  
Stock solutions: TCM 199 + 10% Foetal calf serum supplemented with 10 µg/ml porcine follicle 
stimulating hormone (Folltrophin V; Bioniche), 1 mg/ml oestradiol (Sigma) and 10 mM/ml 
cysteamine (Sigma). Final concentrations were 10 µg/ml follicle stimulating hormone, 1 µg/mL 
oestradiol and 10 µM of cysteamine. H-199: see above under oocyte recovery. B-199: TCM-199 
medium supplemented with 25 mM sodium bicarbonate, 0.33 mM sodium pyruvate, 10 % (v/v) 
foetal calf serum (FCS). 
Fertilisation (IVF-SOF medium):  
IVF-PPHH: IVFSOF supplemented with 1 µl/ml heparin, 1 µl/ml pyruvate and 10 µl/ml 1-
penicillamine-hypotaurine. Final concentrations were 10 µg/mL of heparin (Sigma H3149 100KU), 1 
mM of pyruvate (Sigma P4562), 10 µM hypotaurine (Sigma H1384) and 20 µM penicillamine (Sigma 
P4875). HSOF: HEPES buffered (20 mM Hepes, 5 mM NaHCO3) synthetic oviduct fluid (SOF) medium 
supplemented with 8 mg/ml bovine serum albumin (IVP grade, gamma irradiated, MP Biomedicals 
NZ, Auckland). Nidacon Bovipure™ and Bovidilute™ were purchased from Tek-Event, Sydney, NSW, 
Australia. 
In vitro culture  
Modular incubator chamber MIC-101 (Lab supply, NZ) for culture in low O2 environment was placed 
in Contherm Biocell (Model 1200, Thermofisher, NZ) for in vitro culture. ESOF/LSOF (early/late 
synthetic oviduct fluid) is a biphasic media (Thompson 2000) supplemented with 8 mg/ml BSA: LSOF 
contains 10 µM of 2,4-dinitrophenol (DNP; Aldrich D198501). Modified ESOF and LSOF (mESOF and 
mLSOF) were ESOF/LSOF without BSA, supplemented with 1 mg/ml polyvinyl alcohol (PVA; Sigma 
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P8136) with the addition of CatB or CysC. Modified LOSF for PKM was LSOF without 2,4-dinitrophenol 
added.  
Proteins 
Recombinant human CatB (CTSB) protein was acquired from Creative Biomart (Shirley, NY, US). 
Segment: Arg18-Ile339, fused to His tag at C-terminus, was expressed in a human 293 cell line 
(HEK293). Human CysC (CSTX) purified from human urine was bought from Byorbyt (Cambridge, UK), 
kept in ammonium bicarbonate (NH4HCO3) buffer. Recombinant mouse pyruvate kinase (PKM) 
protein was acquired from Cusabio Technology (Houston, TX, US) at a purity of at least 90% and 
treated for endotoxin removal; no specific isoform was available (i.e. isoform M2), however 
homology of the protein purchased to bovine PKM2 was 96%. It was N-t 10xHis-tagged and C-t Myc-
tagged was expressed in a mammalian cell line and kept in Tri-based buffer with 6% trehalose. 
7.2.2 Experimental procedures 
Ovaries were sourced from local abattoirs predominantly from Friesian, Jersey, or Friesian–Jersey 
cross dairy cows. Oocytes were aspirated, matured, and fertilised using standard in vitro embryo 
production (IVP) techniques (Thompson et al. 2000). Furthermore, presumptive zygotes were 
cultured in vitro for 24 h in ESOF to ensure a homogenous population of embryos were selected (>4-
cells). These embryos were transferred into mESOF which included one of the potential biomarker 
proteins (as determined in chapter 6) to test their effect on embryo development. Embryos were 
transferred to mLSOF on day 5 of in vitro culture (fertilisation = day 1) and graded on day 7. 
All media and culture plates were prepared in a laminar flow hood using a pipettor and sterile 
pipette tips. Ovaries were collected and maintained in saline solution at 30 °C. Oocyte/embryo 
manipulations were performed on a warm stage of the stereomicroscope set at 37.5±1°C. 
For reference, day of IVF is considered day 1, whereas the day into culture is day 2. Figure 7-1 
provides a schematic representation of the experimental steps undertaken. 
Oocyte recovery 
Bovine ovaries collected at the abattoir in thermos flasks filled with pre-warmed (30 °C) 0.9% saline 
solution were transported back to the aspiration lab within 1 h. The ovaries were rinsed with warm 
(30 °C) saline solution twice to remove blood and miscellanea tissue and fluid. Follicles between 3 
and 10 mm in diameter were punctured with an 18” blunt needle and the follicular fluid plus the 
cumulus cell oocyte complex (COC) were collected in 15 ml conical tubes containing 1.5 ml of pre-





Figure 7-1 Experimental workflow of this embryo culture experiment.  
Maturation (IVM) day 0 
A 60 mm sterile plastic petri dish containing 12 x 40 µl drops of IVM medium were overlaid with 8 ml 
pre-gassed mineral oil and pre-equilibrated for 2 h at 38.5 °C and 5% CO2 prior to aspiration.  
The pellet resulting from aspiration, containing the COCs, was transferred to a 90 mm petri dish 
containing fresh aspiration medium. The contents of the dishes were searched for COCs, and these 
were transferred into a 35 mm petri dish containing 3 ml H199 + 10% FCS. High quality COCs were 
selected based upon morphological characteristics previously described by Thompson et. al. (2000). 
The selected COCs were washed once in 3 ml H199 + 10% FCS, followed by a final wash in 3 ml of 
B199 + 10% FCS. Groups of 10 COCs in a 10 µl total volume were placed into a 40 µl IVM medium 
drops (total drop volume 50 µl) and incubated for 20-22 h at 38.5 °C under 5% CO2 in air.   
Fertilisation (IVF, day 1)  
Oocyte and plate preparation for IVF 
A 60 mm sterile plastic petri dish containing 12 x 30 µl drops of IVFSOF medium was overlaid with 8 
ml pre-gassed mineral oil and pre-equilibrated for 2 h at 38.5 °C and 5% CO2 prior to gamete 
addition. To prepare oocytes for IVF, they were removed from the IVM drops using a 200 µl pipettor 
and transferred to a wash 35 mm petri dish containing warm HSOF. The oocytes were transferred to 
a second wash dish of HSOF and then to a third 35 mm petri dish of equilibrated IVFSOF. Five oocytes 
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in 10 µl of IVFSOF medium were transferred into each IVF drop awaiting sperm addition. The IVF 
plate was placed in an incubator (38.5 °C and 5% CO2 in air) awaiting sperm addition. 
Semen preparation 
Frozen– thawed spermatozoa from the same Friesian bull as in Farm Trials A, B and C (Blitz GL295 @ 
1.5 million sperm/ml) was used throughout the entire data set.  
To obtain healthy, motile sperm and exclude immotile or abnormal sperm, white blood cells and 
miscellanea components of semen a two-layer gradient for density gradient centrifugation was 
performed. Frozen-thawed sperm was placed on a Nidacon Bovipure™ gradient of colloidal silica 
particles and then centrifuged, causing spermatozoa to precipitate to the bottom of the tube. In this 
system, the sperm with the best motility and intact morphology tend to accumulate towards the 
bottom (Moohan and Lindsay 1995). Briefly, a 1 ml, two-layer gradient of 40% and 80% Bovipure™ 
gradient was prepared according to manufactures protocol. To make the gradient, 0.5 ml of 80% 
solution was pipetted into a 15 ml conical centrifuge tube and carefully overlaid with 0.5ml of 40% 
solution. This Bovipure™ gradient was used for sperm selection as explained next. 
Sperm straws (stored in liquid nitrogen at -80 °C) were thawed in a water bath 30-35 °C for 30 s, 
dried with a tissue and wiped with ethanol (70% v/v). Next, the contents of the straw were emptied 
into a sterile 5 ml Falcon tube. Using a sterile glass Pasteur pipette, the thawed semen was aspirated 
and gently laid on top of the Bovipure™ gradient. The gradient was centrifuged at 300 g for 15 min. 
During centrifugation oocytes were prepared for IVF as described in the previous section. 
Immediately after centrifugation, the gradient supernatant was aspirated with a sterile Pasteur 
pipette and discarded. A clean Pasteur pipette was used to carefully remove the sperm pellet at the 
bottom of the centrifuge tube and transfer the sperm to an empty tube. One ml of HSOF was 
carefully added, mixed gently, and centrifuged at 300 g for a further 5 min. Immediately after 
centrifugation, the supernatant was removed, and the sperm pellet was resuspended in 200 µl of 
equilibrated IVFSOF medium. A 10 µl aliquot of this was diluted 1:20 with water for sperm count; the 
remaining volume of the sperm preparation was measured for subsequent calculations. 
The sperm concentration of the diluted aliquot was estimated using a haemocytometer. This consists 
of a counting chamber and a cover glass and is commonly used to determine the concentration of 
cells in any fluid medium. To fill the counting grids, 10 µl out of the diluted sperm solution were 
introduced into each side. The haemocytometer was then placed under the microscope and the 
spermatozoa heads in 25 large squares (i.e. 400 small squares) were counted at 400x. The counts in 
both sides were averaged, and the sperm concentration calculated using the following formula:  
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𝑉𝑜𝑙. 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑜𝑓 𝑢𝑛𝑑𝑖𝑙𝑢𝑡𝑒𝑑 𝑠𝑝𝑒𝑟𝑚(𝐴) × 𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑝𝑒𝑟𝑚 𝑐𝑜𝑢𝑛𝑡𝑒𝑑(𝐵) = 𝑇𝑜𝑡𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒(𝐶)





𝑇𝑜𝑡𝑎𝑙 𝑉𝑜𝑙. (𝐶) − 𝑉𝑜𝑙. 𝑢𝑛𝑑𝑖𝑙𝑢𝑡𝑒𝑑 𝑠𝑝𝑒𝑟𝑚 𝑝𝑟𝑒𝑝. = 𝑉𝑜𝑙. 𝑜𝑓 𝐼𝑉𝐹 𝑚𝑒𝑑𝑖𝑎 𝑎𝑑𝑑(𝐷) 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑓𝑒𝑟𝑡𝑖𝑙𝑖𝑠𝑒𝑑 𝑔𝑟𝑜𝑢𝑝 𝐼𝑉𝐹 𝑑𝑟𝑜𝑝𝑠 (𝐸) × 𝑖𝑛𝑠𝑒𝑚𝑖𝑛𝑎𝑡𝑖𝑜𝑛 𝑉𝑜𝑙. (𝐹)
= 𝑇𝑜𝑡𝑎𝑙 𝑉𝑜𝑙. 𝑜𝑓 𝑠𝑝𝑒𝑟𝑚 𝑝𝑟𝑒𝑝. 𝑓𝑜𝑟 𝑔𝑟𝑜𝑢𝑝 𝐼𝑉𝐹(𝐺) 
Figure 7-2 Formulae for adjusting sperm preparation for in vitro fertilisation experiments. 
Sperm, 10 µl (i.e. 15,000 spermatozoa), was added to each 40 µl drop containing five oocytes for a 
final drop volume of 50 µl. The final sperm concentration was 3,000 spermatozoa per oocyte.  The 
plates were placed in an incubator for 24 h at 38.5 °C and 5% CO2 in air.  
In vitro embryo culture (IVC, day 2) 
The following day, embryos (25-55 per treatment, balanced per treatment in each run) were placed 
in culture for six days in a gassed modular incubator chamber. A modular incubator chamber was set 
up by placing a small amount of sterile water at the bottom (to humidify), sealed, and kept at 38.5 °C 
in a hot air incubator. An indicator plate of B199 + FCS was placed in modular incubator chamber to 
monitor the chamber’s pH environment. In detail, IVC plates were prepared by making 20 µl drops of 
ESOF x 5 with a central wash drop of 40 µl in a 35 mm petri dish. The drops of medium were overlaid 
with 3 ml of gassed mineral oil and placed in the modular incubator chamber, gassed for 5 min (5% 
CO2, 7% O2, 88% N2) to purge atmospheric air and returned to incubator running at 38.5 oC. 
On day 2 (24 h post-fertilisation), the cumulus cells were removed from the presumptive zygotes. 
This was accomplished by transferring the embryos to an Eppendorf tube containing HSOF, vortex-
shaking for 2 min and centrifuging briefly. The bottom half of the medium which contained the 
zygotes, was transferred to 35 mm petri dish containing HSOF. The Eppendorf tube was rinsed once 
with HSOF, quickly centrifuged and the entire tube contents was placed into the 35 mm petri dish 
containing the cumulus free zygotes. Zygotes were washed twice by placing into 35 mm dishes 
containing 2.5 ml HSOF. After the final wash, zygotes were transferred into a central wash drop of an 
IVC plate. Embryos in groups of 10 were moved to drops and plates were placed in the modular 
incubator chamber and re-gassed for 5 min (in an atmosphere of 5% CO2, 7% O2, 88% N2) and 
returned to an incubator. On day 2, only embryos ≥ 4 cells were transferred into fresh mESOF drops 
with the addition of the test proteins where applicable (for Exp. E1 and E2). The number of 
unfertilised oocytes and 1 – 3 cell embryos was recorded and not cultured further. On day 5 (CysC 
and CatB, i.e. Exp. E1 and E2), embryos were changed to fresh drops containing mLSOF medium 
supplemented with a test protein when applicable. For this, mLSOF plates were equilibrated in the 
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gassed modular incubator chamber overnight, embryos were transferred from IVC plates to the 
central wash drops of new plates and then into culture drops. Cleavage and tight morula rates were 
recorded, plates were returned to the modular incubator chamber, re-gassed, and cultured for a 
further two days. In Exp. E3 (testing PKM), on day 4 only embryos at ≥ 8-cell stage were taken 
through to mLSOF, in controls and treatments, to test the effect of this protein after the oviduct 
phase. This was decided to prevent potential differences in bioavailability of pyruvate in the medium 
that could affect embryo metabolism, which was not the focus of this study. 
On day, 7 plates were removed from the modular incubator chamber for embryo development 
scoring. In a similar fashion as detailed in Chapter 2, the number (proportion) and quality of the 
following phenotypes were recorded: oocytes, cleaved embryos, tight morulae, blastocysts, hatched 
blastocysts. Tight morulae and early blastocysts were cultured for a further 24 h (i.e. day 8) to 
determine if they develop to the blastocyst stage and were re-graded. 
The experimental design was as follows (Figure 7-3). In Exp. E1, controls adding BSA (as per typical 
protocol in the laboratory) were included, but similar results with the controls without BSA were 
observed (Table S7-2) therefore these were not included in subsequent runs. 
A dilution control (i.e. adding to each IVC drop 15 µl of distilled, sterile water) was included in Exp. E2 
to test for a potential effect of the addition of the small volume of liquid containing a protein. No 
effect of dilution was found (i.e. similar proportions of embryo development were observed between 
standard controls and dilution controls). Therefore, these were further treated as replicates of the 
standard controls.  
 
Figure 7-3 Overview of Embryo experiments 1-3 (Exp. E1-3): composition of the controls and 
treatments in each experiment. Treatments (addition of the test proteins) occurred 
from day 2 to 7 (Exp. E1 and E2) or day 4 to 7 (Exp. E3). Abbreviations: BSA, bovine 
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serum albumin; CatB, cathepsin B; CysC, cystatin C; DNP, 2,4-dinitrophenol; E/LSOF, 
Early/late synthetic oviduct fluid; PKM, pyruvate kinase M; PVA, polyvinyl alcohol. 
In embryo experiment 1 (“Exp. E1”), CysC was dissolved in a buffer containing ammonium 
bicarbonate, with known detrimental effects on embryo quality (Gardner and Lane 1993) because of 
recommendations form the protein supplier. Therefore, a control containing the maximum 
concentration of NH4HCO3 used (1mM) was added. 
Statistical analysis 
Outcome variables (i.e. proportions) were logit-transformed, i.e. to the natural logarithm of the odds 
ratio, logit(p) = ln(p/(1-p)). They were then checked for normality of distribution. Experiments E1, E2 
and E3 (testing the effect of each of the proteins, CatB, CysC, and PKM) were analysed separately. 
Generalised linear regression models and ANOVA were performed using R 4.0.2 (R Team 2019) as 
follows: 
For experiment E1 (CysC): Var ~ CysC concentration + Run + NH4HCO3 concentration 
For experiment E2 (CatB): Var ~ CatB concentration + Run  
For experiment E3 (PKM): Var ~ PKM concentration + Run 
In each case, the test protein concentration was included as the main explanatory variable and run 
was added as a random effect, whereas “Var” is the (logit-transformed) variable, i.e. % of one cell 
oocytes/embryos at day 2, % developed to TM on day 5, % total development to TM-B on day 7, % B 
at day 7, % B1-2 at day 7, % of embryos less than 8 cells at day 7, and % of embryos greater than 8 
cells  (degenerate or morulae stage) at day 7. 
7.3 Results and discussion 
7.3.1 Descriptive parameters across experiments 
Three experiments were conducted in triplicate, each testing the effect of one target protein. The 
first steps of the experiments were identical; treatments were conducted differently from the 
timepoint of medium changeover at day 4 (Exp. E3) or day 5 (Exp. E1 and E2).  
A total of 1802 oocytes were cultured in the three experiments; the raw data is displayed in Table S7-
2. Out of those, at day 2, 79 oocytes or 1-cell zygotes were removed to eliminate the confounding 
effect of oocyte quality on embryo development (Table 7-1). Thus, the overall cleavage rate, i.e. in 
which embryonic cell division was observed, was 94.1% (1690 embryos out of 1802 oocytes placed 
into culture). A midway determination of development kinetics showed that 21.6% of the embryos 
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had reached the tight morula stage by day 5. Replicates from Exp. E3 were not included in this 
calculation as they were transferred to fresh mLSOF at day 4.  
The overall rates of development at day 7 of culture were as follows: 20.4% (257/1259) embryos of 
had arrested < 8 cell stage, 22.8% (287/1259) embryos > 8-cell (including degenerate and morulae), 
and 56.9% (716/1259) transferable embryos (i.e. tight morulae and blastocysts, TM-B). The 
proportion of blastocysts (B) out of all or viable embryos was 44.2% (557/1259) and 77.78% 
(557/716) respectively. Blastocysts of grades 1 and 2 (i.e. of transferable quality, B1-2) were 26.4% 
(332/1259) and 46.41% (332/716) of all or viable embryos, respectively. Most development 
parameters observed were better than those reported in similar recent studies (Table S7-3): cleavage 
was 94.1% (vs 73%), 56.9% (vs 44%) TM-B/cleaved embryos, B/cleaved embryos (44.2% vs 31%), 
while the proportion of B1-2/cleaved embryos (26.4% vs 39%) was worse than the two studies that 
reported it (Zullo et al. 2016a, Zullo et al. 2016b). However, the media used in the latter studies (Zullo 
et al. 2016a, Zullo et al. 2016b) were supplemented with bovine serum, BSA and hormones, all of 
which is known to improve embryo development (Thompson et al. 2000, Gilardi et al. 2004, Camargo 
et al. 2006) and thus are not directly comparable to the present study. To sum up, the experimental 
setup of these embryo culture experiments was of comparable quality to those reported in similar 
studies. 
Table 7-1 Overall combined embryo development parameters at day 7 of in vitro culture 
throughout the experiments described in this chapter. 
Da
y 










365/563* 64.8 N/A 










716/1259 56.9 44 














grades 1 and 2 
332/716 332/1259 46.4 26.4 N/A 39 
*in experiment E3, medium changeover occurred at day 4 and thus is not included in this calculation. 
7.3.2 Effect of the test proteins on in vitro embryo development 
The three proteins tested were not found to exert a clear, concentration-dependent effect on the 
embryo development parameters measured (Table 7-2, Table 7-3 and Table 7-44). Generalised linear 
model analysis showed similar figures, with the following differences. Higher %TM-B (p=0.04) and %B 
(p=0.07) at day 7 in CysC0.1 (Table S7-4a), of a complex interpretation because of the interaction 
effect of ammonium bicarbonate, as examined later. Lower development to TM at day 5 was 
observed in CatB15 (Table S7-4b), which however did not result in any difference at day 7. Lastly, a 
tendency (p<0.1) for lower proportion of TM-B at day 7 was found in PKM1 (Table S7-4c), though a 
difference was only observed in replicate 3 (Table S7-2), precluding confident conclusions. 
Table 7-2 Effect on embryo development parameters of different concentrations of CysC and 
ammonium bicarbonate in culture medium by generalised linear models. Results 
expressed as mean percentage (to total embryos cleaved) ± standard deviation. Green 
(red) font: positive (negative) parameters. Abbreviations: B, blastocyst; B1-2, 
blastocyst grade 1 or 2., CysC, cystatin C; deg, degenerate; dev., development; TM, 
tight morula. 














0.01 1  
p-value 
(NH4HCO3) 
% Dev. to TM 
on Day 5 
(kinetics) 
43±12.3 28±11.5 34.1±7.4 36.9±4.9 0.42 0.23 0.8 
% Total Dev. 
(TM and B) on 
Day 7 
73±13.2a 50.3±6.3b 53.9±5.1b 52.6±8.5b 0.28 0.048 0.71 
% B Day 7 63.7±12.9a 20.7±12.7c 44.9±12.2ab 31±5.2bc 0.42 0.005 0.14 
% B1-2 Day 7 33.8±11.3a 9.1±1b 31.5±5a 18.8±9ab 0.41 0.008 0.17 
% < 8-cells 9.1±5b 27±3a 30±8a 16±13ab 0.55 0.02 0.38 
% total deg > 
8-cells 




The absence of clear, significant effects of supplementing the chosen proteins on embryo 
development parameters measured is likely underpinned by several distinct factors. Two of the most 
determining aspects were a detrimental effect of ammonium bicarbonate -a solubilising aid of CysC 
in the formulation used- on several parameters of embryo development, and significant inter-run 
variations (Table S7-2). These factors are discussed next. Additionally, because no clear effect of the 
proteins tested was found, coupled with the strong confounding effect of ammonium bicarbonate, 
experiments of co-supplementation of those proteins were not carried out, though the possibility of 
an interaction effect cannot be discarded. 
Table 7-3 Effect of the addition of CatB at different concentrations to culture medium on embryo 
development parameters by generalised linear models. Results expressed as mean 
percentage (to  cleaved) ± standard deviation. Green (red) font: positive (negative) 
parameters. Abbreviations: B, blastocyst; B1-2, blastocyst grade 1 or 2., CatB, 
cathepsin B; deg, degenerate; dev., development; std, standard; TM, tight morula. 
CatB (ng/ml) 
0 (std or dilution 
controls) 
15 30 60 90 
p-
value 
% Dev. to TM on Day 
5 (kinetics) 
30.7±11.8 21.2±7.7 24.5±7 30±8.6 29±8.7 0.69 
% Total Dev. (TM and 
B) on Day 7 
52.5±14.8 48.8±4.7 56.6±4.8 50.5±11.5 53.4±1.8 0.94 
% B Day 7 40.7±12.4 34.1±9.7 51.2±6.3 40.3±10.2 36.7±7.1 0.5 
% B1-2 Day 7 28.1±5.6 19.9±6.6 34±2.9 22.4±7.8 25±8.8 0.27 
% <8 cells 24±10.8 32.8±1.7 27.4±8 20.7±7.8 24.6±6.7 0.61 
% total deg + >8cells 24±5.2 18.4±3.1 18.3±6.2 27.6±2.4 21.1±8.5 0.33 
Table 7-4 Effect of the addition of pyruvate kinase M (PKM) at different concentrations to culture 
medium on embryo development parameters by generalised linear models. Results 
expressed as mean percentage (to total embryos cleaved) ± standard deviation. Green 
(red) font: positive (negative) parameters. Abbreviations: B, blastocyst; B1-2, 
blastocyst grade 1 or 2., deg, degenerate; dev., development; PKM, pyruvate kinase 




0.1 1 10 p-value 
% Total Dev. (TM - B) Day 7 60±4.3 63.9±6.9 48.7±9.2 59.3±10 0.32 
% B Day 7 46.9±7.2 42.9±5.1 41.3±8.6 43.3±7.3 0.87 
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% <8 cells 12.1±10.2 16.5±1.2 23.2±12.2 6.2±8.7 0.32 
% total deg + >8cells 27.9±10.3 19.6±5.7 17.3±7 33±15.3 0.47 
Effect of ammonium bicarbonate on embryo development 
Ammonium bicarbonate showed a strong detrimental effect on most embryo development 
parameters measured for CysC. This can be observed from contrasting outcomes from standard 
controls and controls with the addition of 1 mM ammonium bicarbonate (Table S7-2). All parameters 
measured at day 7 were worse in ammonium bicarbonate controls (p<0.05): % TM-B (50.3±6.3 vs 
73±13.2), % B (20.7±12.7 vs 63.7±12.9), % B1-2 (9.1±1 vs 33.8±11.3), % < 8-cell (27±3 vs 9.1±5) and % 
> 8-cell degenerate and morulae (8.3±+5 vs 20.6±13). 
Interestingly, a non-statistically significant interaction effect of ammonium bicarbonate and CysC was 
suggested in some of those parameters (% B and % B1-2; p <0.15). In those, the CysC10 treatment 
might have compensated for some of the negative effect of ammonium bicarbonate seen in the 
ammonium bicarbonate controls, both with 1 mM NH4HCO3. Thirty one percent of cleaved embryos in 
CysC10 treatment became blastocysts at day 7, significantly lower than 73±13.2 % in standard 
controls but tending to be higher than in ammonium bicarbonate controls (20.7±12.7 %). A similar 
trend was seen for % B1-2 at day 7: 18.8±9, 9.1±1 and 33.8±11.3 in Cys10, ammonium bicarbonate 
control and standard control, respectively. Trends were inconclusive for the treatment CysC0.1, 
generally showing better embryo development than CysC at 10 µg/ml and ammonium bicarbonate 
control but lower than standard controls. Whether the intermediate values observed for CysC0.1 are 
caused by CysC, ammonium bicarbonate or their interaction cannot be determined in this 
experimental design. Overall, these results point at a strong negative influence of ammonium 
bicarbonate at these relatively high concentrations and suggest that CysC supplementation may 
partially offset the impact of ammonium toxicity, though it is unclear through what mechanism, this 
is worth further consideration in future work.  
Ammonium toxicity is a well-known issue in embryo IVP. Ammonia (Gardner and Lane 1993) and 
ammonium bicarbonate (Ménézo et al. 1993) exert a considerable negative effect on mammal 
embryo growth and quality at concentrations as low as 75 µM, particularly from cleavage to hatching 
-i.e. morula and blastocyst stages- (Gardner and Lane 1993). In the same work, one mechanism 
proposed to underlie this negative effect is excessive conversion of alpha-ketoglutarate to glutamate 
by glutamate dehydrogenase (alpha-ketoglutarate + NADH + NH4+ ---> glutamate + NAD+ + H20), 
reducing alpha-ketoglutarate abundance and thus disrupting the TCA cycle (Gardner and Lane 1993). 
Other possible mechanisms mediating the negative effect of ammonium bicarbonate are an increase 
  
 152 
of pH (Gardner and Lane 1993) or a disruption of calcium transport by competitively using membrane 
cation transporters (Hammon et al. 2000, Lin et al. 2020). This detrimental effect is usually a side 
effect of amino acid supplementation to in vitro culture medium, a practice that substantially 
stimulates embryo development (Gardner and Lane 1993). This is a noteworthy difference between 
in vivo and in vitro growth: ammonium concentration is kept within physiologically-compatible 
parameters in vivo by endogenous mechanisms (Guerin et al. 2001). However, when culturing 
embryos in vitro there is typically a build-up resulting from two main processes: as a result of 
spontaneous breakdown of amino acids at temperatures over 35 °C, and as a by-product of embryo 
metabolism (Wale and Gardner 2015). Medium changeover -as performed in this work- prevents the 
accumulation of toxic by-products (Gardner and Lane 1993) but also of potentially beneficial 
paracrine factors that underlie the better developmental performance of embryos cultured in groups 
compared to individually (Fujita et al. 2005).  
More replicates would be required to formulate hypotheses about an embryo-protective effect of 
CysC that is only apparent in the presence of intense stress, as caused by ammonium bicarbonate in 
this experiment. For future similar experiments, removal of ammonium bicarbonate by dialysis and 
replacement with another protein-solubilisation adjuvant would be an important step to 
appropriately test the effect of a target protein without interference. If this were not possible, adding 
ammonium bicarbonate to the same final concentration in all treatments is another option, though 
less preferable because its effect could mask the effect of the test protein. Finally, considering that 
ammonium toxicity is widespread in embryo IVP, research on molecules to reduce this toxicity would 
be an important endeavour.  
Run effects 
Random (run) effects were found significant for one or more measures of embryo development in 
most experiments (Tables S7-2, S7-4a,b,c). These effects can result from several components. 
Regarding the biological origin of the embryos, all semen used was taken from the same high 
conception outcome bull, and were furthermore from the same batch, minimising variations in this 
respect (Ponsart et al. 2001). Supporting this, the proportion of one-cell embryos per replicate run 
was constantly <3% and not significantly different between runs (data not shown). To the same 
effect, all chemicals and consumables used in all experiments belonged to the same batch.  
Another crucial factor is the source of ovaries for oocyte collection. There are reports of sizeable 
differences in oocyte quality (determined by in vitro culture performance in a similar manner as in 
the present work) at the breed (Fischer et al. 2000), herd (Lopes et al. 2006), cow (Domínguez 1995), 
follicle (Lonergan et al. 1994) and individual oocyte (Humblot et al. 2005) levels. In this project, all 
ovaries came from the same abattoir, and the utmost care was taken to harvest oocytes from 
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healthy ovaries and follicles of normal appearance. However, it was not possible to choose the cows 
from which the ovaries were taken, and little information was available as to whether they were 
predominantly dairy or beef cattle on a given day. To interpret the inter-experimental differences 
observed, two aspects deserve consideration in this context. One is that many cows whose ovaries 
were sourced might have been culled due to reproductive issues, many of which would not affect 
ovarian morphology and could therefore go unnoticed (Dubuc and Denis-Robichaud 2017). Another 
one is differences in the oestrus cycle stage at which the animals were when slaughtered, a crucial 
determinant of oocyte capability and embryo development (Hagemann et al. 1999). In addition, 
although technical variation was kept to the minimum as stated above, a small effect of inter-
experimental differences in other aspects (pipetting, manipulation time, etc.) cannot be ruled out. 
An important consideration when relating these results to those of other studies is the way 
experimental outcomes are presented. Most papers on both molecular biology and embryo culture 
report mean values ± SEM (standard error of the mean). This parameter expresses the confidence in 
the mean value considering the (square root of the) number of observations but not the spread or 
variability across replicates. This effectively precludes the reader from assessing consistency and 
repeatability across replicates and experiments. In fact, it was not possible to determine whether the 
inter-run differences observed here were excessive, normal, or even lower than those reported in 
other articles. In this work, standard deviation of the mean (square root of the variance) was chosen 
to reflect experimental outcomes more accurately and transparently. Similar considerations apply to 
the use of bar plots compared to the clearer and more apparent use of strip charts and/or boxplots 
as used here. 
Finally, it is conceivable that a greater number of replicates would have reduced the effects of 
random variation across runs that potentially obscured any effect caused by the addition of the 
proteins tested. The number of replicates in similar studies went from two (Leroy et al. 2005b) to 
seven (Hill and Gilbert 2008) with a median of four.  
Biochemical considerations 
Other considerations about testing the effect of the supplementation of a molecule to embryo IVC 
are the concentration range, timing of supplementation, and the use of complementary technologies 
to assess embryo quality and development. 
The protein concentrations used were decided based on an extensive literature search. 
Concentrations of CatB used here were chosen based on the work of Tsai et al. (2009) in human 
blood, who used ELISA for measurements. For the other two proteins, no reports of absolute 
concentration in biological fluids was found. Thus, the range found in several similar studies was 
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adopted, as explained in the introduction of this chapter. This leads to a logical means of optimising 
this experiment: by using targeted proteomics, e.g. by multiple reaction monitoring using spiked 
peptides as described by Deutsch et al. (2019) and discussed in the review performed as part of this 
doctoral project (Aranciaga et al. 2020). Knowledge of the actual concentrations of these proteins in 
vivo is likely to result in an experiment that better mimics the conditions in which embryo 
development and fate are decided. Importantly, an in-depth embryological investigation was beyond 
the scope of this thesis. 
The timing of supplementation could also be adjusted: supplementing selected proteins/metabolites 
only at specific stages can significantly alter experimental outcome, as examined in the introduction 
of this chapter. The equivalences between in vivo and in vitro developmental stages are as follows: 
IVM (day 0 to 1) mimics the final step of oocyte maturation in the follicle; IVF (day 1 to 2) represents 
the early oviduct phase -including the fertilisation process and the initial hours of development 
(Miller 2018)-, early IVC (day 2 to 4-5) the late oviduct phase and the late IVC (day 4-5 to 7) the early 
uterine phase. 
The parameters analysed here are typical indicators of an effect on embryo development but are not 
the only ones. Some were not analysed here due to practical limitations and the fact that embryo 
culture was not the focus of this thesis; they may have shown an effect of the tested proteins. 
Common response variables analysed in similar embryology studies are cell numbers of the whole 
blastocyst and of its main parts -the inner cell mass and the outer trophectoderm-, apoptotic cells 
(with differential staining immunohistochemistry), interaction or absorption of supplemented 
molecules, and lipid micro-drop accumulation. The distinction between apoptosis, necrosis and 
embryonic senescence is only starting to be investigated but is extremely promising (Ramos-Ibeas et 
al. 2020a). 
The outcomes from a study comparable to the present, published recently (Sang et al. 2020), provide 
valuable insight into the results presented here. In their study, Sang et al. (2020) tested the effect of 
several putative embryokines discovered in vivo, i.e. embryotrophic factors -CLP, IL-8, LIF, BMP-4, IL-
6; Tríbulo et al. (2018)- on IVC from day 5 to day 7. They found no differences in development rates 
(cleavage, development to blastocyst, etc.) though some subtler changes were observed in other 
parameters: in the number of total cells or cells in the inner cell mass, in transcript abundance of 
important genes, or in growth rate in male vs female embryos, dependent on the specific molecule 
added (Sang et al. 2020). The authors’ interpretation on the relatively minor effect of these 
molecules is related to oocyte effects. They posit that most embryos are likely derived from 
suboptimal oocytes not capable of becoming blastocysts, regardless of the molecular milieu, and that 
only a small number of the embryos placed in culture are intrinsically viable and may manifest 
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differential development related to specific embryokines after fertilisation (Sang et al. 2020). Their 
conclusion is that regulatory molecules (embryokines) are more likely to affect the physiology of the 
blastocyst that is formed rather than determine whether the early embryo becomes a blastocyst 
(Sang et al. 2020). This suggests that in vitro culture should include more that the median of four 
replicates in future studies to reduce the confounding effect of the variability between ova, sperm 
and embryos.  
Regarding the outcome variables tested, it is noteworthy that visual grading of embryos is one out of 
many ways of estimating potential reproductive success. In a study by Tao et al. (2013), embryo 
groups graded as of good or bad quality at day 3 of IVC showed no differences in implantation and 
pregnancy rates. Similarly, Alvarez et al. (2008) showed that when poor quality (grade 3) embryos -
derived from live donor cows- developed to blastocysts, pregnancy rates were equal to good quality 
blastocysts. This indicates that visual assessment of embryo quality is not always a good predictor of 
pregnancy success. It is also possible that the proteins tested in this study exert an effect on embryo 
morphology at day 7 after insemination but whose main effect would only become apparent later in 
pregnancy, as reported by Kruip et al. (2000). Lastly, recent evidence links transcriptional profiles of 
genes in stress response with embryo survival after transfer of both in vitro (Zolini et al. 2020b) and 
in vivo (Zolini et al. 2020a) produced embryos, opening a new realm for improved selection of 
transferrable embryos. 
If the effect of the selected test proteins is mediated by an interaction with maternal structures or 
secreted molecules, it follows that no differences were observed on embryo development when 
those were absent. Co-culture with oviduct cells in vitro has been suggested to better mimic the 
environment of the reproductive tract by adding embryotrophic factors or removing toxic products 
(Bavister 1992). Indeed, embryos co-cultured with oviduct cells showed substantially improved 
blastocyst rate at day 7.5 in a recent study by Sponchiado et al. (2020) and could be a key missing 
element in the experiments described in this chapter. However, co-culture technologies still face 
important challenges: despite improvements on in vitro development rates, co-culture has been 
linked to detrimental effects later in pregnancy (Camous et al. 1984), during the neonatal period 
(Young et al. 1998), and in adult life (Siqueira et al. 2017). 
Lastly, the molecular factors in the reproductive tract that are crucial for embryo development is 
largely unknown. A recent study (Banliat et al. 2020) shed light on this, reporting that only 0.03% 
(56/1707) proteins in oviduct fluid (OLF) interacted physically with embryos in vitro (i.e. were 
detected in OLF-treated embryos but not in controls). This suggests that a vast majority of proteins in 
the reproductive tract fulfil physiological functions in the cow and are not strong determinants of 
pregnancy by themselves. 
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7.3.3 Conclusions and recommendations 
Based on these experiments, it is strongly suggested that, when using products containing 
ammonium bicarbonate, this should be removed prior to adding it to oocytes or embryos in culture. 
Regarding the protein concentration ranges tested, they were within physiological typical 
boundaries. It is possible that higher concentrations produce an effect on embryo development, but 
its biological meaning would be limited.  
To sum up, the present experiment showed the negative impact of ammonium bicarbonate on IVP 
embryos. No significant effect of the supplementation of CysC, CatB and PKM was observed in 
embryo development. However, some tendencies for differences were apparent for some of the 
treatments -protein concentrations-, namely for improved development to TM-B stages with 0.1 or 
10 µg/ml CysC (in the presence of ammonium bicarbonate), and less TM-B when adding 1 µg/ml PKM 
to embryo culture. These could not be confirmed in this experiment due to having three replicates -
with sizable inter-replicate variation- but deserve further consideration. While the experimental 
design is likely adequate, future similar experiments will benefit from increasing the number of 
replicates (runs), ensuring the absence of detrimental molecules such as ammonium bicarbonate, 
and measuring other parameters such as cell numbers, expression of key developmental genes, and 
uptake by the embryo of the test molecule(s). 
In conclusion, the experiments presented in this chapter provide important insight on factors 





Discussion, conclusions, and further research 
8.1 Recap – biological model and approach 
This project aimed to provide insight into direct determinants of dairy cow subfertility, a pressing 
multifactorial issue in New Zealand and across the world. This was attempted through ascertaining 
the influence on early embryo development of biologically relevant molecules -metabolites and 
proteins- present in bovine uterine luminal fluid (ULF). This effect and overall molecular changes 
were studied at two timepoints in the early and mid-postpartum period, i.e. at first and third oestrus 
after calving (OC1 and OC3). These goals were fulfilled in this work, advancing the characterisation of 
the molecular environment of bovine ULF and determining that multiple interacting factors at the 
animal and organ levels intervene in ULF composition and likely affect embryo fate.  
Here a unique animal model was employed, determining changes in the uterine tract of a large group 
of cows at contrasting physiological situations across the postpartum period, and investigating 
implications of those changes on embryo early development in vivo. The day-7 timepoint was chosen 
in the present work because the first week of pregnancy was associated with the highest embryo 
losses in this animal model (moderately producing grazing dairy cows), of around 30% of 
inseminations (Diskin and Morris 2008, Berg et al. 2017). As previously discussed, sampling ULF in 
vivo from animals pregnant by a single embryo as in the present work may not detect subtle 
molecular differences caused by the embryo itself in its surrounding fluid/endometrial 
microenvironment. Rather, in the present study, the embryo functioned as a sensor to appraise the 
ULF molecular milieu due to maternal factors. 
8.2 Molecular and systemic determinants of subfertility 
Untargeted LC-MS/MS proteomic experiments allowed the comprehensive characterisation of the 
ULF proteome in relation to embryo quality and time postpartum. Of the 1504 proteins detected, 
472 are reported here for the first time in bovine ULF, to the knowledge of the author. This is an 
important contribution towards characterising this relatively unexplored biofluid. Only two proteins 
showed a statistically significant trend over time, whereas 20 proteins were significantly related to 
embryo quality.  
The proteins found to be correlated with embryo quality in the present work might exert disparate 
effects at different points in the postpartum period. However, no statistically significant interaction 
effects of these proteins’ abundances with dpp or OC were found on embryo quality (Chapter 5). A 
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possibility is that the lower reproductive performance observed at OC1 might be caused indirectly by 
a strong metabolic imbalance (Moyes et al. 2013). As presented in Chapter 1, one of the 
manifestations of this metabolic imbalance is an increase in NEFA in blood in the early postpartum 
period, which is accompanied by a heightened systemic oxidative status until around day 30 
postpartum (Bernabucci et al. 2005). This mechanism may have impacted the reproductive tract at 
several levels, i.e. at the ovary (follicular fluid) oviduct (oviduct luminal fluid) and/or uterus (ULF) 
(Jordaens et al. 2020).  
GC-MS/MS metabolomic experiments (Exp. M1, M2 and M4) resulted in 132 compounds not 
previously reported in bovine ULF. Change patterns in metabolites’ abundances were dissimilar to 
those observed in proteins: while no significant associations were found between metabolite 
abundance and embryo quality, 31 compounds fluctuated along dpp and/or OC. An interpretation of 
the seemingly divergent trends in proteins and metabolites in ULF (metabolite abundance changes in 
time, protein changes correlated to embryo quality) can be extrapolated from the review of Roche et 
al. (2009). They discuss how some processes (e.g. body fat mobilisation) are predominantly regulated 
by genetic factors, while others (e.g. lipogenesis) are modulated mostly by the metabolic conditions 
(Roche et al. 2009).  
Interaction between the proteins and metabolites studied at the biological function level in ULF was 
determined by joint pathway analysis, with several processes fluctuating between the two 
timepoints examined. These processes encompassed metabolism, regulation of transcription, 
signalling and defence. This points at the ULF environment at OC1 being generally more metabolically 
active, in part likely due to incomplete postpartum recovery. The ULF at OC3 contained a higher 
abundance of enzymes in the pathways impacted, which may account for its improved ability to cope 
with stress and better host an embryo. The EGFR1 signalling pathway also appeared to be 
differentially regulated between ULF containing >16-cells vs <16-cells embryos. This central pathway 
to development may be affecting embryo development in a myriad of ways and is a promising target 
for future studies. 
Cow-level (Chapter 2) and uterine molecular (Chapters 5-6) variables were associated with 
differential embryo quality, but in the present work links between those systemic and local factors 
were not apparent by multivariate analysis. Furthermore, PCA and PLS-DA analyses of molecular data 
evidenced a high degree of variation within groups in all the variables scrutinised, i.e. no variable 
showed definite clusters or clear separation between classes, with two implications.  
Firstly, that the molecular composition of ULF is a result of complex interactions between the cow-
level phenotypical variables measured, and likely others. Thus, no variable, or small subset of 
variables, appears to be a key determining factor of the ULF molecular milieu. Secondly, that 
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potentially subtle molecular signatures of uterine suitability may be manifested predominantly at 
levels of regulation other than those measured herein. Important regulatory processes of uterine 
function and early embryo have been described for mRNA transcription (Bauersachs et al. 2017), 
DNA methylation (O'Doherty et al. 2017), protein post-translational modifications (Bhojwani et al. 
2006), and protein stability and degradation (Deutsch et al. 2014). In addition, the extracellular 
vesicle fraction of ULF was not isolated in the present work and thus some potentially relevant signal 
molecules within (Almiñana et al. 2018, Koh et al. 2020) could provide valuable additional insight. 
The proteins selected for biological validation by in vitro embryo culture (cystatin C, cathepsin B and 
pyruvate kinase M) were not found to consistently affect the embryonic development parameters 
measured. In these experiments a detrimental effect of ammonium bicarbonate on embryo 
development to the blastocyst stage was observed, and the data suggests potential detrimental 
effects of PKM on blastocyst rate and a protective effect of CysC against ammonium bicarbonate-
induced damage. More in vitro studies are needed to better understand the molecular dynamics of 
early embryo development. State-of-the-art oviduct and endometrial cell culture systems have been 
shown to closely mimic the endocrine and morphological properties of the organs in vivo (Jordaens 
et al. 2020) and constitute an excellent strategy for future work due to practical, logistic and ethical 
purposes (Rodríguez-Alonso et al. 2020b). 
Integrative studies conjunctly assessing the molecular milieu of follicular, oviductal and uterine fluids 
will greatly help clarify the spatiotemporal nature of the pregnancy losses observed here, and better 
understand the interaction between these microenvironments. Furthermore, there is an increasing 
amount of evidence on carry-over effects of metabolic and disease conditions on reproductive 
performance (Britt 1991, Gilbert 2019). This implies that measurements across time (ideally starting 
weeks before calving) may provide essential insight to ascertain the direct mechanisms determining 
readiness for pregnancy. 
8.3 Technical aspects 
The proof-of-concept test of a rapid metabolic fingerprinting platform (REIMS) on ULF samples (Exp. 
M3 and M5) succeeded at obtaining good quality spectra and determine a small subset of metabolic 
features potentially associated to embryo quality differences. However, its sensitivity appeared to be 
insufficient for determinations of subtle changes associated with the phenomena of interest in this 
work. Replacing the sampling setup for an automated system (as opposed to the standard handheld 
device employed in this work) or trialling similar techniques originally developed for liquid samples 
(e.g. DART-MS) may form the basis of a diagnostic application for health and pregnancy parameters.  
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Some suggestions to improve the scope, precision, and consistency of the proteomic and 
metabolomic data generated include the use of data-independent acquisition methods (Doerr 2015) 
for improved coverage in LC-MS/MS proteomic analyses and the incorporation of orthogonal 
technologies to GC-MS/MS (e.g. hydrophilic interaction chromatography, "HILIC"; Tang et al. 2016) 
for detection of additional metabolite classes.  
8.4 Perspectives 
A multifactorial approach will likely be necessary for understanding molecular pathways underlying 
dairy cows’ reproductive function. Ameliorating it will also require a similarly multifaceted strategy, 
with each factor representing a small percentage of improvement that can however compound for 
greater total gains (Diskin et al. 2015). This is especially true in countries with predominantly grazing 
dairy systems that have a higher dependence on timely and compact calving seasons (Brownlie et al. 
2014). These factors include genetic improvements (Crowe et al. 2018), management -i.e. housing 
and quality of feed adjustments peripartum (Sawa and Bogucki 2011)-, potentially reducing milking 
frequency in the first one or two weeks postpartum (Stelwagen et al. 2013), and setting the voluntary 
waiting time to about day 24 (Humblot 2001), as longer waiting times imply risking impregnating 
oocytes produced peripartum, of lower quality (Britt 1991); after 3 months postpartum, longer waits 
do not improve reproductive outcome in moderate producing dairy cows (Stadnik 2017). 
In addition, further studies may test differences in development of dairy and beef embryos 
transferred to early postpartum dairy cows. This could help determine whether production of a beef 
calf represents a viable alternative to culling, for dairy cows not pregnant on time to keep up with 
the annual calving pattern.  
8.5 Conclusion 
The present work provided evidence for links between proteins and metabolites associated with (and 
potentially determinant of) postpartum recovery and embryo quality. Worthy of note, proteins 
related to immune processes such as myeloid leukocyte activation and response to wounding tended 
to be in higher abundance in ULF holding poorer quality embryos. The abundance of many 
metabolites changed with time postpartum; at OC1 the “pentose and glucuronate conversion” 
pathway was upregulated, whereas “cysteine and methionine metabolism” and “glycine, serine and 
threonine metabolism” were downregulated, accounting for time-specific molecular signatures of 
the uterine environment. Additionally, dysregulation of protein metabolism and EGFR1 signalling is 
putatively associated with embryo development beyond the 16-cell stage. Targeted studies are 
needed for empirical validation of these findings. 
  
 161 
Important future avenues of related research include integration with other omics (genomics, 
epigenomics, lipidomics, etc.), tissues (endometrium) and fluids (follicular fluid) for systems biology 
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Appendices 
A.1 Chapter 2 
 
Figure A-8-1 PCA plot (PC1 and PC2) using normalised protein abundance as features. 
Abbreviations: NR, non-recovery (i.e. uterine flushing samples in which no embryo 





A.2 Chapter 4 
Table A-1 Isotope-labelled proline (tracer) peak areas per sample. Stock solution area in purple, 
positive controls in orange, blank in light green, plasma samples in light blue, ULF 
samples and QCs in yellow.  
Sample Type Area 




Spiked saline(a) Standard 3560 
Spiked saline(b) Standard 856 
Spiked saline(c) Standard 618 
Blank Blank 0 
Plasma #1 T0 Plasma 0 
Plasma #1 T1 Plasma 0 
Plasma #1 T2 Plasma 0 
Plasma #1 T6 Plasma 0 
Plasma #1 T24 Plasma 0 
Plasma #2 T0 Plasma 0 
Plasma #2 T6 Plasma 0 
Plasma #2 T24 Plasma 0 
QCA QC 760 
QCB QC 450 
QCC QC 577 
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ULF #1 Sample 1824 
ULF #2 Sample 4355 
ULF #3 Sample 780 
ULF #4 Sample 461 
ULF #5 Sample 4487 
















Figure A-8-2 GC-MS/MS chromatogram example. A, qualifier ion chromatogram; B, quantifier ion 







Figure A-8-3 Example chromatograms obtained by REIMS metabolic fingerprinting, showing 
distinct degrees of signal-to-noise ratio according to ionisation mode. A, positive 






Figure A-8-4 PCA of ULF sample replicates analysed in REIMS, after removal of features present in 
blanks, in negative (A) or positive (B) ionisation mode. Colours indicate technical 





A.3 Chapter 5 
 
Figure A-8-5 Graphic representation of batch correction done on sample intensity, LC-MS/MS Exp. 












Figure A-8-7 PCA of proteomic features in ULF bearing embryos of different quality, according to 
the EQ3 classification system. “Bad”, non-pregnant ULF (embryo classes IV and V); 
“good” pregnant ULF (embryo classes I, II and III). Coloured areas indicate Hotelling T2 















Figure A-8-89 Treemap displaying enriched GO terms using all proteins identified in Exp. P3. A, 
biological process; B, cellular location; C, molecular function. 
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Figure A-8-910 Graphic representation of batch correction done on sample intensity, GC-MS/MS 




Figure A-8-10 KEGG pathways overrepresented in the metabolite sets identified by targeted 
analysis (A) or untargeted analysis (B) vs the background of all compounds identified 






Figure A-8-11 Relevant pathways differentially regulated across days postpartum (dpp, subplot A) 
or oestrus after calving (OC, subplot B). a: Pentose and glucuronate interconversions, 
b: beta alanine metabolism, c: cysteine and methionine metabolism, d: glycerolipid 





Figure A-8-12 PCA using auto-scaled metabolite abundance, coloured by embryo grade (EQ1). 
Coloured areas indicate Hotelling T2 confidence ellipses, i.e. the space of 95% 




Figure A-8-13 OPLS-DA showing predictive component 1 (x-axis) and orthogonal component 1 
(variation unrelated to embryo grade) (y-axis), using embryo classification system EQ2 
(A) or EQ3 (B). “Optimal”, embryo class I; “suboptimal”, embryo classes III, IV, V; “bad” 





classes I, II and III). Coloured areas indicate Hotelling T2 confidence ellipses, i.e. the 




Figure A-8-14 Graphic representation of batch correction done on sample intensity, REIMS Exp. 










Figure A-8-15 PCA of all samples; variables are peak area values from REIMS analysis in positive 
ionisation mode. A, OC; B, EQ1; C, EQ2; D: EQ3. Coloured areas indicate Hotelling T2 










Figure A-8-16 PCA of all samples; variables are peak area values from REIMS analysis in negative 
ionisation mode. A, OC; B, EQ1; C, EQ2; D: EQ3. Coloured areas indicate Hotelling T2 






Table S1-1 Studies investigating proteomics and metabolomics of bovine ULF. Abbreviations: AA, amino acids; AI, artificial 
insemination; ET, embryo transfer; M, metabolomics; P, proteomics; P4, progesterone; T, transcriptomics; ULF, uterine luminal 
fluid.  
Reference Collection day Omics Research subject 
Beltman et al., 2014  Preg: 7  P  Viable vs degenerate embryo  
Faulkner et al., 2012  Oestrus:7  P  ULF vs blood plasma proteomes 
Faulkner et al., 2013  Oestrus: 7,15  P  Low vs high P4 effect on ULF proteome 
Forde et al., 2013  Preg: 13-19  P, (T)  Effect of P4 on gene expression 
Forde et al., 2014a  Preg: 10-19 P, (T)  Protein changes in pregnancy 
Forde et al., 2014b  Preg+Oestrus: 10-19  
M, 
(T)  
Changes pregnant vs oestrus at different days  
Forde et al., 2015  Preg+Oestrus: 16  P, (T)  Effect of embryo on ULF composition  
Forde et al., 2016b  Preg: 19  
M, 
(T)  
AA consumption differences by embryo gender  
Forde et al., 2017  Preg: 19  
M, 
(T)  
Heifers, lactating and dry cows  
Gegenfurtner et al., 2019b Pregnancy: 19 P Effect of genetic merit on ULF proteome 
Groebner et al., 2011b  Oestrus: 12,15,18  
M, 
(T)  
Changes in 41 AA through oestrus  
Harlow et al., 2018  Oestrus: 9  P  Effect of diet on ULF composition  
Helfrich et al., 2020 43-62 dpp P, (T) Subclinical endometritis effect on ULF 
Hugentobler et al., 2007a  Oestrus: 0-14  M  Changes in [AA] through oestrus 
Hugentobler et al., 2010  Oestrus: 3,6  M  Effect of infused P4 on fluid composition 
Ledgard et al., 2012  Oestrus: 5,9,14  P  Asynchronic ET effect on proteome 
Ledgard et al., 2015  15 and 42 dpp P Subclinical endometritis vs healthy cows 
Moraes et al., 2020a Preg+Oestrus: 17 M, (T) Effect of preg. on ULF lipid composition  
Moraes et al., 2020b Preg+Oestrus: 17 
P, M, 
(T) 
Effect of preg. on ULF proteome, metabolome 
Mullen et al., 2012  Oestrus: 7, 13  P  High fertility heifers’ ULF proteome 
Muñoz et al., 2012  Preg+Oestrus: 8  P  Differences in ULF of in vivo vs AI pregnancies 
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Passaro et al., 2016  Preg+Oestrus: 7  P  Proteome changes induced by pregnancy  
Ribeiro et al., 2016 Preg+Oestrus: 15  
M, 
(T)  
Non-preg vs several embryo shapes  
Simintiras et al., 2019a  Oestrus: 12,13,14  M  Lipids (P4 suppl. effect)  
Simintiras et al., 2019b  Oestrus: 12,13,14  M  Nucleotides, vitamins, etc. (P4 suppl. effect)  
Simintiras et al., 2019c  Oestrus: 12,13,14   M  AA, carbohydrates (P4 suppl. effect)  
Sponchiado et al., 2019 Preg+Oestrus: 7 M, (T) Embryo modulates ULF metabolome 





Table S2-1 Details of the daily feed regime for cows either pregnant and non-lactating (dry), or milking, for the 
years 2017 and 2018. 
  Farm Trial 1 
Farm Trial 2 Farm Trial 3 
2017 2018 
  Dry Dry Milking Dry Milking 
Maize silage (kg) 3 2 2 3 2 
Grass silage (kg)   3.5 3.5     
Mg oxide (g) 5 20 20 5 5 
Sodium chloride (g) 10 10 10 10 10 
Calimate (g)     75   50 
Trace elements (g)   5 5     
Dicalcium phosphate (g) 10     10   
Zinc (g) 10     10 20 
Total supplements (kg) 3.1 5.6 5.6 3.1 2.1 
Pasture (Rye grass 70%, white clover 30%) (kg) 1.9 0.4 7.4 1.9 13.9 





Table S2-2 Instrument quality assurance values for oestradiol, progesterone NEFA and BOH concentration tests. 
 
  
date Oestradiol Progesterone NEFA BOH
Expected range87.8-107.3 7.54-8.68 1.48-1.72 0.65-0.95
mean 97.69 8.02 1.595 0.83
std dev 6 0.35 0.024 0.049
CV 6.14 4.31 1.47 5.87
date Oestradiol Progesterone NEFA BOH
Expected range471.6-576.4 16.46-18.94 2.3-2.66 1.41-1.71
mean 513.1 17.5 2.501 1.634
std dev 14.38 0.62 0.019 0.117
CV 2.8 3.57 0.73 7.11
Quality Controls-mid range
Quality Control B-high range
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Table S2-3 Viability estimates according to embryo quality, from similar studies in literature.  
 
  
Article Column1 Grade 1 Grade 2 Grade 3 Grade 4 TOTAL G2/G1 G3/G1 Day M EB MB XB HB
Farin (1999) 76 65 54 66 0.85 0.71 Day 43 rates
Alkan (2019) 44.66 33.07 39 0.73 Day 30 rates
Erdem (2019) 44.15 32.58 39 0.73 Day 30 rates
Arreseigor 1998 57.1 52.9 31.2 46.5 0.92 0.55 Day 35 
Wright 1981 64 45 33 59 0.7 0.52 Day40-60 49 65 65 65




Table S3-1 a. Top 5 proteins used to generate an Exclusion Scheduled Precursor List (ESPL). b. MS/MS peptide list. First 10 entries of ESPL made from albumin-
only peptides; tolerance was 5 min (Rt), 0.05 Da (m/z). 
Protein Ranking A    
Serum albumin 1     
Haemoglobin, subunit alpha 2     
Serum transferrin 3     
Haemoglobin, subunit beta 4     
Lactotransferrin 5     
      
Order Sequence 
m/z meas-
ured Rt (min) m/z B 
1 R.RPCFSALTPDETYVPK.A 627.65 43.3 44.78  
2 K.LGEYGFQNAL.I 556.27 48.46 48.49  
3 R.MPCTED.Y 752.26 10.35 49.01  
4 R.HPEYAVSVLLR.L 428.58 43.52 45.78  
5 R.HPYFYAPELLYYANK.Y 630.31 53.42 53.45  
6 R.PCFSALTPDETYVPK.A 862.91 47.7 47.74  
7 F.YAPELLYYANK.Y 672.85 45.04 45.04  
8 K.LFTFHAD.I 425.71 37.91 37.99  
9 K.TVMENFVAFVDK.C 700.84 53.01 39.23  















Carboxymethylenebutenolidase homolog CMBL 8  
Isocitrate dehydrogenase [NADP] (EC 1.1.1.42) IDH1 8  
Fructose-bisphosphate aldolase (EC 4.1.2.13) ALDOA 7  
Albumin ALB 7  
Branched-chain-amino-acid aminotransferase (EC 2.6.1.42) BCAT1 7  
GM2 ganglioside activator GM2A 7  
WAP four-disulfide core domain 2 WFDC2 7  
DPP7 protein (Dipeptidyl peptidase 7) DPP7 7  
Acid sphingomyelinase-like phosphodiesterase SMPDL3B 7  
Phosphatidylethanolamine-binding protein 1 (PEBP-1) (Basic cytosolic 21 kDa protein) 




Ezrin (Cytovillin) (Villin-2) (p81) EZR VIL2 7  
Peroxiredoxin-2 (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 2) PRDX2 7  
Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) CNDP2 7  
Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19) KRT19 7  
Phosphatidylethanolamine-binding protein 4 PEBP4 7  
Inter-alpha (Globulin) inhibitor H4 (Plasma Kallikrein-sensitive glycoprotein) ITIH4 6  
FGG protein (Fibrinogen gamma-B chain) FGG 6  
Adenylyl cyclase-associated protein CAP1 6  
Cathepsin S (EC 3.4.22.27) CTSS 6  
Galectin-3-binding protein (Lectin galactoside-binding soluble 3-binding protein) LGALS3BP 6  
S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase D) ESD 6  
Coactosin-like protein COTL1 6  
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Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alka-
line phosphatase liver/bone/kidney isozyme) 
ALPL 6  
Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase) ARSA 6  
Leukocyte elastase inhibitor (LEI) (Serpin B1) SERPINB1 6  
Chloride intracellular channel protein 1 CLIC1 6  





Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) ALAD 6  
Acyl-CoA-binding protein (ACBP) (Diazepam-binding inhibitor) (DBI) DBI 6  
Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-inde-





Phosphoglycerate kinase 1 (EC 2.7.2.3) PGK1 6  
Tubulin alpha-1D chain [Cleaved into: Detyrosinated tubulin alpha-1D chain] TUBA1D 6  
Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phospho-
glycerate mutase isozyme B) (PGAM-B) 
PGAM1 6  
Heat shock 70kD protein binding protein (ST13 Hsp70 interacting protein) (ST13 protein) ST13 6  
Alpha-actinin-4 (Non-muscle alpha-actinin 4) ACTN4 6  
Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 
1) 
ASRGL1 6  
Clathrin heavy chain 1 CLTC 6  




Gamma-ECS (EC 6.3.2.2) (Gamma-glutamylcysteine synthetase) GCLC 6  





Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3)  GOT1 6  
L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (LDH muscle subunit) (LDH-M) LDHA 6  
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Plastin-1 PLS1 6  
Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase) MDH1 6  
Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) AHCY 6  
Parkinson disease protein 7 homolog (Maillard deglycase) (Parkinsonism-associated de-
glycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-) (EC 3.5.1.-) 
(EC 3.5.1.124) 
PARK7 6  
Protein ABHD14B (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 14B) (Ab-
hydrolase domain-containing protein 14B) 
ABHD14B 6  




Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.33) (EC 1.1.1.372)  AKR1A1 6  
N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 (DDAH-2) (Dimethylarginine dime-
thylaminohydrolase 2) (EC 3.5.3.18) (DDAHII) (Dimethylargininase-2) 
DDAH2 6  
Phosphoserine aminotransferase (EC 2.6.1.52) PSAT1 6  
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1) RNH1 6  
Cystatin E/M CST6 6   
Uncharacterized protein   
Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Methylglyoxal synthase) (EC 4.2.3.3) (Tri-
ose-phosphate isomerase) 
TPI1 6   





Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha) ARHGDIA 6  
DPYSL3 protein (Dihydropyrimidinase like 3) DPYSL3 6  





Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-




Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophos-






3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (Bisphosphate 3'-nucleotidase 1) BPNT1 6  
EGF containing fibulin extracellular matrix protein 1 (EGF-containing fibulin-like extracellu-
lar matrix protein 1) 
EFEMP1 6  
Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) ECSOD 6  
CD48 molecule CD48 6  
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E1BKK0 Transcription factor E2F8 (E2F-8) E2F8 
P0CG53 Polyubiquitin-B [Cleaved into: Ubiquitin] UBB 
P02672 Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain] FGA 
P33433 Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG) (Fragments) HRG 
EQ3T056 L-lactate dehydrogenase A-like 6B (EC 1.1.1.27) LDHAL6B 
Q56K04 Cysteine-rich protein 1 (CRP-1) CRIP1 
P55206 C-type natriuretic peptide (SVSP15) [Cleaved into: CNP-22; CNP-29; CNP-53] NPPC 
P0C0S9 Histone H2A type 1 (H2A.1b) 
A4FV45 Transmembrane protein 214 TMEM214 
EQ24K09 DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) DNMT1 
P38573 Uroplakin-1b (UP1b) (Uroplakin Ib) (UPIb) UPK1B 
EQ3SZZ0 Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2) BRIX1  
Q4U5R3 
Proteasome activator complex subunit 1 (Proteasome activator 28 subunit alpha) (PA28a) 
(PA28alpha) 
PSME1 
Q9TTK4 Lysosomal-trafficking regulator LYST 
A5D989 Elongation factor 1-delta (EF-1-delta) EEF1D 
P31098 Osteopontin-K 
Q5E9T6 Leucine-rich glioma-inactivated protein 1 LGI1 
P0CH28 Polyubiquitin-C [Cleaved into: Ubiquitin-related; Ubiquitin] UBC 
EQ3SZK4 




Cadherin-1 (Epithelial cadherin) (E-cadherin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1; 
E-Cad/CTF2; E-Cad/CTF3] 
CDH1 
P04973 Clathrin light chain A (Lca) CLTA 
EQ29RP1 
Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (Ubiqui-
tin thioesterase 1) (Ubiquitin-specific-processing protease 1) 
USP1 
EQ2TA29 Ras-related protein Rab-11A RAB11A 




Iron-sulfur cluster assembly 1 homolog, mitochondrial (HESB-like domain-containing protein 




Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) 
(Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde 




Phosphatidate cytidylyltransferase, mitochondrial (EC 2.7.7.41) (CDP-diacylglycerol synthase) 
(CDP-DAG synthase) (Mitochondrial translocator assembly and maintenance protein 41 hom-
olog) (TAM41) 
TAMM41 
EQ32LK1 Alanyl-tRNA editing protein Aarsd1 (Alanyl-tRNA synthetase domain-containing protein 1) AARSD1 
Q0P5D2 Cleavage and polyadenylation specificity factor subunit 6 CPSF6 
P61285 Dynein light chain 1, cytoplasmic (Dynein light chain LC8-type 1) 
DYNLL1 
DNCL1 
P20288 D(2) dopamine receptor (Dopamine D2 receptor) DRD2 
EQ1JP75 L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) DCXR 
EQ29RR5 Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1) 
TFIP11 
STIP 
EQ3T160 Nucleophosmin (NPM) NPM1 
EQ3T0S5 Fructose-bisphosphate aldolase B (EC 4.1.2.13) (Liver-type aldolase) ALDOB 




Polyribonucleotide 5'-hydroxyl-kinase Clp1 (EC 2.7.1.78) (Polyadenylation factor Clp1) (Poly-




A1A4R1 Histone H2A type 2-C (H2A-clustered histone 20) H2AC20 
O18738 
Dystroglycan (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Al-
pha-DG); Beta-dystroglycan (Beta-DG)] 
DAG1 
Q4ZHA6 Potassium voltage-gated channel subfamily B member 2 KCNB2 
P31096 Osteopontin (Bone sialoprotein 1) (Secreted phosphoprotein 1) (SPP-1) SPP1 OPN 




Table S5-3 Full list of proteins identified in the present study and similar studies surveyed. 
All Article 
A0A096LNF2 Aranciaga 2020 
A0A0A0MP90 Aranciaga 2020 
A0A0F7RPX0 Aranciaga 2020 
A0A0F7RQ40 Aranciaga 2020 
A0A0M4MD57 Aranciaga 2020 
A0A0N4STN1 Aranciaga 2020 
A0A140T831 Aranciaga 2020 
A0A140T846 Aranciaga 2020 
A0A140T887 Aranciaga 2020 
A0A140T894 Aranciaga 2020 
A0A140T8A5 Aranciaga 2020 
A0A1K0FUD3 Aranciaga 2020 
A0A3Q1LFG8 Aranciaga 2020 
A0A3Q1LFQ2 Aranciaga 2020 
A0A3Q1LGC4 Aranciaga 2020 
A0A3Q1LGM4 Aranciaga 2020 
A0A3Q1LHZ0 Aranciaga 2020 
A0A3Q1LI44 Aranciaga 2020 
A0A3Q1LI46 Aranciaga 2020 
A0A3Q1LI93 Aranciaga 2020 
A0A3Q1LJB2 Aranciaga 2020 
A0A3Q1LJT1 Aranciaga 2020 
A0A3Q1LK49 Aranciaga 2020 
A0A3Q1LKJ1 Aranciaga 2020 
A0A3Q1LKR8 Aranciaga 2020 
A0A3Q1LKS8 Aranciaga 2020 
A0A3Q1LKU1 Aranciaga 2020 
A0A3Q1LL25 Aranciaga 2020 
A0A3Q1LL35 Aranciaga 2020 
A0A3Q1LL88 Aranciaga 2020 
A0A3Q1LLB2 Aranciaga 2020 
A0A3Q1LLT0 Aranciaga 2020 
A0A3Q1LM10 Aranciaga 2020 
A0A3Q1LM31 Aranciaga 2020 
A0A3Q1LMA3 Aranciaga 2020 
A0A3Q1LMV9 Aranciaga 2020 
A0A3Q1LN27 Aranciaga 2020 
A0A3Q1LN63 Aranciaga 2020 
A0A3Q1LNX9 Aranciaga 2020 
A0A3Q1LP76 Aranciaga 2020 
A0A3Q1LP77 Aranciaga 2020 
A0A3Q1LPA7 Aranciaga 2020 
A0A3Q1LPD0 Aranciaga 2020 
A0A3Q1LPD2 Aranciaga 2020 
A0A3Q1LPF4 Aranciaga 2020 
A0A3Q1LPG0 Aranciaga 2020 
A0A3Q1LPL7 Aranciaga 2020 
A0A3Q1LPY0 Aranciaga 2020 
A0A3Q1LPY4 Aranciaga 2020 
A0A3Q1LPZ4 Aranciaga 2020 
A0A3Q1LQ12 Aranciaga 2020 
A0A3Q1LQ34 Aranciaga 2020 
A0A3Q1LQD7 Aranciaga 2020 
A0A3Q1LQQ0 Aranciaga 2020 
A0A3Q1LQQ5 Aranciaga 2020 
A0A3Q1LQR2 Aranciaga 2020 
A0A3Q1LQU4 Aranciaga 2020 
A0A3Q1LR88 Aranciaga 2020 
A0A3Q1LR94 Aranciaga 2020 
A0A3Q1LRC3 Aranciaga 2020 
A0A3Q1LRD8 Aranciaga 2020 
A0A3Q1LRW4 Aranciaga 2020 
A0A3Q1LRY6 Aranciaga 2020 
A0A3Q1LSB6 Aranciaga 2020 
A0A3Q1LSF0 Aranciaga 2020 
A0A3Q1LSF9 Aranciaga 2020 
A0A3Q1LSK2 Aranciaga 2020 
A0A3Q1LSL4 Aranciaga 2020 
A0A3Q1LSN0 Aranciaga 2020 
A0A3Q1LSN6 Aranciaga 2020 
A0A3Q1LSS0 Aranciaga 2020 
A0A3Q1LT32 Aranciaga 2020 
A0A3Q1LT59 Aranciaga 2020 
A0A3Q1LTB0 Aranciaga 2020 
A0A3Q1LTK7 Aranciaga 2020 
A0A3Q1LTK9 Aranciaga 2020 
A0A3Q1LTM0 Aranciaga 2020 
A0A3Q1LTP0 Aranciaga 2020 
A0A3Q1LTS9 Aranciaga 2020 
A0A3Q1LTY4 Aranciaga 2020 
A0A3Q1LU13 Aranciaga 2020 
A0A3Q1LU27 Aranciaga 2020 
A0A3Q1LU36 Aranciaga 2020 
A0A3Q1LU85 Aranciaga 2020 
A0A3Q1LUB2 Aranciaga 2020 
A0A3Q1LUE9 Aranciaga 2020 
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A0A3Q1LUP1 Aranciaga 2020 
A0A3Q1LUW6 Aranciaga 2020 
A0A3Q1LV18 Aranciaga 2020 
A0A3Q1LV21 Aranciaga 2020 
A0A3Q1LV73 Aranciaga 2020 
A0A3Q1LVA2 Aranciaga 2020 
A0A3Q1LVA9 Aranciaga 2020 
A0A3Q1LVC7 Aranciaga 2020 
A0A3Q1LVC8 Aranciaga 2020 
A0A3Q1LWH4 Aranciaga 2020 
A0A3Q1LWK1 Aranciaga 2020 
A0A3Q1LWV4 Aranciaga 2020 
A0A3Q1LWV8 Aranciaga 2020 
A0A3Q1LX34 Aranciaga 2020 
A0A3Q1LX44 Aranciaga 2020 
A0A3Q1LX69 Aranciaga 2020 
A0A3Q1LX83 Aranciaga 2020 
A0A3Q1LXG6 Aranciaga 2020 
A0A3Q1LXM2 Aranciaga 2020 
A0A3Q1LXR9 Aranciaga 2020 
A0A3Q1LY19 Aranciaga 2020 
A0A3Q1LY29 Aranciaga 2020 
A0A3Q1LY31 Aranciaga 2020 
A0A3Q1LY57 Aranciaga 2020 
A0A3Q1LYE7 Aranciaga 2020 
A0A3Q1LYV7 Aranciaga 2020 
A0A3Q1LZ35 Aranciaga 2020 
A0A3Q1LZ97 Aranciaga 2020 
A0A3Q1LZK3 Aranciaga 2020 
A0A3Q1LZN1 Aranciaga 2020 
A0A3Q1LZU8 Aranciaga 2020 
A0A3Q1M013 Aranciaga 2020 
A0A3Q1M026 Aranciaga 2020 
A0A3Q1M032 Aranciaga 2020 
A0A3Q1M053 Aranciaga 2020 
A0A3Q1M057 Aranciaga 2020 
A0A3Q1M0D3 Aranciaga 2020 
A0A3Q1M0K3 Aranciaga 2020 
A0A3Q1M0M2 Aranciaga 2020 
A0A3Q1M0T4 Aranciaga 2020 
A0A3Q1M0U8 Aranciaga 2020 
A0A3Q1M0V5 Aranciaga 2020 
A0A3Q1M0Y7 Aranciaga 2020 
A0A3Q1M103 Aranciaga 2020 
A0A3Q1M104 Aranciaga 2020 
A0A3Q1M124 Aranciaga 2020 
A0A3Q1M193 Aranciaga 2020 
A0A3Q1M1A9 Aranciaga 2020 
A0A3Q1M1N7 Aranciaga 2020 
A0A3Q1M1P3 Aranciaga 2020 
A0A3Q1M1P4 Aranciaga 2020 
A0A3Q1M1Z4 Aranciaga 2020 
A0A3Q1M299 Aranciaga 2020 
A0A3Q1M2A1 Aranciaga 2020 
A0A3Q1M2A8 Aranciaga 2020 
A0A3Q1M2E0 Aranciaga 2020 
A0A3Q1M2E4 Aranciaga 2020 
A0A3Q1M2H2 Aranciaga 2020 
A0A3Q1M2Q2 Aranciaga 2020 
A0A3Q1M2S8 Aranciaga 2020 
A0A3Q1M352 Aranciaga 2020 
A0A3Q1M3L6 Aranciaga 2020 
A0A3Q1M3R8 Aranciaga 2020 
A0A3Q1M3U5 Aranciaga 2020 
A0A3Q1M3Z8 Aranciaga 2020 
A0A3Q1M471 Aranciaga 2020 
A0A3Q1M478 Aranciaga 2020 
A0A3Q1M4K3 Aranciaga 2020 
A0A3Q1M4L0 Aranciaga 2020 
A0A3Q1M5R4 Aranciaga 2020 
A0A3Q1M667 Aranciaga 2020 
A0A3Q1M6A2 Aranciaga 2020 
A0A3Q1M6C1 Aranciaga 2020 
A0A3Q1M6C6 Aranciaga 2020 
A0A3Q1M6K6 Aranciaga 2020 
A0A3Q1M6S0 Aranciaga 2020 
A0A3Q1M6S3 Aranciaga 2020 
A0A3Q1M6W0 Aranciaga 2020 
A0A3Q1M796 Aranciaga 2020 
A0A3Q1M808 Aranciaga 2020 
A0A3Q1M8A4 Aranciaga 2020 
A0A3Q1M8H9 Aranciaga 2020 
A0A3Q1M8I4 Aranciaga 2020 
A0A3Q1M8I6 Aranciaga 2020 
A0A3Q1M8I9 Aranciaga 2020 
A0A3Q1M8L6 Aranciaga 2020 
A0A3Q1M913 Aranciaga 2020 
A0A3Q1M927 Aranciaga 2020 
A0A3Q1M930 Aranciaga 2020 
A0A3Q1M970 Aranciaga 2020 
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A0A3Q1M990 Aranciaga 2020 
A0A3Q1M9I5 Aranciaga 2020 
A0A3Q1M9P4 Aranciaga 2020 
A0A3Q1M9W4 Aranciaga 2020 
A0A3Q1MA07 Aranciaga 2020 
A0A3Q1MA31 Aranciaga 2020 
A0A3Q1MAJ0 Aranciaga 2020 
A0A3Q1MAJ2 Aranciaga 2020 
A0A3Q1MAM8 Aranciaga 2020 
A0A3Q1MAU7 Aranciaga 2020 
A0A3Q1MAV6 Aranciaga 2020 
A0A3Q1MAZ2 Aranciaga 2020 
A0A3Q1MB09 Aranciaga 2020 
A0A3Q1MB39 Aranciaga 2020 
A0A3Q1MB98 Aranciaga 2020 
A0A3Q1MBL5 Aranciaga 2020 
A0A3Q1MBP1 Aranciaga 2020 
A0A3Q1MBP6 Aranciaga 2020 
A0A3Q1MBQ7 Aranciaga 2020 
A0A3Q1MBT3 Aranciaga 2020 
A0A3Q1MBX2 Aranciaga 2020 
A0A3Q1MC73 Aranciaga 2020 
A0A3Q1MC82 Aranciaga 2020 
A0A3Q1MCC9 Aranciaga 2020 
A0A3Q1MCP9 Aranciaga 2020 
A0A3Q1MCW7 Aranciaga 2020 
A0A3Q1MCX8 Aranciaga 2020 
A0A3Q1MD16 Aranciaga 2020 
A0A3Q1MD56 Aranciaga 2020 
A0A3Q1MDA4 Aranciaga 2020 
A0A3Q1MDA5 Aranciaga 2020 
A0A3Q1MDE6 Aranciaga 2020 
A0A3Q1MDK7 Aranciaga 2020 
A0A3Q1MDS1 Aranciaga 2020 
A0A3Q1ME14 Aranciaga 2020 
A0A3Q1MEU1 Aranciaga 2020 
A0A3Q1MF14 Aranciaga 2020 
A0A3Q1MF62 Aranciaga 2020 
A0A3Q1MF86 Aranciaga 2020 
A0A3Q1MFC3 Aranciaga 2020 
A0A3Q1MFG3 Aranciaga 2020 
A0A3Q1MFI5 Aranciaga 2020 
A0A3Q1MFI7 Aranciaga 2020 
A0A3Q1MFJ2 Aranciaga 2020 
A0A3Q1MFK7 Aranciaga 2020 
A0A3Q1MFL7 Aranciaga 2020 
A0A3Q1MFR4 Aranciaga 2020 
A0A3Q1MG04 Aranciaga 2020 
A0A3Q1MG31 Aranciaga 2020 
A0A3Q1MGK4 Aranciaga 2020 
A0A3Q1MGT0 Aranciaga 2020 
A0A3Q1MGU4 Aranciaga 2020 
A0A3Q1MHC4 Aranciaga 2020 
A0A3Q1MHG7 Aranciaga 2020 
A0A3Q1MHJ3 Aranciaga 2020 
A0A3Q1MHT0 Aranciaga 2020 
A0A3Q1MI29 Aranciaga 2020 
A0A3Q1MI98 Aranciaga 2020 
A0A3Q1MIB0 Aranciaga 2020 
A0A3Q1MIF4 Aranciaga 2020 
A0A3Q1MIL5 Aranciaga 2020 
A0A3Q1MIN7 Aranciaga 2020 
A0A3Q1MJ46 Aranciaga 2020 
A0A3Q1MJ74 Aranciaga 2020 
A0A3Q1MJD9 Aranciaga 2020 
A0A3Q1MJM1 Aranciaga 2020 
A0A3Q1MJX6 Aranciaga 2020 
A0A3Q1MK01 Aranciaga 2020 
A0A3Q1MK05 Aranciaga 2020 
A0A3Q1MK49 Aranciaga 2020 
A0A3Q1MKI2 Aranciaga 2020 
A0A3Q1MKQ7 Aranciaga 2020 
A0A3Q1MKR2 Aranciaga 2020 
A0A3Q1MKT5 Aranciaga 2020 
A0A3Q1MKY2 Aranciaga 2020 
A0A3Q1ML09 Aranciaga 2020 
A0A3Q1ML26 Aranciaga 2020 
A0A3Q1ML30 Aranciaga 2020 
A0A3Q1ML78 Aranciaga 2020 
A0A3Q1MLJ3 Aranciaga 2020 
A0A3Q1MLP4 Aranciaga 2020 
A0A3Q1MM55 Aranciaga 2020 
A0A3Q1MM86 Aranciaga 2020 
A0A3Q1MMY7 Aranciaga 2020 
A0A3Q1MN08 Aranciaga 2020 
A0A3Q1MN33 Aranciaga 2020 
A0A3Q1MN44 Aranciaga 2020 
A0A3Q1MN97 Aranciaga 2020 
A0A3Q1MNN6 Aranciaga 2020 
A0A3Q1MP70 Aranciaga 2020 
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A0A3Q1MPF1 Aranciaga 2020 
A0A3Q1MQ34 Aranciaga 2020 
A0A3Q1MQH2 Aranciaga 2020 
A0A3Q1MQW8 Aranciaga 2020 
A0A3Q1MQZ2 Aranciaga 2020 
A0A3Q1MR74 Aranciaga 2020 
A0A3Q1MR90 Aranciaga 2020 
A0A3Q1MR92 Aranciaga 2020 
A0A3Q1MRD9 Aranciaga 2020 
A0A3Q1MRM3 Aranciaga 2020 
A0A3Q1MRN4 Aranciaga 2020 
A0A3Q1MS48 Aranciaga 2020 
A0A3Q1MSF7 Aranciaga 2020 
A0A3Q1MSP0 Aranciaga 2020 
A0A3Q1MTF0 Aranciaga 2020 
A0A3Q1MTI5 Aranciaga 2020 
A0A3Q1MTT6 Aranciaga 2020 
A0A3Q1MTU9 Aranciaga 2020 
A0A3Q1MU19 Aranciaga 2020 
A0A3Q1MU31 Aranciaga 2020 
A0A3Q1MU51 Aranciaga 2020 
A0A3Q1MUA3 Aranciaga 2020 
A0A3Q1MUH1 Aranciaga 2020 
A0A3Q1MUR2 Aranciaga 2020 
A0A3Q1MUU1 Aranciaga 2020 
A0A3Q1MV38 Aranciaga 2020 
A0A3Q1MV83 Aranciaga 2020 
A0A3Q1MVR5 Aranciaga 2020 
A0A3Q1MWF7 Aranciaga 2020 
A0A3Q1MWI6 Aranciaga 2020 
A0A3Q1MXB7 Aranciaga 2020 
A0A3Q1MY21 Aranciaga 2020 
A0A3Q1MZC5 Aranciaga 2020 
A0A3Q1MZI6 Aranciaga 2020 
A0A3Q1MZY9 Aranciaga 2020 
A0A3Q1N0C4 Aranciaga 2020 
A0A3Q1N0Z7 Aranciaga 2020 
A0A3Q1N147 Aranciaga 2020 
A0A3Q1N1K0 Aranciaga 2020 
A0A3Q1N1N6 Aranciaga 2020 
A0A3Q1N1T6 Aranciaga 2020 
A0A3Q1N2B9 Aranciaga 2020 
A0A3Q1N2J5 Aranciaga 2020 
A0A3Q1N3K8 Aranciaga 2020 
A0A3Q1N3Q6 Aranciaga 2020 
A0A3Q1N461 Aranciaga 2020 
A0A3Q1N4K8 Aranciaga 2020 
A0A3Q1N522 Aranciaga 2020 
A0A3Q1N5F9 Aranciaga 2020 
A0A3Q1N5G3 Aranciaga 2020 
A0A3Q1N5N9 Aranciaga 2020 
A0A3Q1N6D1 Aranciaga 2020 
A0A3Q1N6F8 Aranciaga 2020 
A0A3Q1N6L6 Aranciaga 2020 
A0A3Q1N716 Aranciaga 2020 
A0A3Q1N7K2 Aranciaga 2020 
A0A3Q1N894 Aranciaga 2020 
A0A3Q1N8B9 Aranciaga 2020 
A0A3Q1N8C6 Aranciaga 2020 
A0A3Q1N8Q5 Aranciaga 2020 
A0A3Q1N9S5 Aranciaga 2020 
A0A3Q1N9Y5 Aranciaga 2020 
A0A3Q1NAY2 Aranciaga 2020 
A0A3Q1NE05 Aranciaga 2020 
A0A3Q1NE82 Aranciaga 2020 
A0A3Q1NEW0 Aranciaga 2020 
A0A3Q1NG86 Aranciaga 2020 
A0A3Q1NGS3 Aranciaga 2020 
A0A3Q1NH43 Aranciaga 2020 
A0A3Q1NHQ0 Aranciaga 2020 
A0A3Q1NHX9 Aranciaga 2020 
A0A3Q1NJB1 Aranciaga 2020 
A0A3Q1NJM8 Aranciaga 2020 
A0A3Q1NKD1 Aranciaga 2020 
A0A3Q1NKP5 Aranciaga 2020 
A0A3Q1NLD8 Aranciaga 2020 
A0A3Q1NLS8 Aranciaga 2020 
A0A3Q1NM24 Aranciaga 2020 
A0A3Q1NND6 Aranciaga 2020 
A0A3Q1NNJ3 Aranciaga 2020 
A0A3Q1NNJ8 Aranciaga 2020 
A0A3Q1NNP6 Aranciaga 2020 
A0A3S5ZP98 Aranciaga 2020 
A0A3S5ZPB0 Aranciaga 2020 
A0A3S5ZPB2 Aranciaga 2020 
A0A3S5ZPK1 Aranciaga 2020 
A0A3S5ZPM3 Aranciaga 2020 
A0A452DHV9 Aranciaga 2020 
A0A452DHX8 Aranciaga 2020 
A0A452DHY4 Aranciaga 2020 
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A0A452DI24 Aranciaga 2020 
A0A452DI25 Aranciaga 2020 
A0A452DI45 Aranciaga 2020 
A0A452DI66 Aranciaga 2020 
A0A452DI72 Aranciaga 2020 
A0A452DI85 Aranciaga 2020 
A0A452DID1 Aranciaga 2020 
A0A452DID9 Aranciaga 2020 
A0A452DIE3 Aranciaga 2020 
A0A452DIF5 Aranciaga 2020 
A0A452DII8 Aranciaga 2020 
A0A452DIL8 Aranciaga 2020 
A0A452DIM3 Aranciaga 2020 
A0A452DIS6 Aranciaga 2020 
A0A452DIT4 Aranciaga 2020 
A0A452DIW4 Aranciaga 2020 
A0A452DIX3 Aranciaga 2020 
A0A452DIY3 Aranciaga 2020 
A0A452DJ01 Aranciaga 2020 
A0A452DJ53 Aranciaga 2020 
A0A452DJ82 Aranciaga 2020 
A0A452DJE9 Aranciaga 2020 
A0A452DJK6 Aranciaga 2020 
A0A452DJS8 Aranciaga 2020 
A0A452DK44 Aranciaga 2020 
A0A452DKI9 Aranciaga 2020 
A0A498UZ20 Aranciaga 2020 
A0JN68 Aranciaga 2020 
A0JNL5 Aranciaga 2020 
A1A4N9 Aranciaga 2020 
A1A4R1 Aranciaga 2020 
A1L528 Aranciaga 2020 
A1L548 Aranciaga 2020 
A1L5B6 Aranciaga 2020 
A2T1U6 Aranciaga 2020 
A2VDX0 Aranciaga 2020 
A2VE01 Aranciaga 2020 
A2VE41 Aranciaga 2020 
A3KMX4 Aranciaga 2020 
A4FUA8 Aranciaga 2020 
A4FUD0 Aranciaga 2020 
A4FV12 Aranciaga 2020 
A4FV45 Aranciaga 2020 
A4FV56 Aranciaga 2020 
A4IF97 Aranciaga 2020 
A4IFI0 Aranciaga 2020 
A4IFQ7 Aranciaga 2020 
A4IFU5 Aranciaga 2020 
A4IFV2 Aranciaga 2020 
A4ZVC5 Aranciaga 2020 
A5D785 Aranciaga 2020 
A5D7A0 Aranciaga 2020 
A5D7D1 Aranciaga 2020 
A5D7E8 Aranciaga 2020 
A5D7J6 Aranciaga 2020 
A5D7Q2 Aranciaga 2020 
A5D7R6 Aranciaga 2020 
A5D7S8 Aranciaga 2020 
A5D986 Aranciaga 2020 
A5D9D1 Aranciaga 2020 
A5D9D7 Aranciaga 2020 
A5D9E1 Aranciaga 2020 
A5D9H5 Aranciaga 2020 
A5PJR3 Aranciaga 2020 
A5PJV5 Aranciaga 2020 
A5PJZ8 Aranciaga 2020 
A5PK11 Aranciaga 2020 
A5PK20 Aranciaga 2020 
A5PK51 Aranciaga 2020 
A5PK65 Aranciaga 2020 
A5PK72 Aranciaga 2020 
A5PK73 Aranciaga 2020 
A6H6Y0 Aranciaga 2020 
A6H714 Aranciaga 2020 
A6H742 Aranciaga 2020 
A6H768 Aranciaga 2020 
A6H7A2 Aranciaga 2020 
A6H7D3 Aranciaga 2020 
A6H7E3 Aranciaga 2020 
A6H7G2 Aranciaga 2020 
A6H7H6 Aranciaga 2020 
A6H7J7 Aranciaga 2020 
A6QLL8 Aranciaga 2020 
A6QLT9 Aranciaga 2020 
A6QLU7 Aranciaga 2020 
A6QLZ0 Aranciaga 2020 
A6QM09 Aranciaga 2020 
A6QNJ7 Aranciaga 2020 
A6QNJ8 Aranciaga 2020 
A6QNL5 Aranciaga 2020 
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A6QNM1 Aranciaga 2020 
A6QNS1 Aranciaga 2020 
A6QNX2 Aranciaga 2020 
A6QP39 Aranciaga 2020 
A6QPP2 Aranciaga 2020 
A6QPZ0 Aranciaga 2020 
A6QQ11 Aranciaga 2020 
A6QQ85 Aranciaga 2020 
A6QQA8 Aranciaga 2020 
A6QQN6 Aranciaga 2020 
A6QR56 Aranciaga 2020 
A7E3D5 Aranciaga 2020 
A7E3Q2 Aranciaga 2020 
A7E3W2 Aranciaga 2020 
A7E3W4 Aranciaga 2020 
A7E3W7 Aranciaga 2020 
A7MAZ5 Aranciaga 2020 
A7MB40 Aranciaga 2020 
A7MB62 Aranciaga 2020 
A7MBA2 Aranciaga 2020 
A7MBG0 Aranciaga 2020 
A7MBI5 Aranciaga 2020 
A7MBI7 Aranciaga 2020 
A7YY28 Aranciaga 2020 
A7YY37 Aranciaga 2020 
A7Z014 Aranciaga 2020 
A7Z055 Aranciaga 2020 
A7Z057 Aranciaga 2020 
A8E4L8 Aranciaga 2020 
A8E646 Aranciaga 2020 
A8YXX7 Aranciaga 2020 
B0JYL8 Aranciaga 2020 
B0JYM5 Aranciaga 2020 
B0JYN6 Aranciaga 2020 
B0JYP6 Aranciaga 2020 
B0JYQ0 Aranciaga 2020 
B3VTM3 Aranciaga 2020 
B5B3R8 Aranciaga 2020 
B6VAP7 Aranciaga 2020 
B8Y9S9 Aranciaga 2020 
B8Y9T0 Aranciaga 2020 
C1K3N7 Aranciaga 2020 
C6KEF7 Aranciaga 2020 
D2U6Q4 Aranciaga 2020 
D3U796 Aranciaga 2020 
D4QBB3 Aranciaga 2020 
D4QBB4 Aranciaga 2020 
E1B726 Aranciaga 2020 
E1B748 Aranciaga 2020 
E1B864 Aranciaga 2020 
E1B8H0 Aranciaga 2020 
E1B8K6 Aranciaga 2020 
E1B8Y9 Aranciaga 2020 
E1B9E8 Aranciaga 2020 
E1B9H0 Aranciaga 2020 
E1B9K1 Aranciaga 2020 
E1BAR2 Aranciaga 2020 
E1BBY7 Aranciaga 2020 
E1BCC9 Aranciaga 2020 
E1BCL3 Aranciaga 2020 
E1BDB0 Aranciaga 2020 
E1BDF5 Aranciaga 2020 
E1BE11 Aranciaga 2020 
E1BE76 Aranciaga 2020 
E1BEX4 Aranciaga 2020 
E1BFV0 Aranciaga 2020 
E1BG21 Aranciaga 2020 
E1BG59 Aranciaga 2020 
E1BGA6 Aranciaga 2020 
E1BGV8 Aranciaga 2020 
E1BH02 Aranciaga 2020 
E1BH06 Aranciaga 2020 
E1BH22 Aranciaga 2020 
E1BH94 Aranciaga 2020 
E1BI28 Aranciaga 2020 
E1BI72 Aranciaga 2020 
E1BJG5 Aranciaga 2020 
E1BJP1 Aranciaga 2020 
E1BKB7 Aranciaga 2020 
E1BKQ7 Aranciaga 2020 
E1BKU2 Aranciaga 2020 
E1BKX7 Aranciaga 2020 
E1BLV6 Aranciaga 2020 
E1BLZ8 Aranciaga 2020 
E1BM96 Aranciaga 2020 
E1BMD1 Aranciaga 2020 
E1BMG2 Aranciaga 2020 
E1BNG8 Aranciaga 2020 
E1BNR0 Aranciaga 2020 
E1BP41 Aranciaga 2020 
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E1BP73 Aranciaga 2020 
E1BPJ0 Aranciaga 2020 
E1BPK6 Aranciaga 2020 
E1BPP3 Aranciaga 2020 
E2CT01 Aranciaga 2020 
E3SAZ8 Aranciaga 2020 
E3W9A0 Aranciaga 2020 
E9QB09 Aranciaga 2020 
E9RHW1 Aranciaga 2020 
F1MAV0 Aranciaga 2020 
F1MB19 Aranciaga 2020 
F1MBV6 Aranciaga 2020 
F1MC40 Aranciaga 2020 
F1MC48 Aranciaga 2020 
F1MCK2 Aranciaga 2020 
F1MCY7 Aranciaga 2020 
F1MD34 Aranciaga 2020 
F1MD63 Aranciaga 2020 
F1MD74 Aranciaga 2020 
F1MDH3 Aranciaga 2020 
F1MDS0 Aranciaga 2020 
F1MET0 Aranciaga 2020 
F1MG05 Aranciaga 2020 
F1MGZ5 Aranciaga 2020 
F1MHB8 Aranciaga 2020 
F1MHL1 Aranciaga 2020 
F1MIA9 Aranciaga 2020 
F1MIJ5 Aranciaga 2020 
F1MJ95 Aranciaga 2020 
F1MJI7 Aranciaga 2020 
F1MJI8 Aranciaga 2020 
F1MJK3 Aranciaga 2020 
F1MKS5 Aranciaga 2020 
F1MKU4 Aranciaga 2020 
F1ML12 Aranciaga 2020 
F1MLH6 Aranciaga 2020 
F1MLM2 Aranciaga 2020 
F1MLS8 Aranciaga 2020 
F1MLW7 Aranciaga 2020 
F1MLW8 Aranciaga 2020 
F1MLX9 Aranciaga 2020 
F1MLZ4 Aranciaga 2020 
F1MM32 Aranciaga 2020 
F1MM57 Aranciaga 2020 
F1MM83 Aranciaga 2020 
F1MM86 Aranciaga 2020 
F1MMK0 Aranciaga 2020 
F1MMK2 Aranciaga 2020 
F1MMK9 Aranciaga 2020 
F1MMP5 Aranciaga 2020 
F1MMR8 Aranciaga 2020 
F1MNN6 Aranciaga 2020 
F1MNV5 Aranciaga 2020 
F1MNW5 Aranciaga 2020 
F1MP31 Aranciaga 2020 
F1MPE1 Aranciaga 2020 
F1MPU0 Aranciaga 2020 
F1MQ37 Aranciaga 2020 
F1MQH8 Aranciaga 2020 
F1MR60 Aranciaga 2020 
F1MR96 Aranciaga 2020 
F1MRD0 Aranciaga 2020 
F1MRG7 Aranciaga 2020 
F1MRN2 Aranciaga 2020 
F1MRY9 Aranciaga 2020 
F1MS05 Aranciaga 2020 
F1MS40 Aranciaga 2020 
F1MS53 Aranciaga 2020 
F1MTC2 Aranciaga 2020 
F1MTI7 Aranciaga 2020 
F1MTP5 Aranciaga 2020 
F1MTR1 Aranciaga 2020 
F1MTV9 Aranciaga 2020 
F1MU12 Aranciaga 2020 
F1MU19 Aranciaga 2020 
F1MU79 Aranciaga 2020 
F1MUC5 Aranciaga 2020 
F1MUP9 Aranciaga 2020 
F1MUR6 Aranciaga 2020 
F1MUZ9 Aranciaga 2020 
F1MVK1 Aranciaga 2020 
F1MW03 Aranciaga 2020 
F1MWD3 Aranciaga 2020 
F1MWI1 Aranciaga 2020 
F1MWN1 Aranciaga 2020 
F1MWQ2 Aranciaga 2020 
F1MWR8 Aranciaga 2020 
F1MWU9 Aranciaga 2020 
F1MXF5 Aranciaga 2020 
F1MY85 Aranciaga 2020 
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F1MYN5 Aranciaga 2020 
F1MYQ7 Aranciaga 2020 
F1MYS7 Aranciaga 2020 
F1MYX5 Aranciaga 2020 
F1MZ46 Aranciaga 2020 
F1MZ92 Aranciaga 2020 
F1MZ96 Aranciaga 2020 
F1MZR1 Aranciaga 2020 
F1N049 Aranciaga 2020 
F1N076 Aranciaga 2020 
F1N091 Aranciaga 2020 
F1N093 Aranciaga 2020 
F1N0E5 Aranciaga 2020 
F1N0F2 Aranciaga 2020 
F1N160 Aranciaga 2020 
F1N161 Aranciaga 2020 
F1N169 Aranciaga 2020 
F1N1C9 Aranciaga 2020 
F1N1I6 Aranciaga 2020 
F1N2I5 Aranciaga 2020 
F1N2L9 Aranciaga 2020 
F1N2W0 Aranciaga 2020 
F1N3J3 Aranciaga 2020 
F1N3P2 Aranciaga 2020 
F1N3Q7 Aranciaga 2020 
F1N3U5 Aranciaga 2020 
F1N3Y1 Aranciaga 2020 
F1N458 Aranciaga 2020 
F1N468 Aranciaga 2020 
F1N469 Aranciaga 2020 
F1N474 Aranciaga 2020 
F1N4A6 Aranciaga 2020 
F1N4K1 Aranciaga 2020 
F1N4M7 Aranciaga 2020 
F1N510 Aranciaga 2020 
F1N5T0 Aranciaga 2020 
F1N619 Aranciaga 2020 
F1N647 Aranciaga 2020 
F1N650 Aranciaga 2020 
F1N694 Aranciaga 2020 
F1N6C0 Aranciaga 2020 
F1N6Y1 Aranciaga 2020 
F1N712 Aranciaga 2020 
F1N726 Aranciaga 2020 
F1N789 Aranciaga 2020 
F1N7D7 Aranciaga 2020 
F1N7I3 Aranciaga 2020 
F1N7X3 Aranciaga 2020 
F2FB38 Aranciaga 2020 
F2FB42 Aranciaga 2020 
F2Z4C1 Aranciaga 2020 
F2Z4D5 Aranciaga 2020 
F2Z4F0 Aranciaga 2020 
F2Z4F5 Aranciaga 2020 
F2Z4G5 Aranciaga 2020 
F2Z4I6 Aranciaga 2020 
F2Z4J1 Aranciaga 2020 
F6Q4T4 Aranciaga 2020 
F6Q9Q9 Aranciaga 2020 
F6QEU6 Aranciaga 2020 
F6QH94 Aranciaga 2020 
F6QND5 Aranciaga 2020 
F6QQ60 Aranciaga 2020 
F6QS88 Aranciaga 2020 
F6R4P6 Aranciaga 2020 
F6R9I4 Aranciaga 2020 
F6RMV5 Aranciaga 2020 
F8UZU9 Aranciaga 2020 
G3MWT1 Aranciaga 2020 
G3MWV5 Aranciaga 2020 
G3MX65 Aranciaga 2020 
G3MXG6 Aranciaga 2020 
G3MXL6 Aranciaga 2020 
G3MY44 Aranciaga 2020 
G3MYC9 Aranciaga 2020 
G3MYM8 Aranciaga 2020 
G3MYZ3 Aranciaga 2020 
G3MZE0 Aranciaga 2020 
G3MZK6 Aranciaga 2020 
G3MZU3 Aranciaga 2020 
G3N022 Aranciaga 2020 
G3N0D7 Aranciaga 2020 
G3N0V0 Aranciaga 2020 
G3N148 Aranciaga 2020 
G3N1E4 Aranciaga 2020 
G3N1F5 Aranciaga 2020 
G3N1H5 Aranciaga 2020 
G3N1U4 Aranciaga 2020 
G3N1Y3 Aranciaga 2020 
G3N2N7 Aranciaga 2020 
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G3N3Q3 Aranciaga 2020 
G3X6I0 Aranciaga 2020 
G3X6K8 Aranciaga 2020 
G3X6L4 Aranciaga 2020 
G3X6L9 Aranciaga 2020 
G3X6N3 Aranciaga 2020 
G3X6S5 Aranciaga 2020 
G3X743 Aranciaga 2020 
G3X757 Aranciaga 2020 
G3X7I5 Aranciaga 2020 
G3X7K5 Aranciaga 2020 
G3X8A0 Aranciaga 2020 
G5E531 Aranciaga 2020 
G5E569 Aranciaga 2020 
G5E580 Aranciaga 2020 
G5E589 Aranciaga 2020 
G5E5A8 Aranciaga 2020 
G5E5A9 Aranciaga 2020 
G5E5B0 Aranciaga 2020 
G5E5C3 Aranciaga 2020 
G5E5C8 Aranciaga 2020 
G5E5H2 Aranciaga 2020 
G5E5Q6 Aranciaga 2020 
G5E5T5 Aranciaga 2020 
G5E5V1 Aranciaga 2020 
G5E5V6 Aranciaga 2020 
G5E5Y5 Aranciaga 2020 
G5E6J5 Aranciaga 2020 
G5E6N4 Aranciaga 2020 
G8JKV3 Aranciaga 2020 
G8JKY5 Aranciaga 2020 
H2CNR1 Aranciaga 2020 
H9KUV2 Aranciaga 2020 
K4JBR5 Aranciaga 2020 
L7R4Y6 Aranciaga 2020 
M5FJW2 Aranciaga 2020 
M5FJZ9 Aranciaga 2020 
M5FK91 Aranciaga 2020 
M5FMU4 Aranciaga 2020 
O02675 Aranciaga 2020 
O02751 Aranciaga 2020 
O18738 Aranciaga 2020 
O18836 Aranciaga 2020 
O46375 Aranciaga 2020 
O46415 Aranciaga 2020 
O62652 Aranciaga 2020 
O77834 Aranciaga 2020 
O97680 Aranciaga 2020 
P00366 Aranciaga 2020 
P00435 Aranciaga 2020 
P00442 Aranciaga 2020 
P00515 Aranciaga 2020 
P00727 Aranciaga 2020 
P00735 Aranciaga 2020 
P00921 Aranciaga 2020 
P00978 Aranciaga 2020 
P01045 Aranciaga 2020 
P01252 Aranciaga 2020 
P01888 Aranciaga 2020 
P01966 Aranciaga 2020 
P02070 Aranciaga 2020 
P02081 Aranciaga 2020 
P02253 Aranciaga 2020 
P02453 Aranciaga 2020 
P02584 Aranciaga 2020 
P02633 Aranciaga 2020 
P02662 Aranciaga 2020 
P02702 Aranciaga 2020 
P04272 Aranciaga 2020 
P05786 Aranciaga 2020 
P07107 Aranciaga 2020 
P07589 Aranciaga 2020 
P08728 Aranciaga 2020 
P09487 Aranciaga 2020 
P0C0S9 Aranciaga 2020 
P0CB32 Aranciaga 2020 
P0CG53 Aranciaga 2020 
P0CH28 Aranciaga 2020 
P10096 Aranciaga 2020 
P10103 Aranciaga 2020 
P10462 Aranciaga 2020 
P10575 Aranciaga 2020 
P10790 Aranciaga 2020 
P11019 Aranciaga 2020 
P11116 Aranciaga 2020 
P12763 Aranciaga 2020 
P13214 Aranciaga 2020 
P13696 Aranciaga 2020 
P15497 Aranciaga 2020 
P17248 Aranciaga 2020 
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P17697 Aranciaga 2020 
P18203 Aranciaga 2020 
P19035 Aranciaga 2020 
P19120 Aranciaga 2020 
P19660 Aranciaga 2020 
P19803 Aranciaga 2020 
P19858 Aranciaga 2020 
P20000 Aranciaga 2020 
P20004 Aranciaga 2020 
P21752 Aranciaga 2020 
P21856 Aranciaga 2020 
P22226 Aranciaga 2020 
P25417 Aranciaga 2020 
P26285 Aranciaga 2020 
P26452 Aranciaga 2020 
P26882 Aranciaga 2020 
P28800 Aranciaga 2020 
P28801 Aranciaga 2020 
P31408 Aranciaga 2020 
P31754 Aranciaga 2020 
P31976 Aranciaga 2020 
P33046 Aranciaga 2020 
P34955 Aranciaga 2020 
P35466 Aranciaga 2020 
P35478 Aranciaga 2020 
P35604 Aranciaga 2020 
P38657 Aranciaga 2020 
P41541 Aranciaga 2020 
P42899 Aranciaga 2020 
P46193 Aranciaga 2020 
P48034 Aranciaga 2020 
P48427 Aranciaga 2020 
P49951 Aranciaga 2020 
P50227 Aranciaga 2020 
P50397 Aranciaga 2020 
P50448 Aranciaga 2020 
P51122 Aranciaga 2020 
P54149 Aranciaga 2020 
P56701 Aranciaga 2020 
P60661 Aranciaga 2020 
P60902 Aranciaga 2020 
P61157 Aranciaga 2020 
P61603 Aranciaga 2020 
P61955 Aranciaga 2020 
P62157 Aranciaga 2020 
P62261 Aranciaga 2020 
P62326 Aranciaga 2020 
P62935 Aranciaga 2020 
P62992 Aranciaga 2020 
P63048 Aranciaga 2020 
P63103 Aranciaga 2020 
P63258 Aranciaga 2020 
P68103 Aranciaga 2020 
P68138 Aranciaga 2020 
P68250 Aranciaga 2020 
P68252 Aranciaga 2020 
P68401 Aranciaga 2020 
P68509 Aranciaga 2020 
P79098 Aranciaga 2020 
P79126 Aranciaga 2020 
P79136 Aranciaga 2020 
P80177 Aranciaga 2020 
P80311 Aranciaga 2020 
P81187 Aranciaga 2020 
P81265 Aranciaga 2020 
P81287 Aranciaga 2020 
P81644 Aranciaga 2020 
P84080 Aranciaga 2020 
Q08DB4 Aranciaga 2020 
Q08DD1 Aranciaga 2020 
Q08DD6 Aranciaga 2020 
Q08DJ3 Aranciaga 2020 
Q08DW2 Aranciaga 2020 
Q08E18 Aranciaga 2020 
Q08E20 Aranciaga 2020 
Q0II59 Aranciaga 2020 
Q0IIA4 Aranciaga 2020 
Q0IIK5 Aranciaga 2020 
Q0P570 Aranciaga 2020 
Q0P5D6 Aranciaga 2020 
Q0P5K3 Aranciaga 2020 
Q0VCC0 Aranciaga 2020 
Q0VCK0 Aranciaga 2020 
Q0VCM5 Aranciaga 2020 
Q0VCN1 Aranciaga 2020 
Q0VCU1 Aranciaga 2020 
Q0VCX2 Aranciaga 2020 
Q0VCY8 Aranciaga 2020 
Q0VD18 Aranciaga 2020 
Q0VD27 Aranciaga 2020 
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Q0VD52 Aranciaga 2020 
Q0VFX8 Aranciaga 2020 
Q148C4 Aranciaga 2020 
Q17QG8 Aranciaga 2020 
Q17QK4 Aranciaga 2020 
Q17QL7 Aranciaga 2020 
Q17QQ2 Aranciaga 2020 
Q17QV0 Aranciaga 2020 
Q17QV3 Aranciaga 2020 
Q17QX0 Aranciaga 2020 
Q17R18 Aranciaga 2020 
Q1JP75 Aranciaga 2020 
Q1JPA2 Aranciaga 2020 
Q1JPB0 Aranciaga 2020 
Q1JPJ2 Aranciaga 2020 
Q1LZA1 Aranciaga 2020 
Q1P9Q3 Aranciaga 2020 
Q1RMN8 Aranciaga 2020 
Q1RMP3 Aranciaga 2020 
Q27965 Aranciaga 2020 
Q27970 Aranciaga 2020 
Q27971 Aranciaga 2020 
Q28908 Aranciaga 2020 
Q29437 Aranciaga 2020 
Q29443 Aranciaga 2020 
Q29460 Aranciaga 2020 
Q29RP1 Aranciaga 2020 
Q29RR5 Aranciaga 2020 
Q29RU4 Aranciaga 2020 
Q2HJ49 Aranciaga 2020 
Q2HJ81 Aranciaga 2020 
Q2HJF0 Aranciaga 2020 
Q2KHU0 Aranciaga 2020 
Q2KI90 Aranciaga 2020 
Q2KIC5 Aranciaga 2020 
Q2KIF2 Aranciaga 2020 
Q2KIL3 Aranciaga 2020 
Q2KIT0 Aranciaga 2020 
Q2KIU3 Aranciaga 2020 
Q2KIV8 Aranciaga 2020 
Q2KIX7 Aranciaga 2020 
Q2KJ23 Aranciaga 2020 
Q2KJ44 Aranciaga 2020 
Q2KJ57 Aranciaga 2020 
Q2KJ75 Aranciaga 2020 
Q2KJ93 Aranciaga 2020 
Q2KJC9 Aranciaga 2020 
Q2KJD0 Aranciaga 2020 
Q2KJE7 Aranciaga 2020 
Q2KJF1 Aranciaga 2020 
Q2KJG3 Aranciaga 2020 
Q2KJH4 Aranciaga 2020 
Q2KJH6 Aranciaga 2020 
Q2KJH9 Aranciaga 2020 
Q2NKY7 Aranciaga 2020 
Q2T9X2 Aranciaga 2020 
Q2TA29 Aranciaga 2020 
Q2TA40 Aranciaga 2020 
Q2TBI4 Aranciaga 2020 
Q2TBR3 Aranciaga 2020 
Q2TBU0 Aranciaga 2020 
Q2TBX6 Aranciaga 2020 
Q2YDE4 Aranciaga 2020 
Q32L92 Aranciaga 2020 
Q32LE5 Aranciaga 2020 
Q32LG3 Aranciaga 2020 
Q32LK1 Aranciaga 2020 
Q32P66 Aranciaga 2020 
Q32PB7 Aranciaga 2020 
Q32PF2 Aranciaga 2020 
Q32PI4 Aranciaga 2020 
Q3B7M5 Aranciaga 2020 
Q3MHF7 Aranciaga 2020 
Q3MHG9 Aranciaga 2020 
Q3MHH4 Aranciaga 2020 
Q3MHL4 Aranciaga 2020 
Q3MHL7 Aranciaga 2020 
Q3MHM5 Aranciaga 2020 
Q3MHN2 Aranciaga 2020 
Q3MHN5 Aranciaga 2020 
Q3MHP6 Aranciaga 2020 
Q3MHY1 Aranciaga 2020 
Q3MHY9 Aranciaga 2020 
Q3SX44 Aranciaga 2020 
Q3SYR8 Aranciaga 2020 
Q3SYT9 Aranciaga 2020 
Q3SYU2 Aranciaga 2020 
Q3SYU9 Aranciaga 2020 
Q3SYV4 Aranciaga 2020 
Q3SZ54 Aranciaga 2020 
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Q3SZ62 Aranciaga 2020 
Q3SZ65 Aranciaga 2020 
Q3SZA5 Aranciaga 2020 
Q3SZB6 Aranciaga 2020 
Q3SZC4 Aranciaga 2020 
Q3SZC6 Aranciaga 2020 
Q3SZH7 Aranciaga 2020 
Q3SZI4 Aranciaga 2020 
Q3SZJ4 Aranciaga 2020 
Q3SZN8 Aranciaga 2020 
Q3SZR3 Aranciaga 2020 
Q3SZV3 Aranciaga 2020 
Q3SZZ0 Aranciaga 2020 
Q3SZZ9 Aranciaga 2020 
Q3T035 Aranciaga 2020 
Q3T054 Aranciaga 2020 
Q3T056 Aranciaga 2020 
Q3T063 Aranciaga 2020 
Q3T0B6 Aranciaga 2020 
Q3T0C7 Aranciaga 2020 
Q3T0D0 Aranciaga 2020 
Q3T0E0 Aranciaga 2020 
Q3T0K2 Aranciaga 2020 
Q3T0M7 Aranciaga 2020 
Q3T0P6 Aranciaga 2020 
Q3T0Q4 Aranciaga 2020 
Q3T0R1 Aranciaga 2020 
Q3T0S5 Aranciaga 2020 
Q3T0S6 Aranciaga 2020 
Q3T0U1 Aranciaga 2020 
Q3T0X5 Aranciaga 2020 
Q3T0X8 Aranciaga 2020 
Q3T0Y1 Aranciaga 2020 
Q3T0Y5 Aranciaga 2020 
Q3T0Z0 Aranciaga 2020 
Q3T0Z7 Aranciaga 2020 
Q3T101 Aranciaga 2020 
Q3T145 Aranciaga 2020 
Q3T147 Aranciaga 2020 
Q3T149 Aranciaga 2020 
Q3T160 Aranciaga 2020 
Q3ZBD7 Aranciaga 2020 
Q3ZBD9 Aranciaga 2020 
Q3ZBG0 Aranciaga 2020 
Q3ZBG1 Aranciaga 2020 
Q3ZBH0 Aranciaga 2020 
Q3ZBH5 Aranciaga 2020 
Q3ZBN0 Aranciaga 2020 
Q3ZBX9 Aranciaga 2020 
Q3ZBY4 Aranciaga 2020 
Q3ZBZ8 Aranciaga 2020 
Q3ZC00 Aranciaga 2020 
Q3ZC42 Aranciaga 2020 
Q3ZC84 Aranciaga 2020 
Q3ZC87 Aranciaga 2020 
Q3ZCA8 Aranciaga 2020 
Q3ZCC8 Aranciaga 2020 
Q3ZCF3 Aranciaga 2020 
Q3ZCG6 Aranciaga 2020 
Q3ZCH0 Aranciaga 2020 
Q3ZCH5 Aranciaga 2020 
Q3ZCI4 Aranciaga 2020 
Q3ZCI9 Aranciaga 2020 
Q3ZCJ2 Aranciaga 2020 
Q3ZCK3 Aranciaga 2020 
Q3ZCK9 Aranciaga 2020 
Q3ZCL8 Aranciaga 2020 
Q4U5R3 Aranciaga 2020 
Q4ZHA6 Aranciaga 2020 
Q56JV4 Aranciaga 2020 
Q56JW4 Aranciaga 2020 
Q56JX6 Aranciaga 2020 
Q56JY8 Aranciaga 2020 
Q56K04 Aranciaga 2020 
Q56K14 Aranciaga 2020 
Q58CQ9 Aranciaga 2020 
Q58CS3 Aranciaga 2020 
Q58D57 Aranciaga 2020 
Q58DA7 Aranciaga 2020 
Q58DK5 Aranciaga 2020 
Q58DU5 Aranciaga 2020 
Q58DW0 Aranciaga 2020 
Q59A32 Aranciaga 2020 
Q5DPW9 Aranciaga 2020 
Q5E946 Aranciaga 2020 
Q5E947 Aranciaga 2020 
Q5E956 Aranciaga 2020 
Q5E983 Aranciaga 2020 
Q5E984 Aranciaga 2020 
Q5E987 Aranciaga 2020 
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Q5E995 Aranciaga 2020 
Q5E9A1 Aranciaga 2020 
Q5E9A3 Aranciaga 2020 
Q5E9B1 Aranciaga 2020 
Q5E9B7 Aranciaga 2020 
Q5E9D5 Aranciaga 2020 
Q5E9E2 Aranciaga 2020 
Q5E9F5 Aranciaga 2020 
Q5E9F7 Aranciaga 2020 
Q5E9I6 Aranciaga 2020 
Q5EA61 Aranciaga 2020 
Q5EA67 Aranciaga 2020 
Q5EAD2 Aranciaga 2020 
Q5GN72 Aranciaga 2020 
Q5H9M6 Aranciaga 2020 
Q5KR47 Aranciaga 2020 
Q687I9 Aranciaga 2020 
Q6B855 Aranciaga 2020 
Q6B856 Aranciaga 2020 
Q6EWQ7 Aranciaga 2020 
Q76LV1 Aranciaga 2020 
Q7SIH1 Aranciaga 2020 
Q861U5 Aranciaga 2020 
Q862F3 Aranciaga 2020 
Q862L1 Aranciaga 2020 
Q862L2 Aranciaga 2020 
Q862L8 Aranciaga 2020 
Q862N7 Aranciaga 2020 
Q862Q3 Aranciaga 2020 
Q862S8 Aranciaga 2020 
Q863C3 Aranciaga 2020 
Q865V6 Aranciaga 2020 
Q8MII0 Aranciaga 2020 
Q8SPP7 Aranciaga 2020 
Q95121 Aranciaga 2020 
Q95140 Aranciaga 2020 
Q95L54 Aranciaga 2020 
Q95M18 Aranciaga 2020 
Q95ND9 Aranciaga 2020 
Q9BGI1 Aranciaga 2020 
Q9BGI3 Aranciaga 2020 
Q9BGU1 Aranciaga 2020 
Q9TRY0 Aranciaga 2020 
Q9TTK4 Aranciaga 2020 
Q9TTK8 Aranciaga 2020 
Q9TU03 Aranciaga 2020 
Q9XSA7 Aranciaga 2020 
Q9XSK7 Aranciaga 2020 
Q9XSX1 Aranciaga 2020 
U3Q4C5 Aranciaga 2020 
V6F7P3 Aranciaga 2020 
V6F7X3 Aranciaga 2020 
V6F869 Aranciaga 2020 
V6F9A2 Aranciaga 2020 
V6F9A3 Aranciaga 2020 
V6F9B4 Aranciaga 2020 
A0A140T897 Aranciaga 2020 
F1MB08 Aranciaga 2020 
Q76LV2 Aranciaga 2020 
A6QR28 Aranciaga 2020 
P02672 Aranciaga 2020 
A5PJE3 Aranciaga 2020 
F1MD73 Aranciaga 2020 
F1MJH1 Aranciaga 2020 
A5PJ79 Aranciaga 2020 
Q5E962 Aranciaga 2020 
G5E513 Aranciaga 2020 
A5D984 Aranciaga 2020 
E1B9K8 Aranciaga 2020 
A8QQK1 Aranciaga 2020 
F1N7T6 Aranciaga 2020 
Q2TBL6 Aranciaga 2020 
G3N3L5 Aranciaga 2020 
Q3SZV7 Aranciaga 2020 
A3KMV5 Aranciaga 2020 
A6H7J6 Aranciaga 2020 
F1MN84 Aranciaga 2020 
Q32S38 Aranciaga 2020 
G3N0I4 Aranciaga 2020 
A6QR15 Aranciaga 2020 
F1MHF7 Aranciaga 2020 
L7R5X3 Aranciaga 2020 
A5D989 Aranciaga 2020 
A0A0A0MP99 Aranciaga 2020 
Q0VCM4 Aranciaga 2020 
G5E619 Aranciaga 2020 
B0JYN2 Aranciaga 2020 
E1BCU6 Aranciaga 2020 
Q5E9K0 Aranciaga 2020 
A6QR19 Aranciaga 2020 
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A7E3S8 Aranciaga 2020 
E1BH17 Aranciaga 2020 
Q9N0V4 Aranciaga 2020 
E1BEL8 Aranciaga 2020 
F1MHV5 Aranciaga 2020 
A6QPM9 Aranciaga 2020 
Q95107 Aranciaga 2020 
B0JYR3 Aranciaga 2020 
F1N4E4 Aranciaga 2020 
Q6R8F2 Aranciaga 2020 
A6QLC4 Aranciaga 2020 
P00829 Aranciaga 2020 
G5E631 Aranciaga 2020 
F1MCF1 Aranciaga 2020 
Q28910 Aranciaga 2020 
G3MZV0 Aranciaga 2020 
Q3ZBV8 Aranciaga 2020 
Q148F1 Aranciaga 2020 
F1MX83 Aranciaga 2020 
Q862H7 Aranciaga 2020 
Q56J78 Aranciaga 2020 
F1MMW8 Aranciaga 2020 
F1N4R4 Aranciaga 2020 
P04973 Aranciaga 2020 
F1MV90 Aranciaga 2020 
Q2HJ86 Aranciaga 2020 
G5E604 Aranciaga 2020 
Q5E9G3 Aranciaga 2020 
F1MSZ6 Aranciaga 2020 
P41361 Aranciaga 2020 
E1BKM4 Aranciaga 2020 
F1MGH3 Aranciaga 2020 
Q29RK4 Aranciaga 2020 
Q3SZK8 Aranciaga 2020 
Q0VCX4 Aranciaga 2020 
P52556 Aranciaga 2020 
Q3T0W4 Aranciaga 2020 
A7E350 Aranciaga 2020 
Q0VC36 Aranciaga 2020 
Q2T9S0 Aranciaga 2020 
Q32PA4 Aranciaga 2020 
Q2YDE9 Aranciaga 2020 
G3N2F0 Aranciaga 2020 
E1BLA8 Aranciaga 2020 
O18879 Aranciaga 2020 
F1MI18 Aranciaga 2020 
F1MGU7 Aranciaga 2020 
Q76I81 Aranciaga 2020 
Q3T0Q6 Aranciaga 2020 
Q2HJH2 Aranciaga 2020 
A5D7A2 Aranciaga 2020 
P63243 Aranciaga 2020 
G3N3D0 Aranciaga 2020 
E1BDE6 Aranciaga 2020 
G3MX23 Aranciaga 2020 
F1MGU5 Aranciaga 2020 
F1MSB7 Aranciaga 2020 
G1K1Z4 Aranciaga 2020 
Q28034 Aranciaga 2020 
Q2HJ57 Aranciaga 2020 
Q3T169 Aranciaga 2020 
P83939 Aranciaga 2020 
Q2UVX4 Aranciaga 2020 
P33097 Aranciaga 2020 
E1B953 Aranciaga 2020 
P48644 Aranciaga 2020 
Q2KIT8 Aranciaga 2020 
Q2HJH0 Aranciaga 2020 
P48616 Aranciaga 2020 
Q29S11 Aranciaga 2020 
Q95M59 Aranciaga 2020 
Q0VCS3 Aranciaga 2020 
F1N1A3 Aranciaga 2020 
F1N284 Aranciaga 2020 
Q2KHW3 Aranciaga 2020 
Q5E9T6 Aranciaga 2020 
Q32PI5 Aranciaga 2020 
A5D973 Aranciaga 2020 
F1MX51 Aranciaga 2020 
G3MZH0 Aranciaga 2020 
G3MXD9 Aranciaga 2020 
F1MMD7 Aranciaga 2020 
Q3T052 Aranciaga 2020 
A6QPH7 Aranciaga 2020 
Q2KI84 Aranciaga 2020 
A5PK49 Aranciaga 2020 
O18789 Aranciaga 2020 
F1MHP6 Aranciaga 2020 
A3KN12 Aranciaga 2020 
F1MHR6 Aranciaga 2020 
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P13135 Aranciaga 2020 
G3MYJ0 Aranciaga 2020 
G3X7M4 Aranciaga 2020 
G3MXT4 Aranciaga 2020 
Q28085 Aranciaga 2020 
G3N2V5 Aranciaga 2020 
B0JYN9 Aranciaga 2020 
Q9TU25 Aranciaga 2020 
A5PK69 Aranciaga 2020 
P62998 Aranciaga 2020 
A7MBG9 Aranciaga 2020 
Q1JPH6 Aranciaga 2020 
G3MXW7 Aranciaga 2020 
Q32L81 Aranciaga 2020 
F1MFT4 Aranciaga 2020 
A2VDN7 Aranciaga 2020 
F1MNG1 Aranciaga 2020 
E1BEL7 Aranciaga 2020 
P55206 Aranciaga 2020 
Q3MHN0 Aranciaga 2020 
F1MMI1 Aranciaga 2020 
E1BAP8 Aranciaga 2020 
Q9TS96 Aranciaga 2020 
P61585 Aranciaga 2020 
Q2NKU6 Aranciaga 2020 
Q9N1C3 Aranciaga 2020 
Q3SZ52 Aranciaga 2020 
Q862Q9 Aranciaga 2020 
Q3SZ43 Aranciaga 2020 
K4JDS8 Aranciaga 2020 
Q29RV1 Aranciaga 2020 
F1MEN8 Aranciaga 2020 
E1BNW1 Aranciaga 2020 
A1L558 Aranciaga 2020 
F1ME49 Aranciaga 2020 
E1BN82 Aranciaga 2020 
M5FMW2 Aranciaga 2020 
E1BE15 Aranciaga 2020 
G3MXR2 Aranciaga 2020 
F1MQ84 Aranciaga 2020 
A6QNS7 Aranciaga 2020 
A0A140T861 Aranciaga 2020 
Q28009 Aranciaga 2020 
H7BWW2 Aranciaga 2020 
E1BMS2 Aranciaga 2020 
F1MQ57 Aranciaga 2020 
F1MZ95 Aranciaga 2020 
G3N1K4 Aranciaga 2020 
G3N029 Aranciaga 2020 
A5D987 Aranciaga 2020 
Q8WMY2 Aranciaga 2020 
Q0VCD7 Aranciaga 2020 
Q2NL07 Aranciaga 2020 
F1N431 Aranciaga 2020 
F1MI46 Aranciaga 2020 
P31098 Aranciaga 2020 
P31096 Aranciaga 2020 
A0A0M3T9B6 Aranciaga 2020 
E1BP91 Aranciaga 2020 
P38573 Aranciaga 2020 
Q3SZC2 Aranciaga 2020 
Q2NKZ1 Aranciaga 2020 
F1MNQ4 Aranciaga 2020 
Q6PVY3 Aranciaga 2020 
Q0III3 Aranciaga 2020 
E1BB08 Aranciaga 2020 
Q45VK8 Aranciaga 2020 
F1N5U0 Aranciaga 2020 
F6RCB9 Aranciaga 2020 
M1NM98 Aranciaga 2020 
Q95M58 Aranciaga 2020 
G3MXR5 Aranciaga 2020 
E1BJL8 Aranciaga 2020 
G3MWY4 Aranciaga 2020 
F1N0N6 Aranciaga 2020 
Q2TA22 Aranciaga 2020 
Q07130 Aranciaga 2020 
F1MJX4 Aranciaga 2020 
G3N188 Aranciaga 2020 
G3MY71 Aranciaga 2020 
Q2KJ32 Aranciaga 2020 
Q0VCP0 Aranciaga 2020 
A4FUZ1 Aranciaga 2020 
F1MW96 Aranciaga 2020 
A7E322 Aranciaga 2020 
F1N1A4 Aranciaga 2020 
Q32LE4 Aranciaga 2020 
G3N2Z0 Aranciaga 2020 
G1K208 Aranciaga 2020 
A4IFC3 Aranciaga 2020 
  
 244 
Q29S21 Aranciaga 2020 
E1B7J1 Aranciaga 2020 
G3N309 Aranciaga 2020 
E1B9R5 Aranciaga 2020 
F1MQN0 Aranciaga 2020 
K4JDR8 Aranciaga 2020 
F1MFD0 Aranciaga 2020 
Q2T9P4 Aranciaga 2020 
A5D969 Aranciaga 2020 
Q08E32 Aranciaga 2020 
H9GW31 Aranciaga 2020 
Q3SZ96 Aranciaga 2020 
F1MG94 Aranciaga 2020 
Q17QI3 Aranciaga 2020 
Q1JPB6 Aranciaga 2020 
Q3MHL8 Aranciaga 2020 
E1BEE0 Aranciaga 2020 
E1B8K5 Aranciaga 2020 
A5PJ69 Aranciaga 2020 
F1N4T4 Aranciaga 2020 
A4ZZF8 Aranciaga 2020 
Q3B7N2 Aranciaga 2020 
F1MVW5 Aranciaga 2020 
A2VDL8 Aranciaga 2020 
G3N1R1 Aranciaga 2020 
F1N679 Aranciaga 2020 
Q0VC64 Aranciaga 2020 
E1BP20 Aranciaga 2020 
F1MIY8 Aranciaga 2020 
E1B944 Aranciaga 2020 
Q3ZCF0 Aranciaga 2020 
F1MGY6 Aranciaga 2020 
A6QLB7 Aranciaga 2020 
E1BJZ1 Aranciaga 2020 
Q0VCA5 Aranciaga 2020 
F1N441 Aranciaga 2020 
Q3ZC41 Aranciaga 2020 
M5FMV8 Aranciaga 2020 
F1MSP9 Aranciaga 2020 
F1MG70 Aranciaga 2020 
Q3T030 Aranciaga 2020 
O46738 Aranciaga 2020 
C7FE01 Aranciaga 2020 
B9VPZ5 Aranciaga 2020 
P24627 Aranciaga 2020 
Q862H8 Aranciaga 2020 
F1MZL6 Aranciaga 2020 
F1MXJ5 Aranciaga 2020 
Q3ZBV1 Aranciaga 2020 
F1MNF8 Aranciaga 2020 
Q3SZF2 Aranciaga 2020 
B1P383 Aranciaga 2020 
Q24K09 Aranciaga 2020 
A0A0A0MP92 Aranciaga 2020 
Q3SZQ8 Aranciaga 2020 
Q3MHG3 Aranciaga 2020 
F6S1Q0 Aranciaga 2020 
P20288 Aranciaga 2020 
Q58DM8 Aranciaga 2020 
Q95KZ6 Aranciaga 2020 
P67808 Aranciaga 2020 
G3N2D7 Aranciaga 2020 
F1N2D3 Aranciaga 2020 
P33433 Aranciaga 2020 
Q32PH8 Aranciaga 2020 
E1BKW7 Aranciaga 2020 
G3MXE8 Aranciaga 2020 
A7YWR0 Aranciaga 2020 
A5PKI0 Aranciaga 2020 
E1BKK0 Aranciaga 2020 
F1MKG1 Aranciaga 2020 
F1MKA1 Aranciaga 2020 
Q0IIF8 Aranciaga 2020 
E1BP42 Aranciaga 2020 
F2Z4E9 Aranciaga 2020 
Q0P5D2 Aranciaga 2020 
G3N2L2 Aranciaga 2020 
A4IF88 Aranciaga 2020 
G3X8B1 Aranciaga 2020 
Q3SZG8 Aranciaga 2020 
G5E648 Aranciaga 2020 
Q5E951 Aranciaga 2020 
F1MCF8 Aranciaga 2020 
Q05FF2 Aranciaga 2020 
B0JYL6 Aranciaga 2020 
G3MZJ9 Aranciaga 2020 
O46626 Aranciaga 2020 
Q8SQ28 Aranciaga 2020 
F1MHZ0 Aranciaga 2020 
Q9MZT5 Aranciaga 2020 
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B8Y7I4 Aranciaga 2020 
A7MBJ5 Aranciaga 2020 
G3MXB5 Aranciaga 2020 
P55859 Aranciaga 2020 
F1MAZ3 Aranciaga 2020 
F1N0J2 Aranciaga 2020 
G3N2G7 Aranciaga 2020 
F1MAZ1 Aranciaga 2020 
P36225 Aranciaga 2020 
G3N126 Aranciaga 2020 
E1BFG0 Aranciaga 2020 
A0A0A0MP89 Aranciaga 2020 
A6QPQ2 Aranciaga 2020 
H7BWW0 Aranciaga 2020 
Q0IIM3 Aranciaga 2020 
Q32LP2 Aranciaga 2020 
F1MJJ8 Aranciaga 2020 
Q9XSG3 Aranciaga 2020 
Q3ZCJ7 Aranciaga 2020 
F1MKZ5 Aranciaga 2020 
Q2HJB8 Aranciaga 2020 
Q5EAC6 Aranciaga 2020 
G3MYE2 Aranciaga 2020 
Q58DW5 Aranciaga 2020 
Q08E58 Aranciaga 2020 
P81282 Aranciaga 2020 
F1MZ85 Aranciaga 2020 
F1MZ83 Aranciaga 2020 
F1MLV3 Aranciaga 2020 
Q0II43 Aranciaga 2020 
Q27991 Aranciaga 2020 
Q3SZK4 Aranciaga 2020 
E1BAI4 Aranciaga 2020 
Q3T108 Aranciaga 2020 
A0JN92 Aranciaga 2020 
Q58DR7 Aranciaga 2020 
Q2VYC3 Aranciaga 2020 
F1MJV6 Aranciaga 2020 
Q27984 Aranciaga 2020 
E1BN16 Aranciaga 2020 
Q3ZBU7 Aranciaga 2020 
P25326 Aranciaga 2020 
E1BBM1 Aranciaga 2020 
A7MBI6 Aranciaga 2020 
E1B8W0 Aranciaga 2020 
F6QDN3 Aranciaga 2020 
A6QP95 Aranciaga 2020 
O02739 Aranciaga 2020 
F1N2A2 Aranciaga 2020 
Q862F5 Aranciaga 2020 
Q862K7 Aranciaga 2020 
P61285 Aranciaga 2020 
F1ME41 Aranciaga 2020 
F1MHG0 Aranciaga 2020 
Q148J6 Aranciaga 2020 
Q3MHR7 Aranciaga 2020 
Q32PA1 Aranciaga 2020 
P81948 Aranciaga 2020 
F1MUX6 Aranciaga 2020 
F1MR22 Aranciaga 2020 
Q3MHP1 Aranciaga 2020 
Q3ZBF7 Aranciaga 2020 
A0A0A0MP93 Aranciaga 2020 
A0A0A0MPA2 Aranciaga 2020 
G8JL00 Aranciaga 2020 
Q9XSC6 Aranciaga 2020 
A1A4J1 Aranciaga 2020 
F1MNW4 Aranciaga 2020 
A1AG Beltman 2014 
ACBP Beltman 2014 
ALBU Beltman 2014 
ALDR Beltman 2014 
AMPN Beltman 2014 
APOA1 Beltman 2014 
B2MG Beltman 2014 
CYC Beltman 2014 
DPYL2 Beltman 2014 
ENOA Beltman 2014 
GDIR1 Beltman 2014 
HBA Beltman 2014 
HBB Beltman 2014 
HS90A Beltman 2014 
HS90B Beltman 2014 
HSP7C Beltman 2014 
HSPB1 Beltman 2014 
IDHC Beltman 2014 
KCRB Beltman 2014 
LDHB Beltman 2014 
NDKB Beltman 2014 
PA1B3 Beltman 2014 
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PNPH Beltman 2014 
PPIA Beltman 2014 
PRDX1 Beltman 2014 
PRDX2 Beltman 2014 
S10A4 Beltman 2014 
SERA Beltman 2014 
TBA1B Beltman 2014 
TBA1C Beltman 2014 
TBA1D Beltman 2014 
TBB4A Beltman 2014 
TBB4B Beltman 2014 
TBB5 Beltman 2014 
TERA Beltman 2014 
TKT Beltman 2014 
TPIS Beltman 2014 
TPM3 Beltman 2014 
TRFE Beltman 2014 
ZA2G Beltman 2014 
1433E Faulkner 2012 
A0A0A0MP89 Faulkner 2012 
A0A0A0MP92 Faulkner 2012 
A0A0F6QNP7 Faulkner 2012 
A0A0F7RPX0 Faulkner 2012 
A0A140T843 Faulkner 2012 
A0A140T879 Faulkner 2012 
A0A140T897 Faulkner 2012 
A0A140T8A5 Faulkner 2012 
A0A140T8D4 Faulkner 2012 
A1A4L7 Faulkner 2012 
A1AG Faulkner 2012 
A1AT Faulkner 2012 
A1BG Faulkner 2012 
A1EA81 Faulkner 2012 
A1L514 Faulkner 2012 
A1L5B6 Faulkner 2012 
A2MG Faulkner 2012 
A3KLR9 Faulkner 2012 
A4IFI0 Faulkner 2012 
A4IFQ7 Faulkner 2012 
A4ZVC5 Faulkner 2012 
A5PJE3 Faulkner 2012 
A6H7J6 Faulkner 2012 
A6QLB7 Faulkner 2012 
A6QLL8 Faulkner 2012 
A6QPX7 Faulkner 2012 
A8KC76 Faulkner 2012 
ACBP Faulkner 2012 
ACTB Faulkner 2012 
ACTC Faulkner 2012 
ALBU Faulkner 2012 
ALDR Faulkner 2012 
AMPN Faulkner 2012 
ANXA1 Faulkner 2012 
ANXA2 Faulkner 2012 
ANXA3 Faulkner 2012 
ANXA4 Faulkner 2012 
ANXA5 Faulkner 2012 
AOCX Faulkner 2012 
APOA1 Faulkner 2012 
APOA2 Faulkner 2012 
APOH Faulkner 2012 
ARSA Faulkner 2012 
B0JYL8 Faulkner 2012 
B0JYN6 Faulkner 2012 
B0JYQ0 Faulkner 2012 
B1B3F7 Faulkner 2012 
B1B3F8 Faulkner 2012 
B1B3F9 Faulkner 2012 
B1B3G0 Faulkner 2012 
B2MG Faulkner 2012 
B3RFM8 Faulkner 2012 
B9VPZ5 Faulkner 2012 
C6KEF7 Faulkner 2012 
CAP1 Faulkner 2012 
CATD Faulkner 2012 
CFAB Faulkner 2012 
CLUS Faulkner 2012 
CMGA Faulkner 2012 
CNDP2 Faulkner 2012 
CO3 Faulkner 2012 
CO4 Faulkner 2012 
COF1 Faulkner 2012 
D4QBB3 Faulkner 2012 
D4QBB4 Faulkner 2012 
E1BI28 Faulkner 2012 
E1BJL8 Faulkner 2012 
ENOA Faulkner 2012 
EZRI Faulkner 2012 
F16P1 Faulkner 2012 
F1MAV0 Faulkner 2012 
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F1MB08 Faulkner 2012 
F1MCF8 Faulkner 2012 
F1MD73 Faulkner 2012 
F1MGU7 Faulkner 2012 
F1MIH9 Faulkner 2012 
F1MLW7 Faulkner 2012 
F1MMD7 Faulkner 2012 
F1MMK2 Faulkner 2012 
F1MMR6 Faulkner 2012 
F1MN84 Faulkner 2012 
F1MRD0 Faulkner 2012 
F1MWQ2 Faulkner 2012 
F1MX83 Faulkner 2012 
F1MXZ0 Faulkner 2012 
F1N076 Faulkner 2012 
F1N2I5 Faulkner 2012 
F1N3J3 Faulkner 2012 
F1N430 Faulkner 2012 
F1N4M7 Faulkner 2012 
F1N5M2 Faulkner 2012 
F1N650 Faulkner 2012 
F6QVC9 Faulkner 2012 
FETUA Faulkner 2012 
FIBA Faulkner 2012 
FIBB Faulkner 2012 
FIBG Faulkner 2012 
FUCO Faulkner 2012 
G1K122 Faulkner 2012 
G3MX65 Faulkner 2012 
G3N2D7 Faulkner 2012 
G3N2H5 Faulkner 2012 
G3X6N3 Faulkner 2012 
G3X7A5 Faulkner 2012 
G8JKZ8 Faulkner 2012 
G9BHW9 Faulkner 2012 
GDF8 Faulkner 2012 
GDIB Faulkner 2012 
GNS Faulkner 2012 
GRP Faulkner 2012 
GSTM1 Faulkner 2012 
GSTP1 Faulkner 2012 
H6S1N4 Faulkner 2012 
HBB Faulkner 2012 
HEMO Faulkner 2012 
HP20 Faulkner 2012 
HP252 Faulkner 2012 
HS90A Faulkner 2012 
HSP7C Faulkner 2012 
IDHC Faulkner 2012 
ITIH4 Faulkner 2012 
K4JB97 Faulkner 2012 
K4JBA2 Faulkner 2012 
K4JBA5 Faulkner 2012 
K4JBB0 Faulkner 2012 
K4JBR5 Faulkner 2012 
K4JBR9 Faulkner 2012 
K4JBS4 Faulkner 2012 
K4JBS8 Faulkner 2012 
K4JBT0 Faulkner 2012 
K4JDR8 Faulkner 2012 
K4JDS3 Faulkner 2012 
K4JDS8 Faulkner 2012 
K4JDT2 Faulkner 2012 
K4JF02 Faulkner 2012 
K4JF05 Faulkner 2012 
K4JF08 Faulkner 2012 
K4JF13 Faulkner 2012 
K4JF16 Faulkner 2012 
K4JR71 Faulkner 2012 
K4JR76 Faulkner 2012 
K4JR81 Faulkner 2012 
K4JR84 Faulkner 2012 
K4JR88 Faulkner 2012 
LGMN Faulkner 2012 
MDHC Faulkner 2012 
MIF Faulkner 2012 
NUCB1 Faulkner 2012 
PARK7 Faulkner 2012 
PDIA1 Faulkner 2012 
PEBP1 Faulkner 2012 
PEDF Faulkner 2012 
PGAM1 Faulkner 2012 
PLBL2 Faulkner 2012 
PPBT Faulkner 2012 
PPIA Faulkner 2012 
PPIB Faulkner 2012 
PRDX1 Faulkner 2012 
PRDX2 Faulkner 2012 
PRDX6 Faulkner 2012 
PROF1 Faulkner 2012 
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Q0QEQ4 Faulkner 2012 
Q0VBX6 Faulkner 2012 
Q32L14 Faulkner 2012 
Q32P72 Faulkner 2012 
Q32PI4 Faulkner 2012 
Q3SZQ8 Faulkner 2012 
Q3SZZ9 Faulkner 2012 
Q3T010 Faulkner 2012 
Q3T0Z0 Faulkner 2012 
Q3T141 Faulkner 2012 
Q3ZBS7 Faulkner 2012 
Q3ZC20 Faulkner 2012 
Q5E962 Faulkner 2012 
Q5EA67 Faulkner 2012 
Q6VUQ8 Faulkner 2012 
Q862H7 Faulkner 2012 
Q864S5 Faulkner 2012 
Q9BGI4 Faulkner 2012 
R9QSM8 Faulkner 2012 
RET4 Faulkner 2012 
S100G Faulkner 2012 
S10AC Faulkner 2012 
SPA31 Faulkner 2012 
SPA37 Faulkner 2012 
SPA38 Faulkner 2012 
THIO Faulkner 2012 
TIMP2 Faulkner 2012 
TPIS Faulkner 2012 
TPM3 Faulkner 2012 
TRFE Faulkner 2012 
TRFL Faulkner 2012 
UBA1 Faulkner 2012 
V6F9A2 Faulkner 2012 
VTDB Faulkner 2012 
ZA2G Faulkner 2012 
A0A0F6QNP7 Faulkner 2013 
A0A140T897 Faulkner 2013 
A0A140T8A5 Faulkner 2013 
A1EA81 Faulkner 2013 
A2MG Faulkner 2013 
A4IFI0 Faulkner 2013 
A4ZVC5 Faulkner 2013 
A5PJE3 Faulkner 2013 
A6H7J6 Faulkner 2013 
A6QPX7 Faulkner 2013 
ACTB Faulkner 2013 
ALBU Faulkner 2013 
AMPN Faulkner 2013 
ANXA1 Faulkner 2013 
ANXA4 Faulkner 2013 
ANXA5 Faulkner 2013 
APOH Faulkner 2013 
B0JYL8 Faulkner 2013 
B1B3F8 Faulkner 2013 
B1B3F9 Faulkner 2013 
B1B3G0 Faulkner 2013 
B2MG Faulkner 2013 
C6KEF7 Faulkner 2013 
CAP1 Faulkner 2013 
CATD Faulkner 2013 
CMGA Faulkner 2013 
CO3 Faulkner 2013 
D4QBB4 Faulkner 2013 
F16P1 Faulkner 2013 
F1MAV0 Faulkner 2013 
F1MB08 Faulkner 2013 
F1MCF8 Faulkner 2013 
F1MGU7 Faulkner 2013 
F1MMD7 Faulkner 2013 
F1MX83 Faulkner 2013 
F1MXZ0 Faulkner 2013 
F1N2I5 Faulkner 2013 
F1N4M7 Faulkner 2013 
F6QVC9 Faulkner 2013 
FETUA Faulkner 2013 
FIBA Faulkner 2013 
G1K122 Faulkner 2013 
G3MX65 Faulkner 2013 
G3N2D7 Faulkner 2013 
G8JKZ8 Faulkner 2013 
H6S1N4 Faulkner 2013 
HBB Faulkner 2013 
HSP7C Faulkner 2013 
IDHC Faulkner 2013 
K4JB97 Faulkner 2013 
K4JBA2 Faulkner 2013 
K4JBA5 Faulkner 2013 
K4JBB0 Faulkner 2013 
K4JBR5 Faulkner 2013 
K4JBS4 Faulkner 2013 
  
 249 
K4JBS8 Faulkner 2013 
K4JBT0 Faulkner 2013 
K4JDR8 Faulkner 2013 
K4JDS3 Faulkner 2013 
K4JDS8 Faulkner 2013 
K4JDT2 Faulkner 2013 
K4JF02 Faulkner 2013 
K4JF05 Faulkner 2013 
K4JF08 Faulkner 2013 
K4JF13 Faulkner 2013 
K4JF16 Faulkner 2013 
K4JR71 Faulkner 2013 
K4JR76 Faulkner 2013 
K4JR81 Faulkner 2013 
K4JR84 Faulkner 2013 
K4JR88 Faulkner 2013 
LGMN Faulkner 2013 
MIF Faulkner 2013 
PDIA1 Faulkner 2013 
PLBL2 Faulkner 2013 
PPIA Faulkner 2013 
Q0VBX6 Faulkner 2013 
Q3SZZ9 Faulkner 2013 
Q3ZC20 Faulkner 2013 
Q5EA67 Faulkner 2013 
Q9BGI4 Faulkner 2013 
R9QSM8 Faulkner 2013 
RET4 Faulkner 2013 
S10AC Faulkner 2013 
TIMP2 Faulkner 2013 
TRFE Faulkner 2013 
TRFL Faulkner 2013 
V6F9A2 Faulkner 2013 
VTDB Faulkner 2013 
A0A0F7RQ40 Forde 2014 
A0A0N4STN3 Forde 2014 
A0A140T831 Forde 2014 
A0A140T853 Forde 2014 
A0A140T865 Forde 2014 
A0A140T867 Forde 2014 
A0A140T882 Forde 2014 
A0A140T897 Forde 2014 
A0A140T8A3 Forde 2014 
A0A140T8A5 Forde 2014 
A0JN36 Forde 2014 
A0JN59 Forde 2014 
A0JN92 Forde 2014 
A0JND2 Forde 2014 
A0JNJ0 Forde 2014 
A0JNL5 Forde 2014 
A1A4L7 Forde 2014 
A1L502 Forde 2014 
A1L555 Forde 2014 
A1L568 Forde 2014 
A1L595 Forde 2014 
A1L5C0 Forde 2014 
A2I7M9 Forde 2014 
A2I7N1 Forde 2014 
A2I7N2 Forde 2014 
A2T1U6 Forde 2014 
A2VDQ0 Forde 2014 
A2VDW1 Forde 2014 
A2VDX0 Forde 2014 
A2VE52 Forde 2014 
A2VE56 Forde 2014 
A3KFF6 Forde 2014 
A3KLR9 Forde 2014 
A3KMV5 Forde 2014 
A3KMV6 Forde 2014 
A3KMX7 Forde 2014 
A3KMY1 Forde 2014 
A3KMY4 Forde 2014 
A3KMY8 Forde 2014 
A4D7S0 Forde 2014 
A4D7S3 Forde 2014 
A4FUA8 Forde 2014 
A4FUD7 Forde 2014 
A4FUG8 Forde 2014 
A4FUW9 Forde 2014 
A4FUY5 Forde 2014 
A4FUZ0 Forde 2014 
A4FV03 Forde 2014 
A4FV18 Forde 2014 
A4FV72 Forde 2014 
A4FV94 Forde 2014 
A4IF68 Forde 2014 
A4IF70 Forde 2014 
A4IF82 Forde 2014 
A4IF91 Forde 2014 
A4IFE0 Forde 2014 
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A4IFP2 Forde 2014 
A4IFQ7 Forde 2014 
A4IFV6 Forde 2014 
A4ZZF8 Forde 2014 
A5ACB9 Forde 2014 
A5D7A5 Forde 2014 
A5D7C6 Forde 2014 
A5D7D1 Forde 2014 
A5D7D5 Forde 2014 
A5D7F2 Forde 2014 
A5D7L9 Forde 2014 
A5D7N5 Forde 2014 
A5D7P0 Forde 2014 
A5D7U3 Forde 2014 
A5D9D1 Forde 2014 
A5H027 Forde 2014 
A5LIP3 Forde 2014 
A5PJ79 Forde 2014 
A5PJF6 Forde 2014 
A5PJJ7 Forde 2014 
A5PJU2 Forde 2014 
A5PK21 Forde 2014 
A5PK49 Forde 2014 
A5PK65 Forde 2014 
A5PK74 Forde 2014 
A5PK77 Forde 2014 
A5PK80 Forde 2014 
A5PK87 Forde 2014 
A5PKE1 Forde 2014 
A5PKE3 Forde 2014 
A5PKG8 Forde 2014 
A5PKI3 Forde 2014 
A5PKM0 Forde 2014 
A6BMK7 Forde 2014 
A6H701 Forde 2014 
A6H742 Forde 2014 
A6H754 Forde 2014 
A6H7D3 Forde 2014 
A6H7H0 Forde 2014 
A6QL48 Forde 2014 
A6QLA0 Forde 2014 
A6QLB7 Forde 2014 
A6QLC4 Forde 2014 
A6QLF1 Forde 2014 
A6QLJ7 Forde 2014 
A6QLJ8 Forde 2014 
A6QLL8 Forde 2014 
A6QLN2 Forde 2014 
A6QLP2 Forde 2014 
A6QLS8 Forde 2014 
A6QLV0 Forde 2014 
A6QLY7 Forde 2014 
A6QLZ0 Forde 2014 
A6QLZ9 Forde 2014 
A6QM00 Forde 2014 
A6QM09 Forde 2014 
A6QNP8 Forde 2014 
A6QNU9 Forde 2014 
A6QNX2 Forde 2014 
A6QP06 Forde 2014 
A6QP32 Forde 2014 
A6QP58 Forde 2014 
A6QP90 Forde 2014 
A6QP92 Forde 2014 
A6QP94 Forde 2014 
A6QP98 Forde 2014 
A6QPD1 Forde 2014 
A6QPE1 Forde 2014 
A6QPF3 Forde 2014 
A6QPM3 Forde 2014 
A6QPN6 Forde 2014 
A6QPP2 Forde 2014 
A6QPY4 Forde 2014 
A6QPZ0 Forde 2014 
A6QQ07 Forde 2014 
A6QQ11 Forde 2014 
A6QQ67 Forde 2014 
A6QQI6 Forde 2014 
A6QQN6 Forde 2014 
A6QQP7 Forde 2014 
A6QQS6 Forde 2014 
A6QQS9 Forde 2014 
A6QQU9 Forde 2014 
A6QQX5 Forde 2014 
A6QQZ4 Forde 2014 
A6QR19 Forde 2014 
A6QR20 Forde 2014 
A6QR28 Forde 2014 
A6QR64 Forde 2014 
A7E2Y6 Forde 2014 
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A7E302 Forde 2014 
A7E305 Forde 2014 
A7E322 Forde 2014 
A7E326 Forde 2014 
A7E3S4 Forde 2014 
A7E3S8 Forde 2014 
A7E3W2 Forde 2014 
A7E3W4 Forde 2014 
A7LN90 Forde 2014 
A7MB01 Forde 2014 
A7MB14 Forde 2014 
A7MB29 Forde 2014 
A7MB31 Forde 2014 
A7MB40 Forde 2014 
A7MB59 Forde 2014 
A7MBA2 Forde 2014 
A7MBA6 Forde 2014 
A7MBB6 Forde 2014 
A7MBI5 Forde 2014 
A7MBI6 Forde 2014 
A7MBJ4 Forde 2014 
A7MBK4 Forde 2014 
A7YVI6 Forde 2014 
A7YVI7 Forde 2014 
A7YW33 Forde 2014 
A7YWC9 Forde 2014 
A7YWF3 Forde 2014 
A7YWH4 Forde 2014 
A7YWK3 Forde 2014 
A7YY28 Forde 2014 
A7YY55 Forde 2014 
A7YY60 Forde 2014 
A7Z028 Forde 2014 
A7Z031 Forde 2014 
A7Z042 Forde 2014 
A7Z089 Forde 2014 
A8E4L8 Forde 2014 
A8KC67 Forde 2014 
A8NGN2 Forde 2014 
A8WFL7 Forde 2014 
A8YXY5 Forde 2014 
A8YXZ5 Forde 2014 
A9CR99 Forde 2014 
B0JYN6 Forde 2014 
B0JYQ3 Forde 2014 
B6DXC7 Forde 2014 
C9EF40 Forde 2014 
C9EF41 Forde 2014 
D4QBB3 Forde 2014 
D4QBB4 Forde 2014 
D5HSX1 Forde 2014 
D6C4G0 Forde 2014 
D6C4G1 Forde 2014 
D9ZDE4 Forde 2014 
E1B709 Forde 2014 
E1B757 Forde 2014 
E1B778 Forde 2014 
E1B7B4 Forde 2014 
E1B7K5 Forde 2014 
E1B7Q7 Forde 2014 
E1B898 Forde 2014 
E1B8J9 Forde 2014 
E1B988 Forde 2014 
E1B9Q4 Forde 2014 
E1BAI4 Forde 2014 
E1BAL6 Forde 2014 
E1BAX4 Forde 2014 
E1BB16 Forde 2014 
E1BB27 Forde 2014 
E1BB46 Forde 2014 
E1BB52 Forde 2014 
E1BBH1 Forde 2014 
E1BBY7 Forde 2014 
E1BCF2 Forde 2014 
E1BCI2 Forde 2014 
E1BCK4 Forde 2014 
E1BDC9 Forde 2014 
E1BDL3 Forde 2014 
E1BEK2 Forde 2014 
E1BFC2 Forde 2014 
E1BFI7 Forde 2014 
E1BFP1 Forde 2014 
E1BFQ6 Forde 2014 
E1BFU2 Forde 2014 
E1BFU9 Forde 2014 
E1BFX4 Forde 2014 
E1BG25 Forde 2014 
E1BGA4 Forde 2014 
E1BGL2 Forde 2014 
E1BGM1 Forde 2014 
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E1BH45 Forde 2014 
E1BHH1 Forde 2014 
E1BHL6 Forde 2014 
E1BI28 Forde 2014 
E1BI80 Forde 2014 
E1BIU0 Forde 2014 
E1BJ10 Forde 2014 
E1BJI4 Forde 2014 
E1BJT7 Forde 2014 
E1BK18 Forde 2014 
E1BKJ5 Forde 2014 
E1BKK2 Forde 2014 
E1BKT9 Forde 2014 
E1BKX1 Forde 2014 
E1BKX7 Forde 2014 
E1BL45 Forde 2014 
E1BLD1 Forde 2014 
E1BLD2 Forde 2014 
E1BLK3 Forde 2014 
E1BM24 Forde 2014 
E1BMI4 Forde 2014 
E1BMJ6 Forde 2014 
E1BMV7 Forde 2014 
E1BMW6 Forde 2014 
E1BN35 Forde 2014 
E1BNH9 Forde 2014 
E1BNJ2 Forde 2014 
E1BNQ6 Forde 2014 
E1BNY8 Forde 2014 
E1BP65 Forde 2014 
E1BP91 Forde 2014 
E1BP98 Forde 2014 
E1BPL6 Forde 2014 
E9LZ03 Forde 2014 
F1MAW5 Forde 2014 
F1MB07 Forde 2014 
F1MB09 Forde 2014 
F1MBP8 Forde 2014 
F1MCD1 Forde 2014 
F1MCZ7 Forde 2014 
F1MGY2 Forde 2014 
F1MHR4 Forde 2014 
F1MI83 Forde 2014 
F1MI98 Forde 2014 
F1MJQ2 Forde 2014 
F1MKI1 Forde 2014 
F1MKV7 Forde 2014 
F1ML50 Forde 2014 
F1MME2 Forde 2014 
F1MME5 Forde 2014 
F1MMU9 Forde 2014 
F1MNS5 Forde 2014 
F1MQ26 Forde 2014 
F1MSS2 Forde 2014 
F1MWK8 Forde 2014 
F1MWU9 Forde 2014 
F1MX49 Forde 2014 
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Q6B857 Helfrich 2020 
Q6BBL6 Helfrich 2020 
Q6EWQ7 Helfrich 2020 
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Q9BE40 Helfrich 2020 
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Q9BGI3 Helfrich 2020 
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Q9N2I8 Helfrich 2020 
Q9N2J2-1 Helfrich 2020 
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1433B Mullen 2012 
1433Z Mullen 2012 
A0FJZ6 Mullen 2012 
A0JN34 Mullen 2012 
A0JNJ8 Mullen 2012 
A0PDJ3 Mullen 2012 
A1A4N9 Mullen 2012 
A1A4Q6 Mullen 2012 
A1AG Mullen 2012 
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A1L528 Mullen 2012 
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A1L5B6 Mullen 2012 
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Q2KJC5 Moraes 2020 
Q0IIL6 Moraes 2020 
Q9GJT9 Moraes 2020 
A6QPN6 Moraes 2020 
Q3SYR8 Moraes 2020 
Q2HJF0 Moraes 2020 
Q0VCM5 Moraes 2020 
Q28125 Moraes 2020 
Q9GLL5 Moraes 2020 
P56831 Moraes 2020 
Q0VC51 Moraes 2020 
Q0V8D5 Moraes 2020 
Q32LE5 Moraes 2020 
A0A140T853 Moraes 2020 
Q1LZ95 Moraes 2020 
A5D7R6 Moraes 2020 
Q0VCZ4 Moraes 2020 
A4FV94 Moraes 2020 
A0A140T867 Moraes 2020 
A1L595 Moraes 2020 
F6S1Q0 Moraes 2020 
Q5XQN5 Moraes 2020 
Q29S21 Moraes 2020 
Q2KHX6 Moraes 2020 
P01044 Moraes 2020 
P01045 Moraes 2020 
P05786 Moraes 2020 
P24627 Moraes 2020 
Q95M12 Moraes 2020 
Q2KIF2 Moraes 2020 
P62803 Moraes 2020 
A6QQ85 Moraes 2020 
Q05443 Moraes 2020 
A0JNL5 Moraes 2020 
Q9MYM4 Moraes 2020 
Q8WMP9 Moraes 2020 
G3MXJ5 Moraes 2020 
Q6B411 Moraes 2020 
Q56J78 Moraes 2020 
A6QLB0 Moraes 2020 
A0A060IHZ1 Moraes 2020 
E1B7B4 Moraes 2020 
Z4YHD9 Moraes 2020 
Q5E9I4 Moraes 2020 
O46738 Moraes 2020 
P55918 Moraes 2020 
Q9N0E6 Moraes 2020 
Q3ZC41 Moraes 2020 
A6QP39 Moraes 2020 
Q28910 Moraes 2020 
Q8WML4 Moraes 2020 
A6QLD6 Moraes 2020 
Q27966 Moraes 2020 
P85100 Moraes 2020 
Q5E9E2 Moraes 2020 
C6KEF7 Moraes 2020 
O18836 Moraes 2020 
M5FJT7 Moraes 2020 
Q1LZH9 Moraes 2020 
A6QPY4 Moraes 2020 
E1BFX4 Moraes 2020 
Q1RMN0 Moraes 2020 
Q28030 Moraes 2020 
Q3SZK8 Moraes 2020 
A6QM01 Moraes 2020 
A6BMK7 Moraes 2020 
Q05B89 Moraes 2020 
Q0P569 Moraes 2020 
Q17QX0 Moraes 2020 
A1L579 Moraes 2020 
P13214 Moraes 2020 
F1N726 Moraes 2020 
Q95114 Moraes 2020 
A5D7E8 Moraes 2020 
A6QNL5 Moraes 2020 
Q8SPP7 Moraes 2020 
Q5E947 Moraes 2020 
Q9BGI3 Moraes 2020 
Q9BGI1 Moraes 2020 
O77834 Moraes 2020 
A6QQ11 Moraes 2020 
Q2KIW4 Moraes 2020 
P80109 Moraes 2020 
A1A4J1 Moraes 2020 
Q08DP0 Moraes 2020 
Q2HJ26 Moraes 2020 
Q95121 Moraes 2020 
  
 359 
Q1RML9 Moraes 2020 
Q2KJD1 Moraes 2020 
Q2KJ75 Moraes 2020 
F1MYX5 Moraes 2020 
Q17QC7 Moraes 2020 
Q5E9A3 Moraes 2020 
A7MAZ5 Moraes 2020 
G3N0V2 Moraes 2020 
P60661 Moraes 2020 
F1MU80 Moraes 2020 
G8JKW7 Moraes 2020 
O46499 Moraes 2020 
Q28057 Moraes 2020 
A5D7C6 Moraes 2020 
P60986 Moraes 2020 
Q08DU0 Moraes 2020 
Q2YDE4 Moraes 2020 
Q1RMP3 Moraes 2020 
Q2KIT0 Moraes 2020 
Q2KIX7 Moraes 2020 
Q2KIU3 Moraes 2020 
P28782 Moraes 2020 
P02702 Moraes 2020 
A6QR28 Moraes 2020 
A8YXY5 Moraes 2020 
A7MBJ4 Moraes 2020 
Q2KIY5 Moraes 2020 
Q0II59 Moraes 2020 
Q58D08 Moraes 2020 
A5D984 Moraes 2020 
A6QQA8 Moraes 2020 
P50397 Moraes 2020 
P62833 Moraes 2020 
A6QLS9 Moraes 2020 
Q2HJH2 Moraes 2020 
Q1KZG2 Moraes 2020 
Q3T0R7 Moraes 2020 
Q3ZCK3 Moraes 2020 
Q2KJH9 Moraes 2020 
Q3T0V4 Moraes 2020 
Q3ZBZ1 Moraes 2020 
Q95140 Moraes 2020 
P42899 Moraes 2020 
Q3ZC91 Moraes 2020 
P07107 Moraes 2020 
P41500 Moraes 2020 
Q3MHL4 Moraes 2020 
P08166 Moraes 2020 
Q3SYV4 Moraes 2020 
Q3Y5Z3 Moraes 2020 
P16116 Moraes 2020 
Q3SZR3 Moraes 2020 
P28800 Moraes 2020 
P12763 Moraes 2020 
Q9XSJ4 Moraes 2020 
P79098 Moraes 2020 
P04272 Moraes 2020 
Q3SWX7 Moraes 2020 
P81287 Moraes 2020 
Q3SYW1 Moraes 2020 
P15497 Moraes 2020 
Q3SZJ0 Moraes 2020 
P33097 Moraes 2020 
P12344 Moraes 2020 
Q5EA01 Moraes 2020 
P06504 Moraes 2020 
Q3T168 Moraes 2020 
P25975 Moraes 2020 
P25326 Moraes 2020 
Q9XSK2 Moraes 2020 
Q9XSA7 Moraes 2020 
P05059 Moraes 2020 
Q29RK1 Moraes 2020 
Q2HJ57 Moraes 2020 
Q28104 Moraes 2020 
Q3T0B6 Moraes 2020 
Q28085 Moraes 2020 
Q9TTK8 Moraes 2020 
P25417 Moraes 2020 
Q3ZC84 Moraes 2020 
Q3ZCJ8 Moraes 2020 
Q3MHR3 Moraes 2020 
Q3SZV3 Moraes 2020 
Q3T0L2 Moraes 2020 
Q3T0L5 Moraes 2020 
P79136 Moraes 2020 
P10790 Moraes 2020 
Q3SZZ9 Moraes 2020 
P07589 Moraes 2020 
Q2KIB0 Moraes 2020 
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Q2YDG0 Moraes 2020 
P15103 Moraes 2020 
P10575 Moraes 2020 
P28801 Moraes 2020 
Q3T054 Moraes 2020 
P38409 Moraes 2020 
Q3ZCH9 Moraes 2020 
Q27975 Moraes 2020 
Q3SZV7 Moraes 2020 
P09867 Moraes 2020 
Q3T0D0 Moraes 2020 
P10103 Moraes 2020 
Q2M2T1 Moraes 2020 
P24591 Moraes 2020 
Q05718 Moraes 2020 
Q3T052 Moraes 2020 
Q04467 Moraes 2020 
Q9XT56 Moraes 2020 
P06394 Moraes 2020 
P19858 Moraes 2020 
Q5E9B1 Moraes 2020 
Q1JPB0 Moraes 2020 
Q3SZH7 Moraes 2020 
Q3MI05 Moraes 2020 
Q3SYU9 Moraes 2020 
Q32LG3 Moraes 2020 
P12624 Moraes 2020 
Q3SX44 Moraes 2020 
Q3T063 Moraes 2020 
Q3T0Q4 Moraes 2020 
P45478 Moraes 2020 
Q1JQD4 Moraes 2020 
P10731 Moraes 2020 
P62935 Moraes 2020 
P80311 Moraes 2020 
P13696 Moraes 2020 
Q3T0P6 Moraes 2020 
Q3SZ62 Moraes 2020 
Q3ZBG9 Moraes 2020 
Q2KHU0 Moraes 2020 
Q3T0I2 Moraes 2020 
Q2TBR0 Moraes 2020 
P26779 Moraes 2020 
Q3T0X5 Moraes 2020 
Q3ZCK9 Moraes 2020 
Q3ZBG0 Moraes 2020 
Q2TBX6 Moraes 2020 
Q3T108 Moraes 2020 
Q3T112 Moraes 2020 
Q29RV1 Moraes 2020 
P05307 Moraes 2020 
Q2HJE5 Moraes 2020 
P51176 Moraes 2020 
P00735 Moraes 2020 
Q3MHP2 Moraes 2020 
Q3ZBK2 Moraes 2020 
P19803 Moraes 2020 
Q9TU03 Moraes 2020 
Q3T114 Moraes 2020 
Q3MHF7 Moraes 2020 
P02769 Moraes 2020 
Q3T147 Moraes 2020 
Q9N0T1 Moraes 2020 
Q3ZCH0 Moraes 2020 
Q3ZBZ8 Moraes 2020 
Q3T0K2 Moraes 2020 
Q3MHL7 Moraes 2020 
Q2KIS7 Moraes 2020 
O62768 Moraes 2020 
P00586 Moraes 2020 
Q3ZBV8 Moraes 2020 
Q9TS87 Moraes 2020 
Q3ZBT1 Moraes 2020 
P17248 Moraes 2020 
Q3ZCC8 Moraes 2020 
P46201 Moraes 2020 
Q9MZ13 Moraes 2020 
Q0P5D6 Moraes 2020 
Q2NKZ9 Moraes 2020 
P61585 Moraes 2020 
Q58DQ3 Moraes 2020 
Q0III8 Moraes 2020 
A6QLG5 Moraes 2020 
A2VE17 Moraes 2020 
Q2KJ32 Moraes 2020 
Q9N2I2 Moraes 2020 
F1N152 Moraes 2020 
Q29443 Moraes 2020 
A2I7N1 Moraes 2020 
Q32T06 Moraes 2020 
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Q2KJH6 Moraes 2020 
O02739 Moraes 2020 
A5PK77 Moraes 2020 
Q9TTE1 Moraes 2020 
Q3ZEJ6 Moraes 2020 
A6QPQ2 Moraes 2020 
A6QPZ4 Moraes 2020 
A6QPP2 Moraes 2020 
Q2TBR3 Moraes 2020 
A5PKC2 Moraes 2020 
Q862Q2 Moraes 2020 
A7MB31 Moraes 2020 
Q08DL0 Moraes 2020 
A3KMY4 Moraes 2020 
A6QQN6 Moraes 2020 
Q27960 Moraes 2020 
Q0VD19 Moraes 2020 
C4T8T2 Moraes 2020 
A8E4P3 Moraes 2020 
A7YWC6 Moraes 2020 
Q24JZ7 Moraes 2020 
Q0V7N1 Moraes 2020 
Q3SZA6 Moraes 2020 
A8YXX7 Moraes 2020 
O97680 Moraes 2020 
Q2KIM0 Moraes 2020 
A7MBA6 Moraes 2020 
Q5EAD2 Moraes 2020 
Q3T149 Moraes 2020 
Q3ZC44 Moraes 2020 
E9LZ03 Moraes 2020 
E1BM92 Moraes 2020 
Q56K14 Moraes 2020 
G3MZJ9 Moraes 2020 
O46375 Moraes 2020 
P15696 Moraes 2020 
Q3ZBU7 Moraes 2020 
A0A140T894 Moraes 2020 
P68250 Moraes 2020 
A3KMV5 Moraes 2020 
O02741 Moraes 2020 
Q0P568 Moraes 2020 
P63048 Moraes 2020 
A8E4P0 Moraes 2020 
A5D7Q2 Moraes 2020 
A6QM09 Moraes 2020 
P01035 Moraes 2020 
P04836 Moraes 2020 
P40682 Moraes 2020 
Q58CQ9 Moraes 2020 
A5D9D1 Moraes 2020 
Q3ZBS7 Moraes 2020 
Q8SPF8 Moraes 2020 
Q3T0Z0 Moraes 2020 
Q2KJH4 Moraes 2020 
Q0III5 Moraes 2020 
Q3ZCH5 Moraes 2020 
P02662 Moraes 2020 
P02668 Moraes 2020 
P12234 Moraes 2020 
P08169 Moraes 2020 
P10568 Moraes 2020 
P10279 Moraes 2020 
P20414 Moraes 2020 
Q28193 Moraes 2020 
Q28017 Moraes 2020 
P42201 Moraes 2020 
P41541 Moraes 2020 
Q28150 Moraes 2020 
P50448 Moraes 2020 
P54229 Moraes 2020 
O02703 Moraes 2020 
Q28065 Moraes 2020 
Q28046 Moraes 2020 
O02717 Moraes 2020 
Q9TTW1 Moraes 2020 
Q9TT36 Moraes 2020 
Q9N0K1 Moraes 2020 
Q9GLC9 Moraes 2020 
Q9GKI7 Moraes 2020 
Q9BGI2 Moraes 2020 
P80209 Moraes 2020 
A0A0P0QLR2 Moraes 2020 
Q8WN55 Moraes 2020 
Q8SPU8 Moraes 2020 
P81282 Moraes 2020 
Q8MKB7 Moraes 2020 
Q58DU5 Moraes 2020 
Q862I1 Moraes 2020 
P62998 Moraes 2020 
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Q8MJ05 Moraes 2020 
Q27991 Moraes 2020 
P54228 Moraes 2020 
O46415 Moraes 2020 
Q9BEA3 Moraes 2020 
P62992 Moraes 2020 
Q03763 Moraes 2020 
P62958 Moraes 2020 
Q865V6 Moraes 2020 
A0A140T897 Moraes 2020 
Q07130 Moraes 2020 
P61286 Moraes 2020 
Q6B855 Moraes 2020 
Q68V19 Moraes 2020 
P68002 Moraes 2020 
Q5E987 Moraes 2020 
P69678 Moraes 2020 
Q58DK5 Moraes 2020 
Q58DT1 Moraes 2020 
Q3YJH8 Moraes 2020 
Q3SZG7 Moraes 2020 
Q3SZ43 Moraes 2020 
P50227 Moraes 2020 
A0A140T8A5 Moraes 2020 
Q5E946 Moraes 2020 
Q58DS5 Moraes 2020 
Q58DW5 Moraes 2020 
Q3ZCM0 Moraes 2020 
Q3SZB7 Moraes 2020 
Q3T2L0 Moraes 2020 
Q3SZF2 Moraes 2020 
Q3T145 Moraes 2020 
Q3MHM5 Moraes 2020 
Q3ZCA7 Moraes 2020 
A0A0M4MD57 Moraes 2020 
Q2TBW8 Moraes 2020 
Q2TBV8 Moraes 2020 
Q2QDE9 Moraes 2020 
Q32PB8 Moraes 2020 
Q3T0Y5 Moraes 2020 
Q3T0T1 Moraes 2020 
Q3MHN0 Moraes 2020 
Q3SZC2 Moraes 2020 
Q3T087 Moraes 2020 
Q3T0U2 Moraes 2020 
Q3T0L7 Moraes 2020 
Q3T0S6 Moraes 2020 
Q3ZBH8 Moraes 2020 
O18789 Moraes 2020 
Q17R18 Moraes 2020 
Q8SPJ1 Moraes 2020 
Q17QK3 Moraes 2020 
Q17QC8 Moraes 2020 
Q58DS9 Moraes 2020 
Q17QI3 Moraes 2020 
Q17R14 Moraes 2020 
P20456 Moraes 2020 
Q3SZ54 Moraes 2020 
Q148N0 Moraes 2020 
Q148I9 Moraes 2020 
Q148H5 Moraes 2020 
P80177 Moraes 2020 
Q3MHR5 Moraes 2020 
P11179 Moraes 2020 
Q0V8I2 Moraes 2020 
Q0V8B6 Moraes 2020 
Q32KP9 Moraes 2020 
Q0VC27 Moraes 2020 
Q0VCH9 Moraes 2020 
Q0VCC0 Moraes 2020 
Q0VCK1 Moraes 2020 
Q0VFX8 Moraes 2020 
Q0P5J6 Moraes 2020 
Q0IIA4 Moraes 2020 
Q2HJ49 Moraes 2020 
Q1RMX7 Moraes 2020 
Q2NL19 Moraes 2020 
Q2KIT8 Moraes 2020 
Q2KI48 Moraes 2020 
Q2LGB2 Moraes 2020 
Q2HJH1 Moraes 2020 
Q29S11 Moraes 2020 
Q58DH9 Moraes 2020 
Q08E55 Moraes 2020 
Q08DJ3 Moraes 2020 
Q08DX9 Moraes 2020 
Q3ZCI9 Moraes 2020 
Q2T9X2 Moraes 2020 
Q3ZBA8 Moraes 2020 
Q32LE4 Moraes 2020 
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Q148I8 Moraes 2020 
Q0VD04 Moraes 2020 
Q32PA4 Moraes 2020 
Q32L99 Moraes 2020 
Q9TR36 Moraes 2020 
A0JND7 Moraes 2020 
P79103 Moraes 2020 
P46193 Moraes 2020 
A1A4I4 Moraes 2020 
Q5E958 Moraes 2020 
E1BJW3 Moraes 2020 
A1L5B1 Moraes 2020 
Q32PF2 Moraes 2020 
P26452 Moraes 2020 
Q3SZC4 Moraes 2020 
Q3SZJ4 Moraes 2020 
Q3T0E5 Moraes 2020 
Q3ZBW4 Moraes 2020 
Q3ZC42 Moraes 2020 
Q3SZR8 Moraes 2020 
Q3T106 Moraes 2020 
Q0P5B0 Moraes 2020 
Q1RMI2 Moraes 2020 
P31404 Moraes 2020 
A2VDN8 Moraes 2020 
B1H0W7 Moraes 2020 
A2VDN7 Moraes 2020 
Q32L48 Moraes 2020 
Q9BEG5 Moraes 2020 
A3KN04 Moraes 2020 
A4FUD0 Moraes 2020 
A4FV56 Moraes 2020 
P80227 Moraes 2020 
A4FUZ7 Moraes 2020 
P31408 Moraes 2020 
A4FUZ0 Moraes 2020 
A3KN26 Moraes 2020 
A5D7N6 Moraes 2020 
A5D7R9 Moraes 2020 
A5D7H3 Moraes 2020 
P81134 Moraes 2020 
A5D977 Moraes 2020 
Q9TRY0 Moraes 2020 
A5D9B6 Moraes 2020 
A2VE07 Moraes 2020 
P35071 Moraes 2020 
A4IFP2 Moraes 2020 
A5PJY0 Moraes 2020 
P61284 Moraes 2020 
Q3T0W9 Moraes 2020 
A5PJJ1 Moraes 2020 
A0A0F7RQ40 Moraes 2020 
Q862H7 Moraes 2020 
A5PKJ3 Moraes 2020 
A6H730 Moraes 2020 
A6H742 Moraes 2020 
A6H769 Moraes 2020 
A6H7G2 Moraes 2020 
A6H768 Moraes 2020 
A6QLN9 Moraes 2020 
A6QNS6 Moraes 2020 
A6QLY4 Moraes 2020 
A6QLZ0 Moraes 2020 
A6QLU7 Moraes 2020 
A6QPP7 Moraes 2020 
A6QL85 Moraes 2020 
A6QLZ3 Moraes 2020 
A0A140T891 Moraes 2020 
A6QQR7 Moraes 2020 
P00435 Moraes 2020 
P56701 Moraes 2020 
A7E3T7 Moraes 2020 
A7E3V1 Moraes 2020 
A7E3W2 Moraes 2020 
A7YY47 Moraes 2020 
B0JYN3 Moraes 2020 
A8E4P2 Moraes 2020 
A7MB45 Moraes 2020 
A7MBG8 Moraes 2020 
A7MBI5 Moraes 2020 
Q56JV9 Moraes 2020 
O18736 Moraes 2020 
A7E306 Moraes 2020 
A6QLN6 Moraes 2020 
A7YW37 Moraes 2020 
A7YWN0 Moraes 2020 
A7Z014 Moraes 2020 
A4FV54 Moraes 2020 
P02754 Moraes 2020 
Q29460 Moraes 2020 
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P18203 Moraes 2020 
Q0P5F6 Moraes 2020 
Q3SYR7 Moraes 2020 
G5E5C8 Moraes 2020 
Q2TBL6 Moraes 2020 
F1N1I6 Moraes 2020 
C4T8B4 Moraes 2020 
A2I7M9 Moraes 2020 
Q5H9M6 Moraes 2020 
F1MWD3 Moraes 2020 
Q3ZBH0 Moraes 2020 
Q2NKZ1 Moraes 2020 
F1N3I4 Moraes 2020 
F2Z4F0 Moraes 2020 
F1MI98 Moraes 2020 
F1MYC9 Moraes 2020 
E1B898 Moraes 2020 
F1MN49 Moraes 2020 
E1BI28 Moraes 2020 
E1B7W1 Moraes 2020 
F1MNS5 Moraes 2020 
A6QNU3 Moraes 2020 
F6K7I7 Moraes 2020 
G3X6L9 Moraes 2020 
E1BFE9 Moraes 2020 
P31800 Moraes 2020 
P23004 Moraes 2020 
E1BJT7 Moraes 2020 
P02253 Moraes 2020 
K4JDR8 Moraes 2020 
K4JDT2 Moraes 2020 
L7R4Y6 Moraes 2020 
F1MHS5 Moraes 2020 
A0A0A0MP92 Moraes 2020 
C1ITJ8 Moraes 2020 
A6QLT9 Moraes 2020 
E1B9T2 Moraes 2020 
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Table S5-4 proteins identified as containing Sec signal peptides and thus putatively se-
creted through the classical secretion path as determined by SignalP analysis. Protein ID is 
in FASTA format. SP= probability of having a signal peptide. CS position: cleavage site posi-
tion. Pr: probability of the signal peptide sequence being 100% accurate. 
Protein ID SP CS Position 
tr_F1MDS0_F1MDS0_BOVIN 0.999857 CS pos: 23-24. ASS-QD. Pr: 0.9702 
sp_A0JNL5_LY66C_BOVIN 0.999795 CS pos: 18-19. VSA-DI. Pr: 0.9147 
tr_EQ3T0Z0_EQ3T0Z0_BOVIN 0.999712 CS pos: 26-27. VTG-SI. Pr: 0.7706 
tr_A0A3EQ1LEQ34_A0A3EQ1LEQ34_BOVIN 0.999712 CS pos: 26-27. VTG-SI. Pr: 0.7706 
tr_G3MX65_G3MX65_BOVIN 0.999712 CS pos: 26-27. VTG-SI. Pr: 0.7706 
sp_Q0VCX2_BIP_BOVIN 0.999595 CS pos: 19-20. ARA-EE. Pr: 0.9836 
tr_A0A3EQ1NJB1_A0A3EQ1NJB1_BOVIN 0.999585 CS pos: 19-20. AWA-KD. Pr: 0.9459 
tr_F1N076_F1N076_BOVIN 0.999585 CS pos: 19-20. AWA-KD. Pr: 0.9459 
tr_A2VE41_A2VE41_BOVIN 0.99955 CS pos: 17-18. VKS-QD. Pr: 0.9219 
tr_F1MIA9_F1MIA9_BOVIN 0.999462 CS pos: 20-21. AQA-DV. Pr: 0.9826 
tr_E1BNR0_E1BNR0_BOVIN 0.999423 CS pos: 22-23. ANA-QA. Pr: 0.5942 
tr_B0JYN6_B0JYN6_BOVIN 0.999422 CS pos: 18-19. CHS-IP. Pr: 0.9728 
sp_P12763_FETUA_BOVIN 0.999422 CS pos: 18-19. CHS-IP. Pr: 0.9728 
tr_A4IFI0_A4IFI0_BOVIN 0.9993 CS pos: 19-20. SWA-QA. Pr: 0.7011 
tr_A0A3EQ1MFR4_A0A3EQ1MFR4_BOVIN 0.999284 CS pos: 22-23. ANA-QA. Pr: 0.5580 
sp_A8YXX7_TFF3_BOVIN 0.999268 CS pos: 23-24. STG-QY. Pr: 0.4884 
sp_P00978_AMBP_BOVIN 0.999247 CS pos: 19-20. VNA-SS. Pr: 0.7151 
tr_F1MM86_F1MM86_BOVIN 0.999217 CS pos: 21-22. SQA-CF. Pr: 0.9878 
tr_F1MZ96_F1MZ96_BOVIN 0.999108 CS pos: 20-21. SSG-DV. Pr: 0.8459 
tr_A5D7S8_A5D7S8_BOVIN 0.999103 CS pos: 29-30. AGA-DV. Pr: 0.8354 
tr_F1MAV0_F1MAV0_BOVIN 0.999091 CS pos: 16-17. VQA-QF. Pr: 0.9701 
sp_P17697_CLUS_BOVIN 0.99909 CS pos: 19-20. GWA-IS. Pr: 0.9421 
tr_A0A3EQ1LXG6_A0A3EQ1LXG6_BOVIN 0.99898 CS pos: 19-20. SWA-QA. Pr: 0.6887 
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tr_B0JYP6_B0JYP6_BOVIN 0.998946 CS pos: 20-21. SSG-DV. Pr: 0.8461 
sp_Q863C3_GRP_BOVIN 0.998939 CS pos: 23-24. GWA-AP. Pr: 0.9839 
tr_EQ1RMN8_EQ1RMN8_BOVIN 0.998936 CS pos: 19-20. SWA-QA. Pr: 0.7045 
tr_E1BJP1_E1BJP1_BOVIN 0.998843 CS pos: 15-16. VCA-QE. Pr: 0.8173 
sp_P01888_B2MG_BOVIN 0.998792 CS pos: 20-21. LDA-IQ. Pr: 0.8371 
tr_A0A3EQ1MIF4_A0A3EQ1MIF4_BOVIN 0.998732 CS pos: 20-21. CEA-HH. Pr: 0.9015 
sp_EQ29RU4_CO6_BOVIN 0.998718 CS pos: 21-22. SQA-CF. Pr: 0.9860 
tr_A0A3EQ1LUE9_A0A3EQ1LUE9_BOVIN 0.998647 CS pos: 22-23. SWA-QA. Pr: 0.7345 
tr_A0A3EQ1LTY4_A0A3EQ1LTY4_BOVIN 0.998638 CS pos: 24-25. LQA-AV. Pr: 0.8696 
tr_A5PK72_A5PK72_BOVIN 0.998626 CS pos: 19-20. SWA-QA. Pr: 0.6963 
sp_Q95M18_ENPL_BOVIN 0.998426 CS pos: 21-22. VRA-DD. Pr: 0.9497 
tr_Q5DPW9_Q5DPW9_BOVIN 0.998413 CS pos: 28-29. ARA-RP. Pr: 0.8568 
sp_O46375_TTHY_BOVIN 0.998381 CS pos: 20-21. SEA-GS. Pr: 0.7141 
tr_G5E5H2_G5E5H2_BOVIN 0.99823 CS pos: 19-20. SWA-QA. Pr: 0.7064 
sp_P50448_F12AI_BOVIN 0.998151 CS pos: 23-24. VTS-DM. Pr: 0.9450 
tr_A0A3EQ1LWV8_A0A3EQ1LWV8_BOVIN 0.998137 CS pos: 19-20. SWA-QA. Pr: 0.6669 
tr_A0A3EQ1M1Z4_A0A3EQ1M1Z4_BOVIN 0.998079 CS pos: 19-20. SWA-QA. Pr: 0.5952 
tr_A0A3EQ1LSF0_A0A3EQ1LSF0_BOVIN 0.998079 CS pos: 19-20. SWA-QA. Pr: 0.5952 
tr_A0A3EQ1MNN6_A0A3EQ1MNN6_BOVIN 0.998026 CS pos: 24-25. ASA-TS. Pr: 0.9338 
tr_F1MJK3_F1MJK3_BOVIN 0.998026 CS pos: 24-25. ASA-TS. Pr: 0.9338 
tr_F1MKS5_F1MKS5_BOVIN 0.997944 CS pos: 20-21. CSC-AV. Pr: 0.6483 
tr_Q9BGU1_Q9BGU1_BOVIN 0.997944 CS pos: 20-21. CSC-AV. Pr: 0.6483 
tr_G3MZE0_G3MZE0_BOVIN 0.997911 CS pos: 19-20. SWA-QA. Pr: 0.7080 
sp_P19035_APOC3_BOVIN 0.9979 CS pos: 23-24. TKA-EE. Pr: 0.8450 
tr_V6F9A3_V6F9A3_BOVIN 0.9979 CS pos: 23-24. TKA-EE. Pr: 0.8450 
sp_P02702_FOLR1_BOVIN 0.997892 CS pos: 19-20. AWG-AQ. Pr: 0.5668 
tr_G3MZU3_G3MZU3_BOVIN 0.997871 CS pos: 15-16. VCA-QE. Pr: 0.8116 
sp_Q8SPP7_PGRP1_BOVIN 0.997818 CS pos: 21-22. GAA-QD. Pr: 0.8671 
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tr_H2CNR1_H2CNR1_BOVIN 0.997818 CS pos: 21-22. GAA-QD. Pr: 0.8671 
tr_F1MY85_F1MY85_BOVIN 0.997773 CS pos: 18-19. SWG-QE. Pr: 0.9763 
tr_G3X6N3_G3X6N3_BOVIN 0.997717 CS pos: 19-20. CLA-DP. Pr: 0.8990 
sp_EQ29443_TRFE_BOVIN 0.997717 CS pos: 19-20. CLA-DP. Pr: 0.8990 
sp_P15497_APOA1_BOVIN 0.997708 CS pos: 18-19. SQA-RH. Pr: 0.9851 
tr_V6F9A2_V6F9A2_BOVIN 0.997708 CS pos: 18-19. SQA-RH. Pr: 0.9851 
tr_A0A3EQ1NG86_A0A3EQ1NG86_BOVIN 0.997679 CS pos: 15-16. ALA-RP. Pr: 0.8906 
tr_B5B3R8_B5B3R8_BOVIN 0.997679 CS pos: 15-16. ALA-RP. Pr: 0.8906 
sp_P02662_CASA1_BOVIN 0.997679 CS pos: 15-16. ALA-RP. Pr: 0.8906 
sp_P02453_CO1A1_BOVIN 0.997677 CS pos: 22-23. THG-QE. Pr: 0.9195 
tr_V6F7X3_V6F7X3_BOVIN 0.997642 CS pos: 20-21. AEA-EV. Pr: 0.7403 
sp_Q7SIH1_A2MG_BOVIN 0.997579 CS pos: 23-24. TDA-SV. Pr: 0.7099 
tr_K4JBR5_K4JBR5_BOVIN 0.997579 CS pos: 23-24. TDA-SV. Pr: 0.7099 
tr_A5D7J6_A5D7J6_BOVIN 0.997545 CS pos: 17-18. AAA-DR. Pr: 0.9452 
tr_F1MLW8_F1MLW8_BOVIN 0.997439 CS pos: 21-22. ASS-QL. Pr: 0.7709 
sp_Q0VCM5_ITIH1_BOVIN 0.997395 CS pos: 22-23. VAA-QG. Pr: 0.3482 
tr_A5D7R6_A5D7R6_BOVIN 0.997383 CS pos: 18-19. SRG-FE. Pr: 0.9261 
tr_A0A3EQ1LJT1_A0A3EQ1LJT1_BOVIN 0.997359 CS pos: 20-21. VVS-YE. Pr: 0.8633 
sp_P28800_A2AP_BOVIN 0.997351 CS pos: 21-22. CSA-QF. Pr: 0.8684 
tr_Q5GN72_Q5GN72_BOVIN 0.997175 CS pos: 18-19. LDA-QS. Pr: 0.9037 
tr_Q95ND9_Q95ND9_BOVIN 0.996984 CS pos: 22-23. THG-QE. Pr: 0.9209 
tr_F1N3J3_F1N3J3_BOVIN 0.996844 CS pos: 20-21. TLA-KD. Pr: 0.9529 
tr_EQ2HJF0_EQ2HJF0_BOVIN 0.996778 CS pos: 19-20. CLA-VP. Pr: 0.8481 
tr_A0A452DI25_A0A452DI25_BOVIN 0.996775 CS pos: 23-24. AKA-HP. Pr: 0.8565 
sp_EQ3MHN5_VTDB_BOVIN 0.996767 CS pos: 16-17. VHA-LE. Pr: 0.9495 
tr_A0A3EQ1MGT0_A0A3EQ1MGT0_BOVIN 0.996641 CS pos: 22-23. ALG-NP. Pr: 0.9592 
tr_EQ3T101_EQ3T101_BOVIN 0.996299 CS pos: 19-20. SWA-QA. Pr: 0.7279 
sp_EQ3ZCH5_ZA2G_BOVIN 0.995871 CS pos: 17-18. AVS-EE. Pr: 0.7426 
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tr_A0A452DK44_A0A452DK44_BOVIN 0.995871 CS pos: 17-18. AVS-EE. Pr: 0.7426 
tr_A6QNX2_A6QNX2_BOVIN 0.995777 CS pos: 26-27. LEA-RA. Pr: 0.5934 
sp_EQ2KJH6_SERPH_BOVIN 0.995635 CS pos: 18-19. ALA-AE. Pr: 0.9031 
sp_P81265_PIGR_BOVIN 0.99555 CS pos: 17-18. VVS-MK. Pr: 0.4296 
tr_B3VTM3_B3VTM3_BOVIN 0.995394 CS pos: 19-20. CLA-AP. Pr: 0.9374 
tr_G3X6K8_G3X6K8_BOVIN 0.995265 CS pos: 25-26. SEA-TA. Pr: 0.3054 
sp_EQ2TBU0_HPT_BOVIN 0.995265 CS pos: 25-26. SEA-TA. Pr: 0.3054 
tr_A0A0M4MD57_A0A0M4MD57_BOVIN 0.995265 CS pos: 25-26. SEA-TA. Pr: 0.3054 
tr_F2FB42_F2FB42_BOVIN 0.994941 CS pos: 23-24. GTA-DT. Pr: 0.4840 
sp_P81644_APOA2_BOVIN 0.994938 CS pos: 18-19. LEG-AL. Pr: 0.7387 
tr_A0A3EQ1MA31_A0A3EQ1MA31_BOVIN 0.994909 CS pos: 27-28. SKA-QK. Pr: 0.9597 
tr_Q5EA67_Q5EA67_BOVIN 0.994909 CS pos: 27-28. SKA-QK. Pr: 0.9597 
sp_P38657_PDIA3_BOVIN 0.994643 CS pos: 24-25. AAA-SD. Pr: 0.7666 
tr_A5D7E8_A5D7E8_BOVIN 0.994643 CS pos: 24-25. AAA-SD. Pr: 0.7666 
tr_EQ3SYR8_EQ3SYR8_BOVIN 0.994132 CS pos: 22-23. VTA-QD. Pr: 0.9059 
tr_B8Y9T0_B8Y9T0_BOVIN 0.993492 CS pos: 27-28. AGA-SK. Pr: 0.3492 
tr_A0A3EQ1NHX9_A0A3EQ1NHX9_BOVIN 0.993492 CS pos: 27-28. AGA-SK. Pr: 0.3492 
tr_B8Y9S9_B8Y9S9_BOVIN 0.993492 CS pos: 27-28. AGA-SK. Pr: 0.3492 
sp_P07589_FINC_BOVIN 0.993492 CS pos: 27-28. AGA-SK. Pr: 0.3492 
tr_A6H7J7_A6H7J7_BOVIN 0.993254 CS pos: 19-20. SWA-LA. Pr: 0.6170 
tr_A6QM09_A6QM09_BOVIN 0.992805 CS pos: 20-21. VVS-YK. Pr: 0.7769 
sp_Q08DD1_ARSA_BOVIN 0.99147 CS pos: 18-19. AAA-SP. Pr: 0.7940 
tr_A0A3EQ1M471_A0A3EQ1M471_BOVIN 0.99147 CS pos: 18-19. AAA-SP. Pr: 0.7940 
sp_P81187_CFAB_BOVIN 0.991105 CS pos: 25-26. VGM-TP. Pr: 0.4070 
sp_Q95121_PEDF_BOVIN 0.990579 CS pos: 19-20. GRC-QN. Pr: 0.7169 
tr_B0JYQ0_B0JYQ0_BOVIN 0.989765 CS pos: 18-19. AYS-RG. Pr: 0.7603 
sp_P34955_A1AT_BOVIN 0.98954 CS pos: 24-25. SLA-GV. Pr: 0.8586 
sp_G3MYZ3_AFAM_BOVIN 0.989477 CS pos: 21-22. SLT-LP. Pr: 0.5642 
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tr_A0A3EQ1LGM4_A0A3EQ1LGM4_BOVIN 0.989301 CS pos: 18-19. SFC-ED. Pr: 0.8860 
tr_F1N4M7_F1N4M7_BOVIN 0.989301 CS pos: 18-19. SFC-ED. Pr: 0.8860 
tr_EQ32PI4_EQ32PI4_BOVIN 0.989301 CS pos: 18-19. SFC-ED. Pr: 0.8860 
tr_A0A3EQ1MF14_A0A3EQ1MF14_BOVIN 0.989301 CS pos: 18-19. SFC-ED. Pr: 0.8860 
tr_A0A3EQ1M2A8_A0A3EQ1M2A8_BOVIN 0.989301 CS pos: 18-19. SFC-ED. Pr: 0.8860 
tr_A5D7EQ2_A5D7EQ2_BOVIN 0.989301 CS pos: 19-20. VLS-QV. Pr: 0.8885 
tr_A0A452DHX8_A0A452DHX8_BOVIN 0.988933 CS pos: 16-17. AMG-RE. Pr: 0.6640 
tr_E1BE11_E1BE11_BOVIN 0.988441 CS pos: 21-22. SRA-QD. Pr: 0.9189 
sp_A7E3W2_LG3BP_BOVIN 0.98815 CS pos: 18-19. TRG-VK. Pr: 0.8984 
tr_E1BI28_E1BI28_BOVIN 0.987815 CS pos: 23-24. ALP-AR. Pr: 0.7955 
tr_A6QQA8_A6QQA8_BOVIN 0.987162 CS pos: 30-31. AGA-AP. Pr: 0.8227 
sp_EQ3T0U1_MESD_BOVIN 0.986983 CS pos: 31-32. AFA-TE. Pr: 0.9478 
sp_EQ2KJF1_A1BG_BOVIN 0.985782 CS pos: 21-22. TEQ-AT. Pr: 0.6990 
sp_EQ29437_AOCX_BOVIN 0.985416 CS pos: 16-17. VMG-RE. Pr: 0.6743 
tr_EQ3SZZ9_EQ3SZZ9_BOVIN 0.984901 CS pos: 24-25. CLA-YV. Pr: 0.7933 
tr_A6QQN6_A6QQN6_BOVIN 0.984277 CS pos: 18-19. ARA-VP. Pr: 0.9105 
sp_P19660_CTHL2_BOVIN 0.983956 CS pos: 29-30. ASA-QA. Pr: 0.6715 
sp_EQ3SZR3_A1AG_BOVIN 0.983368 CS pos: 18-19. LDA-QS. Pr: 0.9028 
sp_P22226_CTHL1_BOVIN 0.983131 CS pos: 29-30. ASA-QA. Pr: 0.6743 
tr_A0A3EQ1N0C4_A0A3EQ1N0C4_BOVIN 0.982411 CS pos: 18-19. TES-GL. Pr: 0.6920 
tr_F6QH94_F6QH94_BOVIN 0.981621 CS pos: 19-20. VNG-LY. Pr: 0.7405 
sp_P33046_CTHL4_BOVIN 0.981136 CS pos: 29-30. ASA-QA. Pr: 0.6778 
tr_A6QPP2_A6QPP2_BOVIN 0.980914 CS pos: 20-21. CRT-LG. Pr: 0.6016 
sp_A6QQ85_UPK3L_BOVIN 0.979813 CS pos: 26-27. GMS-LE. Pr: 0.8444 
tr_G3N3EQ3_G3N3EQ3_BOVIN 0.979522 CS pos: 26-27. VLS-QV. Pr: 0.8740 
tr_A0A3EQ1M9I5_A0A3EQ1M9I5_BOVIN 0.979386 CS pos: 26-27. GHM-AN. Pr: 0.4934 
tr_A0A3EQ1MRM3_A0A3EQ1MRM3_BOVIN 0.979386 CS pos: 26-27. GHM-AN. Pr: 0.4934 
tr_E1B864_E1B864_BOVIN 0.979386 CS pos: 26-27. GHM-AN. Pr: 0.4934 
  
 370 
sp_P09487_PPBT_BOVIN 0.978646 CS pos: 17-18. ASS-LV. Pr: 0.4388 
tr_G3N148_G3N148_BOVIN 0.978434 CS pos: 26-27. VLS-QV. Pr: 0.8727 
tr_A0A3EQ1MDA5_A0A3EQ1MDA5_BOVIN 0.975879 CS pos: 38-39. AQA-AD. Pr: 0.7951 
tr_A6QP39_A6QP39_BOVIN 0.975879 CS pos: 38-39. AQA-AD. Pr: 0.7951 
tr_F1MNV5_F1MNV5_BOVIN 0.975812 CS pos: 18-19. SLT-QE. Pr: 0.7490 
sp_P01045_KNG2_BOVIN 0.975812 CS pos: 18-19. SLT-QE. Pr: 0.7490 
tr_A0A3EQ1LSS0_A0A3EQ1LSS0_BOVIN 0.975286 CS pos: 37-38. ASA-SD. Pr: 0.6590 
tr_F1MET0_F1MET0_BOVIN 0.975286 CS pos: 37-38. ASA-SD. Pr: 0.6590 
tr_A5D9D7_A5D9D7_BOVIN 0.975286 CS pos: 37-38. ASA-SD. Pr: 0.6590 
sp_EQ2KIU3_HP252_BOVIN 0.973409 CS pos: 30-31. ADA-TS. Pr: 0.4920 
tr_A0A3EQ1MUR2_A0A3EQ1MUR2_BOVIN 0.973121 CS pos: 26-27. VLS-QV. Pr: 0.8595 
tr_A5D986_A5D986_BOVIN 0.973028 CS pos: 22-23. VSA-GG. Pr: 0.8361 
tr_A0A3EQ1M0K3_A0A3EQ1M0K3_BOVIN 0.972978 CS pos: 26-27. VLS-QV. Pr: 0.8591 
tr_G3MWT1_G3MWT1_BOVIN 0.972096 CS pos: 26-27. VLS-KV. Pr: 0.8451 
tr_A0A3EQ1MBP6_A0A3EQ1MBP6_BOVIN 0.971938 CS pos: 23-24. VGG-QV. Pr: 0.8777 
tr_A0A3EQ1MZY9_A0A3EQ1MZY9_BOVIN 0.971938 CS pos: 23-24. VGG-QV. Pr: 0.8777 
tr_E3W9A0_E3W9A0_BOVIN 0.971938 CS pos: 23-24. VGG-QV. Pr: 0.8777 
tr_A0A3EQ1N0Z7_A0A3EQ1N0Z7_BOVIN 0.971938 CS pos: 23-24. VGG-QV. Pr: 0.8777 
tr_A0A3EQ1MI29_A0A3EQ1MI29_BOVIN 0.97024 CS pos: 26-27. VLS-QV. Pr: 0.8565 
tr_G3N1U4_G3N1U4_BOVIN 0.96835 CS pos: 24-25. VHC-LP. Pr: 0.7415 
tr_G3N1H5_G3N1H5_BOVIN 0.967645 CS pos: 26-27. VLS-QV. Pr: 0.8539 
tr_A0A3EQ1MFI7_A0A3EQ1MFI7_BOVIN 0.966937 CS pos: 26-27. VLS-QV. Pr: 0.8534 
tr_EQ32PB7_EQ32PB7_BOVIN 0.963594 CS pos: 18-19. VSS-QR. Pr: 0.8634 
tr_Q0IIA4_Q0IIA4_BOVIN 0.961539 CS pos: 26-27. SST-EQ. Pr: 0.3310 
tr_A0A3EQ1M193_A0A3EQ1M193_BOVIN 0.961539 CS pos: 26-27. SST-EQ. Pr: 0.3310 
tr_F1N726_F1N726_BOVIN 0.961539 CS pos: 26-27. SST-EQ. Pr: 0.3310 
tr_E1B726_E1B726_BOVIN 0.952875 CS pos: 26-27. GLG-DL. Pr: 0.9093 
sp_O18836_GDF8_BOVIN 0.952142 CS pos: 18-19. IVA-GP. Pr: 0.2308 
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tr_C6KEF7_C6KEF7_BOVIN 0.952142 CS pos: 18-19. IVA-GP. Pr: 0.2308 
tr_Q0P5D6_Q0P5D6_BOVIN 0.951882 CS pos: 38-39. AAA-SG. Pr: 0.5163 
tr_G3X6I0_G3X6I0_BOVIN 0.951538 CS pos: 24-25. QEA-SV. Pr: 0.2476 
tr_A4ZVC5_A4ZVC5_BOVIN 0.943421 CS pos: 23-24. VDL-NE. Pr: 0.2328 
tr_A0A3EQ1LQU4_A0A3EQ1LQU4_BOVIN 0.937515 CS pos: 29-30. TQS-HW. Pr: 0.6158 
tr_F2FB38_F2FB38_BOVIN 0.935466 CS pos: 34-35. SVA-TT. Pr: 0.6452 
tr_A6H7H6_A6H7H6_BOVIN 0.933153 CS pos: 22-23. GYG-QE. Pr: 0.8682 
sp_O18738_DAG1_BOVIN 0.926522 CS pos: 29-30. TQS-HW. Pr: 0.6044 
tr_F1MGZ5_F1MGZ5_BOVIN 0.926382 CS pos: 21-22. ALS-DS. Pr: 0.8187 
tr_A0A3EQ1MIL5_A0A3EQ1MIL5_BOVIN 0.904803 CS pos: 22-23. VLS-QV. Pr: 0.7571 
sp_P00735_THRB_BOVIN 0.876908 CS pos: 24-25. VHS-QH. Pr: 0.7859 
tr_A0A452DI66_A0A452DI66_BOVIN 0.876908 CS pos: 24-25. VHS-QH. Pr: 0.7859 
sp_EQ2KIX7_HP251_BOVIN 0.868945 CS pos: 34-35. SSA-DS. Pr: 0.4685 
tr_A0A3EQ1N1N6_A0A3EQ1N1N6_BOVIN 0.867339 CS pos: 21-22. ALA-AV. Pr: 0.6189 
tr_A0A3EQ1LTK9_A0A3EQ1LTK9_BOVIN 0.867339 CS pos: 21-22. ALA-AV. Pr: 0.6189 
tr_A0A3EQ1M6A2_A0A3EQ1M6A2_BOVIN 0.867339 CS pos: 21-22. ALA-AV. Pr: 0.6189 
tr_A0A3EQ1M299_A0A3EQ1M299_BOVIN 0.867339 CS pos: 21-22. ALA-AV. Pr: 0.6189 
tr_A0A3EQ1LI93_A0A3EQ1LI93_BOVIN 0.867339 CS pos: 21-22. ALA-AV. Pr: 0.6189 
sp_Q58CQ9_VNN1_BOVIN 0.851877 CS pos: 22-23. ASS-LD. Pr: 0.5561 
tr_EQ2KIF2_EQ2KIF2_BOVIN 0.846455 CS pos: 34-35. AQG-LT. Pr: 0.6356 
tr_A0A3EQ1MBP1_A0A3EQ1MBP1_BOVIN 0.836941 CS pos: 30-31. ALS-DT. Pr: 0.4228 
tr_A0A3EQ1M930_A0A3EQ1M930_BOVIN 0.836941 CS pos: 30-31. ALS-DT. Pr: 0.4228 
sp_EQ3MHN2_CO9_BOVIN 0.833904 CS pos: 21-22. LRA-GP. Pr: 0.5508 
tr_F1MUC5_F1MUC5_BOVIN 0.83041 CS pos: 30-31. TRS-AT. Pr: 0.2187 
tr_A0A3EQ1MUA3_A0A3EQ1MUA3_BOVIN 0.83041 CS pos: 30-31. TRS-AT. Pr: 0.2187 
tr_F1MVK1_F1MVK1_BOVIN 0.825893 CS pos: 17-18. ALS-LQ. Pr: 0.4098 
tr_E1BH06_E1BH06_BOVIN 0.825893 CS pos: 17-18. ALS-LQ. Pr: 0.4098 
tr_E1B748_E1B748_BOVIN 0.812407 CS pos: 30-31. ALS-DT. Pr: 0.4103 
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tr_E1BI72_E1BI72_BOVIN 0.812233 CS pos: 20-21. AEM-GS. Pr: 0.3983 
tr_A0A3EQ1MG04_A0A3EQ1MG04_BOVIN 0.790749 CS pos: 36-37. VQA-QF. Pr: 0.7598 
tr_A0A3EQ1M1A9_A0A3EQ1M1A9_BOVIN 0.79051 CS pos: 35-36. SQA-LL. Pr: 0.2895 
tr_E1B9H0_E1B9H0_BOVIN 0.788252 CS pos: 25-26. VQA-AL. Pr: 0.4165 
tr_E1B9E8_E1B9E8_BOVIN 0.788252 CS pos: 25-26. VQA-AL. Pr: 0.4165 
tr_F1MPE1_F1MPE1_BOVIN 0.782109 CS pos: 21-22. ALA-AV. Pr: 0.4713 
tr_A0A3EQ1LWV4_A0A3EQ1LWV4_BOVIN 0.782061 CS pos: 37-38. AHG-LL. Pr: 0.4996 
sp_EQ2KIT0_HP20_BOVIN 0.753053 CS pos: 23-24. GGC-TG. Pr: 0.2734 
tr_F6RMV5_F6RMV5_BOVIN 0.719747 CS pos: 41-42. AQG-LT. Pr: 0.5350 
sp_P80311_PPIB_BOVIN 0.717989 CS pos: 33-34. SAA-DE. Pr: 0.6327 
tr_A6QNJ8_A6QNJ8_BOVIN 0.663636 CS pos: 28-29. TFA-VD. Pr: 0.5160 
tr_F1N0F2_F1N0F2_BOVIN 0.653929 CS pos: 22-23. VSA-GG. Pr: 0.5277 
tr_EQ2KI90_EQ2KI90_BOVIN 0.653929 CS pos: 22-23. VSA-GG. Pr: 0.5277 
tr_G3MYC9_G3MYC9_BOVIN 0.612735 CS pos: 17-18. SRA-LE. Pr: 0.2653 
tr_Q58D57_Q58D57_BOVIN 0.602769 CS pos: 17-18. SRA-LE. Pr: 0.2623 
tr_A6QNL5_A6QNL5_BOVIN 0.551335 CS pos: 32-33. VNG-LY. Pr: 0.4709 
tr_E1BH94_E1BH94_BOVIN 0.544842 CS pos: 31-32. GTA-TL. Pr: 0.3593 
sp_P42899_RLA2_BOVIN 0.50869 CS pos: 16-17. GNS-SP. Pr: 0.3016 
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Table S5-5 General linear model analysis of protein abundance (Exp. P3) across dpp and OC.  
Col-
umn1 p_Q p_Oestrus p_inter Molecule Q_FDRcorr Oest_FDRcorr inter_FDRcorr 
239 8.03E-05 0.035031622 0.001386 A6H7J7_BOVIN 0.003676911 0.701306609 0.063452081 
641 0.001478 0.251659406 0.018578 G3N1F5_BOVIN 0.063180168 0.990714556 0.524156036 
427 0.004931 0.017793415 0.007187 Q56JV4_BOVIN 0.197554632 0.49589474 0.287922297 
209 0.007645 0.088358798 0.020123 AOCX_BOVIN 0.288258047 0.858055202 0.524156036 
178 0.010978 0.066430485 0.019124 ITIH1_BOVIN 0.357583809 0.858055202 0.524156036 
471 0.011157 0.161012129 0.05448 A0A3Q1LKJ1_BOVIN 0.357583809 0.979315877 0.851397162 
234 0.010813 0.356880786 0.053982 A0A3Q1N3Q6_BOVIN 0.357583809 0.990714556 0.851397162 
106 0.012073 0.025437199 0.015569 CO9_BOVIN 0.368524138 0.582330163 0.501500583 
144 0.014405 0.001547463 0.003038 A2AP_BOVIN 0.403278759 0.070851715 0.129833931 
410 0.014611 0.081049574 0.025505 A0A3Q1M0K3_BOVIN 0.403278759 0.858055202 0.605513873 
275 0.015099 0.600517594 0.127158 CFDP2_BOVIN 0.403278759 0.990714556 0.964775773 
309 0.017596 0.283550297 0.092676 F1MY85_BOVIN 0.451167347 0.990714556 0.964775773 
301 0.021293 0.036104708 0.021071 F1MHB8_BOVIN 0.524949434 0.701306609 0.524156036 
95 0.025124 0.731224731 0.180795 HNRPK_BOVIN 0.536812666 0.990714556 0.964775773 
350 0.024652 0.470807661 0.155207 Q3MHG9_BOVIN 0.536812666 0.990714556 0.964775773 
453 0.024439 0.667061287 0.184064 A0A3Q1M8H9_BOVIN 0.536812666 0.990714556 0.964775773 
137 0.023749 0.653098794 0.200709 A0A3Q1MM55_BOVIN 0.536812666 0.990714556 0.98209708 
291 0.027602 0.029958308 0.021261 A6QM09_BOVIN 0.552905567 0.640109174 0.524156036 
623 0.027225 0.092097339 0.059624 RAN_BOVIN 0.552905567 0.858055202 0.851397162 
45 0.814501 0.011 0.902992 A0A452DI25_BOVIN 0.55430884 0.035124564 0.851397162 
289 0.030266 0.051454758 0.028626 A0A3Q1M478_BOVIN 0.55430884 0.789938111 0.655336063 
345 0.030196 0.102770353 0.049737 A0A3Q1MTF0_BOVIN 0.55430884 0.861265483 0.851397162 
336 0.029182 0.349866019 0.115479 A0A3Q1M2A1_BOVIN 0.55430884 0.990714556 0.964775773 
142 0.464058 0.007 0.251329 PRDX5_BOVIN 0.624235749 0.048244654 0.851397162 
97 0.042295 0.008090475 0.015647 F6R4P6_BOVIN 0.624235749 0.305058511 0.501500583 
526 0.037948 0.097719235 0.039698 DHE3_BOVIN 0.624235749 0.858055202 0.820843466 
394 0.040353 0.096067315 0.072157 GDF8_BOVIN 0.624235749 0.858055202 0.911965137 
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134 0.040723 0.196956504 0.071758 A0A3Q1MJ46_BOVIN 0.624235749 0.984775119 0.911965137 
204 0.038065 0.348312072 0.135871 FABPH_BOVIN 0.624235749 0.990714556 0.964775773 
482 0.036903 0.262423864 0.097281 A7Z055_BOVIN 0.624235749 0.990714556 0.964775773 
650 0.040693 0.505345825 0.172571 PSA6_BOVIN 0.624235749 0.990714556 0.964775773 
652 0.042849 0.384580726 0.130261 EFHD2_BOVIN 0.624235749 0.990714556 0.964775773 
374 0.04148 0.612859836 0.213967 E1BMD1_BOVIN 0.624235749 0.990714556 0.984318014 
487 0.047519 0.239052039 0.105619 G3MXL6_BOVIN 0.662172356 0.990714556 0.964775773 
200 0.046788 0.500554812 0.263942 F1N619_BOVIN 0.662172356 0.990714556 0.994543987 
143 0.05103 0.1768248 0.117081 PURA2_BOVIN 0.666529411 0.984775119 0.964775773 
352 0.050721 0.530622368 0.169103 A0A3Q1LUW6_BOVIN 0.666529411 0.990714556 0.964775773 
418 0.051991 0.3775401 0.212994 F1MHL1_BOVIN 0.666529411 0.990714556 0.984318014 
373 0.050665 0.631704969 0.247687 G5E569_BOVIN 0.666529411 0.990714556 0.994543987 
130 0.471352 0.603213936 0.509952 G3X6I0_BOVIN 0.696436291 0.780714556 0.064543987 
614 0.064354 0.227790081 0.14768 RS28_BOVIN 0.808839841 0.990714556 0.964775773 
264 0.068663 0.025025622 0.018605 A0A3Q1LMV9_BOVIN 0.816449273 0.582330163 0.524156036 
567 0.080535 0.104802976 0.04259 A0A3Q1LUP1_BOVIN 0.816449273 0.861265483 0.827272132 
602 0.081282 0.091442425 0.097429 F1MC40_BOVIN 0.816449273 0.858055202 0.964775773 
625 0.082791 0.131392205 0.129989 F2FB38_BOVIN 0.816449273 0.919683065 0.964775773 
91 0.075247 0.249181826 0.121767 A0A3Q1LVA2_BOVIN 0.816449273 0.990714556 0.964775773 
122 0.072161 0.350704238 0.140539 PCP4_BOVIN 0.816449273 0.990714556 0.964775773 
304 0.077882 0.290871061 0.180905 HMGB1_BOVIN 0.816449273 0.990714556 0.964775773 
339 0.082363 0.463326717 0.171472 SYNC_BOVIN 0.816449273 0.990714556 0.964775773 
415 0.078085 0.293066083 0.182435 A0A3Q1M1Z4_BOVIN 0.816449273 0.990714556 0.964775773 
489 0.067766 0.226580249 0.103732 F1N1C9_BOVIN 0.816449273 0.990714556 0.964775773 
574 0.078132 0.492210783 0.175423 A2VDX0_BOVIN 0.816449273 0.990714556 0.964775773 
105 0.071659 0.496374824 0.270185 NACA_BOVIN 0.816449273 0.990714556 0.994543987 
520 0.078118 0.378601638 0.310041 F6QQ60_BOVIN 0.816449273 0.990714556 0.994543987 
622 0.072465 0.58215903 0.307217 F6QND5_BOVIN 0.816449273 0.990714556 0.994543987 
595 0.08623 0.076853692 0.08536 G5E5H2_BOVIN 0.825379534 0.858055202 0.964775773 
592 0.086272 0.458784345 0.198787 A0A3Q1LJB2_BOVIN 0.825379534 0.990714556 0.98209708 
  
 375 
60 0.091876 0.583488689 0.330882 F6Q9Q9_BOVIN 0.866068051 0.990714556 0.994543987 
507 0.100102 0.007675207 0.007646 KCRU_BOVIN 0.873440845 0.305058511 0.288281874 
493 0.096143 0.039289574 0.036446 A0A3Q1MK01_BOVIN 0.873440845 0.740724019 0.805586197 
490 0.09945 0.382297091 0.183278 DDAH2_BOVIN 0.873440845 0.990714556 0.964775773 
497 0.097193 0.644100442 0.616735 CZIB_BOVIN 0.873440845 0.990714556 0.994543987 
517 0.100834 0.67882282 0.235249 F1MKU4_BOVIN 0.873440845 0.990714556 0.994543987 
528 0.096632 0.226926427 0.225782 A0A3Q1LQR2_BOVIN 0.873440845 0.990714556 0.994543987 
211 0.104841 0.361390483 0.287584 F1MWU9_BOVIN 0.895133384 0.990714556 0.994543987 
359 0.106131 0.713861995 0.34819 DX39B_BOVIN 0.895133384 0.990714556 0.994543987 
183 0.11101 0.459461858 0.230231 PSA5_BOVIN 0.92412292 0.990714556 0.994543987 
71 0.112667 0.047211187 0.057528 Q3SYR8_BOVIN 0.92589524 0.781636274 0.851397162 
93 0.11644 0.367355525 0.170236 APOC3_BOVIN 0.927914382 0.990714556 0.964775773 
171 0.117256 0.599415293 0.306974 A0A3Q1N4K8_BOVIN 0.927914382 0.990714556 0.994543987 
408 0.114439 0.52676939 0.255806 E1BI72_BOVIN 0.927914382 0.990714556 0.994543987 
585 0.121283 0.091426527 0.113266 A5D7J6_BOVIN 0.936658134 0.858055202 0.964775773 
220 0.120297 0.836971811 0.34994 A6H7E3_BOVIN 0.936658134 0.990714556 0.994543987 
323 0.129295 0.855955497 0.421966 A7MBI5_BOVIN 0.986641871 0.990714556 0.994543987 
203 0.134202 0.093379716 0.04916 E1BKX7_BOVIN 0.991368295 0.858055202 0.851397162 
378 0.133705 0.173470071 0.10036 O62652_BOVIN 0.991368295 0.984775119 0.964775773 
361 0.134554 0.355744254 0.309424 UPK3L_BOVIN 0.991368295 0.990714556 0.994543987 
432 0.268203 0.004681947 0.013342 MESD_BOVIN 0.996436291 0.200075189 0.475136946 
401 0.226318 0.021605411 0.038979 E1BLV6_BOVIN 0.996436291 0.532656478 0.820843466 
406 0.315356 0.01372719 0.041987 TM214_BOVIN 0.996436291 0.472981997 0.827272132 
170 0.231752 0.014322099 0.059676 HP252_BOVIN 0.996436291 0.472981997 0.851397162 
17 0.220219 0.016675585 0.059902 APOA1_BOVIN 0.996436291 0.485865903 0.851397162 
485 0.522242 0.015960625 0.056453 E1BP41_BOVIN 0.996436291 0.485865903 0.851397162 
534 0.317073 0.044378772 0.052622 RLA0_BOVIN 0.996436291 0.781636274 0.851397162 
407 0.199105 0.052991168 0.054916 A5D7Q2_BOVIN 0.996436291 0.789938111 0.851397162 
654 0.169575 0.052073107 0.061099 S100G_BOVIN 0.996436291 0.789938111 0.851397162 
238 0.14716 0.065381241 0.059615 G3N1H5_BOVIN 0.996436291 0.858055202 0.851397162 
  
 376 
445 0.182194 0.046067642 0.072559 G3MZE0_BOVIN 0.996436291 0.781636274 0.911965137 
368 0.250774 0.055350438 0.067705 COMT_BOVIN 0.996436291 0.806355243 0.911965137 
250 0.14937 0.060374736 0.068466 A0A3Q1ML26_BOVIN 0.996436291 0.858055202 0.911965137 
308 0.597402 0.014757629 0.079868 D2U6Q4_BOVIN 0.996436291 0.472981997 0.964775773 
498 0.59294 0.019231812 0.103912 F1MMK9_BOVIN 0.996436291 0.513649633 0.964775773 
14 0.496968 0.020464205 0.115238 B0JYQ0_BOVIN 0.996436291 0.524702204 0.964775773 
547 0.492698 0.029259744 0.105795 A0A3Q1MBT3_BOVIN 0.996436291 0.640109174 0.964775773 
518 0.536923 0.034935261 0.085909 F1MTR1_BOVIN 0.996436291 0.701306609 0.964775773 
389 0.609234 0.047556653 0.136723 PSA3_BOVIN 0.996436291 0.781636274 0.964775773 
642 0.596168 0.04302621 0.183544 A0A3Q1LP76_BOVIN 0.996436291 0.781636274 0.964775773 
360 0.287321 0.052241062 0.10251 Q2KJ57_BOVIN 0.996436291 0.789938111 0.964775773 
36 0.374024 0.075583582 0.182445 B0JYN6_BOVIN 0.996436291 0.858055202 0.964775773 
40 0.154621 0.072779191 0.120382 A1BG_BOVIN 0.996436291 0.858055202 0.964775773 
221 0.478133 0.070029238 0.1639 A0A3Q1LWV8_BOVIN 0.996436291 0.858055202 0.964775773 
223 0.85947 0.073940795 0.149898 MVP_BOVIN 0.996436291 0.858055202 0.964775773 
281 0.453483 0.069475166 0.123857 A6QLZ0_BOVIN 0.996436291 0.858055202 0.964775773 
338 0.508588 0.073308363 0.14441 A0A3Q1M8L6_BOVIN 0.996436291 0.858055202 0.964775773 
365 0.271803 0.096460952 0.162621 F1N694_BOVIN 0.996436291 0.858055202 0.964775773 
385 0.325628 0.076116928 0.137883 Q5H9M6_BOVIN 0.996436291 0.858055202 0.964775773 
474 0.365027 0.071950844 0.129319 TBB5_BOVIN 0.996436291 0.858055202 0.964775773 
511 0.472509 0.095415667 0.171329 M5FMU4_BOVIN 0.996436291 0.858055202 0.964775773 
540 0.423131 0.070049855 0.150985 AFAM_BOVIN 0.996436291 0.858055202 0.964775773 
551 0.523184 0.089679336 0.185036 A0A3Q1MBP6_BOVIN 0.996436291 0.858055202 0.964775773 
552 0.425587 0.0863586 0.149719 G3N1E4_BOVIN 0.996436291 0.858055202 0.964775773 
78 0.334923 0.102843494 0.08524 K1C19_BOVIN 0.996436291 0.861265483 0.964775773 
327 0.213769 0.102253213 0.185129 A0A3Q1M9I5_BOVIN 0.996436291 0.861265483 0.964775773 
384 0.273741 0.104206627 0.126151 F1N169_BOVIN 0.996436291 0.861265483 0.964775773 
62 0.276692 0.116375566 0.1518 PDIA3_BOVIN 0.996436291 0.919683065 0.964775773 
69 0.230125 0.136784171 0.139614 HP20_BOVIN 0.996436291 0.919683065 0.964775773 
157 0.288062 0.124040407 0.161139 PSMD2_BOVIN 0.996436291 0.919683065 0.964775773 
  
 377 
248 0.218555 0.127689087 0.180796 RLA2_BOVIN 0.996436291 0.919683065 0.964775773 
294 0.478339 0.113367855 0.148592 E1BLZ8_BOVIN 0.996436291 0.919683065 0.964775773 
324 0.636282 0.122475687 0.147977 Q32PB7_BOVIN 0.996436291 0.919683065 0.964775773 
399 0.342392 0.118252708 0.152294 E1BEX4_BOVIN 0.996436291 0.919683065 0.964775773 
404 0.169021 0.13515889 0.121334 A0A452DHY4_BOVIN 0.996436291 0.919683065 0.964775773 
530 0.314013 0.131718865 0.119218 A0A3Q1NJM8_BOVIN 0.996436291 0.919683065 0.964775773 
594 0.292811 0.127620664 0.168932 F1N3Q7_BOVIN 0.996436291 0.919683065 0.964775773 
231 0.49319 0.14070669 0.164738 Q2TBR3_BOVIN 0.996436291 0.922052917 0.964775773 
557 0.895878 0.142773819 0.181559 A0A3Q1MF86_BOVIN 0.996436291 0.924424424 0.964775773 
129 0.171336 0.183438743 0.098179 SYWC_BOVIN 0.996436291 0.984775119 0.964775773 
267 0.144553 0.17965262 0.089385 MOES_BOVIN 0.996436291 0.984775119 0.964775773 
303 0.194228 0.177157324 0.106104 E1BFV0_BOVIN 0.996436291 0.984775119 0.964775773 
332 0.529266 0.214982964 0.172312 F1MJ95_BOVIN 0.996436291 0.984775119 0.964775773 
500 0.316027 0.209879484 0.166099 F2FB42_BOVIN 0.996436291 0.984775119 0.964775773 
635 0.194042 0.190970193 0.176594 A4IFV2_BOVIN 0.996436291 0.984775119 0.964775773 
70 0.243716 0.226768939 0.150956 LKHA4_BOVIN 0.996436291 0.990714556 0.964775773 
259 0.326859 0.243613738 0.153512 PGAM1_BOVIN 0.996436291 0.990714556 0.964775773 
391 0.825428 0.078855085 0.190728 F2Z4D5_BOVIN 0.996436291 0.858055202 0.97892464 
375 0.437479 0.156048091 0.192116 E1BKQ7_BOVIN 0.996436291 0.974458659 0.97892464 
226 0.252205 0.408863887 0.192425 ENPL_BOVIN 0.996436291 0.990714556 0.97892464 
577 0.976029 0.091366527 0.195505 F1MWD3_BOVIN 0.996436291 0.858055202 0.979054762 
227 0.182553 0.155092517 0.195318 AK1A1_BOVIN 0.996436291 0.974458659 0.979054762 
495 0.285652 0.202004055 0.200207 A0A140T846_BOVIN 0.996436291 0.984775119 0.98209708 
572 0.689052 0.115200879 0.210941 E1B748_BOVIN 0.996436291 0.919683065 0.984318014 
126 0.424565 0.193133802 0.214984 AMPL_BOVIN 0.996436291 0.984775119 0.984318014 
181 0.71001 0.193848214 0.206194 F2Z4C1_BOVIN 0.996436291 0.984775119 0.984318014 
195 0.158174 0.212821043 0.209043 F1MU19_BOVIN 0.996436291 0.984775119 0.984318014 
619 0.552288 0.179973332 0.212258 USO1_BOVIN 0.996436291 0.984775119 0.984318014 
523 0.16933 0.473368981 0.207271 CLP1_BOVIN 0.996436291 0.990714556 0.984318014 
649 0.185619 0.331596143 0.2109 A0A3Q1M6K6_BOVIN 0.996436291 0.990714556 0.984318014 
  
 378 
117 0.414482 0.09145192 0.423321 A0A452DIM3_BOVIN 0.996436291 0.858055202 0.994543987 
645 0.646523 0.083496772 0.280674 F1MQH8_BOVIN 0.996436291 0.858055202 0.994543987 
174 0.732554 0.135271975 0.298717 A0A3Q1LVC8_BOVIN 0.996436291 0.919683065 0.994543987 
266 0.984651 0.121173899 0.314679 A0A3Q1MJ74_BOVIN 0.996436291 0.919683065 0.994543987 
351 0.834779 0.129133075 0.315348 F1MLM2_BOVIN 0.996436291 0.919683065 0.994543987 
456 0.527966 0.120061012 0.245734 E1BM96_BOVIN 0.996436291 0.919683065 0.994543987 
571 0.626249 0.137737245 0.323926 A0A3Q1MFI7_BOVIN 0.996436291 0.919683065 0.994543987 
662 0.96369 0.13771266 0.305402 A0A452DI85_BOVIN 0.996436291 0.919683065 0.994543987 
632 0.663266 0.140969089 0.464763 E1BNG8_BOVIN 0.996436291 0.922052917 0.994543987 
455 0.738553 0.14791416 0.363347 A0A3Q1LV73_BOVIN 0.996436291 0.948129765 0.994543987 
509 0.611729 0.156582281 0.33903 A0A3Q1MDA5_BOVIN 0.996436291 0.974458659 0.994543987 
33 0.516676 0.166529533 0.246246 PRDX6_BOVIN 0.996436291 0.979315877 0.994543987 
307 0.250251 0.166372583 0.238962 A6H7A2_BOVIN 0.996436291 0.979315877 0.994543987 
331 0.713737 0.160024205 0.220101 Q2KJ75_BOVIN 0.996436291 0.979315877 0.994543987 
412 0.490326 0.163491087 0.303497 A0A3Q1N1K0_BOVIN 0.996436291 0.979315877 0.994543987 
640 0.733379 0.164654026 0.488985 A1A4N9_BOVIN 0.996436291 0.979315877 0.994543987 
34 0.652572 0.20618374 0.442941 VTDB_BOVIN 0.996436291 0.984775119 0.994543987 
94 0.468502 0.206531206 0.399105 ASGL1_BOVIN 0.996436291 0.984775119 0.994543987 
110 0.716891 0.194707261 0.231188 A0A3Q1LN63_BOVIN 0.996436291 0.984775119 0.994543987 
233 0.34348 0.210947812 0.314638 ACLY_BOVIN 0.996436291 0.984775119 0.994543987 
240 0.6487 0.209948616 0.479195 C1QBP_BOVIN 0.996436291 0.984775119 0.994543987 
276 0.86946 0.206128567 0.508393 A0A3Q1MIN7_BOVIN 0.996436291 0.984775119 0.994543987 
280 0.534283 0.209251546 0.322738 B8Y9T0_BOVIN 0.996436291 0.984775119 0.994543987 
296 0.309379 0.210624473 0.275715 F1MW03_BOVIN 0.996436291 0.984775119 0.994543987 
376 0.941836 0.198582089 0.461555 A5PJV5_BOVIN 0.996436291 0.984775119 0.994543987 
382 0.938168 0.211841654 0.47609 F193B_BOVIN 0.996436291 0.984775119 0.994543987 
403 0.703142 0.215083489 0.388326 Q0VD52_BOVIN 0.996436291 0.984775119 0.994543987 
423 0.721084 0.204145113 0.338921 G3MYM8_BOVIN 0.996436291 0.984775119 0.994543987 
496 0.794895 0.209954477 0.424436 G3MX65_BOVIN 0.996436291 0.984775119 0.994543987 
501 0.697264 0.210872606 0.399456 ABRAL_BOVIN 0.996436291 0.984775119 0.994543987 
  
 379 
531 0.865612 0.18521478 0.261587 EF1B_BOVIN 0.996436291 0.984775119 0.994543987 
575 0.462516 0.196847797 0.23306 A0A3Q1LY31_BOVIN 0.996436291 0.984775119 0.994543987 
603 0.157407 0.203241039 0.252394 A0A3Q1LHZ0_BOVIN 0.996436291 0.984775119 0.994543987 
15 0.723433 0.80072163 0.890098 HBB_BOVIN 0.996436291 0.990714556 0.994543987 
16 0.378154 0.26301801 0.243661 HBA_BOVIN 0.996436291 0.990714556 0.994543987 
19 0.681659 0.535614671 0.636644 ANXA1_BOVIN 0.996436291 0.990714556 0.994543987 
20 0.189908 0.817346386 0.308922 FOLR1_BOVIN 0.996436291 0.990714556 0.994543987 
21 0.704588 0.574759805 0.803247 ANXA2_BOVIN 0.996436291 0.990714556 0.994543987 
23 0.528609 0.384260109 0.511703 E1BI28_BOVIN 0.996436291 0.990714556 0.994543987 
24 0.819388 0.702126854 0.71177 HSPB1_BOVIN 0.996436291 0.990714556 0.994543987 
25 0.760551 0.691414784 0.891144 KCRB_BOVIN 0.996436291 0.990714556 0.994543987 
26 0.146224 0.96874577 0.491049 A6QLL8_BOVIN 0.996436291 0.990714556 0.994543987 
28 0.730206 0.732515477 0.658286 EZRI_BOVIN 0.996436291 0.990714556 0.994543987 
29 0.407301 0.343646542 0.286354 PIGR_BOVIN 0.996436291 0.990714556 0.994543987 
30 0.706238 0.527172004 0.718603 A1AG_BOVIN 0.996436291 0.990714556 0.994543987 
31 0.963066 0.633982313 0.514856 Q3ZC87_BOVIN 0.996436291 0.990714556 0.994543987 
32 0.608507 0.473309301 0.649614 CFAB_BOVIN 0.996436291 0.990714556 0.994543987 
35 0.390745 0.890161377 0.852026 TPIS_BOVIN 0.996436291 0.990714556 0.994543987 
37 0.743357 0.367085302 0.444899 PPIA_BOVIN 0.996436291 0.990714556 0.994543987 
38 0.174803 0.502714617 0.23225 GSTP1_BOVIN 0.996436291 0.990714556 0.994543987 
41 0.895979 0.776994219 0.835888 A7Z014_BOVIN 0.996436291 0.990714556 0.994543987 
42 0.207064 0.492368317 0.397656 NDKB_BOVIN 0.996436291 0.990714556 0.994543987 
43 0.894252 0.880010325 0.948764 THIO_BOVIN 0.996436291 0.990714556 0.994543987 
44 0.979303 0.668298822 0.870054 F1MAV0_BOVIN 0.996436291 0.990714556 0.994543987 
46 0.821358 0.656276121 0.897613 PROF1_BOVIN 0.996436291 0.990714556 0.994543987 
47 0.515452 0.384780466 0.272359 GDIB_BOVIN 0.996436291 0.990714556 0.994543987 
48 0.897718 0.406262473 0.411169 Q3ZCI4_BOVIN 0.996436291 0.990714556 0.994543987 
49 0.584368 0.424667677 0.654742 MIF_BOVIN 0.996436291 0.990714556 0.994543987 
50 0.505988 0.935073276 0.872726 A7Z057_BOVIN 0.996436291 0.990714556 0.994543987 
51 0.506192 0.693073256 0.907242 GRP_BOVIN 0.996436291 0.990714556 0.994543987 
  
 380 
53 0.689963 0.924942 0.830559 ABHEB_BOVIN 0.996436291 0.990714556 0.994543987 
54 0.477788 0.5749247 0.614507 Q5DPW9_BOVIN 0.996436291 0.990714556 0.994543987 
55 0.589724 0.935988731 0.877385 A0A452DIW4_BOVIN 0.996436291 0.990714556 0.994543987 
56 0.232708 0.668022429 0.507549 BIP_BOVIN 0.996436291 0.990714556 0.994543987 
57 0.713249 0.750601685 0.826317 PEBP1_BOVIN 0.996436291 0.990714556 0.994543987 
58 0.942888 0.632730535 0.949091 PARK7_BOVIN 0.996436291 0.990714556 0.994543987 
59 0.80761 0.334006638 0.318622 A0A3Q1M5R4_BOVIN 0.996436291 0.990714556 0.994543987 
63 0.585049 0.871431216 0.903818 G3X757_BOVIN 0.996436291 0.990714556 0.994543987 
65 0.559229 0.390354201 0.626239 A0A140T831_BOVIN 0.996436291 0.990714556 0.994543987 
66 0.206282 0.361913596 0.302885 S10A4_BOVIN 0.996436291 0.990714556 0.994543987 
67 0.510407 0.708377722 0.860085 A0A3Q1LKR8_BOVIN 0.996436291 0.990714556 0.994543987 
68 0.720969 0.7325528 0.867002 AMPN_BOVIN 0.996436291 0.990714556 0.994543987 
72 0.829751 0.770045678 0.775164 AN32A_BOVIN 0.996436291 0.990714556 0.994543987 
73 0.986005 0.869428089 0.845349 G5E5C8_BOVIN 0.996436291 0.990714556 0.994543987 
74 0.681199 0.797149865 0.913719 ACTN4_BOVIN 0.996436291 0.990714556 0.994543987 
75 0.673507 0.532919572 0.746809 SAHH_BOVIN 0.996436291 0.990714556 0.994543987 
76 0.747467 0.822061365 0.822333 A0A3Q1LJT1_BOVIN 0.996436291 0.990714556 0.994543987 
79 0.638393 0.565568532 0.837065 F1MQ37_BOVIN 0.996436291 0.990714556 0.994543987 
80 0.968668 0.859804838 0.932401 F1N2I5_BOVIN 0.996436291 0.990714556 0.994543987 
81 0.777826 0.590428406 0.798545 F1N0E5_BOVIN 0.996436291 0.990714556 0.994543987 
82 0.64067 0.866036222 0.950515 GLRX1_BOVIN 0.996436291 0.990714556 0.994543987 
84 0.490298 0.374442631 0.31081 F1N3J3_BOVIN 0.996436291 0.990714556 0.994543987 
86 0.743766 0.887701266 0.928412 F1MM83_BOVIN 0.996436291 0.990714556 0.994543987 
87 0.466255 0.751928853 0.642402 ATOX1_BOVIN 0.996436291 0.990714556 0.994543987 
88 0.946111 0.747775769 0.727485 LG3BP_BOVIN 0.996436291 0.990714556 0.994543987 
89 0.794357 0.790459208 0.881808 CAH2_BOVIN 0.996436291 0.990714556 0.994543987 
90 0.205307 0.600660156 0.38462 A0A452DII8_BOVIN 0.996436291 0.990714556 0.994543987 
92 0.489925 0.303290229 0.368187 F1MP31_BOVIN 0.996436291 0.990714556 0.994543987 
96 0.427229 0.523397268 0.832965 A7E3D5_BOVIN 0.996436291 0.990714556 0.994543987 
98 0.755595 0.888701288 0.949335 STIP1_BOVIN 0.996436291 0.990714556 0.994543987 
  
 381 
99 0.145585 0.582897316 0.441809 VNN1_BOVIN 0.996436291 0.990714556 0.994543987 
100 0.906368 0.903204687 0.856701 F1N4K1_BOVIN 0.996436291 0.990714556 0.994543987 
101 0.604591 0.31930205 0.413172 A0A3Q1MFI5_BOVIN 0.996436291 0.990714556 0.994543987 
102 0.891594 0.756329387 0.685218 ANXA8_BOVIN 0.996436291 0.990714556 0.994543987 
103 0.852107 0.79402138 0.592029 ARF1_BOVIN 0.996436291 0.990714556 0.994543987 
104 0.687229 0.563657779 0.702181 A0A3Q1NNJ3_BOVIN 0.996436291 0.990714556 0.994543987 
107 0.601672 0.789707862 0.605064 F1MYN5_BOVIN 0.996436291 0.990714556 0.994543987 
108 0.447802 0.465301896 0.393042 Q17QX0_BOVIN 0.996436291 0.990714556 0.994543987 
109 0.921923 0.282627374 0.488444 TCPD_BOVIN 0.996436291 0.990714556 0.994543987 
111 0.652943 0.829620299 0.55549 Q1RMP3_BOVIN 0.996436291 0.990714556 0.994543987 
112 0.490775 0.948370894 0.760365 A0A3Q1M352_BOVIN 0.996436291 0.990714556 0.994543987 
113 0.86404 0.847842934 0.768784 ACBP_BOVIN 0.996436291 0.990714556 0.994543987 
114 0.832611 0.635768806 0.736783 FKB1A_BOVIN 0.996436291 0.990714556 0.994543987 
115 0.34087 0.332862901 0.344703 Q58CS3_BOVIN 0.996436291 0.990714556 0.994543987 
116 0.729833 0.286585679 0.486887 B3VTM3_BOVIN 0.996436291 0.990714556 0.994543987 
119 0.532251 0.410997354 0.92352 A0A3Q1NJB1_BOVIN 0.996436291 0.990714556 0.994543987 
120 0.185927 0.451922157 0.233191 SERA_BOVIN 0.996436291 0.990714556 0.994543987 
121 0.659861 0.818799038 0.613161 ARSA_BOVIN 0.996436291 0.990714556 0.994543987 
123 0.845791 0.818301495 0.805382 PSME1_BOVIN 0.996436291 0.990714556 0.994543987 
125 0.356951 0.584220447 0.635727 PTMA_BOVIN 0.996436291 0.990714556 0.994543987 
127 0.909141 0.795093632 0.601269 LDHA_BOVIN 0.996436291 0.990714556 0.994543987 
128 0.586323 0.711849251 0.670576 A0A3Q1MKY2_BOVIN 0.996436291 0.990714556 0.994543987 
131 0.489072 0.648789217 0.529004 TAGL2_BOVIN 0.996436291 0.990714556 0.994543987 
132 0.964567 0.81980148 0.958158 CAPG_BOVIN 0.996436291 0.990714556 0.994543987 
133 0.31123 0.595007691 0.550055 TCPZ_BOVIN 0.996436291 0.990714556 0.994543987 
135 0.884675 0.749680819 0.837488 F1MUZ9_BOVIN 0.996436291 0.990714556 0.994543987 
136 0.915957 0.522082528 0.552453 ENOPH_BOVIN 0.996436291 0.990714556 0.994543987 
138 0.532206 0.892004619 0.795274 COF1_BOVIN 0.996436291 0.990714556 0.994543987 
139 0.552898 0.533632062 0.345062 RL40_BOVIN 0.996436291 0.990714556 0.994543987 
140 0.892232 0.78967138 0.850402 PCBP1_BOVIN 0.996436291 0.990714556 0.994543987 
  
 382 
141 0.955429 0.384287218 0.450221 F1MYX5_BOVIN 0.996436291 0.990714556 0.994543987 
145 0.390105 0.679246057 0.722635 A0A3Q1LX83_BOVIN 0.996436291 0.990714556 0.994543987 
146 0.302953 0.709247337 0.526501 ST1A1_BOVIN 0.996436291 0.990714556 0.994543987 
147 0.732723 0.774870663 0.900625 MYL9_BOVIN 0.996436291 0.990714556 0.994543987 
148 0.501743 0.960874196 0.610959 TTHY_BOVIN 0.996436291 0.990714556 0.994543987 
149 0.823127 0.786383399 0.939311 HSP7C_BOVIN 0.996436291 0.990714556 0.994543987 
150 0.443636 0.779872182 0.622464 A0A3Q1MEU1_BOVIN 0.996436291 0.990714556 0.994543987 
151 0.749388 0.482675382 0.636173 THRB_BOVIN 0.996436291 0.990714556 0.994543987 
152 0.200396 0.93798794 0.575028 F6QEU6_BOVIN 0.996436291 0.990714556 0.994543987 
153 0.269047 0.886809486 0.912737 A0A3Q1LU13_BOVIN 0.996436291 0.990714556 0.994543987 
154 0.691878 0.310484282 0.427153 APOA2_BOVIN 0.996436291 0.990714556 0.994543987 
156 0.355443 0.364709552 0.302073 CALM_BOVIN 0.996436291 0.990714556 0.994543987 
158 0.855188 0.715538701 0.914199 F1N647_BOVIN 0.996436291 0.990714556 0.994543987 
159 0.454118 0.860971087 0.942195 PNCB_BOVIN 0.996436291 0.990714556 0.994543987 
160 0.892044 0.375461984 0.404461 APT_BOVIN 0.996436291 0.990714556 0.994543987 
161 0.851103 0.606722933 0.642206 1433T_BOVIN 0.996436291 0.990714556 0.994543987 
162 0.593467 0.274749581 0.471964 TFF3_BOVIN 0.996436291 0.990714556 0.994543987 
163 0.633587 0.793315315 0.719335 PSA1_BOVIN 0.996436291 0.990714556 0.994543987 
164 0.493923 0.744546549 0.922239 CLIC1_BOVIN 0.996436291 0.990714556 0.994543987 
165 0.309016 0.691578587 0.810531 F1MWR8_BOVIN 0.996436291 0.990714556 0.994543987 
166 0.89203 0.736906471 0.798966 1433E_BOVIN 0.996436291 0.990714556 0.994543987 
167 0.427105 0.76452395 0.937412 A1AT_BOVIN 0.996436291 0.990714556 0.994543987 
168 0.946131 0.73522139 0.671586 A0A3Q1MFC3_BOVIN 0.996436291 0.990714556 0.994543987 
169 0.757135 0.92555209 0.867264 G3X6S5_BOVIN 0.996436291 0.990714556 0.994543987 
172 0.35127 0.83791452 0.660112 H9KUV2_BOVIN 0.996436291 0.990714556 0.994543987 
173 0.437201 0.375669612 0.467071 A0A3Q1LPG0_BOVIN 0.996436291 0.990714556 0.994543987 
175 0.449012 0.821423775 0.682826 A6QNL5_BOVIN 0.996436291 0.990714556 0.994543987 
176 0.444478 0.301771079 0.384479 G3P_BOVIN 0.996436291 0.990714556 0.994543987 
177 0.87423 0.445324525 0.522709 GALK1_BOVIN 0.996436291 0.990714556 0.994543987 
179 0.848071 0.274405284 0.279527 F1MCK2_BOVIN 0.996436291 0.990714556 0.994543987 
  
 383 
180 0.779933 0.686143982 0.948804 ESTD_BOVIN 0.996436291 0.990714556 0.994543987 
182 0.934569 0.555397539 0.590936 A0A3Q1MN33_BOVIN 0.996436291 0.990714556 0.994543987 
186 0.51714 0.870745619 0.791412 A4FV56_BOVIN 0.996436291 0.990714556 0.994543987 
187 0.685247 0.482735432 0.806838 STMN1_BOVIN 0.996436291 0.990714556 0.994543987 
188 0.733705 0.582627213 0.571739 GDIA_BOVIN 0.996436291 0.990714556 0.994543987 
189 0.964624 0.589265784 0.758072 PRDX1_BOVIN 0.996436291 0.990714556 0.994543987 
191 0.984067 0.63486794 0.717318 TBB2B_BOVIN 0.996436291 0.990714556 0.994543987 
192 0.34331 0.219015403 0.337027 Q0IIA4_BOVIN 0.996436291 0.990714556 0.994543987 
193 0.409387 0.727194355 0.871887 G6PI_BOVIN 0.996436291 0.990714556 0.994543987 
196 0.199245 0.347396321 0.220741 EF2_BOVIN 0.996436291 0.990714556 0.994543987 
197 0.785559 0.707314969 0.583176 MVD1_BOVIN 0.996436291 0.990714556 0.994543987 
198 0.713439 0.277132513 0.289379 A0A3Q1LGM4_BOVIN 0.996436291 0.990714556 0.994543987 
199 0.829828 0.27445828 0.534442 AN32B_BOVIN 0.996436291 0.990714556 0.994543987 
201 0.508841 0.660267178 0.478981 A5D9D1_BOVIN 0.996436291 0.990714556 0.994543987 
202 0.210206 0.798112926 0.666175 G5E5Y5_BOVIN 0.996436291 0.990714556 0.994543987 
205 0.883598 0.471230092 0.54915 RANG_BOVIN 0.996436291 0.990714556 0.994543987 
206 0.827692 0.794344893 0.568038 Q3SZN8_BOVIN 0.996436291 0.990714556 0.994543987 
207 0.279779 0.480512171 0.340466 GPX1_BOVIN 0.996436291 0.990714556 0.994543987 
208 0.509392 0.297687855 0.382712 PGK1_BOVIN 0.996436291 0.990714556 0.994543987 
210 0.838588 0.842076627 0.869927 Q28908_BOVIN 0.996436291 0.990714556 0.994543987 
212 0.798973 0.855566119 0.832082 LY66C_BOVIN 0.996436291 0.990714556 0.994543987 
213 0.544252 0.695878655 0.460556 BPNT1_BOVIN 0.996436291 0.990714556 0.994543987 
214 0.308363 0.359383888 0.304334 LEG1_BOVIN 0.996436291 0.990714556 0.994543987 
215 0.600387 0.254775638 0.356735 NHRF3_BOVIN 0.996436291 0.990714556 0.994543987 
216 0.669451 0.667756034 0.67294 A0A3Q1N1N6_BOVIN 0.996436291 0.990714556 0.994543987 
217 0.978126 0.718212959 0.859351 CAH1_BOVIN 0.996436291 0.990714556 0.994543987 
218 0.564664 0.904248605 0.718867 SPSY_BOVIN 0.996436291 0.990714556 0.994543987 
219 0.912617 0.68343065 0.685061 A0A3Q1LTP0_BOVIN 0.996436291 0.990714556 0.994543987 
222 0.501214 0.862001438 0.903154 GRP75_BOVIN 0.996436291 0.990714556 0.994543987 
224 0.645407 0.841726277 0.858136 ADHX_BOVIN 0.996436291 0.990714556 0.994543987 
  
 384 
225 0.839588 0.73363831 0.540378 PTGR1_BOVIN 0.996436291 0.990714556 0.994543987 
228 0.94433 0.427248107 0.442156 A0A3Q1LQ34_BOVIN 0.996436291 0.990714556 0.994543987 
229 0.805087 0.273654119 0.530383 DBNL_BOVIN 0.996436291 0.990714556 0.994543987 
230 0.25919 0.600456774 0.300705 F1MKS5_BOVIN 0.996436291 0.990714556 0.994543987 
232 0.688226 0.333307141 0.36379 A0A3Q1LU36_BOVIN 0.996436291 0.990714556 0.994543987 
235 0.585255 0.844395454 0.828028 A0A3Q1MM86_BOVIN 0.996436291 0.990714556 0.994543987 
237 0.565739 0.492116433 0.481949 A6QLT9_BOVIN 0.996436291 0.990714556 0.994543987 
241 0.325185 0.650536707 0.533835 A0A3Q1MDA4_BOVIN 0.996436291 0.990714556 0.994543987 
242 0.900468 0.438404643 0.601973 A0A3Q1MFJ2_BOVIN 0.996436291 0.990714556 0.994543987 
243 0.428455 0.275961018 0.420285 TPMT_BOVIN 0.996436291 0.990714556 0.994543987 
244 0.866451 0.813123135 0.804926 F1N3P2_BOVIN 0.996436291 0.990714556 0.994543987 
245 0.377452 0.42675055 0.753205 A0A452DHV9_BOVIN 0.996436291 0.990714556 0.994543987 
246 0.936633 0.723633891 0.835789 F1MM57_BOVIN 0.996436291 0.990714556 0.994543987 
249 0.613434 0.422741581 0.621289 A0A3Q1LXR9_BOVIN 0.996436291 0.990714556 0.994543987 
251 0.803928 0.258537541 0.246364 PSA4_BOVIN 0.996436291 0.990714556 0.994543987 
253 0.230121 0.436684446 0.437274 TBCA_BOVIN 0.996436291 0.990714556 0.994543987 
254 0.945511 0.49874335 0.639142 ANXA4_BOVIN 0.996436291 0.990714556 0.994543987 
255 0.189832 0.536807879 0.309894 TYB10_BOVIN 0.996436291 0.990714556 0.994543987 
256 0.464883 0.301982209 0.456643 IF5A1_BOVIN 0.996436291 0.990714556 0.994543987 
257 0.773805 0.665656933 0.782986 F1MLX9_BOVIN 0.996436291 0.990714556 0.994543987 
258 0.761543 0.672540592 0.761839 HP251_BOVIN 0.996436291 0.990714556 0.994543987 
260 0.915938 0.56974245 0.833215 A2VE41_BOVIN 0.996436291 0.990714556 0.994543987 
261 0.919921 0.412766421 0.6975 Q0P5D6_BOVIN 0.996436291 0.990714556 0.994543987 
262 0.530028 0.259504611 0.302038 A0A498UZ20_BOVIN 0.996436291 0.990714556 0.994543987 
265 0.16946 0.434920294 0.24864 F1MDH3_BOVIN 0.996436291 0.990714556 0.994543987 
268 0.855502 0.619501812 0.662927 F1MPU0_BOVIN 0.996436291 0.990714556 0.994543987 
269 0.158601 0.523317116 0.420653 WDR1_BOVIN 0.996436291 0.990714556 0.994543987 
270 0.751288 0.59574723 0.589419 B2MG_BOVIN 0.996436291 0.990714556 0.994543987 
272 0.383514 0.696963447 0.521744 SERPH_BOVIN 0.996436291 0.990714556 0.994543987 
273 0.853153 0.680874973 0.835537 E1BDF5_BOVIN 0.996436291 0.990714556 0.994543987 
  
 385 
274 0.650077 0.663010507 0.748937 Q2KIF2_BOVIN 0.996436291 0.990714556 0.994543987 
277 0.949602 0.435473933 0.813008 A0A140T894_BOVIN 0.996436291 0.990714556 0.994543987 
279 0.641343 0.310402833 0.471535 A0A3Q1LKU1_BOVIN 0.996436291 0.990714556 0.994543987 
282 0.958834 0.651496052 0.890244 A0A3Q1LTS9_BOVIN 0.996436291 0.990714556 0.994543987 
283 0.696724 0.461721509 0.591877 PEDF_BOVIN 0.996436291 0.990714556 0.994543987 
285 0.572606 0.352607271 0.511205 Q3T0Z0_BOVIN 0.996436291 0.990714556 0.994543987 
286 0.349002 0.613755964 0.481253 E1BJG5_BOVIN 0.996436291 0.990714556 0.994543987 
287 0.901261 0.797167443 0.91126 SODC_BOVIN 0.996436291 0.990714556 0.994543987 
290 0.81928 0.609643509 0.737224 E1BBY7_BOVIN 0.996436291 0.990714556 0.994543987 
292 0.642805 0.405147859 0.823138 E1BJP1_BOVIN 0.996436291 0.990714556 0.994543987 
293 0.168468 0.264040387 0.275723 A0A3Q1M4L0_BOVIN 0.996436291 0.990714556 0.994543987 
295 0.54478 0.296115952 0.494229 A0A3Q1LQQ0_BOVIN 0.996436291 0.990714556 0.994543987 
297 0.481761 0.360695572 0.339698 A0A3Q1MNN6_BOVIN 0.996436291 0.990714556 0.994543987 
298 0.555997 0.436948529 0.885015 A4IFI0_BOVIN 0.996436291 0.990714556 0.994543987 
299 0.611851 0.890212679 0.574796 A6QQA8_BOVIN 0.996436291 0.990714556 0.994543987 
300 0.929572 0.92489998 0.744646 A0A140T8A5_BOVIN 0.996436291 0.990714556 0.994543987 
302 0.399383 0.24786613 0.277843 FRIL_BOVIN 0.996436291 0.990714556 0.994543987 
305 0.475513 0.726645797 0.622393 V6F9B4_BOVIN 0.996436291 0.990714556 0.994543987 
306 0.786112 0.864826844 0.875057 RL4_BOVIN 0.996436291 0.990714556 0.994543987 
310 0.191953 0.323611895 0.281837 G5E580_BOVIN 0.996436291 0.990714556 0.994543987 
312 0.783997 0.812911518 0.919079 IF4A2_BOVIN 0.996436291 0.990714556 0.994543987 
313 0.981184 0.382644078 0.657354 A0A3Q1NE05_BOVIN 0.996436291 0.990714556 0.994543987 
314 0.846447 0.476341846 0.660698 A0A3Q1MA31_BOVIN 0.996436291 0.990714556 0.994543987 
315 0.5414 0.898553846 0.859655 A5PK72_BOVIN 0.996436291 0.990714556 0.994543987 
316 0.534114 0.336469652 0.326854 A0A3S5ZPB2_BOVIN 0.996436291 0.990714556 0.994543987 
317 0.794221 0.579560403 0.941403 A0A3Q1LTY4_BOVIN 0.996436291 0.990714556 0.994543987 
318 0.724781 0.831791734 0.92641 PUR2_BOVIN 0.996436291 0.990714556 0.994543987 
319 0.966021 0.565383568 0.711619 CAYP1_BOVIN 0.996436291 0.990714556 0.994543987 
320 0.951379 0.389998302 0.631039 G8JKV3_BOVIN 0.996436291 0.990714556 0.994543987 
321 0.443126 0.480917194 0.432693 KAP2_BOVIN 0.996436291 0.990714556 0.994543987 
  
 386 
322 0.938205 0.614098204 0.675822 TCPQ_BOVIN 0.996436291 0.990714556 0.994543987 
325 0.656954 0.904009757 0.848827 TPPP3_BOVIN 0.996436291 0.990714556 0.994543987 
326 0.974359 0.784689335 0.788533 AL9A1_BOVIN 0.996436291 0.990714556 0.994543987 
328 0.692127 0.393534202 0.570686 Q2HJF0_BOVIN 0.996436291 0.990714556 0.994543987 
329 0.925337 0.24930069 0.55547 A0A3Q1LFQ2_BOVIN 0.996436291 0.990714556 0.994543987 
330 0.449621 0.955774448 0.617769 A0A3Q1M9W4_BOVIN 0.996436291 0.990714556 0.994543987 
334 0.517696 0.543208874 0.437409 A6QQN6_BOVIN 0.996436291 0.990714556 0.994543987 
335 0.203309 0.75762044 0.531531 A0A3Q1LRY6_BOVIN 0.996436291 0.990714556 0.994543987 
337 0.64685 0.262999447 0.55175 TCPB_BOVIN 0.996436291 0.990714556 0.994543987 
340 0.271581 0.764362225 0.437944 A0A3Q1NH43_BOVIN 0.996436291 0.990714556 0.994543987 
342 0.707278 0.76224524 0.924633 Q8MII0_BOVIN 0.996436291 0.990714556 0.994543987 
344 0.33389 0.624098192 0.36478 A0A3Q1NG86_BOVIN 0.996436291 0.990714556 0.994543987 
346 0.977851 0.947183776 0.884651 A0A3Q1MBL5_BOVIN 0.996436291 0.990714556 0.994543987 
347 0.943509 0.861152568 0.918811 A0A3Q1MAJ2_BOVIN 0.996436291 0.990714556 0.994543987 
348 0.313585 0.323493306 0.346605 E1BPP3_BOVIN 0.996436291 0.990714556 0.994543987 
349 0.586377 0.556092629 0.951402 A0A3Q1MHJ3_BOVIN 0.996436291 0.990714556 0.994543987 
353 0.283334 0.905484905 0.697608 A0A3Q1MWF7_BOVIN 0.996436291 0.990714556 0.994543987 
355 0.439375 0.844917442 0.6884 A0A3Q1MSF7_BOVIN 0.996436291 0.990714556 0.994543987 
356 0.834829 0.38396983 0.789315 A0A3Q1N147_BOVIN 0.996436291 0.990714556 0.994543987 
357 0.580845 0.778895121 0.625384 TRAP1_BOVIN 0.996436291 0.990714556 0.994543987 
358 0.904172 0.780485571 0.924304 E1BKB7_BOVIN 0.996436291 0.990714556 0.994543987 
362 0.560192 0.282506182 0.254569 F1MIA9_BOVIN 0.996436291 0.990714556 0.994543987 
363 0.60712 0.961653011 0.661818 A0A3Q1NND6_BOVIN 0.996436291 0.990714556 0.994543987 
364 0.909796 0.578867296 0.714411 A0A3Q1M0U8_BOVIN 0.996436291 0.990714556 0.994543987 
366 0.711608 0.412397808 0.402608 A5PJZ8_BOVIN 0.996436291 0.990714556 0.994543987 
367 0.560012 0.520737753 0.543237 TKT_BOVIN 0.996436291 0.990714556 0.994543987 
369 0.555301 0.485511579 0.631722 G3N1U4_BOVIN 0.996436291 0.990714556 0.994543987 
370 0.639257 0.636967482 0.957926 E1BE11_BOVIN 0.996436291 0.990714556 0.994543987 
371 0.474605 0.86906578 0.514072 G3N022_BOVIN 0.996436291 0.990714556 0.994543987 
372 0.815724 0.344292521 0.523099 A0A3Q1MKT5_BOVIN 0.996436291 0.990714556 0.994543987 
  
 387 
377 0.469478 0.962977931 0.71154 A0A3Q1MBX2_BOVIN 0.996436291 0.990714556 0.994543987 
379 0.88015 0.507687227 0.670467 A0A3Q1NEW0_BOVIN 0.996436291 0.990714556 0.994543987 
380 0.249058 0.533756809 0.457475 G3N3Q3_BOVIN 0.996436291 0.990714556 0.994543987 
383 0.926215 0.566311848 0.561679 Q862F3_BOVIN 0.996436291 0.990714556 0.994543987 
386 0.718982 0.511197415 0.79321 F1N469_BOVIN 0.996436291 0.990714556 0.994543987 
387 0.745247 0.315761549 0.331482 V6F869_BOVIN 0.996436291 0.990714556 0.994543987 
390 0.799832 0.274326691 0.358145 G5E6N4_BOVIN 0.996436291 0.990714556 0.994543987 
392 0.956231 0.912866871 0.958858 HS71B_BOVIN 0.996436291 0.990714556 0.994543987 
393 0.943979 0.911039331 0.8734 F1MD63_BOVIN 0.996436291 0.990714556 0.994543987 
395 0.491462 0.623395491 0.507281 TBB6_BOVIN 0.996436291 0.990714556 0.994543987 
396 0.206458 0.914796252 0.463649 A0A3Q1LPD2_BOVIN 0.996436291 0.990714556 0.994543987 
398 0.732872 0.660513296 0.733583 VATB2_BOVIN 0.996436291 0.990714556 0.994543987 
402 0.980702 0.704238726 0.716057 ALDH2_BOVIN 0.996436291 0.990714556 0.994543987 
405 0.984087 0.73688078 0.818833 F1MGZ5_BOVIN 0.996436291 0.990714556 0.994543987 
409 0.798598 0.557333511 0.611437 K4JBR5_BOVIN 0.996436291 0.990714556 0.994543987 
411 0.677948 0.258937319 0.583418 E1BAR2_BOVIN 0.996436291 0.990714556 0.994543987 
414 0.242944 0.731610543 0.583315 A0A3Q1N0C4_BOVIN 0.996436291 0.990714556 0.994543987 
416 0.685878 0.629627018 0.536967 A5D986_BOVIN 0.996436291 0.990714556 0.994543987 
420 0.686496 0.949346635 0.756653 PPID_BOVIN 0.996436291 0.990714556 0.994543987 
422 0.478901 0.532542282 0.521513 F1ML12_BOVIN 0.996436291 0.990714556 0.994543987 
425 0.849375 0.939300043 0.739934 A0A452DI72_BOVIN 0.996436291 0.990714556 0.994543987 
426 0.801456 0.488301301 0.711117 F1N091_BOVIN 0.996436291 0.990714556 0.994543987 
429 0.637939 0.668499669 0.768946 DDX1_BOVIN 0.996436291 0.990714556 0.994543987 
430 0.949671 0.736902402 0.853575 A0A3Q1MMY7_BOVIN 0.996436291 0.990714556 0.994543987 
434 0.713837 0.53803092 0.464725 E1BKU2_BOVIN 0.996436291 0.990714556 0.994543987 
435 0.765542 0.419169934 0.592182 A7E3Q2_BOVIN 0.996436291 0.990714556 0.994543987 
437 0.649433 0.450140396 0.543526 NP1L4_BOVIN 0.996436291 0.990714556 0.994543987 
439 0.744682 0.45014361 0.46079 E1BP73_BOVIN 0.996436291 0.990714556 0.994543987 
441 0.308678 0.836132521 0.783474 A6H7D3_BOVIN 0.996436291 0.990714556 0.994543987 
442 0.558956 0.416937222 0.40748 A16A1_BOVIN 0.996436291 0.990714556 0.994543987 
  
 388 
447 0.727324 0.650192672 0.599709 A0A3Q1LKS8_BOVIN 0.996436291 0.990714556 0.994543987 
449 0.849193 0.759517468 0.666461 RL8_BOVIN 0.996436291 0.990714556 0.994543987 
451 0.339821 0.24606558 0.231666 F1MNW5_BOVIN 0.996436291 0.990714556 0.994543987 
454 0.296525 0.739903088 0.54977 CNN3_BOVIN 0.996436291 0.990714556 0.994543987 
457 0.166513 0.725067955 0.421 FKBP4_BOVIN 0.996436291 0.990714556 0.994543987 
458 0.339006 0.445802998 0.378417 SERB_BOVIN 0.996436291 0.990714556 0.994543987 
459 0.40768 0.533004728 0.553522 G3MYC9_BOVIN 0.996436291 0.990714556 0.994543987 
460 0.749256 0.957907166 0.745446 F1MWI1_BOVIN 0.996436291 0.990714556 0.994543987 
461 0.730171 0.931592671 0.771707 F1MB19_BOVIN 0.996436291 0.990714556 0.994543987 
462 0.773683 0.681793663 0.935264 G5E5V1_BOVIN 0.996436291 0.990714556 0.994543987 
463 0.910543 0.969076485 0.775811 PSB1_BOVIN 0.996436291 0.990714556 0.994543987 
465 0.139739 0.669036609 0.331713 F1MZR1_BOVIN 0.996436291 0.990714556 0.994543987 
466 0.201766 0.57855612 0.466058 S10A2_BOVIN 0.996436291 0.990714556 0.994543987 
467 0.471859 0.547257582 0.895887 A0A3Q1LL25_BOVIN 0.996436291 0.990714556 0.994543987 
468 0.733491 0.94824558 0.70054 A0A3Q1M0V5_BOVIN 0.996436291 0.990714556 0.994543987 
469 0.215155 0.858675619 0.429073 A5D9H5_BOVIN 0.996436291 0.990714556 0.994543987 
470 0.529974 0.497878949 0.520741 A0A3Q1LSS0_BOVIN 0.996436291 0.990714556 0.994543987 
473 0.731661 0.929517183 0.764911 F1MIJ5_BOVIN 0.996436291 0.990714556 0.994543987 
475 0.260491 0.711350347 0.488625 F1MNV5_BOVIN 0.996436291 0.990714556 0.994543987 
476 0.852884 0.837518956 0.957732 CAZA1_BOVIN 0.996436291 0.990714556 0.994543987 
477 0.511373 0.680386391 0.454931 DOPD_BOVIN 0.996436291 0.990714556 0.994543987 
478 0.588291 0.94558492 0.868532 A0A3Q1N522_BOVIN 0.996436291 0.990714556 0.994543987 
480 0.934448 0.452576986 0.789769 A0A3Q1NKD1_BOVIN 0.996436291 0.990714556 0.994543987 
483 0.920107 0.941738804 0.918838 CAN2_BOVIN 0.996436291 0.990714556 0.994543987 
486 0.170138 0.289340939 0.302024 A0A3Q1MKI2_BOVIN 0.996436291 0.990714556 0.994543987 
488 0.399373 0.366858311 0.28671 1433B_BOVIN 0.996436291 0.990714556 0.994543987 
491 0.924 0.677971558 0.87449 E1BCL3_BOVIN 0.996436291 0.990714556 0.994543987 
492 0.591431 0.852259164 0.792639 K2C8_BOVIN 0.996436291 0.990714556 0.994543987 
494 0.914718 0.343877812 0.648057 B0JYP6_BOVIN 0.996436291 0.990714556 0.994543987 
499 0.448278 0.943150766 0.604741 E1B8Y9_BOVIN 0.996436291 0.990714556 0.994543987 
  
 389 
502 0.555656 0.498335136 0.750143 F1MJI7_BOVIN 0.996436291 0.990714556 0.994543987 
503 0.752 0.404608416 0.760341 CO1A1_BOVIN 0.996436291 0.990714556 0.994543987 
504 0.450928 0.389499258 0.311803 E1B726_BOVIN 0.996436291 0.990714556 0.994543987 
505 0.327107 0.877212529 0.826384 HEM2_BOVIN 0.996436291 0.990714556 0.994543987 
506 0.905082 0.475648722 0.517775 A0A3Q1N2B9_BOVIN 0.996436291 0.990714556 0.994543987 
508 0.405107 0.337729399 0.452542 A0A140T887_BOVIN 0.996436291 0.990714556 0.994543987 
510 0.580791 0.43937381 0.490889 A0A3S5ZPB0_BOVIN 0.996436291 0.990714556 0.994543987 
512 0.563159 0.931801111 0.7715 A0A3Q1M2Q2_BOVIN 0.996436291 0.990714556 0.994543987 
513 0.404788 0.731948492 0.412785 A0A3Q1LWV4_BOVIN 0.996436291 0.990714556 0.994543987 
514 0.866396 0.58753631 0.804612 MDHM_BOVIN 0.996436291 0.990714556 0.994543987 
515 0.306819 0.957657302 0.577333 KCNB2_BOVIN 0.996436291 0.990714556 0.994543987 
516 0.306819 0.957657302 0.577333 G3X8A0_BOVIN 0.996436291 0.990714556 0.994543987 
519 0.701126 0.791560236 0.866119 RLA1_BOVIN 0.996436291 0.990714556 0.994543987 
521 0.19367 0.850657766 0.720303 F1N712_BOVIN 0.996436291 0.990714556 0.994543987 
522 0.805802 0.845346691 0.863197 A0A3Q1LI44_BOVIN 0.996436291 0.990714556 0.994543987 
524 0.7446 0.336067585 0.811158 F1MXF5_BOVIN 0.996436291 0.990714556 0.994543987 
525 0.810704 0.968750576 0.815311 Q862L2_BOVIN 0.996436291 0.990714556 0.994543987 
527 0.464757 0.45013281 0.502722 HBBF_BOVIN 0.996436291 0.990714556 0.994543987 
532 0.746164 0.96473863 0.957026 AOXA_BOVIN 0.996436291 0.990714556 0.994543987 
533 0.789313 0.656197795 0.543025 EF1A1_BOVIN 0.996436291 0.990714556 0.994543987 
535 0.725203 0.952504372 0.673965 G3X7I5_BOVIN 0.996436291 0.990714556 0.994543987 
536 0.242062 0.541700379 0.325695 ACTS_BOVIN 0.996436291 0.990714556 0.994543987 
537 0.629444 0.392335661 0.578408 G3MXG6_BOVIN 0.996436291 0.990714556 0.994543987 
538 0.200154 0.581661213 0.432238 Q687I9_BOVIN 0.996436291 0.990714556 0.994543987 
539 0.767672 0.756151255 0.851542 F1N1I6_BOVIN 0.996436291 0.990714556 0.994543987 
541 0.202742 0.911064817 0.604251 A0A3Q1LZ35_BOVIN 0.996436291 0.990714556 0.994543987 
542 0.480391 0.946692827 0.765216 A0A3Q1LN27_BOVIN 0.996436291 0.990714556 0.994543987 
543 0.714299 0.784266132 0.86119 A0A3Q1LR88_BOVIN 0.996436291 0.990714556 0.994543987 
544 0.563877 0.65146102 0.518836 E1B9H0_BOVIN 0.996436291 0.990714556 0.994543987 
545 0.901429 0.670674484 0.699211 CRIP2_BOVIN 0.996436291 0.990714556 0.994543987 
  
 390 
546 0.669159 0.346053445 0.796656 M5FJW2_BOVIN 0.996436291 0.990714556 0.994543987 
548 0.792513 0.618651538 0.715149 NSF1C_BOVIN 0.996436291 0.990714556 0.994543987 
549 0.429379 0.431063598 0.772473 G3MZU3_BOVIN 0.996436291 0.990714556 0.994543987 
550 0.690326 0.513002732 0.713715 A0A3Q1LL35_BOVIN 0.996436291 0.990714556 0.994543987 
553 0.716935 0.348178192 0.401638 G3X6K8_BOVIN 0.996436291 0.990714556 0.994543987 
554 0.250234 0.407156917 0.898705 A0A3Q1MLP4_BOVIN 0.996436291 0.990714556 0.994543987 
555 0.569305 0.235998541 0.319941 A0A3Q1N8C6_BOVIN 0.996436291 0.990714556 0.994543987 
556 0.773201 0.917391168 0.794829 A0A452DHX8_BOVIN 0.996436291 0.990714556 0.994543987 
560 0.978305 0.828976976 0.767022 A0A3Q1MG31_BOVIN 0.996436291 0.990714556 0.994543987 
561 0.680164 0.677659438 0.782033 UBE2N_BOVIN 0.996436291 0.990714556 0.994543987 
562 0.285458 0.549587168 0.454188 IRF6_BOVIN 0.996436291 0.990714556 0.994543987 
563 0.935827 0.844375432 0.810324 A0A3Q1LU85_BOVIN 0.996436291 0.990714556 0.994543987 
564 0.815946 0.793171068 0.821009 CSRP1_BOVIN 0.996436291 0.990714556 0.994543987 
565 0.172988 0.373516739 0.368291 A1L5B6_BOVIN 0.996436291 0.990714556 0.994543987 
566 0.813442 0.665899669 0.788463 A0A3Q1ML30_BOVIN 0.996436291 0.990714556 0.994543987 
568 0.819289 0.436499426 0.453767 F1N160_BOVIN 0.996436291 0.990714556 0.994543987 
569 0.969904 0.367200819 0.610665 A0A452DJE9_BOVIN 0.996436291 0.990714556 0.994543987 
570 0.319703 0.81741894 0.451378 A0A3Q1N5N9_BOVIN 0.996436291 0.990714556 0.994543987 
573 0.322963 0.876679857 0.59433 F1MUP9_BOVIN 0.996436291 0.990714556 0.994543987 
576 0.685684 0.406929441 0.792253 CLIC4_BOVIN 0.996436291 0.990714556 0.994543987 
578 0.524754 0.728012317 0.750387 1433F_BOVIN 0.996436291 0.990714556 0.994543987 
579 0.804248 0.261831931 0.456347 F1MLH6_BOVIN 0.996436291 0.990714556 0.994543987 
580 0.647202 0.468547131 0.824704 SYQ_BOVIN 0.996436291 0.990714556 0.994543987 
581 0.477916 0.940583148 0.865135 S10AA_BOVIN 0.996436291 0.990714556 0.994543987 
582 0.854039 0.887126294 0.876348 LDH6B_BOVIN 0.996436291 0.990714556 0.994543987 
583 0.67919 0.963171077 0.81711 A5D7R6_BOVIN 0.996436291 0.990714556 0.994543987 
584 0.545497 0.807473207 0.802795 E1BH06_BOVIN 0.996436291 0.990714556 0.994543987 
586 0.775173 0.400914346 0.508362 A0A452DIS6_BOVIN 0.996436291 0.990714556 0.994543987 
588 0.513262 0.964642513 0.720979 ANXA5_BOVIN 0.996436291 0.990714556 0.994543987 
589 0.380246 0.510977877 0.370043 Q1JPA2_BOVIN 0.996436291 0.990714556 0.994543987 
  
 391 
590 0.394464 0.727119144 0.93274 A6QNM1_BOVIN 0.996436291 0.990714556 0.994543987 
591 0.625312 0.731761797 0.639505 A0A3Q1MJD9_BOVIN 0.996436291 0.990714556 0.994543987 
593 0.746587 0.765582909 0.842712 SKP1_BOVIN 0.996436291 0.990714556 0.994543987 
596 0.443458 0.402045636 0.29996 CO6_BOVIN 0.996436291 0.990714556 0.994543987 
597 0.534562 0.702573863 0.661414 G5E531_BOVIN 0.996436291 0.990714556 0.994543987 
598 0.535519 0.565030885 0.53679 A0A3Q1MA07_BOVIN 0.996436291 0.990714556 0.994543987 
600 0.826444 0.950022722 0.903888 E1BCC9_BOVIN 0.996436291 0.990714556 0.994543987 
601 0.904306 0.820983862 0.761305 F1MYQ7_BOVIN 0.996436291 0.990714556 0.994543987 
604 0.779905 0.616670423 0.909258 PPM1G_BOVIN 0.996436291 0.990714556 0.994543987 
605 0.554351 0.861487139 0.934739 G5E6J5_BOVIN 0.996436291 0.990714556 0.994543987 
606 0.817039 0.69422036 0.814123 G3X6N3_BOVIN 0.996436291 0.990714556 0.994543987 
607 0.59572 0.930111861 0.796601 A0A452DJ53_BOVIN 0.996436291 0.990714556 0.994543987 
608 0.248156 0.609095791 0.430732 F1MUC5_BOVIN 0.996436291 0.990714556 0.994543987 
609 0.34765 0.236163483 0.224158 A0A3Q1M970_BOVIN 0.996436291 0.990714556 0.994543987 
610 0.769996 0.482749607 0.687289 A0A3Q1MTT6_BOVIN 0.996436291 0.990714556 0.994543987 
611 0.419883 0.502757684 0.458005 RSSA_BOVIN 0.996436291 0.990714556 0.994543987 
612 0.759324 0.879488788 0.937669 A0A3Q1M2E4_BOVIN 0.996436291 0.990714556 0.994543987 
613 0.852869 0.628811351 0.757649 A6QNJ7_BOVIN 0.996436291 0.990714556 0.994543987 
615 0.315446 0.413983065 0.352124 RS6_BOVIN 0.996436291 0.990714556 0.994543987 
616 0.714702 0.849350844 0.774288 PA1B3_BOVIN 0.996436291 0.990714556 0.994543987 
617 0.420985 0.766371211 0.774458 A0A3Q1N7K2_BOVIN 0.996436291 0.990714556 0.994543987 
618 0.714887 0.4299707 0.444159 E1B8H0_BOVIN 0.996436291 0.990714556 0.994543987 
620 0.987109 0.714584459 0.66116 A0A3Q1MTI5_BOVIN 0.996436291 0.990714556 0.994543987 
621 0.520529 0.899251177 0.855326 TCPG_BOVIN 0.996436291 0.990714556 0.994543987 
624 0.414531 0.813181459 0.80941 A0A3Q1M053_BOVIN 0.996436291 0.990714556 0.994543987 
626 0.610261 0.824359714 0.697161 A0A3Q1LQQ5_BOVIN 0.996436291 0.990714556 0.994543987 
627 0.544412 0.596406391 0.403191 XPO2_BOVIN 0.996436291 0.990714556 0.994543987 
629 0.673336 0.529986689 0.639487 A0A3Q1NLD8_BOVIN 0.996436291 0.990714556 0.994543987 
630 0.529682 0.609284262 0.941779 H2A2C_BOVIN 0.996436291 0.990714556 0.994543987 
631 0.143332 0.645666637 0.685458 A0A3Q1MGT0_BOVIN 0.996436291 0.990714556 0.994543987 
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633 0.218308 0.881883399 0.777138 KNG2_BOVIN 0.996436291 0.990714556 0.994543987 
634 0.905802 0.845784226 0.802337 CDC42_BOVIN 0.996436291 0.990714556 0.994543987 
636 0.538815 0.846426795 0.665616 PLSI_BOVIN 0.996436291 0.990714556 0.994543987 
637 0.79827 0.95667617 0.745131 A0A3Q1LYV7_BOVIN 0.996436291 0.990714556 0.994543987 
638 0.526038 0.498597364 0.612603 Q2KIV8_BOVIN 0.996436291 0.990714556 0.994543987 
639 0.598456 0.827495136 0.926044 F12AI_BOVIN 0.996436291 0.990714556 0.994543987 
644 0.563115 0.581456931 0.518538 E1BMG2_BOVIN 0.996436291 0.990714556 0.994543987 
646 0.611479 0.387618201 0.530279 A0A3Q1MI98_BOVIN 0.996436291 0.990714556 0.994543987 
647 0.458698 0.378084927 0.41501 F1MLW8_BOVIN 0.996436291 0.990714556 0.994543987 
648 0.40269 0.383886761 0.255175 G3X7K5_BOVIN 0.996436291 0.990714556 0.994543987 
651 0.899402 0.587786786 0.775196 CTHL2_BOVIN 0.996436291 0.990714556 0.994543987 
653 0.639418 0.715155903 0.9245 MSRA_BOVIN 0.996436291 0.990714556 0.994543987 
655 0.299155 0.249270167 0.245763 Q17QL7_BOVIN 0.996436291 0.990714556 0.994543987 
656 0.655111 0.671178302 0.947239 CTHL1_BOVIN 0.996436291 0.990714556 0.994543987 
657 0.612157 0.82391494 0.903644 A0A3Q1MR74_BOVIN 0.996436291 0.990714556 0.994543987 
658 0.266694 0.721012379 0.746554 A0A3Q1MFR4_BOVIN 0.996436291 0.990714556 0.994543987 
660 0.478504 0.404209979 0.486819 A0A3Q1NNP6_BOVIN 0.996436291 0.990714556 0.994543987 
661 0.968732 0.906269006 0.868895 A0A3Q1LSF9_BOVIN 0.996436291 0.990714556 0.994543987 
663 0.172657 0.300286522 0.380408 A0A3Q1M2E0_BOVIN 0.996436291 0.990714556 0.994543987 
664 0.725034 0.872890817 0.756693 LASP1_BOVIN 0.996436291 0.990714556 0.994543987 
665 0.964232 0.33531165 0.752187 E1BGV8_BOVIN 0.996436291 0.990714556 0.994543987 
666 0.743349 0.2303851 0.323893 Q3T0Y1_BOVIN 0.996436291 0.990714556 0.994543987 
83 0.473293 0.978614608 0.629695 PPBT_BOVIN 0.996436291 0.990983109 0.994543987 
236 0.971478 0.971543316 0.765644 A0A3Q1M0D3_BOVIN 0.996436291 0.990983109 0.994543987 
343 0.969324 0.97713434 0.894482 LYST_BOVIN 0.996436291 0.990983109 0.994543987 
424 0.425641 0.973762599 0.72165 A0A3Q1NNJ8_BOVIN 0.996436291 0.990983109 0.994543987 
61 0.769483 0.98647114 0.955347 A0A452DJ82_BOVIN 0.996436291 0.992789658 0.994543987 
64 0.538447 0.987522784 0.957295 PDXK_BOVIN 0.996436291 0.992789658 0.994543987 
190 0.978443 0.98969203 0.823588 A2MG_BOVIN 0.996436291 0.992789658 0.994543987 
529 0.885574 0.986939179 0.952566 F1MUR6_BOVIN 0.996436291 0.992789658 0.994543987 
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271 0.432422 0.995479009 0.83852 A0A3Q1NKP5_BOVIN 0.996436291 0.997034445 0.994543987 
464 0.834342 0.997882259 0.919953 ACOC_BOVIN 0.996436291 0.997882259 0.994543987 
85 0.770052 0.943675912 0.96542 A6QNX2_BOVIN 0.996436291 0.990714556 0.99651208 
118 0.562395 0.641867346 0.962795 TBB4B_BOVIN 0.996436291 0.990714556 0.99651208 
263 0.939621 0.753071945 0.964104 CPNE1_BOVIN 0.996436291 0.990714556 0.99651208 
341 0.759977 0.844100614 0.969005 A0A3Q1MGU4_BOVIN 0.996436291 0.990714556 0.998604421 
22 0.571604 0.843981761 0.974272 HS90B_BOVIN 0.996436291 0.990714556 0.998796294 
333 0.85421 0.961797274 0.973256 PPIB_BOVIN 0.996436291 0.990714556 0.998796294 
599 0.574612 0.73370591 0.975424 PGRP1_BOVIN 0.996436291 0.990714556 0.998796294 
643 0.887674 0.982149987 0.97178 A0A3Q1N3K8_BOVIN 0.996436291 0.992789658 0.998796294 
18 0.962713 0.742260662 0.980136 ACTG_BOVIN 0.996436291 0.990714556 0.998835126 
52 0.789603 0.677181255 0.977494 Q3SZZ9_BOVIN 0.996436291 0.990714556 0.998835126 
194 0.965885 0.978615145 0.97873 A0A3Q1MRN4_BOVIN 0.996436291 0.990983109 0.998835126 
27 0.798139 0.864651848 0.991795 ZA2G_BOVIN 0.996436291 0.990714556 0.999141681 
77 0.462679 0.845869618 0.996823 A0A452DID9_BOVIN 0.996436291 0.990714556 0.999141681 
184 0.774534 0.589510219 0.993441 PUR9_BOVIN 0.996436291 0.990714556 0.999141681 
185 0.889479 0.82770429 0.996837 F1N049_BOVIN 0.996436291 0.990714556 0.999141681 
247 0.385808 0.679847308 0.996357 CNDP2_BOVIN 0.996436291 0.990714556 0.999141681 
311 0.904442 0.947633114 0.99712 TRFE_BOVIN 0.996436291 0.990714556 0.999141681 
417 0.770272 0.915935106 0.997751 RS18_BOVIN 0.996436291 0.990714556 0.999141681 
481 0.878528 0.887387804 0.986493 ITPA_BOVIN 0.996436291 0.990714556 0.999141681 
587 0.623767 0.75019022 0.98866 CTHL4_BOVIN 0.996436291 0.990714556 0.999141681 
659 0.586882 0.77835884 0.991784 LHPP_BOVIN 0.996436291 0.990714556 0.999141681 
39 0.673528 0.978289946 0.997287 PRDX2_BOVIN 0.996436291 0.990983109 0.999141681 
559 0.826165 0.989150414 0.999142 G3MWT1_BOVIN 0.996436291 0.992789658 0.999141681 
628 0.98929 0.494290105 0.764734 HS71L_BOVIN 0.997067449 0.990714556 0.994543987 
354 0.991962 0.459051892 0.576532 BRX1_BOVIN 0.998190877 0.990714556 0.994543987 
124 0.993699 0.891061686 0.939565 CAN1_BOVIN 0.998371215 0.990714556 0.994543987 
155 0.997382 0.381531115 0.440183 F1MC48_BOVIN 0.998973199 0.990714556 0.994543987 
284 0.997415 0.79405157 0.930936 A0A3Q1LPY0_BOVIN 0.998973199 0.990714556 0.994543987 
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558 0.999753 0.502634152 0.878465 A0A3Q1MUR2_BOVIN 0.999752698 0.990714556 0.994543987 
252 NA NA NA F1MVK1_BOVIN NA NA NA 
278 NA NA NA A0A3Q1MI29_BOVIN NA NA NA 
288 NA NA NA A0A3Q1M032_BOVIN NA NA NA 
381 NA NA NA A0JN68_BOVIN NA NA NA 
388 NA NA NA G5E5T5_BOVIN NA NA NA 
397 NA NA NA F1MZ96_BOVIN NA NA NA 
400 NA NA NA A0A3Q1MV83_BOVIN NA NA NA 
413 NA NA NA A0A3Q1MU51_BOVIN NA NA NA 
419 NA NA NA Q0VCY8_BOVIN NA NA NA 
421 NA NA NA F1MD34_BOVIN NA NA NA 
428 NA NA NA A0A3Q1N8Q5_BOVIN NA NA NA 
431 NA NA NA G3MWV5_BOVIN NA NA NA 
433 NA NA NA Q3ZBG1_BOVIN NA NA NA 
436 NA NA NA F1MR60_BOVIN NA NA NA 
438 NA NA NA A0A3Q1LSF0_BOVIN NA NA NA 
440 NA NA NA Q3ZBH5_BOVIN NA NA NA 
443 NA NA NA ARPC3_BOVIN NA NA NA 
444 NA NA NA F1MZ92_BOVIN NA NA NA 
446 NA NA NA IF4A1_BOVIN NA NA NA 
448 NA NA NA A0A3Q1MCX8_BOVIN NA NA NA 
450 NA NA NA MARE1_BOVIN NA NA NA 
452 NA NA NA A7MBA2_BOVIN NA NA NA 
472 NA NA NA Q3T101_BOVIN NA NA NA 
479 NA NA NA A0A3S5ZP98_BOVIN NA NA NA 
484 NA NA NA Q5EA67_BOVIN NA NA NA 
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Table S6-1 Compounds detected in this study using broadly targeted or untargeted approaches, or 
both. Underlined, those not previously reported in bovine ULF. 
Targeted Both Untargeted 
1-Hexadecanol D-Xylose 2-Hydroxypyridine 
2-Deoxy-glucose Fructose 2-Methyl-2-butanol 
3-Methylcrotonylglycine Hydroxylamine 4-Hydroxypyridine 
5-Methoxytryptamine Maltose Alpha-Lactose 
Allose myo-Inositol Beta-D-Glucose 
Arabitol N-Acetylmannosamine beta-Lactose 
Cadaverine Trehalose D-Galactose 
Cholesterol Benzoic acid Dihydroxyacetone phosphate acyl ester 
Cystamine 3-Hydroxybutyric acid Gamma-valeronolactone 
D-Xylulose Beta-Alanine Glycyl-glycine 
Epinephrine Citric acid Hexamethyldisiloxane 
Fucose Creatinine L-Fucose 
Galactitol D-Glucose L-Iditol 
Galactose D-Mannose Methylamine 
Glucosamine D-Ribose N-Methylalanine 
Glyceraldehyde D-Ribulose Tyrosol 
Isomaltose Ethanolamine 2-Pentenoic acid 
Lactitol Glucose 6-phosphate 3-Phosphoglyceric acid 
Lactose Glyceric acid Allantoin 
L-Arabinose Glycerol conduritol-beta-epoxide 
L-Erythrulose Glycine D-Galacturonic acid 
Levoglucosan Glycolic acid Dihydroxyacetone (dimer) 
Lyxose Hypotaurine D-Maltose 
Maltitol Hypoxanthine L-Malic acid 
Metoprolol Inosine L-Serine 
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N6-Acetyl-L-lysine L-Alanine Methylmalonic acid 
Norvaline L-Asparagine Pyrophosphate 
Octadecanol L-Aspartic acid Tartaric acid 
Phosphoserine L-Glutamic acid 
p-Octopamine L-Isoleucine 
Psicose L-Lactic acid 
Rhamnose L-Leucine 
 







Tryptamine L-Valine   
Xylitol Nicotinic acid 
(S)-3-Hydroxyisobutyric acid O-Phosphoethanolamine 
2-Aminobutyric acid Ornithine 
2-Aminoheptanedioic acid Oxalic acid 
2-Aminoisobutyric acid Palmitic acid 
2-Hydroxy-3-methylbutyric acid Putrescine 
2-Hydroxybutyric acid Pyroglutamic acid 
2-Keto-isovaleric acid Ribitol   
3-Aminoglutaric acid Sarcosine 
 
3-Aminoisobutanoic acid Stearic acid 
3-Dehydroquinate Succinic acid 
3-Hydroxyisovaleric acid Sucrose   
3-Hydroxyphenylacetic acid Taurine 
 










Acetoacetic acid   
Acetylglycine 
 
Adenine     
Adenosine 
  
Adipic acid     
Alkylresorcinol C17 
 








Capric acid     
Caproic acid 
 
Caprylic acid   
cis-Aconitic acid 
 













Docosahexaenoic acid   
Dodecanoic acid 
 





Elaidic acid     
Erythrityl Tetranitrate 
 
Ethylmalonic acid   
Fructose 1-phosphate 
 
Fumaric acid   
Galacturonic acid 
 
Glucaric acid   
Gluconic acid 
 
Glucono-1,5-lactone   
Glucuronic acid 
 
Glutaric acid   
Glycerol 2-phosphate 
 
Glycerol 3-phosphate   
Glyoxylic acid 
 
Guanosine     
Heptadecanoic acid 
 










Ketoleucine   
L-Arginine 
  
L-Cysteine     
L-Glutamine 
 
L-Histidine     
Linoleic acid 
 
L-Kynurenine   
L-Tryptophan 
 
Maleic acid     
Malic acid 
  






Methoprene acid   
Methylsuccinic acid 
 
MG (18:0e/0:0/0:0)   
Myristic acid 
 
N-Acetylglutamine   
N-Acetylneuraminic acid 
N-Acetylornithine   
Niacinamide 
 
Norepinephrine   
Oleic acid 
  
Oxoadipic acid   
Oxoglutaric acid 
 











Pyruvic acid   
Sebacic acid 
 
Spermidine     
Spermine 
  
Suberic acid   
Threo-b-hydroxyaspartic acid 
Triethanolamine   
Tyramine 
  
Uracil     
Urea 
  
Uric acid     
Uridine 
  
Urocanic acid   
Vanillic acid   
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Table S6-2 Pathways to which metabolites detected in this study were mapped, 
as per Metaboanalyst overrepresentation analysis against the bovine metabo-
lome. Colour on the left indicates significance, i.e. p-value (red= highly significant; 
white=non-significant) 






























































































































































28 1 4.05 0.988 1 1 
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Table S6-3 Univariate analysis of ULF metabolomics data, according to EQ1 (a), EQ2 (b) and EQ3 (c) embryo classifica-
tion systems. 
a       
p_dpp p_EQ1 
p_in-
ter_dpp_EQ1 Molecule q_EQ1 q_dpp 
q_interac-
tion 
7.21E-05 0.326971 0.998115665 Glycolic acid 0.652466836 0.000913466 0.998115665 
0.0009 0.923617 0.645579742 3-Hydroxypropionic acid 0.968112837 0.010254491 0.8975133 
0.014534 0.191198 0.242429168 Xylitol 0.597344489 0.150625496 0.658022027 
0.017523 0.214834 0.218631206 Arabinose 0.597344489 0.16510987 0.607901402 
0.018828 0.376209 0.156519571 Lyxose 0.693810023 0.16510987 0.511154922 
0.024384 0.22879 0.338793319 Ribose 0.603942451 0.19855173 0.671872639 
0.089748 0.18683 0.31950061 Acetylglycine 0.597344489 0.447585971 0.671872639 
0.077901 0.259589 0.85730901 Allose 0.603942451 0.447585971 0.960070845 
0.075048 0.247629 0.47442457 Galactose 0.603942451 0.447585971 0.845068766 
0.063001 0.275369 0.909540801 Glucono-1,5-lactone 0.627842302 0.447585971 0.960070845 
0.090302 0.21455 0.571417676 Glucose 0.597344489 0.447585971 0.857061834 
0.089127 0.482234 0.624142126 Mannose 0.792744196 0.447585971 0.8975133 
0.059121 0.041611 0.530809615 Monostearin 0.388831319 0.447585971 0.849432595 
0.068856 0.374185 0.153233807 Ribonolactone 0.693810023 0.447585971 0.511154922 
0.084915 0.571488 0.147201981 Tyrosine 0.831390079 0.447585971 0.511154922 
0.103941 0.214741 0.280931589 Sorbose 0.597344489 0.493718368 0.667212524 
0.132146 0.015113 0.117812302 2-Hydroxyisovaleric acid 0.191433364 0.557950868 0.511154922 
0.127175 0.530685 0.881777077 Malic acid 0.822157584 0.557950868 0.960070845 
0.132138 0.152498 0.62592041 Ribulose 0.579492146 0.557950868 0.8975133 
0.148959 0.194464 0.398319145 Mannitol 0.597344489 0.569361909 0.751306001 
0.151 0.919149 0.216772205 Ribitol 0.968112837 0.569361909 0.607901402 
0.154826 0.331957 0.685760811 Sarcosine 0.652466836 0.569361909 0.909031773 
0.149322 0.19506 0.634951378 D-Xylulose 0.597344489 0.569361909 0.8975133 
0.161797 0.510703 0.00128084 Glutamic acid 0.820002322 0.576402447 0.016223967 
0.17666 0.923043 0.005484824 Cystathionine 0.968112837 0.610278837 0.052105825 
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0.188173 0.430765 0.6824326 Stearic acid 0.767299405 0.630931967 0.909031773 
0.197459 0.595766 0.974463022 Fumaric acid 0.838485125 0.641715701 0.983086589 
0.208276 0.986776 0.905326016 Palmitic acid 0.986775626 0.641715701 0.960070845 
0.207296 0.286905 0.498066191 Suberic acid 0.640160167 0.641715701 0.849432595 
0.216002 0.074993 0.87857049 3-Hydroxyisobutyric acid 0.500088479 0.648007143 0.960070845 
0.226216 0.111131 0.907508643 Isoleucine 0.500088479 0.661246831 0.960070845 
0.237265 0.920986 0.148781368 Alanine 0.968112837 0.676204006 0.511154922 
0.248195 0.668266 0.296638746 Ribose 5-phosphate 0.865708327 0.690104416 0.671872639 
0.256316 0.113176 0.864416074 3-Hydroxybutyric acid 0.500088479 0.695714971 0.960070845 
0.269518 0.321997 0.27318076 Fructose 0.652466836 0.713087769 0.662608652 
0.281482 0.175868 0.836118979 Leucine 0.597344489 0.713087769 0.960070845 
0.275535 0.706888 0.216272124 Phosphoric acid 0.879640574 0.713087769 0.607901402 
0.293222 0.302049 0.684710974 Hydroxylamine 0.640160167 0.726680507 0.909031773 
0.304158 0.973756 0.523528983 Azelaic acid 0.982373277 0.737744538 0.849432595 
0.34289 0.319658 0.331609691 
3-methoxy-4-hydroxybenzoic 
acid 0.652466836 0.798586483 0.671872639 
0.343252 0.682749 0.543934907 Glycerol 0.867444151 0.798586483 0.849432595 
0.369986 0.127498 0.135880278 2-Aminobutyric acid 0.519098778 0.799171288 0.511154922 
0.356955 0.89895 0.161081006 Glutaric acid 0.968112837 0.799171288 0.511154922 
0.362567 0.39138 0.127177835 Lactic acid 0.708211714 0.799171288 0.511154922 
0.371545 0.11376 0.856867823 Nonanoic acid 0.500088479 0.799171288 0.960070845 
0.386802 0.255026 0.341829939 Glycine 0.603942451 0.801734094 0.671872639 
0.384874 0.912703 0.098616981 Inositol 0.968112837 0.801734094 0.46843066 
0.401889 0.212149 0.962700341 Valine 0.597344489 0.81813078 0.983086589 
0.436083 0.063503 0.131228485 2-Hydroxybutyric acid 0.452460338 0.82880145 0.511154922 
0.431646 0.90787 0.089902394 Guanosine 0.968112837 0.82880145 0.461724257 
0.429194 0.486773 0.081744198 Metoprolol 0.792744196 0.82880145 0.44375422 
0.436211 0.709885 0.507569133 Octadecanol 0.879640574 0.82880145 0.849432595 
0.447711 0.841737 0.518474095 2-Hydroxyisocaproic acid 0.968112837 0.836705816 0.849432595 
0.482469 0.092491 0.047316997 2-Hydroxyisobutyric acid 0.500088479 0.851781992 0.296510243 
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0.545417 0.94797 0.417059415 2-Ketoglutaric acid 0.968112837 0.851781992 0.766851183 
0.540483 0.450641 0.402014615 5-Oxoproline 0.781623692 0.851781992 0.751306001 
0.523051 0.879736 0.313307426 Hypotaurine 0.968112837 0.851781992 0.671872639 
0.49221 0.452519 0.004576291 Mannose 6-phosphate 0.781623692 0.851781992 0.047427019 
0.525983 0.923761 0.093154894 N-Acetylmannosamine 0.968112837 0.851781992 0.461724257 
0.503597 0.767912 0.814976382 Norepinephrine 0.931297195 0.851781992 0.960070845 
0.545439 0.121357 0.307304842 Octanoic acid 0.51239648 0.851781992 0.671872639 
0.534642 0.114055 0.002444235 O-Phosphoethanolamine 0.500088479 0.851781992 0.027864281 
0.496113 0.145351 0.159873818 Pyruvic acid 0.571378979 0.851781992 0.511154922 
0.515713 0.951128 0.73117277 Sebacic acid 0.968112837 0.851781992 0.915974678 
0.487996 0.028771 0.109166729 Tagatose 0.298168152 0.851781992 0.497800286 
0.55887 0.461309 0.642342259 Lauric acid 0.784913433 0.860962639 0.8975133 
0.616981 0.296092 0.956862804 2-Aminopimelic acid 0.640160167 0.879738133 0.983086589 
0.640511 0.100965 0.838102219 Batyl alcohol 0.500088479 0.879738133 0.960070845 
0.584721 0.907921 0.183371526 Beta alanine 0.968112837 0.879738133 0.550114579 
0.625627 0.045675 0.049418374 Caproic acid 0.388831319 0.879738133 0.296510243 
0.592227 0.197113 0.540954247 Glyoxylic acid 0.597344489 0.879738133 0.849432595 
0.596929 0.533681 0.805902304 Maltose 0.822157584 0.879738133 0.960070845 
0.611588 0.107798 0.031071759 Psicose 0.500088479 0.879738133 0.251576441 
0.638125 0.051162 0.569147463 Rhamnose 0.388831319 0.879738133 0.857061834 
0.629382 0.620808 0.073590187 Uridine 0.852675876 0.879738133 0.419464063 
0.655888 0.785888 0.578892642 Benzoic acid 0.943065234 0.890133375 0.857061834 
0.693503 0.303234 0.463490699 Gluconic acid 0.640160167 0.930110237 0.838697455 
0.741644 0.557227 0.017736663 3-Aminoglutaric acid 0.831390079 0.939415537 0.155536892 
0.738296 0.684824 0.355076307 5-Aminovaleric acid 0.867444151 0.939415537 0.686079644 
0.735923 0.639603 0.17997055 Serine 0.857820036 0.939415537 0.550114579 
0.723675 0.834421 0.341418748 Succinic acid 0.968112837 0.939415537 0.671872639 
0.738852 0.638001 0.570480155 Trehalose 0.857820036 0.939415537 0.857061834 
0.768155 0.648228 0.527132685 Lactitol 0.859279599 0.962304228 0.849432595 
0.793545 0.08448 0.700803401 Catechol 0.500088479 0.962384712 0.915812392 
  
 407 
0.787405 0.929768 0.661064156 Ethylmalonic acid 0.968112837 0.962384712 0.907967636 
0.778661 0.17255 0.264487044 Urea 0.597344489 0.962384712 0.662608652 
0.935108 0.469556 0.257462725 2-Aminoethanol 0.787196457 0.990668204 0.662608652 
0.972986 0.668214 0.161417344 3-Aminopropanoic acid 0.865708327 0.990668204 0.511154922 
0.893606 0.237204 0.813104946 3-Hydroxyphenylacetic acid 0.603942451 0.990668204 0.960070845 
0.947626 0.377335 0.037587782 Aspartic acid 0.693810023 0.990668204 0.253977363 
0.854456 0.736381 0.332090199 Cadaverine 0.902660044 0.990668204 0.671872639 
0.869517 0.226247 0.897556587 Citric acid 0.603942451 0.990668204 0.960070845 
0.862816 0.94173 0.037873817 Cysteine 0.968112837 0.990668204 0.253977363 
0.876172 0.250522 0.973390587 Cytidine 0.603942451 0.990668204 0.983086589 
0.945656 0.098448 0.941382291 Glucuronic acid 0.500088479 0.990668204 0.983086589 
0.879493 0.251175 0.861335535 Glyceric acid 0.603942451 0.990668204 0.960070845 
0.942966 0.567603 0.327302692 Inosine 0.831390079 0.990668204 0.671872639 
0.960475 0.019014 0.723009783 Lactose 0.216758948 0.990668204 0.915812392 
0.927359 0.570798 0.270407658 Ornithine 0.831390079 0.990668204 0.662608652 
0.874358 0.365458 0.716616313 Putrescine 0.693810023 0.990668204 0.915812392 
0.973288 0.615424 0.264208939 Sucrose 0.852675876 0.990668204 0.662608652 
0.948 0.591861 0.033102163 Threonic acid 0.838485125 0.990668204 0.251576441 
0.960991 0.531681 0.492848932 Threonine 0.822157584 0.990668204 0.849432595 
0.847964 0.942464 0.851678378 Uracil 0.968112837 0.990668204 0.960070845 
0.992158 0.049785 0.721448319 Galacturonic acid 0.388831319 0.992157906 0.915812392 
0.989058 0.576139 0.862640347 Myristic acid 0.831390079 0.992157906 0.960070845 
 
b   
p_EQ2 Metabolites q_EQ2 
0.019951 Succinic acid 0.159607 
0.024891 Mannose 6-phosphate 0.186681 
0.051084 Cystathionine 0.360593 
0.071874 Threonic acid 0.479163 
  
 408 
0.091343 3-Hydroxypropionic acid 0.498233 
0.087774 Glutamic acid 0.498233 
0.088309 Myristic acid 0.498233 
0.087288 O-Phosphoethanolamine 0.498233 
0.112701 2-Hydroxybutyric acid 0.588006 
0.204875 2-Hydroxyisovaleric acid 0.742221 
0.17619 3-Aminoglutaric acid 0.742221 
0.210296 5-Aminovaleric acid 0.742221 
0.182402 Cysteine 0.742221 
0.192877 Cytidine 0.742221 
0.206521 Glutaric acid 0.742221 
0.187636 Glycine 0.742221 
0.19762 Inositol 0.742221 
0.181368 N-Acetylmannosamine 0.742221 
0.191025 Phosphoric acid 0.742221 
0.154946 Uridine 0.742221 
0.222227 Cadaverine 0.761921 
0.233179 Metoprolol 0.777263 
0.261365 Caproic acid 0.825363 
0.254974 Lauric acid 0.825363 
0.296047 Hypotaurine 0.905214 
0.301738 Norepinephrine 0.905214 
0.331225 Octadecanol 0.969438 
0.854885 2-Aminobutyric acid 0.980764 
0.600631 2-Aminoethanol 0.980764 
0.9249 2-Aminopimelic acid 0.980764 
0.781824 2-Hydroxyisobutyric acid 0.980764 
0.660449 2-Hydroxyisocaproic acid 0.980764 
0.642219 2-Ketoglutaric acid 0.980764 
0.86116 3-Aminopropanoic acid 0.980764 
  
 409 
0.400041 3-Hydroxybutyric acid 0.980764 
0.585359 3-Hydroxyisobutyric acid 0.980764 




0.515318 5-Oxoproline 0.980764 
0.604696 Acetylglycine 0.980764 
0.527574 Alanine 0.980764 
0.836107 Allose 0.980764 
0.956261 Arabinose 0.980764 
0.541688 Aspartic acid 0.980764 
0.693997 Azelaic acid 0.980764 
0.504911 Benzoic acid 0.980764 
0.919353 Beta alanine 0.980764 
0.608064 Catechol 0.980764 
0.85018 Citric acid 0.980764 
0.423678 Ethylmalonic acid 0.980764 
0.735502 Fructose 0.980764 
0.720583 Fumaric acid 0.980764 
0.786235 Galactose 0.980764 
0.964418 Galacturonic acid 0.980764 
0.348107 Gluconic acid 0.980764 
0.837074 Glucono-1,5-lactone 0.980764 
0.816494 Glucose 0.980764 
0.753348 Glucuronic acid 0.980764 
0.945298 Glyceric acid 0.980764 
0.396408 Glycerol 0.980764 
0.404778 Glycolic acid 0.980764 
0.786594 Glyoxylic acid 0.980764 
0.93946 Guanosine 0.980764 
  
 410 
0.396171 Hydroxylamine 0.980764 
0.450495 Inosine 0.980764 
0.700857 Isoleucine 0.980764 
0.399172 Lactic acid 0.980764 
0.587961 Lactitol 0.980764 
0.948323 Lactose 0.980764 
0.938772 Leucine 0.980764 
0.934026 Lyxose 0.980764 
0.956545 Malic acid 0.980764 
0.786838 Maltose 0.980764 
0.82404 Mannitol 0.980764 
0.794763 Mannose 0.980764 
0.669764 Monostearin 0.980764 
0.49535 Nonanoic acid 0.980764 
0.947794 Octanoic acid 0.980764 
0.510059 Ornithine 0.980764 
0.46516 Palmitic acid 0.980764 
0.519927 Psicose 0.980764 
0.385903 Putrescine 0.980764 
0.887397 Pyruvic acid 0.980764 
0.518494 Rhamnose 0.980764 
0.714263 Ribitol 0.980764 
0.813239 Ribonolactone 0.980764 
0.701158 Ribose 5-phosphate 0.980764 
0.729859 Ribulose 0.980764 
0.705627 Sarcosine 0.980764 
0.472759 Sebacic acid 0.980764 
0.575973 Serine 0.980764 
0.744084 Sorbose 0.980764 
0.92126 Stearic acid 0.980764 
  
 411 
0.805663 Suberic acid 0.980764 
0.860586 Sucrose 0.980764 
0.860743 Tagatose 0.980764 
0.473324 Threonine 0.980764 
0.800212 Trehalose 0.980764 
0.877133 Tyrosine 0.980764 
0.959654 Uracil 0.980764 
0.921475 Urea 0.980764 
0.9004 Valine 0.980764 
0.948389 Xylitol 0.980764 
0.695401 Xylulose 0.980764 
0.997606 Batyl alcohol 0.997606 
0.994067 Ribose 0.997606 
 
c   
p_EQ3 Metabolites q_EQ3 
0.055577 Monostearin 0.444617 
0.062092 Sarcosine 0.445926 
0.063173 Maltose 0.445926 
0.070936 Lactitol 0.472906 
0.088214 Valine 0.557141 
0.093599 Trehalose 0.561596 
0.119911 Acetylglycine 0.685204 
0.140561 Nonanoic acid 0.766698 
0.16618 Ribitol 0.855363 
0.183143 Cytidine 0.855363 
0.186614 Phosphoric acid 0.855363 
0.199383 2-Aminoethanol 0.855363 
0.202345 Mannose 6-phosphate 0.855363 
  
 412 
0.20318 Isoleucine 0.855363 
0.206713 Batyl alcohol 0.855363 
0.216144 Inosine 0.864575 
0.241796 Leucine 0.890597 
0.248291 Norepinephrine 0.890597 
0.262931 2-Hydroxyisovaleric acid 0.890597 
0.265699 Psicose 0.890597 
0.267952 2-Ketoglutaric acid 0.890597 
0.276277 3-Hydroxypropionic acid 0.890597 
0.329325 Mannitol 0.890597 
0.341206 Glucose 0.890597 
0.345925 Sebacic acid 0.890597 
0.346132 Citric acid 0.890597 
0.364917 Uridine 0.890597 
0.372982 Glycolic acid 0.890597 
0.376315 Galactose 0.890597 
0.392139 Glutamic acid 0.890597 
0.393467 Glucono-1,5-lactone 0.890597 
0.402542 2-Hydroxyisobutyric acid 0.890597 
0.402597 Urea 0.890597 
0.406675 Rhamnose 0.890597 
0.41106 Aspartic acid 0.890597 
0.43091 2-Aminobutyric acid 0.890597 
0.431718 Octanoic acid 0.890597 
0.438629 Allose 0.890597 
0.440765 Tagatose 0.890597 
0.445571 3-Hydroxyphenylacetic acid 0.890597 
0.451366 Fructose 0.890597 
0.479829 Cystathionine 0.890597 
0.487795 Ornithine 0.890597 
  
 413 
0.489355 Glutaric acid 0.890597 
0.494609 Glyoxylic acid 0.890597 
0.520309 Catechol 0.890597 
0.52603 Myristic acid 0.890597 
0.545416 Beta alanine 0.890597 
0.545573 Guanosine 0.890597 
0.554615 2-Aminopimelic acid 0.890597 
0.558679 Inositol 0.890597 
0.573546 Suberic acid 0.890597 
0.577466 O-Phosphoethanolamine 0.890597 
0.583944 Cadaverine 0.890597 
0.596999 3-Aminopropanoic acid 0.890597 
0.600376 3-Hydroxybutyric acid 0.890597 
0.602748 Ribose 5-phosphate 0.890597 
0.612249 Threonic acid 0.890597 
0.624954 Hypotaurine 0.890597 
0.627515 Xylitol 0.890597 
0.63838 Putrescine 0.890597 
0.640731 Malic acid 0.890597 
0.642507 Benzoic acid 0.890597 
0.648781 Mannose 0.890597 
0.651241 Lactose 0.890597 
0.652961 2-Hydroxybutyric acid 0.890597 
0.661961 N-Acetylmannosamine 0.890597 
0.668431 5-Aminovaleric acid 0.890597 
0.668894 Glycine 0.890597 
0.668986 Glycerol 0.890597 
0.671006 Alanine 0.890597 
0.672923 Azelaic acid 0.890597 
0.679631 Serine 0.890597 
  
 414 
0.6851 Hydroxylamine 0.890597 
0.688301 Galacturonic acid 0.890597 
0.707951 Octadecanol 0.890597 
0.710925 Sorbose 0.890597 
0.715646 Caproic acid 0.890597 
0.725609 Palmitic acid 0.890597 
0.730631 3-Hydroxyisobutyric acid 0.890597 
0.731405 Ribose 0.890597 
0.732614 Glucuronic acid 0.890597 
0.737878 Sucrose 0.890597 
0.744543 Lyxose 0.890597 
0.745802 Tyrosine 0.890597 
0.751146 Glyceric acid 0.890597 
0.756627 Ethylmalonic acid 0.890597 
0.757007 Ribonolactone 0.890597 
0.778645 5-Oxoproline 0.893515 
0.779015 Arabinose 0.893515 
0.785954 Cysteine 0.893515 
0.789271 Lauric acid 0.893515 
0.798414 Uracil 0.895417 
0.806656 2-Hydroxyisocaproic acid 0.896285 
0.828542 Fumaric acid 0.912157 
0.840824 Stearic acid 0.917263 
0.849354 Xylulose 0.918221 
0.880274 Threonine 0.94315 




0.937814 Succinic acid 0.973966 
0.942246 Metoprolol 0.973966 
  
 415 
0.949617 Ribulose 0.973966 
0.969929 3-Aminoglutaric acid 0.976228 
0.971253 Lactic acid 0.976228 
0.976228 Pyruvic acid 0.976228 
  
 416 
Table S6-4 differentially regulated pathways across oestrus after calving (OC) by Metaboanalyst - metabolites only 
 
Total 
Cmpd Hits Raw p 
mi-
nuslog(p) FDR Impact p (OC) q (OC) 
Pyrimidine metabolism 10 3 9.70E-06 5.0134 0.000427 0.11416 0.000102 0.001497 
Galactose metabolism 9 7 6.42E-05 4.1925 0.001329 0.23707 2.43E-07 1.07E-05 
Thiamine metabolism 1 1 9.06E-05 4.0427 0.001329 0 0.001593 0.010016 
Glycerophospholipid metabolism 3 2 0.000325 3.4884 0.003052 0.03747 0.002254 0.012396 
Glycerolipid metabolism 4 2 0.000441 3.3556 0.003052 0.33022 6.51E-07 1.43E-05 
Ascorbate and aldarate metabolism 2 2 0.000555 3.2559 0.003052 0.25 0.005665 0.021098 
Inositol phosphate metabolism 4 2 0.000555 3.2559 0.003052 0.12939 0.005665 0.021098 
Phosphatidylinositol signaling system 2 1 0.000555 3.2558 0.003052 0.03736 0.005665 0.021098 
Propanoate metabolism 5 4 0.001365 2.8648 0.006674 0 0.000762 0.006707 
Pentose phosphate pathway 9 4 0.002551 2.5932 0.011226 0.22059 0.005754 0.021098 
beta-Alanine metabolism 8 4 0.003782 2.4222 0.015129 0.39925 0.000655 0.006707 
Pentose and glucuronate interconversions 5 3 0.004472 2.3495 0.016396 0.42188 0.009716 0.032885 
Cysteine and methionine metabolism 10 5 0.006581 2.1817 0.022275 0.33809 0.007872 0.045775 
Butanoate metabolism 5 2 0.009067 2.0425 0.028497 0   
Citrate cycle (TCA cycle) 9 5 0.00975 2.011 0.028601 0.25782   
Pyruvate metabolism 5 3 0.013891 1.8573 0.037046 0.29082   
Glutathione metabolism 6 4 0.017988 1.745 0.037046 0.09925   
Glyoxylate and dicarboxylate metabolism 10 5 0.018501 1.7328 0.037046 0.25927   
Glycine, serine and threonine metabolism 11 7 0.018502 1.7328 0.037046 0.58693   
Primary bile acid biosynthesis 2 1 0.018503 1.7328 0.037046 0.02239   
Porphyrin and chlorophyll metabolism 2 1 0.018503 1.7328 0.037046 0   
Aminoacyl-tRNA biosynthesis 15 8 0.018523 1.7323 0.037046 0.16667   
Starch and sucrose metabolism 4 3 0.13603 0.86638 0.25024 0.54399   
Neomycin, kanamycin and gentamicin biosyn-
thesis 1 1 0.13649 0.86489 0.25024 0   
Amino sugar and nucleotide sugar metabolism 8 5 0.1836 0.73612 0.32314 0.15882   
Pantothenate and CoA biosynthesis 8 5 0.21405 0.66948 0.36225 0.02143   
Histidine metabolism 3 1 0.27928 0.55396 0.45512 0   
  
 417 
Taurine and hypotaurine metabolism 3 2 0.30157 0.52061 0.46877 0.28571   
Sphingolipid metabolism 2 2 0.30896 0.51009 0.46877 0.0142   
Valine, leucine and isoleucine degradation 7 4 0.32884 0.48302 0.48143 0.02837   
Valine, leucine and isoleucine biosynthesis 5 3 0.33919 0.46956 0.48143 0   
Arginine and proline metabolism 8 2 0.42087 0.37586 0.57869 0.11063   
Tyrosine metabolism 10 3 0.45274 0.34415 0.60365 0.11335   
Glycolysis / Gluconeogenesis 5 1 0.56539 0.24765 0.69884 0.10044   
Purine metabolism 14 3 0.57175 0.2428 0.69884 0.01583   
Arginine biosynthesis 9 5 0.57178 0.24277 0.69884 0.06091   
Alanine, aspartate and glutamate metabolism 12 7 0.72801 0.13786 0.83473 0.27404   
D-Glutamine and D-glutamate metabolism 2 1 0.74798 0.12611 0.83473 0   
Fatty acid biosynthesis 5 3 0.77542 0.11046 0.83473 0.01473   
Selenocompound metabolism 1 1 0.77798 0.10903 0.83473 0   
Fatty acid elongation 1 1 0.79679 0.098656 0.83473 0   
Fatty acid degradation 1 1 0.79679 0.098656 0.83473 0   
Fructose and mannose metabolism 6 2 0.82941 0.081233 0.8487 0.15735   
Biosynthesis of unsaturated fatty acids 6 2 0.89188 0.049696 0.89188 0   
  
 418 























































































































































Eukaryotic Translation Elongation 0.00153 0.25 1 1 0.01
14 
0.291 












Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways 0.00244 0.32 1 1 0.01
71 
0.319 
Formation of a pool of free 40S subunits 0.00244 0.32 1 1 0.00
244 
0.32 
Nuclear Receptors Meta-Pathway 0.00248 0.32 1 1 0.00
248 
0.32 
Pathways in clear cell renal cell carcinoma 0.00269 0.32 1 1 0.00
269 
0.32 
Cytoplasmic Ribosomal Proteins 0.00293 0.32 1 1 0.00
293 
0.32 
SRP-dependent cotranslational protein targeting to membrane 0.00293 0.32 1 1 0.00
293 
0.32 
Nonsense-Mediated Decay (NMD) 0.00293 0.32 1 1 0.00
293 
0.32 
Ribosome - Homo sapiens (human) 0.00293 0.32 1 1 0.00
293 
0.32 
Nonsense Mediated Decay (NMD) independent of the Exon Junction 
Complex (EJC) 
0.00293 0.32 1 1 0.00
293 
0.32 
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Com-
plex (EJC) 
0.00293 0.32 1 1 0.00
293 
0.32 
Eukaryotic Translation Termination 0.00293 0.32 1 1 0.02 0.343 
Selenocysteine synthesis 0.00293 0.32 1 1 0.02 0.343 


















































































miR-targeted genes in epithelium - TarBase 0.00528 0.41 1 1 0.00
528 
0.41 























































































































































Pyruvate metabolism - Homo sapiens (human) 0.0156 0.67 0.25 1 0.02
56 
0.373 
Arginine Proline metabolism 0.0156 0.67 0.432 1 0.04
05 
0.522 
Ub-specific processing proteases 0.0134 0.67 1 1 0.01
34 
0.67 
insulin 0.0137 0.67 1 1 0.01
37 
0.67 
insulin Mam 0.0137 0.67 1 1 0.01
37 
0.67 
Regulation of nuclear beta catenin signaling and target gene transcription 0.0156 0.67 1 1 0.01
56 
0.67 





RhoA signaling pathway 0.0156 0.67 1 1 0.01
56 
0.67 
LKB1 signaling events 0.0156 0.67 1 1 0.01
56 
0.67 
Leukocyte transendothelial migration - Homo sapiens (human) 0.0156 0.67 1 1 0.01
56 
0.67 
Alpha6Beta4Integrin 0.0156 0.67 1 1 0.01
56 
0.67 
Recruitment of mitotic centrosome proteins and complexes 0.0156 0.67 1 1 0.01
56 
0.67 
Loss of Nlp from mitotic centrosomes 0.0156 0.67 1 1 0.01
56 
0.67 
Loss of proteins required for interphase microtubule organization from 
the centrosome 
0.0156 0.67 1 1 0.01
56 
0.67 
Centrosome maturation 0.0156 0.67 1 1 0.01
56 
0.67 
AURKA Activation by TPX2 0.0156 0.67 1 1 0.01
56 
0.67 
Recruitment of NuMA to mitotic centrosomes 0.0156 0.67 1 1 0.01
56 
0.67 
Vesicle-mediated transport 0.0139 0.67 1 1 0.07
34 
0.724 












































































































































































































Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding 0.0313 0.93
8 
1 1 0.14 0.982 
Ion channel transport 0.0313 0.93
8 
1 1 0.14 0.982 
Folding of actin by CCT/TriC 0.0313 0.93
8 
1 1 0.14 0.982 
Cargo trafficking to the periciliary membrane 0.0313 0.93
8 
1 1 0.14 0.982 
Metabolism of steroids 0.0313 0.93
8 
1 1 0.14 0.982 
Sterol Regulatory Element-Binding Proteins (SREBP) signalling 0.0313 0.93
8 
1 1 0.14 0.982 
ESR-mediated signaling 0.0313 0.93
8 
1 1 0.14 0.982 


































Chaperonin-mediated protein folding 0.0342 0.96
8 
1 1 0.15 1 
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding 0.0342 0.96
8 
1 1 0.15 1 
Formation of tubulin folding intermediates by CCT/TriC 0.0342 0.96
8 
1 1 0.15 1 





The citric acid (TCA) cycle and respiratory electron transport 0.0781 1 0.0156 1 0.00
941 
0.291 
Transmission across Chemical Synapses 0.0625 1 0.021 1 0.01 0.291 
Glycolysis Gluconeogenesis 0.064 1 0.0244 1 0.01
17 
0.291 
G alpha (i) signalling events 0.0923 1 0.0195 1 0.01
32 
0.291 
Glucagon signaling pathway - Homo sapiens (human) 0.0625 1 0.0313 1 0.01
41 
0.291 
Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1) 0.0625 1 0.0313 1 0.01
41 
0.291 
Gluconeogenesis 0.0625 1 0.0313 1 0.01
41 
0.291 
Glycogenosis_ Type IA. Von gierke disease 0.0625 1 0.0313 1 0.01
41 
0.291 
Glycogenosis_ Type IC 0.0625 1 0.0313 1 0.01
41 
0.291 
Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease 0.0625 1 0.0313 1 0.01
41 
0.291 
Triosephosphate isomerase 0.0625 1 0.0313 1 0.01
41 
0.291 
Fructose-1_6-diphosphatase deficiency 0.0625 1 0.0313 1 0.01
41 
0.291 





Neuronal System 0.0977 1 0.021 1 0.01
47 
0.291 
Pyruvate metabolism and Citric Acid (TCA) cycle 0.188 1 0.0156 1 0.02 0.343 
Class A/1 (Rhodopsin-like receptors) 0.156 1 0.0273 1 0.02
76 
0.396 
Glucose metabolism 0.0398 1 0.109 1 0.02
8 
0.397 
Glutathione conjugation 0.0625 1 0.125 1 0.04
57 
0.554 
GPCR ligand binding 0.156 1 0.0574 1 0.05
12 
0.614 
Tyrosine metabolism - Homo sapiens (human) 0.0625 1 0.156 1 0.05
5 
0.621 
Methionine Cysteine metabolism 0.0625 1 0.156 1 0.05
5 
0.621 
Citrate cycle 0.156 1 0.0625 1 0.05
5 
0.621 
Central carbon metabolism in cancer - Homo sapiens (human) 0.125 1 0.0946 1 0.06
43 
0.674 
Glycolysis 0.102 1 0.125 1 0.06
81 
0.699 
Purine nucleotides nucleosides metabolism 0.0537 1 0.25 1 0.07
13 
0.717 
Metabolism of vitamins and cofactors 0.211 1 0.0645 1 0.07
22 
0.719 
Pyruvate metabolism 0.0625 1 0.25 1 0.08
06 
0.765 
Glutathione metabolism 0.0625 1 0.25 1 0.08
06 
0.765 
HIF-1 signaling pathway - Homo sapiens (human) 0.156 1 0.125 1 0.09
64 
0.851 





The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria  0.625 1 0.0313 1 0.09
64 
0.851 
fig-met-1-last-solution 0.312 1 0.0625 1 0.09
64 
0.851 
Pentose and glucuronate interconversions - Homo sapiens (human) 1 1 0.0223 1 0.10
7 
0.927 
Metabolism of RNA 0.09 1 0.25 1 0.10
8 
0.928 
Platelet activation_ signaling and aggregation 0.0528 1 0.5 1 0.12
2 
0.982 
Neurotransmitter release cycle 1 1 0.0273 1 0.12
6 
0.982 
The oncogenic action of Fumarate 0.875 1 0.0313 1 0.12
6 
0.982 
The oncogenic action of 2-hydroxyglutarate 0.875 1 0.0313 1 0.12
6 
0.982 
Developmental Biology 0.113 1 0.25 1 0.12
9 
0.982 
Purine metabolism 0.0625 1 0.461 1 0.13
1 
0.982 
Axon guidance 0.12 1 0.25 1 0.13
5 
0.982 
Pyruvate metabolism 0.25 1 0.125 1 0.14 0.982 
Pyrimidine metabolism - Homo sapiens (human) 0.25 1 0.125 1 0.14 0.982 
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) 0.25 1 0.125 1 0.14 0.982 
superpathway of methionine degradation 1 1 0.0313 1 0.14 0.982 
Glycolysis 0.125 1 0.25 1 0.14 0.982 
Glycogenosis_ Type VII. Tarui disease 0.125 1 0.25 1 0.14 0.982 
Fanconi-bickel syndrome 0.125 1 0.25 1 0.14 0.982 
Histidine metabolism 0.25 1 0.125 1 0.14 0.982 
Phenylalanine metabolism - Homo sapiens (human) 0.5 1 0.0625 1 0.14 0.982 
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Glutaminolysis and Cancer 0.312 1 0.102 1 0.14
1 
0.987 
Digestion and absorption 1 1 0.00391 1 0.00
391 
1 
Digestion 1 1 0.00391 1 0.00
391 
1 
Digestion 1 1 0.0156 1 0.01
56 
1 
The citric acid (TCA) cycle and respiratory electron transport 1 1 0.0156 1 0.01
56 
1 
Digestion of dietary carbohydrate 1 1 0.0313 1 0.03
13 
1 
HSF1 activation 0.0371 1 1 1 0.03
71 
1 
Attenuation phase 0.0371 1 1 1 0.03
71 
1 
HSF1-dependent transactivation 0.0371 1 1 1 0.03
71 
1 
Human papillomavirus infection - Homo sapiens (human) 0.0469 1 1 1 0.04
69 
1 
Measles - Homo sapiens (human) 0.0469 1 1 1 0.04
69 
1 
TGF_beta_Receptor 0.0469 1 1 1 0.04
69 
1 
Regulation of Actin Cytoskeleton 0.0488 1 1 1 0.04
88 
1 
Post-translational protein phosphorylation 0.0502 1 1 1 0.05
02 
1 
Prefoldin mediated transfer of substrate  to CCT/TriC 0.0537 1 1 1 0.05
37 
1 
Transport of bile salts and organic acids_ metal ions and amine com-
pounds 





miR-targeted genes in squamous cell - TarBase 0.0547 1 1 1 0.05
47 
1 
Phase II - Conjugation of compounds 1 1 0.0579 1 0.05
79 
1 
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by In-
sulin-like Growth Factor Binding Proteins (IGFBPs) 
0.0605 1 1 1 0.06
05 
1 
Ciliary landscape 0.0625 1 1 1 0.06
25 
1 
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex 0.0625 1 1 1 0.06
25 
1 
Beta2 integrin cell surface interactions 0.0625 1 1 1 0.06
25 
1 
Signaling events mediated by HDAC Class II 0.0625 1 1 1 0.06
25 
1 
Insulin-mediated glucose transport 0.0625 1 1 1 0.06
25 
1 
Validated transcriptional targets of TAp63 isoforms 0.0625 1 1 1 0.06
25 
1 
Integrin-linked kinase signaling 0.0625 1 1 1 0.06
25 
1 
EGF 0.0625 1 1 1 0.06
25 
1 
FGF 0.0625 1 1 1 0.06
25 
1 
Fas 0.0625 1 1 1 0.06
25 
1 
integrin signaling pathway 0.0625 1 1 1 0.06
25 
1 
Carbohydrate digestion and absorption - Homo sapiens (human) 1 1 0.0625 1 0.06
25 
1 





Abacavir Pathway_ Pharmacokinetics/Pharmacodynamics 0.0625 1 1 1 0.06
25 
1 
Malonyl-coa decarboxylase deficiency 1 1 0.0625 1 0.06
25 
1 
Malonic Aciduria 1 1 0.0625 1 0.06
25 
1 
Propanoate Metabolism 1 1 0.0625 1 0.06
25 
1 
Methylmalonic Aciduria Due to Cobalamin-Related Disorders 1 1 0.0625 1 0.06
25 
1 
Glucose metabolism 1 1 0.0625 1 0.06
25 
1 
EGF-EGFR Signaling Pathway 0.0625 1 1 1 0.06
25 
1 
HIF-1-alpha transcription factor network 0.0625 1 1 1 0.06
25 
1 
Taste transduction - Homo sapiens (human) 1 1 0.0625 1 0.06
25 
1 
BBSome-mediated cargo-targeting to cilium 0.0625 1 1 1 0.06
25 
1 
Parkin-Ubiquitin Proteasomal System pathway 0.0637 1 1 1 0.06
37 
1 
Class A-1 (Rhodopsin-like receptors) 1 1 0.0645 1 0.06
45 
1 
G13 Signaling Pathway 0.0781 1 1 1 0.07
81 
1 
Formation of the ternary complex_ and subsequently_ the 43S complex 0.0781 1 1 1 0.07
81 
1 
C-MYB transcription factor network 0.0781 1 1 1 0.07
81 
1 





Salmonella infection - Homo sapiens (human) 0.0781 1 1 1 0.07
81 
1 
Integrin-mediated Cell Adhesion 0.0781 1 1 1 0.07
81 
1 
mcalpain and friends in cell motility 0.0781 1 1 1 0.07
81 
1 
Amoebiasis - Homo sapiens (human) 0.0781 1 1 1 0.07
81 
1 
Antigen processing and presentation - Homo sapiens (human) 0.0785 1 1 1 0.07
85 
1 
Biochemical Pathways Part I 1 1 0.0801 1 0.08
01 
1 
Proteasome Degradation 0.0803 1 1 1 0.08
03 
1 
Primary Focal Segmental Glomerulosclerosis FSGS 0.084 1 1 1 0.08
4 
1 
p73 transcription factor network 0.0938 1 1 1 0.09
38 
1 
ucalpain and friends in cell spread 0.0938 1 1 1 0.09
38 
1 
Peroxisome - Homo sapiens (human) 0.0938 1 1 1 0.09
38 
1 
fibrinolysis pathway 0.0938 1 1 1 0.09
38 
1 
downregulated of mta-3 in er-negative breast tumors 0.0938 1 1 1 0.09
38 
1 
Phosphatidylinositol phosphate metabolism 1 1 0.0938 1 0.09
38 
1 
Anchoring of the basal body to the plasma membrane 0.0977 1 1 1 0.09
77 
1 





Proteasome - Homo sapiens (human) 0.102 1 1 1 0.10
2 
1 
IL-1 NFkB 0.102 1 1 1 0.10
2 
1 
MAPK signaling pathway - Homo sapiens (human) 0.105 1 1 1 0.10
5 
1 
MAPK Signaling Pathway 0.105 1 1 1 0.10
5 
1 
Integrin 0.109 1 1 1 0.10
9 
1 
VEGFA-VEGFR2 Signaling Pathway 0.119 1 1 1 0.11
9 
1 
Estrogen signaling pathway - Homo sapiens (human) 0.119 1 1 1 0.11
9 
1 
B cell receptor signaling 0.123 1 1 1 0.12
3 
1 
CD4 T cell receptor signaling-NFkB cascade 0.123 1 1 1 0.12
3 
1 
CD4 T cell receptor signaling 0.123 1 1 1 0.12
3 
1 
Tryptophan metabolism 0.125 1 1 1 0.12
5 
1 
T-Cell antigen Receptor (TCR) Signaling Pathway 0.125 1 1 1 0.12
5 
1 
Transcriptional regulation by RUNX2 0.125 1 1 1 0.12
5 
1 
Tyrosinemia Type 2 (or Richner-Hanhart syndrome) 1 1 0.125 1 0.12
5 
1 
tyrosine degradation 1 1 0.125 1 0.12
5 
1 





Scavenging of heme from plasma 0.125 1 1 1 0.12
5 
1 
Familial lipoprotein lipase deficiency 1 1 0.125 1 0.12
5 
1 
Tyrosinemia Type 3 (TYRO3) 1 1 0.125 1 0.12
5 
1 
D-glyceric acidura 1 1 0.125 1 0.12
5 
1 
Signaling mediated by p38-alpha and p38-beta 0.125 1 1 1 0.12
5 
1 
Nectin adhesion pathway 0.125 1 1 1 0.12
5 
1 
FOXA2 and FOXA3 transcription factor networks 0.125 1 1 1 0.12
5 
1 
Lissencephaly gene (LIS1) in neuronal migration and development 0.125 1 1 1 0.12
5 
1 
Posttranslational regulation of adherens junction stability and dissassem-
bly 
0.125 1 1 1 0.12
5 
1 
E-cadherin signaling in the nascent adherens junction 0.125 1 1 1 0.12
5 
1 
Tryptophan metabolism - Homo sapiens (human) 0.125 1 1 1 0.12
5 
1 
Regulation of cholesterol biosynthesis by SREBP (SREBF) 0.125 1 1 1 0.12
5 
1 
EPHA-mediated growth cone collapse 0.125 1 1 1 0.12
5 
1 
Glycosphingolipid metabolism 1 1 0.125 1 0.12
5 
1 
Butanoate metabolism - Homo sapiens (human) 1 1 0.125 1 0.12
5 
1 





Oxytocin signaling pathway - Homo sapiens (human) 0.125 1 1 1 0.12
5 
1 
Ubiquitin mediated proteolysis - Homo sapiens (human) 0.125 1 1 1 0.12
5 
1 
Alzheimer disease - Homo sapiens (human) 0.125 1 1 1 0.12
5 
1 
IL-17 signaling pathway - Homo sapiens (human) 0.125 1 1 1 0.12
5 
1 
Vibrio cholerae infection - Homo sapiens (human) 0.125 1 1 1 0.12
5 
1 
Free fatty acid receptors 1 1 0.125 1 0.12
5 
1 
RHO GTPases activate CIT 0.125 1 1 1 0.12
5 
1 
RHO GTPases activate IQGAPs 0.125 1 1 1 0.12
5 
1 
Sema4D induced cell migration and growth-cone collapse 0.125 1 1 1 0.12
5 
1 
L-cysteine degradation II 1 1 0.125 1 0.12
5 
1 
COPI-independent Golgi-to-ER retrograde traffic 0.125 1 1 1 0.12
5 
1 
L-cysteine degradation I 1 1 0.125 1 0.12
5 
1 
Sphingolipid de novo biosynthesis 1 1 0.125 1 0.12
5 
1 
Antimetabolite Pathway - Folate Cycle_ Pharmacodynamics 0.125 1 1 1 0.12
5 
1 
Methotrexate Pathway (Cancer Cell)_ Pharmacodynamics 0.125 1 1 1 0.12
5 
1 





Phenylalanine and Tyrosine Metabolism 1 1 0.125 1 0.12
5 
1 
Morphine Metabolism Pathway 0.125 1 1 1 0.12
5 
1 
Sorafenib Metabolism Pathway 0.125 1 1 1 0.12
5 
1 
Glycerol Kinase Deficiency 1 1 0.125 1 0.12
5 
1 
Vitamin A Deficiency 0.125 1 1 1 0.12
5 
1 
Phenylketonuria 1 1 0.125 1 0.12
5 
1 
Retinol Metabolism 0.125 1 1 1 0.12
5 
1 
Gamma carboxylation_ hypusine formation and arylsulfatase activation 0.125 1 1 1 0.12
5 
1 
Fibroblast growth factor-1 0.125 1 1 1 0.12
5 
1 
4-hydroxyproline degradation 1 1 0.125 1 0.12
5 
1 
TNF alpha Signaling Pathway 0.125 1 1 1 0.12
5 
1 
Mesodermal Commitment Pathway 0.125 1 1 1 0.12
5 
1 
XBP1(S) activates chaperone genes 0.125 1 1 1 0.12
5 
1 
Histidine_ lysine_ phenylalanine_ tyrosine_ proline and tryptophan ca-
tabolism 
1 1 0.125 1 0.12
5 
1 
TGF-beta Signaling Pathway 0.125 1 1 1 0.12
5 
1 





Nucleobase catabolism 1 1 0.125 1 0.12
5 
1 
triacylglycerol degradation 1 1 0.148 1 0.14
8 
1 
Adherens junction - Homo sapiens (human) 0.148 1 1 1 0.14
8 
1 
Legionellosis - Homo sapiens (human) 0.151 1 1 1 0.15
1 
1 
G alpha (i) signalling events 1 1 0.156 1 0.15
6 
1 
RNA transport - Homo sapiens (human) 0.156 1 1 1 0.15
6 
1 
Peptide ligand-binding receptors 0.156 1 1 1 0.15
6 
1 
intrinsic prothrombin activation pathway 0.156 1 1 1 0.15
6 
1 
Longevity regulating pathway - multiple species - Homo sapiens (human) 0.156 1 1 1 0.15
6 
1 
Antigen processing: Ubiquitination & Proteasome degradation 0.156 1 1 1 0.15
6 
1 
Protein ubiquitination 0.156 1 1 1 0.15
6 
1 
Neurotransmitter release cycle 1 1 0.156 1 0.15
6 
1 
Pentose phosphate cycle 0.0645 1 0.563 1 0.15
7 
1 
Pyrimidine nucleotides nucleosides metabolism 0.125 1 0.297 1 0.15
9 
1 
Translation initiation complex formation 0.164 1 1 1 0.16
4 
1 
Activation of the mRNA upon binding of the cap-binding complex and 
eIFs_ and subsequent binding to 43S 





Spliceosome - Homo sapiens (human) 0.164 1 1 1 0.16
4 
1 
Collagen formation 0.0391 1 1 1 0.16
6 
1 
Tyrosine metabolism 0.25 1 0.156 1 0.16
6 
1 
Integration of energy metabolism 0.125 1 0.312 1 0.16
6 
1 
Citrate cycle (TCA cycle) - Homo sapiens (human) 0.313 1 0.125 1 0.16
6 
1 
Lysine degradation 0.25 1 0.156 1 0.16
6 
1 
Visual phototransduction 0.156 1 0.25 1 0.16
6 
1 
Sulfur amino acid metabolism 0.25 1 0.156 1 0.16
6 
1 
Pathogenic Escherichia coli infection - Homo sapiens (human) 0.168 1 1 1 0.16
8 
1 
Pathogenic Escherichia coli infection 0.168 1 1 1 0.16
8 
1 
3-Phosphoglycerate dehydrogenase deficiency 0.75 1 0.0537 1 0.17 1 
Non Ketotic Hyperglycinemia 0.75 1 0.0537 1 0.17 1 
Glycine and Serine Metabolism 0.75 1 0.0537 1 0.17 1 
Dimethylglycine Dehydrogenase Deficiency 0.75 1 0.0537 1 0.17 1 
Hyperglycinemia_ non-ketotic 0.75 1 0.0537 1 0.17 1 
Dimethylglycine Dehydrogenase Deficiency 0.75 1 0.0537 1 0.17 1 
Sarcosinemia 0.75 1 0.0537 1 0.17 1 
Dihydropyrimidine Dehydrogenase Deficiency (DHPD) 0.75 1 0.0537 1 0.17 1 
SLC-mediated transmembrane transport 0.875 1 0.0463 1 0.17 1 





Ferroptosis 0.188 1 1 1 0.18
8 
1 
Dissolution of Fibrin Clot 0.188 1 1 1 0.18
8 
1 
Pyrimidine catabolism 1 1 0.188 1 0.18
8 
1 
Toxoplasmosis - Homo sapiens (human) 0.188 1 1 1 0.18
8 
1 
Shigellosis - Homo sapiens (human) 0.188 1 1 1 0.18
8 
1 
pentose phosphate pathway 0.188 1 1 1 0.18
8 
1 
Glycerophospholipid biosynthesis 1 1 0.188 1 0.18
8 
1 
Glucose Alanine cycle 1 1 0.188 1 0.18
8 
1 
Human metabolism overview 1 1 0.191 1 0.19
1 
1 
Notch 0.193 1 1 1 0.19
3 
1 
TLR JNK 0.193 1 1 1 0.19
3 
1 
TLR p38 0.193 1 1 1 0.19
3 
1 
Wnt Canonical 0.193 1 1 1 0.19
3 
1 
DroToll-like 0.193 1 1 1 0.19
3 
1 
Wnt Mammals 0.193 1 1 1 0.19
3 
1 





IL-1 p38 0.193 1 1 1 0.19
3 
1 
chondroitin sulfate degradation (metazoa) 1 1 0.195 1 0.19
5 
1 
dermatan sulfate degradation (metazoa) 1 1 0.195 1 0.19
5 
1 
Pentose phosphate pathway - Homo sapiens (human) 0.084 1 0.578 1 0.19
5 
1 
Infectious disease 0.0494 1 1 1 0.19
8 
1 
Membrane Trafficking 0.0504 1 1 1 0.20
1 
1 
Viral carcinogenesis - Homo sapiens (human) 0.206 1 1 1 0.20
6 
1 
Endocytosis - Homo sapiens (human) 0.207 1 1 1 0.20
7 
1 
miR-targeted genes in leukocytes - TarBase 0.208 1 1 1 0.20
8 
1 
sphingosine and sphingosine-1-phosphate metabolism 1 1 0.0547 1 0.21
4 
1 
The oncogenic action of Succinate 0.875 1 0.0625 1 0.21
4 
1 
Methionine De Novo and Salvage Pathway 0.125 1 0.438 1 0.21
4 
1 
Lysine degradation - Homo sapiens (human) 0.125 1 0.438 1 0.21
4 
1 
fatty acid &beta;-oxidation 1 1 0.219 1 0.21
9 
1 
phospholipases 1 1 0.219 1 0.21
9 
1 





acyl-CoA hydrolysis 1 1 0.219 1 0.21
9 
1 
sphingomyelin metabolism/ceramide salvage 1 1 0.219 1 0.21
9 
1 
fatty acid &beta;-oxidation (peroxisome) 1 1 0.219 1 0.21
9 
1 
Pyruvate Carboxylase Deficiency 1 1 0.219 1 0.21
9 
1 
Primary Hyperoxaluria Type I 1 1 0.219 1 0.21
9 
1 
Lactic Acidemia 1 1 0.219 1 0.21
9 
1 
Alanine Metabolism 1 1 0.219 1 0.21
9 
1 
Chylomicron assembly 0.219 1 1 1 0.21
9 
1 
Blood Clotting Cascade 0.219 1 1 1 0.21
9 
1 
Dengue-2 Interactions with Blood Clotting Cascade 0.219 1 1 1 0.21
9 
1 
miR-targeted genes in muscle cell - TarBase 0.222 1 1 1 0.22
2 
1 
Adaptive Immune System 0.0602 1 1 1 0.22
9 
1 
One carbon metabolism and related pathways 0.312 1 0.195 1 0.23
2 
1 
Glutamate Glutamine metabolism 0.125 1 0.496 1 0.23
4 
1 
Starch and sucrose metabolism - Homo sapiens (human) 0.5 1 0.125 1 0.23
6 
1 





Interconversion of nucleotide di- and triphosphates 0.125 1 0.5 1 0.23
6 
1 
Activation of BAD and translocation to mitochondria  0.0625 1 1 1 0.23
6 
1 
Activation of BH3-only proteins 0.0625 1 1 1 0.23
6 
1 
Intrinsic Pathway for Apoptosis 0.0625 1 1 1 0.23
6 
1 
Cystinosis_ ocular nonnephropathic 1 1 0.0625 1 0.23
6 
1 
Signaling by Interleukins 0.0625 1 1 1 0.23
6 
1 
Proximal tubule bicarbonate reclamation - Homo sapiens (human) 0.125 1 0.5 1 0.23
6 
1 
RHO GTPases Activate ROCKs 0.0625 1 1 1 0.23
6 
1 
Beta-mercaptolactate-cysteine disulfiduria 1 1 0.0625 1 0.23
6 
1 
Thyroid hormone synthesis - Homo sapiens (human) 0.0625 1 1 1 0.23
6 
1 
Propanoate metabolism 0.0625 1 1 1 0.23
6 
1 
Phenytoin (Antiarrhythmic) Action Pathway 0.0625 1 1 1 0.23
6 
1 
Sphingolipid metabolism 0.5 1 0.125 1 0.23
6 
1 
Transfer of Acetyl Groups into Mitochondria 0.5 1 0.125 1 0.23
6 
1 
Translocation of GLUT4 to the plasma membrane 0.0625 1 1 1 0.23
6 
1 





Butanoate metabolism 0.5 1 0.125 1 0.23
6 
1 
G alpha (q) signalling events 0.25 1 0.25 1 0.23
6 
1 
Trans-sulfuration pathway 0.5 1 0.125 1 0.23
6 
1 
One Carbon Metabolism 0.0625 1 1 1 0.23
6 
1 
Interferon Signaling 0.0625 1 1 1 0.23
6 
1 
Pyruvate dehydrogenase deficiency (E2) 1 1 0.0625 1 0.23
6 
1 
Citric Acid Cycle 1 1 0.0625 1 0.23
6 
1 
2-ketoglutarate dehydrogenase complex deficiency 1 1 0.0625 1 0.23
6 
1 
Arachidonic acid metabolism 0.125 1 0.5 1 0.23
6 
1 
Citric acid cycle (TCA cycle) 1 1 0.0625 1 0.23
6 
1 
RHO GTPases activate PAKs 0.0625 1 1 1 0.23
6 
1 
Pyruvate dehydrogenase deficiency (E3) 1 1 0.0625 1 0.23
6 
1 
Mitochondrial complex II deficiency 1 1 0.0625 1 0.23
6 
1 
Fumarase deficiency 1 1 0.0625 1 0.23
6 
1 
Congenital lactic acidosis 1 1 0.0625 1 0.23
6 
1 





HIF1A and PPARG regulation of glycolysis 0.25 1 0.25 1 0.23
6 
1 
Propanoate metabolism - Homo sapiens (human) 0.25 1 0.25 1 0.23
6 
1 
Signaling by Receptor Tyrosine Kinases 0.064 1 1 1 0.24 1 
Tyrosine metabolism 0.5 1 0.129 1 0.24
1 
1 
ErbB1 downstream signaling 0.244 1 1 1 0.24
4 
1 
Selenium Micronutrient Network 0.266 1 0.25 1 0.24
7 
1 
Integrin cell surface interactions 0.25 1 1 1 0.25 1 
Bile salt and organic anion SLC transporters 1 1 0.25 1 0.25 1 
Drug metabolism - cytochrome P450 - Homo sapiens (human) 0.25 1 1 1 0.25 1 
Validated targets of C-MYC transcriptional repression 0.25 1 1 1 0.25 1 
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-
Met) 
0.25 1 1 1 0.25 1 
GRB2:SOS provides linkage to MAPK signaling for Integrins  0.25 1 1 1 0.25 1 
TCR signaling in na&#xef;ve CD4+ T cells 0.25 1 1 1 0.25 1 
p130Cas linkage to MAPK signaling for integrins 0.25 1 1 1 0.25 1 
Synthesis of active ubiquitin: roles of E1 and E2 enzymes 0.25 1 1 1 0.25 1 
Activation of C3 and C5 0.25 1 1 1 0.25 1 
corticosteroids and cardioprotection 0.25 1 1 1 0.25 1 
extrinsic prothrombin activation pathway 0.25 1 1 1 0.25 1 
Chemical carcinogenesis - Homo sapiens (human) 0.25 1 1 1 0.25 1 
Prostate cancer - Homo sapiens (human) 0.25 1 1 1 0.25 1 
Prolactin 0.25 1 1 1 0.25 1 
Ifosfamide Pathway_ Pharmacodynamics 0.25 1 1 1 0.25 1 
Integration of energy metabolism 1 1 0.25 1 0.25 1 
Liver steatosis AOP 0.25 1 1 1 0.25 1 
Exercise-induced Circadian Regulation 0.25 1 1 1 0.25 1 
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PI3K-Akt Signaling Pathway 0.25 1 1 1 0.25 1 
Serine biosynthesis 1 1 0.25 1 0.25 1 
One carbon pool by folate - Homo sapiens (human) 0.25 1 1 1 0.25 1 
Degradation of beta-catenin by the destruction complex 0.25 1 1 1 0.25 1 
&beta;-alanine degradation 1 1 0.25 1 0.25 1 
Nucleotide-binding domain_ leucine rich repeat containing receptor 
(NLR) signaling pathways 
0.25 1 1 1 0.25 1 
Histidine catabolism 1 1 0.25 1 0.25 1 
Regulation of pyruvate dehydrogenase (PDH) complex 1 1 0.25 1 0.25 1 
Lysine catabolism 1 1 0.25 1 0.25 1 
Signaling by the B Cell Receptor (BCR) 0.25 1 1 1 0.25 1 
Arachidonic acid metabolism - Homo sapiens (human) 0.25 1 1 1 0.25 1 
Interleukin-1 signaling 0.25 1 1 1 0.25 1 
Stabilization and expansion of the E-cadherin adherens junction 0.25 1 1 1 0.25 1 
FOXA1 transcription factor network 0.25 1 1 1 0.25 1 
Arf6 downstream pathway 0.25 1 1 1 0.25 1 
IL4-mediated signaling events 0.25 1 1 1 0.25 1 
p53 pathway 0.25 1 1 1 0.25 1 
Fatty acyl-CoA biosynthesis 1 1 0.25 1 0.25 1 
Prostaglandin formation from arachidonate 1 1 0.25 1 0.25 1 
Retrograde endocannabinoid signaling - Homo sapiens (human) 1 1 0.25 1 0.25 1 
mechanism of protein import into the nucleus 0.25 1 1 1 0.25 1 
role of ran in mitotic spindle regulation 0.25 1 1 1 0.25 1 
T cell receptor signaling pathway - Homo sapiens (human) 0.25 1 1 1 0.25 1 
RNA degradation - Homo sapiens (human) 0.25 1 1 1 0.25 1 
mRNA surveillance pathway - Homo sapiens (human) 0.25 1 1 1 0.25 1 
Axon guidance - Homo sapiens (human) 0.25 1 1 1 0.25 1 
Signaling by NOTCH1 0.25 1 1 1 0.25 1 
NOD-like receptor signaling pathway - Homo sapiens (human) 0.25 1 1 1 0.25 1 
Collecting duct acid secretion - Homo sapiens (human) 0.25 1 1 1 0.25 1 
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Vitamin digestion and absorption - Homo sapiens (human) 0.25 1 1 1 0.25 1 
Cellular senescence - Homo sapiens (human) 0.25 1 1 1 0.25 1 
Influenza A - Homo sapiens (human) 0.25 1 1 1 0.25 1 
Progesterone-mediated oocyte maturation - Homo sapiens (human) 0.25 1 1 1 0.25 1 
Synthesis of PE 1 1 0.25 1 0.25 1 
Signaling by NOTCH 0.25 1 1 1 0.25 1 
Sphingolipid metabolism 1 1 0.25 1 0.25 1 
Peroxisomal protein import 0.25 1 1 1 0.25 1 
4-hydroxybenzoate biosynthesis 1 1 0.25 1 0.25 1 
Sema3A PAK dependent Axon repulsion 0.25 1 1 1 0.25 1 
Fat digestion and absorption - Homo sapiens (human) 0.25 1 1 1 0.25 1 
Ovarian tumor domain proteases 0.25 1 1 1 0.25 1 
Regulation of Telomerase 0.25 1 1 1 0.25 1 
p75 NTR receptor-mediated signalling 0.25 1 1 1 0.25 1 
Death Receptor Signalling 0.25 1 1 1 0.25 1 
ATM pathway 0.25 1 1 1 0.25 1 
Lamivudine Pathway_ Pharmacokinetics/Pharmacodynamics 0.25 1 1 1 0.25 1 
Doxorubicin Pathway_ Pharmacokinetics 0.25 1 1 1 0.25 1 
Glucocorticoid Pathway (Peripheral Tissue)_ Pharmacodynamics 0.25 1 1 1 0.25 1 
Cyclophosphamide Pathway_ Pharmacodynamics 0.25 1 1 1 0.25 1 
Plasmalogen Synthesis 1 1 0.25 1 0.25 1 
Lactose Degradation 1 1 0.25 1 0.25 1 
Lactose Intolerance 1 1 0.25 1 0.25 1 
NOTCH-Ncore 0.25 1 1 1 0.25 1 
Translation Factors 0.25 1 1 1 0.25 1 
Cell-Cell communication 0.25 1 1 1 0.25 1 
pyrimidine ribonucleosides degradation 1 1 0.25 1 0.25 1 
(S)-reticuline biosynthesis 1 1 0.25 1 0.25 1 
Alzheimers Disease 0.25 1 1 1 0.25 1 
Aryl Hydrocarbon Receptor 0.25 1 1 1 0.25 1 
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ISG15 antiviral mechanism 0.25 1 1 1 0.25 1 
Antiviral mechanism by IFN-stimulated genes 0.25 1 1 1 0.25 1 
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer 1 1 0.25 1 0.25 1 
Constitutive Androstane Receptor Pathway 0.25 1 1 1 0.25 1 
Copper homeostasis 0.25 1 1 1 0.25 1 
NOTCH1 Intracellular Domain Regulates Transcription 0.25 1 1 1 0.25 1 
Interleukin-1 family signaling 0.25 1 1 1 0.25 1 
Prion disease pathway 0.25 1 1 1 0.25 1 
Interleukin-4 and Interleukin-13 signaling 0.25 1 1 1 0.25 1 
Oxidative Stress 0.25 1 1 1 0.25 1 
Nicotinate metabolism 1 1 0.25 1 0.25 1 
Disorders of the Krebs cycle 1 1 0.25 1 0.25 1 
miR-targeted genes in lymphocytes - TarBase 0.252 1 1 1 0.25
2 
1 
Disulfiram Action Pathway 0.125 1 0.563 1 0.25
7 
1 
HSP90 chaperone cycle for steroid hormone receptors (SHR) 0.0742 1 1 1 0.26
7 
1 
Vitamin B12 Metabolism 0.297 1 0.25 1 0.26
7 
1 
Folate Metabolism 0.301 1 0.25 1 0.27 1 
beta-Alanine metabolism - Homo sapiens (human) 0.125 1 0.625 1 0.27
7 
1 
Nucleobase biosynthesis 0.125 1 0.625 1 0.27
7 
1 
TCA cycle 0.625 1 0.125 1 0.27
7 
1 
Pantothenate and CoA biosynthesis - Homo sapiens (human) 0.25 1 0.312 1 0.27
7 
1 





Retinoid metabolism and transport 0.156 1 0.5 1 0.27
7 
1 
Gamma-glutamyl-transpeptidase deficiency 0.25 1 0.313 1 0.27
7 
1 
5-oxoprolinase deficiency 0.25 1 0.313 1 0.27
7 
1 
Gamma-Glutamyltransferase Deficiency 0.25 1 0.313 1 0.27
7 
1 
Glutathione Metabolism 0.25 1 0.313 1 0.27
7 
1 
Glutathione Synthetase Deficiency 0.25 1 0.313 1 0.27
7 
1 
5-Oxoprolinuria 0.25 1 0.313 1 0.27
7 
1 
Hedgehog 0.278 1 1 1 0.27
8 
1 
erk and pi-3 kinase are necessary for collagen binding in corneal epithelia 0.297 1 1 1 0.29
7 
1 
Systemic lupus erythematosus - Homo sapiens (human) 0.297 1 1 1 0.29
7 
1 
Bacterial invasion of epithelial cells - Homo sapiens (human) 0.297 1 1 1 0.29
7 
1 
Platelet degranulation  0.0865 1 1 1 0.29
8 
1 
Response to elevated platelet cytosolic Ca2+ 0.0865 1 1 1 0.29
8 
1 
Androgen receptor signaling pathway 0.301 1 1 1 0.30
1 
1 
Proteoglycans in cancer - Homo sapiens (human) 0.301 1 1 1 0.30
1 
1 





G alpha (q) signalling events 1 1 0.312 1 0.31
2 
1 
Transport of vitamins_ nucleosides_ and related molecules 1 1 0.312 1 0.31
2 
1 
Direct p53 effectors 0.312 1 1 1 0.31
2 
1 
Integrins in angiogenesis 0.312 1 1 1 0.31
2 
1 
Apoptotic execution phase 0.312 1 1 1 0.31
2 
1 
Cholesterol metabolism - Homo sapiens (human) 0.312 1 1 1 0.31
2 
1 
PPAR signaling pathway - Homo sapiens (human) 0.312 1 1 1 0.31
2 
1 
Sulfur amino acid metabolism 1 1 0.312 1 0.31
2 
1 
Chylomicron remodeling 0.312 1 1 1 0.31
2 
1 
Common Pathway of Fibrin Clot Formation 0.312 1 1 1 0.31
2 
1 
O-linked glycosylation 0.312 1 1 1 0.31
2 
1 
PPAR signaling pathway 0.312 1 1 1 0.31
2 
1 
Validated nuclear estrogen receptor alpha network 0.313 1 1 1 0.31
3 
1 
mechanism of gene regulation by peroxisome proliferators via ppara 0.313 1 1 1 0.31
3 
1 
AGE-RAGE pathway 0.313 1 1 1 0.31
3 
1 





Ferroptosis - Homo sapiens (human) 0.188 1 0.5 1 0.31
6 
1 
Phospholipid metabolism 0.5 1 0.188 1 0.31
6 
1 
Signaling by WNT 0.0938 1 1 1 0.31
6 
1 
Pentose phosphate pathway (hexose monophosphate shunt) 0.0938 1 1 1 0.31
6 
1 
Porphyrin and chlorophyll metabolism - Homo sapiens (human) 0.125 1 0.75 1 0.31
6 
1 
Signaling events mediated by focal adhesion kinase 0.0938 1 1 1 0.31
6 
1 
Histidine_ lysine_ phenylalanine_ tyrosine_ proline and tryptophan ca-
tabolism 
0.5 1 0.206 1 0.33
7 
1 
Transport of bile salts and organic acids_ metal ions and amine com-
pounds 
1 1 0.107 1 0.34
6 
1 
Purine Nucleoside Phosphorylase Deficiency 0.129 1 0.844 1 0.35 1 
Xanthine Dehydrogenase Deficiency (Xanthinuria) 0.129 1 0.844 1 0.35 1 
Adenylosuccinate Lyase Deficiency 0.129 1 0.844 1 0.35 1 
Adenine phosphoribosyltransferase deficiency (APRT) 0.129 1 0.844 1 0.35 1 
Mitochondrial DNA depletion syndrome 0.129 1 0.844 1 0.35 1 
Myoadenylate deaminase deficiency 0.129 1 0.844 1 0.35 1 
Purine Metabolism 0.129 1 0.844 1 0.35 1 
Molybdenum Cofactor Deficiency 0.129 1 0.844 1 0.35 1 
Adenosine Deaminase Deficiency 0.129 1 0.844 1 0.35 1 
Gout or Kelley-Seegmiller Syndrome 0.129 1 0.844 1 0.35 1 
Lesch-Nyhan Syndrome (LNS) 0.129 1 0.844 1 0.35 1 
Xanthinuria type I 0.129 1 0.844 1 0.35 1 
Xanthinuria type II 0.129 1 0.844 1 0.35 1 
AICA-Ribosiduria 0.129 1 0.844 1 0.35 1 
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Galactose metabolism - Homo sapiens (human) 0.5 1 0.219 1 0.35
1 
1 
Pyrimidine metabolism 0.5 1 0.219 1 0.35
1 
1 
Valine_ leucine and isoleucine degradation 0.25 1 0.438 1 0.35
1 
1 
Binding and Uptake of Ligands by Scavenger Receptors 0.11 1 1 1 0.35
2 
1 
TNF 0.359 1 1 1 0.35
9 
1 
proteasome complex 0.359 1 1 1 0.35
9 
1 
Glycerophospholipid metabolism 0.25 1 0.461 1 0.36
4 
1 
Regulation of TLR by endogenous ligand 0.375 1 1 1 0.37
5 
1 
Assembly of collagen fibrils and other multimeric structures 0.375 1 1 1 0.37
5 
1 
Arf6 trafficking events 0.375 1 1 1 0.37
5 
1 
Plasma lipoprotein clearance 0.375 1 1 1 0.37
5 
1 
role of pi3k subunit p85 in regulation of actin organization and cell migra-
tion 
0.375 1 1 1 0.37
5 
1 
Pertussis - Homo sapiens (human) 0.375 1 1 1 0.37
5 
1 
Neurotrophin signaling pathway - Homo sapiens (human) 0.375 1 1 1 0.37
5 
1 
how does salmonella hijack a cell 0.375 1 1 1 0.37
5 
1 





KitReceptor 0.375 1 1 1 0.37
5 
1 
Pentose Phosphate Pathway (Erythrocyte) 0.375 1 1 1 0.37
5 
1 
Statin Pathway_ Pharmacodynamics 0.375 1 1 1 0.37
5 
1 
Sialuria or French Type Sialuria 1 1 0.375 1 0.37
5 
1 
Sialuria or French Type Sialuria 1 1 0.375 1 0.37
5 
1 
G(M2)-Gangliosidosis: Variant B_ Tay-sachs disease 1 1 0.375 1 0.37
5 
1 
Tay-Sachs Disease 1 1 0.375 1 0.37
5 
1 
Amino Sugar Metabolism 1 1 0.375 1 0.37
5 
1 
Salla Disease/Infantile Sialic Acid Storage Disease 1 1 0.375 1 0.37
5 
1 
PPAR Alpha Pathway 0.375 1 1 1 0.37
5 
1 
Factors involved in megakaryocyte development and platelet production 0.375 1 1 1 0.37
5 
1 
Tryptophan catabolism 1 1 0.375 1 0.37
5 
1 
Urea cycle and metabolism of amino groups 0.125 1 1 1 0.38
5 
1 
TCA Cycle (aka Krebs or citric acid cycle) 1 1 0.125 1 0.38
5 
1 
Toll Like Receptor 5 (TLR5) Cascade 0.125 1 1 1 0.38
5 
1 





Interleukin-17 signaling 0.125 1 1 1 0.38
5 
1 
lactate fermentation (reoxidation of cytosolic NADH) 0.25 1 0.5 1 0.38
5 
1 
TRIF(TICAM1)-mediated TLR4 signaling  0.125 1 1 1 0.38
5 
1 
Toll Like Receptor 4 (TLR4) Cascade 0.125 1 1 1 0.38
5 
1 
Fatty acyl-CoA biosynthesis 0.5 1 0.25 1 0.38
5 
1 
Toll Like Receptor 9 (TLR9) Cascade 0.125 1 1 1 0.38
5 
1 
Late Phase of HIV Life Cycle 0.125 1 1 1 0.38
5 
1 
MyD88 cascade initiated on plasma membrane 0.125 1 1 1 0.38
5 
1 
Toll Like Receptor 10 (TLR10) Cascade 0.125 1 1 1 0.38
5 
1 
Toll Like Receptor 3 (TLR3) Cascade 0.125 1 1 1 0.38
5 
1 
Toll Like Receptor 7/8 (TLR7/8) Cascade 0.125 1 1 1 0.38
5 
1 
Glycogenosis_ Type III. Cori disease_ Debrancher glycogenosis 1 1 0.125 1 0.38
5 
1 
Glycogenosis_ Type VI. Hers disease 1 1 0.125 1 0.38
5 
1 
Fatty acid biosynthesis - Homo sapiens (human) 1 1 0.125 1 0.38
5 
1 
Phase I - Functionalization of compounds 0.125 1 1 1 0.38
5 
1 





hypoxia-inducible factor in the cardivascular system 0.25 1 0.5 1 0.38
5 
1 
RHO GTPases Activate Formins 0.125 1 1 1 0.38
5 
1 
Nucleotide salvage 0.25 1 0.5 1 0.38
5 
1 
Sucrase-isomaltase deficiency 1 1 0.125 1 0.38
5 
1 
Signaling by Hedgehog 0.125 1 1 1 0.38
5 
1 
Nicotinate metabolism 1 1 0.125 1 0.38
5 
1 
MAP kinase activation 0.125 1 1 1 0.38
5 
1 
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 
activation 
0.125 1 1 1 0.38
5 
1 
Sema4D in semaphorin signaling 0.125 1 1 1 0.38
5 
1 
ABC-family proteins mediated transport 0.125 1 1 1 0.38
5 
1 
MyD88 dependent cascade initiated on endosome 0.125 1 1 1 0.38
5 
1 
leucine degradation 1 1 0.125 1 0.38
5 
1 
Negative regulation of MAPK pathway 0.125 1 1 1 0.38
5 
1 
Glycerolipid metabolism - Homo sapiens (human) 0.25 1 0.5 1 0.38
5 
1 
Glycogen synthetase deficiency 1 1 0.125 1 0.38
5 
1 





Glycogenosis_ Type IV. Amylopectinosis_ Anderson disease 1 1 0.125 1 0.38
5 
1 
Pyruvate Dehydrogenase Complex Deficiency 0.5 1 0.25 1 0.38
5 
1 
Primary hyperoxaluria II_ PH2 0.5 1 0.25 1 0.38
5 
1 
Pyruvate kinase deficiency 0.5 1 0.25 1 0.38
5 
1 
Irinotecan Action Pathway 0.125 1 1 1 0.38
5 
1 
Starch and Sucrose Metabolism 1 1 0.125 1 0.38
5 
1 
Leigh Syndrome 0.5 1 0.25 1 0.38
5 
1 
Morphine Action Pathway 0.125 1 1 1 0.38
5 
1 
MyD88-independent TLR4 cascade  0.125 1 1 1 0.38
5 
1 
Etoposide Action Pathway 0.125 1 1 1 0.38
5 
1 
Lamivudine Metabolism Pathway 0.25 1 0.5 1 0.38
5 
1 
Pyruvate Metabolism 0.5 1 0.25 1 0.38
5 
1 
Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency) 0.5 1 0.25 1 0.38
5 
1 
Irinotecan Metabolism Pathway 0.125 1 1 1 0.38
5 
1 
Etoposide Metabolism Pathway 0.125 1 1 1 0.38
5 
1 





Fatty Acid Biosynthesis 1 1 0.125 1 0.38
5 
1 
Propanoate metabolism 0.5 1 0.25 1 0.38
5 
1 
De novo fatty acid biosynthesis 1 1 0.125 1 0.38
5 
1 
Toll Like Receptor TLR1:TLR2 Cascade 0.125 1 1 1 0.38
5 
1 
Toll Like Receptor TLR6:TLR2 Cascade 0.125 1 1 1 0.38
5 
1 
Toll Like Receptor 2 (TLR2) Cascade 0.125 1 1 1 0.38
5 
1 
Cellular response to heat stress 0.125 1 1 1 0.38
5 
1 
Pyrimidine metabolism 0.25 1 0.5 1 0.38
5 
1 
MyD88:Mal cascade initiated on plasma membrane 0.125 1 1 1 0.38
5 
1 
Hereditary leiomyomatosis and renal cell carcinoma pathway 1 1 0.125 1 0.38
5 
1 
Asparagine N-linked glycosylation 0.358 1 0.375 1 0.40
3 
1 
MAPK family signaling cascades 0.273 1 0.5 1 0.40
9 
1 
Ebola Virus Pathway on Host 0.413 1 1 1 0.41
3 
1 
Hawkinsinuria 0.25 1 0.563 1 0.41
6 
1 
Tyrosinemia_ transient_ of the newborn 0.25 1 0.563 1 0.41
6 
1 





Tyrosine Metabolism 0.25 1 0.563 1 0.41
6 
1 
Alkaptonuria 0.25 1 0.563 1 0.41
6 
1 
Monoamine oxidase-a deficiency (MAO-A) 0.25 1 0.563 1 0.41
6 
1 
Tyrosinemia Type I 0.25 1 0.563 1 0.41
6 
1 
Hyperornithinemia with gyrate atrophy (HOGA) 0.25 1 0.57 1 0.42 1 
Creatine deficiency_ guanidinoacetate methyltransferase deficiency 0.25 1 0.57 1 0.42 1 
L-arginine:glycine amidinotransferase deficiency 0.25 1 0.57 1 0.42 1 
Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome] 0.25 1 0.57 1 0.42 1 
Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency) 0.25 1 0.57 1 0.42 1 
Prolinemia Type II 0.25 1 0.57 1 0.42 1 
Prolidase Deficiency (PD) 0.25 1 0.57 1 0.42 1 
Arginine and Proline Metabolism 0.25 1 0.57 1 0.42 1 
Hyperprolinemia Type I 0.25 1 0.57 1 0.42 1 
Hyperprolinemia Type II 0.25 1 0.57 1 0.42 1 
Ornithine Aminotransferase Deficiency (OAT Deficiency) 0.25 1 0.57 1 0.42 1 
Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency) 0.25 1 0.57 1 0.42 1 
Complement and coagulation cascades - Homo sapiens (human) 0.431 1 1 1 0.43
1 
1 
Golgi-to-ER retrograde transport 0.148 1 1 1 0.43
2 
1 
Intra-Golgi and retrograde Golgi-to-ER traffic 0.148 1 1 1 0.43
2 
1 
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signal-
ing 
0.438 1 1 1 0.43
8 
1 





Transport of inorganic cations-anions and amino acids-oligopeptides 1 1 0.438 1 0.43
8 
1 
Complement Activation 0.438 1 1 1 0.43
8 
1 
Prostaglandin Synthesis and Regulation 0.438 1 1 1 0.43
8 
1 
Prion diseases - Homo sapiens (human) 0.438 1 1 1 0.43
8 
1 
Herpes simplex infection - Homo sapiens (human) 0.438 1 1 1 0.43
8 
1 
Collagen biosynthesis and modifying enzymes 0.156 1 1 1 0.44
6 
1 
Plasma lipoprotein remodeling 0.156 1 1 1 0.44
6 
1 
mTOR signaling pathway 0.156 1 1 1 0.44
6 
1 
Amino sugar and nucleotide sugar metabolism - Homo sapiens (human) 0.25 1 0.625 1 0.44
6 
1 
Transport of vitamins_ nucleosides_ and related molecules 1 1 0.156 1 0.44
6 
1 
Carboxyterminal post-translational modifications of tubulin 0.625 1 0.25 1 0.44
6 
1 
Purine ribonucleoside monophosphate biosynthesis 0.25 1 0.625 1 0.44
6 
1 
Lysine metabolism 0.25 1 0.625 1 0.44
6 
1 
L1CAM interactions 0.313 1 0.5 1 0.44
6 
1 
Ammonia Recycling 0.5 1 0.313 1 0.44
6 
1 





Aspartate Metabolism 0.5 1 0.313 1 0.44
6 
1 
Canavan Disease 0.5 1 0.313 1 0.44
6 
1 
Ribosomal scanning and start codon recognition 0.164 1 1 1 0.46
1 
1 
Glyoxylate and dicarboxylate metabolism - Homo sapiens (human) 1 1 0.164 1 0.46
1 
1 
Formation of Fibrin Clot (Clotting Cascade) 0.461 1 1 1 0.46
1 
1 
Protein folding 0.168 1 1 1 0.46
7 
1 
Cell surface interactions at the vascular wall 0.469 1 1 1 0.46
9 
1 
mRNA Processing 0.469 1 1 1 0.46
9 
1 
Flavan-3-ols 1 1 0.174 1 0.47
8 
1 
Phagosome - Homo sapiens (human) 0.492 1 1 1 0.49
2 
1 
Vitamin D Receptor Pathway 0.492 1 1 1 0.49
2 
1 
JAK STAT pathway and regulation 0.492 1 1 1 0.49
2 
1 
Amine compound SLC transporters 1 1 0.496 1 0.49
6 
1 
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway 0.496 1 1 1 0.49
6 
1 
fatty acid &alpha;-oxidation III 1 1 0.5 1 0.5 1 
LncRNA involvement in canonical Wnt signaling and colorectal cancer 0.5 1 1 1 0.5 1 
Breast cancer pathway 0.5 1 1 1 0.5 1 
Pancreatic adenocarcinoma pathway 0.5 1 1 1 0.5 1 
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MTHFR deficiency 0.5 1 1 1 0.5 1 
Transcriptional regulation by RUNX2 0.5 1 1 1 0.5 1 
Passive transport by Aquaporins 1 1 0.5 1 0.5 1 
creatine biosynthesis 1 1 0.5 1 0.5 1 
Insulin Signaling 0.5 1 1 1 0.5 1 
Interferon type I signaling pathways 0.5 1 1 1 0.5 1 
Notch Signaling Pathway 0.5 1 1 1 0.5 1 
Sulfation Biotransformation Reaction 0.5 1 1 1 0.5 1 
Estrogen metabolism 0.5 1 1 1 0.5 1 
Signaling by NOTCH1 in Cancer 0.5 1 1 1 0.5 1 
FoxO signaling pathway - Homo sapiens (human) 1 1 0.5 1 0.5 1 
uracil degradation 1 1 0.5 1 0.5 1 
Biosynthesis of unsaturated fatty acids - Homo sapiens (human) 1 1 0.5 1 0.5 1 
UTP and CTP dephosphorylation II 1 1 0.5 1 0.5 1 
stearate biosynthesis 1 1 0.5 1 0.5 1 
Intestinal absorption 1 1 0.5 1 0.5 1 
VLDL assembly 0.5 1 1 1 0.5 1 
VEGFA-VEGFR2 Pathway 0.5 1 1 1 0.5 1 
Assembly Of The HIV Virion 0.5 1 1 1 0.5 1 
Budding and maturation of HIV virion 0.5 1 1 1 0.5 1 
The NLRP3 inflammasome 0.5 1 1 1 0.5 1 
IL6 0.5 1 1 1 0.5 1 
Neurotransmitter uptake and metabolism In glial cells 1 1 0.5 1 0.5 1 
TICAM1_ RIP1-mediated IKK complex recruitment  0.5 1 1 1 0.5 1 
pyrimidine deoxyribonucleotide phosphorylation 0.5 1 1 1 0.5 1 
Senescence-Associated Secretory Phenotype (SASP) 0.5 1 1 1 0.5 1 
Inflammasomes 0.5 1 1 1 0.5 1 
Kinesins 0.5 1 1 1 0.5 1 
guanosine deoxyribonucleotides <i>de novo</i> biosynthesis 0.5 1 1 1 0.5 1 
Activation of NF-kappaB in B cells 0.5 1 1 1 0.5 1 
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adenosine deoxyribonucleotides <i>de novo</i> biosynthesis 0.5 1 1 1 0.5 1 
Downstream signaling events of B Cell Receptor (BCR) 0.5 1 1 1 0.5 1 
Vitamin B6 metabolism - Homo sapiens (human) 0.5 1 1 1 0.5 1 
Import of palmitoyl-CoA into the mitochondrial matrix 1 1 0.5 1 0.5 1 
Organic anion transport 1 1 0.5 1 0.5 1 
Canonical NF-kappaB pathway 0.5 1 1 1 0.5 1 
PAR1-mediated thrombin signaling events 0.5 1 1 1 0.5 1 
CXCR4-mediated signaling events 0.5 1 1 1 0.5 1 
Internalization of ErbB1 0.5 1 1 1 0.5 1 
Class I PI3K signaling events 0.5 1 1 1 0.5 1 
Validated transcriptional targets of deltaNp63 isoforms 0.5 1 1 1 0.5 1 
FAS (CD95) signaling pathway 0.5 1 1 1 0.5 1 
Alpha-synuclein signaling 0.5 1 1 1 0.5 1 
IL1-mediated signaling events 0.5 1 1 1 0.5 1 
Notch signaling pathway 0.5 1 1 1 0.5 1 
E2F transcription factor network 0.5 1 1 1 0.5 1 
TGF-beta receptor signaling 0.5 1 1 1 0.5 1 
ROS_ RNS production in phagocytes 0.5 1 1 1 0.5 1 
Cleavage of Growing Transcript in the Termination Region  0.5 1 1 1 0.5 1 
RNA Polymerase II Transcription Termination 0.5 1 1 1 0.5 1 
Ethanol oxidation 0.5 1 1 1 0.5 1 
Notch 0.5 1 1 1 0.5 1 
Choline catabolism 1 1 0.5 1 0.5 1 
Retinol metabolism - Homo sapiens (human) 0.5 1 1 1 0.5 1 
L-glutamine tRNA biosynthesis 1 1 0.5 1 0.5 1 
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion 1 1 0.5 1 0.5 1 
Neomycin_ kanamycin and gentamicin biosynthesis - Homo sapiens (hu-
man) 
1 1 0.5 1 0.5 1 
Melanin biosynthesis 1 1 0.5 1 0.5 1 
SCF(Skp2)-mediated degradation of p27/p21 0.5 1 1 1 0.5 1 
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Formation of xylulose-5-phosphate 1 1 0.5 1 0.5 1 
Vitamins B6 activation to pyridoxal phosphate 0.5 1 1 1 0.5 1 
regulators of bone mineralization 0.5 1 1 1 0.5 1 
prion pathway 0.5 1 1 1 0.5 1 
Primary immunodeficiency - Homo sapiens (human) 0.5 1 1 1 0.5 1 
TGF-beta signaling pathway - Homo sapiens (human) 0.5 1 1 1 0.5 1 
p38 mapk signaling pathway 0.5 1 1 1 0.5 1 
akt signaling pathway 0.5 1 1 1 0.5 1 
Th17 cell differentiation - Homo sapiens (human) 0.5 1 1 1 0.5 1 
cycling of ran in nucleocytoplasmic transport 0.5 1 1 1 0.5 1 
VEGF signaling pathway - Homo sapiens (human) 0.5 1 1 1 0.5 1 
role of mal in rho-mediated activation of srf 0.5 1 1 1 0.5 1 
stress induction of hsp regulation 0.5 1 1 1 0.5 1 
Gastric acid secretion - Homo sapiens (human) 0.5 1 1 1 0.5 1 
Rheumatoid arthritis - Homo sapiens (human) 0.5 1 1 1 0.5 1 
Thyroid cancer - Homo sapiens (human) 0.5 1 1 1 0.5 1 
Hepatitis B - Homo sapiens (human) 0.5 1 1 1 0.5 1 
Prolactin signaling pathway - Homo sapiens (human) 1 1 0.5 1 0.5 1 
Orc1 removal from chromatin 0.5 1 1 1 0.5 1 
Switching of origins to a post-replicative state 0.5 1 1 1 0.5 1 
Proton-coupled neutral amino acid transporters 1 1 0.5 1 0.5 1 
Pyrimidine salvage 1 1 0.5 1 0.5 1 
Cysteine formation from homocysteine 1 1 0.5 1 0.5 1 
Synthesis of DNA 0.5 1 1 1 0.5 1 
Separation of Sister Chromatids 0.5 1 1 1 0.5 1 
GLI3 is processed to GLI3R by the proteasome 0.5 1 1 1 0.5 1 
Degradation of GLI2 by the proteasome 0.5 1 1 1 0.5 1 
tetrahydrofolate salvage from 5_10-methenyltetrahydrofolate 0.5 1 1 1 0.5 1 
Degradation of GLI1 by the proteasome 0.5 1 1 1 0.5 1 
CMP phosphorylation 0.5 1 1 1 0.5 1 
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superpathway of pyrimidine deoxyribonucleoside salvage 0.5 1 1 1 0.5 1 
glutamine biosynthesis 1 1 0.5 1 0.5 1 
Type II diabetes mellitus - Homo sapiens (human) 1 1 0.5 1 0.5 1 
Insulin secretion - Homo sapiens (human) 1 1 0.5 1 0.5 1 
NF-kappa B signaling pathway - Homo sapiens (human) 0.5 1 1 1 0.5 1 
Sialic acid metabolism 1 1 0.5 1 0.5 1 
Triglyceride biosynthesis 1 1 0.5 1 0.5 1 
MAP3K8 (TPL2)-dependent MAPK1/3 activation 0.5 1 1 1 0.5 1 
purine deoxyribonucleosides salvage 0.5 1 1 1 0.5 1 
The role of GTSE1 in G2/M progression after G2 checkpoint 0.5 1 1 1 0.5 1 
Vpu mediated degradation of CD4 0.5 1 1 1 0.5 1 
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis 0.5 1 1 1 0.5 1 
pyrimidine deoxyribonucleosides degradation 1 1 0.5 1 0.5 1 
Cell death signalling via NRAGE_ NRIF and NADE 0.5 1 1 1 0.5 1 
The role of Nef in HIV-1 replication and disease pathogenesis 0.5 1 1 1 0.5 1 
pyrimidine ribonucleosides degradation 1 1 0.5 1 0.5 1 
Josephin domain DUBs 0.5 1 1 1 0.5 1 
lysine degradation II (pipecolate pathway) 1 1 0.5 1 0.5 1 
TCR signaling in na&#xef;ve CD8+ T cells 0.5 1 1 1 0.5 1 
Free fatty acids regulate insulin secretion 1 1 0.5 1 0.5 1 
SCF-beta-TrCP mediated degradation of Emi1 0.5 1 1 1 0.5 1 
hydrogen sulfide biosynthesis (trans-sulfuration) 1 1 0.5 1 0.5 1 
Multifunctional anion exchangers 1 1 0.5 1 0.5 1 
Intestinal hexose absorption 1 1 0.5 1 0.5 1 
Astrocytic Glutamate-Glutamine Uptake And Metabolism 1 1 0.5 1 0.5 1 
cysteine biosynthesis/homocysteine degradation (trans-sulfuration) 1 1 0.5 1 0.5 1 
Regulation of TP53 Activity through Methylation 0.5 1 1 1 0.5 1 
formaldehyde oxidation 0.5 1 1 1 0.5 1 
Signaling by VEGF 0.5 1 1 1 0.5 1 
Signaling events mediated by PTP1B 0.5 1 1 1 0.5 1 
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Signaling events mediated by HDAC Class I 0.5 1 1 1 0.5 1 
Glycerophospholipid metabolism - Homo sapiens (human) 1 1 0.5 1 0.5 1 
Reversible hydration of carbon dioxide 0.5 1 1 1 0.5 1 
Sialic acid metabolism 1 1 0.5 1 0.5 1 
Translesion Synthesis by POLH 0.5 1 1 1 0.5 1 
Nuclear import of Rev protein 0.5 1 1 1 0.5 1 
cardiac protection against ros 0.5 1 1 1 0.5 1 
Proton-coupled monocarboxylate transport 1 1 0.5 1 0.5 1 
Porphyrin metabolism 0.5 1 1 1 0.5 1 
superoxide radicals degradation 0.5 1 1 1 0.5 1 
Regulation of APC/C activators between G1/S and early anaphase 0.5 1 1 1 0.5 1 
glycine betaine degradation 1 1 0.5 1 0.5 1 
Estrogen Metabolism Pathway 0.5 1 1 1 0.5 1 
Tenofovir/Adefovir Pathway_ Pharmacodynamics 0.5 1 1 1 0.5 1 
Tenofovir/Adefovir Pathway_ Pharmacokinetics 0.5 1 1 1 0.5 1 
Doxorubicin Pathway (Cancer Cell)_ Pharmacodynamics 0.5 1 1 1 0.5 1 
Busulfan Pathway_ Pharmacodynamics 0.5 1 1 1 0.5 1 
Zidovudine Pathway_ Pharmacokinetics/Pharmacodynamics 0.5 1 1 1 0.5 1 
Estrogen-dependent gene expression 0.5 1 1 1 0.5 1 
Oxidative Stress Pathway (Erythrocyte) 0.5 1 1 1 0.5 1 
Pathway_PA165980337 0.5 1 1 1 0.5 1 
Oxidative Stress Pathway (Erythrocyte) 0.5 1 1 1 0.5 1 
Methylene Blue Pathway_ Pharmacodynamics 0.5 1 1 1 0.5 1 
Tacrolimus/Cyclosporine Pathway_ Pharmacodynamics 0.5 1 1 1 0.5 1 
Advanced glycosylation endproduct receptor signaling 0.5 1 1 1 0.5 1 
Polythiazide Action Pathway 1 1 0.5 1 0.5 1 
Methyclothiazide Action Pathway 1 1 0.5 1 0.5 1 
Bumetanide Action Pathway 1 1 0.5 1 0.5 1 
Transcriptional activation of mitochondrial biogenesis 0.5 1 1 1 0.5 1 
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Translesion synthesis by Y family DNA polymerases bypasses lesions on 
DNA template 
0.5 1 1 1 0.5 1 
Digestion of dietary lipid 1 1 0.5 1 0.5 1 
Activation of gene expression by SREBF (SREBP) 0.5 1 1 1 0.5 1 
pentose phosphate pathway (non-oxidative branch) 0.5 1 1 1 0.5 1 
Mitochondrial biogenesis 0.5 1 1 1 0.5 1 
Spironolactone Action Pathway 1 1 0.5 1 0.5 1 
Eplerenone Action Pathway 1 1 0.5 1 0.5 1 
Triamterene Action Pathway 1 1 0.5 1 0.5 1 
Amiloride Action Pathway 1 1 0.5 1 0.5 1 
Leucine Stimulation on Insulin Signaling 1 1 0.5 1 0.5 1 
Signaling by Hippo 0.5 1 1 1 0.5 1 
Hyperlysinemia I_ Familial 1 1 0.5 1 0.5 1 
Signaling by ERBB4 0.5 1 1 1 0.5 1 
Glycosphingolipid metabolism 0.5 1 1 1 0.5 1 
UTP and CTP dephosphorylation I 1 1 0.5 1 0.5 1 
APC/C-mediated degradation of cell cycle proteins 0.5 1 1 1 0.5 1 
Regulation of mitotic cell cycle 0.5 1 1 1 0.5 1 
Trehalose Degradation 1 1 0.5 1 0.5 1 
Synthesis of PG 1 1 0.5 1 0.5 1 
Passive transport by Aquaporins 1 1 0.5 1 0.5 1 
lysine degradation I (saccharopine pathway) 1 1 0.5 1 0.5 1 
2-aminoadipic 2-oxoadipic aciduria 1 1 0.5 1 0.5 1 
Ethacrynic Acid Action Pathway 1 1 0.5 1 0.5 1 
Quinethazone Action Pathway 1 1 0.5 1 0.5 1 
Bendroflumethiazide Action Pathway 1 1 0.5 1 0.5 1 
Constitutive Signaling by NOTCH1 PEST Domain Mutants 0.5 1 1 1 0.5 1 
Adefovir Dipivoxil Metabolism Pathway 0.5 1 1 1 0.5 1 
Chlorthalidone Action Pathway 1 1 0.5 1 0.5 1 
Trichlormethiazide Action Pathway 1 1 0.5 1 0.5 1 
  
 468 
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants 0.5 1 1 1 0.5 1 
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer 0.5 1 1 1 0.5 1 
Iminoglycinuria 1 1 0.5 1 0.5 1 
Lysinuric Protein Intolerance 1 1 0.5 1 0.5 1 
Insulin Signalling 1 1 0.5 1 0.5 1 
Lysine Degradation 1 1 0.5 1 0.5 1 
Blue diaper syndrome 1 1 0.5 1 0.5 1 
Lysinuric protein intolerance (LPI) 1 1 0.5 1 0.5 1 
Metoprolol Action Pathway 1 1 0.5 1 0.5 1 
Pyridoxine dependency with seizures 1 1 0.5 1 0.5 1 
IKK complex recruitment mediated by RIP1 0.5 1 1 1 0.5 1 
Saccharopinuria/Hyperlysinemia II 1 1 0.5 1 0.5 1 
Tenofovir Metabolism Pathway 0.5 1 1 1 0.5 1 
Cystinuria 1 1 0.5 1 0.5 1 
Indapamide Action Pathway 1 1 0.5 1 0.5 1 
Furosemide Action Pathway 1 1 0.5 1 0.5 1 
Torsemide Action Pathway 1 1 0.5 1 0.5 1 
Scavenging by Class B Receptors 0.5 1 1 1 0.5 1 
Hartnup Disorder 1 1 0.5 1 0.5 1 
Glucose Transporter Defect (SGLT2) 1 1 0.5 1 0.5 1 
Glutaric Aciduria Type I 1 1 0.5 1 0.5 1 
IL1 0.5 1 1 1 0.5 1 
Kidney Function 1 1 0.5 1 0.5 1 
Type I hemidesmosome assembly 0.5 1 1 1 0.5 1 
Kennedy pathway from Sphingolipids 1 1 0.5 1 0.5 1 
Hyperlysinemia II or Saccharopinuria 1 1 0.5 1 0.5 1 
Glucose Transporter Defect (SGLT2) 1 1 0.5 1 0.5 1 
Homocysteine Degradation 1 1 0.5 1 0.5 1 
Gamma-cystathionase deficiency (CTH) 1 1 0.5 1 0.5 1 
Homocystinuria_ cystathionine beta-synthase deficiency 1 1 0.5 1 0.5 1 
  
 469 
Metolazone Action Pathway 1 1 0.5 1 0.5 1 
Hydrochlorothiazide Action Pathway 1 1 0.5 1 0.5 1 
Cyclothiazide Action Pathway 1 1 0.5 1 0.5 1 
Hydroflumethiazide Action Pathway 1 1 0.5 1 0.5 1 
Chlorothiazide Action Pathway 1 1 0.5 1 0.5 1 
tryptophan degradation X (mammalian_ via tryptamine) 0.5 1 1 1 0.5 1 
Biopterin metabolism 1 1 0.5 1 0.5 1 
Vitamin B3 (nicotinate and nicotinamide) metabolism 1 1 0.5 1 0.5 1 
Platelet sensitization by LDL 0.5 1 1 1 0.5 1 
Platelet homeostasis 0.5 1 1 1 0.5 1 
Target Of Rapamycin (TOR) Signaling 0.5 1 1 1 0.5 1 
Human Thyroid Stimulating Hormone (TSH) signaling pathway 0.5 1 1 1 0.5 1 
L1CAM interactions 1 1 0.5 1 0.5 1 
phosphatidylethanolamine biosynthesis II 1 1 0.5 1 0.5 1 
superpathway of choline degradation to L-serine 1 1 0.5 1 0.5 1 
carnosine biosynthesis 1 1 0.5 1 0.5 1 
RAGE 0.5 1 1 1 0.5 1 
B Cell Receptor Signaling Pathway 0.5 1 1 1 0.5 1 
Corticotropin-releasing hormone signaling pathway 0.5 1 1 1 0.5 1 
Adipogenesis 0.5 1 1 1 0.5 1 
Histone Modifications 0.5 1 1 1 0.5 1 
D-galactose degradation V (Leloir pathway) 0.5 1 1 1 0.5 1 
Integrated Lung Cancer Pathway 0.5 1 1 1 0.5 1 
Nef-mediates down modulation of cell surface receptors by recruiting 
them to clathrin adapters 
0.5 1 1 1 0.5 1 
Iron uptake and transport 1 1 0.5 1 0.5 1 
Visual phototransduction 1 1 0.5 1 0.5 1 
TCF dependent signaling in response to WNT 0.5 1 1 1 0.5 1 
IL-3 Signaling Pathway 0.5 1 1 1 0.5 1 
proline biosynthesis 1 1 0.5 1 0.5 1 
  
 470 
mRNA 3_-end processing 0.5 1 1 1 0.5 1 
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transi-
tion) 
0.5 1 1 1 0.5 1 
Signaling by NOTCH1 PEST Domain Mutants in Cancer 0.5 1 1 1 0.5 1 
Photodynamic therapy-induced HIF-1 survival signaling 0.5 1 1 1 0.5 1 
Lung fibrosis 0.5 1 1 1 0.5 1 
NAD+ metabolism 1 1 0.5 1 0.5 1 
Wnt 0.5 1 1 1 0.5 1 
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt sig-
naling 
0.5 1 1 1 0.5 1 
Oxidative Damage 0.5 1 1 1 0.5 1 
Regulation of RUNX2 expression and activity 0.5 1 1 1 0.5 1 
Wnt Signaling Pathway and Pluripotency 0.5 1 1 1 0.5 1 
p38 MAPK Signaling Pathway 0.5 1 1 1 0.5 1 
InlA-mediated entry of Listeria monocytogenes into host cells 0.5 1 1 1 0.5 1 
Import of palmitoyl-CoA into the mitochondrial matrix 1 1 0.5 1 0.5 1 
Nucleotide salvage 1 1 0.5 1 0.5 1 
Triglyceride metabolism 1 1 0.5 1 0.5 1 
Degradation pathway of sphingolipids_ including diseases 0.5 1 1 1 0.5 1 
Listeria monocytogenes entry into host cells 0.5 1 1 1 0.5 1 
Pyrimidine metabolism and related diseases 1 1 0.5 1 0.5 1 
tRNA modification in the nucleus and cytosol 1 1 0.5 1 0.5 1 
Synthesis of wybutosine at G37 of tRNA(Phe) 1 1 0.5 1 0.5 1 
4-aminobutyrate degradation 1 1 0.5 1 0.5 1 
Amino acid conjugation of benzoic acid 1 1 0.5 1 0.5 1 
Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human) 0.5 1 1 1 0.5 1 
Coregulation of Androgen receptor activity 0.5 1 1 1 0.5 1 
Syndecan-1-mediated signaling events 0.5 1 1 1 0.5 1 
EPHB forward signaling 0.5 1 1 1 0.5 1 
Arf1 pathway 0.5 1 1 1 0.5 1 
  
 471 
GABA synthesis_ release_ reuptake and degradation 1 1 0.5 1 0.5 1 
mtor signaling pathway 0.5 1 1 1 0.5 1 
endocytotic role of ndk phosphins and dynamin 0.5 1 1 1 0.5 1 
cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 
adrenergic receptor (b2ar) pathway 
0.5 1 1 1 0.5 1 
ion channels and their functional role in vascular endothelium 0.5 1 1 1 0.5 1 
vegf hypoxia and angiogenesis 0.5 1 1 1 0.5 1 
Vasopressin-regulated water reabsorption - Homo sapiens (human) 0.5 1 1 1 0.5 1 
Pancreatic secretion - Homo sapiens (human) 0.5 1 1 1 0.5 1 
Hepatocellular carcinoma - Homo sapiens (human) 0.5 1 1 1 0.5 1 
Tuberculosis - Homo sapiens (human) 0.5 1 1 1 0.5 1 
Hedgehog _off_ state 0.5 1 1 1 0.5 1 
Inositol phosphate metabolism 1 1 0.5 1 0.5 1 
Organic cation/anion/zwitterion transport 1 1 0.5 1 0.5 1 
GPCR Dopamine D1like receptor 0.5 1 1 1 0.5 1 
Mitotic Prophase 1 1 0.5 1 0.5 1 
Synthesis of IP2_ IP_ and Ins in the cytosol 1 1 0.5 1 0.5 1 
Inositol phosphate metabolism 1 1 0.5 1 0.5 1 
Degradation of GABA 1 1 0.5 1 0.5 1 
Neurexins and neuroligins 0.5 1 1 1 0.5 1 
Initial triggering of complement 0.5 1 1 1 0.5 1 
Non-integrin membrane-ECM interactions 0.5 1 1 1 0.5 1 
Synthesis of wybutosine at G37 of tRNA(Phe) 1 1 0.5 1 0.5 1 
retinol biosynthesis 1 1 0.5 1 0.5 1 
Doxorubicin Pathway (Cardiomyocyte Cell)_ Pharmacodynamics 0.5 1 1 1 0.5 1 
Inositol Metabolism 1 1 0.5 1 0.5 1 
N-Glycan biosynthesis 1 1 0.5 1 0.5 1 
Nephrin family interactions 0.5 1 1 1 0.5 1 
fatty acid activation 1 1 0.5 1 0.5 1 
Incretin synthesis_ secretion_ and inactivation 1 1 0.5 1 0.5 1 
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Inositol phosphate metabolism 1 1 0.5 1 0.5 1 
Regulation of Microtubule Cytoskeleton 0.5 1 1 1 0.5 1 
JAK-STAT 0.5 1 1 1 0.5 1 
Branched-chain amino acid catabolism 1 1 0.5 1 0.5 1 
Selenoamino acid metabolism 1 1 0.5 1 0.5 1 
superpathway of pyrimidine deoxyribonucleotides <i>de novo</i> bio-
synthesis 
0.25 1 0.75 1 0.50
1 
1 
superpathway of tryptophan utilization 0.188 1 1 1 0.50
1 
1 
Tryptophan degradation 0.188 1 1 1 0.50
1 
1 
adenosine ribonucleotides <i>de novo</i> biosynthesis 0.25 1 0.75 1 0.50
1 
1 
Nitrogen metabolism - Homo sapiens (human) 0.375 1 0.5 1 0.50
1 
1 
Glycerophospholipid biosynthesis 1 1 0.188 1 0.50
1 
1 
Pentose Phosphate Metabolism 0.188 1 1 1 0.50
1 
1 
superpathway of pyrimidine ribonucleotides <i>de novo</i> biosynthesis 0.25 1 0.75 1 0.50
1 
1 
Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins 
(HSP) regulation 
0.188 1 1 1 0.50
1 
1 
Oxidative phosphorylation - Homo sapiens (human) 0.375 1 0.5 1 0.50
1 
1 
Fatty acid degradation - Homo sapiens (human) 0.25 1 0.75 1 0.50
1 
1 
Nucleobase catabolism 0.875 1 0.219 1 0.50
8 
1 





DNA Repair 0.812 1 0.25 1 0.52
7 
1 
PDGFR-beta signaling pathway 0.206 1 1 1 0.53
2 
1 
RAF/MAP kinase cascade 0.413 1 0.5 1 0.53
2 
1 
MAPK1/MAPK3 signaling 0.413 1 0.5 1 0.53
2 
1 
Methionine and cysteine metabolism 0.5 1 0.413 1 0.53
2 
1 
Trans-sulfuration and one carbon metabolism 0.312 1 0.688 1 0.54
5 
1 
CDC42 signaling events 0.547 1 1 1 0.54
7 
1 
Diseases of signal transduction 0.217 1 1 1 0.54
8 
1 
Metabolism of water-soluble vitamins and cofactors 1 1 0.219 1 0.55
1 
1 
Cargo recognition for clathrin-mediated endocytosis 0.219 1 1 1 0.55
1 
1 
Phenprocoumon Action Pathway 0.563 1 1 1 0.56
3 
1 
Alteplase Action Pathway 0.563 1 1 1 0.56
3 
1 
Aminocaproic Acid Action Pathway 0.563 1 1 1 0.56
3 
1 
Tranexamic Acid Action Pathway 0.563 1 1 1 0.56
3 
1 
Urokinase Action Pathway 0.563 1 1 1 0.56
3 
1 





Streptokinase Action Pathway 0.563 1 1 1 0.56
3 
1 
Tenecteplase Action Pathway 0.563 1 1 1 0.56
3 
1 
Anistreplase Action Pathway 0.563 1 1 1 0.56
3 
1 
Aprotinin Action Pathway 0.563 1 1 1 0.56
3 
1 
Phenindione Action Pathway 0.563 1 1 1 0.56
3 
1 
Dicoumarol Action Pathway 0.563 1 1 1 0.56
3 
1 
Warfarin Action Pathway 0.563 1 1 1 0.56
3 
1 
Coagulation  0.563 1 1 1 0.56
3 
1 
Bivalirudin Action Pathway 0.563 1 1 1 0.56
3 
1 
Argatroban Action Pathway 0.563 1 1 1 0.56
3 
1 
Ardeparin Action Pathway 0.563 1 1 1 0.56
3 
1 
Heparin Action Pathway 0.563 1 1 1 0.56
3 
1 
Fondaparinux Action Pathway 0.563 1 1 1 0.56
3 
1 
Enoxaparin Action Pathway 0.563 1 1 1 0.56
3 
1 
Dicumarol Action Pathway 0.563 1 1 1 0.56
3 
1 





Lepirudin Action Pathway 0.563 1 1 1 0.56
3 
1 
Acenocoumarol Action Pathway 0.563 1 1 1 0.56
3 
1 
Alanine_ aspartate and glutamate metabolism - Homo sapiens (human) 0.5 1 0.461 1 0.56
9 
1 
Valine Leucine Isoleucine degradation 0.5 1 0.469 1 0.57
4 
1 
3-Methylglutaconic Aciduria Type IV 0.5 1 0.469 1 0.57
4 
1 
Beta-Ketothiolase Deficiency 0.5 1 0.469 1 0.57
4 
1 
3-Methylglutaconic Aciduria Type I 0.5 1 0.469 1 0.57
4 
1 
Valine_ Leucine and Isoleucine Degradation 0.5 1 0.469 1 0.57
4 
1 
2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency 0.5 1 0.469 1 0.57
4 
1 
Isovaleric Aciduria 0.5 1 0.469 1 0.57
4 
1 
3-Methylcrotonyl Coa Carboxylase Deficiency Type I 0.5 1 0.469 1 0.57
4 
1 
Propionic Acidemia 0.5 1 0.469 1 0.57
4 
1 
Maple Syrup Urine Disease 0.5 1 0.469 1 0.57
4 
1 
3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency 0.5 1 0.469 1 0.57
4 
1 
Isobutyryl-coa dehydrogenase deficiency 0.5 1 0.469 1 0.57
4 
1 





3-hydroxyisobutyric acid dehydrogenase deficiency 0.5 1 0.469 1 0.57
4 
1 
Isovaleric acidemia 0.5 1 0.469 1 0.57
4 
1 
Methylmalonate Semialdehyde Dehydrogenase Deficiency 0.5 1 0.469 1 0.57
4 
1 
Methylmalonic Aciduria 0.5 1 0.469 1 0.57
4 
1 
3-Methylglutaconic Aciduria Type III 0.5 1 0.469 1 0.57
4 
1 
Glucose Homeostasis 1 1 0.578 1 0.57
8 
1 
Glyoxylate metabolism and glycine degradation 1 1 0.578 1 0.57
8 
1 
COPI-mediated anterograde transport 0.578 1 1 1 0.57
8 
1 
Mineral absorption - Homo sapiens (human) 0.625 1 0.383 1 0.58
1 
1 
Complement and Coagulation Cascades 0.583 1 1 1 0.58
3 
1 
Extracellular matrix organization 0.491 1 0.5 1 0.59 1 
EPH-Ephrin signaling 0.492 1 0.5 1 0.59
1 
1 
2-Hydroxyglutric Aciduria (D And L Form) 0.5 1 0.496 1 0.59
4 
1 
Homocarnosinosis 0.5 1 0.496 1 0.59
4 
1 
Hyperinsulinism-Hyperammonemia Syndrome 0.5 1 0.496 1 0.59
4 
1 
Succinic semialdehyde dehydrogenase deficiency 0.5 1 0.496 1 0.59
4 
1 
4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Defi-
ciency 





Glutamate Metabolism 0.5 1 0.496 1 0.59
4 
1 
Glucuronidation 0.5 1 0.5 1 0.59
7 
1 
glutathione biosynthesis 1 1 0.25 1 0.59
7 
1 
Transport of fatty acids 1 1 0.25 1 0.59
7 
1 
Stimuli-sensing channels 0.25 1 1 1 0.59
7 
1 
Vitamin B6 metabolism 0.5 1 0.5 1 0.59
7 
1 
Thiamine metabolism - Homo sapiens (human) 1 1 0.25 1 0.59
7 
1 
serine and glycine biosynthesis 1 1 0.25 1 0.59
7 
1 
Integrin alphaIIb beta3 signaling 0.25 1 1 1 0.59
7 
1 
Valine_ leucine and isoleucine degradation - Homo sapiens (human) 0.25 1 1 1 0.59
7 
1 
Integrin signaling 0.25 1 1 1 0.59
7 
1 
Histidine degradation 0.5 1 0.5 1 0.59
7 
1 
tRNA processing 1 1 0.25 1 0.59
7 
1 
GABA synthesis_ release_ reuptake and degradation 1 1 0.25 1 0.59
7 
1 
Linoleate metabolism 0.5 1 0.5 1 0.59
7 
1 





MECP2 and Associated Rett Syndrome 0.5 1 0.5 1 0.59
7 
1 
Glycogen Synthesis and Degradation 0.25 1 1 1 0.59
7 
1 
Biogenic Amine Synthesis 0.5 1 0.5 1 0.59
7 
1 
GLUT-1 deficiency syndrome 1 1 0.25 1 0.59
7 
1 
Magnesium salicylate Action Pathway 0.25 1 1 1 0.59
7 
1 
Congenital disorder of glycosylation CDG-IId 1 1 0.25 1 0.59
7 
1 
Cytosolic sulfonation of small molecules 0.25 1 1 1 0.59
7 
1 
Chromatin organization 0.25 1 1 1 0.59
7 
1 
Transferrin endocytosis and recycling 0.25 1 1 1 0.59
7 
1 
Globoid Cell Leukodystrophy 1 1 0.25 1 0.59
7 
1 
Lactose Synthesis 1 1 0.25 1 0.59
7 
1 
MAPK6/MAPK4 signaling 0.25 1 1 1 0.59
7 
1 
Histidine metabolism - Homo sapiens (human) 0.25 1 1 1 0.59
7 
1 
Metachromatic Leukodystrophy (MLD) 1 1 0.25 1 0.59
7 
1 
Cellular Senescence 0.25 1 1 1 0.59
7 
1 





MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy) 1 1 0.25 1 0.59
7 
1 
Metabolism of porphyrins 0.25 1 1 1 0.59
7 
1 
5-aminoimidazole ribonucleotide biosynthesis 0.5 1 0.5 1 0.59
7 
1 
Arachidonic Acid Metabolism 0.25 1 1 1 0.59
7 
1 
The canonical retinoid cycle in rods (twilight vision) 1 1 0.25 1 0.59
7 
1 
Sphingolipid Metabolism 1 1 0.25 1 0.59
7 
1 
Cyclin D associated events in G1 0.25 1 1 1 0.59
7 
1 
G1 Phase 0.25 1 1 1 0.59
7 
1 
Signaling by TGF-beta family members 0.25 1 1 1 0.59
7 
1 
Biosynthesis of specialized proresolving mediators (SPMs) 0.25 1 1 1 0.59
7 
1 
Dopaminergic synapse - Homo sapiens (human) 0.25 1 1 1 0.59
7 
1 
Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens 
(human) 
0.25 1 1 1 0.59
7 
1 
G1/S Transition 0.25 1 1 1 0.59
7 
1 
Hedgehog ligand biogenesis 0.25 1 1 1 0.59
7 
1 
Pyrimidine Metabolism 1 1 0.25 1 0.59
7 
1 





Synthesis of substrates in N-glycan biosythesis 1 1 0.25 1 0.59
7 
1 
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccha-
ride_ LLO) and transfer to a nascent protein 
1 1 0.25 1 0.59
7 
1 
Methylation 0.25 1 1 1 0.59
7 
1 
serine biosynthesis (phosphorylated route) 1 1 0.25 1 0.59
7 
1 
Galactose metabolism 1 1 0.25 1 0.59
7 
1 
Mitotic G1-G1/S phases 0.25 1 1 1 0.59
7 
1 
Beta Ureidopropionase Deficiency 1 1 0.25 1 0.59
7 
1 
Regulation of TP53 Activity 0.25 1 1 1 0.59
7 
1 
Neurotransmitter receptors and postsynaptic signal transmission 0.5 1 0.5 1 0.59
7 
1 
Interactions of Rev with host cellular proteins 0.25 1 1 1 0.59
7 
1 
Nicotinamide salvaging 1 1 0.25 1 0.59
7 
1 
Chromatin modifying enzymes 0.25 1 1 1 0.59
7 
1 
Etodolac Action Pathway 0.25 1 1 1 0.59
7 
1 
Ketoprofen Action Pathway 0.25 1 1 1 0.59
7 
1 
Rofecoxib Action Pathway 0.25 1 1 1 0.59
7 
1 





Diflunisal Action Pathway 0.25 1 1 1 0.59
7 
1 
Leukotriene C4 Synthesis Deficiency 0.25 1 1 1 0.59
7 
1 
Mitochondrial Electron Transport Chain 0.5 1 0.5 1 0.59
7 
1 
Histidine Metabolism 1 1 0.25 1 0.59
7 
1 
Celecoxib Action Pathway 0.25 1 1 1 0.59
7 
1 
Sulindac Action Pathway 0.25 1 1 1 0.59
7 
1 
Diclofenac Action Pathway 0.25 1 1 1 0.59
7 
1 
Ketorolac Action Pathway 0.25 1 1 1 0.59
7 
1 
Gaucher Disease 1 1 0.25 1 0.59
7 
1 
Naproxen Action Pathway 0.25 1 1 1 0.59
7 
1 
Etoricoxib Action Pathway 0.25 1 1 1 0.59
7 
1 
Carprofen Action Pathway 0.25 1 1 1 0.59
7 
1 
Flurbiprofen Action Pathway 0.25 1 1 1 0.59
7 
1 
Fenoprofen Action Pathway 0.25 1 1 1 0.59
7 
1 
Antrafenine Action Pathway 0.25 1 1 1 0.59
7 
1 





Lumiracoxib Action Pathway 0.25 1 1 1 0.59
7 
1 
UMP Synthase Deiciency (Orotic Aciduria) 1 1 0.25 1 0.59
7 
1 
Histidinemia 1 1 0.25 1 0.59
7 
1 
Trisalicylate-choline Action Pathway 0.25 1 1 1 0.59
7 
1 
Nepafenac Action Pathway 0.25 1 1 1 0.59
7 
1 
Phenylbutazone Action Pathway 0.25 1 1 1 0.59
7 
1 
Lornoxicam Action Pathway 0.25 1 1 1 0.59
7 
1 
Salsalate Action Pathway 0.25 1 1 1 0.59
7 
1 
Tenoxicam Action Pathway 0.25 1 1 1 0.59
7 
1 
Tiaprofenic Acid Action Pathway 0.25 1 1 1 0.59
7 
1 
Tolmetin Action Pathway 0.25 1 1 1 0.59
7 
1 
Salicylic Acid Action Pathway 0.25 1 1 1 0.59
7 
1 
Salicylate-sodium Action Pathway 0.25 1 1 1 0.59
7 
1 
Fabry disease 1 1 0.25 1 0.59
7 
1 
Oxaprozin Action Pathway 0.25 1 1 1 0.59
7 
1 





Nabumetone Action Pathway 0.25 1 1 1 0.59
7 
1 
Tryptophan Metabolism 0.25 1 1 1 0.59
7 
1 
Signaling by TGF-beta Receptor Complex 0.25 1 1 1 0.59
7 
1 
Mercaptopurine Metabolism Pathway 0.25 1 1 1 0.59
7 
1 
Krabbe disease 1 1 0.25 1 0.59
7 
1 
Indomethacin Action Pathway 0.25 1 1 1 0.59
7 
1 
Meloxicam Action Pathway 0.25 1 1 1 0.59
7 
1 
Suprofen Action Pathway 0.25 1 1 1 0.59
7 
1 
Bromfenac Action Pathway 0.25 1 1 1 0.59
7 
1 
Mefenamic Acid Action Pathway 0.25 1 1 1 0.59
7 
1 
Piroxicam Action Pathway 0.25 1 1 1 0.59
7 
1 
Dihydropyrimidinase Deficiency 1 1 0.25 1 0.59
7 
1 
Arachidonic acid metabolism 0.5 1 0.5 1 0.59
7 
1 
Bile acid biosynthesis 0.25 1 1 1 0.59
7 
1 
Dopamine metabolism 0.25 1 1 1 0.59
7 
1 





Acetaminophen  Action Pathway 0.25 1 1 1 0.59
7 
1 
Lipid Metabolism Pathway 0.5 1 0.5 1 0.59
7 
1 
Purine metabolism 0.25 1 1 1 0.59
7 
1 
glutathione-mediated detoxification 0.5 1 0.5 1 0.59
7 
1 
Human Complement System 0.611 1 1 1 0.61
1 
1 
Aurora B signaling 0.625 1 1 1 0.62
5 
1 
Beta1 integrin cell surface interactions 0.625 1 1 1 0.62
5 
1 
Beta3 integrin cell surface interactions 0.625 1 1 1 0.62
5 
1 
Apoptotic cleavage of cellular proteins 0.625 1 1 1 0.62
5 
1 
ECM-receptor interaction - Homo sapiens (human) 0.625 1 1 1 0.62
5 
1 
Fc gamma R-mediated phagocytosis - Homo sapiens (human) 0.625 1 1 1 0.62
5 
1 
granzyme a mediated apoptosis pathway 0.625 1 1 1 0.62
5 
1 
rho cell motility signaling pathway 0.625 1 1 1 0.62
5 
1 
y branching of actin filaments 0.625 1 1 1 0.62
5 
1 
Human immunodeficiency virus 1 infection - Homo sapiens (human) 0.625 1 1 1 0.62
5 
1 





alanine biosynthesis/degradation 1 1 0.625 1 0.62
5 
1 
Intrinsic Pathway of Fibrin Clot Formation 0.625 1 1 1 0.62
5 
1 
Integrated Breast Cancer Pathway 0.625 1 1 1 0.62
5 
1 
Prolactin Signaling Pathway 0.625 1 1 1 0.62
5 
1 
Arrhythmogenic Right Ventricular Cardiomyopathy 0.625 1 1 1 0.62
5 
1 
Allograft Rejection 0.625 1 1 1 0.62
5 
1 
E3 ubiquitin ligases ubiquitinate target proteins 0.625 1 1 1 0.62
5 
1 
Apoptosis-related network due to altered Notch3 in ovarian cancer 0.625 1 1 1 0.62
5 
1 
Striated Muscle Contraction Pathway 0.625 1 1 1 0.62
5 
1 
Pentose Phosphate Pathway 0.313 1 0.875 1 0.62
8 
1 
Glucose-6-phosphate dehydrogenase deficiency 0.313 1 0.875 1 0.62
8 
1 
Ribose-5-phosphate isomerase deficiency 0.313 1 0.875 1 0.62
8 
1 
Transaldolase deficiency 0.313 1 0.875 1 0.62
8 
1 
Alanine Aspartate Asparagine metabolism 1 1 0.275 1 0.63
1 
1 
Dengue-2 Interactions with Complement and Coagulation Cascades 0.639 1 1 1 0.63
9 
1 





Complement cascade 0.641 1 1 1 0.64
1 
1 
Argininemia 0.5 1 0.57 1 0.64
3 
1 
Citrullinemia Type I 0.5 1 0.57 1 0.64
3 
1 
Carbamoyl Phosphate Synthetase Deficiency 0.5 1 0.57 1 0.64
3 
1 
Argininosuccinic Aciduria 0.5 1 0.57 1 0.64
3 
1 
Urea Cycle 0.5 1 0.57 1 0.64
3 
1 
Ornithine Transcarbamylase Deficiency (OTC Deficiency) 0.5 1 0.57 1 0.64
3 
1 
Glycine Serine metabolism 0.75 1 0.38 1 0.64
3 
1 
Detoxification of Reactive Oxygen Species 0.652 1 1 1 0.65
2 
1 
Smooth Muscle Contraction 0.297 1 1 1 0.65
7 
1 
Branched-chain amino acid catabolism 1 1 0.297 1 0.65
7 
1 
Insulin signaling pathway - Homo sapiens (human) 0.312 1 1 1 0.67
6 
1 
Platelet Aggregation (Plug Formation) 0.312 1 1 1 0.67
6 
1 
S-Adenosylhomocysteine (SAH) Hydrolase Deficiency 1 1 0.312 1 0.67
6 
1 
Methionine Metabolism 1 1 0.312 1 0.67
6 
1 





Glycine N-methyltransferase Deficiency 1 1 0.312 1 0.67
6 
1 
Hypermethioninemia 1 1 0.312 1 0.67
6 
1 
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD) 1 1 0.312 1 0.67
6 
1 
Glucose-Alanine Cycle 1 1 0.312 1 0.67
6 
1 
Homocystinuria-megaloblastic anemia due to defect in cobalamin metab-
olism_ cblG complementation type 
1 1 0.312 1 0.67
6 
1 
Cystathionine Beta-Synthase Deficiency 1 1 0.312 1 0.67
6 
1 
Calcium Regulation in the Cardiac Cell 0.313 1 1 1 0.67
6 
1 
Galactosemia 1 1 0.313 1 0.67
6 
1 
Huntington disease - Homo sapiens (human) 0.313 1 1 1 0.67
6 
1 
Galactose Metabolism 1 1 0.313 1 0.67
6 
1 
&gamma;-glutamyl cycle 0.5 1 0.638 1 0.68
3 
1 
Glycine_ serine and threonine metabolism - Homo sapiens (human) 0.75 1 0.426 1 0.68
4 
1 
Class I MHC mediated antigen processing & presentation 0.322 1 1 1 0.68
7 
1 
Plasma lipoprotein assembly_ remodeling_ and clearance 0.322 1 1 1 0.68
7 
1 
RAC1 signaling pathway 0.688 1 1 1 0.68
8 
1 





mRNA Splicing - Major Pathway 0.688 1 1 1 0.68
8 
1 
mRNA Splicing 0.688 1 1 1 0.68
8 
1 
TGF-beta super family signaling pathway canonical 0.695 1 1 1 0.69
5 
1 
<i>S</i>-methyl-5-thio-&alpha;-D-ribose 1-phosphate degradation 1 1 0.34 1 0.70
6 
1 
Phenylalanine and tyrosine catabolism 0.5 1 0.688 1 0.71
1 
1 
Urea cycle 0.5 1 0.688 1 0.71
1 
1 
Mitochondrial tRNA aminoacylation 1 1 0.734 1 0.73
4 
1 
Signaling by BRAF and RAF fusions 0.734 1 1 1 0.73
4 
1 
Oncogenic MAPK signaling 0.734 1 1 1 0.73
4 
1 
Glycine_ serine_ alanine and threonine metabolism 0.5 1 0.735 1 0.73
6 
1 
ABC transporters - Homo sapiens (human) 1 1 0.371 1 0.73
8 
1 
Post-translational modification: synthesis of GPI-anchored proteins 0.742 1 1 1 0.74
2 
1 
Aminosugars metabolism 1 1 0.375 1 0.74
3 
1 
Synaptic vesicle cycle - Homo sapiens (human) 0.375 1 1 1 0.74
3 
1 
Lysosome - Homo sapiens (human) 0.375 1 1 1 0.74
3 
1 





Signaling by NTRK1 (TRKA) 0.375 1 1 1 0.74
3 
1 
Signaling by NTRKs 0.375 1 1 1 0.74
3 
1 
Beta-catenin independent WNT signaling 0.375 1 1 1 0.74
3 
1 
Mitochondrial protein import 0.375 1 1 1 0.74
3 
1 
Parkinson disease - Homo sapiens (human) 0.75 1 0.5 1 0.74
3 
1 
rRNA processing 0.75 1 1 1 0.75 1 
iron-sulfur cluster biosynthesis 1 1 0.75 1 0.75 1 
Chagas disease (American trypanosomiasis) - Homo sapiens (human) 0.75 1 1 1 0.75 1 
rRNA modification in the nucleus and cytosol 0.75 1 1 1 0.75 1 
rRNA processing in the nucleus and cytosol 0.75 1 1 1 0.75 1 
Retinoblastoma Gene in Cancer 0.75 1 1 1 0.75 1 
Metabolism of polyamines 1 1 0.75 1 0.75 1 
Collagen chain trimerization 0.75 1 1 1 0.75 1 
amb2 Integrin signaling 0.75 1 1 1 0.75 1 
Caspase-mediated cleavage of cytoskeletal proteins 0.75 1 1 1 0.75 1 
LDL clearance 0.75 1 1 1 0.75 1 
Immunoregulatory interactions between a Lymphoid and a non-Lym-
phoid cell 
0.75 1 1 1 0.75 1 
Gap junction degradation 0.75 1 1 1 0.75 1 
Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens 
(human) 
0.75 1 1 1 0.75 1 
Endocrine and other factor-regulated calcium reabsorption - Homo sapi-
ens (human) 
0.75 1 1 1 0.75 1 
pentose phosphate pathway (oxidative branch) 0.75 1 1 1 0.75 1 
Netrin-1 signaling 0.75 1 1 1 0.75 1 
Platinum Pathway_ Pharmacokinetics/Pharmacodynamics 0.75 1 1 1 0.75 1 
  
 490 
Gap junction trafficking 0.75 1 1 1 0.75 1 
Gap junction trafficking and regulation 0.75 1 1 1 0.75 1 
Angiogenesis overview 0.75 1 1 1 0.75 1 
Synaptic Vesicle Pathway 0.75 1 1 1 0.75 1 
Recycling pathway of L1 0.438 1 1 1 0.79
9 
1 
Gap junction - Homo sapiens (human) 0.438 1 1 1 0.79
9 
1 
AMPK signaling pathway - Homo sapiens (human) 0.875 1 0.5 1 0.79
9 
1 
Carnosinuria_ carnosinemia 1 1 0.438 1 0.79
9 
1 
Ureidopropionase deficiency 1 1 0.438 1 0.79
9 
1 
GABA-Transaminase Deficiency 1 1 0.438 1 0.79
9 
1 
Beta-Alanine Metabolism 1 1 0.438 1 0.79
9 
1 
Mitotic Prophase 0.875 1 0.5 1 0.79
9 
1 
Caspase Cascade in Apoptosis 0.812 1 1 1 0.81
2 
1 
RHO GTPases Activate WASPs and WAVEs 0.812 1 1 1 0.81
2 
1 
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alz-
heimer_s disease models 
0.813 1 1 1 0.81
3 
1 
Neurodegenerative Diseases 0.813 1 1 1 0.81
3 
1 
Staphylococcus aureus infection - Homo sapiens (human) 0.813 1 1 1 0.81
3 
1 





Transport to the Golgi and subsequent modification 0.461 1 1 1 0.81
8 
1 
Alanine and aspartate metabolism 1 1 0.461 1 0.81
8 
1 
ER to Golgi Anterograde Transport 0.461 1 1 1 0.81
8 
1 
Plasma lipoprotein assembly 0.469 1 1 1 0.82
4 
1 
Glycerophospholipid Biosynthetic Pathway 1 1 0.829 1 0.82
9 
1 
Na+/Cl- dependent neurotransmitter transporters 1 1 0.844 1 0.84
4 
1 
Platelet activation - Homo sapiens (human) 0.844 1 1 1 0.84
4 
1 
GPCR signaling-G alpha s PKA and ERK 0.844 1 1 1 0.84
4 
1 
Amino acid synthesis and interconversion (transamination) 1 1 0.844 1 0.84
4 
1 
Transport of inorganic cations/anions and amino acids/oligopeptides 1 1 0.497 1 0.84
5 
1 
Amino acid and oligopeptide SLC transporters 1 1 0.497 1 0.84
5 
1 
RAF activation 0.5 1 1 1 0.84
7 
1 
ESR-mediated signaling 0.5 1 1 1 0.84
7 
1 
HDR through Homologous Recombination (HR) or Single Strand Anneal-
ing (SSA) 
0.5 1 1 1 0.84
7 
1 
ABC transporter disorders 0.5 1 1 1 0.84
7 
1 





Heme Biosynthesis 0.5 1 1 1 0.84
7 
1 
Methylation Pathways 0.5 1 1 1 0.84
7 
1 
Folate Metabolism 1 1 0.5 1 0.84
7 
1 
Homology Directed Repair 0.5 1 1 1 0.84
7 
1 
serotonin degradation 0.5 1 1 1 0.84
7 
1 
Triglyceride catabolism 1 1 0.5 1 0.84
7 
1 
pyrimidine deoxyribonucleotides biosynthesis from CTP 0.5 1 1 1 0.84
7 
1 
DNA Double-Strand Break Repair 0.5 1 1 1 0.84
7 
1 
acetyl-CoA biosynthesis from citrate 1 1 0.5 1 0.84
7 
1 
glutamate biosynthesis/degradation 1 1 0.5 1 0.84
7 
1 
Defective CFTR causes cystic fibrosis 0.5 1 1 1 0.84
7 
1 
Fructose metabolism 1 1 0.5 1 0.84
7 
1 
Simvastatin Action Pathway 1 1 0.5 1 0.84
7 
1 
Amphetamine addiction - Homo sapiens (human) 1 1 0.5 1 0.84
7 
1 
Mevalonic aciduria 1 1 0.5 1 0.84
7 
1 





Rev-mediated nuclear export of HIV RNA 0.5 1 1 1 0.84
7 
1 
Insulin effects increased synthesis of Xylulose-5-Phosphate 0.5 1 1 1 0.84
7 
1 
Oxidative Stress Induced Senescence 0.5 1 1 1 0.84
7 
1 
palmitate biosynthesis 1 1 0.5 1 0.84
7 
1 
ABC transporters in lipid homeostasis 0.5 1 1 1 0.84
7 
1 
Smith-Lemli-Opitz Syndrome (SLOS) 1 1 0.5 1 0.84
7 
1 
Chondrodysplasia Punctata II_ X Linked Dominant (CDPX2) 1 1 0.5 1 0.84
7 
1 
Desmosterolosis 1 1 0.5 1 0.84
7 
1 
Downstream TCR signaling 0.5 1 1 1 0.84
7 
1 
TCR signaling 0.5 1 1 1 0.84
7 
1 
Synthesis of Leukotrienes (LT) and Eoxins (EX) 0.5 1 1 1 0.84
7 
1 
malate-aspartate shuttle 0.5 1 1 1 0.84
7 
1 
Sulfite oxidase deficiency 0.5 1 1 1 0.84
7 
1 
Hypercholesterolemia 1 1 0.5 1 0.84
7 
1 
Protein repair 0.5 1 1 1 0.84
7 
1 





guanosine ribonucleotides <i>de novo</i> biosynthesis 0.5 1 1 1 0.84
7 
1 
guanosine nucleotides <i>de novo</i> biosynthesis 0.5 1 1 1 0.84
7 
1 
Insulin receptor recycling 0.5 1 1 1 0.84
7 
1 
Signaling by Insulin receptor 0.5 1 1 1 0.84
7 
1 
Heme biosynthesis 0.5 1 1 1 0.84
7 
1 
Rosuvastatin Action Pathway 1 1 0.5 1 0.84
7 
1 
heme biosynthesis 0.5 1 1 1 0.84
7 
1 
Methotrexate Action Pathway 1 1 0.5 1 0.84
7 
1 
Respiratory electron transport_ ATP synthesis by chemiosmotic coupling_ 
and heat production by uncoupling proteins. 
0.5 1 1 1 0.84
7 
1 
eNOS activation 0.5 1 1 1 0.84
7 
1 
EPHB-mediated forward signaling 1 1 0.5 1 0.84
7 
1 
Aminosugars metabolism 1 1 0.5 1 0.84
7 
1 
Cyclin E associated events during G1/S transition  0.5 1 1 1 0.84
7 
1 
Type II diabetes mellitus 1 1 0.5 1 0.84
7 
1 
Arginine biosynthesis - Homo sapiens (human) 0.5 1 1 1 0.84
7 
1 





Downregulation of SMAD2/3:SMAD4 transcriptional activity 0.5 1 1 1 0.84
7 
1 
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer 0.5 1 1 1 0.84
7 
1 
pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis 0.5 1 1 1 0.84
7 
1 
Vascular smooth muscle contraction - Homo sapiens (human) 0.5 1 1 1 0.84
7 
1 
Bile secretion - Homo sapiens (human) 1 1 0.5 1 0.84
7 
1 
Alcoholism - Homo sapiens (human) 1 1 0.5 1 0.84
7 
1 
Cocaine addiction - Homo sapiens (human) 1 1 0.5 1 0.84
7 
1 
Cyclin A:Cdk2-associated events at S phase entry 0.5 1 1 1 0.84
7 
1 
DNA Replication 0.5 1 1 1 0.84
7 
1 
Folate-Alcohol and Cancer Pathway Hypotheses 1 1 0.5 1 0.84
7 
1 
Metabolism of cofactors 0.5 1 1 1 0.84
7 
1 
S Phase 0.5 1 1 1 0.84
7 
1 
EGFR downregulation 0.5 1 1 1 0.84
7 
1 
Signaling by EGFR 0.5 1 1 1 0.84
7 
1 
Base Excision Repair 1 1 0.5 1 0.84
7 
1 





Downregulation of ERBB2 signaling 0.5 1 1 1 0.84
7 
1 
Steroid Biosynthesis 1 1 0.5 1 0.84
7 
1 
Famotidine Action Pathway 1 1 0.5 1 0.84
7 
1 
D-Glutamine and D-glutamate metabolism - Homo sapiens (human) 1 1 0.5 1 0.84
7 
1 
Triglyceride metabolism 1 1 0.5 1 0.84
7 
1 
Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human) 0.5 1 1 1 0.84
7 
1 
Aquaporin-mediated transport 1 1 0.5 1 0.84
7 
1 
Insulin resistance - Homo sapiens (human) 1 1 0.5 1 0.84
7 
1 
Regulation of TP53 Degradation 0.5 1 1 1 0.84
7 
1 
Regulation of TP53 Expression and Degradation 0.5 1 1 1 0.84
7 
1 
PIP3 activates AKT signaling 0.5 1 1 1 0.84
7 
1 
Neurotransmitter clearance 0.5 1 1 1 0.84
7 
1 
Signaling by PDGF 0.5 1 1 1 0.84
7 
1 
Interferon gamma signaling 0.5 1 1 1 0.84
7 
1 
Glutamate binding_ activation of AMPA receptors and synaptic plasticity 1 1 0.5 1 0.84
7 
1 





Nicotinate Nicotinamide metabolism 1 1 0.5 1 0.84
7 
1 
Mitotic Anaphase 0.5 1 1 1 0.84
7 
1 
Mitotic Metaphase and Anaphase 0.5 1 1 1 0.84
7 
1 
Phenylalanine degradation 1 1 0.5 1 0.84
7 
1 
Fructose catabolism 1 1 0.5 1 0.84
7 
1 
Galactose catabolism 0.5 1 1 1 0.84
7 
1 
Signaling by ERBB2 0.5 1 1 1 0.84
7 
1 
Pravastatin Action Pathway 1 1 0.5 1 0.84
7 
1 
Atorvastatin Action Pathway 1 1 0.5 1 0.84
7 
1 
Folate malabsorption_ hereditary 1 1 0.5 1 0.84
7 
1 
Sulfate/Sulfite Metabolism 0.5 1 1 1 0.84
7 
1 
Hyper-IgD syndrome 1 1 0.5 1 0.84
7 
1 
Cholesteryl ester storage disease 1 1 0.5 1 0.84
7 
1 
Lysosomal Acid Lipase Deficiency (Wolman Disease) 1 1 0.5 1 0.84
7 
1 
Alendronate Action Pathway 1 1 0.5 1 0.84
7 
1 





Porphyria Variegata (PV) 0.5 1 1 1 0.84
7 
1 
Congenital Erythropoietic Porphyria (CEP) or Gunther Disease 0.5 1 1 1 0.84
7 
1 
Acute Intermittent Porphyria 0.5 1 1 1 0.84
7 
1 
Wolman disease 1 1 0.5 1 0.84
7 
1 
Oxidation of Branched Chain Fatty Acids 0.5 1 1 1 0.84
7 
1 
Risedronate Action Pathway 1 1 0.5 1 0.84
7 
1 
Cerivastatin Action Pathway 1 1 0.5 1 0.84
7 
1 
Fluvastatin Action Pathway 1 1 0.5 1 0.84
7 
1 
Hh mutants that don_t undergo autocatalytic processing are degraded by 
ERAD 
0.5 1 1 1 0.84
7 
1 
Hh mutants abrogate ligand secretion 0.5 1 1 1 0.84
7 
1 
CHILD Syndrome 1 1 0.5 1 0.84
7 
1 
Porphyrin Metabolism 0.5 1 1 1 0.84
7 
1 
Formation of Incision Complex in GG-NER 0.5 1 1 1 0.84
7 
1 
Zoledronate Action Pathway 1 1 0.5 1 0.84
7 
1 
Ibandronate Action Pathway 1 1 0.5 1 0.84
7 
1 
Recruitment and ATM-mediated phosphorylation of repair and signaling 
proteins at DNA double strand breaks 





DNA Double Strand Break Response 0.5 1 1 1 0.84
7 
1 
Leukotriene metabolism 0.5 1 1 1 0.84
7 
1 
Vitamin B5 - CoA biosynthesis from pantothenate 1 1 0.5 1 0.84
7 
1 
Ethanol effects on histone modifications 0.5 1 1 1 0.84
7 
1 
Global Genome Nucleotide Excision Repair (GG-NER) 0.5 1 1 1 0.84
7 
1 
AMP-activated Protein Kinase (AMPK) Signaling 0.5 1 1 1 0.84
7 
1 
Catabolism of glucuronate to xylulose-5-phosphate 1 1 0.5 1 0.84
7 
1 
L-dopa degradation 1 1 0.5 1 0.84
7 
1 
TGF-beta receptor signaling activates SMADs 0.5 1 1 1 0.84
7 
1 
Activation of gene expression by SREBF (SREBP) 0.5 1 1 1 0.84
7 
1 
Amyotrophic lateral sclerosis (ALS) 0.5 1 1 1 0.84
7 
1 
Nicotinate and Nicotinamide Metabolism 1 1 0.5 1 0.84
7 
1 
Regulation of lipid metabolism by Peroxisome proliferator-activated re-
ceptor alpha (PPARalpha) 
0.5 1 1 1 0.84
7 
1 
Processing of DNA double-strand break ends 0.5 1 1 1 0.84
7 
1 
Pamidronate Action Pathway 1 1 0.5 1 0.84
7 
1 





Lovastatin Action Pathway 1 1 0.5 1 0.84
7 
1 
Angiopoietin Like Protein 8 Regulatory Pathway 0.5 1 1 1 0.84
7 
1 
Nucleotide Excision Repair 0.5 1 1 1 0.84
7 
1 
NO-cGMP-PKG mediated Neuroprotection 0.5 1 1 1 0.84
7 
1 
Nucleotide Metabolism 1 1 0.5 1 0.84
7 
1 
Glycogen breakdown (glycogenolysis) 0.5 1 1 1 0.84
7 
1 
Glycogen metabolism 0.5 1 1 1 0.84
7 
1 
Thiamine metabolic pathways 1 1 0.5 1 0.84
7 
1 
folate polyglutamylation 1 1 0.5 1 0.84
7 
1 
Regulation of insulin secretion 1 1 0.5 1 0.84
7 
1 
Metabolism of nitric oxide 0.5 1 1 1 0.84
7 
1 
GABAergic synapse - Homo sapiens (human) 1 1 0.5 1 0.84
7 
1 
Vitamin B9 (folate) metabolism 1 1 0.5 1 0.84
7 
1 
Metabolism of folate and pterines 1 1 0.5 1 0.84
7 
1 
eNOS activation and regulation 0.5 1 1 1 0.84
7 
1 





Vitamin B5 (pantothenate) metabolism 0.5 1 1 1 0.84
7 
1 
Intracellular signaling by second messengers 0.5 1 1 1 0.84
7 
1 
Protein-protein interactions at synapses 0.5 1 1 1 0.84
7 
1 
HDL remodeling 0.5 1 1 1 0.84
7 
1 
Fructose and mannose metabolism 1 1 0.5 1 0.84
7 
1 
Parkinsons Disease Pathway 0.5 1 1 1 0.84
7 
1 
GABA shunt 1 1 0.5 1 0.84
7 
1 
Fructose and mannose metabolism - Homo sapiens (human) 0.844 1 0.625 1 0.86
5 
1 
Tigecycline Action Pathway 1 1 0.875 1 0.87
5 
1 
RAB GEFs exchange GTP for GDP on RABs 0.875 1 1 1 0.87
5 
1 
Tobramycin Action Pathway 1 1 0.875 1 0.87
5 
1 
Troleandomycin Action Pathway 1 1 0.875 1 0.87
5 
1 
Clarithromycin Action Pathway 1 1 0.875 1 0.87
5 
1 
Clindamycin Action Pathway 1 1 0.875 1 0.87
5 
1 
Azithromycin Action Pathway 1 1 0.875 1 0.87
5 
1 





Dilated cardiomyopathy (DCM) - Homo sapiens (human) 0.875 1 1 1 0.87
5 
1 
Methacycline Action Pathway 1 1 0.875 1 0.87
5 
1 
Rolitetracycline Action Pathway 1 1 0.875 1 0.87
5 
1 
Minocycline Action Pathway 1 1 0.875 1 0.87
5 
1 
glycine biosynthesis 1 1 0.875 1 0.87
5 
1 
Erythromycin Action Pathway 1 1 0.875 1 0.87
5 
1 
Telithromycin Action Pathway 1 1 0.875 1 0.87
5 
1 
Streptomycin Action Pathway 1 1 0.875 1 0.87
5 
1 
Spectinomycin Action Pathway 1 1 0.875 1 0.87
5 
1 
Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human) 0.875 1 1 1 0.87
5 
1 
Oxidative Stress Regulatory Pathway (Erythrocyte) 0.875 1 1 1 0.87
5 
1 
Josamycin Action Pathway 1 1 0.875 1 0.87
5 
1 
Kanamycin Action Pathway 1 1 0.875 1 0.87
5 
1 
Gentamicin Action Pathway 1 1 0.875 1 0.87
5 
1 
Netilmicin Action Pathway 1 1 0.875 1 0.87
5 
1 





Roxithromycin Action Pathway 1 1 0.875 1 0.87
5 
1 
Amikacin Action Pathway 1 1 0.875 1 0.87
5 
1 
Doxycycline Action Pathway 1 1 0.875 1 0.87
5 
1 
Demeclocycline Action Pathway 1 1 0.875 1 0.87
5 
1 
Oxytetracycline Action Pathway 1 1 0.875 1 0.87
5 
1 
Clomocycline Action Pathway 1 1 0.875 1 0.87
5 
1 
Lincomycin Action Pathway 1 1 0.875 1 0.87
5 
1 
Chloramphenicol Action Pathway 1 1 0.875 1 0.87
5 
1 
Scavenging by Class F Receptors 0.875 1 1 1 0.87
5 
1 
Arbekacin Action Pathway 1 1 0.875 1 0.87
5 
1 
Paromomycin Action Pathway 1 1 0.875 1 0.87
5 
1 
Glyoxylate metabolism and glycine degradation 1 1 0.875 1 0.87
5 
1 
Lymecycline Action Pathway 1 1 0.875 1 0.87
5 
1 
Tetracycline Action Pathway 1 1 0.875 1 0.87
5 
1 
Rho GTPase cycle 0.563 1 1 1 0.88
6 
1 





Protein digestion and absorption - Homo sapiens (human) 0.75 1 0.765 1 0.89
2 
1 
Processing of Capped Intron-Containing Pre-mRNA 0.578 1 1 1 0.89
5 
1 
Lysosome Vesicle Biogenesis 0.625 1 1 1 0.91
9 
1 
ornithine <i>de novo </i> biosynthesis 1 1 0.625 1 0.91
9 
1 
sucrose degradation 0.625 1 1 1 0.91
9 
1 
Degradation of cysteine and homocysteine 1 1 0.625 1 0.91
9 
1 
Valine_ leucine and isoleucine biosynthesis - Homo sapiens (human) 1 1 0.625 1 0.91
9 
1 
COPI-dependent Golgi-to-ER retrograde traffic 0.625 1 1 1 0.91
9 
1 
COPII-mediated vesicle transport 0.625 1 1 1 0.91
9 
1 
Tryptophan metabolism 1 1 0.625 1 0.91
9 
1 
tRNA charging 1 1 0.652 1 0.93
1 
1 
Aminoacyl-tRNA biosynthesis - Homo sapiens (human) 1 1 0.652 1 0.93
1 
1 
leukotriene biosynthesis 1 1 0.652 1 0.93
1 
1 
Nicotinate and nicotinamide metabolism - Homo sapiens (human) 0.75 1 0.875 1 0.93
3 
1 
Keratinization 0.938 1 1 1 0.93
8 
1 





Amino acid synthesis and interconversion (transamination) 0.75 1 0.91 1 0.94
3 
1 
Golgi Associated Vesicle Biogenesis 0.688 1 1 1 0.94
5 
1 
Clathrin derived vesicle budding 0.688 1 1 1 0.94
5 
1 
trans-Golgi Network Vesicle Budding 0.688 1 1 1 0.94
5 
1 
MAP2K and MAPK activation 0.945 1 1 1 0.94
5 
1 
Signaling by RAS mutants 0.945 1 1 1 0.94
5 
1 
Signaling by high-kinase activity BRAF mutants 0.945 1 1 1 0.94
5 
1 
Signaling by moderate kinase activity BRAF mutants 0.945 1 1 1 0.94
5 
1 
Paradoxical activation of RAF signaling by kinase inactive BRAF 0.945 1 1 1 0.94
5 
1 
Toll-Like Receptors Cascades 0.734 1 1 1 0.96
1 
1 
tRNA Aminoacylation 1 1 0.734 1 0.96
1 
1 
Cytosolic tRNA aminoacylation 1 1 0.734 1 0.96
1 
1 
Regulation of actin dynamics for phagocytic cup formation 0.742 1 1 1 0.96
3 
1 
Fcgamma receptor (FCGR) dependent phagocytosis 0.742 1 1 1 0.96
3 
1 
isoleucine degradation 1 1 0.75 1 0.96
6 
1 





Pyrimidine biosynthesis 1 1 0.75 1 0.96
6 
1 
UMP biosynthesis 1 1 0.75 1 0.96
6 
1 
MHC class II antigen presentation 0.75 1 1 1 0.96
6 
1 
hemoglobins chaperone 0.75 1 1 1 0.96
6 
1 
AGE-RAGE signaling pathway in diabetic complications - Homo sapiens 
(human) 
0.75 1 1 1 0.96
6 
1 
Neuroactive ligand-receptor interaction - Homo sapiens (human) 0.75 1 1 1 0.96
6 
1 
Amine-derived hormones 1 1 0.75 1 0.96
6 
1 
Metabolism of ingested SeMet_ Sec_ MeSec into H2Se 1 1 0.812 1 0.98
1 
1 
urea cycle 1 1 0.812 1 0.98
1 
1 
Influenza Life Cycle 0.844 1 1 1 0.98
7 
1 
Influenza Infection 0.844 1 1 1 0.98
7 
1 
Signaling by ROBO receptors 0.844 1 1 1 0.98
7 
1 
Inositol phosphate metabolism - Homo sapiens (human) 1 1 0.85 1 0.98
8 
1 
N-glycan trimming in the ER and Calnexin/Calreticulin cycle 0.875 1 1 1 0.99
2 
1 
Fructosuria 0.875 1 1 1 0.99
2 
1 





Antigen Presentation: Folding_ assembly and peptide loading of class I 
MHC 
0.875 1 1 1 0.99
2 
1 
mTOR signaling pathway - Homo sapiens (human) 0.875 1 1 1 0.99
2 
1 
Purine catabolism 0.875 1 1 1 0.99
2 
1 
Fructose intolerance_ hereditary 0.875 1 1 1 0.99
2 
1 
Malate-Aspartate Shuttle 1 1 0.875 1 0.99
2 
1 
Fructose and Mannose Degradation 0.875 1 1 1 0.99
2 
1 
Degradation of the extracellular matrix 0.945 1 1 1 0.99
8 
1 
Clathrin-mediated endocytosis 0.966 1 1 1 0.99
9 
1 
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway 1 1 1 1 1 1 
Epithelial to mesenchymal transition in colorectal cancer 1 1 1 1 1 1 
POLB-Dependent Long Patch Base Excision Repair 1 1 1 1 1 1 
phosphatidylserine biosynthesis II 1 1 1 1 1 1 
Wnt Signaling 1 1 1 1 1 1 
Cholesterol biosynthesis_ regulation and transport 1 1 1 1 1 1 
Genotoxicity pathway 1 1 1 1 1 1 
Methionine metabolism and related disorders 1 1 1 1 1 1 
Extracellular vesicles in the crosstalk of cardiac cells 1 1 1 1 1 1 
Rett syndrome causing genes 1 1 1 1 1 1 
Malate-aspartate shuttle 1 1 1 1 1 1 
Vindesine Action Pathway 1 1 1 1 1 1 
Nonalcoholic fatty liver disease 1 1 1 1 1 1 
tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde 1 1 1 1 1 1 
tryptophan degradation 1 1 1 1 1 1 
  
 508 
glycine/serine biosynthesis 1 1 1 1 1 1 
G alpha (z) signalling events 1 1 1 1 1 1 
G alpha (s) signalling events 1 1 1 1 1 1 
COPII-mediated vesicle transport 1 1 1 1 1 1 
Negative regulation of FGFR2 signaling 1 1 1 1 1 1 
Signaling by FGFR2 1 1 1 1 1 1 
Signaling by PTK6 1 1 1 1 1 1 
ATF6 (ATF6-alpha) activates chaperones 1 1 1 1 1 1 
Leptin 1 1 1 1 1 1 
AOP CYP2E1 Activation Leading To Neurodegeneration 1 1 1 1 1 1 
Signaling by NTRK3 (TRKC) 1 1 1 1 1 1 
GABA receptor activation 1 1 1 1 1 1 
Glutamate binding_ activation of AMPA receptors and synaptic plasticity 1 1 1 1 1 1 
DNA Replication Pre-Initiation 1 1 1 1 1 1 
Inflammatory Response Pathway 1 1 1 1 1 1 
DNA Replication 1 1 1 1 1 1 
Endochondral Ossification 1 1 1 1 1 1 
Hypertrophy Model 1 1 1 1 1 1 
Acetylcholine Synthesis 1 1 1 1 1 1 
TGF-beta Receptor Signaling 1 1 1 1 1 1 
Monoamine GPCRs 1 1 1 1 1 1 
Senescence and Autophagy in Cancer 1 1 1 1 1 1 
Oxidative phosphorylation 1 1 1 1 1 1 
TET1_2_3 and TDG demethylate DNA 1 1 1 1 1 1 
Arachidonate Epoxygenase - Epoxide Hydrolase 1 1 1 1 1 1 
Polyol Pathway 1 1 1 1 1 1 
Tamoxifen metabolism 1 1 1 1 1 1 
Role of phospholipids in phagocytosis 1 1 1 1 1 1 
Amino acid conjugation 1 1 1 1 1 1 
glutamate removal from folates 1 1 1 1 1 1 
  
 509 
thio-molybdenum cofactor biosynthesis 1 1 1 1 1 1 
NADE modulates death signalling 1 1 1 1 1 1 
agrin in postsynaptic differentiation 1 1 1 1 1 1 
RUNX2 regulates genes involved in differentiation of myeloid cells 1 1 1 1 1 1 
Steroids metabolism 1 1 1 1 1 1 
BCR 1 1 1 1 1 1 
VxPx cargo-targeting to cilium 1 1 1 1 1 1 
UDP-<i>N</i>-acetyl-D-galactosamine biosynthesis II 1 1 1 1 1 1 
Resolution of Sister Chromatid Cohesion 1 1 1 1 1 1 
Antigen activates B Cell Receptor (BCR) leading to generation of second 
messengers 
1 1 1 1 1 1 
glutathione redox reactions I 1 1 1 1 1 1 
p53-Independent DNA Damage Response 1 1 1 1 1 1 
Pink/Parkin Mediated Mitophagy 1 1 1 1 1 1 
Endometrial cancer 1 1 1 1 1 1 
activation of camp-dependent protein kinase pka 1 1 1 1 1 1 
NRF2-ARE regulation 1 1 1 1 1 1 
Integrin alphaIIb beta3 signaling 1 1 1 1 1 1 
Mepivacaine Action Pathway 1 1 1 1 1 1 
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic 
proteins 
1 1 1 1 1 1 
PERK regulates gene expression 1 1 1 1 1 1 
Acebutolol Action Pathway 1 1 1 1 1 1 
Syndecan-2-mediated signaling events 1 1 1 1 1 1 
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion 1 1 1 1 1 1 
Negative regulation of FGFR3 signaling 1 1 1 1 1 1 
Signaling by FGFR3 1 1 1 1 1 1 
thyroid hormone metabolism II (via conjugation and/or degradation) 1 1 1 1 1 1 
Benzocaine Action Pathway 1 1 1 1 1 1 
G1/S DNA Damage Checkpoints 1 1 1 1 1 1 
  
 510 
adenine and adenosine salvage I 1 1 1 1 1 1 
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 1 1 1 1 1 1 
Joubert syndrome 1 1 1 1 1 1 
Ca-dependent events 1 1 1 1 1 1 
Bladder cancer - Homo sapiens (human) 1 1 1 1 1 1 
G alpha (12-13) signalling events 1 1 1 1 1 1 
Thermogenesis 1 1 1 1 1 1 
adenine and adenosine salvage II 1 1 1 1 1 1 
Oxprenolol Action Pathway 1 1 1 1 1 1 
folate transformations 1 1 1 1 1 1 
mRNA capping 1 1 1 1 1 1 
Glucuronidation 1 1 1 1 1 1 
Esmolol Action Pathway 1 1 1 1 1 1 
methylglyoxal degradation VI 1 1 1 1 1 1 
Epigenetic regulation of gene expression 1 1 1 1 1 1 
Bisoprolol Action Pathway 1 1 1 1 1 1 
Amino acid transport across the plasma membrane 1 1 1 1 1 1 
Tamoxifen Action Pathway 1 1 1 1 1 1 
CREB phosphorylation through the activation of CaMKII 1 1 1 1 1 1 
DCC mediated attractive signaling 1 1 1 1 1 1 
COPI-mediated anterograde transport 1 1 1 1 1 1 
Nonhomologous End-Joining (NHEJ) 1 1 1 1 1 1 
Post NMDA receptor activation events 1 1 1 1 1 1 
signal dependent regulation of myogenesis by corepressor mitr 1 1 1 1 1 1 
DNA Damage Recognition in GG-NER 1 1 1 1 1 1 
Pancreatic cancer - Homo sapiens (human) 1 1 1 1 1 1 
Activation of NMDA receptor and postsynaptic events 1 1 1 1 1 1 
Synthesis of PIPs in the nucleus 1 1 1 1 1 1 
GDP-glucose biosynthesis II 1 1 1 1 1 1 
Coenzyme A biosynthesis 1 1 1 1 1 1 
  
 511 
asparagine biosynthesis 1 1 1 1 1 1 
glutamate dependent acid resistance 1 1 1 1 1 1 
DAP12 signaling 1 1 1 1 1 1 
Negative regulation of FGFR4 signaling 1 1 1 1 1 1 
Signaling by FGFR4 1 1 1 1 1 1 
induction of apoptosis through dr3 and dr4/5 death receptors 1 1 1 1 1 1 
Anileridine Action Pathway 1 1 1 1 1 1 
Mitochondrial translation 1 1 1 1 1 1 
p75NTR signals via NF-kB 1 1 1 1 1 1 
thioredoxin pathway 1 1 1 1 1 1 
Transcriptional regulation by RUNX3 1 1 1 1 1 1 
Differentiation Pathway 1 1 1 1 1 1 
L-carnitine biosynthesis 1 1 1 1 1 1 
Cimetidine Action Pathway 1 1 1 1 1 1 
NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde 1 1 1 1 1 1 
cardiolipin biosynthesis 1 1 1 1 1 1 
Degradation of beta catenin 1 1 1 1 1 1 
trehalose degradation 1 1 1 1 1 1 
Endometrial cancer - Homo sapiens (human) 1 1 1 1 1 1 
Hematopoietic cell lineage - Homo sapiens (human) 1 1 1 1 1 1 
regulation of bad phosphorylation 1 1 1 1 1 1 
Oxybuprocaine Action Pathway 1 1 1 1 1 1 
citrulline-nitric oxide cycle 1 1 1 1 1 1 
Aryl hydrocarbon receptor signalling 1 1 1 1 1 1 
Sulfur metabolism - Homo sapiens (human) 1 1 1 1 1 1 
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA 1 1 1 1 1 1 
Peroxisomal lipid metabolism 1 1 1 1 1 1 
L-serine degradation 1 1 1 1 1 1 
APC/C:Cdc20 mediated degradation of mitotic proteins 1 1 1 1 1 1 
4-hydroxy-2-nonenal detoxification 1 1 1 1 1 1 
  
 512 
ccr3 signaling in eosinophils 1 1 1 1 1 1 
aspartate biosynthesis 1 1 1 1 1 1 
HDL assembly 1 1 1 1 1 1 
Nuclear Envelope Breakdown 1 1 1 1 1 1 
asparagine degradation 1 1 1 1 1 1 
Growth hormone receptor signaling 1 1 1 1 1 1 
TCR signaling 1 1 1 1 1 1 
spermine biosynthesis 1 1 1 1 1 1 
IL-2 Signaling Pathway 1 1 1 1 1 1 
Vitamin A and Carotenoid Metabolism 1 1 1 1 1 1 
Mitochondrial biogenesis 1 1 1 1 1 1 
IL-7 signaling 1 1 1 1 1 1 
Post-chaperonin tubulin folding pathway 1 1 1 1 1 1 
Termination of translesion DNA synthesis 1 1 1 1 1 1 
Tristetraprolin (TTP_ ZFP36) binds and destabilizes mRNA 1 1 1 1 1 1 
glycogen biosynthesis 1 1 1 1 1 1 
arsenate detoxification I (glutaredoxin) 1 1 1 1 1 1 
Smooth Muscle Contraction 1 1 1 1 1 1 
Regulation of PTEN localization 1 1 1 1 1 1 
transcription regulation by methyltransferase of carm1 1 1 1 1 1 1 
CMP-<i>N</i>-acetylneuraminate biosynthesis I (eukaryotes) 1 1 1 1 1 1 
DNA Damage Bypass 1 1 1 1 1 1 
Fructose biosynthesis 1 1 1 1 1 1 
Gamma-carboxylation of protein precursors 1 1 1 1 1 1 
TGFBR1 KD Mutants in Cancer 1 1 1 1 1 1 
Prolactin receptor signaling 1 1 1 1 1 1 
Loss of Function of TGFBR1 in Cancer 1 1 1 1 1 1 
Hyaluronan uptake and degradation 1 1 1 1 1 1 
Hyaluronan metabolism 1 1 1 1 1 1 
Signaling by TGF-beta Receptor Complex in Cancer 1 1 1 1 1 1 
  
 513 
TBC/RABGAPs 1 1 1 1 1 1 
Rab regulation of trafficking 1 1 1 1 1 1 
signal transduction through il1r 1 1 1 1 1 1 
glutathione redox reactions II 1 1 1 1 1 1 
Transcriptional Regulation by E2F6 1 1 1 1 1 1 
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Al-
pha 
1 1 1 1 1 1 
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants 1 1 1 1 1 1 
Pentose phosphate pathway 1 1 1 1 1 1 
TSH 1 1 1 1 1 1 
hiv-1 nef: negative effector of fas and tnf 1 1 1 1 1 1 
Transcription of the HIV genome 1 1 1 1 1 1 
ErbB Signaling Pathway 1 1 1 1 1 1 
Intracellular Signalling Through FSH Receptor and Follicle Stimulating 
Hormone 
1 1 1 1 1 1 
LDL remodeling 1 1 1 1 1 1 
cAMP signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
sumoylation by ranbp2 regulates transcriptional repression 1 1 1 1 1 1 
Transport of Ribonucleoproteins into the Host Nucleus 1 1 1 1 1 1 
SALM protein interactions at the synapse 1 1 1 1 1 1 
Choline metabolism in cancer - Homo sapiens (human) 1 1 1 1 1 1 
Cellular response to hypoxia 1 1 1 1 1 1 
GDP-L-fucose biosynthesis I (from GDP-D-mannose) 1 1 1 1 1 1 
p53-Independent G1/S DNA damage checkpoint 1 1 1 1 1 1 
Flecainide Action Pathway 1 1 1 1 1 1 
Lysosomal oligosaccharide catabolism 1 1 1 1 1 1 
ncRNAs involved in Wnt signaling in hepatocellular carcinoma 1 1 1 1 1 1 
toll-like receptor pathway 1 1 1 1 1 1 
IRE1alpha activates chaperones 1 1 1 1 1 1 
Adherens junctions interactions 1 1 1 1 1 1 
  
 514 
Oncogene Induced Senescence 1 1 1 1 1 1 
Unfolded Protein Response (UPR) 1 1 1 1 1 1 
Conjugation of benzoate with glycine 1 1 1 1 1 1 
NIK-->noncanonical NF-kB signaling 1 1 1 1 1 1 
Verapamil Action Pathway 1 1 1 1 1 1 
Glucagon signaling in metabolic regulation 1 1 1 1 1 1 
Synthesis of very long-chain fatty acyl-CoAs 1 1 1 1 1 1 
MicroRNA (miRNA) biogenesis 1 1 1 1 1 1 
b cell survival pathway 1 1 1 1 1 1 
Conjugation of salicylate with glycine 1 1 1 1 1 1 
Conjugation of carboxylic acids 1 1 1 1 1 1 
Amino Acid conjugation 1 1 1 1 1 1 
SUMO is transferred from E1 to E2 (UBE2I_ UBC9) 1 1 1 1 1 1 
Synthesis_ secretion_ and deacylation of Ghrelin 1 1 1 1 1 1 
HIF-2-alpha transcription factor network 1 1 1 1 1 1 
Spermidine and Spermine Biosynthesis 1 1 1 1 1 1 
ER Quality Control Compartment (ERQC) 1 1 1 1 1 1 
Calnexin/calreticulin cycle 1 1 1 1 1 1 
Thyroid hormone signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
Phase 3 - rapid repolarisation 1 1 1 1 1 1 
Cardiac conduction 1 1 1 1 1 1 
Phosphorylation of CD3 and TCR zeta chains 1 1 1 1 1 1 
selenocysteine biosynthesis 1 1 1 1 1 1 
PP2A-mediated dephosphorylation of key metabolic factors 1 1 1 1 1 1 
BMP2 signaling TGF-beta MV 1 1 1 1 1 1 
snRNP Assembly 1 1 1 1 1 1 
Translocation of ZAP-70 to Immunological synapse 1 1 1 1 1 1 
Glutamatergic synapse - Homo sapiens (human) 1 1 1 1 1 1 
Renin secretion - Homo sapiens (human) 1 1 1 1 1 1 
tetrapyrrole biosynthesis 1 1 1 1 1 1 
  
 515 
GDP-mannose biosynthesis 1 1 1 1 1 1 
Serotonergic synapse - Homo sapiens (human) 1 1 1 1 1 1 
Escitalopram Action Pathway 1 1 1 1 1 1 
Autodegradation of Cdh1 by Cdh1:APC/C 1 1 1 1 1 1 
Entry of Influenza Virion into Host Cell via Endocytosis 1 1 1 1 1 1 
ACE Inhibitor Pathway 1 1 1 1 1 1 
pyridoxal 5_-phosphate salvage 1 1 1 1 1 1 
Plus-strand DNA synthesis 1 1 1 1 1 1 
Vitamin A (retinol) metabolism 1 1 1 1 1 1 
HS-GAG degradation 1 1 1 1 1 1 
Heparan sulfate/heparin (HS-GAG) metabolism 1 1 1 1 1 1 
eicosanoid metabolism 1 1 1 1 1 1 
fatty acid elongation -- saturated 1 1 1 1 1 1 
p75NTR regulates axonogenesis 1 1 1 1 1 1 
Ion transport by P-type ATPases 1 1 1 1 1 1 
Retinoid metabolism and transport 1 1 1 1 1 1 
rho-selective guanine exchange factor akap13 mediates stress fiber for-
mation 
1 1 1 1 1 1 
Thrombin signalling through proteinase activated receptors (PARs) 1 1 1 1 1 1 
GP1b-IX-V activation signalling 1 1 1 1 1 1 
ER-Phagosome pathway 1 1 1 1 1 1 
p75(NTR)-mediated signaling 1 1 1 1 1 1 
NOTCH3 Activation and Transmission of Signal to the Nucleus 1 1 1 1 1 1 
Ion influx/efflux at host-pathogen interface 1 1 1 1 1 1 
NAD <i>de novo</i> biosynthesis 1 1 1 1 1 1 
TYROBP Causal Network 1 1 1 1 1 1 
Trafficking and processing of endosomal TLR 1 1 1 1 1 1 
RNA Polymerase II Transcription Initiation And Promoter Clearance 1 1 1 1 1 1 
Other types of O-glycan biosynthesis - Homo sapiens (human) 1 1 1 1 1 1 
Regulation of IFNA signaling 1 1 1 1 1 1 
  
 516 
Glycosaminoglycan metabolism 1 1 1 1 1 1 
Interferon alpha/beta signaling 1 1 1 1 1 1 
Nuclear Receptors 1 1 1 1 1 1 
bupropion degradation 1 1 1 1 1 1 
Loss of Function of TGFBR2 in Cancer 1 1 1 1 1 1 
nfat and hypertrophy of the heart  1 1 1 1 1 1 
DDX1 as a regulatory component of the Drosha microprocessor 1 1 1 1 1 1 
Docetaxel Action Pathway 1 1 1 1 1 1 
APC-Cdc20 mediated degradation of Nek2A 1 1 1 1 1 1 
vRNP Assembly 1 1 1 1 1 1 
Regulation of RUNX3 expression and activity 1 1 1 1 1 1 
signaling pathway from g-protein families 1 1 1 1 1 1 
Glycine degradation 1 1 1 1 1 1 
APC:Cdc20 mediated degradation of cell cycle proteins prior to satis-
fation of the cell cycle checkpoint 
1 1 1 1 1 1 
Segawa syndrome 1 1 1 1 1 1 
NF-kB is activated and signals survival 1 1 1 1 1 1 
NOD1/2 Signaling Pathway 1 1 1 1 1 1 
Synthesis of 5-eicosatetraenoic acids 1 1 1 1 1 1 
Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase de-
ficiency 
1 1 1 1 1 1 
Tyrosine hydroxylase deficiency 1 1 1 1 1 1 
Hyperphenylalaninemia due to dhpr-deficiency 1 1 1 1 1 1 
Human cytomegalovirus infection - Homo sapiens (human) 1 1 1 1 1 1 
Transport of Mature mRNA derived from an Intron-Containing Transcript 1 1 1 1 1 1 
Interleukin-12 family signaling 1 1 1 1 1 1 
Signaling by MET 1 1 1 1 1 1 
Constitutive Signaling by EGFRvIII 1 1 1 1 1 1 
Synthesis of 15-eicosatetraenoic acid derivatives 1 1 1 1 1 1 
Signal attenuation 1 1 1 1 1 1 
  
 517 
Laminin interactions 1 1 1 1 1 1 
Mitochondrial Fatty Acid Beta-Oxidation 1 1 1 1 1 1 
Synthesis of 12-eicosatetraenoic acid derivatives 1 1 1 1 1 1 
CDK-mediated phosphorylation and removal of Cdc6 1 1 1 1 1 1 
AUF1 (hnRNP D0) binds and destabilizes mRNA 1 1 1 1 1 1 
Pancreas Function 1 1 1 1 1 1 
Succinyl CoA: 3-ketoacid CoA transferase deficiency 1 1 1 1 1 1 
Influenza Viral RNA Transcription and Replication 1 1 1 1 1 1 
Vitamin B1 (thiamin) metabolism 1 1 1 1 1 1 
CD28 co-stimulation 1 1 1 1 1 1 
methionine degradation 1 1 1 1 1 1 
SUMOylation of RNA binding proteins 1 1 1 1 1 1 
Cytosolic sensors of pathogen-associated DNA  1 1 1 1 1 1 
Phosphatidylinositol signaling system - Homo sapiens (human) 1 1 1 1 1 1 
Notch signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
D-<i>myo</i>-inositol (1_4_5)-trisphosphate degradation 1 1 1 1 1 1 
CTLA4 inhibitory signaling 1 1 1 1 1 1 
Adefovir Dipivoxil  Action Pathway 1 1 1 1 1 1 
SUMO E3 ligases SUMOylate target proteins 1 1 1 1 1 1 
Potassium Channels 1 1 1 1 1 1 
Osteoblast Signaling 1 1 1 1 1 1 
Export of Viral Ribonucleoproteins from Nucleus 1 1 1 1 1 1 
VEGF 1 1 1 1 1 1 
tRNA Aminoacylation 1 1 1 1 1 1 
Insulin receptor signalling cascade 1 1 1 1 1 1 
Carfentanil Action Pathway 1 1 1 1 1 1 
Proline catabolism 1 1 1 1 1 1 
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate 1 1 1 1 1 1 
NADPH regeneration 1 1 1 1 1 1 
how progesterone initiates the oocyte maturation 1 1 1 1 1 1 
  
 518 
Phospholipid Biosynthesis 1 1 1 1 1 1 
Reactions specific to the complex N-glycan synthesis pathway 1 1 1 1 1 1 
Adrenoleukodystrophy_ X-linked 1 1 1 1 1 1 
er associated degradation (erad) pathway 1 1 1 1 1 1 
HDACs deacetylate histones 1 1 1 1 1 1 
HuR (ELAVL1) binds and stabilizes mRNA 1 1 1 1 1 1 
Endosomal Sorting Complex Required For Transport (ESCRT) 1 1 1 1 1 1 
Dectin-2 family 1 1 1 1 1 1 
Gastrin 1 1 1 1 1 1 
N-glycan antennae elongation in the medial/trans-Golgi 1 1 1 1 1 1 
Folate biosynthesis - Homo sapiens (human) 1 1 1 1 1 1 
ROBO receptors bind AKAP5 1 1 1 1 1 1 
protein kinase a at the centrosome 1 1 1 1 1 1 
Assembly of Viral Components at the Budding Site 1 1 1 1 1 1 
BMP signaling Dro 1 1 1 1 1 1 
alpha-linolenic acid (ALA) metabolism 1 1 1 1 1 1 
IL-7 1 1 1 1 1 1 
nuclear receptors coordinate the activities of chromatin remodeling com-
plexes and coactivators to facilitate initiation of transcription in carci-
noma cells 
1 1 1 1 1 1 
gata3 participate in activating the th2 cytokine genes expression 1 1 1 1 1 1 
Metabolism of Angiotensinogen to Angiotensins 1 1 1 1 1 1 
Doxorubicin Metabolism Pathway 1 1 1 1 1 1 
Regulation of innate immune responses to cytosolic DNA 1 1 1 1 1 1 
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism 1 1 1 1 1 1 
Heme degradation 1 1 1 1 1 1 
Prostaglandin Leukotriene metabolism 1 1 1 1 1 1 
O-linked glycosylation of mucins 1 1 1 1 1 1 
Transport of organic anions 1 1 1 1 1 1 
Gemcitabine Metabolism Pathway 1 1 1 1 1 1 
  
 519 
Pathway_PA165986194 -need delete 1 1 1 1 1 1 
HDMs demethylate histones 1 1 1 1 1 1 
Signaling by PTK6 1 1 1 1 1 1 
MASTL Facilitates Mitotic Progression 1 1 1 1 1 1 
Terpenoid backbone biosynthesis - Homo sapiens (human) 1 1 1 1 1 1 
RUNX1 regulates transcription of genes involved in differentiation of 
HSCs 
1 1 1 1 1 1 
Virus Assembly and Release 1 1 1 1 1 1 
RANKL 1 1 1 1 1 1 
Fatty acid elongation - Homo sapiens (human) 1 1 1 1 1 1 
Dectin-1 mediated noncanonical NF-kB signaling 1 1 1 1 1 1 
Signaling by NTRK1 (TRKA) 1 1 1 1 1 1 
Activation of Ca-permeable Kainate Receptor 1 1 1 1 1 1 
Ionotropic activity of kainate receptors 1 1 1 1 1 1 
Taurine and hypotaurine metabolism - Homo sapiens (human) 1 1 1 1 1 1 
morphine biosynthesis 1 1 1 1 1 1 
wybutosine biosynthesis 1 1 1 1 1 1 
Methionine salvage pathway 1 1 1 1 1 1 
Osteopontin-mediated events 1 1 1 1 1 1 
BMP receptor signaling 1 1 1 1 1 1 
Notch-mediated HES/HEY network 1 1 1 1 1 1 
Regulation of Ras family activation 1 1 1 1 1 1 
Regulation of RAC1 activity 1 1 1 1 1 1 
Glucocorticoid receptor regulatory network 1 1 1 1 1 1 
ALK1 signaling events 1 1 1 1 1 1 
Neurotrophic factor-mediated Trk receptor signaling 1 1 1 1 1 1 
Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor 
Alpha 
1 1 1 1 1 1 
TNF receptor signaling pathway  1 1 1 1 1 1 
Downstream signaling in na&#xef;ve CD8+ T cells 1 1 1 1 1 1 
  
 520 
Fc-epsilon receptor I signaling in mast cells 1 1 1 1 1 1 
D-<i>myo</i>-inositol (1_3_4)-trisphosphate biosynthesis 1 1 1 1 1 1 
Visual signal transduction: Rods 1 1 1 1 1 1 
Netrin-mediated signaling events 1 1 1 1 1 1 
N-cadherin signaling events 1 1 1 1 1 1 
Fanconi anemia pathway 1 1 1 1 1 1 
Endogenous TLR signaling 1 1 1 1 1 1 
Signaling events mediated by TCPTP 1 1 1 1 1 1 
Primary bile acid biosynthesis - Homo sapiens (human) 1 1 1 1 1 1 
Thromboxane A2 receptor signaling 1 1 1 1 1 1 
AP-1 transcription factor network 1 1 1 1 1 1 
PLK1 signaling events 1 1 1 1 1 1 
Noncanonical Wnt signaling pathway 1 1 1 1 1 1 
Regulation of p38-alpha and p38-beta 1 1 1 1 1 1 
VEGFR3 signaling in lymphatic endothelium 1 1 1 1 1 1 
E-cadherin signaling in keratinocytes 1 1 1 1 1 1 
Aromatic L-Aminoacid Decarboxylase Deficiency 1 1 1 1 1 1 
p38 MAPK signaling pathway 1 1 1 1 1 1 
IGF1 pathway 1 1 1 1 1 1 
Regulation of Androgen receptor activity 1 1 1 1 1 1 
Sumoylation by RanBP2 regulates transcriptional repression 1 1 1 1 1 1 
Arf6 signaling events 1 1 1 1 1 1 
Plasma membrane estrogen receptor signaling 1 1 1 1 1 1 
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 1 1 1 1 1 1 
ATF-2 transcription factor network 1 1 1 1 1 1 
FOXM1 transcription factor network 1 1 1 1 1 1 
Nongenotropic Androgen signaling 1 1 1 1 1 1 
Alpha4 beta1 integrin signaling events 1 1 1 1 1 1 
Lactose synthesis 1 1 1 1 1 1 
Regulation of IFNG signaling 1 1 1 1 1 1 
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Validated transcriptional targets of AP1 family members Fra1 and Fra2 1 1 1 1 1 1 
Trk receptor signaling mediated by the MAPK pathway 1 1 1 1 1 1 
RXR and RAR heterodimerization with other nuclear receptor 1 1 1 1 1 1 
Hedgehog signaling events mediated by Gli proteins 1 1 1 1 1 1 
ErbB receptor signaling network 1 1 1 1 1 1 
ATR signaling pathway 1 1 1 1 1 1 
IL6-mediated signaling events 1 1 1 1 1 1 
Angiopoietin receptor Tie2-mediated signaling 1 1 1 1 1 1 
Endothelins 1 1 1 1 1 1 
IL8- and CXCR2-mediated signaling events 1 1 1 1 1 1 
FGF signaling pathway 1 1 1 1 1 1 
Nephrin/Neph1 signaling in the kidney podocyte 1 1 1 1 1 1 
IL3-mediated signaling events 1 1 1 1 1 1 
Caffeine metabolism - Homo sapiens (human) 1 1 1 1 1 1 
Signaling mediated by p38-gamma and p38-delta 1 1 1 1 1 1 
lactose degradation III 1 1 1 1 1 1 
Regulation of RhoA activity 1 1 1 1 1 1 
Cellular roles of Anthrax toxin 1 1 1 1 1 1 
Ubiquitin-dependent degradation of Cyclin D1 1 1 1 1 1 1 
Basigin interactions 1 1 1 1 1 1 
RMTs methylate histone arginines 1 1 1 1 1 1 
M-G1 Transition 1 1 1 1 1 1 
Removal of aminoterminal propeptides from gamma-carboxylated pro-
teins 
1 1 1 1 1 1 
Gamma-carboxylation_ transport_ and amino-terminal cleavage of pro-
teins 
1 1 1 1 1 1 
Vitamin B2 (riboflavin) metabolism 1 1 1 1 1 1 
Collagen degradation 1 1 1 1 1 1 
Processing of Intronless Pre-mRNAs 1 1 1 1 1 1 
Processing of Capped Intronless Pre-mRNA 1 1 1 1 1 1 
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serotonin and melatonin biosynthesis 1 1 1 1 1 1 
Notch Signaling 1 1 1 1 1 1 
GABA receptor Signaling 1 1 1 1 1 1 
Carnitine palmitoyl transferase deficiency (I) 1 1 1 1 1 1 
Propionyl-CoA catabolism 1 1 1 1 1 1 
Mitochondrial Fatty Acid Beta-Oxidation 1 1 1 1 1 1 
Synthesis of diphthamide-EEF2 1 1 1 1 1 1 
SUMO is conjugated to E1 (UBA2:SAE1) 1 1 1 1 1 1 
#NAME? 1 1 1 1 1 1 
Formation of ATP by chemiosmotic coupling 1 1 1 1 1 1 
Cell adhesion molecules (CAMs) - Homo sapiens (human) 1 1 1 1 1 1 
IGF-Core 1 1 1 1 1 1 
Phosphate bond hydrolysis by NTPDase proteins 1 1 1 1 1 1 
Fatty acids 1 1 1 1 1 1 
Fc epsilon receptor (FCERI) signaling 1 1 1 1 1 1 
The activation of arylsulfatases 1 1 1 1 1 1 
RUNX2 regulates osteoblast differentiation 1 1 1 1 1 1 
Collagen degradation 1 1 1 1 1 1 
Splicing factor NOVA regulated synaptic proteins 1 1 1 1 1 1 
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) 1 1 1 1 1 1 
Riboflavin metabolism - Homo sapiens (human) 1 1 1 1 1 1 
BCR signaling pathway 1 1 1 1 1 1 
TGF-Core 1 1 1 1 1 1 
Amplification  of signal from unattached  kinetochores via a MAD2  inhib-
itory signal 
1 1 1 1 1 1 
Amplification of signal from the kinetochores 1 1 1 1 1 1 
EGF-Ncore 1 1 1 1 1 1 
HDL clearance 1 1 1 1 1 1 
NEP/NS2 Interacts with the Cellular Export Machinery 1 1 1 1 1 1 
Chylomicron clearance 1 1 1 1 1 1 
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Acyl chain remodeling of DAG and TAG 1 1 1 1 1 1 
Gastric cancer - Homo sapiens (human) 1 1 1 1 1 1 
Alpha-oxidation of phytanate 1 1 1 1 1 1 
Interleukin-12 signaling 1 1 1 1 1 1 
Mitotic Spindle Checkpoint 1 1 1 1 1 1 
Alternative complement activation 1 1 1 1 1 1 
RAF-independent MAPK1/3 activation 1 1 1 1 1 1 
Uptake and actions of bacterial toxins 1 1 1 1 1 1 
Parathyroid hormone synthesis_ secretion and action - Homo sapiens 
(human) 
1 1 1 1 1 1 
Regulation of Hypoxia-inducible Factor (HIF) by oxygen 1 1 1 1 1 1 
PCNA-Dependent Long Patch Base Excision Repair 1 1 1 1 1 1 
TNFR2 non-canonical NF-kB pathway 1 1 1 1 1 1 
Phosphonate and phosphinate metabolism - Homo sapiens (human) 1 1 1 1 1 1 
Signaling by FGFR1 1 1 1 1 1 1 
Sphingolipid metabolism - Homo sapiens (human) 1 1 1 1 1 1 
NOSTRIN mediated eNOS trafficking 1 1 1 1 1 1 
Relaxin signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
sorbitol degradation I 1 1 1 1 1 1 
Fluoxetine Action Pathway 1 1 1 1 1 1 
Metabolism of nitric oxide 1 1 1 1 1 1 
Apoptotic cleavage of cell adhesion  proteins 1 1 1 1 1 1 
phenylalanine degradation/tyrosine biosynthesis 1 1 1 1 1 1 
Beta-oxidation of very long chain fatty acids 1 1 1 1 1 1 
the igf-1 receptor and longevity 1 1 1 1 1 1 
NAD+ biosynthetic pathways 1 1 1 1 1 1 
Abacavir transmembrane transport 1 1 1 1 1 1 
ARMS-mediated activation 1 1 1 1 1 1 
Prolonged ERK activation events 1 1 1 1 1 1 
Synthesis of Lipoxins (LX) 1 1 1 1 1 1 
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RHO GTPases activate PAKs 1 1 1 1 1 1 
Dual Incision in GG-NER 1 1 1 1 1 1 
African trypanosomiasis - Homo sapiens (human) 1 1 1 1 1 1 
Antimicrobial peptides 1 1 1 1 1 1 
Cobalamin (Cbl_ vitamin B12) transport and metabolism 1 1 1 1 1 1 
Nuclear Receptor transcription pathway 1 1 1 1 1 1 
Abacavir transport and metabolism 1 1 1 1 1 1 
Pyrophosphate hydrolysis 1 1 1 1 1 1 
O2/CO2 exchange in erythrocytes 1 1 1 1 1 1 
Collagen biosynthesis and modifying enzymes 1 1 1 1 1 1 
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 1 1 1 1 1 1 
Biosynthesis of E-series 18(S)-resolvins 1 1 1 1 1 1 
Metabolism of water-soluble vitamins and cofactors 1 1 1 1 1 1 
Vitamin B2 (riboflavin) metabolism 1 1 1 1 1 1 
Activation of DNA fragmentation factor 1 1 1 1 1 1 
Apoptosis induced DNA fragmentation 1 1 1 1 1 1 
Inhibition of replication initiation of damaged DNA by RB1/E2F1 1 1 1 1 1 1 
Retrograde neurotrophin signalling 1 1 1 1 1 1 
Desipramine Action Pathway 1 1 1 1 1 1 
Binding and entry of HIV virion 1 1 1 1 1 1 
Biosynthesis of E-series 18(R)-resolvins 1 1 1 1 1 1 
Biosynthesis of EPA-derived SPMs 1 1 1 1 1 1 
Xenobiotics metabolism 1 1 1 1 1 1 
Axonal growth inhibition (RHOA activation) 1 1 1 1 1 1 
VLDL clearance 1 1 1 1 1 1 
nicotine degradation IV 1 1 1 1 1 1 
Regulation of RAS by GAPs 1 1 1 1 1 1 
ras-independent pathway in nk cell-mediated cytotoxicity 1 1 1 1 1 1 
Gastric acid production 1 1 1 1 1 1 
glycine cleavage 1 1 1 1 1 1 
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Molecules associated with elastic fibres 1 1 1 1 1 1 
PLC beta mediated events 1 1 1 1 1 1 
creatine-phosphate biosynthesis 1 1 1 1 1 1 
Apoptosis Modulation and Signaling 1 1 1 1 1 1 
Epstein-Barr virus infection - Homo sapiens (human) 1 1 1 1 1 1 
Trafficking of AMPA receptors 1 1 1 1 1 1 
Biosynthesis of D-series resolvins 1 1 1 1 1 1 
Signaling by FGFR 1 1 1 1 1 1 
Cholesterol biosynthesis 1 1 1 1 1 1 
RNA Polymerase II Transcription 1 1 1 1 1 1 
Gap-filling DNA repair synthesis and ligation in GG-NER 1 1 1 1 1 1 
Arylamine metabolism 1 1 1 1 1 1 
Syndecan-4-mediated signaling events 1 1 1 1 1 1 
Biosynthesis of aspirin-triggered D-series resolvins 1 1 1 1 1 1 
pyruvate decarboxylation to acetyl CoA 1 1 1 1 1 1 
Benzo(a)pyrene metabolism 1 1 1 1 1 1 
Transcriptional regulation of white adipocyte differentiation 1 1 1 1 1 1 
Monoamine Transport 1 1 1 1 1 1 
adenosine nucleotides degradation 1 1 1 1 1 1 
regulation of cell cycle progression by plk3 1 1 1 1 1 1 
EPH-Ephrin signaling 1 1 1 1 1 1 
Biosynthesis of protectins 1 1 1 1 1 1 
Ion homeostasis 1 1 1 1 1 1 
Fatty Acid Beta Oxidation 1 1 1 1 1 1 
Elastic fibre formation 1 1 1 1 1 1 
Nucleotide-binding Oligomerization Domain (NOD) pathway 1 1 1 1 1 1 
APC/C:Cdc20 mediated degradation of Cyclin B 1 1 1 1 1 1 
PKA activation 1 1 1 1 1 1 
PKA-mediated phosphorylation of CREB 1 1 1 1 1 1 
Syndecan interactions 1 1 1 1 1 1 
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Class C-3 (Metabotropic glutamate-pheromone receptors) 1 1 1 1 1 1 
APC/C:Cdc20 mediated degradation of Securin 1 1 1 1 1 1 
Vitamin D Metabolism 1 1 1 1 1 1 
G alpha (s) signalling events 1 1 1 1 1 1 
Fanconi Anemia Pathway 1 1 1 1 1 1 
guanosine nucleotides degradation 1 1 1 1 1 1 
Calmodulin induced events 1 1 1 1 1 1 
CaM pathway 1 1 1 1 1 1 
Presynaptic function of Kainate receptors 1 1 1 1 1 1 
Activation of kainate receptors upon glutamate binding 1 1 1 1 1 1 
Resolution of Abasic Sites (AP sites) 1 1 1 1 1 1 
Hypothetical Craniofacial Development Pathway 1 1 1 1 1 1 
Clathrin-mediated endocytosis 1 1 1 1 1 1 
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription 1 1 1 1 1 1 
role of nicotinic acetylcholine receptors in the regulation of apoptosis 1 1 1 1 1 1 
Formation of TC-NER Pre-Incision Complex 1 1 1 1 1 1 
Biosynthesis of maresin conjugates in tissue regeneration (MCTR) 1 1 1 1 1 1 
Synthesis of bile acids and bile salts 1 1 1 1 1 1 
Fluoropyrimidine Activity 1 1 1 1 1 1 
Type 2 papillary renal cell carcinoma 1 1 1 1 1 1 
purine nucleotides degradation 1 1 1 1 1 1 
Biosynthesis of maresins 1 1 1 1 1 1 
Biotin metabolism - Homo sapiens (human) 1 1 1 1 1 1 
D-Arginine and D-ornithine metabolism - Homo sapiens (human) 1 1 1 1 1 1 
Biosynthesis of protectin and resolvin conjugates in tissue regeneration 
(PCTR and RCTR) 
1 1 1 1 1 1 
Biosynthesis of DHA-derived sulfido conjugates 1 1 1 1 1 1 
DAP12 interactions 1 1 1 1 1 1 
ahr signal transduction pathway 1 1 1 1 1 1 
mets affect on macrophage differentiation 1 1 1 1 1 1 
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phospholipase c-epsilon pathway 1 1 1 1 1 1 
roles of  arrestin dependent recruitment of src kinases in gpcr signaling 1 1 1 1 1 1 
g-protein signaling through tubby proteins 1 1 1 1 1 1 
activation of pkc through g-protein coupled receptors 1 1 1 1 1 1 
Recycling of bile acids and salts 1 1 1 1 1 1 
akap95 role in mitosis and chromosome dynamics 1 1 1 1 1 1 
tnfr1 signaling pathway 1 1 1 1 1 1 
alternative complement pathway 1 1 1 1 1 1 
cyclin e destruction pathway 1 1 1 1 1 1 
repression of pain sensation by the transcriptional regulator dream 1 1 1 1 1 1 
Regulation of lipolysis in adipocytes - Homo sapiens (human) 1 1 1 1 1 1 
B cell receptor signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
Sulfur relay system - Homo sapiens (human) 1 1 1 1 1 1 
Inositol transporters 1 1 1 1 1 1 
p53 signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
Circadian rhythm - Homo sapiens (human) 1 1 1 1 1 1 
Penbutolol Action Pathway 1 1 1 1 1 1 
thrombin signaling and protease-activated receptors 1 1 1 1 1 1 
antigen processing and presentation 1 1 1 1 1 1 
Leishmaniasis - Homo sapiens (human) 1 1 1 1 1 1 
transcriptional activation of dbpb from mrna 1 1 1 1 1 1 
Adrenaline_noradrenaline inhibits insulin secretion 1 1 1 1 1 1 
rac1 cell motility signaling pathway 1 1 1 1 1 1 
Surfactant metabolism 1 1 1 1 1 1 
Melanogenesis - Homo sapiens (human) 1 1 1 1 1 1 
Chemokine signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
Intestinal immune network for IgA production - Homo sapiens (human) 1 1 1 1 1 1 
Synthesis of PC 1 1 1 1 1 1 
Melanoma - Homo sapiens (human) 1 1 1 1 1 1 
Renal cell carcinoma - Homo sapiens (human) 1 1 1 1 1 1 
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Nicotine addiction - Homo sapiens (human) 1 1 1 1 1 1 
GnRH signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human) 1 1 1 1 1 1 
Amine ligand-binding receptors 1 1 1 1 1 1 
Butanoate metabolism 1 1 1 1 1 1 
RANKL-RANK (Receptor activator of NFKB (ligand)) Signaling Pathway 1 1 1 1 1 1 
Nuclear Events (kinase and transcription factor activation) 1 1 1 1 1 1 
<i>S</i>-methyl-5_-thioadenosine degradation 1 1 1 1 1 1 
Inactivation of CDC42 and RAC1 1 1 1 1 1 1 
Cleavage of the damaged pyrimidine  1 1 1 1 1 1 
Depyrimidination 1 1 1 1 1 1 
Base-Excision Repair_ AP Site Formation 1 1 1 1 1 1 
Amyloid fiber formation 1 1 1 1 1 1 
RUNX1 regulates genes involved in megakaryocyte differentiation and 
platelet function 
1 1 1 1 1 1 
Mitophagy 1 1 1 1 1 1 
Processing and activation of SUMO 1 1 1 1 1 1 
Buprenorphine Action Pathway 1 1 1 1 1 1 
Nucleobase biosynthesis 1 1 1 1 1 1 
Molybdenum cofactor biosynthesis 1 1 1 1 1 1 
Degradation of DVL 1 1 1 1 1 1 
NCAM signaling for neurite out-growth 1 1 1 1 1 1 
Cargo concentration in the ER 1 1 1 1 1 1 
ketolysis 1 1 1 1 1 1 
Alvimopan Action Pathway 1 1 1 1 1 1 
Downregulation of ERBB4 signaling 1 1 1 1 1 1 
Gap-filling DNA repair synthesis and ligation in TC-NER 1 1 1 1 1 1 
Hydroxycarboxylic acid-binding receptors 1 1 1 1 1 1 
Utilization of Ketone Bodies 1 1 1 1 1 1 
Ketone body metabolism 1 1 1 1 1 1 
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Lysosphingolipid and LPA receptors 1 1 1 1 1 1 
Synaptic adhesion-like molecules 1 1 1 1 1 1 
Intra-Golgi and retrograde Golgi-to-ER traffic 1 1 1 1 1 1 
Transcription-Coupled Nucleotide Excision Repair (TC-NER) 1 1 1 1 1 1 
Initiation of Nuclear Envelope Reformation 1 1 1 1 1 1 
27-Hydroxylase Deficiency 1 1 1 1 1 1 
Abasic sugar-phosphate removal via the single-nucleotide replacement 
pathway 
1 1 1 1 1 1 
Resolution of AP sites via the single-nucleotide replacement pathway 1 1 1 1 1 1 
Opioid Signalling 1 1 1 1 1 1 
Disassembly of the destruction complex and recruitment of AXIN to the 
membrane 
1 1 1 1 1 1 
Mitotic Prometaphase 1 1 1 1 1 1 
VEGFR2 mediated vascular permeability 1 1 1 1 1 1 
Antigen processing-Cross presentation 1 1 1 1 1 1 
Signaling by NOTCH3 1 1 1 1 1 1 
NADPH regeneration 1 1 1 1 1 1 
Constitutive Signaling by NOTCH1 HD Domain Mutants 1 1 1 1 1 1 
Erythrocytes take up oxygen and release carbon dioxide 1 1 1 1 1 1 
Spry regulation of FGF signaling 1 1 1 1 1 1 
Choline catabolism 1 1 1 1 1 1 
DNA Damage Reversal 1 1 1 1 1 1 
Transcriptional regulation by small RNAs 1 1 1 1 1 1 
Regulation of FZD by ubiquitination 1 1 1 1 1 1 
Activation of Matrix Metalloproteinases 1 1 1 1 1 1 
Signaling by NOTCH1 HD Domain Mutants in Cancer 1 1 1 1 1 1 
Host Interactions with Influenza Factors 1 1 1 1 1 1 
Eukaryotic Translation Termination 1 1 1 1 1 1 
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Re-
placement Pathway 
1 1 1 1 1 1 
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hypoxia and p53 in the cardiovascular system 1 1 1 1 1 1 
JNK signaling in the CD4+ TCR pathway 1 1 1 1 1 1 
Interferon gamma signaling 1 1 1 1 1 1 
APOBEC3G mediated resistance to HIV-1 infection 1 1 1 1 1 1 
Influenza Life Cycle 1 1 1 1 1 1 
Peptide hormone metabolism 1 1 1 1 1 1 
Hedgehog 1 1 1 1 1 1 
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate 1 1 1 1 1 1 
PIP3 activates AKT signaling 1 1 1 1 1 1 
Diseases of metabolism 1 1 1 1 1 1 
JAK-STAT signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
multi-drug resistance factors 1 1 1 1 1 1 
Effects of Nitric Oxide 1 1 1 1 1 1 
PDGF 1 1 1 1 1 1 
Tetrahydrobiopterin (BH4) synthesis_ recycling_ salvage and regulation 1 1 1 1 1 1 
Rapoport-Luebering glycolytic shunt 1 1 1 1 1 1 
MTF1 activates gene expression 1 1 1 1 1 1 
Response to metal ions 1 1 1 1 1 1 
Chromatin organization 1 1 1 1 1 1 
5-Phosphoribose 1-diphosphate biosynthesis 1 1 1 1 1 1 
skeletal muscle hypertrophy is regulated via akt-mtor pathway 1 1 1 1 1 1 
Ubiquitin-dependent degradation of Cyclin D 1 1 1 1 1 1 
Class C/3 (Metabotropic glutamate/pheromone receptors) 1 1 1 1 1 1 
Fatty Acid Omega Oxidation 1 1 1 1 1 1 
3-phosphoinositide biosynthesis 1 1 1 1 1 1 
Metalloprotease DUBs 1 1 1 1 1 1 
actions of nitric oxide in the heart 1 1 1 1 1 1 
Striated Muscle Contraction 1 1 1 1 1 1 
Abacavir transport and metabolism 1 1 1 1 1 1 
heme degradation 1 1 1 1 1 1 
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S1P4 pathway 1 1 1 1 1 1 
Signaling by Retinoic Acid 1 1 1 1 1 1 
sumoylation as a mechanism to modulate ctbp-dependent gene re-
sponses 
1 1 1 1 1 1 
Synthesis And Processing Of GAG_ GAGPOL Polyproteins 1 1 1 1 1 1 
D-<i>myo</i>-inositol (1_4_5)-trisphosphate biosynthesis 1 1 1 1 1 1 
GPVI-mediated activation cascade 1 1 1 1 1 1 
GDP-fucose biosynthesis 1 1 1 1 1 1 
Viral Acute Myocarditis 1 1 1 1 1 1 
VLDLR internalisation and degradation 1 1 1 1 1 1 
catecholamine biosynthesis 1 1 1 1 1 1 
glycogenolysis 1 1 1 1 1 1 
Activated PKN1 stimulates transcription of AR (androgen receptor) regu-
lated genes KLK2 and KLK3 
1 1 1 1 1 1 
Adrenaline signalling through Alpha-2 adrenergic receptor 1 1 1 1 1 1 
Resolution of AP sites via the multiple-nucleotide patch replacement 
pathway 
1 1 1 1 1 1 
Resolution of Abasic Sites (AP sites) 1 1 1 1 1 1 
Disorders of Folate Metabolism and Transport 1 1 1 1 1 1 
Signaling by Ligand-Responsive EGFR Variants in Cancer 1 1 1 1 1 1 
Alpha6 beta4 integrin-ligand interactions 1 1 1 1 1 1 
Deactivation of the beta-catenin transactivating complex 1 1 1 1 1 1 
Effects of PIP2 hydrolysis 1 1 1 1 1 1 
Response to elevated platelet cytosolic Ca2+ 1 1 1 1 1 1 
CRMPs in Sema3A signaling 1 1 1 1 1 1 
InlB-mediated entry of Listeria monocytogenes into host cell 1 1 1 1 1 1 
RAF-MAP kinase cascade 1 1 1 1 1 1 
Phase 2 - plateau phase 1 1 1 1 1 1 
ethanol degradation II 1 1 1 1 1 1 
Downregulation of ERBB2:ERBB3 signaling 1 1 1 1 1 1 
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RHO GTPases activate KTN1 1 1 1 1 1 1 
Organic cation transport 1 1 1 1 1 1 
Signaling by TGF-beta Receptor Complex 1 1 1 1 1 1 
NOTCH2 Activation and Transmission of Signal to the Nucleus 1 1 1 1 1 1 
Glycosaminoglycan metabolism 1 1 1 1 1 1 
Termination of O-glycan biosynthesis 1 1 1 1 1 1 
Linoleic acid (LA) metabolism 1 1 1 1 1 1 
D-<i>myo</i>-inositol (1_4_5_6)-tetrakisphosphate biosynthesis 1 1 1 1 1 1 
Cyclin A/B1/B2 associated events during G2/M transition 1 1 1 1 1 1 
RUNX1 regulates transcription of genes involved in differentiation of my-
eloid cells 
1 1 1 1 1 1 
trefoil factors initiate mucosal healing 1 1 1 1 1 1 
Fanconi anemia pathway - Homo sapiens (human) 1 1 1 1 1 1 
lipoate biosynthesis and incorporation 1 1 1 1 1 1 
Inflammatory mediator regulation of TRP channels - Homo sapiens (hu-
man) 
1 1 1 1 1 1 
cell to cell adhesion signaling 1 1 1 1 1 1 
DARPP-32 events 1 1 1 1 1 1 
classical complement pathway 1 1 1 1 1 1 
Activation of Na-permeable kainate receptors 1 1 1 1 1 1 
Assembly of the primary cilium 1 1 1 1 1 1 
Ribosome biogenesis in eukaryotes - Homo sapiens (human) 1 1 1 1 1 1 
Synthesis of PI 1 1 1 1 1 1 
CDO in myogenesis 1 1 1 1 1 1 
Myogenesis 1 1 1 1 1 1 
Synthesis of Dolichyl-phosphate 1 1 1 1 1 1 
IL2 1 1 1 1 1 1 
Aurora A signaling 1 1 1 1 1 1 
Neural Crest Differentiation 1 1 1 1 1 1 
GPCR Adenosine A2A receptor 1 1 1 1 1 1 
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Cytokine-cytokine receptor interaction - Homo sapiens (human) 1 1 1 1 1 1 
Interleukin-23 signaling 1 1 1 1 1 1 
TGFBR2 Kinase Domain Mutants in Cancer 1 1 1 1 1 1 
regulation of p27 phosphorylation during cell cycle progression 1 1 1 1 1 1 
Frs2-mediated activation 1 1 1 1 1 1 
lissencephaly gene (lis1) in neuronal migration and development 1 1 1 1 1 1 
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 1 1 1 1 1 1 
Synthesis of UDP-N-acetyl-glucosamine 1 1 1 1 1 1 
Visual signal transduction: Cones 1 1 1 1 1 1 
Long-term potentiation - Homo sapiens (human) 1 1 1 1 1 1 
lectin induced complement pathway 1 1 1 1 1 1 
Rap1 signalling 1 1 1 1 1 1 
Hedgehog _on_ state 1 1 1 1 1 1 
RalA downstream regulated genes 1 1 1 1 1 1 
Signalling to ERKs 1 1 1 1 1 1 
Recognition of DNA damage by PCNA-containing replication complex 1 1 1 1 1 1 
DNA Damage Response (only ATM dependent) 1 1 1 1 1 1 
regulation of pgc-1a 1 1 1 1 1 1 
Refsum Disease 1 1 1 1 1 1 
Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human) 1 1 1 1 1 1 
tRNA processing in the nucleus 1 1 1 1 1 1 
Asymmetric localization of PCP proteins 1 1 1 1 1 1 
TAK1 activates NFkB by phosphorylation and activation of IKKs complex 1 1 1 1 1 1 
ERK/MAPK targets 1 1 1 1 1 1 
JNK (c-Jun kinases) phosphorylation and  activation mediated by acti-
vated human TAK1 
1 1 1 1 1 1 
il-2 receptor beta chain in t cell activation 1 1 1 1 1 1 
Viral myocarditis - Homo sapiens (human) 1 1 1 1 1 1 
Renin-angiotensin system - Homo sapiens (human) 1 1 1 1 1 1 
Cellular hexose transport 1 1 1 1 1 1 
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Type I diabetes mellitus - Homo sapiens (human) 1 1 1 1 1 1 
Small cell lung cancer - Homo sapiens (human) 1 1 1 1 1 1 
WNT5A-dependent internalization of FZD4 1 1 1 1 1 1 
activated TAK1 mediates p38 MAPK activation 1 1 1 1 1 1 
ras signaling pathway 1 1 1 1 1 1 
GPCR signaling-G alpha i 1 1 1 1 1 1 
Cytochrome P450 - arranged by substrate type 1 1 1 1 1 1 
Synthesis of PIPs at the ER membrane 1 1 1 1 1 1 
CHL1 interactions 1 1 1 1 1 1 
Nef mediated downregulation of MHC class I complex cell surface expres-
sion 
1 1 1 1 1 1 
cdc25 and chk1 regulatory pathway in response to dna damage 1 1 1 1 1 1 
SUMOylation 1 1 1 1 1 1 
tRNA processing in the nucleus 1 1 1 1 1 1 
HIV Life Cycle 1 1 1 1 1 1 
RUNX2 regulates bone development 1 1 1 1 1 1 
Ras signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
GPCR signaling-G alpha q 1 1 1 1 1 1 
role of mef2d in t-cell apoptosis 1 1 1 1 1 1 
PI Metabolism 1 1 1 1 1 1 
Breast cancer - Homo sapiens (human) 1 1 1 1 1 1 
adp-ribosylation factor 1 1 1 1 1 1 
Golgi Cisternae Pericentriolar Stack Reorganization 1 1 1 1 1 1 
ErbB signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
Interleukin-11 Signaling Pathway 1 1 1 1 1 1 
Cell-cell junction organization 1 1 1 1 1 1 
control of skeletal myogenesis by hdac and calcium/calmodulin-depend-
ent kinase (camk) 
1 1 1 1 1 1 
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling 1 1 1 1 1 1 
Sema4D mediated inhibition of cell attachment and migration 1 1 1 1 1 1 
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GPCR signaling-G alpha s Epac and ERK 1 1 1 1 1 1 
Mitochondrial translation initiation 1 1 1 1 1 1 
il-10 anti-inflammatory signaling pathway 1 1 1 1 1 1 
D-<i>myo</i>-inositol-5-phosphate metabolism 1 1 1 1 1 1 
Progressive trimming of alpha-1_2-linked mannose residues from 
Man9/8/7GlcNAc2 to produce Man5GlcNAc2 
1 1 1 1 1 1 
N-glycan trimming and elongation in the cis-Golgi 1 1 1 1 1 1 
CLEC7A (Dectin-1) signaling 1 1 1 1 1 1 
GPCR signaling-cholera toxin 1 1 1 1 1 1 
platelet amyloid precursor protein pathway 1 1 1 1 1 1 
putrescine biosynthesis II 1 1 1 1 1 1 
Receptor-ligand binding initiates the second proteolytic cleavage of 
Notch receptor 
1 1 1 1 1 1 
MAPK targets/ Nuclear events mediated by MAP kinases 1 1 1 1 1 1 
multiple antiapoptotic pathways from igf-1r signaling lead to bad phos-
phorylation 
1 1 1 1 1 1 
Deadenylation-dependent mRNA decay 1 1 1 1 1 1 
Synthesis of IP3 and IP4 in the cytosol 1 1 1 1 1 1 
Energy dependent regulation of mTOR by LKB1-AMPK 1 1 1 1 1 1 
Adenylate cyclase inhibitory pathway 1 1 1 1 1 1 
Inhibition of adenylate cyclase pathway 1 1 1 1 1 1 
Transport of nucleosides and free purine and pyrimidine bases across the 
plasma membrane 
1 1 1 1 1 1 
Codeine Action Pathway 1 1 1 1 1 1 
Base excision repair - Homo sapiens (human) 1 1 1 1 1 1 
activation of csk by camp-dependent protein kinase inhibits signaling 
through the t cell receptor 
1 1 1 1 1 1 
Congenital Bile Acid Synthesis Defect Type II 1 1 1 1 1 1 
role of -arrestins in the activation and targeting of map kinases 1 1 1 1 1 1 
DNA Replication Pre-Initiation 1 1 1 1 1 1 
D-<i>myo</i>-inositol (3_4_5_6)-tetrakisphosphate biosynthesis 1 1 1 1 1 1 
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1D-<i>myo</i>-inositol hexakisphosphate biosynthesis II (mammalian) 1 1 1 1 1 1 
west nile virus 1 1 1 1 1 1 
Gastric Cancer Network 2 1 1 1 1 1 1 
basic mechanisms of sumoylation 1 1 1 1 1 1 
Eicosanoid Synthesis 1 1 1 1 1 1 
ErbB2/ErbB3 signaling events 1 1 1 1 1 1 
Formyl peptide receptors bind formyl peptides and many other ligands 1 1 1 1 1 1 
Deadenylation of mRNA 1 1 1 1 1 1 
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion 1 1 1 1 1 1 
tgf beta signaling pathway 1 1 1 1 1 1 
Arachidonate production from DAG 1 1 1 1 1 1 
dopamine degradation 1 1 1 1 1 1 
Dual incision in TC-NER 1 1 1 1 1 1 
GPCR signaling-pertussis toxin 1 1 1 1 1 1 
anandamide degradation 1 1 1 1 1 1 
triacylglycerol biosynthesis 1 1 1 1 1 1 
Tamoxifen Metabolism Pathway 1 1 1 1 1 1 
gamma-aminobutyric acid receptor life cycle pathway 1 1 1 1 1 1 
PAR4-mediated thrombin signaling events 1 1 1 1 1 1 
Apelin signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
map kinase inactivation of smrt corepressor 1 1 1 1 1 1 
d4gdi signaling pathway 1 1 1 1 1 1 
Sphingolipid signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
methylglyoxal degradation I 1 1 1 1 1 1 
Synthesis of pyrophosphates in the cytosol 1 1 1 1 1 1 
C-type lectin receptor signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
e2f1 destruction pathway 1 1 1 1 1 1 
Sodium-coupled sulphate_ di- and tri-carboxylate transporters 1 1 1 1 1 1 
Validated nuclear estrogen receptor beta network 1 1 1 1 1 1 
Synthesis of IPs in the ER lumen 1 1 1 1 1 1 
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CD40/CD40L signaling 1 1 1 1 1 1 
Signaling by EGFR 1 1 1 1 1 1 
GAB1 signalosome 1 1 1 1 1 1 
deregulation of cdk5 in alzheimers disease 1 1 1 1 1 1 
Intra-Golgi traffic 1 1 1 1 1 1 
superpathway of D-<i>myo</i>-inositol (1_4_5)-trisphosphate metabo-
lism 
1 1 1 1 1 1 
Catecholamine biosynthesis 1 1 1 1 1 1 
2_-deoxy-&alpha;-D-ribose 1-phosphate degradation 1 1 1 1 1 1 
Salivary secretion - Homo sapiens (human) 1 1 1 1 1 1 
guanine and guanosine salvage 1 1 1 1 1 1 
Signaling by PDGF 1 1 1 1 1 1 
Scavenging by Class H Receptors 1 1 1 1 1 1 
Metabolism of non-coding RNA 1 1 1 1 1 1 
attenuation of gpcr signaling 1 1 1 1 1 1 
Carboxyterminal post-translational modifications of tubulin 1 1 1 1 1 1 
Endosomal Sorting Complex Required For Transport (ESCRT) 1 1 1 1 1 1 
metabolism of anandamide an endogenous cannabinoid 1 1 1 1 1 1 
Methadyl Acetate Action Pathway 1 1 1 1 1 1 
the information processing pathway at the ifn beta enhancer 1 1 1 1 1 1 
Cardiac muscle contraction - Homo sapiens (human) 1 1 1 1 1 1 
Adrenergic signaling in cardiomyocytes - Homo sapiens (human) 1 1 1 1 1 1 
CD28 dependent Vav1 pathway 1 1 1 1 1 1 
PTEN Regulation 1 1 1 1 1 1 
Phospholipase D signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
Glutamate Neurotransmitter Release Cycle 1 1 1 1 1 1 
NRIF signals cell death from the nucleus 1 1 1 1 1 1 
PKMTs methylate histone lysines 1 1 1 1 1 1 
Nef Mediated CD4 Down-regulation 1 1 1 1 1 1 
ABC-family proteins mediated transport 1 1 1 1 1 1 
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rb tumor suppressor/checkpoint signaling in response to dna damage 1 1 1 1 1 1 
NS1 Mediated Effects on Host Pathways 1 1 1 1 1 1 
ECM proteoglycans 1 1 1 1 1 1 
Activation of the pre-replicative complex 1 1 1 1 1 1 
PTK6 Down-Regulation 1 1 1 1 1 1 
Signaling by FGFR1 1 1 1 1 1 1 
Bile acid and bile salt metabolism 1 1 1 1 1 1 
Activation of GABAB receptors 1 1 1 1 1 1 
Retinoic acid receptors-mediated signaling 1 1 1 1 1 1 
Mitochondrial translation elongation 1 1 1 1 1 1 
Serotonin and melatonin biosynthesis 1 1 1 1 1 1 
Adrenoceptors 1 1 1 1 1 1 
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 tar-
geted proteins in late mitosis/early G1 
1 1 1 1 1 1 
Condensation of Prophase Chromosomes 1 1 1 1 1 1 
MicroRNAs in cancer - Homo sapiens (human) 1 1 1 1 1 1 
Negative regulation of MET activity 1 1 1 1 1 1 
PTK6 Regulates RHO GTPases_ RAS GTPase and MAP kinases 1 1 1 1 1 1 
Signaling by Non-Receptor Tyrosine Kinases 1 1 1 1 1 1 
internal ribosome entry pathway 1 1 1 1 1 1 
E2F mediated regulation of DNA replication 1 1 1 1 1 1 
Synthesis of PIPs at the Golgi membrane 1 1 1 1 1 1 
Vitamin D (calciferol) metabolism 1 1 1 1 1 1 
Longevity regulating pathway - Homo sapiens (human) 1 1 1 1 1 1 
Cytosine methylation 1 1 1 1 1 1 
Glucocorticoid Receptor Pathway 1 1 1 1 1 1 
Regulation of TP53 Activity through Phosphorylation 1 1 1 1 1 1 
purine deoxyribonucleosides degradation 1 1 1 1 1 1 
Signaling by Retinoic Acid 1 1 1 1 1 1 
Phosphatidylinositol Phosphate Metabolism 1 1 1 1 1 1 
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Protein export - Homo sapiens (human) 1 1 1 1 1 1 
Ether lipid metabolism - Homo sapiens (human) 1 1 1 1 1 1 
phenylethylamine degradation I 1 1 1 1 1 1 
Association Between Physico-Chemical Features and Toxicity Associated 
Pathways 
1 1 1 1 1 1 
GABA synthesis 1 1 1 1 1 1 
Reuptake of GABA 1 1 1 1 1 1 
Beta-catenin phosphorylation cascade 1 1 1 1 1 1 
Depolymerisation of the Nuclear Lamina 1 1 1 1 1 1 
Autodegradation of the E3 ubiquitin ligase COP1 1 1 1 1 1 1 
Glibenclamide Action Pathway 1 1 1 1 1 1 
Stabilization of p53 1 1 1 1 1 1 
homocarnosine biosynthesis 1 1 1 1 1 1 
Phytochemical activity on NRF2 transcriptional activation 1 1 1 1 1 1 
Selenocompound metabolism - Homo sapiens (human) 1 1 1 1 1 1 
Kit receptor signaling pathway 1 1 1 1 1 1 
p53-Dependent G1 DNA Damage Response 1 1 1 1 1 1 
Axonal growth stimulation 1 1 1 1 1 1 
Wnt signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
Cardiac Progenitor Differentiation 1 1 1 1 1 1 
p53-Dependent G1/S DNA damage checkpoint 1 1 1 1 1 1 
putrescine degradation III 1 1 1 1 1 1 
Enzymatic degradation of dopamine by COMT 1 1 1 1 1 1 
adenine and adenosine salvage III 1 1 1 1 1 1 
Electron Transport Chain (OXPHOS system in mitochondria) 1 1 1 1 1 1 
Enzymatic degradation of Dopamine by monoamine oxidase 1 1 1 1 1 1 
Dopamine clearance from the synaptic cleft 1 1 1 1 1 1 
Aromatase Inhibitor Pathway (Multiple Tissues)_ Pharmacodynamics 1 1 1 1 1 1 
Metabolism of serotonin 1 1 1 1 1 1 
Serotonin clearance from the synaptic cleft 1 1 1 1 1 1 
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Sodium-coupled phosphate cotransporters 1 1 1 1 1 1 
miR-517 relationship with ARCN1 and USP1 1 1 1 1 1 1 
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A 1 1 1 1 1 1 
Transport of Mature Transcript to Cytoplasm 1 1 1 1 1 1 
Condensation of Prometaphase Chromosomes 1 1 1 1 1 1 
Ca2+ pathway 1 1 1 1 1 1 
eukaryotic protein translation 1 1 1 1 1 1 
Phenytoin Pathway_ Pharmacokinetics 1 1 1 1 1 1 
Circadian entrainment - Homo sapiens (human) 1 1 1 1 1 1 
ethanol degradation IV 1 1 1 1 1 1 
Signaling by NOTCH2 1 1 1 1 1 1 
Ras activation upon Ca2+ influx through NMDA receptor 1 1 1 1 1 1 
Thermogenesis - Homo sapiens (human) 1 1 1 1 1 1 
Regulation of expression of SLITs and ROBOs 1 1 1 1 1 1 
CREB phosphorylation through the activation of Ras 1 1 1 1 1 1 
TRP channels 1 1 1 1 1 1 
propionyl-CoA degradation 1 1 1 1 1 1 
2-oxobutanoate degradation 1 1 1 1 1 1 
7-(3-amino-3-carboxypropyl)-wyosine biosynthesis 1 1 1 1 1 1 
Phase I biotransformations_ non P450 1 1 1 1 1 1 
putrescine biosynthesis I 1 1 1 1 1 1 
RAF-independent MAPK1-3 activation 1 1 1 1 1 1 
Cholesterol biosynthesis 1 1 1 1 1 1 
urate biosynthesis/inosine 5_-phosphate degradation 1 1 1 1 1 1 
Glycogen synthesis 1 1 1 1 1 1 
Synthesis of PIPs at the plasma membrane 1 1 1 1 1 1 
PI5P Regulates TP53 Acetylation 1 1 1 1 1 1 
Regulation of TP53 Activity through Acetylation 1 1 1 1 1 1 
Negative regulation of the PI3K/AKT network 1 1 1 1 1 1 
2-oxoglutarate decarboxylation to succinyl-CoA 1 1 1 1 1 1 
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cell cycle: g2/m checkpoint 1 1 1 1 1 1 
Mitochondrial translation 1 1 1 1 1 1 
Signaling by EGFRvIII in Cancer 1 1 1 1 1 1 
Signaling by EGFR in Cancer 1 1 1 1 1 1 
aspirin blocks signaling pathway involved in platelet activation 1 1 1 1 1 1 
MET in type 1 papillary renal cell carcinoma 1 1 1 1 1 1 
Detoxification of Reactive Oxygen Species 1 1 1 1 1 1 
C-type lectin receptors (CLRs) 1 1 1 1 1 1 
BMAL1-CLOCK_NPAS2 activates circadian gene expression 1 1 1 1 1 1 
Trafficking of GluR2-containing AMPA receptors 1 1 1 1 1 1 
RHO GTPases activate PKNs 1 1 1 1 1 1 
Dezocine Action Pathway 1 1 1 1 1 1 
Synthesis of PIPs at the early endosome membrane 1 1 1 1 1 1 
chaperones modulate interferon signaling pathway 1 1 1 1 1 1 
NCAM1 interactions 1 1 1 1 1 1 
SLIT2:ROBO1 increases RHOA activity 1 1 1 1 1 1 
mevalonate pathway 1 1 1 1 1 1 
superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalo-
nate) 
1 1 1 1 1 1 
Activation of AMPA receptors 1 1 1 1 1 1 
Ubiquinone and other terpenoid-quinone biosynthesis - Homo sapiens 
(human) 
1 1 1 1 1 1 
Uncoating of the HIV Virion 1 1 1 1 1 1 
GABA B receptor activation 1 1 1 1 1 1 
Unblocking of NMDA receptor_ glutamate binding and activation 1 1 1 1 1 1 
bile acid biosynthesis_ neutral pathway 1 1 1 1 1 1 
Translesion synthesis by REV1 1 1 1 1 1 1 
GABA receptor activation 1 1 1 1 1 1 
Synthesis of PIPs at the late endosome membrane 1 1 1 1 1 1 
S-adenosyl-L-methionine biosynthesis 1 1 1 1 1 1 
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Carnitine synthesis 1 1 1 1 1 1 
fructose 2_6-bisphosphate synthesis 1 1 1 1 1 1 
Adenylate cyclase activating pathway 1 1 1 1 1 1 
G-protein mediated events 1 1 1 1 1 1 
Regulation of nuclear SMAD2/3 signaling 1 1 1 1 1 1 
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation 1 1 1 1 1 1 
mRNA Capping 1 1 1 1 1 1 
ALK2 signaling events 1 1 1 1 1 1 
NADH repair 1 1 1 1 1 1 
Sulindac Metabolic Pathway 1 1 1 1 1 1 
Glycerophospholipid catabolism 1 1 1 1 1 1 
PI Metabolism 1 1 1 1 1 1 
mTORC1-mediated signalling 1 1 1 1 1 1 
Cdc20:Phospho-APC/C mediated degradation of Cyclin A 1 1 1 1 1 1 
PKA activation in glucagon signalling 1 1 1 1 1 1 
superpathway of melatonin degradation 1 1 1 1 1 1 
FCERI mediated NF-kB activation 1 1 1 1 1 1 
Synthesis of PS 1 1 1 1 1 1 
oxidative ethanol degradation III 1 1 1 1 1 1 
Nuclear Envelope Reassembly 1 1 1 1 1 1 
Oxidative Stress Induced Senescence 1 1 1 1 1 1 
Terminal pathway of complement 1 1 1 1 1 1 
WNT-Ncore 1 1 1 1 1 1 
Regulation of RUNX1 Expression and Activity 1 1 1 1 1 1 
Plasmalogen biosynthesis 1 1 1 1 1 1 
TFAP2A acts as a transcriptional repressor during retinoic acid induced 
cell differentiation 
1 1 1 1 1 1 
AlphaE beta7 integrin cell surface interactions 1 1 1 1 1 1 
Calcium signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
Energy dependent regulation of mTOR by LKB1-AMPK 1 1 1 1 1 1 
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Regulation of PTEN stability and activity 1 1 1 1 1 1 
Medium chain acyl-coa dehydrogenase deficiency (MCAD) 1 1 1 1 1 1 
G alpha (12/13) signalling events 1 1 1 1 1 1 
Phosphate bond hydrolysis by NUDT proteins 1 1 1 1 1 1 
Transcriptional regulation by the AP-2 (TFAP2) family of transcription fac-
tors 
1 1 1 1 1 1 
chrebp regulation by carbohydrates and camp 1 1 1 1 1 1 
Calcium signaling in the CD4+ TCR pathway 1 1 1 1 1 1 
histidine degradation 1 1 1 1 1 1 
G alpha (z) signalling events 1 1 1 1 1 1 
Vasopressin regulates renal water homeostasis via Aquaporins 1 1 1 1 1 1 
IL12-mediated signaling events 1 1 1 1 1 1 
Membrane binding and targetting of GAG proteins 1 1 1 1 1 1 
Integration of provirus 1 1 1 1 1 1 
Translesion synthesis by POLK 1 1 1 1 1 1 
IL3 1 1 1 1 1 1 
caspase cascade in apoptosis 1 1 1 1 1 1 
VEGFR1 specific signals 1 1 1 1 1 1 
Vif-mediated degradation of APOBEC3G 1 1 1 1 1 1 
HDR through Homologous Recombination (HRR) or Single Strand Anneal-
ing (SSA) 
1 1 1 1 1 1 
CDT1 association with the CDC6:ORC:origin complex 1 1 1 1 1 1 
Assembly of the pre-replicative complex 1 1 1 1 1 1 
M/G1 Transition 1 1 1 1 1 1 
Erythrocytes take up carbon dioxide and release oxygen 1 1 1 1 1 1 
Sympathetic Nerve Pathway (Pre- and Post- Ganglionic Junction) 1 1 1 1 1 1 
glutamine degradation/glutamate biosynthesis 1 1 1 1 1 1 
IL2 signaling events mediated by PI3K 1 1 1 1 1 1 
Inactivation_ recovery and regulation of the phototransduction cascade 1 1 1 1 1 1 
The phototransduction cascade 1 1 1 1 1 1 
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superpathway of cholesterol biosynthesis 1 1 1 1 1 1 
Steroid hormone biosynthesis - Homo sapiens (human) 1 1 1 1 1 1 
PI5P_ PP2A and IER3 Regulate PI3K/AKT Signaling 1 1 1 1 1 1 
Translesion synthesis by POLI 1 1 1 1 1 1 
Cristae formation 1 1 1 1 1 1 
Sympathetic Nerve Pathway (Neuroeffector Junction) 1 1 1 1 1 1 
Displacement of DNA glycosylase by APEX1 1 1 1 1 1 1 
superpathway of inositol phosphate compounds 1 1 1 1 1 1 
Regulation of lipid metabolism by Peroxisome proliferator-activated re-
ceptor alpha (PPARalpha) 
1 1 1 1 1 1 
Warfarin Pathway_ Pharmacodynamics 1 1 1 1 1 1 
ascorbate recycling (cytosolic) 1 1 1 1 1 1 
Tamoxifen Pathway_ Pharmacokinetics 1 1 1 1 1 1 
Fluoropyrimidine Pathway_ Pharmacokinetics 1 1 1 1 1 1 
Bisphosphonate Pathway_ Pharmacodynamics 1 1 1 1 1 1 
Taxane Pathway_ Pharmacokinetics 1 1 1 1 1 1 
Selective Serotonin Reuptake Inhibitor Pathway_ Pharmacodynamics 1 1 1 1 1 1 
Nicotine Pathway (Dopaminergic Neuron)_ Pharmacodynamics 1 1 1 1 1 1 
D-glucuronate degradation 1 1 1 1 1 1 
Benzodiazepine Pathway_ Pharmacodynamics 1 1 1 1 1 1 
Methotrexate Pathway_ Pharmacokinetics 1 1 1 1 1 1 
Leukotriene modifiers pathway_ Pharmacodynamics 1 1 1 1 1 1 
Acetaminophen Pathway_ Pharmacokinetics 1 1 1 1 1 1 
Nicotine Pathway_ Pharmacokinetics 1 1 1 1 1 1 
ACE Inhibitor Pathway_ Pharmacodynamics 1 1 1 1 1 1 
Beta-agonist/Beta-blocker Pathway_ Pharmacodynamics 1 1 1 1 1 1 
Etoposide Pathway_ Pharmacokinetics/Pharmacodynamics 1 1 1 1 1 1 
Long chain acyl-CoA dehydrogenase deficiency (LCAD) 1 1 1 1 1 1 
Levomethadyl Acetate Action Action Pathway 1 1 1 1 1 1 
Intracellular Signalling Through Adenosine Receptor A2b and Adenosine 1 1 1 1 1 1 
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Excitatory Neural Signalling Through 5-HTR 4 and Serotonin 1 1 1 1 1 1 
Disopyramide Action Pathway 1 1 1 1 1 1 
Procainamide (Antiarrhythmic) Action Pathway 1 1 1 1 1 1 
Fosphenytoin (Antiarrhythmic) Action Pathway 1 1 1 1 1 1 
UDP-<i>N</i>-acetyl-D-glucosamine biosynthesis II 1 1 1 1 1 1 
Intracellular Signalling Through Adenosine Receptor A2a and Adenosine 1 1 1 1 1 1 
Sepiapterin reductase deficiency 1 1 1 1 1 1 
Galactosemia III 1 1 1 1 1 1 
Galactosemia II (GALK) 1 1 1 1 1 1 
Agents Acting on the Renin-Angiotensin System Pathway_ Pharmacody-
namics 
1 1 1 1 1 1 
Mycophenolic Acid Metabolism Pathway 1 1 1 1 1 1 
Bopindolol Action Pathway 1 1 1 1 1 1 
Timolol Action Pathway 1 1 1 1 1 1 
Carteolol Action Pathway 1 1 1 1 1 1 
Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin 1 1 1 1 1 1 
Hydrolysis of LPE 1 1 1 1 1 1 
Citalopram Action Pathway 1 1 1 1 1 1 
Imipramine Action Pathway 1 1 1 1 1 1 
Bile Acid Biosynthesis 1 1 1 1 1 1 
Mitochondrial translation termination 1 1 1 1 1 1 
D-Arginine and D-Ornithine Metabolism 1 1 1 1 1 1 
Levallorphan Action Pathway 1 1 1 1 1 1 
Dimethylthiambutene Action Pathway 1 1 1 1 1 1 
Ethylmorphine Action Pathway 1 1 1 1 1 1 
Pentazocine Action Pathway 1 1 1 1 1 1 
Naltrexone Action Pathway 1 1 1 1 1 1 
Naloxone Action Pathway 1 1 1 1 1 1 
Dihydromorphine Action Pathway 1 1 1 1 1 1 
Minus-strand DNA synthesis 1 1 1 1 1 1 
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Nuclear signaling by ERBB4 1 1 1 1 1 1 
Bevantolol Action Pathway 1 1 1 1 1 1 
Practolol Action Pathway 1 1 1 1 1 1 
Transport of glycerol from adipocytes to the liver by Aquaporins 1 1 1 1 1 1 
Clopidogrel Metabolism Pathway 1 1 1 1 1 1 
ALKBH2 mediated reversal of alkylation damage 1 1 1 1 1 1 
melatonin degradation I 1 1 1 1 1 1 
Cerebrotendinous Xanthomatosis (CTX) 1 1 1 1 1 1 
Zellweger Syndrome 1 1 1 1 1 1 
Capecitabine Action Pathway 1 1 1 1 1 1 
Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin  1 1 1 1 1 1 
Excitatory Neural Signalling Through 5-HTR 6 and Serotonin  1 1 1 1 1 1 
Vitamin K Metabolism 1 1 1 1 1 1 
Hypophosphatasia 1 1 1 1 1 1 
Dobutamine Action Pathway 1 1 1 1 1 1 
Isoprenaline Action Pathway 1 1 1 1 1 1 
Arbutamine Action Pathway 1 1 1 1 1 1 
Amiodarone Action Pathway 1 1 1 1 1 1 
Levobunolol Action Pathway 1 1 1 1 1 1 
Metipranolol Action Pathway 1 1 1 1 1 1 
Degradation of Superoxides 1 1 1 1 1 1 
Pantoprazole Action Pathway 1 1 1 1 1 1 
Rabeprazole Action Pathway 1 1 1 1 1 1 
mRNA decay by 3_ to 5_ exoribonuclease 1 1 1 1 1 1 
Omeprazole Action Pathway 1 1 1 1 1 1 
Lansoprazole Action Pathway 1 1 1 1 1 1 
Mexiletine Action Pathway 1 1 1 1 1 1 
Lidocaine (Antiarrhythmic) Action Pathway 1 1 1 1 1 1 
L-dopachrome biosynthesis 1 1 1 1 1 1 
fatty acid &alpha;-oxidation 1 1 1 1 1 1 
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Pterine Biosynthesis 1 1 1 1 1 1 
Quinidine Action Pathway 1 1 1 1 1 1 
ALKBH3 mediated reversal of alkylation damage 1 1 1 1 1 1 
Reversal of alkylation damage by DNA dioxygenases 1 1 1 1 1 1 
DNA Damage Reversal 1 1 1 1 1 1 
Thyroid hormone synthesis 1 1 1 1 1 1 
Endosomal/Vacuolar pathway 1 1 1 1 1 1 
Betaxolol Action Pathway 1 1 1 1 1 1 
Atenolol Action Pathway 1 1 1 1 1 1 
Respiratory electron transport 1 1 1 1 1 1 
Long-term depression - Homo sapiens (human) 1 1 1 1 1 1 
Hypusine synthesis from eIF5A-lysine 1 1 1 1 1 1 
Alprenolol Action Pathway 1 1 1 1 1 1 
Trifunctional protein deficiency 1 1 1 1 1 1 
coenzyme A biosynthesis 1 1 1 1 1 1 
Carnitine palmitoyl transferase deficiency (II) 1 1 1 1 1 1 
Very-long-chain acyl coa dehydrogenase deficiency (VLCAD) 1 1 1 1 1 1 
Citalopram Metabolism Pathway 1 1 1 1 1 1 
Nicotine Metabolism Pathway 1 1 1 1 1 1 
Clopidogrel Action Pathway 1 1 1 1 1 1 
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol 1 1 1 1 1 1 
Nicotine Action Pathway 1 1 1 1 1 1 
Paclitaxel Action Pathway 1 1 1 1 1 1 
Vincristine Action Pathway 1 1 1 1 1 1 
Vinblastine Action Pathway 1 1 1 1 1 1 
Vinorelbine Action Pathway 1 1 1 1 1 1 
Capecitabine Metabolism Pathway 1 1 1 1 1 1 
Glycerol Phosphate Shuttle 1 1 1 1 1 1 
Betaine Metabolism 1 1 1 1 1 1 
Nalbuphine Action Pathway 1 1 1 1 1 1 
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Ketobemidone  Action Pathway 1 1 1 1 1 1 
Beta Oxidation of Very Long Chain Fatty Acids 1 1 1 1 1 1 
Fatty Acid Elongation In Mitochondria 1 1 1 1 1 1 
Lidocaine (Local Anaesthetic) Action Pathway 1 1 1 1 1 1 
L-kynurenine degradation 1 1 1 1 1 1 
Chloroprocaine Action Pathway 1 1 1 1 1 1 
Cocaine Action Pathway 1 1 1 1 1 1 
Dibucaine Action Pathway 1 1 1 1 1 1 
Levobupivacaine Action Pathway 1 1 1 1 1 1 
Bupivacaine Action Pathway 1 1 1 1 1 1 
Gastric Acid Production 1 1 1 1 1 1 
Muscle/Heart Contraction 1 1 1 1 1 1 
Diltiazem Action Pathway 1 1 1 1 1 1 
Propranolol Action Pathway 1 1 1 1 1 1 
Pindolol Action Pathway 1 1 1 1 1 1 
Erlotinib Action Pathway 1 1 1 1 1 1 
Levorphanol Action Pathway 1 1 1 1 1 1 
Propoxyphene Action Pathway 1 1 1 1 1 1 
Tramadol Action Action Pathway 1 1 1 1 1 1 
Bupranolol Action Pathway 1 1 1 1 1 1 
Diphenoxylate Action Pathway 1 1 1 1 1 1 
Nizatidine Action Pathway 1 1 1 1 1 1 
Ranitidine Action Pathway 1 1 1 1 1 1 
Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency) 1 1 1 1 1 1 
Methadone Action Pathway 1 1 1 1 1 1 
Oxycodone Action Pathway 1 1 1 1 1 1 
Mitochondrial ABC transporters 1 1 1 1 1 1 
Prilocaine Action Pathway 1 1 1 1 1 1 
Procaine Action Pathway 1 1 1 1 1 1 
Proparacaine Action Pathway 1 1 1 1 1 1 
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Heroin Action Pathway 1 1 1 1 1 1 
Fatty acid Metabolism 1 1 1 1 1 1 
Vitamin B6 Metabolism 1 1 1 1 1 1 
Catecholamine Biosynthesis 1 1 1 1 1 1 
Nucleotide Sugars Metabolism 1 1 1 1 1 1 
proline degradation 1 1 1 1 1 1 
Nebivolol Action Pathway 1 1 1 1 1 1 
sarcosine oncometabolite pathway  1 1 1 1 1 1 
Amlodipine Action Pathway 1 1 1 1 1 1 
Gemcitabine Action Pathway 1 1 1 1 1 1 
Prednisolone Action Pathway 1 1 1 1 1 1 
Ethanol Degradation 1 1 1 1 1 1 
Type II Na+/Pi cotransporters 1 1 1 1 1 1 
Glutaric Aciduria Type I 1 1 1 1 1 1 
Ethylmalonic Encephalopathy 1 1 1 1 1 1 
Prednisolone Metabolism Pathway 1 1 1 1 1 1 
Nitrendipine Action Pathway 1 1 1 1 1 1 
Nisoldipine Action Pathway 1 1 1 1 1 1 
Nimodipine Action Pathway 1 1 1 1 1 1 
Intracellular Signalling Through LHCGR Receptor and Luteinizing Hor-
mone/Choriogonadotropin 
1 1 1 1 1 1 
Ibutilide Action Pathway 1 1 1 1 1 1 
Tocainide Action Pathway 1 1 1 1 1 1 
Intracellular Signalling Through Histamine H2 Receptor and Histamine 1 1 1 1 1 1 
Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids 1 1 1 1 1 1 
Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids 1 1 1 1 1 1 
Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids 1 1 1 1 1 1 
Dopa-responsive dystonia 1 1 1 1 1 1 
Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase defi-
ciency (ptps) 
1 1 1 1 1 1 
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Metal ion SLC transporters 1 1 1 1 1 1 
Nevirapine Metabolism Pathway 1 1 1 1 1 1 
Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD) 1 1 1 1 1 1 
Thyroxine biosynthesis 1 1 1 1 1 1 
Tenofovir  Action Pathway 1 1 1 1 1 1 
Chemokine signaling pathway 1 1 1 1 1 1 
Alfentanil Action Pathway 1 1 1 1 1 1 
Oxymorphone Action Pathway 1 1 1 1 1 1 
Hydrocodone Action Pathway 1 1 1 1 1 1 
Hydromorphone Action Pathway 1 1 1 1 1 1 
Sufentanil Action Pathway 1 1 1 1 1 1 
Remifentanil Action Pathway 1 1 1 1 1 1 
Fentanyl Action Pathway 1 1 1 1 1 1 
dTMP <i>de novo</i> biosynthesis (mitochondrial) 1 1 1 1 1 1 
Taurine and Hypotaurine Metabolism 1 1 1 1 1 1 
Pantothenate and CoA Biosynthesis 1 1 1 1 1 1 
Selenoamino Acid Metabolism 1 1 1 1 1 1 
Betazole Action Pathway 1 1 1 1 1 1 
Roxatidine acetate Action Pathway 1 1 1 1 1 1 
Metiamide Action Pathway 1 1 1 1 1 1 
Isradipine Action Pathway 1 1 1 1 1 1 
Aflatoxin activation and detoxification 1 1 1 1 1 1 
Nifedipine Action Pathway 1 1 1 1 1 1 
Felodipine Action Pathway 1 1 1 1 1 1 
Nadolol Action Pathway 1 1 1 1 1 1 
valine degradation 1 1 1 1 1 1 
Pirenzepine Action Pathway 1 1 1 1 1 1 
Carvedilol Action Pathway 1 1 1 1 1 1 
Labetalol Action Pathway 1 1 1 1 1 1 
Repaglinide Action Pathway 1 1 1 1 1 1 
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Nateglinide Action Pathway 1 1 1 1 1 1 
Threonine and 2-Oxobutanoate Degradation 1 1 1 1 1 1 
Phytanic Acid Peroxisomal Oxidation 1 1 1 1 1 1 
Carnitine-acylcarnitine translocase deficiency 1 1 1 1 1 1 
Pyruvaldehyde Degradation 1 1 1 1 1 1 
3-Methylthiofentanyl Action Pathway 1 1 1 1 1 1 
Ketone Body Metabolism 1 1 1 1 1 1 
Riboflavin Metabolism 1 1 1 1 1 1 
Butyrate Metabolism 1 1 1 1 1 1 
Thiamine Metabolism 1 1 1 1 1 1 
EGF-Core 1 1 1 1 1 1 
Malaria - Homo sapiens (human) 1 1 1 1 1 1 
NHR 1 1 1 1 1 1 
Norepinephrine Neurotransmitter Release Cycle 1 1 1 1 1 1 
Selenoamino acid metabolism 1 1 1 1 1 1 
Androgen and estrogen biosynthesis and metabolism 1 1 1 1 1 1 
Di-unsaturated fatty acid beta-oxidation 1 1 1 1 1 1 
<i>myo</i>-inositol <i>de novo</i> biosynthesis 1 1 1 1 1 1 
Lipoate metabolism 1 1 1 1 1 1 
Mono-unsaturated fatty acid beta-oxidation 1 1 1 1 1 1 
Omega-6 fatty acid metabolism 1 1 1 1 1 1 
Putative anti-Inflammatory metabolites formation from EPA 1 1 1 1 1 1 
Saturated fatty acids beta-oxidation 1 1 1 1 1 1 
Squalene and cholesterol biosynthesis 1 1 1 1 1 1 
Phytanic acid peroxisomal oxidation 1 1 1 1 1 1 
Vitamin B1 (thiamin) metabolism 1 1 1 1 1 1 
Vitamin B6 (pyridoxine) metabolism 1 1 1 1 1 1 
Vitamin H (biotin) metabolism 1 1 1 1 1 1 
Formation of annular gap junctions 1 1 1 1 1 1 
IL-5 Signaling Pathway 1 1 1 1 1 1 
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Sphingolipid pathway 1 1 1 1 1 1 
Inositol Phosphate Metabolism 1 1 1 1 1 1 
Glycine Metabolism 1 1 1 1 1 1 
Resolution of D-Loop Structures 1 1 1 1 1 1 
Gliclazide Action Pathway 1 1 1 1 1 1 
Nicotine Metabolism 1 1 1 1 1 1 
nitric oxide signaling pathway 1 1 1 1 1 1 
Nicotine Activity on Dopaminergic Neurons 1 1 1 1 1 1 
Asparagine N-linked glycosylation 1 1 1 1 1 1 
Processing of Capped Intron-Containing Pre-mRNA 1 1 1 1 1 1 
Apoptosis 1 1 1 1 1 1 
Respiratory electron transport_ ATP synthesis by chemiosmotic coupling_ 
and heat production by uncoupling proteins. 
1 1 1 1 1 1 
Dopaminergic Neurogenesis 1 1 1 1 1 1 
Gene Silencing by RNA 1 1 1 1 1 1 
Semaphorin interactions 1 1 1 1 1 1 
Carnitine Synthesis 1 1 1 1 1 1 
Threonine catabolism 1 1 1 1 1 1 
Signaling by Insulin receptor 1 1 1 1 1 1 
Signaling by Rho GTPases 1 1 1 1 1 1 
Signaling by ROBO receptors 1 1 1 1 1 1 
Transport of glycerol from adipocytes to the liver by Aquaporins 1 1 1 1 1 1 
Downregulation of TGF-beta receptor signaling 1 1 1 1 1 1 
fatty acid biosynthesis initiation 1 1 1 1 1 1 
Cholesterol Biosynthesis Pathway 1 1 1 1 1 1 
Opioid Signalling 1 1 1 1 1 1 
Nucleotide Excision Repair 1 1 1 1 1 1 
Thyroxine (Thyroid Hormone) Production 1 1 1 1 1 1 
Genes targeted by miRNAs in adipocytes 1 1 1 1 1 1 
threonine degradation 1 1 1 1 1 1 
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miR-targeted genes in adipocytes - TarBase 1 1 1 1 1 1 
Iron metabolism in placenta 1 1 1 1 1 1 
SREBF and miR33 in cholesterol and lipid homeostasis 1 1 1 1 1 1 
miRs in Muscle Cell Differentiation 1 1 1 1 1 1 
Leptin signaling pathway 1 1 1 1 1 1 
Follicle Stimulating Hormone (FSH) signaling pathway 1 1 1 1 1 1 
Eukaryotic Translation Initiation 1 1 1 1 1 1 
Factors involved in megakaryocyte development and platelet production 1 1 1 1 1 1 
Interferon alpha-beta signaling 1 1 1 1 1 1 
3-phosphoinositide degradation 1 1 1 1 1 1 
MAPK targets- Nuclear events mediated by MAP kinases 1 1 1 1 1 1 
Mitotic G1-G1-S phases 1 1 1 1 1 1 
Mitotic G2-G2-M phases 1 1 1 1 1 1 
mRNA Capping 1 1 1 1 1 1 
Neurotransmitter clearance 1 1 1 1 1 1 
Neurotransmitter uptake and metabolism In glial cells 1 1 1 1 1 1 
mTOR signalling 1 1 1 1 1 1 
Peroxisomal lipid metabolism 1 1 1 1 1 1 
Platelet Aggregation (Plug Formation) 1 1 1 1 1 1 
Protein folding 1 1 1 1 1 1 
Circadian Clock 1 1 1 1 1 1 
Sotalol Action Pathway 1 1 1 1 1 1 
Costimulation by the CD28 family 1 1 1 1 1 1 
Effects of PIP2 hydrolysis 1 1 1 1 1 1 
Eukaryotic Translation Elongation 1 1 1 1 1 1 
Intrinsic Pathway for Apoptosis 1 1 1 1 1 1 
EPO signaling 1 1 1 1 1 1 
biotin-carboxyl carrier protein assembly 1 1 1 1 1 1 
NCAM signaling for neurite out-growth 1 1 1 1 1 1 
stathmin and breast cancer resistance to antimicrotubule agents 1 1 1 1 1 1 
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heme biosynthesis from uroporphyrinogen-III I 1 1 1 1 1 1 
Familial Hypercholanemia (FHCA) 1 1 1 1 1 1 
Mitochondrial protein import 1 1 1 1 1 1 
Fcgamma receptor (FCGR) dependent phagocytosis 1 1 1 1 1 1 
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism 1 1 1 1 1 1 
DAG and IP3 signaling 1 1 1 1 1 1 
Regulation of Hypoxia-inducible Factor (HIF) by oxygen 1 1 1 1 1 1 
Epinephrine Action Pathway 1 1 1 1 1 1 
Deadenylation-dependent mRNA decay 1 1 1 1 1 1 
Voltage gated Potassium channels 1 1 1 1 1 1 
Transcriptional regulation of white adipocyte differentiation 1 1 1 1 1 1 
Transcriptional activity of SMAD2-SMAD3-SMAD4 heterotrimer 1 1 1 1 1 1 
Mitotic Metaphase and Anaphase 1 1 1 1 1 1 
Fc epsilon receptor (FCERI) signaling 1 1 1 1 1 1 
Esomeprazole Action Pathway 1 1 1 1 1 1 
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway 1 1 1 1 1 1 
Metastatic brain tumor 1 1 1 1 1 1 
Glial Cell Differentiation 1 1 1 1 1 1 
CDP-diacylglycerol biosynthesis 1 1 1 1 1 1 
miRNA Biogenesis 1 1 1 1 1 1 
Congenital Bile Acid Synthesis Defect Type III 1 1 1 1 1 1 
Oncostatin M Signaling Pathway 1 1 1 1 1 1 
Alpha 6 Beta 4 signaling pathway 1 1 1 1 1 1 
NAD Biosynthesis II (from tryptophan) 1 1 1 1 1 1 
Bile acid and bile salt metabolism 1 1 1 1 1 1 
Negative regulation of FGFR1 signaling 1 1 1 1 1 1 
Nifedipine Activity 1 1 1 1 1 1 
EBV LMP1 signaling 1 1 1 1 1 1 
Common Pathways Underlying Drug Addiction 1 1 1 1 1 1 
Arachidonic acid metabolism 1 1 1 1 1 1 
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ATF6 (ATF6-alpha) activates chaperone genes 1 1 1 1 1 1 
Growth hormone receptor signaling 1 1 1 1 1 1 
O-glycosylation of TSR domain-containing proteins 1 1 1 1 1 1 
MHC class II antigen presentation 1 1 1 1 1 1 
Host Interactions of HIV factors 1 1 1 1 1 1 
Cell-extracellular matrix interactions 1 1 1 1 1 1 
S Phase 1 1 1 1 1 1 
CRH 1 1 1 1 1 1 
Translocation of SLC2A4 (GLUT4) to the plasma membrane 1 1 1 1 1 1 
Signaling by ERBB2 1 1 1 1 1 1 
Signaling by ERBB4 1 1 1 1 1 1 
Binding and Uptake of Ligands by Scavenger Receptors 1 1 1 1 1 1 
ERKs are inactivated 1 1 1 1 1 1 
mRNA Splicing - Minor Pathway 1 1 1 1 1 1 
Selenium Metabolism and Selenoproteins 1 1 1 1 1 1 
Mammary gland development pathway - Embryonic development (Stage 
1 of 4) 
1 1 1 1 1 1 
Mammary gland development pathway - Puberty (Stage 2 of 4) 1 1 1 1 1 1 
Mammary gland development pathway - Involution (Stage 4 of 4) 1 1 1 1 1 1 
Mammary gland development pathway - Pregnancy and lactation (Stage 
3 of 4) 
1 1 1 1 1 1 
Regulation of TP53 Activity through Acetylation 1 1 1 1 1 1 
Bladder Cancer 1 1 1 1 1 1 
IL1 and megakaryocytes in obesity 1 1 1 1 1 1 
Aryl Hydrocarbon Receptor Pathway 1 1 1 1 1 1 
Liver X Receptor Pathway 1 1 1 1 1 1 
Pregnane X Receptor pathway 1 1 1 1 1 1 
Lipid storage and perilipins in skeletal muscle 1 1 1 1 1 1 
Reverse Transcription of HIV RNA 1 1 1 1 1 1 
glycerol degradation 1 1 1 1 1 1 
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Synthesis and Degradation of Ketone Bodies 1 1 1 1 1 1 
Triacylglyceride Synthesis 1 1 1 1 1 1 
Formation of the cornified envelope 1 1 1 1 1 1 
Melatonin metabolism and effects 1 1 1 1 1 1 
eIF5A regulation in response to inhibition of the nuclear export system 1 1 1 1 1 1 
RAC1-PAK1-p38-MMP2 Pathway 1 1 1 1 1 1 
MAPK6-MAPK4 signaling 1 1 1 1 1 1 
Transcriptional regulation by RUNX1 1 1 1 1 1 1 
Signaling by FGFR4 1 1 1 1 1 1 
Signaling by FGFR3 1 1 1 1 1 1 
Signaling by FGFR2 1 1 1 1 1 1 
Macroautophagy 1 1 1 1 1 1 
TP53 Regulates Metabolic Genes 1 1 1 1 1 1 
transcription factor creb and its extracellular signals 1 1 1 1 1 1 
RHO GTPases Activate ROCKs 1 1 1 1 1 1 
RORA activates gene expression 1 1 1 1 1 1 
TET1_2_3 and TDG demethylate DNA 1 1 1 1 1 1 
RHO GTPases Activate Formins 1 1 1 1 1 1 
phosphoinositides and their downstream targets 1 1 1 1 1 1 
Activated PKN1 stimulates transcription of AR (androgen receptor) regu-
lated genes KLK2 and KLK3 
1 1 1 1 1 1 
taurine biosynthesis 1 1 1 1 1 1 
Base-Excision Repair_ AP Site Formation 1 1 1 1 1 1 
Ovarian Infertility Genes 1 1 1 1 1 1 
Hedgehog ligand biogenesis 1 1 1 1 1 1 
NOTCH1 regulation of human endothelial cell calcification 1 1 1 1 1 1 
Synthesis_ secretion_ and deacylation of Ghrelin 1 1 1 1 1 1 
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate 1 1 1 1 1 1 
G Protein Signaling Pathways 1 1 1 1 1 1 
Preimplantation Embryo 1 1 1 1 1 1 
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DNA Double Strand Break Response 1 1 1 1 1 1 
Amine-derived hormones 1 1 1 1 1 1 
Early Phase of HIV Life Cycle 1 1 1 1 1 1 
Beta-catenin independent WNT signaling 1 1 1 1 1 1 
Gene Silencing by RNA 1 1 1 1 1 1 
nicotine degradation III 1 1 1 1 1 1 
Class I MHC mediated antigen processing & presentation 1 1 1 1 1 1 
trans-Golgi Network Vesicle Budding 1 1 1 1 1 1 
Surfactant metabolism 1 1 1 1 1 1 
Degradation of AXIN 1 1 1 1 1 1 
Composition of Lipid Particles 1 1 1 1 1 1 
Olfactory bulb development and olfactory learning 1 1 1 1 1 1 
Photodynamic therapy-induced AP-1 survival signaling. 1 1 1 1 1 1 
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling 1 1 1 1 1 1 
Photodynamic therapy-induced unfolded protein response 1 1 1 1 1 1 
IL-1 signaling pathway 1 1 1 1 1 1 
Pathways Affected in Adenoid Cystic Carcinoma 1 1 1 1 1 1 
Ropivacaine Action Pathway 1 1 1 1 1 1 
Interleukin-1 Induced Activation of NF-kappa-B 1 1 1 1 1 1 
Wnt-beta-catenin Signaling Pathway in Leukemia 1 1 1 1 1 1 
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease 1 1 1 1 1 1 
Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway 1 1 1 1 1 1 
Lysosomal oligosaccharide catabolism 1 1 1 1 1 1 
Striated Muscle Contraction 1 1 1 1 1 1 
KSRP (KHSRP) binds and destabilizes mRNA 1 1 1 1 1 1 
Metabolism of folate and pterines 1 1 1 1 1 1 
Regulation of TP53 Expression and Degradation 1 1 1 1 1 1 
Cardiac conduction 1 1 1 1 1 1 
PI3K-AKT-mTOR - VitD3 Signalling 1 1 1 1 1 1 
tumor suppressor arf inhibits ribosomal biogenesis 1 1 1 1 1 1 
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Resolution of D-loop Structures through Synthesis-Dependent Strand An-
nealing (SDSA) 
1 1 1 1 1 1 
rRNA modification in the nucleus and cytosol 1 1 1 1 1 1 
Activated NOTCH1 Transmits Signal to the Nucleus 1 1 1 1 1 1 
Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD) 1 1 1 1 1 1 
ERK Pathway in Huntington_s Disease 1 1 1 1 1 1 
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus in-
fection 
1 1 1 1 1 1 
Cannabinoid receptor signaling 1 1 1 1 1 1 
Regulation of Apoptosis by Parathyroid Hormone-related Protein 1 1 1 1 1 1 
Simplified Depiction of MYD88 Distinct Input-Output Pathway 1 1 1 1 1 1 
ESC Pluripotency Pathways 1 1 1 1 1 1 
Steroid hormones 1 1 1 1 1 1 
Serotonin and anxiety 1 1 1 1 1 1 
IL-4 Signaling Pathway 1 1 1 1 1 1 
Mevalonate pathway 1 1 1 1 1 1 
miR-509-3p alteration of YAP1-ECM axis 1 1 1 1 1 1 
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity 1 1 1 1 1 1 
Role of Osx and miRNAs in tooth development 1 1 1 1 1 1 
Protein alkylation leading to liver fibrosis 1 1 1 1 1 1 
MAP kinase cascade 1 1 1 1 1 1 
Steatosis AOP 1 1 1 1 1 1 
cGMP-PKG signaling pathway - Homo sapiens (human) 1 1 1 1 1 1 
MTF1 activates gene expression 1 1 1 1 1 1 
Pyrophosphate hydrolysis 1 1 1 1 1 1 
Fructose metabolism 1 1 1 1 1 1 
Cellular hexose transport 1 1 1 1 1 1 
RAB geranylgeranylation 1 1 1 1 1 1 
Pentose phosphate pathway 1 1 1 1 1 1 
TBC-RABGAPs 1 1 1 1 1 1 
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HSP90 chaperone cycle for steroid hormone receptors (SHR) 1 1 1 1 1 1 
Interconversion of nucleotide di- and triphosphates 1 1 1 1 1 1 
Glycogen metabolism 1 1 1 1 1 1 
Cargo recognition for clathrin-mediated endocytosis 1 1 1 1 1 1 
Phase I - Functionalization of compounds 1 1 1 1 1 1 
Transcriptional regulation by the AP-2 (TFAP2) family of transcription fac-
tors 
1 1 1 1 1 1 
Plasmalogen biosynthesis 1 1 1 1 1 1 
regulation of ck1/cdk5 by type 1 glutamate receptors 1 1 1 1 1 1 
Ion channel transport 1 1 1 1 1 1 
Antimicrobial peptides 1 1 1 1 1 1 
Creatine metabolism 1 1 1 1 1 1 
Synthesis of PA 1 1 1 1 1 1 
Resolution of D-loop Structures through Holliday Junction Intermediates 1 1 1 1 1 1 
Ketone body metabolism 1 1 1 1 1 1 
Uptake and function of diphtheria toxin 1 1 1 1 1 1 
Lactose synthesis 1 1 1 1 1 1 
Regulation of RUNX1 Expression and Activity 1 1 1 1 1 1 
Signaling by MET 1 1 1 1 1 1 
Cilium Assembly 1 1 1 1 1 1 
IRAK1 recruits IKK complex 1 1 1 1 1 1 
Plasma lipoprotein assembly_ remodeling_ and clearance 1 1 1 1 1 1 
RUNX1 regulates genes involved in megakaryocyte differentiation and 
platelet function 
1 1 1 1 1 1 
Miscellaneous transport and binding events 1 1 1 1 1 1 
Fibrin Complement Receptor 3 Signaling Pathway 1 1 1 1 1 1 
tRNA splicing 1 1 1 1 1 1 
HDR through Homologous Recombination (HRR) 1 1 1 1 1 1 
molybdenum cofactor biosynthesis 1 1 1 1 1 1 
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Phenylalanine_ tyrosine and tryptophan biosynthesis - Homo sapiens 
(human) 
1 1 1 1 1 1 
Neurotransmitter Disorders 1 1 1 1 1 1 
Ras Signaling 1 1 1 1 1 1 
Vitamin B6-dependent and responsive disorders 1 1 1 1 1 1 
IL11 1 1 1 1 1 1 
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lites P_joint Q_joint 
Metabolism 1.20E-05 0.0549 0.00309 1 6.68E-07 
0.00066
7 
Metabolism of proteins 
0.00013
7 0.185 0.127 1 
0.00020
9 0.069 
EGFR1 8.66E-05 0.185 1 1 8.66E-05 0.078 
Immune System 
0.00016
1 0.185 1 1 0.00157 0.104 
Signaling by Rho GTPases 
0.00046
5 0.356 0.75 1 0.00313 0.558 
Innate Immune System 
0.00044
5 0.356 1 1 0.00388 0.578 
Nuclear Receptors Meta-Pathway 
0.00085
2 0.558 1 1 
0.00085
2 0.476 
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimula-
tion 0.00101 0.578 1 1 0.00101 0.476 
Metabolism of carbohydrates 0.00192 0.874 0.105 1 0.00191 0.185 
Signal Transduction 0.00209 0.874 0.597 1 0.0096 1 
Metabolism of RNA 0.00187 0.874 0.875 1 0.0121 1 
Biochemical Pathways Part I 1 1 0.000168 0.716 
0.00016
8 0.624 
Neutrophil degranulation 0.00284 1 1 1 0.00284 0.646 
Insulin 0.00391 1 1 1 0.00391 0.716 
insulin Mam 0.00391 1 1 1 0.00391 1 
Proteoglycans in cancer - Homo sapiens (human) 0.00391 1 1 1 0.00391 1 
NRF2 pathway 0.00403 1 1 1 0.00403 1 
Post-translational protein modification 0.00271 1 0.563 1 0.0114 1 
ABC transporters - Homo sapiens (human) 1 1 0.00166 1 0.0123 1 
Developmental Biology 0.00456 1 0.375 1 0.0126 1 
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Transcriptional Regulation by TP53 0.00403 1 0.5 1 0.0145 1 
Cell Cycle Checkpoints 0.0156 1 1 1 0.0156 1 
Leukocyte transendothelial migration - Homo sapiens (human) 0.0156 1 1 1 0.0156 1 
Amino Acid metabolism 0.966 1 0.00248 1 0.0169 1 
Human metabolism overview 1 1 0.0171 1 0.0171 1 
Central carbon metabolism in cancer - Homo sapiens (human) 0.125 1 0.0214 1 0.0185 1 
Hippo signaling pathway - Homo sapiens (human) 0.0234 1 1 1 0.0234 1 
VEGFA-VEGFR2 Signaling Pathway 0.0254 1 1 1 0.0254 1 
Metabolism of amino acids and derivatives 0.6 1 0.00671 1 0.0262 1 
Tight junction - Homo sapiens (human) 0.0268 1 1 1 0.0268 1 
RHO GTPase Effectors 0.00628 1 0.75 1 0.03 1 
a6b1 and a6b4 Integrin signaling 0.0313 1 1 1 0.0313 1 
Signaling events mediated by VEGFR1 and VEGFR2 0.0313 1 1 1 0.0313 1 
downregulated of mta-3 in er-negative breast tumors 0.0313 1 1 1 0.0313 1 
Integrated Breast Cancer Pathway 0.0313 1 1 1 0.0313 1 
RNA Polymerase II Transcription 0.0115 1 0.5 1 0.0353 1 
Role of Calcineurin-dependent NFAT signaling in lymphocytes 0.0391 1 1 1 0.0391 1 
PI3K-Akt signaling pathway - Homo sapiens (human) 0.0419 1 1 1 0.0419 1 
Axon guidance 0.0187 1 0.375 1 0.0419 1 
Ebola Virus Pathway on Host 0.042 1 1 1 0.042 1 
Glycolysis / Gluconeogenesis - Homo sapiens (human) 0.00763 1 1 1 0.0448 1 
Vitamin B12 Metabolism 0.0313 1 0.25 1 0.0457 1 
Gene expression (Transcription) 0.00794 1 1 1 0.0463 1 
RhoA signaling pathway 0.0469 1 1 1 0.0469 1 
LKB1 signaling events 0.0469 1 1 1 0.0469 1 
TNFalpha 0.0479 1 1 1 0.0479 1 
miR-targeted genes in leukocytes - TarBase 0.0479 1 1 1 0.0479 1 
Amine compound SLC transporters 1 1 0.0488 1 0.0488 1 
Vitamin D Receptor Pathway 0.0488 1 1 1 0.0488 1 
Post-translational modification: synthesis of GPI-anchored proteins 0.0547 1 1 1 0.0547 1 
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Adherens junction - Homo sapiens (human) 0.0547 1 1 1 0.0547 1 
Oocyte meiosis - Homo sapiens (human) 0.0547 1 1 1 0.0547 1 
Membrane Trafficking 0.0107 1 1 1 0.059 1 
Integrin-linked kinase signaling 0.0625 1 1 1 0.0625 1 
GPCR signaling-cholera toxin 0.0625 1 1 1 0.0625 1 
Carbohydrate digestion and absorption - Homo sapiens (human) 1 1 0.0625 1 0.0625 1 
pentose phosphate pathway 0.0625 1 1 1 0.0625 1 
p38 signaling mediated by MAPKAP kinases 0.0625 1 1 1 0.0625 1 
FoxO family signaling 0.0625 1 1 1 0.0625 1 
G2/M DNA damage checkpoint 0.0625 1 1 1 0.0625 1 
G2/M Checkpoints 0.0625 1 1 1 0.0625 1 
Peroxisome - Homo sapiens (human) 0.0625 1 1 1 0.0625 1 
Peptide ligand-binding receptors 0.0625 1 1 1 0.0625 1 
Hepatitis C - Homo sapiens (human) 0.0625 1 1 1 0.0625 1 
Cysteine and methionine metabolism - Homo sapiens (human) 0.0371 1 0.312 1 0.0633 1 
Pentose Phosphate Pathway 0.0313 1 0.375 1 0.0638 1 
Glucose-6-phosphate dehydrogenase deficiency 0.0313 1 0.375 1 0.0638 1 
Ribose-5-phosphate isomerase deficiency 0.0313 1 0.375 1 0.0638 1 
Transaldolase deficiency 0.0313 1 0.375 1 0.0638 1 
Cell Cycle 0.0159 1 0.75 1 0.0648 1 
The citric acid (TCA) cycle and respiratory electron transport 0.0313 1 0.383 1 0.0649 1 
Viral carcinogenesis - Homo sapiens (human) 0.0674 1 1 1 0.0674 1 
L13a-mediated translational silencing of Ceruloplasmin expression 0.0676 1 1 1 0.0676 1 
miR-targeted genes in lymphocytes - TarBase 0.0691 1 1 1 0.0691 1 
Metabolism of lipids 0.0181 1 0.733 1 0.0706 1 
Glycolysis and Gluconeogenesis 0.0166 1 0.812 1 0.0716 1 
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Table S6-8b differential abundance in OC of proteins in impacted pathways (joint analysis) 
athway Gene  log2FC(OC1vs3) 
Biological oxidations ADH5 -0.461955121 
Biological oxidations SULT1A1 -0.081857484 
Biological oxidations CMBL -0.025696322 
Biological oxidations CNDP2 -0.169728243 
Biological oxidations GSTP1 -0.244477177 
Biological oxidations GCLC -0.19616332 
Biological oxidations BPNT1 -0.50538059 
Biological oxidations COMT -1.253649193 
Biological oxidations ESD -0.572131017 
Biological oxidations GSTM3 -0.567137926 
Biological oxidations HSP90AB1 -0.181804247 
Biological oxidations AKR1A1 -0.521130784 
Biological oxidations ABHD14B -0.030154879 
Biological oxidations ALDH2 -1.740970054 
Biological oxidations TPMT -0.44646877 
Biological oxidations AHCY -0.342424948 
Cellular responses to stress EEF1A1 -0.584186662 
Cellular responses to stress STIP1 -0.227325234 
Cellular responses to stress GSTP1 -0.244477177 
Cellular responses to stress UBA52 -0.56264169 
Cellular responses to stress HSPA8 -0.040015987 
Cellular responses to stress P4HB -0.130908045 
Cellular responses to stress PRDX1 0.079494291 
Cellular responses to stress GPX1 -0.027806156 
Cellular responses to stress EHMT1 -0.733202728 
Cellular responses to stress SOD1 -1.32947E-05 
Cellular responses to stress PRDX2 0.288294606 
Cellular responses to stress PRDX5 -0.654602069 
Cellular responses to stress SERPINH1 -0.023967053 
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Cellular responses to stress HSPA1B 0.332135449 
Cellular responses to stress HSPA1L -0.782702761 
Cellular responses to stress HSPA2 -1.098617006 
Cellular responses to stress YWHAE -0.026348434 
Cellular responses to stress HSPA4 -0.153271187 
Cellular responses to stress HSPA5 -0.215020617 
Cellular responses to stress HSPA6 -0.464705228 
Cellular responses to stress FKBP4 -0.065549673 
Cellular responses to stress HSPA9 -0.941051019 
Cellular responses to stress HSPB1 -0.026840004 
Cellular responses to stress PRDX6 0.022805961 
Cellular responses to stress VCP -0.247401608 
Cellular responses to stress HSP90AA1 -0.119311243 
Cellular responses to stress PGR -0.283094143 
Cellular responses to stress HSP90AB1 -0.181804247 
Cellular responses to stress TXN -0.139915362 
EGFR RPLP0 -1.622601242 
EGFR KRT18 0.532455503 
EGFR MYO6 -0.161782418 
EGFR KIAA1217 0.197866408 
EGFR ANXA4 -0.221868523 
EGFR CSTB -0.709759021 
EGFR EEF1A1 -0.584186662 
EGFR PGAM1 -0.468100438 
EGFR RPS2 -0.735239887 
EGFR CLTC -0.110048171 
EGFR LDHA -0.666815508 
EGFR ANXA2 -0.066673901 
EGFR AHNAK -0.722285923 
EGFR IQGAP1 -0.437717098 
EGFR TKT -0.392120777 
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EGFR S100A10 -0.450436617 
EGFR S100A11 -0.524093587 
EGFR EPPK1 -0.373392312 
EGFR CDH1 -0.288124075 
EGFR ALDOA 0.094877154 
EGFR ITGB4 -0.630294167 
EGFR MVP -0.602269316 
EGFR CFL1 -0.120754082 
EGFR PEBP1 -0.188771067 
EGFR ANXA1 -0.162080636 
EGFR KRT8 -0.520489786 
EGFR VCL -0.100053317 
EGFR MYH9 -0.060815779 
EGFR PFN1 -0.26552506 
EGFR ACTR2 1.109122485 
EGFR TLN1 -0.185504188 
EGFR FLNB -0.515881508 
EGFR STIP1 -0.227325234 
EGFR CLTA 0.134502662 
EGFR CDC42 -0.133886647 
EGFR ACTN4 -0.157529641 
EGFR TAGLN2 -0.028676414 
EGFR PDLIM1 0.2663088 
EGFR WASL 0.109509251 
EGFR ACTR3 0.212629308 
EGFR ALB -0.4031327 
EGFR GSN 0.367776272 
EGFR PLEC -3.353136521 
EGFR CBLB -0.692515925 
Gene and protein expression by JAK-STAT signaling after Inter-
leukin-12 stimulation RPLP0 -1.622601242 
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Gene and protein expression by JAK-STAT signaling after Inter-
leukin-12 stimulation ANXA2 -0.066673901 
Gene and protein expression by JAK-STAT signaling after Inter-
leukin-12 stimulation CFL1 -0.120754082 
Gene and protein expression by JAK-STAT signaling after Inter-
leukin-12 stimulation CDC42 -0.133886647 
Gene and protein expression by JAK-STAT signaling after Inter-
leukin-12 stimulation LCP1 -0.623435078 
Gene and protein expression by JAK-STAT signaling after Inter-
leukin-12 stimulation TCP1 -0.16166513 
Gene and protein expression by JAK-STAT signaling after Inter-
leukin-12 stimulation PPIA -0.037388918 
Gene and protein expression by JAK-STAT signaling after Inter-
leukin-12 stimulation SOD1 -1.32947E-05 
Gene and protein expression by JAK-STAT signaling after Inter-
leukin-12 stimulation TALDO1 -0.521132053 
Gene and protein expression by JAK-STAT signaling after Inter-
leukin-12 stimulation CA1 -0.077725967 
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Table S6-8b differential abundance in OC of metabolites in impacted pathways (joint analysis) 
Column1 
Metabo-
lites Name log2FC(OC1vs3) 
Biological oxidations 1004 Phosphoric acid 1.092805 
Biological oxidations 750 Glycine -0.06685 
Biological oxidations 33032 Glutamic acid 0.104083 
Biological oxidations 5862 Cysteine 0.073015 
Biological oxidations 243 Benzoic acid 0.459337 
Biological oxidations 3893 Lauric acid 0.328612 
Biological oxidations 94715 Glucuronic acid 0.454688 
Biological oxidations 7405 5-Oxoproline 0.637694 
Cellular responses to stress 1110 Succinic acid -0.0611 
Cellular responses to stress 51 2-Ketoglutaric acid 0.328762 
Cellular responses to stress 1004 Phosphoric acid 1.092805 
Gene expression (Transcription) 1110 Succinic acid -0.0611 
Gene expression (Transcription) 33032 Glutamic acid 0.104083 
Gene expression (Transcription) 51 2-Ketoglutaric acid 0.328762 
Gene expression (Transcription) 1004 Phosphoric acid 1.092805 
Generic Transcription Pathway 33032 Glutamic acid 0.104083 
Generic Transcription Pathway 1004 Phosphoric acid 1.092805 
Glycolysis / Gluconeogenesis 107689 Lactic acid 0.239245 
Glycolysis / Gluconeogenesis 5793 Glucose 0.575084 
Glycolysis / Gluconeogenesis 1060 Pyruvic acid 0.534754 
Immune System 1004 Phosphoric acid 1.092805 
Metabolic reprogramming in colon can-
cer 311 Citric acid 0.728172 
Metabolic reprogramming in colon can-
cer 439167 Ribose 5-phosphate -0.1762 
Metabolic reprogramming in colon can-
cer 107689 Lactic acid 0.239245 
Metabolic reprogramming in colon can-
cer 1060 Pyruvic acid 0.534754 
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Metabolic reprogramming in colon can-
cer 750 Glycine -0.06685 
Metabolic reprogramming in colon can-
cer 51 2-Ketoglutaric acid 0.328762 
Metabolic reprogramming in colon can-
cer 444972 Fumaric acid 0.20274 
Metabolic reprogramming in colon can-
cer 525 Malic acid 0.192412 
Metabolism 311 Citric acid 0.728172 
Metabolism 18950 Mannose -0.23222 
Metabolism 753 Glycerol 0.111351 
Metabolism 440995 Lactose 1.039342 
Metabolism 1174 Uracil 0.523595 
Metabolism 985 Palmitic acid 0.382639 
Metabolism 750 Glycine -0.06685 
Metabolism 6306 Isoleucine -0.1574 
Metabolism 3893 Lauric acid 0.328612 
Metabolism 94715 Glucuronic acid 0.454688 
Metabolism 439167 Ribose 5-phosphate -0.1762 
Metabolism 7405 5-Oxoproline 0.637694 
Metabolism 700 2-Aminoethanol 0.182196 
Metabolism 107689 Lactic acid 0.239245 
Metabolism 243 Benzoic acid 0.459337 
Metabolism 1176 Urea 0.733166 
Metabolism 760 Glyoxylic acid 0.325168 
Metabolism 5960 Aspartic acid -0.48643 
Metabolism 439258 Cystathionine 0.728488 
Metabolism 6912 Xylitol 0.996198 
Metabolism 1110 Succinic acid -0.0611 
Metabolism 6057 Tyrosine 0.149945 
Metabolism 5950 Alanine -0.4088 
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Metabolism 1088 Sarcosine -0.02407 
Metabolism 6106 Leucine 0.505591 
Metabolism 444972 Fumaric acid 0.20274 
Metabolism 757 Glycolic acid -0.38301 
Metabolism 1004 Phosphoric acid 1.092805 
Metabolism 5984 Fructose 0.884417 
Metabolism 107812 Hypotaurine -0.55682 
Metabolism 1060 Pyruvic acid 0.534754 
Metabolism 439194 Glyceric acid 0.199412 
Metabolism 33032 Glutamic acid 0.104083 
Metabolism 51 2-Ketoglutaric acid 0.328762 




Metabolism 5779 Ribose -0.93597 
Metabolism 5281 Stearic acid 0.329851 
Metabolism 5862 Cysteine 0.073015 
Metabolism 892 Inositol -0.16909 
Metabolism 439260 Norepinephrine -0.07602 




Metabolism of amino acids and deriva-
tives 6262 Ornithine -0.75966 
Metabolism of amino acids and deriva-
tives 750 Glycine -0.06685 
Metabolism of amino acids and deriva-
tives 6306 Isoleucine -0.1574 
Metabolism of amino acids and deriva-
tives 1176 Urea 0.733166 
Metabolism of amino acids and deriva-
tives 760 Glyoxylic acid 0.325168 
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Metabolism of amino acids and deriva-
tives 5960 Aspartic acid -0.48643 
Metabolism of amino acids and deriva-
tives 6057 Tyrosine 0.149945 
Metabolism of amino acids and deriva-
tives 1110 Succinic acid -0.0611 
Metabolism of amino acids and deriva-
tives 439258 Cystathionine 0.728488 
Metabolism of amino acids and deriva-
tives 5950 Alanine -0.4088 
Metabolism of amino acids and deriva-
tives 1088 Sarcosine -0.02407 
Metabolism of amino acids and deriva-
tives 6106 Leucine 0.505591 
Metabolism of amino acids and deriva-
tives 444972 Fumaric acid 0.20274 
Metabolism of amino acids and deriva-
tives 757 Glycolic acid -0.38301 
Metabolism of amino acids and deriva-
tives 1004 Phosphoric acid 1.092805 
Metabolism of amino acids and deriva-
tives 107812 Hypotaurine -0.55682 
Metabolism of amino acids and deriva-
tives 1060 Pyruvic acid 0.534754 
Metabolism of amino acids and deriva-
tives 33032 Glutamic acid 0.104083 
Metabolism of amino acids and deriva-
tives 51 2-Ketoglutaric acid 0.328762 




Metabolism of amino acids and deriva-
tives 5862 Cysteine 0.073015 
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Metabolism of amino acids and deriva-
tives 439260 Norepinephrine -0.07602 
Metabolism of carbohydrates 311 Citric acid 0.728172 
Metabolism of carbohydrates 18950 Mannose -0.23222 
Metabolism of carbohydrates 753 Glycerol 0.111351 
Metabolism of carbohydrates 439167 Ribose 5-phosphate -0.1762 
Metabolism of carbohydrates 1004 Phosphoric acid 1.092805 
Metabolism of carbohydrates 5984 Fructose 0.884417 
Metabolism of carbohydrates 6912 Xylitol 0.996198 
Metabolism of carbohydrates 1060 Pyruvic acid 0.534754 
Metabolism of carbohydrates 439194 Glyceric acid 0.199412 
Metabolism of carbohydrates 33032 Glutamic acid 0.104083 
Metabolism of carbohydrates 51 2-Ketoglutaric acid 0.328762 
Metabolism of carbohydrates 94715 Glucuronic acid 0.454688 
Metabolism of carbohydrates 440995 Lactose 1.039342 
Metabolism of carbohydrates 6036 Galactose 0.338039 
Metabolism of carbohydrates 5960 Aspartic acid -0.48643 
Metabolism of carbohydrates 5779 Ribose -0.93597 
Metabolism of lipids 311 Citric acid 0.728172 
Metabolism of lipids 753 Glycerol 0.111351 
Metabolism of lipids 700 2-Aminoethanol 0.182196 
Metabolism of lipids 1004 Phosphoric acid 1.092805 
Metabolism of lipids 985 Palmitic acid 0.382639 
Metabolism of lipids 750 Glycine -0.06685 
Metabolism of lipids 33032 Glutamic acid 0.104083 
Metabolism of lipids 51 2-Ketoglutaric acid 0.328762 
Metabolism of lipids 5281 Stearic acid 0.329851 
Metabolism of lipids 1110 Succinic acid -0.0611 
Metabolism of lipids 892 Inositol -0.16909 





Metabolism of proteins 18950 Mannose -0.23222 
Metabolism of proteins 1004 Phosphoric acid 1.092805 
Metabolism of proteins 1060 Pyruvic acid 0.534754 
Metabolism of proteins 750 Glycine -0.06685 
Metabolism of proteins 33032 Glutamic acid 0.104083 
Metabolism of proteins 5862 Cysteine 0.073015 
Metabolism of proteins 6306 Isoleucine -0.1574 
Metabolism of proteins 5960 Aspartic acid -0.48643 
Metabolism of proteins 6057 Tyrosine 0.149945 
Metabolism of proteins 379 Octanoic acid 0.801524 
Metabolism of proteins 5950 Alanine -0.4088 
Metabolism of proteins 6106 Leucine 0.505591 
Phase II - Conjugation of compounds 94715 Glucuronic acid 0.454688 
Phase II - Conjugation of compounds 1004 Phosphoric acid 1.092805 
Phase II - Conjugation of compounds 750 Glycine -0.06685 
Phase II - Conjugation of compounds 33032 Glutamic acid 0.104083 
Phase II - Conjugation of compounds 5862 Cysteine 0.073015 
Phase II - Conjugation of compounds 243 Benzoic acid 0.459337 
Phase II - Conjugation of compounds 7405 5-Oxoproline 0.637694 
RNA Polymerase II Transcription 33032 Glutamic acid 0.104083 
RNA Polymerase II Transcription 1004 Phosphoric acid 1.092805 
Signal Transduction 6262 Ornithine -0.75966 
Signal Transduction 753 Glycerol 0.111351 
Signal Transduction 1004 Phosphoric acid 1.092805 
Signal Transduction 107689 Lactic acid 0.239245 
Signal Transduction 1060 Pyruvic acid 0.534754 
Signal Transduction 750 Glycine -0.06685 
Signal Transduction 5281 Stearic acid 0.329851 
Signal Transduction 3893 Lauric acid 0.328612 
Signal Transduction 33032 Glutamic acid 0.104083 
Signal Transduction 1110 Succinic acid -0.0611 
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Signal Transduction 11005 Myristic acid -0.06268 
Signal Transduction 51 2-Ketoglutaric acid 0.328762 
Signal Transduction 985 Palmitic acid 0.382639 
Signal Transduction 439260 Norepinephrine -0.07602 
Signal Transduction 8892 Caproic acid 0.613227 
Signal Transduction 5988 Sucrose 0.208571 
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Table S6-8.c Proteins in the epithelial growth factor receptor (EGFR1) pathway. 
   
Path-
way 
Gene  log2FC(OC1vs3) Log2FC(NONvsPREG) Trends of discussed proteins 
EGFR1 ITGB4 -0.63029 -0.18355   
EGFR1 S100A10 -0.45044 -0.25727   
EGFR1 S100A11 -0.52409 -0.24169   
EGFR1 FLNB -0.51588 -0.08339   
EGFR1 PEBP1 -0.18877 -0.15321   
EGFR1 KRT8 -0.52049 -0.13364   
EGFR1 MYH9 -0.06082 -0.10988   
EGFR1 TKT -0.39212 -0.26492   
EGFR1 EPPK1 -0.37339 -0.23248   
EGFR1 RPLP0 -1.6226 -1.64123   
EGFR1 KRT18 0.532456 -1.62982 lower in good embryos and at OC3 
EGFR1 PDLIM1 0.266309 0.059882   
EGFR1 MYO6 -0.16178 -1.38882   
EGFR1 RPS2 -0.73524 -0.47644   
EGFR1 ANXA1 -0.16208 -0.1531   
EGFR1 ANXA2 -0.06667 -0.41436   
EGFR1 CFL1 -0.12075 -0.15604   
EGFR1 AHNAK -0.72229 -0.38611   
EGFR1 ANXA4 -0.22187 -0.74195   
EGFR1 TLN1 -0.1855 -0.09468   
EGFR1 CLTA 0.134503 -0.05987   
EGFR1 CLTC -0.11005 -0.47524   
EGFR1 CSTB -0.70976 -0.73884 
lower in good embryos and higher at 
OC3 
EGFR1 GSN 0.367776 0.708319   
EGFR1 ACTN4 -0.15753 -0.02493   
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EGFR1 STIP1 -0.22733 -0.07429   
EGFR1 ALB -0.40313 0.311389 higher in good embryos and at OC3 
EGFR1 TAGLN2 -0.02868 0.046614   
EGFR1 PLEC -3.35314 0.82575 higher in good embryos and at OC3 
EGFR1 KIAA1217 0.197866 -1.27964 lower in good embryos and at OC3 
EGFR1 PFN1 -0.26553 -0.10886   
EGFR1 WASL 0.109509 0.074823   
EGFR1 ALDOA 0.094877 -0.1873   
EGFR1 LDHA -0.66682 -0.41988   
EGFR1 CBLB -0.69252 0.983516 higher in good embryos and at OC3 
EGFR1 CDC42 -0.13389 -0.05502   
EGFR1 CDH1 -0.28812 -0.19979   
EGFR1 MVP -0.60227 -0.17915   
EGFR1 PGAM1 -0.4681 -0.49507   
EGFR1 ACTR3 0.212629 0.154175   
EGFR1 ACTR2 1.109122 -0.1015 lower in good embryos and at OC3 
EGFR1 VCL -0.10005 -0.11923   
EGFR1 IQGAP1 -0.43772 -0.2842   
EGFR1 EEF1A1 -0.58419 -0.70752   
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Table S6-9 Univariate analysis of ULF according to EQ1 embryo classification of REIMS fea-
tures in negative ionisation mode. 
FDRcorr p MW Column1 Potential id 
0.00090751 >0.001 539.6951 Gr3>all None 
0.00140161 0.005 626.6677 Gr3>all None 
0.00288648 >0.001 535.7748 Gr3>all None 
0.003 0.001 533.7749 Gr3>all None 
0.016 0.003 655.6149 
Gr3>(1c,2-
16) 5 candidates 
0.043 0.007 825.5636 Gr3>all Many 
0.04999084 0.01 181.0208 Gr3<(1c=216) 
2-methyl-1,3-thiazolidine-2-carbox-
amide 
0.19 0.022 599.6497 NS  
0.19 0.023 593.7315 NS  
0.26 0.038 597.6531 NS  
0.00414367 0.09 624.6703 NS  
0.00414367 0.014 564.716 NS  
0.00416313 0.019 566.7119 NS  
0.00428122 0.019 1128.61 NS  
0.00608721 0.15 682.6269 NS  
0.00614137 0.087 651.6882 NS  
0.00620309 0.00098306 572.6311 NS  
0.00889328 0.00142349 508.7549 NS  
0.01389071 0.00226742 678.4923 NS  
0.01389071 0.00225714 678.7061 NS  
0.01464662 0.00241402 736.6637 NS  
0.01520787 0.00253063 506.7565 NS  
0.01769041 0.00297176 384.7109 NS  
0.01919969 0.00325573 790.7008 NS  
0.02239045 0.00383228 324.7554 NS  
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0.02782447 0.00480645 709.6478 NS  
0.02812154 0.04 390.8445 NS  
0.02862979 0.04 243.9629 NS  
0.02912725 0.035 446.6611 NS  
0.03062952 0.00551298 363.8261 NS  
0.03062952 0.14 848.6588 NS  
0.03667705 0.073 794.4069 NS  
0.03775004 0.04 386.7066 NS  
0.03970566 0.07 591.7329 NS  
0.04127559 0.13 444.664 NS  
0.04232915 0.09 680.4885 NS  
0.04766125 0.089 707.5063 NS  
0.04766125 0.093 411.7286 NS  
0.04909755 0.11 583.6026 NS  
0.04909755 0.086 676.7088 NS  
0.12 0.011 550.9904 NS  
0.05072055 0.01012803 208.8395 NS  
0.05391694 0.01085174 644.7677 NS  
0.05993325 0.01215762 270.7928 NS  
0.06254254 0.01278603 618.7534 NS  
0.06316271 0.01301292 388.7031 NS  
0.06415877 0.01331981 326.7532 NS  
0.06551489 0.01370517 763.6838 NS  
0.06612604 0.01393782 353.7707 NS  
0.06898885 0.01465056 355.7671 NS  
0.07086561 0.01516142 266.7989 NS  
0.07533786 0.01623764 875.6808 NS  
0.07567849 0.01643099 622.5318 NS  
0.07682522 0.01680171 268.7954 NS  
0.07886346 0.01737246 272.79 NS  
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0.08281468 0.0183741 559.7809 NS  
0.0844277 0.01886578 1240.602 NS  
0.08451835 0.01915392 155.9496 NS  
0.08451835 0.01902476 620.7518 NS  
0.08483254 0.0194005 96.91983 NS  
0.08483254 0.01949401 703.7278 NS  
0.08544834 0.01977093 471.6825 NS  
0.08723289 0.02032208 295.8139 NS  
0.08843567 0.02074244 504.6192 NS  
0.09013532 0.02128393 469.6863 NS  
0.09098163 0.02219861 92.92608 NS  
0.09098163 0.02187557 293.8167 NS  
0.09098163 0.0223489 529.64 NS  
0.09098163 0.02226975 531.6375 NS  
0.09098163 0.02188132 761.6858 NS  
0.09098163 0.02229807 815.7227 NS  
0.09264427 0.02290413 527.6441 NS  
0.09498292 0.02363283 846.6607 NS  
0.09806371 0.02455478 1155.624 NS  
0.09818649 0.02474113 705.7262 NS  
0.09910593 0.02512987 468.1563 NS  
0.10312472 0.02631233 179.8993 NS  
0.1035734 0.02659095 560.7955 NS  
0.10529583 0.02720003 154.8752 NS  
0.10686447 0.0277746 701.512 NS  
0.11013667 0.0287996 506.6158 NS  
0.11301812 0.02973218 1325.577 NS  
0.11536175 0.03053156 900.699 NS  
0.12037208 0.03204835 995.3561 NS  
0.12622512 0.03380673 384.1823 NS  
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0.14434974 0.03888979 383.1797 NS  
0.15765839 0.04297503 995.298 NS  
0.15765839 0.04284043 612.6213 NS  
0.18196784 0.04988976 448.7998 NS  
0.1835841 0.05062383 645.7722 NS  
0.1886606 0.05232267 442.6681 NS  
0.19024474 0.05306351 391.8063 NS  
0.19156174 0.05373443 338.9772 NS  
0.19252572 0.05430995 444.0953 NS  
0.19388014 0.05499928 225.866 NS  
0.19977577 0.05698833 150.8853 NS  
0.2005004 0.05751279 235.8594 NS  
0.20056228 0.05784839 788.7028 NS  
0.20649547 0.05988696 452.2774 NS  
0.21315574 0.06215635 421.1306 NS  
0.21659357 0.06350208 865.5443 NS  
0.23048692 0.06794068 215.8763 NS  
0.23620016 0.0699991 954.2307 NS  
0.23865684 0.07110536 94.92291 NS  
0.24723715 0.0740536 152.8816 NS  
0.24945446 0.07511307 171.9436 NS  
0.2537481 0.07680806 446.0926 NS  
0.25444729 0.07809753 905.7243 NS  
0.25444729 0.07768705 476.7849 NS  
0.25444729 0.07822943 1070.649 NS  
0.27201308 0.0843084 356.1534 NS  
0.27201308 0.08449218 616.5384 NS  
0.27438622 0.08566416 186.1204 NS  
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Table S7-1a,b Earle's salts and TCM 199 medium composition  
a Earle's salts  
Components g/l 
Calcium Chloride•2 H2O 0.265 
Magnesium sulfate (anhydrous) 0.098 
Potassium chloride 0.4 
Sodium chloride 6.8 
Sodium phosphate monobasic (anhydrous) 0.122 
D-glucose 1 
Phenol red•Na 0.011 
  
  
b TCM199  
Component 
  
 g/l  
Inorganic salts   
Calcium Chloride 0.1396 
Ferric Nitrate • 9H2O 0.0007 
Magnesium Sulfate (anhydrous) 0.0977 
Potassium Chloride 0.4 
Potassium Phosphate Monobasic 0.06 
Sodium Acetate (anhydrous) 0.05 
Sodium Chloride 8 
Sodium Phosphate Dibasic (anhydrous) 0.0479 
Amino Acids   
L-Alanine 0.025 
L-Arginine • HCl 0.07 
L-Aspartic Acid 0.03 
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L-Cysteine • HCl • H2O 0.0001 
L-Cystine • 2HCl 0.026 
L-Glutamic Acid 0.0668 
L-Glutamine 0.1 
Glycine 0.05 











L-Tyrosine • 2Na • 2H2O 0.0577 
L-Valine 0.025 
Vitamins   
Ascorbic Acid • Na 0.00006 
D-Biotin 0.00001 
Calciferol 0.0001 
Choline Chloride 0.0005 
Folic Acid 0.00001 





Nicotinic Acid 0.00003 
p-Aminobenzoic Acid 0.00005 
D-Pantothenic Acid (hemicalcium) 0.00001 
Pyridoxal • HCl 0.00003 
Pyridoxine • HCl 0.00003 
Retinol Acetate 0.0001 
Riboflavin 0.00001 
DL-α-Tocopherol Phosphate • Na 0.00001 
Thiamine • HCl 0.00001 
Other   
Adenine Sulfate 0.01 
Adenosine Triphosphate • 2Na 0.001 




Glutathione (reduced) 0.00005 
Guanine • HCl 0.0003 
Hypoxanthine 0.0003 
Phenol Red • Na 0.0213 




Xanthine • Na 0.0003 
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No. of TM  
D5 
No. <8 cells 





B) on Day 7 
Total No. of 
blastocysts 
on Day 7 
No. of G1,2 
Bs on Day 
7 
No. of additional B 
on D8 (dev. from 
TMs on D7) 
E1-1 Overall 136 4 CysC: Exp E1, run (replicate) 1   
E1-1 LSOF + PVA (Control) 25   10 4 1 20 15 5 6 
E1-1 Lab Std+BSA 23   5 2 9 12 11 6 1 
E1-1 0µg/ml CysC 25   5 6 8 11 2 2 4 
E1-1 0.1µg/ml CysC 25   6 10 3 12 7 6 0 
E1-1 10µg/ml CysC 25   10 8 4 13 8 2 3 
E1-2 Overall 167 6 CysC: Exp E1, run (replicate) 2   
E1-2 LSOF + PVA (Control) 30   13 4 1 25 20 9 0 
E1-2 Lab Std+BSA 22   12 0 3 19 19 9 0 
E1-2 0µg/ml CysC 30   6 9 4 17 10 3 6 
E1-2 0.1µg/ml CysC 30   11 6 8 16 15 11 0 
E1-2 10µg/ml CysC 30   9 5 6 19 11 9 5 
E1-3 Overall 215 9 CysC: Exp E1, run (replicate) 3   
E1-3 LSOF + PVA (Control) 54   30 4 16 34 31 28 3 
E1-3 0.1µg/ml Cystatin C 53   22 16 5 32 30 18 0 
E1-3 1.0µg/ml Cystatin C 54   30 18 5 31 30 15 1 
E1-3 10µg/ml Cystatin C 54   22 0 31 23 13 10 0 
E2-1 Overall 295 19 CatB: Exp E2, run (replicate) 1   




42   15 14 5 24 16 11 4 
E2-1 15ng/ml Cathepsin 42   13 9 12 21 18 9 3 
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E2-1 30ng/ml Cathepsin 42   10 15 5 22 20 13 1 
E2-1 60ng/ml Cathepsin 42   10 13 6 23 19 11 0 
E2-1 90ng/ml Cathepsin 43   10 17 13 12 9 7 2 
E2-2 Overall 243 15 CatB: Exp E2, run (replicate) 2   




37   6 9 7 19 10 5 6 
E2-2 15ng/ml Cathepsin 37   7 4 9 24 19 12 3 
E2-2 30ng/ml Cathepsin 37   6 11 6 20 17 14 2 
E2-2 60ng/ml Cathepsin 37   4 13 8 16 8 4 2 
E2-2 90ng/ml Cathepsin 36   9 4 7 26 19 12 3 
E2-3 Overall 182 13 CatB: Exp E2, run (replicate) 3   




30   11 5 10 16 14 11 1 
E2-3 15ng/ml Cathepsin 31   12 9 9 11 8 4 0 
E2-3 30ng/ml Cathepsin 30   10 5 8 19 18 10 0 
E2-3 60ng/ml Cathepsin 30   9 10 6 15 11 7 3 
E2-3 90ng/ml Cathepsin 31   9 8 9 13 11 9 0 


















54   n/a 8 7 37 26 11 8 
















44   n/a 8 12 24 17 12 3 
















50   n/a 8 9 33 20 13 13 
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Table S7-3 Embryo development parameters reported  in experiments conducting in vitro embryo culture.  
Study Cleavage day 2 (%) B/oocytes day 7 (%) TM-B/cleaved day 7 (%) B/cleaved day 7 (%) B1-2/cleaved  day 7 (%) 
Matoba et al. 2010 50 15       
Matoba et al. 2014 80 22       
Zullo et al. 2016a 78   50   42-46 
Zullo et al. 2016b 76   38-53   34-46±8.7 
Sang et al. 2020 61 14-33       
Lopes et al. 2020 86 26       
Hill et al. 2008 60   40 30   
Leroy et al. 2005 76 22-33   29-43   
Azari-Dolatabad et al. 2019 87 30       
Gilardi et al. 2004 21-67 24-38   Mar-45   
AVERAGE 73 25 44 31 39 
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t value P(>|t|) 
TM_D5 (Intercept) -0.58368 0.229615 -2.54199 0.038552 
TM_D5 df$Group_protCys_0.1 -0.43579 0.299324 -1.45592 0.188752 
TM_D5 df$Group_protCys_10 0.681535 0.382692 1.780896 0.11814 
TM_D5 NH4HCO31 -0.97909 0.344798 -2.83961 0.025059 
TM_D5 Run2 0.352952 0.257221 1.372176 0.212362 
TM_D5 Run3 0.663298 0.306716 2.162579 0.067351 
TM_B_D7 (Intercept) 0.84089 0.271842 3.093299 0.017486 
TM_B_D7 df$Group_protCys_0.1 -0.88948 0.354371 -2.51001 0.040396 
TM_B_D7 df$Group_protCys_10 0.20614 0.453071 0.454984 0.662896 
TM_B_D7 NH4HCO31 -1.14448 0.408208 -2.80368 0.026384 
TM_B_D7 Run2 0.634292 0.304524 2.082894 0.075761 
TM_B_D7 Run3 -0.01383 0.363122 -0.0381 0.970675 
B_D7 (Intercept) 0.135266 0.30521 0.443191 0.671001 
B_D7 df$Group_protCys_0.1 -0.84662 0.397869 -2.12789 0.07089 
B_D7 df$Group_protCys_10 0.778473 0.508683 1.530369 0.169779 
B_D7 NH4HCO31 -2.21515 0.458313 -4.83328 0.001892 
B_D7 Run2 1.024282 0.341904 2.995822 0.02006 
B_D7 Run3 0.431026 0.407694 1.05723 0.325521 
B1,2_D7 (Intercept) -1.17524 0.215305 -5.45847 0.000947 
B1,2_D7 df$Group_protCys_0.1 -0.13807 0.28067 -0.49192 0.637824 
B1,2_D7 df$Group_protCys_10 0.570035 0.358842 1.588539 0.156188 
B1,2_D7 NH4HCO31 -1.51045 0.323309 -4.67185 0.002283 
B1,2_D7 Run2 0.731807 0.24119 3.034149 0.019003 
B1,2_D7 Run3 0.843908 0.287601 2.934302 0.02189 
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<8 cells (Intercept) -2.12889 1.222405 -1.74156 0.125123 
<8 cells df$Group_protCys_0.1 2.388666 1.593514 1.498993 0.177553 
<8 cells df$Group_protCys_10 -1.58354 2.037341 -0.77726 0.462461 
<8 cells NH4HCO31 1.758912 1.835603 0.95822 0.369869 
<8 cells Run2 -1.26001 1.369367 -0.92014 0.388107 
<8 cells Run3 -2.14939 1.632866 -1.31633 0.229526 
Deg_>8 
cells 
(Intercept) -1.96081 0.640731 -3.06027 0.018317 
Deg_>8 
cells 
df$Group_protCys_0.1 0.072965 0.83525 0.087357 0.932834 
Deg_>8 
cells 
df$Group_protCys_10 0.119015 1.067885 0.11145 0.914388 
Deg_>8 
cells 
NH4HCO31 0.793871 0.962143 0.825108 0.436522 
Deg_>8 
cells 
Run2 -0.2917 0.717762 -0.4064 0.696584 
Deg_>8 
cells 
Run3 0.689435 0.855877 0.80553 0.447009 
  
 590 






t value Pr(>|t|) 
















-0.0943 0.236533 -0.39868 0.697762 
TM_D5 Run4 -0.48599 0.193128 -2.51641 0.028658 
TM_D5 Run5 0.486121 0.193128 2.517086 0.028623 
















0.029672 0.361375 0.082108 0.936036 
TM_B_D7 Run4 0.366655 0.295061 1.242641 0.239838 
TM_B_D7 Run5 0.180117 0.295061 0.610441 0.553972 


















-0.15515 0.383483 -0.40459 0.693536 
B_D7 Run4 0.06301 0.313113 0.201238 0.844185 
B_D7 Run5 0.251883 0.313113 0.804449 0.438179 
















-0.20033 0.343912 -0.58251 0.571972 
B1,2_D7 Run4 0.013414 0.280803 0.04777 0.962756 
B1,2_D7 Run5 0.151541 0.280803 0.53967 0.600179 
















0.093965 0.353219 0.266025 0.79514 
<8 cells Run4 -0.63612 0.288402 -2.20566 0.049593 
<8 cells Run5 -0.54558 0.288402 -1.89174 0.085132 
Deg_>8 
cells 






















-0.22564 0.247046 -0.91334 3.81E-01 
Deg_>8 
cells 
Run4 0.172758 0.201712 0.856456 4.10E-01 
Deg_>8 
cells 
Run5 0.461093 0.201712 2.285895 4.31E-02 
 






t value Pr(>|t|) 












-0.01973 0.22263 -0.08864 0.932253 
TM_B_D7 Run7 -0.6371 0.192803 -3.30443 0.016318 
TM_B_D7 Run9 -0.44158 0.192803 -2.29034 0.061915 














-0.14867 0.17241 -0.86229 0.421649 
B_D7 Run7 -0.50256 0.149311 -3.36586 0.01512 
B_D7 Run9 -0.57358 0.149311 -3.84153 0.008544 












-0.02532 0.484199 -0.05229 0.959992 
B1,2_D7 Run7 -0.50225 0.419329 -1.19774 0.276185 
B1,2_D7 Run9 -0.04494 0.419329 -0.10717 0.918151 












-0.97596 2.240624 -0.43557 0.678379 
<8 cells Run7 -2.71982 1.940437 -1.40165 0.210572 
<8 cells Run9 -1.04859 1.940437 -0.54039 0.608389 
Deg_>8 
cells 




















Run7 0.618095 0.499914 1.236403 0.26251 
Deg_>8 
cells 
Run9 0.200471 0.499914 0.40101 0.702303 
 
